Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6805469542842101,-2.310125512594097,0.0,0.0009595325944128106,0.001,15/35,7.89%,PDE7B;RIMS2;AKAP6;PDE4D;CD36;PDE9A;ADCY2;PDE7A;ADGRG6;HTR2C;RAPGEF2;GUCY1B1;APOE;HTR2B;EPHA5
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6649957664911537,-2.2850123477235478,0.0,0.0004797662972064053,0.001,16/37,6.86%,GRM7;GRIK2;GRID2;PLCB1;GRIA4;GRM8;GRM5;GRIN2B;GRIN2A;GRM1;APP;GRIA2;GRIA3;HOMER1;GRIK4;GRIN3A
prerank,regulation of cation channel activity (GO:2001257),-0.5484637456599643,-2.2575968699949867,0.0,0.0006396883962752071,0.002,29/89,8.78%,DLG2;FGF14;NLGN1;AHNAK;DMD;ANK3;GRIA4;ANK2;LRRC7;PDE4D;FGF12;SHISA9;GRIA1;GRIN2B;GRIN2A;SHISA6;APP;DLG3;CACNG2;GRIA2;GRIA3;CALM1;HOMER1;NETO1;OPRM1;DAPK1;GSG1L;FGF11;ACTN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5795811634006769,-2.1956866440194966,0.0,0.002638714634635229,0.011,21/57,9.51%,DLG2;NLGN1;GRIA4;LRRC7;SHISA9;GRIA1;GRIN2B;GRIN2A;SHISA6;APP;DLG3;CACNG2;GRIA2;GRIA3;NETO1;OPRM1;DAPK1;GSG1L;ACTN2;DLGAP1;DLGAP2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6586959908295139,-2.1483299162791294,0.0,0.005181476009829177,0.026,15/32,8.78%,DLG2;NLGN1;GRIA4;LRRC7;CCR2;GRIA1;GRIN2B;GRIN2A;APP;DLG3;GRIA2;GRIA3;OPRM1;DAPK1;ACTN2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.86283671709674,-2.145213536904364,0.0,0.0044778187739264496,0.027,6/11,7.59%,TMEM106A;CIITA;PF4;JAK2;TAF7;SIRT1
prerank,neuron cell-cell adhesion (GO:0007158),-0.7870876309763131,-2.072773478835875,0.0,0.013296380236863234,0.089,8/14,13.85%,NRXN1;NLGN1;NRXN3;ASTN2;RET;NCAM2;ASTN1;NRXN2
prerank,cellular zinc ion homeostasis (GO:0006882),0.6821408355858873,2.069813567146471,0.0,0.08656208092183673,0.075,12/26,9.09%,SLC30A5;SLC30A10;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC30A8;MT2A
prerank,cellular response to copper ion (GO:0071280),0.7798461746640395,2.06370049789255,0.0,0.046372543350983966,0.079,9/16,9.09%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;MT2A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.672880529334257,-2.053361909117467,0.002352941176470588,0.017871294570938594,0.134,7/22,8.15%,AKAP6;ANK2;HTT;RYR2;CALM1;PKD2;VMP1
prerank,regulation of synapse assembly (GO:0051963),-0.5799184011514892,-2.033945323890155,0.0,0.022602323335057316,0.182,20/46,15.15%,NRXN1;NLGN1;PDLIM5;GRID2;LRFN5;GPC6;PTPRD;BDNF;CLSTN2;APP;SLITRK1;IL1RAPL1;IL1RAPL2;SYNDIG1;SETD5;LHFPL4;MDGA1;IL1RAP;SNCA;GPC4
prerank,zinc ion homeostasis (GO:0055069),0.6454904808510573,2.0273507590893143,0.0,0.05667755298453596,0.135,12/28,9.09%,SLC30A5;SLC30A10;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC30A8;MT2A
prerank,chemical synaptic transmission (GO:0007268),-0.41877901856725663,-2.026985615309493,0.0,0.023124735525348737,0.2,102/284,18.62%,DLG2;NRXN1;NLGN1;GRM7;GRIK2;PDE7B;KCND2;GRID2;GRIA4;RIT2;CACNA1E;PTPRN2;GRM5;SYN3;SYN1;DTNA;GABRB1;GRIA1;CDH8;GRIN2B;GRIN2A;GRM1;SHISA6;SYN2;GPR176;NAPB;SYT1;HRH1;NOVA1;KIF1B;HTR2C;UNC13C;CAMK4;GABBR2;SNPH;LRP6;GLRA1;SLC5A7;GRIA2;APOE;GABRA3;APBA2;SYT10;GABRG3;GRIA3;CALM1;HTR2B;GABRG1;KCNQ3;SLC1A6;ERC2;CHAT;GABRA2;SNAP25;HOMER1;SLC12A4;GRIK4;SDCBP;CHRM2;GIPC1;CHRM3;HTR1D;SLC12A5;GABRG2;GRIN2D;GABRB3;HCRTR2;RAB3A;DLGAP1;DLGAP2;HTR4;CHRNA4;UNC119;GRIK1;GLRA2;KCNMB4;UNC13B;PDLIM4;GABRA5;HTR6;NRXN2;PCDHB16;HSPA8;KCNIP2;CRHBP;SNCA;GABRQ;GRIK3;CACNA1B;CACNB3;RIMS1;PTCHD1;SLC1A1;HTR1F;SLC18A3;CRH;SLC1A4;NTSR1;PCDHB13;SYPL1;BSN;PCDHB6
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.6406877282703383,-2.024428265505732,0.0,0.021720328728071805,0.204,9/26,4.99%,NRXN1;NLGN1;RIMS2;LRRK2;SLC8A3;APP;MTMR2;SHANK3;PRKCZ
prerank,cGMP-mediated signaling (GO:0019934),-0.780498547471325,-2.022117667386517,0.0,0.020390067631272223,0.208,7/13,5.35%,CD36;KCNC2;PDE9A;HTR2C;GUCY1B1;APOE;HTR2B
prerank,cAMP-mediated signaling (GO:0019933),-0.6425046781837479,-2.018712483879152,0.004464285714285714,0.019854943684388157,0.217,11/24,13.66%,PDE7B;RIMS2;AKAP6;PDE4D;ADCY2;PDE7A;ADGRG6;RAPGEF2;EPHA5;AHR;PDE2A
prerank,receptor clustering (GO:0043113),-0.6179695833302241,-1.9830493444273725,0.0022172949002217295,0.03447463535640312,0.355,9/27,4.57%,DLG2;MAGI2;NRXN1;NLGN1;ITGA4;LRRC7;ITGB7;DLG3;ITGAL
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4231082408841381,-1.9643982503390416,0.0,0.04100402620124077,0.427,81/224,18.62%,DLG2;NRXN1;NLGN1;GRM7;GRIK2;PDE7B;KCND2;GRIA4;RIT2;CACNA1E;GRM5;SYN1;DTNA;GABRB1;GRIA1;GRIN2B;GRIN2A;GRM1;SYN2;GPR176;SYT1;HRH1;NOVA1;HTR2C;UNC13C;CAMK4;GABBR2;LRP6;GLRA1;GRIA2;GABRA3;APBA2;SYT10;GABRG3;GRIA3;CALM1;HTR2B;GABRG1;KCNQ3;SLC1A6;GABRA2;SNAP25;HOMER1;SLC12A4;GRIK4;SDCBP;CHRM2;GIPC1;CHRM3;HTR1D;SLC12A5;GABRG2;GABRB3;HCRTR2;DLGAP1;HTR4;CHRNA4;UNC119;GRIK1;GLRA2;KCNMB4;UNC13B;GABRA5;HTR6;NRXN2;PCDHB16;KCNIP2;SNCA;GABRQ;CACNA1B;CACNB3;PTCHD1;SLC1A1;HTR1F;SLC18A3;CRH;NTSR1;PCDHB13;SYPL1;BSN;PCDHB6
prerank,response to copper ion (GO:0046688),0.6973529634030389,1.9518869253739846,0.0,0.15483276974411866,0.41,9/20,9.09%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;MT2A
prerank,synapse assembly (GO:0007416),-0.5067902228363258,-1.9440581928297738,0.0,0.049955665696616955,0.513,24/67,14.18%,NRXN1;NLGN1;GRID2;DNM3;ADGRL3;KIRREL3;NRCAM;GPM6A;BDNF;SLITRK1;SHANK3;PLXND1;GABRA2;GABRG2;GABRB3;LRRTM3;PLXNB2;SDK1;OBSL1;ACHE;CDH1;NRXN2;PCDHB16;PLXNB1
prerank,response to cadmium ion (GO:0046686),0.6421034937445672,1.9333992801227136,0.0,0.1619947514394373,0.494,13/26,14.92%,SUMO1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;JUN;MT2A;MAPK8;AKT1
prerank,regulation of axonogenesis (GO:0050770),-0.5256300219738987,-1.9232660615490922,0.0,0.06191807388652078,0.604,20/51,15.91%,LRRC4C;ROBO1;SLIT2;ARHGAP35;PLXNC1;LINGO1;SLITRK1;NTRK2;PLXND1;GSK3B;PLXNA2;CHN1;RTN4;PAK3;PLXNB2;PLXNB1;THY1;PAK1;TIAM1;ARHGDIA
prerank,positive regulation of synapse assembly (GO:0051965),-0.6067345859449718,-1.9188130324468367,0.0,0.06204977443869508,0.623,9/27,8.13%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;IL1RAPL1;SEMA4A;SYNDIG1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5290105067771785,1.9161713138359222,0.0,0.17432641296758788,0.58,16/65,6.62%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;SMAD7;PMEPA1;SKI;TGFB1I1;SMURF1;SKIL;RPS27A;UBC;SPRY2;PDPK1;EID2;ASPN
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5361420932571996,-1.9157287916312298,0.0,0.06156159118890611,0.64,15/46,7.37%,NRXN1;NLGN1;GRM7;GRM8;LRRK2;GRM5;CCR2;GRM1;SYT1;DGKI;ATAD1;CACNG2;SHANK3;HOMER1;TPRG1L
prerank,synaptic membrane adhesion (GO:0099560),-0.7271665122536893,-1.9151272383943418,0.0,0.05901125455638785,0.647,5/14,2.26%,LRRC4C;LRFN5;GPC6;PTPRD;SLITRK1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7937367430005005,-1.9149222340998717,0.0,0.05642965495713434,0.65,4/10,5.75%,MAGI2;BDNF;RAPGEF2;KIDINS220
prerank,cellular response to cadmium ion (GO:0071276),0.6500751336687014,1.91282003604295,0.0,0.15634171758331739,0.592,13/24,14.92%,SUMO1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;JUN;MT2A;MAPK8;AKT1
prerank,cellular response to zinc ion (GO:0071294),0.720518595918921,1.9112428877307523,0.001834862385321101,0.1388600048121131,0.594,10/15,10.72%,MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;MT2A;HVCN1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6389077677123762,-1.900184449348242,0.0,0.06629497925033964,0.723,7/21,5.31%,DMD;AKAP6;ANK2;PDE4D;RYR2;CALM1;CACNA1C
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6565455222266456,-1.8908573257372696,0.0020833333333333333,0.07121400602881164,0.762,11/18,18.05%,GRIK2;GRID2;CDH8;NAPB;UNC13C;GRIA2;GRIK4;GRIK1;UNC13B;GRIK3;SLC1A4
prerank,neuron migration (GO:0001764),-0.5091791512522045,-1.8794281659460514,0.0,0.07856173116754887,0.808,20/48,15.68%,AUTS2;ADGRL3;SPOCK1;NRCAM;CDKL5;NAV1;GPM6A;MAP1B;ASTN2;RAPGEF2;NTRK2;SH3RF1;NR4A2;DCDC2;DDIT4;ASTN1;TUBB2A;MDGA1;POMGNT2;RELN
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.44179209059022395,-1.8661629714741272,0.0,0.08908300606528533,0.85,39/107,16.96%,LRRC4C;NLGN1;GRM7;GRIK2;RIMS2;GRID2;NRG3;GRM8;LRRK2;GRM5;SYN3;SYN1;MCTP2;GRM1;SLC8A3;BDNF;CLSTN2;APP;SYT1;DGKI;HOMER1;CNTNAP4;CPLX2;GRIK4;TPRG1L;LGI1;DLGAP1;DLGAP2;GRIK1;MCTP1;KCNMB4;TMEM108;SLC4A8;RELN;ABR;GRIK3;CACNA1B;RIMS1;ITGB1
prerank,axonal fasciculation (GO:0007413),-0.7267426005479457,-1.8638595883129758,0.0,0.08779723238877217,0.857,10/12,25.84%,NRCAM;ARHGAP35;SEMA5A;RTN4;EPHA4;EPHB2;CNTN4;MEGF8;AMIGO1;EPHA3
prerank,regulation of presynapse organization (GO:0099174),-0.6477097942375127,-1.8433223590496521,0.0,0.10407501747256093,0.926,7/18,3.64%,LRFN5;GPC6;PTPRD;APP;SLITRK1;IL1RAPL1;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),-0.6477097942375127,-1.8433223590496521,0.0,0.10407501747256093,0.926,7/18,3.64%,LRFN5;GPC6;PTPRD;APP;SLITRK1;IL1RAPL1;IL1RAPL2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.48256356000898654,1.8389739569255739,0.0,0.3369738150171501,0.915,25/87,13.05%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;SKI;SMURF1;SRC;ID1;HPGD;RPS27A;UBC;EID2;CGN;GCNT2;JUN;LPXN;LEFTY1;APPL1;ZYX;ENG;SMAD9;USP9Y
prerank,regulation of macrophage migration (GO:1905521),0.7716638000391626,1.8378346710133313,0.0055658627087198514,0.30739843736885586,0.916,4/10,5.64%,CX3CR1;P2RY12;MTUS1;PTK2B
prerank,central nervous system neuron development (GO:0021954),-0.6865540061782334,-1.8345466784997027,0.0,0.110941820312626,0.941,7/15,8.85%,B4GALT5;ARHGAP35;B4GALT6;RAPGEF2;NTRK2;MAP2;ATP7A
prerank,endocrine system development (GO:0035270),0.6604446576042668,1.8342958531505205,0.003669724770642202,0.2941611840850296,0.925,4/21,2.84%,TGFBR1;SALL1;TG;FOXE1
prerank,synapse organization (GO:0050808),-0.42305886574092466,-1.8206774836103765,0.0,0.12515503473124426,0.961,27/125,6.72%,NRXN1;LRRC4C;NLGN1;CTNND2;ANK3;GPHN;LRFN5;GPC6;DNM3;PTPRD;ADGRL3;LRRK2;KIRREL3;GRM5;NRCAM;GPM6A;SLC8A3;PPFIA2;BDNF;APP;SLITRK1;UNC13C;SHANK3;PLXND1;CAST;CDC42;PAK3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7257536015874094,1.8117035263555945,0.0019157088122605363,0.35303245502943537,0.966,6/13,6.14%,TLR7;UNC93B1;IRAK2;EPG5;PIK3C3;PIK3AP1
prerank,cardiolipin metabolic process (GO:0032048),0.7180781891639846,1.7970684675954876,0.0,0.3877854394410488,0.975,8/13,18.75%,PLA2G4A;PLA2G6;PLSCR3;PLA2G5;CRLS1;PGS1;HADHB;TAMM41
prerank,regulation of exocytosis (GO:0017157),-0.505886026195443,-1.796228913047003,0.0,0.15819906742077014,0.988,12/46,9.03%,RIMS2;STXBP5L;CADPS;RAB3C;SYT1;IL1RAPL1;STXBP5;STXBP6;CPLX2;RAB3D;RAB8A;RAB3A
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6003924902179602,-1.7920547188664488,0.004246284501061571,0.16015198708621317,0.988,11/22,13.25%,MAGI2;BDNF;RAPGEF2;NTRK2;EHD1;NTRK3;SH3GL2;KIDINS220;WASF1;STMN2;TMEM108
prerank,negative regulation of interleukin-17 production (GO:0032700),0.7560829818136373,1.7867375679865043,0.0018248175182481751,0.4102129906270375,0.984,5/10,10.24%,DDIT3;VSIR;TLR4;IL12B;NCKAP1L
prerank,positive regulation of synaptic transmission (GO:0050806),-0.46215024646155245,-1.7862258758982434,0.0,0.16567929463527864,0.992,20/72,8.74%,NRXN1;NLGN1;GRIK2;RIMS2;CCR2;GRIN2B;ADRA1A;GRIN2A;SLC8A3;CLSTN2;APP;SYT1;NPTN;SLC24A2;CACNG2;SHANK3;PRKCZ;PLK2;LGI1;GRIN2D
prerank,response to zinc ion (GO:0010043),0.5978386921072869,1.7856710581310138,0.00528169014084507,0.3869874617719891,0.984,12/25,10.72%,SLC30A5;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC30A8;MT2A;HVCN1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6177086582836749,-1.785575550627375,0.004310344827586207,0.16187879298682006,0.993,5/18,4.99%,NRXN1;NLGN1;RIMS2;SHANK3;PRKCZ
prerank,anterior/posterior axis specification (GO:0009948),0.6861263152374546,1.7783661062205407,0.003484320557491289,0.3957123699283965,0.986,6/15,24.87%,DDIT3;SKI;SHH;TASOR;WLS;FZD5
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7545838570609553,1.7713441020534595,0.0018867924528301887,0.40086487474517246,0.988,4/10,5.59%,QRICH1;NFE2L2;DDIT3;EIF2S1
prerank,regulation of potassium ion transport (GO:0043266),-0.5418125558383211,-1.7705236996811462,0.0,0.18225636250446756,0.999,11/31,10.43%,KCNIP4;DPP6;ANK3;DPP10;ANK2;KCNIP1;KCNN2;KCNAB2;KIF5B;ACTN2;ADRA2A
prerank,cytosolic calcium ion transport (GO:0060401),-0.5541986917685722,-1.7629129832322163,0.002070393374741201,0.19140009890217757,1.0,15/28,22.32%,ADRA1A;MCU;ATP2B1;RYR2;ATP2A2;CACNA1C;MCUB;MICU2;ATP2A3;MICU3;SLC35G1;CACNB3;ITPR3;JPH4;SMDT1
prerank,neurotransmitter secretion (GO:0007269),-0.4930304469766542,-1.7548289056917403,0.0,0.2027466438680906,1.0,12/44,6.28%,NRXN1;RIMS2;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;SNAP25;CPLX2
prerank,tRNA processing (GO:0008033),0.49633759749818795,1.7521325294572578,0.0,0.47099619030684575,0.996,26/61,20.33%,FAM98B;ADAT1;QTRT1;KARS1;POP1;TRNT1;CSTF2;SSB;TRMT6;AARS2;ANKRD16;THUMPD1;CTU2;SARS1;NSUN6;TSEN2;CPSF1;TRMT10B;RPP21;TSEN54;CDKAL1;ELAC2;TYW5;QTRT2;TRMT61A;RTCB
prerank,response to sterol (GO:0036314),0.7149133781058006,1.7497832433577518,0.005244755244755245,0.45824750733621455,0.996,3/11,4.18%,TGFBR1;TGFBR2;CCL3
prerank,positive regulation of cellular component movement (GO:0051272),0.5987095708076839,1.7487240107837552,0.0033277870216306157,0.43986933620816676,0.996,6/24,8.12%,TGFBR1;CSF1R;ETS1;LYN;DUOX1;CCR7
prerank,toll-like receptor signaling pathway (GO:0002224),0.45715481752462533,1.748430743394637,0.0,0.42000274977891194,0.996,16/84,6.14%,ITGAM;TLR7;UNC93B1;LGALS9;IRAK2;RIPK2;TLR4;ITGB2;PLCG2;EPG5;RPS27A;UBC;CTSS;LGMN;PIK3C3;PIK3AP1
prerank,primary alcohol metabolic process (GO:0034308),-0.5548757302303096,-1.7469708094358931,0.00437636761487965,0.2137485108343274,1.0,9/25,18.63%,GPD2;RETSAT;NAPEPLD;GDPD1;RDH10;RBP4;ALDH3A2;DHRS9;RDH12
prerank,arachidonic acid metabolic process (GO:0019369),0.542155529267901,1.7441633709013162,0.005199306759098787,0.42011650637876286,0.997,10/35,13.00%,TBXAS1;HPGDS;DAGLB;PTGS1;ALOXE3;PLA2G4A;CBR1;PLA2G4B;PTGES2;GPX4
prerank,cyclooxygenase pathway (GO:0019371),0.7578111726668793,1.7364318924304918,0.0,0.4363499513963603,0.999,5/10,12.98%,TBXAS1;HPGDS;PTGS1;CBR1;PTGES2
prerank,acylglycerol homeostasis (GO:0055090),0.6063271369241587,1.735025315926891,0.005494505494505495,0.42482402214318093,0.999,5/20,11.15%,IL18;LIPC;MLXIPL;MTLN;APOC4
prerank,regulation of actin filament-based movement (GO:1903115),-0.7286887785073886,-1.733423426443829,0.014736842105263158,0.2376934460159529,1.0,3/10,1.16%,PDE4B;ANK2;PDE4D
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5860973300952242,1.7297338149412862,0.0017730496453900709,0.4297601217576523,0.999,10/24,23.81%,LPCAT4;PLA2G4A;PLA2G15;PLA2G4B;PLA2G5;CRLS1;PGS1;SERAC1;LPCAT1;PLA2G3
prerank,positive regulation of locomotion (GO:0040017),0.5806350319389261,1.7283926313928388,0.006837606837606838,0.41945352673800285,0.999,13/27,23.67%,CSF1R;P2RY12;AIF1;PDGFB;DUOX1;CCR7;PDGFRB;STX4;CFAP20;THBS1;PPM1F;TWIST1;TGFB1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.6085334085369801,1.7268693678505822,0.005415162454873646,0.41067371724822016,0.999,7/20,15.95%,FDXR;HSD3B2;CYP46A1;AKR1D1;TSPO;FDX1;HSD17B10
prerank,neurotrophin signaling pathway (GO:0038179),-0.5807359753780498,-1.7246438392662304,0.008583690987124463,0.25300475683179785,1.0,7/21,10.50%,MAGI2;BDNF;RAPGEF2;NTRK2;KIDINS220;BCAR1;DDIT4
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5027043039834244,-1.7235141614474496,0.006928406466512702,0.249572087483371,1.0,13/37,10.01%,NLGN1;GRID2;PTPRD;ALCAM;TENM3;IL1RAPL1;TENM2;ITGAL;JAML;FAT4;NECTIN1;TENM4;VCAM1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.43563248879681027,1.7232230264238142,0.0,0.4115379204370656,0.999,29/112,13.05%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;MEF2C;ARRB2;SKI;SMURF1;SRC;ID1;HPGD;RPS27A;UBC;CGN;GCNT2;ZFP36L1;JUN;LPXN;ZFP36L2;OVOL2;LEFTY1;LIMS1;APPL1;ZYX;ENG;SMAD9;USP9Y
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5633765764922982,1.7212500134532476,0.005291005291005291,0.4055198963382598,0.999,13/27,21.69%,BAG6;BRD8;TAF6L;TAF6;CPA4;MORF4L1;ATAT1;MRGBP;NAA50;KAT5;MORF4L2;PHF20;KAT6B
prerank,icosanoid metabolic process (GO:0006690),0.524119002862572,1.7207711569626907,0.005291005291005291,0.39409791841914,0.999,16/40,20.96%,TBXAS1;DAGLB;PTGS1;ALOXE3;PLA2G4A;HPGD;PLA2G4B;DPEP1;PON2;FADS1;GPX4;PON3;ABCC10;PTGR1;DAGLA;GGT5
prerank,neuron projection fasciculation (GO:0106030),-0.7268198169167972,-1.7188701410509226,0.012552301255230125,0.25500720997228077,1.0,8/10,25.66%,NRCAM;ARHGAP35;SEMA5A;RTN4;EPHA4;EPHB2;CNTN4;AMIGO1
prerank,neuron projection morphogenesis (GO:0048812),-0.38910401601647815,-1.7181130902089334,0.0,0.25068346896822125,1.0,40/137,15.06%,CNTNAP2;NLGN1;CTNND2;ANK3;CTNNA2;IQGAP1;NYAP2;DCC;ALCAM;LRRK2;NRCAM;GPM6A;MAP1B;BDNF;APP;SLITRK1;CTTN;PLPPR4;DCLK1;MAP2;SHANK3;CDC42;PAK3;DCDC2;ZDHHC17;ACTB;ATP7A;RAB8A;RAB3A;SPTBN4;CNTNAP1;NEFH;DTNBP1;PARD3;NTNG1;NTNG2;PLXNB1;EIF2AK4;MYO16;PAK1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6826225277188589,1.7177534755691302,0.00718132854578097,0.3946153850319216,0.999,6/14,8.32%,RASAL3;IL18;TGFBR2;LGALS9;EBI3;IL12B
prerank,axon extension (GO:0048675),-0.5599455754405341,-1.71434444417182,0.002277904328018223,0.2531639520122345,1.0,5/23,3.07%,AUTS2;ALCAM;SLIT2;MAP1B;SEMA5A
prerank,detection of calcium ion (GO:0005513),-0.6650077055114957,-1.7096672945438183,0.008438818565400843,0.25753854834039835,1.0,10/13,26.27%,SYT1;RYR2;KCNMB2;CALM1;KCNMB4;KCNIP2;KCNMB3;CASQ2;KCNMB1;CALM3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45244596374944307,-1.7050666176391835,0.002352941176470588,0.26207755470005545,1.0,12/54,3.86%,KCNIP4;DPP6;AKAP6;DPP10;KCNIP1;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;YWHAE;NEDD4L
prerank,protein localization to kinetochore (GO:0034501),-0.6312874960798825,-1.7040867894115892,0.014861995753715499,0.25860424198781,1.0,8/14,16.16%,KNL1;MTBP;CENPT;ZW10;SPDL1;AURKB;TTK;RCC2
prerank,response to fatty acid (GO:0070542),-0.6063964406772162,-1.7035844636705642,0.011286681715575621,0.254516020667998,1.0,9/17,22.07%,PID1;CD36;IRS1;FFAR1;NR1H4;FOXO1;GLDC;PDK3;PDK4
prerank,triglyceride metabolic process (GO:0006641),0.49485178840873706,1.700700738387994,0.0,0.45251873553335187,0.999,12/48,11.54%,LIPC;LIPH;AGMO;SEL1L;LPIN2;DGAT1;LMF1;GK5;PNPLA1;MOGAT1;MOGAT2;APOH
prerank,integrated stress response signaling (GO:0140467),0.6547971715274982,1.6960687901514475,0.011320754716981131,0.46007183918521666,0.999,5/14,5.59%,QRICH1;NFE2L2;DDIT3;IMPACT;EIF2S1
prerank,positive regulation of cell projection organization (GO:0031346),-0.3992047378652732,-1.6955177788161202,0.0,0.26833622737221924,1.0,39/115,15.91%,MAGI2;ROBO1;PTPRD;RIT2;LRRC7;TENM3;CDKL5;SLIT2;ARHGAP35;PLXNC1;FUT9;BDNF;SLITRK1;IL1RAPL1;RAPGEF2;ROR1;NTRK2;GRIP1;NTRK3;NPTN;APOE;PLXND1;KIDINS220;PLXNA2;RET;CARMIL1;CUL7;PLXNB2;SCARF1;P3H1;SERPINI1;MAP3K13;STMN2;OBSL1;PLXNB1;CX3CL1;TIAM1;RELN;ARHGDIA
prerank,negative regulation of glycolytic process (GO:0045820),-0.7009555826840913,-1.6947185731899488,0.016293279022403257,0.2598640038045047,1.0,6/10,25.50%,PFKFB1;HDAC4;TIGAR;CBFA2T3;NCOR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.7009555826840913,-1.6947185731899488,0.016293279022403257,0.2598640038045047,1.0,6/10,25.50%,PFKFB1;HDAC4;TIGAR;CBFA2T3;NCOR1;PPARA
prerank,axon development (GO:0061564),-0.4204376767263762,-1.6861674801844588,0.0,0.27505370869841067,1.0,23/78,14.19%,GRM7;ANK3;CTNNA2;DCC;NRCAM;ARHGAP35;MAP1B;APP;SLITRK1;PLPPR4;SEMA5A;RTN4;PAK3;ZDHHC17;ACTB;RAB8A;RAB3A;SPTBN4;NEFH;PARD3;NTNG1;NTNG2;VASH2
prerank,membrane assembly (GO:0071709),-0.49386949501495225,-1.684997185607509,0.004576659038901602,0.2725434655903859,1.0,6/34,2.64%,NRXN1;NLGN1;ANK3;PTPRD;SPTBN1;IL1RAPL1
prerank,phagosome-lysosome fusion (GO:0090385),0.7101567687720473,1.6834514042109119,0.014625228519195612,0.5062184438223098,1.0,6/10,17.54%,PLA2G5;RAB39A;RAB34;CLN3;RAB20;RAB7B
prerank,positive regulation of cation channel activity (GO:2001259),-0.48225428649079377,-1.6809865210334747,0.007177033492822967,0.277180535930471,1.0,9/40,8.78%,ANK3;AKAP6;ANK2;CCR2;HTT;SHANK3;CALM1;PKD2;ACTN2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5755717054055013,-1.6799866316602834,0.0091324200913242,0.2744263220020638,1.0,6/20,7.31%,KCNB2;ATP2B1;CTTN;ZDHHC21;CHRM2;CHRM3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4858876647011518,-1.675615746515269,0.004545454545454545,0.2797037512713343,1.0,12/39,8.44%,FGF14;DMD;ANK3;FGF12;UTRN;HECW2;HECW1;NEDD4L;FXYD5;PTPN3;NETO1;FGF11
prerank,mitochondrion morphogenesis (GO:0070584),-0.674578043717829,-1.6738893218052482,0.02591792656587473,0.27920715106896277,1.0,5/11,9.61%,PID1;DNM1L;WASF1;FIS1;MFF
prerank,neuron fate commitment (GO:0048663),0.6410913773009284,1.670882839733835,0.007518796992481203,0.5572065923284899,1.0,6/14,11.38%,TGFBR1;EPOP;PAX6;SHH;POU4F1;DLL1
prerank,phagolysosome assembly (GO:0001845),0.6740227567262812,1.670493453379618,0.011090573012939002,0.5438468834107063,1.0,6/12,17.54%,PLA2G5;RAB39A;RAB34;CLN3;RAB20;RAB7B
prerank,positive regulation of endocytosis (GO:0045807),-0.4759487647651822,-1.6703145736307252,0.004750593824228029,0.28235073773868,1.0,17/45,14.97%,NLGN1;DAB2;HIP1;STAP1;BICD1;B2M;SGIP1;NEDD4L;APOE;CDC42;TOR1A;ANO6;GPC3;CD151;TFR2;CBLL1;SNCA
prerank,response to histamine (GO:0034776),-0.6953307119238913,-1.6677982493304166,0.017977528089887642,0.2835825398097657,1.0,4/10,8.78%,GABRB1;HRH1;GABRG2;GABRB3
prerank,presynapse assembly (GO:0099054),-0.5978532120872146,-1.667608435610994,0.013015184381778741,0.2792719616038485,1.0,5/16,8.97%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4392257788329231,-1.6658378599492105,0.002398081534772182,0.27906668454881434,1.0,8/56,2.64%,CNTNAP2;NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;IL1RAPL1
prerank,postsynaptic membrane organization (GO:0001941),-0.5870872131800743,-1.6655556392097692,0.01263157894736842,0.2752310912747971,1.0,5/17,4.61%,NRXN1;NLGN1;GPHN;SHANK3;APOE
prerank,water transport (GO:0006833),-0.6647685857886969,-1.6654747721540406,0.004484304932735426,0.2711060346118735,1.0,5/12,29.34%,AQP4;AQP11;CFTR;AQP1;SLC5A1
prerank,positive regulation of neuron death (GO:1901216),0.48439583798034364,1.6628788564161998,0.005208333333333333,0.5686415721303542,1.0,10/46,6.40%,ITGAM;DDIT3;PICALM;TLR4;ITGB2;EGR1;CCL3;CLU;EIF2S1;C1QA
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5715934821724815,-1.662496656817119,0.008948545861297539,0.2733618405301371,1.0,6/20,5.31%,DMD;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,skeletal muscle organ development (GO:0060538),0.557921502299209,1.6624854737406265,0.009057971014492754,0.5554400192484523,1.0,5/26,6.17%,BASP1;LARGE1;CFLAR;MEF2C;ZBTB18
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5471888592642845,1.6614644648407342,0.012589928057553957,0.5469582036269903,1.0,9/29,9.13%,LPCAT2;TMEM86B;MBOAT2;LPCAT4;PLA2G4A;PLA2G6;PLA2G4B;PLB1;PLA2G5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4501586589412441,1.6611471180560107,0.004792332268370607,0.534675424836845,1.0,16/67,8.12%,TBC1D16;TWF2;SDCCAG8;TBC1D17;RAC1;PLD1;TBC1D9B;TBC1D10B;CAPZB;TBC1D8;TBC1D15;TRPM2;FSCN1;ABITRAM;DYNLT2B;CCR7
prerank,regulation of plasminogen activation (GO:0010755),0.6801709444444127,1.6595272535386008,0.017761989342806393,0.5292250801074896,1.0,7/12,18.17%,PLGRKT;F12;RUNX1;SERPINE1;SERPINE2;HPN;THBS1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5055210380857432,1.657965942613977,0.007380073800738007,0.5244023116616827,1.0,22/37,26.31%,SIRPA;ABCD2;TLR4;NOS2;PLD4;APPL1;PYCARD;MAPK14;GBP5;ADCY7;TICAM1;NOD2;ZC3H12A;ABCD1;MYD88;PDCD4;HIF1A;MEFV;APPL2;STAT3;CARD9;CUEDC2
prerank,regulation of secretion (GO:0051046),-0.6464451447834136,-1.6574322231071494,0.020179372197309416,0.28099542976381303,1.0,6/13,13.53%,OAS2;FGF10;ACSL3;ERBB3;MYO6;KCNQ1
prerank,microglial cell activation (GO:0001774),0.5879583175990368,1.6542910137505704,0.014625228519195612,0.5304683447411008,1.0,7/21,6.40%,CX3CR1;ITGAM;AIF1;AGER;ITGB2;CLU;C1QA
prerank,cell junction assembly (GO:0034329),-0.39553424643861085,-1.6523588292236935,0.0,0.2898660737485245,1.0,31/100,14.11%,NRXN1;NLGN1;CTNND2;DNM3;ADGRL3;KIRREL3;NRCAM;GPM6A;CDH8;BDNF;SLITRK1;FN1;SHANK3;PLXND1;CDH22;CDC42;CDH7;CDH20;PKP4;VMP1;CDH10;ACTB;CDH11;CDHR3;SDK1;CDH5;OBSL1;ACHE;CDH1;NRXN2;PCDHB16
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.6464333215374662,-1.651161498859523,0.02412280701754386,0.2885472046601389,1.0,5/12,7.59%,CD74;CD44;ING2;RPL26;SIRT1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5556844164735889,-1.6510583377070462,0.013422818791946308,0.28458607888408183,1.0,9/20,32.51%,WNT4;SIK1;CDA;C1QTNF3;CRY1;NCOR1;UGT1A8;C1QTNF12;GCK
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5837168144695142,-1.6499091433071778,0.01583710407239819,0.2833124282024955,1.0,10/18,19.40%,NLGN1;RIMS2;LRRK2;SYN1;GSK3B;RIMS4;DTNBP1;SLC4A8;RIMS1;RAB5A
prerank,lipid catabolic process (GO:0016042),0.6045859453946161,1.6497469866970644,0.01079136690647482,0.5399356638452446,1.0,4/18,6.89%,LIPC;LIPH;SIRT2;PPT1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6467175665703104,-1.6485519158044744,0.006535947712418301,0.2824589805781482,1.0,5/12,7.59%,SORBS1;IRS1;PRKCZ;ZBTB7B;SIRT1
prerank,B cell homeostasis (GO:0001782),0.6962418452994718,1.6480531310675863,0.019400352733686066,0.5358605009447036,1.0,5/10,10.24%,MEF2C;LYN;TNFRSF13B;DOCK10;NCKAP1L
prerank,AMP metabolic process (GO:0046033),-0.6332696630014412,-1.6475540170508824,0.01735357917570499,0.28067004113753874,1.0,5/13,15.86%,XDH;AMPD3;AK3;AK4;ADSS2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5766209190436192,-1.6473213559187523,0.023758099352051837,0.2772382855773569,1.0,5/18,4.59%,NRXN1;NLGN1;CCR2;CACNG2;SHANK3
prerank,protein localization to condensed chromosome (GO:1903083),-0.6460375329562309,-1.6470886046703155,0.012578616352201259,0.27411085923129797,1.0,6/12,10.52%,KNL1;MTBP;ZW10;SPDL1;AURKB;TTK
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.5777512009847181,-1.646634724070181,0.012958963282937365,0.27146992427873784,1.0,7/17,11.57%,KNL1;MTBP;ZW10;SPDL1;AURKB;TTK;CTCF
prerank,prostaglandin biosynthetic process (GO:0001516),0.5998722784029649,1.646489326116005,0.02154398563734291,0.5313128553890274,1.0,7/18,8.21%,TBXAS1;HPGDS;DAGLB;PTGS1;PLA2G4A;CBR1;EDN2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.6228204029147493,-1.6459166896617274,0.019313304721030045,0.2696414527979253,1.0,5/13,7.59%,SORBS1;IRS1;PRKCZ;ZBTB7B;SIRT1
prerank,androgen receptor signaling pathway (GO:0030521),0.6692154408493565,1.6416419637125896,0.016544117647058824,0.5438633275750152,1.0,7/11,18.27%,PMEPA1;DDX5;DDX17;PLPP1;KDM3A;ZMIZ1;ARID1A
prerank,regulation of mast cell degranulation (GO:0043304),0.6481376794335917,1.6394607279599012,0.007168458781362007,0.5434175080093083,1.0,4/14,2.90%,CD84;LGALS9;GAB2;LYN
prerank,regulation of tissue remodeling (GO:0034103),0.5915735659853595,1.6387393699933506,0.00718132854578097,0.5358394703127984,1.0,7/18,15.46%,IL18;CST3;IL12B;DDR2;CEACAM1;RUNX1;GPNMB
prerank,cellular calcium ion homeostasis (GO:0006874),-0.37475185628150887,-1.6358544766012444,0.0,0.289071819495733,1.0,42/133,18.14%,ANK2;CCR2;MCU;SLC8A3;TRPC5;ATP2B1;CCR1;RYR2;TRPC4;HTR2C;CD40;YWHAE;ATP2A2;PDZD8;NPTN;SLC24A2;SLC8B1;TPT1;LETM1;HTR2B;ATP13A3;MCUB;RMDN3;TMEM165;MICU2;STIM2;TRPC3;HCRTR2;DMPK;BAK1;ATP2A3;MICU3;ADCY8;CDH5;SLC35G1;CCL5;CCL14;BCL2;SELENOK;ATP13A5;CALB1;CCL7
prerank,positive regulation of cell adhesion (GO:0045785),0.44709077398697505,1.635779922155901,0.0016806722689075631,0.5387665136613653,1.0,19/74,10.24%,ZFHX3;P2RY12;SMAD7;RAC1;MAGI1;TGM2;PRKCA;NPNT;ITGAV;ATM;FLCN;TFE3;PDGFB;C1QBP;CCR7;IL12B;FUT7;LIMS1;NCKAP1L
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5951789515228808,-1.6332198598420127,0.027659574468085105,0.29159821700337357,1.0,5/15,6.21%,GRM7;GRM8;GRM5;GRM1;HOMER1
prerank,ceramide catabolic process (GO:0046514),0.6303256470706078,1.6323345265290996,0.018148820326678767,0.5446904797875707,1.0,6/14,10.75%,HEXB;HEXA;NEU3;ACER3;ACER2;ASAH1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6069259913461766,1.6281572020269213,0.012962962962962963,0.5553012979649238,1.0,8/17,23.81%,LPCAT4;PLA2G4A;PLA2G4B;PLA2G5;CRLS1;SERAC1;LPCAT1;PLA2G3
prerank,skeletal muscle tissue development (GO:0007519),0.5152528741281358,1.6269379115399816,0.01607142857142857,0.5503069578460793,1.0,6/32,8.10%,CFLAR;MEF2C;SKI;ZBTB18;EGR2;KLHL40
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6016645904845455,1.6269077569480632,0.0054446460980036296,0.5402305883633766,1.0,8/17,20.24%,LYN;SEMA4C;MID1;ARL6IP5;TAOK2;EIF2AK2;PDCD10;NOD2
prerank,phosphatidylserine metabolic process (GO:0006658),0.5146551547468144,1.626478134841903,0.010416666666666666,0.5321881702389287,1.0,10/32,13.49%,ABHD12;MBOAT2;LPCAT4;PLA2G4A;PLA2G15;PLA2G4B;PLA2G5;MBOAT1;PTDSS2;OSBPL5
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.4796043818864528,-1.624704728113198,0.008869179600886918,0.3081329798057959,1.0,13/33,16.29%,LRRC4C;NLGN1;GRIK2;GRID2;NRG3;BDNF;GRIK4;GRIK1;SLC4A8;RELN;ABR;GRIK3;CACNA1B
prerank,signal release from synapse (GO:0099643),-0.459035698639751,-1.6245510736831859,0.011682242990654205,0.30463337975275573,1.0,16/43,16.70%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;SNAP25;CPLX2;RAB3A;NRXN2;HSPA8;SNCA;RIMS1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5372825325074262,-1.623717369892014,0.008968609865470852,0.3029964050007053,1.0,5/24,6.61%,DMD;AKAP6;PDE4D;CALM1;PKD2
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.48470111029913915,-1.6226561035967604,0.011547344110854504,0.30170784749506013,1.0,14/34,9.92%,GRID2;LRRK2;GRIN2B;GRIN2A;GLRA1;GABRA3;GABRG3;GSK3B;GABRG1;GABRA2;INSYN2A;GABRG2;GRIN2D;CHRNA4
prerank,granulocyte differentiation (GO:0030851),-0.5748512621878916,-1.6198037223120925,0.019189765458422176,0.304885631066168,1.0,10/18,19.16%,LBR;JAGN1;RARA;CEBPA;CBFA2T3;CDKN1A;CDK2;E2F1;CDK4;LEF1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.49756642880491386,-1.619583928946534,0.02088167053364269,0.30162849302198363,1.0,8/29,6.34%,KCNIP4;DPP6;DPP10;KCNIP1;FGF12;KCNN2;HOMER1;KCNAB2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.4191000227382028,-1.6191399342137598,0.004761904761904762,0.2992485163789571,1.0,33/63,26.99%,AUTS2;NEDD9;MKLN1;FGF10;MCU;GSN;CTTN;THSD7B;CDC42BPA;BCAR1;FGF7;PHACTR1;THSD7A;KIT;PDLIM4;DTNBP1;CDC42BPG;FER;PAK1;PARVG;S1PR2;NRK;PARVB;EFS;MICALL2;EZR;ANXA1;TNIK;FLNA;SYDE1;PTK7;GPR65;CAPN10
prerank,regulation of regulated secretory pathway (GO:1903305),-0.484295166789122,-1.618861169852263,0.009345794392523364,0.29634881962970716,1.0,14/34,19.40%,RIMS2;LRRK2;SYN1;SYT1;SYT10;GSK3B;RAB3D;RAB3A;RIMS4;DTNBP1;SYT3;RIMS1;TRPV6;RAB5A
prerank,axonogenesis (GO:0007409),-0.34187752582771236,-1.617154830424264,0.0,0.29681913499027907,1.0,47/237,9.48%,NRXN1;DAB1;AUTS2;ANK3;CTNNA2;ROBO1;UNC5C;DCC;SPTBN1;B4GALT5;KIF5C;NRCAM;NRXN3;SLIT2;ARHGAP35;DOK6;B4GALT6;MAP1B;SHC3;BDNF;APP;SLITRK1;PLPPR4;SEMA5A;CNTN6;EMB;NPTN;SHANK3;SEMA4A;PALLD;DOK5;NCAM1;GFRA2;PAK3;DOK1;RET;ZDHHC17;EPHA5;LGI1;SPTBN2;DOK2;KIF5B;ACTB;RAB8A;RAB3A;GRB10;SPTBN4
prerank,glycosphingolipid metabolic process (GO:0006687),0.4856544781748162,1.6114433387386038,0.008635578583765112,0.5950591009288764,1.0,15/42,18.24%,HEXB;LARGE1;ST3GAL5;CPTP;HEXA;NEU3;SMPD2;ASAH1;CERK;B4GALNT1;ARSA;CTSA;NEU4;SMPD3;GLB1
prerank,positive regulation of protein maturation (GO:1903319),-0.6378893902937134,-1.6100953389678208,0.02771855010660981,0.31021578486263357,1.0,3/11,11.64%,NLRC4;CCBE1;TFR2
prerank,outer dynein arm assembly (GO:0036158),-0.5897719997086854,-1.6075069496767063,0.026373626373626374,0.3128403371170222,1.0,10/14,29.81%,ODAD2;DNAH8;DNAAF5;ODAD3;DNAH17;DNAAF1;DNAL1;ODAD4;DNAAF4;CCDC63
prerank,stress-activated MAPK cascade (GO:0051403),0.44609182658551527,1.6070764621489928,0.004815409309791332,0.607272409808792,1.0,24/61,20.24%,LGALS9;IRAK2;RIPK2;GPS2;MAP4K3;RPS27A;UBC;ZFP36L1;ADORA2B;TAB2;MAP3K8;MAP4K2;MAP3K11;MAP3K10;TAOK2;MAPK8;GPS1;MAPK14;TNIP2;TNFRSF19;CCM2;TRIB1;CRKL;NOD2
prerank,triglyceride catabolic process (GO:0019433),0.5753990231123514,1.6068675036850084,0.020754716981132074,0.5977260932619932,1.0,3/19,8.12%,LIPC;LIPH;PNPLA1
prerank,positive regulation of chemokine production (GO:0032722),0.4717241564012249,1.6000028651357183,0.013628620102214651,0.6222653868043336,1.0,13/44,16.05%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;EGR1;IL6R;IL33;MAVS;PYCARD;EIF2AK2
prerank,prostaglandin metabolic process (GO:0006693),0.5372131709740682,1.5995685115732325,0.02702702702702703,0.613903773902804,1.0,7/26,8.21%,TBXAS1;HPGDS;DAGLB;PTGS1;PLA2G4A;HPGD;EDN2
prerank,glucose import (GO:0046323),0.6315283794348616,1.5994762308867425,0.024714828897338403,0.6043803682786165,1.0,5/13,13.76%,SORT1;TRARG1;SLC27A4;ZDHHC7;RAB4B
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5324782954766651,-1.5982139470873267,0.02857142857142857,0.33273140369402426,1.0,7/21,13.66%,XDH;PDE4D;AMPD3;PDE9A;HINT1;NUDT3;PDE2A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6709676225174159,1.5968028758475517,0.018148820326678767,0.6080952942792471,1.0,3/11,8.53%,GREM1;MEF2C;GPER1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5632310179325989,1.5948030602305239,0.024299065420560748,0.608273640068092,1.0,6/19,10.41%,ITGAM;LGALS9;TLR4;ITGB2;PIK3AP1;TICAM2
prerank,cellular metal ion homeostasis (GO:0006875),-0.3793589740954744,-1.5912778414711497,0.0,0.34716955413182615,1.0,25/102,12.34%,ANK2;CCR2;SLC8A3;ATP2B1;CCR1;RYR2;HTR2C;CD40;NEDD4L;ATP2A2;NPTN;SLC24A2;SLC8B1;TPT1;LETM1;HTR2B;ATP13A3;RMDN3;TMEM165;ATP1B3;STIM2;DMPK;ATP2A3;ATP1A1;CDH5
prerank,diol biosynthetic process (GO:0034312),0.607280833741265,1.5891494233271382,0.01838235294117647,0.6272691567098202,1.0,5/15,10.75%,QDPR;SPTLC3;ACER3;ACER2;ASAH1
prerank,protein homotrimerization (GO:0070207),-0.5957398525853032,-1.5890248046453914,0.03002309468822171,0.34505626471253725,1.0,6/14,16.69%,DISP1;ALOX5AP;SLC1A5;MLKL;SCARA5;STEAP4
prerank,protein trimerization (GO:0070206),-0.5957398525853032,-1.5890248046453914,0.03002309468822171,0.34505626471253725,1.0,6/14,16.69%,DISP1;ALOX5AP;SLC1A5;MLKL;SCARA5;STEAP4
prerank,regulation of defense response to virus (GO:0050688),0.60623160173601,1.5889809876392162,0.0374331550802139,0.6184432627618918,1.0,5/14,7.32%,RNF216;ITCH;PCBP2;DHX9;C1QBP
prerank,calcium ion homeostasis (GO:0055074),-0.3853007353875529,-1.5889283218707166,0.0024390243902439024,0.3415626509466247,1.0,28/95,18.14%,ANK2;CCR2;SLC8A3;ATP2B1;CCR1;RYR2;HTR2C;CD40;ATP2A2;NPTN;SLC24A2;SLC8B1;TPT1;HTR2B;ATP13A3;RMDN3;TMEM165;STIM2;DMPK;ATP2A3;CDH5;CCL5;CCL14;SNCA;TMTC2;ATP13A5;TRPV6;CCL7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5058007111605629,-1.5881600311943584,0.01545253863134658,0.33996035664174723,1.0,6/27,5.30%,AHNAK;DMD;ANK2;PDE4D;YWHAE;CALM1
prerank,nuclear export (GO:0051168),0.41807933065615643,1.5878317004938884,0.004709576138147566,0.614756279245216,1.0,33/80,26.82%,SRRM1;NCBP1;SMURF1;MAGOHB;MAGOH;U2AF2;STRADA;NUP42;EGR2;RANBP3;DHX38;NUP62CL;SRSF5;RBM8A;U2AF1L4;SLU7;ALYREF;NEMF;CSE1L;NUP62;THOC6;WASHC4;SRSF9;DDX39B;NUP153;TGFB1;XPO5;HNRNPA1;XPO1;NUP188;THOC3;ZC3H11A;THOC5
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3928792843566883,1.5862006837510498,0.0,0.6139171037660116,1.0,26/140,6.18%,SRGAP3;SRGAP2;ARHGAP5;CHN2;FGD2;ARHGAP22;ARHGAP45;OPHN1;ARHGAP39;ARHGEF2;PREX1;VAV2;RAC1;TGM2;ARAP3;CYRIB;ARHGAP25;ITGAV;RHOQ;SRC;RHOB;FLCN;ARHGAP30;ARHGAP28;RHOH;ARHGAP17
prerank,positive regulation of T cell activation (GO:0050870),0.4419359445417762,1.5854457858646647,0.01335559265442404,0.608813907379879,1.0,16/62,10.24%,DOCK8;SIRPA;CCDC88B;LGALS9;AIF1;CYRIB;TNFRSF13C;RHOH;IL6ST;CD86;PNP;FLOT2;CCR7;PDCD1LG2;IL12B;NCKAP1L
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4528599798665905,1.584074752988353,0.010050251256281407,0.606830654247079,1.0,16/50,17.86%,IVNS1ABP;SENP2;SMAD7;ARRB2;U2AF2;SPRY2;KLHL40;TAF1;GNL3L;ABL1;AKT1;USP4;DTX3L;HDAC8;ARRB1;SPOPL
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.40939936370485885,1.5839685749775365,0.004807692307692308,0.5987063382670371,1.0,19/95,6.62%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;SMAD7;PMEPA1;SKI;TGFB1I1;SMURF1;LTBP4;FLCN;SKIL;RPS27A;UBC;SPRY2;NREP;PDPK1;EID2;ASPN
prerank,negative regulation of bone remodeling (GO:0046851),0.6492979641823774,1.5828311117507128,0.029574861367837338,0.595586014525079,1.0,5/11,16.89%,TMEM119;GREM1;UBASH3B;GPR137;CARTPT
prerank,ruffle organization (GO:0031529),0.5937465212810951,1.5799971159239325,0.03508771929824561,0.6006389365022817,1.0,8/16,10.80%,CSF1R;RAC1;AIF1;PLEK;ARFIP2;CCR7;INPP5K;CYFIP1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5346661875332468,-1.5789974670784162,0.0319634703196347,0.36043074349074894,1.0,6/21,5.00%,HS6ST3;HS3ST5;SULF2;EXT1;HS6ST2;HS3ST4
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6048045855644664,-1.578880068916479,0.022123893805309734,0.35697611051514094,1.0,5/13,14.18%,PLXNC1;PLXND1;PLXNA2;PLXNB2;PLXNB1
prerank,in utero embryonic development (GO:0001701),0.5154885384275473,1.5777409710268593,0.02982456140350877,0.6031959748516118,1.0,5/25,4.54%,TGFBR1;SOX8;CHD7;FLCN;ZNF568
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6311327101918384,-1.5773934155182157,0.036170212765957444,0.357430837463073,1.0,4/12,9.48%,B4GALT5;ARHGAP35;B4GALT6;SPTBN4
prerank,positive regulation of histone methylation (GO:0031062),-0.5008705978764585,-1.5772365427053727,0.03296703296703297,0.3541360653807852,1.0,13/24,23.77%,AUTS2;MTF2;JARID2;SIRT1;TET1;DNMT3B;RIF1;DNMT1;SNW1;CHTOP;MYB;FAM47E;CTNNB1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.5730248000479066,-1.575823753584492,0.03512396694214876,0.354300141300609,1.0,4/16,3.73%,ANK2;LRRK2;RYR2;VAPA
prerank,long-term synaptic potentiation (GO:0060291),-0.5315448979764456,-1.5747576706678672,0.033936651583710405,0.35341504517412636,1.0,10/21,14.86%,GRIN2B;GRIN2A;SLC8A3;NPTN;SLC24A2;PRKCZ;PLK2;GRIN2D;TSHZ3;MPP2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5406780097587808,1.5741464153596676,0.014492753623188406,0.6124239373842562,1.0,9/23,11.73%,LGALS9;DDIT3;VSIR;TLR4;C1QBP;PDCD1LG2;INHA;AXL;HAVCR2
prerank,regulation of dendrite development (GO:0050773),-0.46311033478322494,-1.5739725733807242,0.017391304347826087,0.35205345892233186,1.0,12/37,12.92%,ADGRB3;DCC;CDKL5;BCL11A;HECW2;HECW1;NEDD4L;GSK3B;ALK;MFSD2A;SARM1;ZDHHC15
prerank,regulation of chemokine production (GO:0032642),0.48808136541798114,1.5732447262690243,0.018581081081081082,0.6087787491117175,1.0,8/36,3.88%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;EGR1
prerank,mononuclear cell differentiation (GO:1903131),0.5387006929450268,1.5729393325377303,0.026455026455026454,0.6022600169651037,1.0,10/24,13.51%,IKZF1;CSF1R;LYN;MYH9;TRPM2;MT1G;AXL;IRF8;PDE1B;RELB
prerank,negative regulation of transmembrane transport (GO:0034763),0.6609457750490366,1.5715155761443804,0.03213610586011342,0.6013709193294269,1.0,6/10,24.83%,CTTNBP2NL;INPP5K;PRKCB;AKT1;THBS1;OAZ3
prerank,positive regulation of GTPase activity (GO:0043547),0.37044358771275454,1.5709476817968198,0.001488095238095238,0.5964883076221011,1.0,44/188,13.84%,SRGAP2;DOCK8;TBC1D16;ARHGAP22;F11R;ARHGAP45;SIPA1L2;ITGA6;TBC1D17;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;TBC1D9B;PICALM;TBC1D10B;TGM2;RGS10;TBC1D7;SNX18;ARHGAP25;TBCK;TBC1D8;GARNL3;TBC1D15;CCL3;FLCN;SIPA1;TAX1BP3;RAB3GAP1;SGSM2;CCR7;DOCK10;LIMS1;SLC27A4;TBC1D9;RUNDC1;RAPGEF3;CCDC125;PIN1;SEMA4D;GMIP;EZH2;TBC1D30
prerank,negative regulation of bone mineralization (GO:0030502),0.6128124130751664,1.5707714827496302,0.03935599284436494,0.5899422350468638,1.0,5/13,6.16%,GREM1;TRPM4;CCL3;PTK2B;BCOR
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.38938704239050903,1.5705306267834704,0.0015337423312883436,0.5835726955480492,1.0,27/128,13.05%,TGFBR1;ITGB5;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;DDX5;SKI;TGFB1I1;SMURF1;SRC;ID1;HPGD;RPS27A;UBC;EID2;CGN;GCNT2;JUN;LPXN;LEFTY1;APPL1;ZYX;ENG;SMAD9;USP9Y
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.38791404555536135,-1.5674865950134338,0.0025380710659898475,0.36585472675792763,1.0,45/91,27.00%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;SEC62;RPL18A;RPS25;RPL38;RPL37;RPS14;RPS15A;RPL24;RPS9;SRP19;RPLP1;RPL22;RPL8;RPLP0;RPS12;RPS10;RPL19;RPL13A;RPS6;RPS5;RPS19;RPL23A;RPL29;RPS11;SSR2;RPL18;RPS23;RPS15;RPL23;RPL17;SSR1
prerank,heart process (GO:0003015),-0.598786477011952,-1.566311036354092,0.026785714285714284,0.36560055017214316,1.0,6/14,21.44%,SGCZ;SGCD;PPCS;ACE;NOX4;FYN
prerank,response to muscle stretch (GO:0035994),-0.5833243125672836,-1.5655168788521894,0.037815126050420166,0.36432714507858716,1.0,3/15,2.52%,DMD;GSN;RYR2
prerank,sphingoid biosynthetic process (GO:0046520),0.6488232768604848,1.5642625835025763,0.0248565965583174,0.5992111760212104,1.0,4/11,10.75%,SPTLC3;ACER3;ACER2;ASAH1
prerank,sphingosine biosynthetic process (GO:0046512),0.6488232768604848,1.5642625835025763,0.0248565965583174,0.5992111760212104,1.0,4/11,10.75%,SPTLC3;ACER3;ACER2;ASAH1
prerank,macrophage activation involved in immune response (GO:0002281),0.61303398445858,1.5638065675306063,0.03467153284671533,0.5941893386054593,1.0,3/13,4.37%,CX3CR1;SBNO2;PLCG2
prerank,protein targeting to ER (GO:0045047),-0.3790551865591898,-1.5621293842839663,0.00516795865633075,0.36990438434896905,1.0,46/99,26.39%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPS7;SPCS2;RPL4;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;SEC62;RPL18A;RPS25;GET3;RPL38;RPL37;RPS14;RPS15A;RPL24;RPS9;SRP19;RPLP1;RPL22;RPL8;RPLP0;RPS12;RPS10;RPL19;RPL13A;RPS6;RPS5;RPS19;RPL23A;RPL29;RPS11;RPL18;RPS23;SPCS1;RPS15;RPL23;RPL17
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.39115869946355,-1.5607833574630396,0.005208333333333333,0.37000844147758144,1.0,36/87,20.91%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;RPLP2;RPL7A;RPL41;RPL26;SRP68;RPS27;RPL18A;RPS25;RPL38;RPL37;RPS14;RPS15A;RPL24;RPS9;SRP19;RPLP1;RPL22;RPL8;RPLP0;RPS12;RPS10;RPL19;RPL13A;RPS6;RPS5;RPS19;RPL23A;RPL29
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6281675702554882,1.5595325091414358,0.03153988868274583,0.6073331034745535,1.0,6/13,12.45%,HEXB;ARSB;HEXA;BGN;BCAN;CSPG5
prerank,membrane repolarization during action potential (GO:0086011),-0.587878670474464,-1.559452179347879,0.03854875283446712,0.36980565540556526,1.0,6/13,17.16%,YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.655019083950299,1.5591519760955996,0.0433996383363472,0.6019095509253991,1.0,3/11,1.07%,TGFBR1;TGFBR2;SMAD7
prerank,cell differentiation in spinal cord (GO:0021515),-0.6518145363605654,-1.5582204265203008,0.03941908713692946,0.36984650777978223,1.0,4/10,21.19%,MDGA2;SOX13;MDGA1;SOX6
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6264072764251305,-1.5581737942150986,0.053691275167785234,0.36658546632231814,1.0,6/11,14.70%,KCNJ3;YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2
prerank,purine-containing compound catabolic process (GO:0072523),-0.6034740371053231,-1.5565749365201793,0.04904051172707889,0.36724801597612483,1.0,3/13,1.60%,DPYD;XDH;GDA
prerank,regulation of proteolysis (GO:0030162),0.45274848903058257,1.5561069643469008,0.009917355371900827,0.6103681171091527,1.0,16/48,20.52%,BAG6;CST3;CAPN3;GSAP;ITCH;ASPH;LTBP4;SHH;CLN3;SERPINE2;DNAJC1;AKT1;SPOPL;STUB1;IST1;FGFR4
prerank,regulation of secretion by cell (GO:1903530),-0.41584712007181873,-1.553660186108879,0.007481296758104738,0.3717886248027078,1.0,16/54,12.23%,RIMS2;STXBP5L;SYN1;DISP1;MCTP2;RAB3C;SYT1;RIC1;STXBP5;CPLX2;RAB3D;RAB8A;RAB3A;P3H1;MCTP1;KCNMB4
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5392048778201753,1.5509636194393517,0.025951557093425604,0.627883052488457,1.0,5/22,4.25%,GSAP;AGER;PICALM;LYN;CLU
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.43717252830718384,1.5498816390111825,0.01779935275080906,0.6259824942854038,1.0,11/56,9.69%,TLR7;UNC93B1;IRAK2;TLR4;PLCG2;RPS27A;UBC;CTSS;LGMN;TAB2;CLEC4E
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6162036061470045,-1.5479131060840532,0.05970149253731343,0.38399295012657664,1.0,4/11,7.59%,CD74;CD44;ING2;SIRT1
prerank,response to cholesterol (GO:0070723),0.5720308479697915,1.547311548033455,0.042328042328042326,0.6313844666489776,1.0,4/17,4.18%,TGFBR1;TGFBR2;GRAMD1A;CCL3
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5477008345238428,-1.5468641027239847,0.034482758620689655,0.3835498031595774,1.0,10/18,23.42%,IRS1;PRKN;ADRA2A;CRHBP;SFRP1;CCN3;FFAR4;CRH;INHBB;REST
prerank,regulation of receptor binding (GO:1900120),-0.6533699709268238,-1.5465759132497263,0.05319148936170213,0.38106911122320686,1.0,4/10,10.17%,BDNF;B2M;ATP2A2;ATP2A3
prerank,negative regulation of protein depolymerization (GO:1901880),0.5239167144687829,1.5432073764430063,0.0481283422459893,0.6439486019899601,1.0,11/24,22.78%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;PLEKHH2;CIB1;ATXN7;TTBK2;KATNB1;PIK3CA
prerank,regulation of neuron projection development (GO:0010975),-0.34880588657077966,-1.5431094646861254,0.0027397260273972603,0.38701704225429395,1.0,46/163,15.06%,MAGI2;LRRC4C;PDLIM5;CTNNA2;DCC;RIT2;LRRC7;TENM3;LRRK2;SPOCK1;CDKL5;ARHGAP35;FUT9;PPFIA2;BDNF;IL1RAPL1;RAPGEF2;ROR1;NTRK2;NTRK3;NPTN;SHANK3;APOE;GSK3B;KIDINS220;CHN1;PAK3;RET;PLXNB2;ABI2;CCDC88A;SCARF1;P3H1;KANK1;SERPINI1;MFSD2A;SRCIN1;FBXO7;PAQR3;STMN2;MINAR1;ZDHHC15;NTNG1;NTNG2;CX3CL1;PAK1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5106970197182787,-1.542842990521921,0.041379310344827586,0.38455750270906525,1.0,5/22,5.58%,AHNAK;DMD;PDE4B;GPR35;CBARP
prerank,monoacylglycerol metabolic process (GO:0046462),0.6174034535020883,1.542749421246014,0.023090586145648313,0.639125756822023,1.0,5/13,10.94%,ABHD12;DGAT1;PLA2G4A;MOGAT2;ABHD6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5106949089612481,1.5419591530859156,0.02702702702702703,0.6361439262155635,1.0,12/25,26.13%,ETS1;PRMT1;NCKAP1L;ARNT;TAL1;MAPK14;HMGB2;ACVR1B;STAT5B;HIF1A;BRD1;STAT3
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.5605002228624432,-1.5417608893842447,0.0378619153674833,0.3839360547644079,1.0,5/15,9.84%,NTRK3;VEGFD;F7;IL16;CDH13
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5311101777144397,1.5417062943311812,0.04332129963898917,0.6307773961285813,1.0,7/21,15.58%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CIB1;ATXN7
prerank,epithelial cell-cell adhesion (GO:0090136),0.6337137039921192,1.5399468736531152,0.04655493482309125,0.6325412243045919,1.0,2/11,2.18%,ITGB5;DSP
prerank,phosphatidylcholine metabolic process (GO:0046470),0.42068301262069724,1.5372373777577144,0.013136288998357963,0.6384116178663883,1.0,17/70,9.25%,LIPC;LPCAT2;PCTP;TMEM86B;MBOAT2;LPCAT4;LPIN2;CSNK2A2;CSNK2A1;PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;PLB1;LCAT;PLA2G5;CHKB
prerank,osteoclast differentiation (GO:0030316),0.5368566898953716,1.5362288175254906,0.0285204991087344,0.6366778451929539,1.0,11/22,24.43%,CSF1R;GAB2;SBNO2;SRC;OSTM1;MAPK14;OSCAR;CSF1;EPHA2;TYROBP;EFNA2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5628842931237944,-1.5361935693631938,0.029345372460496615,0.39622190843524246,1.0,5/16,5.31%,DMD;ANK2;RYR2;CALM1;CACNA1C
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4445095237624088,-1.5361347491722417,0.019138755980861243,0.393053578548293,1.0,12/38,13.53%,AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;KIF5B;ACTN2;ADRA2A;KCNMB4;KCNQ1
prerank,organelle fission (GO:0048285),-0.48427327596899616,-1.5333734121175713,0.03464203233256351,0.39751036555036706,1.0,12/24,20.32%,DNM3;TMCC1;PEX11A;DNM1L;DNM1;PRKN;FIS1;MFF;MTFR2;WASHC5;MTFR1;PEX19
prerank,phagosome maturation (GO:0090382),0.4729174375772896,1.5331263022218482,0.031088082901554404,0.6448280100285622,1.0,11/35,17.01%,ATP6V0B;MCOLN1;ATP6V1D;ATP6V0A2;TCIRG1;RAB39A;RAB34;ATP6V0A4;RAB20;RAB32;ATP6V0E2
prerank,glycolipid metabolic process (GO:0006664),0.4540681423761258,1.5329111465193164,0.018835616438356163,0.6392681180226121,1.0,17/47,22.09%,ST3GAL6;HEXB;CPTP;HEXA;NEU3;SMPD2;ASAH1;CERK;B4GALNT1;ARSA;CTSA;NEU4;SMPD3;GLB1;SUMF2;ST6GALNAC4;GBGT1
prerank,histone modification (GO:0016570),0.3866022256624382,1.5323173277750555,0.00322061191626409,0.6356213214779989,1.0,45/109,24.02%,BRD8;PRMT2;SIRT2;MTA1;HDAC10;PRKCD;SUDS3;RPS6KA5;PADI2;RBM14;TAF6L;TAF6;SIN3A;CPA4;EHMT2;PRMT8;MIDEAS;EYA3;PRMT1;USP36;MORF4L1;BAZ1B;KDM4A;UBE2U;PRMT6;BRMS1L;EZH2;MRGBP;HDAC5;NAA50;ATXN7;UBE2A;SIN3B;RPS6KA4;KAT5;CARM1;MIER3;MORF4L2;PHF20;TAF10;KAT6B;PARK7;EYA4;BRMS1;PHC1
prerank,spliceosomal snRNP assembly (GO:0000387),0.4674888939251421,1.5313721878285929,0.018835616438356163,0.6336756523863791,1.0,18/38,28.66%,SNRPC;COIL;SART3;SNRPF;GEMIN6;SMN1;TGS1;SNUPN;PRPF31;DDX20;USP4;PRPF3;GEMIN2;WDR77;CD2BP2;SRSF10;CLNS1A;SNRPG
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6551388661069899,1.5311350271986663,0.0575139146567718,0.6287178204248588,1.0,3/10,2.90%,NBR1;GREM1;LYN
prerank,negative regulation of complement activation (GO:0045916),-0.6451585099583319,-1.5310844879831802,0.03644646924829157,0.40052952296365485,1.0,5/10,14.41%,SERPING1;VSIG4;CR1L;CR2;CD46
prerank,cellular response to cAMP (GO:0071320),-0.46650614766695103,-1.53091805116534,0.023310023310023312,0.3976869352777816,1.0,16/30,23.75%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;HCN2;CRHBP;CFTR;SLC26A3;AQP1;HCN4;SLC5A5;EZR;WT1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6282088204102664,1.5305359955604483,0.04980842911877394,0.6251099667317607,1.0,3/11,5.43%,TGFBR2;LRP5;CTNNBIP1
prerank,mRNA polyadenylation (GO:0006378),-0.4910699946227701,-1.5295712362977296,0.04279279279279279,0.3949637350921312,1.0,7/26,7.82%,SCAF8;APP;PAPOLA;CSTF3;CDC73;GRSF1;PABPC1
prerank,RNA polyadenylation (GO:0043631),-0.4910699946227701,-1.5295712362977296,0.04279279279279279,0.3949637350921312,1.0,7/26,7.82%,SCAF8;APP;PAPOLA;CSTF3;CDC73;GRSF1;PABPC1
prerank,regulation of interleukin-17 production (GO:0032660),0.49227052963075396,1.5286868190067988,0.022569444444444444,0.6277451693665885,1.0,13/31,23.67%,IL18;SLC7A5;DDIT3;VSIR;TLR4;IL12B;NCKAP1L;LY9;OSM;SLAMF6;NOD2;MYD88;TGFB1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5536851096009665,1.5279820568151534,0.03903345724907063,0.6250781035798018,1.0,9/20,17.76%,PLEK;FMNL3;RHOQ;NCKAP1L;FHOD1;LLGL1;FMNL2;RAB13;ROCK2
prerank,response to ethanol (GO:0045471),-0.5622656499159702,-1.527738943504239,0.05919661733615222,0.3968703573098938,1.0,5/14,11.62%,GRIN2B;GRIN2A;GLRA1;GRIN3A;GLRA2
prerank,JNK cascade (GO:0007254),0.4668934558071436,1.5269589903418634,0.026455026455026454,0.6239928690487959,1.0,17/40,20.24%,IRAK2;RIPK2;GPS2;MAP4K3;RPS27A;UBC;ADORA2B;TAB2;MAP4K2;MAP3K11;MAP3K10;MAPK8;GPS1;TNFRSF19;TRIB1;CRKL;NOD2
prerank,transport along microtubule (GO:0010970),-0.600764854089626,-1.5267522424286417,0.04487179487179487,0.39602803999876035,1.0,7/13,11.89%,BORCS5;APP;DYNC1I2;CDC42;BAG3;COPG2;ARHGAP21
prerank,"phagocytosis, engulfment (GO:0006911)",0.470712467011268,1.5267447419142761,0.024029574861367836,0.6190685928820352,1.0,10/36,5.91%,ELMO1;ITGAM;BIN2;RAC1;AIF1;ARHGAP25;ITGB2;MYH9;RHOBTB1;RHOH
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5309064762725937,1.5253036043110872,0.04285714285714286,0.6199859767849621,1.0,6/21,6.62%,GREM1;TRPM4;CCL3;PTK2B;BCOR;ASPN
prerank,transcription by RNA polymerase III (GO:0006383),0.4978471546583961,1.5249017904523543,0.02413793103448276,0.6162109510596493,1.0,7/27,12.39%,IVNS1ABP;POLR3G;GTF3C2;GTF3A;BRF1;POLR3H;GTF3C6
prerank,calcium ion transmembrane transport (GO:0070588),-0.3705040498324755,-1.52409213362181,0.01098901098901099,0.4003441977381575,1.0,25/86,10.95%,GRIN2B;GRIN2A;MCU;SLC8A3;TRPC5;ATP2B1;RYR3;NALCN;TRPC4;TRPM3;ATP2A2;SLC24A2;SLC8B1;LETM1;CACNA1C;PARL;MCUB;PKD2;TMEM165;MICU2;ANO6;TRPC3;GRIN2D;ATP2A3;MICU3
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4289745805039324,1.5240849719998737,0.011647254575707155,0.6144432900034964,1.0,20/59,17.76%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;WNK1;TAF1;MARK2;MAP3K10;MAPK8;AKT1;DYRK4;DYRK1A;STK39;MAP2K1;CDC42BPB;ULK1;ROCK2
prerank,acylglycerol catabolic process (GO:0046464),0.4830922531674204,1.5238563706156767,0.034722222222222224,0.6098598383041829,1.0,5/30,10.94%,LIPC;LIPH;ABHD12;PNPLA1;ABHD6
prerank,sphingosine metabolic process (GO:0006670),0.570204579770389,1.5236811131175882,0.053703703703703705,0.605228998225695,1.0,6/17,11.56%,SPTLC3;ACER3;ACER2;PLPP1;ASAH1;PLPP2
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6184642679222287,-1.5213101996057625,0.03991130820399113,0.40519262338438466,1.0,4/10,17.67%,SLIT2;HMOX1;CD200R1;ADTRP
prerank,positive regulation of cell communication (GO:0010647),-0.4772516285817737,-1.5198511715808736,0.023255813953488372,0.4062244463462545,1.0,8/28,7.93%,GRIK2;RIMS2;ANK3;CLSTN2;SYT1;SOX11;HOMER1;LGI1
prerank,regulation of platelet activation (GO:0010543),0.5488395334693028,1.5182587001025607,0.04267161410018553,0.6245479901034605,1.0,7/21,8.52%,PRKCA;TLR4;LYN;PLEK;PLA2G4A;PDGFB;SELP
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.5226760824831718,-1.5176411948221824,0.046,0.4089749347986109,1.0,11/20,27.06%,HECW2;HECW1;YWHAE;NEDD4L;ACTN2;ADRA2A;PRKCE;CASQ2;CAB39;MMP9;TCAF2
prerank,import into nucleus (GO:0051170),0.41061101079459594,1.5175972231634136,0.009950248756218905,0.6219848469440532,1.0,35/73,26.83%,BACH2;SPRN;PHB2;FAM53A;SNRPF;PTTG1IP;SEC13;NUP62CL;APPL1;TNPO1;NUP50;GEMIN6;SMN1;SNUPN;NUP88;IPO4;DDX20;RPAIN;AKT1;TNPO3;CSE1L;NUP62;NUP107;GEMIN2;E2F3;IPO7;NUP153;IPO5;HNRNPA1;PRICKLE1;NUP188;APPL2;STAT3;IPO9;HIKESHI
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3378852532591335,-1.5175048511297684,0.0,0.4062192225461073,1.0,43/159,14.35%,LRRC4C;NLGN1;GRID2;LRFN5;GPC6;ROBO1;PTPRD;ADGRL3;ALCAM;TENM3;KIRREL3;PTPRT;CDH8;SLITRK1;IL1RAPL1;TENM2;CNTN6;EMB;NPTN;ITGAL;PALLD;CDH22;JAML;FAT4;CDH4;CDH7;CDH20;NECTIN1;CDH10;TENM4;PLXNB2;CDH11;CDH13;VCAM1;CDHR3;SDK1;CDH5;OBSL1;CDH1;PECAM1;PCDHB16;NTNG1;PKD1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5608737641012974,1.51631478020465,0.04789272030651341,0.6220700420632873,1.0,10/16,26.31%,SIRPA;ABCD2;PYCARD;ADCY7;ZC3H12A;ABCD1;PDCD4;MEFV;APPL2;CUEDC2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5535553554837889,-1.5162917561889326,0.06041666666666667,0.4066310136277137,1.0,5/16,10.58%,RBPJ;AKAP6;ZFPM2;ERBB4;PIM1
prerank,cardiac muscle cell action potential (GO:0086001),-0.4591569146883067,-1.515535316496328,0.03263403263403263,0.4054566301203004,1.0,10/30,14.70%,DMD;ANK2;FGF12;YWHAE;KCND3;CACNA1C;ATP1A1;KCNQ1;HCN2;KCNIP2
prerank,cilium movement (GO:0003341),-0.4241913373241984,-1.5145768388992273,0.020833333333333332,0.40511609349928923,1.0,23/47,30.27%,ODAD2;DNAI4;CFAP53;DNAAF5;DNAH9;DNAI3;CFAP61;CFAP206;CFAP91;ODAD3;SPA17;DNAH17;SPEF2;DNAAF1;CCDC39;TEKT5;CFAP100;CFAP70;DNAH11;ODAD4;DNAAF4;CCDC63;TEKT2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.42143257899137015,1.5144824771032719,0.0196078431372549,0.6247255274976906,1.0,15/54,17.86%,IVNS1ABP;SENP2;SMAD7;CAPN3;ARRB2;U2AF2;SPRY2;KLHL40;GNL3L;PIAS3;AKT1;USP4;HDAC8;ARRB1;SPOPL
prerank,protein localization to synapse (GO:0035418),-0.593644878090591,-1.5134666878684226,0.053497942386831275,0.4049440777887486,1.0,7/12,18.60%,NRXN1;NLGN1;PCLO;ZDHHC15;NRXN2;MPP4;BSN
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.618178655927571,1.5133454866037472,0.05225225225225225,0.6245368855672174,1.0,6/12,17.12%,SOX8;GDNF;PAX2;SMO;NOG;AGT
prerank,lipid oxidation (GO:0034440),-0.5997836943802775,-1.5120477824544973,0.05084745762711865,0.40594578591713154,1.0,3/12,6.03%,PLA2G7;ADIPOR2;ALOX5
prerank,aminoglycan biosynthetic process (GO:0006023),-0.4136109476539581,-1.5119022240969329,0.015317286652078774,0.4033959073562061,1.0,18/49,17.28%,B3GALT1;GPC6;HS3ST5;HS3ST2;EXT1;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;GPC3;PXYLP1;NDST1;B3GALT2;GPC4;EXT2;AGRN;B4GALT7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5469446123770495,1.5118121234288935,0.041044776119402986,0.6260425467890958,1.0,7/18,21.11%,SEL1L;RPS27A;UBC;OS9;RNF103;MAN1B1;SYVN1
prerank,negative regulation of macrophage activation (GO:0043031),-0.5351607232818575,-1.5112494029085166,0.04793028322440087,0.4022527511012313,1.0,4/16,14.67%,LRFN5;LDLR;FCGR2B;CX3CL1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4294992383138997,-1.5111906645970643,0.029213483146067417,0.3994969086608502,1.0,8/41,3.52%,ANK3;AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.46468031133667576,-1.5111072005987862,0.04866180048661801,0.3969106576788591,1.0,11/30,16.78%,SH3BP5;PRKCZ;CADM4;PARP14;PTPN2;PPP2R1A;SRCIN1;INPP5F;THY1;SFRP1;SFRP2
prerank,neurotransmitter transport (GO:0006836),-0.3818257100749064,-1.5110777614155142,0.020512820512820513,0.39417735082392363,1.0,18/73,9.03%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;PPFIA2;SYT1;SNPH;SLC5A7;GLS;SLC1A6;CHAT;GABRA2;SNAP25;SLC28A2;CASK;SLC6A15;RAB3A
prerank,t-circle formation (GO:0090656),0.6503773747207852,1.5099493112275022,0.032015065913371,0.6186011407940981,1.0,5/10,13.39%,NBN;SLX4;EXO1;BLM;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6503773747207852,1.5099493112275022,0.032015065913371,0.6186011407940981,1.0,5/10,13.39%,NBN;SLX4;EXO1;BLM;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6503773747207852,1.5099493112275022,0.032015065913371,0.6186011407940981,1.0,5/10,13.39%,NBN;SLX4;EXO1;BLM;TERF1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5125595202731519,1.5098357446894966,0.03625954198473282,0.6139315945899689,1.0,3/24,4.18%,ITGAM;DDIT3;CCL3
prerank,dendritic cell differentiation (GO:0097028),0.525039568187326,1.50885186522133,0.03873239436619718,0.6133676881557472,1.0,7/22,10.29%,TGFBR2;LGALS9;LYN;TRPM2;CCR7;AXL;IRF8
prerank,regulation of histone modification (GO:0031056),0.6079293649185769,1.5084465520893942,0.04914933837429111,0.6100649483628906,1.0,5/13,4.47%,AKAP8;AKAP8L;CDK9;HPF1;FLCN
prerank,ethanol metabolic process (GO:0006067),0.6015932887304953,1.5067468595210185,0.06985294117647059,0.612425060423667,1.0,4/12,18.57%,ACSS1;SULT2A1;ALDH1B1;ACSS2
prerank,regulation of acrosome reaction (GO:0060046),-0.6359436805604192,-1.5063474041575644,0.06118143459915612,0.40426729947841705,1.0,2/10,4.08%,PLCB1;GLRA1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5309029146799437,1.5062257600720663,0.03932584269662921,0.6095619298438674,1.0,7/21,13.49%,MBOAT2;LPCAT4;PLA2G4A;PLA2G4B;PLA2G5;MBOAT1;OSBPL5
prerank,chloride transmembrane transport (GO:1902476),-0.4218246686080233,-1.5053194198015898,0.020930232558139535,0.4044127934633573,1.0,21/48,17.56%,GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;SLC12A8;ANO3;GABRA2;SLC12A4;SLC12A5;GABRG2;ANO6;GABRB3;ANO5;GLRA2;GABRA5;SLC4A8;CFTR;GABRQ;SLC1A1;SLC12A1
prerank,lymphocyte mediated immunity (GO:0002449),-0.6021335429105541,-1.503679106058134,0.03836930455635491,0.4059755753277423,1.0,9/12,26.97%,MYO1G;BTN3A3;KLRD1;JAG1;CD46;KLRC2;MSH2;CD8A;SLA2
prerank,endocardial cushion morphogenesis (GO:0003203),0.5405517509708437,1.5026350999941356,0.05350553505535055,0.6206314730492801,1.0,9/18,26.10%,TGFBR2;HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;ISL1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.38141581350406084,1.5025573353900568,0.004792332268370607,0.616061064108505,1.0,17/104,6.62%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;GREM1;SMAD7;PMEPA1;SKI;TGFB1I1;SMURF1;SKIL;RPS27A;UBC;SPRY2;PDPK1;EID2;ASPN
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.6423290096196879,1.5005985173825263,0.05847953216374269,0.6197175168377329,1.0,4/10,7.65%,SIRT2;VHL;IMPACT;JUN
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6063825972761713,1.4990206665531092,0.05309734513274336,0.6218873604359605,1.0,9/13,30.89%,SOX8;ANKRD2;EID2B;DLL1;TGFB1;SOX9;PRICKLE1;SRA1;NOTCH1
prerank,T cell activation involved in immune response (GO:0002286),-0.5949121635918259,-1.4989986906436636,0.056338028169014086,0.4160599504035631,1.0,3/12,4.57%,CD74;LILRB1;ITGAL
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.635870613315636,1.498962154383819,0.05009633911368015,0.6173017847717138,1.0,3/10,6.91%,TGFBR2;LRP5;SHH
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.5541904621126581,-1.49840763803937,0.05263157894736842,0.4150241356477711,1.0,3/14,6.45%,PPP2R2B;PPP2R2A;PPTC7
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.48778877843171337,1.4979503640455363,0.05956678700361011,0.6170576837214392,1.0,7/28,9.12%,IRAK2;RIPK2;OTULIN;ITCH;RPS27A;UBC;TAB2
prerank,ceramide metabolic process (GO:0006672),0.4405494130476612,1.497830826444381,0.025041736227045076,0.6129294820829044,1.0,15/49,13.68%,ALOXE3;CERS3;DEGS2;PLA2G15;SPTLC3;ACER3;PNPLA1;FUT7;SMPD2;ACER2;PLPP1;ASAH1;CERK;PLPP2;CERS2
prerank,autophagy of peroxisome (GO:0030242),0.603925250795847,1.4972795915022412,0.04788213627992634,0.6106376798720797,1.0,5/12,14.52%,NBR1;ATM;PIK3C3;RB1CC1;TRAPPC8
prerank,glycerophospholipid catabolic process (GO:0046475),0.49330749733159074,1.49690719894739,0.03571428571428571,0.6076033627890368,1.0,7/27,9.13%,LIPC;ABHD12;PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;PLA2G5
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.43358829767551765,1.4967713996637009,0.0297029702970297,0.6037437977381687,1.0,15/47,17.07%,NBR1;GREM1;MAP4K4;LGALS9;AGER;SEMA4C;IGF1R;MID1;ARL6IP5;TAOK2;MAPK8IP1;MAP2K1;EIF2AK2;PDCD10;QARS1
prerank,retinol metabolic process (GO:0042572),-0.552766108423651,-1.4953319773585532,0.046610169491525424,0.42042540730295724,1.0,5/14,18.63%,RETSAT;RDH10;RBP4;DHRS9;RDH12
prerank,I-kappaB phosphorylation (GO:0007252),0.6275209760926155,1.493963294605579,0.053604436229205174,0.6115720128994473,1.0,2/10,2.87%,TLR7;TLR4
prerank,peptidyl-threonine modification (GO:0018210),0.41040869359121734,1.4932278297152213,0.014657980456026058,0.6103424026902743,1.0,23/66,17.76%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;GALNT1;WNK1;GALNT11;TAF1;GALNT3;MARK2;MAP3K10;MAPK8;AKT1;DYRK4;DYRK1A;STK39;MAP2K1;CDC42BPB;ULK1;ROCK2
prerank,positive regulation of nervous system development (GO:0051962),-0.42573854285573665,-1.4910676979779844,0.02088167053364269,0.42967610244672033,1.0,12/42,8.13%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;CLSTN2;MME;IL1RAPL1;SOX11;OPRM1;LIG4;SYNDIG1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.46736103226410175,-1.490119963421769,0.0425531914893617,0.4295550513095148,1.0,9/27,14.17%,CTNNA2;IL1RAPL1;GSK3B;HOMER1;CCDC88A;FCGR2B;FBXO7;NTNG1;NTNG2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5154059298284713,-1.4891079775490317,0.0546218487394958,0.42965950512616835,1.0,5/17,7.83%,SLIT2;FSTL1;DOK5;CASK;ZDHHC17
prerank,regulation of histone methylation (GO:0031060),-0.5675356515575309,-1.4870750036779385,0.07883817427385892,0.4325966915883504,1.0,8/13,23.43%,JARID2;TET1;NSD1;TTLL12;AASS;PIH1D1;CHTOP;FAM47E
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.46727304903559197,-1.486693706930835,0.025,0.430823822176915,1.0,8/26,5.14%,PLCB1;EGFR;FGF10;MTBP;KMT2E;ANKRD17;CCND2;UBE2E2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3905465605838019,1.4856664935396442,0.019736842105263157,0.6392466302030567,1.0,35/84,25.59%,SMOC2;ANXA3;ETS1;RAC1;PRKCA;PIK3CG;SPARC;RHOB;LGMN;PTK2B;PDPK1;PDGFB;MET;GATA2;PIK3CD;PIK3CB;PDCD6;ABL1;AKT1;MAPK14;PROX1;AGT;SCARB1;ROCK2;GATA3;THBS1;FGF18;ADAM17;ZC3H12A;FGF1;TGFB1;ITGB3;HIF1A;GPLD1;PLCG1
prerank,membrane lipid metabolic process (GO:0006643),0.5205869741257668,1.4853121585918843,0.04570383912248629,0.6361008140779816,1.0,3/22,1.91%,ST3GAL6;AGMO;ALOXE3
prerank,activation of GTPase activity (GO:0090630),0.38925555011182644,1.4842978688213888,0.00975609756097561,0.6360914410733304,1.0,23/89,13.84%,TBC1D16;ARHGAP22;ARHGAP45;SIPA1L2;TBC1D17;TBC1D9B;TBC1D10B;TBC1D7;ARHGAP25;TBCK;TBC1D8;GARNL3;TBC1D15;SIPA1;TAX1BP3;SGSM2;CCR7;SLC27A4;TBC1D9;RUNDC1;CCDC125;GMIP;TBC1D30
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5102069396006309,1.4834597093340662,0.04562043795620438,0.6351832533702154,1.0,8/21,12.14%,ABCD2;COA8;SIRT2;SLC30A10;AATF;BRCA1;PAX2;PINK1
prerank,regulation of interleukin-1 production (GO:0032652),0.5622825131613773,1.4820320832840352,0.05850091407678245,0.6373213035409645,1.0,5/15,11.33%,SIRPA;TLR4;CCR7;ORM2;CEACAM1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.38927615618176853,-1.4820021405321788,0.022727272727272728,0.4411529495998715,1.0,31/63,22.99%,SLC25A30;GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;SLC12A8;SLC37A4;ANO3;GABRA2;SLC12A4;SLC12A5;GABRG2;ANO6;GABRB3;ANO5;XPR1;GLRA2;GABRA5;SLC4A8;SLC26A2;CFTR;GABRQ;SLC1A1;SLC12A1;SLC5A6;SLC6A1;ANO2;SLC37A3;SLC5A5;SLC12A3
prerank,plasma membrane invagination (GO:0099024),0.48270801373885414,1.481656206592562,0.046762589928057555,0.634529166610853,1.0,8/29,3.78%,ELMO1;ITGAM;BIN2;AIF1;SNX18;ARHGAP25;ITGB2;MYH9
prerank,prostanoid biosynthetic process (GO:0046457),0.5603781983742486,1.4812970178004303,0.07553956834532374,0.6316684655099771,1.0,5/15,8.21%,TBXAS1;DAGLB;PTGS1;PLA2G4A;EDN2
prerank,membrane repolarization (GO:0086009),-0.539379729232221,-1.4805750059978828,0.06292134831460675,0.44223237286391975,1.0,6/15,17.16%,KCND3;ATP1B3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,error-prone translesion synthesis (GO:0042276),0.5264771049810886,1.479967305168311,0.05765765765765766,0.632748912209679,1.0,5/21,5.46%,PCNA;PRIMPOL;RFC2;RPS27A;UBC
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5103764354382909,1.4799149882050509,0.046181172291296625,0.6286126458724479,1.0,7/23,11.91%,PREB;SEL1L;TMED9;SEC13;OS9;UFD1;AUP1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5538135952063072,1.4770470637907762,0.06792452830188679,0.6363658908196934,1.0,10/15,29.13%,TLR4;APPL1;GBP5;TICAM1;NOD2;MYD88;HIF1A;STAT3;CARD9;TLR6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.35019370804428157,-1.476627122642249,0.013089005235602094,0.45044793354744356,1.0,45/110,20.91%,RPL36A;PPP2R2A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;RPLP2;RPL7A;SMG7;RPL41;RPL26;PABPC1;EIF3E;RPS27;RPL18A;RPS25;EIF4A3;SMG6;SMG5;RPL38;RPL37;PPP2R1A;RPS14;RPS15A;RPL24;HELZ2;RPS9;RPLP1;RPL22;RPL8;RPLP0;RPS12;SMG1;RPS10;RPL19;RPL13A;RPS6;RPS5;RPS19;RPL23A;UPF1;RPL29
prerank,regulation of RNA export from nucleus (GO:0046831),0.614028600508384,1.4762146371598461,0.06201550387596899,0.6355753948380131,1.0,6/11,25.39%,AKAP8L;DHX9;SETD2;KHDRBS1;NUP153;IWS1
prerank,central nervous system myelination (GO:0022010),-0.599101063681348,-1.4744907426210772,0.06302521008403361,0.45348371530944415,1.0,5/11,9.52%,B4GALT5;B4GALT6;MYRF;TENM4;CNTNAP1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6061502755284002,1.4740763253693954,0.07364341085271318,0.6407226191084051,1.0,3/11,7.34%,BIN1;CACNB2;NOS1AP
prerank,glycogen biosynthetic process (GO:0005978),-0.5777072828670731,-1.4739087385962264,0.09276018099547512,0.449577458429025,1.0,5/12,21.20%,GBE1;PER2;GYG1;UGP2;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),-0.5777072828670731,-1.4739087385962264,0.09276018099547512,0.449577458429025,1.0,5/12,21.20%,GBE1;PER2;GYG1;UGP2;PGM2L1
prerank,cell part morphogenesis (GO:0032990),-0.5627372908307854,-1.4719951513182303,0.07543103448275862,0.4525433315875613,1.0,5/13,9.61%,PID1;DNM1L;WASF1;FIS1;MFF
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6282393578750083,1.4718373484090082,0.0622568093385214,0.6462134141072007,1.0,3/10,6.54%,RPS27A;UBC;DIS3L2
prerank,defense response to fungus (GO:0050832),0.5436480040088494,1.4715583173841404,0.0595446584938704,0.6431144952499376,1.0,4/17,9.69%,CX3CR1;PLCG2;GAPDH;CLEC4E
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5708805265221506,-1.4711039392933383,0.06971677559912855,0.45202980814916,1.0,3/13,5.83%,MDFIC;SP100;BARD1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.48292293485600923,-1.4698598201987405,0.06040268456375839,0.4529113042224045,1.0,5/22,5.31%,CCR2;GABBR2;PALM;EDNRB;CACNA1C
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5357326855841033,-1.4686537788954206,0.06136363636363636,0.45395368580855944,1.0,4/15,4.61%,APP;IAPP;LDLR;APOE
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.505005348521819,-1.4675911583937364,0.058695652173913045,0.4542592129635175,1.0,5/19,4.60%,HS6ST3;HS3ST5;NDST4;EXT1;HS6ST2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.5011413742763028,-1.4670430641366943,0.06279069767441861,0.45310416286043464,1.0,9/21,17.58%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,covalent chromatin modification (GO:0016569),-0.5481843592894156,-1.4658975073489982,0.05714285714285714,0.45367864133649094,1.0,5/14,10.48%,SIRT1;HLCS;AURKB;HELLS;SETD5
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.627488019807255,1.4658767114721738,0.055248618784530384,0.6645917660248912,1.0,3/10,3.48%,HK2;PFKL;GFPT1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4272358724170587,1.4657963729419836,0.03225806451612903,0.6605713234119249,1.0,13/50,9.79%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;LRRC19;TRADD;TRIM44;CD86;IL12B;LIMS1;RTKN2
prerank,negative regulation of B cell proliferation (GO:0030889),0.6137569137878156,1.465102643364081,0.07678244972577697,0.6591994214418662,1.0,4/11,7.30%,LYN;ATM;TNFRSF21;TNFRSF13B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.503309711763427,1.4647859781668,0.055357142857142855,0.6562762006110866,1.0,8/22,16.35%,SEL1L;RPS27A;UBC;OS9;RNF103;MAN1C1;MAN1B1;EDEM1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5504024375833935,1.464240285361901,0.04504504504504504,0.654394534832176,1.0,2/15,0.45%,TGFBR1;TGFBR2
prerank,positive regulation of protein acetylation (GO:1901985),0.5801018681834631,1.4637672830114161,0.07378640776699029,0.652366183107473,1.0,6/12,21.64%,DIP2B;CEP295;RAPGEF3;KAT5;CAMK1;DDX3X
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5819479281054072,1.4636063502367669,0.08620689655172414,0.6488699325399918,1.0,3/13,3.48%,ITGAM;GAB2;ITGB2
prerank,prostanoid metabolic process (GO:0006692),0.5752318035086399,1.4631620132296779,0.06605504587155964,0.64654537800244,1.0,3/13,5.13%,HPGDS;PTGS1;HPGD
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.47591012415871825,-1.4629673234050293,0.052995391705069124,0.4593270968820457,1.0,9/25,9.92%,GRID2;LRRK2;GRIN2B;GRIN2A;GLRA1;GSK3B;INSYN2A;GRIN2D;CHRNA4
prerank,regulation of interferon-alpha production (GO:0032647),0.5013117991361928,1.4626293792705278,0.054409005628517824,0.6448875028676836,1.0,8/23,16.20%,TLR7;RIPK2;TLR4;DHX9;HAVCR2;SETD2;MAVS;IRF3
prerank,striated muscle cell differentiation (GO:0051146),0.550550419053637,1.4623535120387143,0.06666666666666667,0.6419188920179685,1.0,6/16,14.39%,MEF2C;SKI;MTLN;SORT1;AKAP13;MYEF2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6093316825752165,1.4620280360460642,0.06902654867256637,0.6392413753672265,1.0,4/11,17.39%,ARRB2;GTF2H2;GRK2;ARRB1
prerank,synaptic vesicle membrane organization (GO:0048499),0.5513848723261147,1.4618962452526878,0.06826568265682657,0.6358317385737573,1.0,6/17,13.36%,SNAP47;SYNGR1;AP3D1;STX1A;STX19;STX4
prerank,hemidesmosome assembly (GO:0031581),0.6037845519984859,1.4611386198855738,0.06343283582089553,0.6349582490732087,1.0,5/11,19.49%,DST;ITGA6;LAMA3;LAMC2;ITGB4
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5801943036242482,1.4604307098662197,0.10076045627376426,0.6340204017995743,1.0,5/13,11.45%,TGFBR2;SHH;PNP;NCKAP1L;RUNX1
prerank,cranial nerve development (GO:0021545),0.5946681485586683,1.4600036261975369,0.06533575317604355,0.6321068077872278,1.0,5/11,14.55%,SALL1;CHD7;POU4F1;PAX2;TMEM126A
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5392467203958244,1.4596719678202992,0.06111111111111111,0.6298026965502099,1.0,7/18,9.05%,MTUS1;LYN;CAMK1D;PTK2B;EDN3;EDN2;IL6R
prerank,atrioventricular valve development (GO:0003171),0.5574885786424355,1.4591303079489288,0.07608695652173914,0.6280842032306883,1.0,3/14,6.25%,TGFBR2;HEYL;MDM4
prerank,negative regulation of insulin secretion (GO:0046676),-0.5147104257453073,-1.4587419631343905,0.05868544600938967,0.4686023940270993,1.0,10/17,29.14%,IRS1;PRKN;ADRA2A;PIM3;SFRP1;CCN3;INHBB;REST;KLF7;FAM3D
prerank,positive regulation of integrin activation (GO:0033625),0.6069752642202935,1.4585402392074334,0.08287292817679558,0.6268555653006186,1.0,4/11,11.20%,P2RY12;PLEK;SRC;RASIP1
prerank,tRNA metabolic process (GO:0006399),0.5389300709526388,1.4584190002558215,0.05525846702317291,0.6236470594818212,1.0,7/17,16.33%,ADAT1;KARS1;POP1;SSB;SARS1;RPP21;DARS2
prerank,telomere capping (GO:0016233),0.5527074653711908,1.4572894868378208,0.07220216606498195,0.6247909261858303,1.0,8/16,19.17%,NBN;CTC1;DCLRE1B;DCLRE1C;TERF1;TEN1;DCLRE1A;ACD
prerank,cellular response to lipopolysaccharide (GO:0071222),0.36921983727089486,1.4565836889017945,0.02403846153846154,0.6239443681728905,1.0,37/101,24.18%,CX3CR1;IL18;SIRPA;MEF2C;SBNO2;TLR4;LYN;CCL3;CTR9;CASP1;MTDH;CD86;NLRP3;PDCD1LG2;CXCL1;AXL;PABPN1;TICAM2;CD180;SERPINE1;MAPK8;CCR5;PYCARD;MAPK14;TNIP2;HMGB2;TICAM1;NOD2;IL1A;ACOD1;ZC3H12A;SHPK;CXCL10;IL36G;MYD88;TGFB1;PDCD4
prerank,anterior/posterior pattern specification (GO:0009952),0.42072689065206964,1.4564869082012608,0.038523274478330656,0.6207904589534807,1.0,7/53,2.25%,TGFBR1;BASP1;LRP5;HEYL;HOXD9;DDIT3;SKI
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.5063165073096224,-1.456153921939724,0.0702576112412178,0.4677890727043819,1.0,9/20,17.58%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.5063165073096224,-1.456153921939724,0.0702576112412178,0.4677890727043819,1.0,9/20,17.58%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.5063165073096224,-1.456153921939724,0.0702576112412178,0.4677890727043819,1.0,9/20,17.58%,CENPF;ZW10;BUB1B;KNTC1;BUB1;TTK;TEX14;MAD1L1;TRIP13
prerank,response to hexose (GO:0009746),0.48587761382635253,1.4558182946439038,0.0564373897707231,0.6198404070388227,1.0,17/25,36.70%,PFKL;EIF2B3;SLC30A8;EIF2B4;KHK;THBS1;SELENOT;EIF2B2;GPLD1;TCF7L2;EIF2B5;LPL;ZBED3;SELENOS;VAMP2;EIF2B1;IRS2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.45097530581551737,1.4550845956745007,0.03716814159292035,0.6193840761688759,1.0,13/34,17.88%,SMAD3;SIRT2;CCDC85B;GPS2;FLCN;ZFP36L2;GATA2;WNT10B;GPER1;TRIO;BBS12;ANKRD26;GATA3
prerank,negative regulation of cartilage development (GO:0061037),0.5745897352310156,1.4550217636890705,0.06813996316758748,0.61606977763222,1.0,3/13,2.99%,TGFBR1;GREM1;EFEMP1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4668667540969303,-1.4550105618271454,0.06855791962174941,0.4682126269613996,1.0,6/25,5.16%,PDE4B;SPTBN1;PDE4D;CCR2;RPS3;IRF4
prerank,positive regulation of macrophage migration (GO:1905523),0.5255664593593525,1.454176253180356,0.06533575317604355,0.6160823810242023,1.0,8/19,18.17%,CSF1R;P2RY12;CCL3;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,fatty acid transport (GO:0015908),-0.5155612782986874,-1.4535817482119202,0.06950672645739911,0.4696744689314473,1.0,6/17,14.52%,PPARG;CD36;FABP4;APOE;MFSD2A;CPT1B
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5571055944524265,1.4530716704973472,0.05714285714285714,0.6170558717933365,1.0,8/14,24.37%,TGFBR1;GREM1;EFEMP1;PTPN11;CHADL;RFLNA;PTHLH;SOX9
prerank,cortical cytoskeleton organization (GO:0030865),0.43835296572179344,1.452262778700322,0.03873239436619718,0.6168728448348397,1.0,16/41,17.76%,RAC1;RND1;PLEK;FMNL3;RHOQ;RHOB;RHOBTB1;RND2;RHOH;NCKAP1L;FHOD1;LLGL1;FMNL2;TRPV4;RAB13;ROCK2
prerank,regulation of mRNA metabolic process (GO:1903311),0.5975481548797027,1.4510009577590122,0.09090909090909091,0.618609728302126,1.0,8/11,26.94%,NCBP1;DHX9;SLTM;CDK11B;SAFB;SAFB2;IWS1;PTCD2
prerank,protein kinase B signaling (GO:0043491),0.515008114927459,1.4508562002164482,0.058823529411764705,0.6158011861738215,1.0,10/23,23.67%,SIRT2;CCL3;THEM4;ZFP36L1;PAX2;PLK3;AKT1;PIK3R3;EPHA2;TGFB1
prerank,ganglioside biosynthetic process (GO:0001574),-0.5382039807382117,-1.4501480673943623,0.07608695652173914,0.4767712243683538,1.0,7/15,16.40%,B4GALT5;ST3GAL1;B4GALT6;ST8SIA4;ST8SIA2;B3GALT4;ST8SIA3
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.36670387505201996,-1.4499079935291157,0.01856763925729443,0.47483628491097396,1.0,21/75,14.17%,ANK3;CTNNA2;DCC;NRCAM;MAP1B;APP;SLITRK1;PLPPR4;MAP2;PAK3;DCDC2;ZDHHC17;ACTB;RAB8A;RAB3A;SPTBN4;MFSD2A;NEFH;PARD3;NTNG1;NTNG2
prerank,axon guidance (GO:0007411),-0.313161329021052,-1.4496961749078654,0.005494505494505495,0.4727480016587001,1.0,40/201,9.48%,NRXN1;DAB1;ROBO1;UNC5C;NFIB;DCC;ALCAM;SPTBN1;KIF5C;NRXN3;SLIT2;ARHGAP35;DOK6;PLXNC1;SHC3;BDNF;SEMA5A;CNTN6;EMB;NPTN;SHANK3;SEMA4A;PLXND1;PALLD;PLXNA2;CHN1;DOK5;NCAM1;GFRA2;DOK1;RET;EPHA5;LGI1;SPTBN2;DOK2;KIF5B;GRB10;PLXNB2;TMEFF1;SPTBN4
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4929858760375827,-1.4496924108594713,0.061946902654867256,0.47010009669564445,1.0,11/18,32.27%,RFX3;AQP4;CFAP53;NPHP3;SPA17;SPEF2;DNAAF1;CCDC39;ODAD4;DNAAF4;ROPN1L
prerank,regulation of microtubule depolymerization (GO:0031114),0.4811888377552552,1.4495382383103672,0.058287795992714025,0.6179778387004204,1.0,8/25,15.58%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;TRPV4;CIB1;ATXN7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3776598884012224,1.4488470022628863,0.017741935483870968,0.6174840608563626,1.0,24/87,13.42%,F11R;ABI3;CSF1R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;TRPM2;FSCN1;RND2;PTK2B;RHOH;ARHGAP17;MTOR;LRP1;MLST8;RAPGEF3;PDGFRB;HIP1R;TAOK2;ABL1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4971729326939007,-1.4483227948418849,0.06531531531531531,0.4714178215262035,1.0,6/19,13.36%,DLG2;LRRC7;DLG3;PATJ;MTCL1;PARD3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5376893760172639,-1.4482188287711157,0.048458149779735685,0.4690982353842538,1.0,8/15,29.11%,LRP6;EDA;FOXC1;WNT6;MSX1;HDAC1;TBX1;AMELX
prerank,RNA modification (GO:0009451),0.40897227923176627,1.447915118143375,0.03103448275862069,0.6179253412492891,1.0,26/54,29.78%,QTRT1;SSB;TRMT6;AARS2;ANKRD16;THUMPD1;NSUN5;JMJD6;CTU2;NSUN6;BCDIN3D;FTSJ3;CDKAL1;TYW5;QTRT2;NSUN3;TRMT61A;TFB1M;NSUN4;TRDMT1;FTSJ1;PARN;NOP2;TRMT9B;PUS7;TRUB1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.45564387001644685,1.4474127579355112,0.05319148936170213,0.6165515115131545,1.0,12/30,24.68%,ARHGEF2;CFLAR;TRADD;RFFL;BRCA1;SERPINE1;RNF34;DDX3X;BCL2L1;PARK7;FADD;FAIM
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3513941362219901,1.4472342233856283,0.009146341463414634,0.6139735820325797,1.0,32/150,12.78%,CX3CR1;TGFBR1;IL18;P2RY12;RAC1;PIK3R1;GAB2;IGF1R;SRC;PIK3CG;CCL3;THEM4;SPRY2;PIK3AP1;PDPK1;PDGFB;MTDH;CD86;MET;C1QBP;GCNT2;CCR7;RASD2;CALCR;FRS2;PIK3CD;AXL;PIK3CB;PDGFRB;PINK1;ENG;PTPN11
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.549587440050559,1.4468841588157393,0.06801470588235294,0.6121175722329883,1.0,3/16,8.53%,MRAP;PRKCA;GPER1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6319829756470978,1.4457439458764316,0.0683453237410072,0.6133344403918439,1.0,4/10,11.96%,PDE3B;ACER2;WNK1;SERPINE1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.472085773249147,-1.4456591718446734,0.053488372093023255,0.47369283111998234,1.0,10/24,18.11%,CD74;CD44;TPT1;ING2;SIRT1;CCAR2;BCL2;SNAI2;SFRP2;DDIAS
prerank,negative regulation of protein secretion (GO:0050709),-0.414284535122281,-1.445178599474641,0.03669724770642202,0.4724631880155967,1.0,18/38,29.29%,IRS1;RSAD2;APOE;PRKN;OPRM1;ADRA2A;HMGCR;RAB11FIP1;SFRP1;CCN3;ADTRP;CYP51A1;INHBB;SERGEF;REST;DPH3;FAM3D;IL12A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4427060487532632,1.4449581175028585,0.05714285714285714,0.613175335126591,1.0,9/38,9.70%,CX3CR1;SIRPA;SMAD3;RAC1;TLR4;AGTR2;CLU;NOS1AP;CD34
prerank,positive regulation of calcium ion import (GO:0090280),0.5888567511502161,1.444937338527876,0.08990825688073395,0.6100077571027506,1.0,4/12,11.53%,CCL3;PDGFB;CALCR;PDGFRB
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.407579809713506,-1.4449217800192087,0.04390243902439024,0.47061097792159357,1.0,12/43,14.09%,PID1;SORBS1;IRS1;PRKCZ;ZBTB7B;SIRT1;TNS2;PTPN2;GRB10;KANK1;PRKCQ;NUCKS1
prerank,centromere complex assembly (GO:0034508),-0.4251297543522887,-1.4434491663035132,0.05868544600938967,0.47217439096489733,1.0,13/36,17.22%,KNL1;CENPF;CENPT;CENPP;MIS18BP1;CENPE;DLGAP5;HELLS;CENPW;RBBP7;NASP;CENPS;NPM1
prerank,intracellular protein transport (GO:0006886),0.3205117916185497,1.4429420610342827,0.0027816411682892906,0.6147234987528866,1.0,121/304,26.22%,TBC1D16;HPS4;UNC93B1;ARHGEF2;PREB;HERC2;TBC1D17;TRAK1;SPRN;YWHAH;TBC1D9B;ARFIP1;COPA;ARFGAP3;TBC1D10B;SMURF1;AP2A1;TBCK;VPS26B;TBC1D8;ARL5C;VIPAS39;TBC1D15;FAM91A1;PHB2;STXBP1;AP3D1;FAM53A;STX1A;STRADA;TMED9;ARFIP2;STX12;NUP42;TMED4;SGSM2;PTTG1IP;EGR2;RAB3GAP2;RANBP3;STX19;SEC13;NUP62CL;TRARG1;AP1M2;RAB1A;CLIP3;APPL1;TNPO1;NUP50;TICAM2;SAR1A;TBC1D9;SNX31;RUNDC1;SEC31B;NUP88;PDCD6;IPO4;STX4;TBC1D30;RPAIN;RAB20;SLU7;NAPG;SCG5;AKT1;RAB32;SNX13;PICK1;TNPO3;LTBP2;VPS36;ADPRH;GGA3;CSE1L;NUP62;SGSM3;BCS1L;CTSA;EIF2D;NUP107;ARL11;VPS29;GRTP1;RAB6B;STX5;E2F3;ACD;AP4M1;VPS26A;VPS35;MAIP1;LAMP2;ARF1;IPO7;KIF13A;SIL1;SEC31A;SNX6;STX8;KATNB1;STX16;ARF4;KIF13B;NUP153;TGFB1;IPO5;WLS;XPO5;PRICKLE1;VPS45;XPO1;NUP188;TBC1D22A;TBC1D13;HDAC6;APPL2;COG7;STAT3;IPO9
prerank,cytoplasmic translation (GO:0002181),-0.3549131452661996,-1.4428593784849482,0.0213903743315508,0.47131402101955583,1.0,42/91,26.39%,RPL36A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;EIF3M;RPL7A;RPL41;RPL26;RPS27;RPL18A;RPS25;RWDD1;RPL38;RPL37;RPS14;RPS15A;RPL24;RPS9;RPLP1;RPL22;RPL8;RPLP0;RPS12;RPS10;RPL19;RPL13A;RPS6;RPS5;RPS19;RPL23A;RPL29;RPS11;RPL18;DRG2;RPS23;RPS15;RPL23;RPL17
prerank,regulation of vasoconstriction (GO:0019229),-0.45100485321238715,-1.4411497380595903,0.05296610169491525,0.47370142542758953,1.0,12/27,20.95%,ADRA1A;ATP2B1;KCNMB2;ZDHHC21;PER2;CHRM3;KCNMB4;SMTNL2;ADM;AVPR2;ACE;ADRA1B
prerank,amide transport (GO:0042886),-0.4544771579377536,-1.4408614725326163,0.05088495575221239,0.47196555654696276,1.0,14/26,25.00%,DISP1;PLTP;PLEKHA3;TAP1;SLC14A1;AQP11;SLC46A1;CERT1;SLC14A2;SLC5A6;ABCB9;FOLR2;FOLR1;SLC25A32
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.505474867500572,-1.4407429007261519,0.07159353348729793,0.46974279273896397,1.0,5/18,7.78%,MDFIC;CTNNA1;LATS1;GSK3B;ILRUN
prerank,establishment of protein localization to organelle (GO:0072594),0.38723891772907654,1.4403768605237073,0.03161397670549085,0.6221917925882889,1.0,34/72,26.83%,HK2;SPRN;NEURL1B;PHB2;FAM53A;LAMP5;PTTG1IP;SEC13;NUP62CL;APPL1;TNPO1;NUP50;PINK1;NUP88;IPO4;IL10RA;RPAIN;AKT1;TNPO3;CSE1L;NUP62;NUP107;E2F3;LAMP2;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;CD68;HIKESHI
prerank,serine family amino acid catabolic process (GO:0009071),-0.5892838931593859,-1.4402074207818663,0.07036247334754797,0.46892409200857504,1.0,5/10,17.04%,GCSH;SHMT1;DAO;AMT;GLDC
prerank,response to acidic pH (GO:0010447),0.5734032363777057,1.4401234357150798,0.07380073800738007,0.6200091806466619,1.0,4/13,16.99%,IMPACT;CTSS;LGMN;GPR4
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6142617982597027,1.4398938571085993,0.08719851576994433,0.6176472191549098,1.0,5/10,9.13%,LIPC;PLA2G4A;PLA2G6;PLA2G15;PLA2G5
prerank,neuron development (GO:0048666),-0.3292517903577316,-1.4397389215563137,0.002785515320334262,0.4678078670536967,1.0,30/141,9.27%,CNTNAP2;NLGN1;FRY;TENM3;B4GALT5;GPM6A;B4GALT6;APP;ETV1;TENM2;RAPGEF2;NTRK2;VAPA;MYT1L;EHD1;MAP2;APOE;STMN4;GSK3B;SH3GL2;TOR1A;PBX1;ERCC6;EPHA5;LGI1;ALK;ATP7A;RASGRF1;TENM4;PBX3
prerank,regulation of superoxide anion generation (GO:0032928),0.5585592533231136,1.4391157172041762,0.07246376811594203,0.617650569713157,1.0,8/14,23.86%,ITGAM;ITGB2;PRKCD;AATF;SOD1;MAPT;TGFB1;TYROBP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.36605211090363143,1.4382418516559614,0.024630541871921183,0.6179851185345413,1.0,35/95,24.87%,CX3CR1;SIRPA;MEF2C;SBNO2;SIRT2;CYRIB;TLR4;CTR9;CASP1;CD86;NLRP3;PDCD1LG2;CXCL1;AXL;PABPN1;TICAM2;CD180;SERPINE1;MAPK8;CCR5;PYCARD;MAPK14;TNIP2;HMGB2;TICAM1;NOD2;IL1A;ACOD1;ZC3H12A;SHPK;CXCL10;IL36G;MYD88;PDCD4;FZD5
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46753239062024143,1.4379141754145486,0.05723905723905724,0.6161506496073379,1.0,11/30,15.32%,HEXB;ARSB;CHST11;HEXA;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;CHSY1
prerank,negative regulation of innate immune response (GO:0045824),-0.4320746994579705,-1.4361514719028203,0.04157043879907621,0.47532401667671637,1.0,13/34,24.85%,USP15;SERPING1;VSIG4;PTPN2;TRAFD1;TTLL12;SAMHD1;OAS3;IRAK3;RPS19;LYAR;NMI;NLRC3
prerank,positive regulation of cytokinesis (GO:0032467),-0.4360815434549322,-1.4351284945071554,0.05217391304347826,0.47586251459861,1.0,8/32,9.30%,CUL3;KIF23;RACGAP1;CDC42;GIPC1;KIF14;PKP4;AURKB
prerank,regulation of bone mineralization (GO:0030500),0.41005767455007414,1.4347551041094684,0.02735042735042735,0.6257847213732447,1.0,10/55,6.16%,TMEM119;NBR1;GREM1;BMP2K;MEF2C;TRPM4;CCL3;SLC8A1;PTK2B;BCOR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.44974604083567066,1.4347278047813095,0.0586145648312611,0.6227798912457941,1.0,10/32,15.58%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CLIP3;CIB1;MAPRE1;DYRK1A;ATXN7
prerank,response to growth factor (GO:0070848),0.4227290660459422,1.4344045653969149,0.030874785591766724,0.6208922879359579,1.0,18/41,26.62%,TGFBR1;TGFBR2;TWF2;TBC1D7;PDGFB;PLK5;AKT1;CIB1;ACVR2B;MAPK7;HTRA2;EPHA2;NOS1;ACVR1B;STAT5B;HDAC6;ACVR1;URI1
prerank,triglyceride homeostasis (GO:0070328),0.4771877848305779,1.4344007979176625,0.06813996316758748,0.6178442865417831,1.0,4/26,5.66%,IL18;LIPC;MLXIPL;MTLN
prerank,nucleotide metabolic process (GO:0009117),0.4865575580868848,1.4334231107243183,0.07065217391304347,0.6188209299847148,1.0,6/23,10.73%,FHIT;GUK1;CMPK1;PNP;REXO2;DCTD
prerank,sensory perception of taste (GO:0050909),-0.5809532768182107,-1.4333475640931443,0.09070294784580499,0.47834458137279884,1.0,5/10,34.64%,CD36;ASIC3;TAS1R3;TAS1R1;PKD2L1
prerank,muscle cell development (GO:0055001),-0.44430805590437916,-1.432930598879842,0.048426150121065374,0.4770776069158111,1.0,5/30,3.58%,SGCZ;DMD;MYOF;ANK2;NEBL
prerank,adherens junction organization (GO:0034332),-0.39171970653843197,-1.4327758684102878,0.0410958904109589,0.47505315264939313,1.0,17/48,13.41%,CADM2;CTNNA1;CDH8;AFDN;CDH22;CDH4;CDH7;CDH20;NECTIN1;CDH10;ACTB;CDH11;CDH13;CDHR3;CDH5;JAM3;CDH1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6172881879351191,1.432431325342847,0.0933852140077821,0.6199757766234999,1.0,3/10,10.24%,TGFBR2;LGALS9;NCKAP1L
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4942734038110373,1.4322770784075205,0.04693140794223827,0.6175984229449509,1.0,7/23,12.14%,MBOAT2;LPCAT4;PLA2G4A;PLA2G6;PLA2G4B;PLA2G5;MBOAT1
prerank,positive regulation of cellular respiration (GO:1901857),0.5903120928821384,1.4314777897855013,0.07476635514018691,0.6176973579370091,1.0,6/11,33.03%,ISCU;IL10RB;PINK1;PARK7;IFNAR1;VCP
prerank,phospholipid translocation (GO:0045332),-0.44644791300152525,-1.4313980797668693,0.050724637681159424,0.4767838324928438,1.0,13/28,18.74%,ATP8B4;ATP11A;ANO6;MFSD2A;PLSCR4;PLSCR2;ATP11C;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1;ATP10A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.49765236332346585,1.4311006638976065,0.05719237435008666,0.6161895517677997,1.0,12/24,25.33%,SRC;CTC1;HNRNPC;SLX4;ERCC4;GNL3L;TERF1;EXOSC10;TEN1;ACD;HNRNPA1;STN1
prerank,protein modification by small protein conjugation (GO:0032446),0.31349161700753436,1.4310089304835598,0.0,0.6135463344382199,1.0,94/361,18.67%,HERC2;SUMO1;RNF38;NFE2L2;KLHL7;ARRB2;TRIM69;PJA2;SMURF1;PCNA;OTULIN;ITCH;TRIM11;VHL;TRIM5;RANBP2;UBA2;SPSB1;FBXL15;UBA7;TRPM4;FBXO24;RNF41;PEX10;CTR9;STX1A;ENC1;KLHL24;UBE2H;RNF138;RPS27A;UBC;TRIM44;HLTF;ZSWIM8;SPSB2;NUP42;TRIM72;ARRDC1;EGR2;CDC34;CUL4B;DTX4;BRCA1;ANKRD9;OS9;ASB11;CRBN;RNF8;RNF103;MSL2;RNF20;NUP50;AREL1;MYLIP;ASB5;RNF25;DTX1;NUP35;FBXL2;USP5;MIB2;PINK1;UBE2V2;UHRF2;NUP88;TRIM62;RNF187;ZNRF3;WWP2;PIAS3;UBA5;KLHL18;RRAGA;DTX3;MKRN3;RNF7;PIAS2;CCDC22;UBE2A;FBXO11;ANAPC11;DET1;DTX3L;NUP62;ARRB1;SEH1L;TNFAIP1;LZTR1;NUP107;TRIM47;STUB1;FBH1;CUL4A
prerank,cellular response to fatty acid (GO:0071398),-0.5619451354250566,-1.4307661414397108,0.08744394618834081,0.4761692801473501,1.0,7/12,29.83%,PID1;IRS1;NR1H4;PDK3;PDK4;DGAT2;AKR1C1
prerank,fatty acid catabolic process (GO:0009062),0.39295694869255504,1.4291708962051572,0.0322061191626409,0.6174831133066118,1.0,24/67,23.62%,ABCD2;ACAD10;PPARD;LPIN2;ECHS1;NUDT19;PLA2G15;MTLN;PHYH;ACADM;HAO1;SLC27A4;CROT;ECI1;ECHDC2;HADHB;HSD17B10;LPIN1;MMUT;ACAA2;HACL1;ABCD1;ACOT8;SCP2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.45928774419767276,-1.4289743940249169,0.0625,0.47887530265445055,1.0,6/25,7.62%,NLGN1;SHISA9;SHISA6;CACNG2;SHANK3;GSG1L
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.47611736012010913,-1.4288462594892573,0.06588235294117648,0.47678054349891774,1.0,9/21,10.95%,MCU;SLC8A3;PDZD8;SLC8B1;LETM1;MCUB;MICU2;FIS1;MICU3
prerank,cardiac muscle tissue development (GO:0048738),-0.39231493985236426,-1.4283606638501858,0.033734939759036145,0.4758021675991847,1.0,21/50,32.25%,SGCZ;SGCD;SIK1;RBP4;HEY2;BMP4;SMAD1;GJA5;MSX1;CACNA1G;HCN4;NOTCH2;SHOX2;CBY1;ZFPM1;TTN;ADAMTS9;NRG1;NPPA;MYOCD;TBX18
prerank,negative regulation of cytokine production (GO:0001818),0.34273995408131974,1.4278960138534,0.003105590062111801,0.6198783785311754,1.0,45/163,18.17%,NAV3;SIRPA;ABCD2;CD84;RAC1;LGALS9;DDIT3;VSIR;RNF216;AGER;ITCH;TLR4;OTUD5;UBA7;TNFRSF21;RPS6KA5;PCBP2;C1QBP;SARS1;CCR7;PDCD1LG2;IL12B;INHA;CD34;UFD1;AXL;NCKAP1L;CEACAM1;DLL1;HAVCR2;CD33;PIN1;MAVS;PYCARD;NLRX1;GPNMB;SLAMF1;IRF3;LGALS7;RPS6KA4;ADCY7;ARRB1;KAT5;SLC11A1;THBS1
prerank,fatty acid beta-oxidation (GO:0006635),0.4143024715070934,1.427877622268036,0.03819444444444445,0.6170001839403142,1.0,21/51,25.57%,ABCD2;ACAD10;PPARD;ACOX3;ECHS1;MTLN;IVD;ACADM;CROT;ECI1;ECHDC2;HADHB;HSD17B10;CRAT;ACAA2;ABCD1;ACOT8;SCP2;ETFDH;ETFB;ETFA
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4486630913967653,-1.427111241356554,0.058315334773218146,0.4768780558795044,1.0,7/27,5.31%,CTNNA3;PDE4B;ANK2;PDE4D;RYR2;ATP2A2;CACNA1C
prerank,regulation of nervous system process (GO:0031644),-0.5005914979014751,-1.4268701587551873,0.07126948775055679,0.4752804823275254,1.0,6/18,13.25%,SLC8A3;APP;HTR2C;DLGAP1;DLGAP2;TMEM108
prerank,error-free translesion synthesis (GO:0070987),0.49090753489014055,1.4267342324381582,0.06810035842293907,0.6183005780131196,1.0,11/22,27.90%,PCNA;RFC2;RPS27A;UBC;UFD1;POLDIP2;RFC1;RPA3;SPRTN;NPLOC4;RPA1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.38438136737626266,1.4266526627674656,0.02711323763955343,0.6156659953615228,1.0,11/74,7.88%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;GREM1;SMAD7;TGFB1I1;PHLDB1;SPRY2;GCNT2;OVOL2
prerank,cellular response to pH (GO:0071467),0.5295508459643385,1.4266351821259384,0.08226691042047532,0.6128287630386842,1.0,3/17,10.72%,MCOLN1;IMPACT;HVCN1
prerank,cellular response to cytokine stimulus (GO:0071345),0.309333970674049,1.4259277924576674,0.002607561929595828,0.6128832248179111,1.0,108/416,18.37%,INPP5D;ST3GAL6;SELPLG;DOCK8;IL18;ITGAM;SIRPA;CSF3R;ARHGEF2;CSF1R;SMAD3;NFE2L2;IL1RL2;LGALS9;AIF1;IRAK2;PIK3R1;GAB2;SBNO2;CRNN;LRCH1;PRKACA;TLR4;NPNT;CDK9;ITGB2;EGR1;CCL3;TNFRSF21;FSCN1;CASP1;STX1A;MT1X;EBI3;RPS27A;UBC;MMP2;TRADD;CSK;IL6ST;SOCS6;DHX9;CD86;CDC34;ZFP36L1;BRCA1;ZFP36L2;DUOX1;CNTF;CCR7;NOS2;EDN2;IL12B;GPER1;CTF1;CXCL1;POU4F1;IL6R;MT2A;GAPDH;PIK3CD;INPP5K;IL12RB2;AXL;PIK3CB;IRF8;WNK1;ASAH1;GBP6;PDE1B;IL10RB;PTPN11;LDLRAP1;STX4;IL34;IL10RA;IL18BP;MAPK8;CCR5;IFNGR2;GHR;BAG4;PYCARD;IL4R;NDUFA13;AKT1;CIB1;CSF1;STK39;IL1R2;TEC;OSM;ZEB1;STAT6;GBP5;AIM2;PTPN23;TXLNA;PTPN5;EPRS1;CSF2RA;POU2F1;PTPRJ;GATA3;IL20RA;HTRA2;GBP7;TYK2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3931721560927269,-1.4241614447430297,0.057007125890736345,0.48033915248665177,1.0,13/44,14.70%,AKAP6;ANK2;KCNN2;KCNJ3;KCNMB2;GABBR1;GABBR2;ATP1B3;ANO6;ACTN2;KCNMB4;KCNQ1;KCNIP2
prerank,dendrite self-avoidance (GO:0070593),-0.5149616865977041,-1.4239191652956311,0.07538802660753881,0.4785977575122194,1.0,11/16,31.98%,CNTN6;EMB;NPTN;PALLD;TNN;BSG;DSCAML1;CNTN4;DSCAM;ROBO4;ROBO3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.5576890295695244,1.4236529084209844,0.07526881720430108,0.6190243252013364,1.0,6/15,17.12%,SOX8;GDNF;PAX2;SMO;NOG;AGT
prerank,epiboly involved in wound healing (GO:0090505),-0.5106152225523801,-1.4231776003201166,0.0755939524838013,0.4783529955033047,1.0,5/16,10.46%,CD44;ARHGAP35;TMEFF2;TOR1A;CD151
prerank,regulation of myoblast differentiation (GO:0045661),0.4505410755047131,1.4230544574152908,0.06872852233676977,0.6185820574429249,1.0,12/32,15.05%,MEF2C;IGFBP3;SOX8;ZFP36L1;FLOT2;RBM24;ANKRD2;AKIRIN1;EID2B;DLL1;LRRC8A;MAPK14
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5150002702245343,1.4229563249492,0.07806691449814127,0.6160591196965128,1.0,4/19,5.66%,DAGLB;ABCD2;PRKCD;MTLN
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.4187425683263002,-1.422925517718005,0.04018912529550828,0.47662429831881825,1.0,16/38,20.69%,NEDD9;SH3BP5;GRM5;NCK2;APP;DLG3;ERBB3;UNC119;SRCIN1;LILRA5;THY1;RELN;DOK7;EPHA4;ACE;NOX4
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.37304898616140086,-1.4220812369022797,0.039119804400977995,0.4765600541470259,1.0,15/57,11.19%,GRM7;GRM8;ADCY2;GABBR1;ADCY5;CHRM2;OPRM1;CHRM3;HTR1D;HTR4;ADRA2A;GNAI1;RGS1;ADCY3;ADCY8
prerank,histone H3-K4 trimethylation (GO:0080182),0.6005777903248115,1.4217454826768507,0.08073394495412844,0.6178515064923914,1.0,3/11,6.57%,KMT2D;CTR9;TET3
prerank,intestinal lipid absorption (GO:0098856),-0.5789538795229571,-1.4196856384520742,0.09978308026030369,0.4810192790894006,1.0,3/11,13.18%,CD36;LDLR;UGCG
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5249489713227539,-1.4189295539017948,0.07777777777777778,0.48083707995669206,1.0,7/15,16.01%,CD74;CD44;ING2;PRKN;SIRT1;BCL2;MDM2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5381596095969428,1.4187495792858604,0.09722222222222222,0.6273351070069185,1.0,5/16,11.39%,SALL1;NPNT;SHH;GDNF;PAX2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5230721409460974,1.4185106498356477,0.0632688927943761,0.6254812960895901,1.0,10/19,25.33%,SRC;CTC1;HNRNPC;GNL3L;TERF1;EXOSC10;TEN1;ACD;HNRNPA1;STN1
prerank,neuron apoptotic process (GO:0051402),-0.49424234995022165,-1.4173717911938253,0.078125,0.4828524861759349,1.0,6/19,8.89%,SCN2A;TRPC5;APP;DIABLO;LIG4;ERBB3
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.44092706184676783,-1.416597657547126,0.06046511627906977,0.48273671629054454,1.0,10/32,7.76%,ADGRB3;PTPRD;CDKL5;IL1RAPL1;HECW2;HECW1;RAPGEF2;NEDD4L;GSK3B;CUL7
prerank,positive regulation of axonogenesis (GO:0050772),-0.3964365373186861,-1.4150056272324676,0.05620608899297424,0.485130541329456,1.0,15/43,15.91%,ROBO1;CDKL5;SLIT2;PLXNC1;BDNF;SLITRK1;NTRK2;PLXND1;PLXNA2;PLXNB2;MAP3K13;PLXNB1;SEMA7A;TIAM1;ARHGDIA
prerank,mesenchyme morphogenesis (GO:0072132),0.5191427070967778,1.4146263553784717,0.08538899430740038,0.638616834562163,1.0,11/17,33.64%,HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;ISL1;NOTCH1;BMPR1A;HEY1
prerank,central nervous system neuron differentiation (GO:0021953),-0.42568276614809003,-1.414255747187932,0.07207207207207207,0.48501416741471043,1.0,7/33,5.42%,MDGA2;GRID2;SPOCK1;NTRK2;LRP6;MAP2;NR4A2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5102243674970626,1.4139558676304333,0.08097928436911488,0.6384278400721651,1.0,7/19,16.20%,TLR7;RIPK2;TLR4;DHX9;SETD2;MAVS;IRF3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.42849892373435083,1.4138824641887346,0.06206896551724138,0.6357821257457326,1.0,12/39,12.68%,SALL1;TGFBR2;LRP5;NPNT;PKHD1;SHH;MET;GDNF;NOTCH4;RASIP1;PAX2;ENG
prerank,regulation of actin filament polymerization (GO:0030833),0.38968948360798744,1.4126834618333153,0.036741214057507986,0.6378018886544707,1.0,24/69,20.75%,BIN1;SSH2;TWF2;BAIAP2L2;DBN1;CDC42EP2;CYRIB;PRKCD;ARHGAP28;ABITRAM;PTK2B;SSH1;CCR7;NCKAP1L;HIP1R;PYCARD;TENM1;FCHSD2;CDC42EP3;DBNL;VASP;CCL24;SSH3;FCHSD1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5617552171237409,-1.4126251014589575,0.09766454352441614,0.48743803186456436,1.0,8/12,34.89%,DPYD;DPYSL5;CTPS1;CDA;ALDH6A1;DPYSL4;UMPS;DPYSL3
prerank,negative regulation of secretion by cell (GO:1903531),-0.4138299583969296,-1.4120065096485324,0.05694760820045558,0.48691098591409876,1.0,13/38,23.50%,GRM7;LILRB1;IL1RAPL1;RSAD2;APOE;STXBP6;HMGCR;SNCA;ADTRP;CYP51A1;HRH3;SERGEF;ANXA1
prerank,regulation of endothelial cell migration (GO:0010594),0.37169647208819717,1.4090845241394971,0.035830618892508145,0.6497606274232833,1.0,33/85,24.88%,PTPRM;SMOC2;ANXA3;ETS1;RAC1;PRKCA;PIK3CG;SPARC;RHOB;PTK2B;PIK3CD;PIK3CB;CEACAM1;APOH;PDCD6;ABL1;AKT1;PROX1;PRCP;AGT;SCARB1;ROCK2;GATA3;THBS1;KRIT1;EPHA2;SYNJ2BP;ZC3H12A;STC1;FGF1;DNAJA4;ITGB3;GPLD1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5472566294724895,1.4089063211431991,0.1,0.6475695412156728,1.0,5/14,12.97%,FAM98B;CSTF2;TSEN2;CPSF1;TSEN54
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4252883976196087,1.4086093189101774,0.058919803600654665,0.6457836301371388,1.0,12/39,16.30%,TANC2;MYO1B;TRAK1;MYO1F;MYO1E;BICDL2;MYO7A;RAB1A;CLN3;MYO5B;MYO15A;WASL
prerank,acylglycerol biosynthetic process (GO:0046463),0.4916389013724676,1.40849594230199,0.06401384083044982,0.6434303383475709,1.0,7/23,9.06%,AGMO;LPIN2;DGAT1;PLA2G4A;PLA2G15;MOGAT1;MOGAT2
prerank,regulation of cell differentiation (GO:0045595),0.33791875658882714,1.4084656213638869,0.0182370820668693,0.6407420989923875,1.0,32/148,13.02%,TGFBR1;BIN1;ZFHX3;GREM1;SMAD7;YWHAH;DDX5;RPS6KA1;PRKACA;GPS2;VHL;CDK9;MBOAT2;LTBP4;TAF8;PHLDB1;NREP;SHH;ZFP36L1;FLOT2;EDN3;BCL6B;GDNF;NEUROD4;CDK5RAP1;DDX17;NOTCH4;PRKCB;DLL1;RUNX1;FADS1;PLEKHB1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.36632710739830243,1.4084433309977265,0.03764320785597381,0.6380369116808572,1.0,37/94,26.99%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;ODF2;CEP162;TUBB;CEP164;TUBG1;HAUS7;MKS1;CNTRL;TUBA1A;CEP63;CEP57;HAUS6;HAUS2;SFI1;MAPRE1;TCTN1;CEP135;ACTR1A;OFD1;B9D1;DCTN2;CEP43;MARK4;CEP70;TTBK2;CSNK1D;CCP110;CEP97;DYNLL1;NDE1;TCTN2;CC2D2A;HAUS5
prerank,protein localization to membrane (GO:0072657),-0.30884890673904325,-1.4081732751070184,0.002976190476190476,0.49560306881138677,1.0,52/187,17.48%,DLG2;MAGI2;KCNIP4;NRXN1;NLGN1;DPP6;ANK3;KCNB2;ITGA4;DPP10;ANK2;LRRC7;SPTBN1;RAB3C;FRMPD1;MYO5A;RAPGEF2;ITGB7;LRP6;EHD1;DLG3;ITGAL;SHANK3;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;SPTBN4;P2RY1;ZDHHC23;ITGB1BP1;TM9SF2;TESC;ZDHHC15;EFR3A;CDH1;NRXN2;THY1;NUP54;NUP155;TMED2;AGRN;ARL5B;CACNB3;PLEKHF1;EHD2;WDR19;S100A10
prerank,tryptophan metabolic process (GO:0006568),-0.5849816428224084,-1.407938925204384,0.0967741935483871,0.49397184254601445,1.0,4/11,19.96%,KMO;ATP7A;IDO2;KYAT1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5640047768643496,-1.4077139112104982,0.087248322147651,0.49232018198330624,1.0,6/11,28.87%,PID1;PRKN;TFRC;VAT1;ADCK1;BNIP3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.40052134884987095,-1.4075021004014945,0.04326923076923077,0.49061299515154183,1.0,7/40,3.74%,MAGI2;DAB2;HIP1;BICD1;B2M;ATAD1;SGIP1
prerank,positive regulation of cyclase activity (GO:0031281),0.5418786603180316,1.406728395211825,0.09829867674858223,0.6421270093779685,1.0,7/14,20.49%,AKAP5;NOS2;MAPK8;MAPK14;CACNA1D;ORAI1;NOS1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4011210475228685,-1.4063892053094142,0.04523809523809524,0.491487560045494,1.0,18/41,21.44%,NEDD9;DOCK3;GRM5;STAP1;BDNF;NTRK2;DLG3;ERBB3;ADRA2A;UNC119;SRCIN1;LILRA5;RELN;DOK7;EPHA4;ACE;NOX4;FYN
prerank,kinetochore organization (GO:0051383),-0.5306202827462045,-1.4062882011004936,0.09090909090909091,0.4895062102538011,1.0,6/13,10.94%,CENPF;CENPT;CENPE;NDC80;DLGAP5;CENPW
prerank,neuromuscular junction development (GO:0007528),-0.4564839426357795,-1.4056183346217688,0.055793991416309016,0.4893398155915694,1.0,10/24,19.14%,ANK3;GPHN;LRRK2;UNC13C;PDZRN3;UNC13B;AGRN;CACNB3;DNAJA3;DOK7
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.5341590064651411,-1.4052148257483308,0.08558558558558559,0.4882197359454177,1.0,4/13,5.26%,CCR2;GABBR2;PALM;EDNRB
prerank,signal peptide processing (GO:0006465),-0.5647456040975735,-1.405174151140079,0.10728744939271255,0.4861372478557948,1.0,3/11,5.95%,PCSK5;SPCS2;PARL
prerank,signal transduction by p53 class mediator (GO:0072331),0.45016765737035846,1.4041988541574746,0.05989110707803993,0.6492422578007588,1.0,8/30,10.48%,GREM1;FHIT;DDX5;NBN;MDM4;POU4F1;ACER2;PDK2
prerank,supramolecular fiber organization (GO:0097435),0.308620201192454,1.404064035094193,0.0054869684499314125,0.6469909632031846,1.0,72/333,17.17%,TGFBR1;ELMO1;DST;TSPAN14;ARHGEF2;FGF13;CST3;COL27A1;KIF2A;HOOK2;GREM1;ITGA6;CAPN3;CCDC88B;MYO1B;RAC1;SERF1A;RND1;MYO1F;FLII;DSP;SNCAIP;PPP1R9B;DBN1;CDC42EP2;ARHGAP25;MYO1E;PPP1R9A;GFAP;RHOB;RHOBTB1;CAMSAP1;LOXL3;KLHL24;RPS27A;UBC;RND2;MARCKS;TUBGCP5;RHOH;ARHGAP17;WDR73;MYO7A;MPRIP;CAMSAP2;TLE6;AVIL;P4HA1;P3H2;CLIP3;SHROOM2;DDR2;PSENEN;ERMN;MYO5B;LAMA3;HIP1R;TRPV4;PIN1;PLK3;KASH5;MYO15A;CIB1;LTBP3;LTBP2;COL11A1;CD2AP;LAMC2;ADAM10;MARCKSL1;BFSP2;GGA3
prerank,receptor-mediated endocytosis (GO:0006898),-0.32139484993618017,-1.4033971128615002,0.016172506738544475,0.4889399451494013,1.0,39/132,17.17%,MRC1;DAB2;CD163;LRP1B;DNM3;DNAJC6;MSR1;CD36;STAB1;LILRB1;CTTN;AP2A2;SNAP91;LDLR;SGIP1;LRP6;APOE;WASF1;DNM1;CLEC9A;HSPG2;SNX9;SCARF1;FCGR2B;TFR2;HPX;JCHAIN;EPS15;TMEM108;AP2B1;INPP5F;IGF2R;SNCA;AP1G2;HPR;HP;AP4E1;ITGB1;TFRC
prerank,calcium ion transport into cytosol (GO:0060402),-0.47105827555021257,-1.4027466725358437,0.08137044967880086,0.4885948538005339,1.0,10/21,22.28%,GRIN2B;ADRA1A;GRIN2A;RYR2;CACNA1C;GRIN2D;CACNB3;MS4A1;ITPR3;JPH4
prerank,regulation of membrane repolarization (GO:0060306),-0.5412410383093815,-1.4025978777703028,0.0989010989010989,0.48687110299436864,1.0,5/13,16.53%,AKAP6;YWHAE;NEDD4L;KCNQ1;CACNB3
prerank,histone H2A ubiquitination (GO:0033522),0.5111916605991482,1.4004223810111283,0.0962962962962963,0.6584372693807233,1.0,9/17,23.40%,DDB2;BCOR;CUL4B;RNF8;UBE2A;DTX3L;RNF2;KDM2B;RING1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5251944610579182,-1.4001895870496073,0.09740259740259741,0.4913910770449109,1.0,2/14,0.45%,DMD;ANK3
prerank,neuron maturation (GO:0042551),-0.49132998845182796,-1.3999293874035137,0.09147609147609148,0.49003371866820583,1.0,9/18,17.01%,ADGRB3;B4GALT5;B4GALT6;APP;SCARF1;SRRM4;CX3CL1;CLN5;LGI4
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2968824558085305,-1.3993853750889678,0.0032258064516129032,0.4893868740082811,1.0,56/248,15.25%,CTNND2;DAB2;LRRK2;CCDC88C;EGFR;SHISA6;FGF10;CDK14;CSNK1G1;CUL3;LIMD1;SEMA5A;PPM1A;PSMD14;LATS1;HECW1;APC2;RBMS3;LRP6;GPC5;UBR5;APOE;ATP6AP2;GSK3B;PSMD8;MLLT3;IGFBP4;FRZB;PSMA2;PSMF1;PRKN;BTRC;PSMD6;TLE4;AXIN1;PSME2;SOX13;ZEB2;CCAR2;LGR5;KANK1;GPC3;PSMD5;TLE1;TNKS2;PSMD12;NPHP3;MCC;LGR4;IGFBP2;COL1A1;PSMD11;SCYL2;NKD1;PSMD1;SFRP1
prerank,lytic vacuole organization (GO:0080171),0.4443988659679494,1.3984157033030296,0.064030131826742,0.6636075395168894,1.0,17/32,28.40%,HPS4;HOOK2;ARSB;AKTIP;MYO7A;MBTPS1;MTOR;CLN3;ACP4;ACP2;GAA;HOOK3;ABCA1;GNPTAB;VPS18;HPS1;TMEM106B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.4497215723435163,-1.3981652648900993,0.07582938388625593,0.4909706210381077,1.0,9/25,17.85%,DNAJB4;ST13;ERO1A;DNAJB13;HSPA8;HSPA2;HSPA1B;HSPA5;SDF2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5411603209784089,1.396628280555768,0.09323583180987204,0.667799556490215,1.0,6/14,25.65%,ENTPD1;NUDT15;ENTPD7;NUDT16;ENTPD6;ADPRM
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6000033782101581,1.396213681036759,0.095703125,0.6638114840039872,1.0,2/10,22.49%,REEP6;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6000033782101581,1.396213681036759,0.095703125,0.6638114840039872,1.0,2/10,22.49%,REEP6;CACNA2D4
prerank,peptidyl-serine modification (GO:0018209),0.3323114458360377,1.3959427887124534,0.01059001512859304,0.6622025060837582,1.0,54/166,20.62%,TGFBR1;TGFBR2;ULK2;CSNK1E;RPS6KA1;PRKCA;PRKACA;HPF1;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;CAMK1D;RPS6KA5;ULK3;PDPK1;PDGFB;PKN3;GALNT1;VRK3;NAA11;MTOR;WNK1;PRKCB;GRK2;TAF1;PINK1;GALNT3;UHMK1;MARK2;MAP3K10;MAPK8;MAST3;MORC3;LATS2;AKT1;MAPK14;DYRK4;DYRK1A;STK39;AURKA;MASTL;ULK1;RPS6KA4;VRK2;ROCK2;CAMK1;CAMK1G;CSNK1G2;EIF2AK3;GALNT2;PRKCH
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4769768722393127,1.395399554871817,0.09242144177449169,0.6615343871798841,1.0,6/24,9.12%,IRAK2;RIPK2;ITCH;RPS27A;UBC;TAB2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.42760388699305946,1.3951728925354228,0.07375643224699828,0.6597900006165863,1.0,14/35,26.13%,ETS1;LYN;ZFP36L1;PRMT1;NCKAP1L;ARNT;TAL1;MAPK14;HMGB2;ACVR1B;STAT5B;HIF1A;BRD1;STAT3
prerank,histone H2A acetylation (GO:0043968),0.521974971239425,1.3945549160808994,0.08941605839416059,0.6595887488424254,1.0,6/16,20.64%,BRD8;ACTL6A;MORF4L1;NAA40;MORF4L2;EPC1
prerank,protein deubiquitination (GO:0016579),0.3173493491408212,1.3932063370920331,0.00860832137733142,0.6625315452879951,1.0,56/242,17.19%,TGFBR1;USP35;SMAD3;SMAD7;UCHL5;UCHL1;ARRB2;USP8;OTULIN;USP12;OTUD6B;OTUD5;ZRANB1;INO80C;DDB2;INO80E;SUDS3;WDR48;MYSM1;JOSD2;RPS27A;UBC;FOXK2;MDM4;USP28;USP25;USP19;NLRP3;BRCA1;RCE1;STAMBPL1;NFRKB;OTULINL;PSMD3;UFD1;USP36;ACTL6A;USP5;MINDY2;PSMB3;IL33;OTUB2;USP9Y;ABRAXAS1;INO80B;PSMA7;PSMC1;PSMC2;TNIP2;ATXN7;PSME4;USP4;SNX3;PSMB9;TOMM20;INO80D
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.41999574181240096,-1.3931851821972658,0.07780320366132723,0.5032456426036023,1.0,12/31,19.68%,YWHAQ;TFDP2;YWHAE;GSK3B;ZNF205;BAK1;PPP3CC;BCL2;E2F1;BOK;TFDP1;CHCHD10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4779665521288259,1.3913010818532994,0.08133086876155268,0.6676041363992204,1.0,6/23,13.22%,CX3CR1;PYDC1;CPTP;NLRP3;CEACAM1;CD33
prerank,mesenchymal to epithelial transition (GO:0060231),0.6011932094296388,1.391146351724879,0.11192660550458716,0.6654554608709773,1.0,2/10,0.57%,SALL1;BASP1
prerank,positive regulation of immune system process (GO:0002684),0.5307003855169712,1.39059460161581,0.09498207885304659,0.6649160850058702,1.0,5/16,10.25%,LGALS9;MIA3;PIK3CD;NCKAP1L;PIK3CB
prerank,sister chromatid segregation (GO:0000819),-0.4301272922081606,-1.3904193716702797,0.08181818181818182,0.5085190444727494,1.0,13/31,20.53%,LATS1;TOP2A;SMC4;CDCA8;ZW10;RAN;NDC80;NUSAP1;SPAG5;KIF18B;NCAPG2;KIFC1;KNSTRN
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5741764847605996,-1.390375736555785,0.11297071129707113,0.5064429576976236,1.0,5/10,21.92%,MLLT3;SFRP1;HOXB4;ACE;SP7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4918334115824595,1.3890305110279502,0.10192307692307692,0.6683403697316712,1.0,13/20,31.50%,MBTPS1;MBTPS2;PSENEN;PSEN2;SPPL2B;ADAM10;APH1B;ADAM17;TGFB1;APH1A;TRAF6;NFKB1;ADAM9
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5727934537725813,1.388388638458139,0.12142857142857143,0.6682840299816666,1.0,5/12,15.22%,CSF1R;LYN;IL12B;IL34;CSF1
prerank,activin receptor signaling pathway (GO:0032924),0.5425065879210096,1.388031699785854,0.10458715596330276,0.6670569308215035,1.0,2/15,0.80%,TGFBR1;SMAD3
prerank,actin filament polymerization (GO:0030041),-0.42883479753008374,-1.387639724235927,0.08405172413793104,0.5121391973123242,1.0,8/29,8.22%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;DIAPH3;JAK2;WASF1;MSRB1
prerank,protein transport (GO:0015031),0.3063912440507702,1.3860100352201628,0.00411522633744856,0.6721380703426485,1.0,102/332,19.78%,TBC1D16;UNC93B1;ARHGEF2;DNM2;PREB;HERC2;TBC1D17;YWHAH;TBC1D9B;SEL1L;KIF3B;ATP6V0B;ARFIP1;COPA;ARFGAP3;TBC1D10B;AP2A1;TBCK;VPS26B;TBC1D8;ARL5C;VIPAS39;NEURL1B;TBC1D15;MYH9;FAM91A1;MCOLN1;STXBP1;AP3D1;CLU;ATP6V1D;STX1A;TMED9;ARFIP2;STX12;TMED4;PPT1;ARRDC1;SGSM2;MACF1;ARL6IP5;RAB3GAP2;PPY;ATP6V0A2;MIA3;TCIRG1;STX19;SEC13;GOLGA4;RD3;RAB1A;SCAMP2;RAB34;LRP1;TICAM2;PRKCB;SCAMP5;SAR1A;TBC1D9;SNX31;RUNDC1;ATP6V0A4;BBS2;SEC31B;PDCD6;OPTN;STX4;TVP23B;IL10RA;TBC1D30;ARRDC2;RAB20;SLU7;NAPG;SCG5;TOM1;RAB32;SNX13;PICK1;KIF3A;LTBP2;ADPRH;TANGO2;ATP6V0E2;GGA3;RAB13;SGSM3;PDIA4;CTSA;EIF2D;CHMP1A;ARL11;VPS29;GRTP1;RAB6B;STX5;ACD;AP4M1;VPS26A;RAB8B;VPS35;CHMP2A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3123079457008238,1.3858324217091218,0.004201680672268907,0.6701622838661191,1.0,88/264,25.41%,SRRM1;SNRNP70;NCBP1;DDX5;SNRPA;POLR2H;FUS;SRRT;POLR2J;CSTF2;POLR2D;HNRNPA3;RBM19;SF3B2;SF3B1;MAGOHB;MAGOH;U2AF2;HNRNPC;SNRPC;ZMAT2;RBM14;COIL;SART3;SNRPF;SNRPA1;PCBP2;HNRNPH1;CWC25;DHX9;SNRNP48;DHX38;HNRNPR;DDX17;SRSF5;PABPN1;SRRM2;CPSF1;GEMIN6;SMN1;RBM8A;TGS1;DCPS;TRA2B;SNUPN;RBM17;PRPF31;DDX20;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;POLR2E;METTL14;CCAR1;PRPF3;PCF11;PRPF4;SNRPN;SCNM1;ZCCHC8;GEMIN2;LSM7;RBMX;SNRNP40;HNRNPA2B1;SRSF9;HNRNPH3;WBP4;SNIP1;DDX39B;POLR2I;ELAVL1;HNRNPUL1;SNRNP25;LSM8;DDX46;NOVA2;HNRNPA1;WDR77;SYF2;PNN;CD2BP2;CRNKL1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.450954986757066,-1.3848028859508652,0.08189655172413793,0.517848259617994,1.0,5/22,11.44%,MDFIC;LRRK2;SP100;BARD1;ITGB1BP1
prerank,regulation of glucose import (GO:0046324),-0.42432054107220696,-1.3842931385298831,0.07380952380952381,0.5170900735703521,1.0,7/30,11.37%,PID1;SORBS1;IRS1;CREBL2;PRKAG2;GRB10;OSBPL8
prerank,positive regulation of signaling (GO:0023056),-0.40145339193861884,-1.3835521936696775,0.07345971563981042,0.5171840025724269,1.0,12/37,16.70%,GRIK2;RIMS2;CLSTN2;SYT1;SOX11;HOMER1;LGI1;CD80;INPP5F;SNCA;ANXA2;RIMS1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4878724010935531,1.3831770254286915,0.09769094138543517,0.678229116179669,1.0,8/21,13.32%,FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;JUN;LDLRAP1;GJA1
prerank,regulation of mRNA processing (GO:0050684),0.4365446497651418,1.382887577158768,0.058098591549295774,0.6767906722177862,1.0,11/32,14.60%,SON;NCBP1;QKI;DHX9;RBM39;JMJD6;SLTM;ZFP36L1;PABPN1;CDK11B;SAFB
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4739822825096046,1.381600515769275,0.08719851576994433,0.6793557315467117,1.0,8/23,14.41%,SMAD3;SMAD7;LTBP4;NREP;EID2;BCL9;ENG;LATS2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5482950093628512,1.3812868050093876,0.09398496240601503,0.67791606903828,1.0,3/12,15.38%,NELFB;RNF8;NELFE
prerank,protein modification by small protein removal (GO:0070646),0.31282571392332575,1.3810772531001754,0.005657708628005658,0.6761817239196992,1.0,58/252,17.19%,TGFBR1;USP35;SMAD3;SENP2;SMAD7;UCHL5;UCHL1;ARRB2;USP8;USP12;OTUD6B;OTUD5;ZRANB1;INO80C;DDB2;INO80E;COPS4;SUDS3;WDR48;MYSM1;JOSD2;RPS27A;UBC;FOXK2;MDM4;USP28;USP25;USP19;NLRP3;BRCA1;RCE1;STAMBPL1;NFRKB;OTULINL;PSMD3;UFD1;USP36;ACTL6A;USP5;PSMB3;IL33;OTUB2;USP9Y;ABRAXAS1;INO80B;PSMA7;GPS1;PSMC1;PSMC2;TNIP2;ATXN7;PSME4;USP4;SNX3;COPS6;PSMB9;TOMM20;INO80D
prerank,long-chain fatty acid transport (GO:0015909),-0.4218727728122974,-1.3802789375708566,0.07865168539325842,0.524439219766536,1.0,9/30,14.52%,PPARG;CD36;FABP4;PRKAG2;ACSL3;APOE;MFSD2A;ABCD4;CPT1B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.43301044433978964,-1.3800424419887887,0.0774487471526196,0.5228404410665165,1.0,7/26,13.24%,YWHAE;GPR35;CALM1;CBARP;PKD2;ADRA2A;GNB5
prerank,phagosome acidification (GO:0090383),0.45775294792588556,1.3799453280062457,0.0839041095890411,0.6779934489915975,1.0,8/26,17.01%,ATP6V0B;ATP6V1D;ATP6V0A2;TCIRG1;RAB39A;ATP6V0A4;RAB20;ATP6V0E2
prerank,mitochondrial fission (GO:0000266),-0.4952936511389262,-1.3796848543527382,0.11009174311926606,0.5217087114902155,1.0,7/16,12.11%,DNM3;DNM1L;DNM1;PRKN;FIS1;MFF;MTFR2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.315163932078777,1.3792551527695556,0.01455604075691412,0.6781774770117931,1.0,61/234,17.58%,CX3CR1;IL18;ARHGEF2;SMAD3;CAPN3;ANXA3;CFLAR;LGALS9;DDIT3;IRAK2;RIPK2;AGER;CRNN;TLR4;TRIM5;TRAF5;PHB2;CLU;PLCG2;CAMK1D;RPS6KA5;RPS27A;UBC;TRADD;TAF12;DHX9;SHH;MTDH;FZD2;NLRP3;FLOT2;ABRA;EDA2R;TSSK4;TAB2;RNF31;RTKN2;MBTPS2;PRKCB;RNF25;CRTC1;DDR2;LAMTOR5;TAF1;TRIM62;CEBPG;MAVS;HDAC5;PYCARD;AKT1;SMO;CIB1;TCF3;EIF2AK2;AIM2;AGT;RPS6KA4;FZD1;FANK1;RAB7B;KDM1A
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5692279693599527,1.3787086002044553,0.12593984962406016,0.6778905893187983,1.0,4/12,13.36%,SNAP47;STX1A;STX19;STX4
prerank,O-glycan processing (GO:0016266),0.3968317115127432,1.378693793894158,0.05844155844155844,0.6753586236610483,1.0,16/54,13.56%,XXYLT1;B3GNT2;GALNT12;GALNT5;POMGNT1;GALNT10;GALNT1;MUC6;B3GNT4;POFUT1;GALNT11;GALNT15;GALNT7;GXYLT2;GALNT3;ST3GAL3
prerank,translational termination (GO:0006415),0.3533221481902799,1.378679211507823,0.0379746835443038,0.6728302669207772,1.0,49/95,32.97%,MRPL50;ETF1;MRPS24;MRPL17;MRPL2;MRPL37;MRPL43;MRPS34;ABCE1;MRPL34;MRPL9;MRPS5;MRPL30;MRPS21;CHCHD1;GSPT2;MRPL13;MRPS16;MRPS11;MRPS18B;MRPS28;MRPS35;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,positive regulation of neuron projection development (GO:0010976),-0.34308074493211277,-1.378566702393361,0.0196078431372549,0.522941265902505,1.0,22/85,12.92%,MAGI2;RIT2;LRRC7;TENM3;ARHGAP35;FUT9;BDNF;RAPGEF2;ROR1;NTRK2;NTRK3;NPTN;APOE;KIDINS220;RET;ALK;PLXNB2;SCARF1;P3H1;SERPINI1;STMN2;ZDHHC15
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.49428740402008253,1.3775061833122686,0.08576642335766424,0.6749781309976556,1.0,5/20,3.71%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,positive regulation of immune response (GO:0050778),0.38150908605081063,1.3773582458714295,0.06429780033840947,0.6729445568532397,1.0,13/64,8.32%,SASH3;ITGAM;POLR3G;LGALS9;KARS1;ITGB2;SLC15A4;AKIRIN2;IL6ST;DHX9;NLRP3;CCR7;IL12B
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5313476049417261,-1.3768510036646329,0.1137855579868709,0.5257283066250836,1.0,3/13,5.30%,ANK3;PDE4D;CALM1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.43872228253957973,-1.3767098467743086,0.07294117647058823,0.5239484116673224,1.0,12/24,27.61%,RPS3;DACH1;ZRANB3;CDKN1A;ACVRL1;NIBAN2;XRCC5;MSH6;MSH2;DFFA;ERCC1;H1-0
prerank,secondary palate development (GO:0062009),0.536576235022187,1.3766210181979814,0.11443661971830986,0.6732215952646636,1.0,2/14,4.31%,TGFBR2;CHD7
prerank,reticulophagy (GO:0061709),0.5726951673674259,1.3765225689134843,0.11978221415607986,0.6710544499711446,1.0,7/12,27.64%,ULK2;RB1CC1;UBA5;RETREG1;ULK1;UFC1;ATG2A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5941364827478998,1.3762302091384717,0.10984848484848485,0.6697210264590352,1.0,3/10,1.98%,CX3CR1;LGALS9;ARRB2
prerank,mammary gland development (GO:0030879),-0.4682582430409226,-1.3760964557962547,0.08096280087527352,0.5235099271689778,1.0,5/21,8.58%,ARHGAP35;JAK2;ERBB4;ZBTB7B;WNT4
prerank,monocarboxylic acid catabolic process (GO:0072329),0.48599758684239686,1.3758470380300514,0.0998185117967332,0.668717934134127,1.0,8/21,18.40%,PPARD;LPIN2;NUDT19;PLA2G15;HAO1;AGXT;LPIN1;FAH
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4406755691428378,1.375566474023303,0.08629441624365482,0.6674070250392734,1.0,11/33,14.99%,PDE3B;P2RY12;FERMT3;LYN;PIK3CG;EPHA8;ACER2;NCKAP1L;SERPINE1;PTPN11;CIB1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3823784729848051,1.3754851300820132,0.05517241379310345,0.6652745661642774,1.0,17/59,18.62%,TLR7;IRAK2;RIPK2;TLR4;RPS27A;UBC;TRADD;TAB2;RNF31;TICAM2;RELB;AKT1;NKIRAS1;TBKBP1;ROCK2;TICAM1;MAP3K14
prerank,amino acid import (GO:0043090),0.4836438845318034,1.37540612317261,0.09430604982206406,0.6631121032381321,1.0,5/21,8.58%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC22A2
prerank,synaptic vesicle localization (GO:0097479),-0.5347663705898353,-1.375316214646457,0.11255411255411256,0.5237514286347138,1.0,5/13,8.61%,NLGN1;KIF5C;TOR1A;SYNDIG1;KIF5B
prerank,sphingolipid metabolic process (GO:0006665),0.3492409762647565,1.3752637653484607,0.026771653543307086,0.6612622012012636,1.0,33/108,20.90%,HEXB;ALOXE3;CPTP;CERS3;DEGS2;PLA2G15;SPTLC3;PPM1L;HACD3;HEXA;NEU3;PPT1;ACER3;FUT7;SMPD2;ACER2;PLPP1;ASAH1;CERK;PLPP2;B4GALNT1;ARSA;PRKD3;CERS2;VAPB;CTSA;NEU4;SMPD3;GLB1;ORMDL2;CSNK1G2;SERINC1;SUMF2
prerank,positive regulation of nuclear division (GO:0051785),0.4579491030292964,1.3750425105233794,0.07875457875457875,0.6597214126909224,1.0,8/25,20.44%,LRP5;SIRT2;PDGFB;EDN3;PDGFRB;AURKA;NUP62;IL1A
prerank,regulation of cellular senescence (GO:2000772),0.4529053415191274,1.3745962886072178,0.0875,0.6590185776164621,1.0,6/28,7.25%,NUAK1;ABI3;MAP3K3;SLC30A10;NEK6;CGAS
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.48957098096422874,1.3745853924183278,0.09601449275362318,0.6566547708025222,1.0,5/20,7.01%,IL18;TLR4;LYN;CCL3;MTDH
prerank,regulation of Notch signaling pathway (GO:0008593),0.3712560025731021,1.374250768536371,0.04326923076923077,0.6555934710578866,1.0,25/76,20.53%,MAML3;TSPAN14;BMP2K;SRC;IL6ST;ARRDC1;RFNG;GATA2;JAG2;NOTCH4;DTX1;POFUT1;MAML2;GALNT11;DLL1;LLGL1;WWP2;AKT1;NOTCH3;PDCD10;ZMIZ1;ARRB1;NEPRO;NOD2;SYNJ2BP
prerank,calcium import into the mitochondrion (GO:0036444),-0.5615286875848123,-1.3742190974188262,0.12320328542094455,0.524562761756992,1.0,4/10,10.95%,MCU;MCUB;MICU2;MICU3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5380486728787354,-1.372238418715705,0.11521739130434783,0.5262861466723705,1.0,5/12,16.16%,KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5380486728787354,-1.372238418715705,0.11521739130434783,0.5262861466723705,1.0,5/12,16.16%,KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.4214072005664735,-1.3716375620071748,0.08962264150943396,0.525858683485598,1.0,11/30,17.85%,CCT2;DNAJB4;ST13;ERO1A;DNAJB13;HSPA8;HSPA2;HSPA1B;HSPA5;CHCHD4;SDF2
prerank,negative regulation of type I interferon production (GO:0032480),0.415629277780423,1.3710386068786613,0.0779896013864818,0.6655281384677568,1.0,14/40,16.20%,SIRPA;RNF216;ITCH;OTUD5;UBA7;PCBP2;UFD1;HAVCR2;PIN1;RELB;MAVS;PYCARD;NLRX1;IRF3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5078158367278552,-1.3709532938804825,0.09403669724770643,0.5256966947678764,1.0,7/15,28.52%,REEP3;ATL2;RTN4;REEP4;ATL1;REEP2;RTN3
prerank,neuron projection extension (GO:1990138),-0.4130082985343907,-1.37034319678827,0.0825,0.5254554012219657,1.0,6/32,5.64%,AUTS2;IQGAP1;ALCAM;MAP1B;SEMA5A;SH3GL2
prerank,positive regulation of nervous system process (GO:0031646),-0.491792450260659,-1.3697476877661434,0.11522633744855967,0.5251625105874895,1.0,7/18,16.70%,RIMS2;TPPP;MYRF;TENM4;UNC13B;PARD3;RIMS1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4076878640908439,-1.3696662479975745,0.07371007371007371,0.5233450692026538,1.0,7/33,6.42%,NLGN1;DNM3;DNAJC6;SYT1;ITSN1;SNAP91;DNM1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.325302362201382,1.3696459307688036,0.014771048744460856,0.6683524190274909,1.0,40/172,15.01%,INPP5D;LIPH;LPCAT2;PI4KB;PLD1;PCTP;PIK3R1;LPCAT4;LPIN2;CSNK2A2;CSNK2A1;PIK3CG;PLCG2;PLA2G4A;PLD2;PIK3C3;RAB4A;PISD;DGKD;PLA2G4B;LCAT;PLA2G5;INPP4B;CHKB;PIK3CD;INPP5K;PIK3CB;INPP5E;CLN3;MTMR14;PLEKHA4;MTMR4;PTDSS2;GPD1;BMX;CRLS1;IMPA1;PGS1;CDS1;PITPNM1
prerank,DNA biosynthetic process (GO:0071897),-0.5060451189610735,-1.3696070750985865,0.10154525386313466,0.5213978754232804,1.0,8/16,20.96%,POLA1;POLL;PPIA;SIRT1;POLD1;TERT;POLD3;POLH
prerank,regulation of axon regeneration (GO:0048679),0.5585617743633129,1.3696039752848455,0.11500974658869395,0.6660705992892291,1.0,5/12,14.55%,RTN4RL1;KLK8;CNTF;CERS2;RTN4R
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4216698725962621,1.368912306207872,0.06968641114982578,0.6663943165215355,1.0,13/37,18.67%,PCNA;RFC2;DDB2;GTF2H2;RPS27A;UBC;ERCC2;CUL4B;POLD2;ERCC4;RFC1;NTHL1;CUL4A
prerank,hemopoiesis (GO:0030097),0.3581839077745,1.3688496209481686,0.04966887417218543,0.6642498798970112,1.0,19/87,11.45%,SELPLG;TGFBR2;CSF1R;LYL1;PLEK;FLCN;WNT2B;ARMC6;PDGFB;TNFRSF13B;ZFP36L2;WNT10B;PLD4;CD34;RTKN2;NOTCH4;MFAP5;DLL1;RUNX1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.48524807231858924,-1.3685239132268883,0.08878504672897196,0.5222501694771393,1.0,7/18,20.09%,AOAH;SAMHD1;MANBA;NAGA;OGA;FUCA1;DERA
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3869471664319611,-1.367414488061395,0.05980861244019139,0.5233478913573432,1.0,12/41,10.68%,ITPR1;GRIN2B;GRIN2A;SLC8A3;RYR3;RYR2;HTR2C;SLC24A2;HTR2B;PKD2;GRIN2D;ERO1A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.501012802795894,1.3673862110364527,0.11469534050179211,0.6676142664623629,1.0,7/18,19.51%,PAG1;MIA3;TNFAIP8L2;WNK1;AKT1;GPNMB;IL4I1
prerank,regulation of platelet aggregation (GO:0090330),0.5068668811754355,1.3670619778749753,0.0996309963099631,0.6665660273889901,1.0,7/17,13.46%,F11R;CD9;PRKCA;LYN;PRKCD;CEACAM1;SERPINE2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4278346031881223,1.3670139519382585,0.07130124777183601,0.6643854550174425,1.0,15/33,26.13%,ETS1;PRMT1;NCKAP1L;PITHD1;ARNT;TAL1;MAPK14;RAB7B;HMGB2;FES;ACVR1B;STAT5B;HIF1A;BRD1;STAT3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5790889411123773,-1.3662738152664387,0.12422360248447205,0.5246694240855673,1.0,3/10,3.86%,HECW2;HECW1;NEDD4L
prerank,response to nutrient levels (GO:0031667),0.4948016275397849,1.3660947916087682,0.1014760147601476,0.6654387400375823,1.0,7/17,28.64%,EIF4G1;RPTOR;MTOR;ULK1;KCNB1;CD68;SCTR
prerank,sulfur compound catabolic process (GO:0044273),0.42154350375380645,1.3659471515500627,0.06765676567656766,0.6637149362578257,1.0,12/38,18.24%,HEXB;ARSB;PRELP;HEXA;MPST;BGN;DPEP1;BCAN;CSPG5;GADL1;TXN2;GLB1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.5742844695688141,-1.3655586329417078,0.1191919191919192,0.5246403137521157,1.0,3/10,3.86%,HECW2;HECW1;NEDD4L
prerank,positive regulation of protein polymerization (GO:0032273),0.3793639241027949,1.3651692657875452,0.06,0.6644100913979323,1.0,21/65,20.75%,BIN1;NAV3;RAC1;BAIAP2L2;CDC42EP2;NUMA1;PTK2B;MET;CCR7;NCKAP1L;PINK1;PYCARD;MAPRE1;TENM1;FCHSD2;CDC42EP3;FES;VASP;CCL24;MAPT;FCHSD1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.48371755615409184,-1.3646745211482696,0.11233480176211454,0.525191611579111,1.0,5/18,6.00%,DTNA;KIF1B;SLC5A7;ERC2;CHAT
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.38874078508670756,1.364434678440337,0.07003257328990228,0.6648275169788221,1.0,5/56,1.22%,TGFBR1;LDLRAD4;GREM1;SMAD7;PMEPA1
prerank,endocardial cushion development (GO:0003197),0.4724743483975451,1.3642764150880164,0.10973451327433628,0.6631130574056908,1.0,10/21,31.18%,HEYL;MDM4;ENG;NOG;BMP2;SOX9;ACVR1;ISL1;NOTCH1;BMPR1A
prerank,chromatin remodeling at centromere (GO:0031055),-0.41581677974861897,-1.3642196465057554,0.1029082774049217,0.5246420436007002,1.0,10/31,17.22%,KNL1;CENPT;CENPP;MIS18BP1;HELLS;CENPW;RBBP7;NASP;CENPS;NPM1
prerank,nervous system development (GO:0007399),-0.2726001610696903,-1.363383013590445,0.003968253968253968,0.525093140762475,1.0,94/429,15.12%,LSAMP;RBFOX1;NRXN1;NLGN1;ZBTB16;DNM3;ROBO1;ADGRL3;KIRREL3;SPOCK1;NRCAM;FGF12;NAV1;GPM6A;GDA;DPYSL5;RBFOX2;GSN;SCN2A;TRPC5;BDNF;JARID2;SLITRK1;ADAM22;GSS;WWP1;ADGRG6;ST8SIA4;SEMA5A;CNTN6;MSI1;APC2;IL1RAPL2;DCLK1;MYT1L;ACVR1C;FN1;SHANK3;APBA2;PLXND1;EDNRB;POU6F2;SH3GL2;CDK5RAP2;RBFOX3;HDAC4;ERBB4;FAT4;PKD2;SDHA;GFRA2;PRKN;CHRM2;CHRM3;ERCC6;NINJ1;LGI1;ECRG4;LIG4;MAB21L2;VCAN;ST8SIA2;FGF11;NAB1;ERBB3;ZEB2;RAPGEFL1;PRX;UNC119;SRRM4;GRIK1;SERPINI1;INTU;SDK1;DPF3;MAL;EFNA5;ALDH3A2;HMGCR;OBSL1;ACHE;GDF11;AHI1;CDH1;JAG1;NRXN2;TMEM223;PCDHB16;PKD1;LY6H;ZIC5;CYP26C1;FKTN;POU3F2
prerank,regulation of cell adhesion (GO:0030155),0.339992971593677,1.363227272659104,0.03605015673981191,0.6648870662007863,1.0,37/129,18.49%,PDE3B;ZFHX3;NUAK1;IL18;RND1;TGM2;PRKCA;LYN;ITGAV;SRC;PIK3CG;ATM;PKHD1;FLCN;TFE3;PTK2B;SIPA1;C1QBP;MIA3;LPXN;EPHA8;CCR7;IL12B;FUT7;DLL1;PTPN11;STX4;ABL1;SEMA4D;ADGRG1;PPP1CB;ADAM10;GPR4;PTPRJ;ROCK2;FES;CD164
prerank,rRNA modification (GO:0000154),0.48159508845870663,1.3632201246690487,0.11330935251798561,0.6626192263405886,1.0,9/21,21.23%,BUD23;THUMPD1;METTL5;NHP2;FTSJ3;NSUN3;TFB1M;NSUN4;FBL
prerank,positive regulation of ruffle assembly (GO:1900029),-0.535807364272444,-1.3628669090876149,0.12087912087912088,0.5246106596073534,1.0,3/13,7.43%,NLGN1;EPS8;FAM98A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5343127698455353,1.36258885843102,0.1128747795414462,0.662796263939436,1.0,6/13,29.73%,CYRIB;IL12B;NECTIN2;FADD;STX7;IL12RB1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.42199010986581353,1.3625084572326163,0.07295373665480427,0.6608299174288507,1.0,15/35,18.92%,PMEPA1;DDX5;SRC;CALCOCO1;PADI2;GPER1;DDX17;PLPP1;KDM3A;DDX54;UBE3A;SAFB;ZMIZ1;ARID1A;NCOA4
prerank,regulation of osteoblast proliferation (GO:0033688),0.505221929386743,1.3624721880688957,0.09872029250457039,0.658729276217106,1.0,3/17,2.03%,TMEM119;GREM1;SOX8
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.567777437625719,1.3624694526710177,0.11233885819521179,0.6565027208689301,1.0,3/11,9.52%,GREM1;MEF2C;FRS2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3763349139790886,1.3619970054864807,0.05199306759098787,0.6560797912968025,1.0,14/66,8.60%,CX3CR1;SIRPA;LGALS9;RIPK2;PYDC1;AGER;TLR4;CPTP;EGR1;CCL3;CASP1;NLRP3;CCR7;ORM2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.4578093354448048,1.3617573092461215,0.08586762075134168,0.6547998080800652,1.0,7/24,14.49%,HMBS;FECH;PPOX;SUCLA2;NFE2L1;UROD;TSPO
prerank,regulation of macrophage chemotaxis (GO:0010758),0.48609026468948546,1.361478237975892,0.09888059701492537,0.653618656484475,1.0,9/21,18.17%,CSF1R;MTUS1;PTK2B;DDT;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,cellular response to hydroxyurea (GO:0072711),0.575457564663592,1.3611309508626641,0.11690647482014388,0.6527462830331906,1.0,7/10,34.81%,SPIDR;BLM;NSMCE3;RTF2;DDX11;ATRX;DDI2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.4688112596580202,1.3610725508900097,0.09773123909249563,0.6507699745875989,1.0,8/23,17.12%,SOX8;GDNF;PIK3CD;PAX2;GJA1;SMO;NOG;AGT
prerank,regulation of actin filament-based process (GO:0032970),0.36538161131537483,1.360782707505532,0.054009819967266774,0.6495213221995709,1.0,19/70,13.42%,F11R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;FSCN1;RND2;RHOH;ARHGAP17;MTOR;LRP1;MLST8;PDGFRB;HIP1R;TAOK2;ABL1
prerank,mitochondrial translational elongation (GO:0070125),0.35437504909991907,1.3597082231893118,0.04462809917355372,0.651482024314909,1.0,48/88,32.97%,MRPL50;MRPS24;MRPL17;MRPL2;MRPL37;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;MRPS21;CHCHD1;MRPL13;MRPS16;MRPS11;MRPS18B;MRPS28;MRPS35;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;TUFM;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,ureteric bud morphogenesis (GO:0060675),0.5144431976437619,1.3595424220328245,0.10314685314685315,0.6499048823925762,1.0,5/16,11.39%,SALL1;NPNT;SHH;GDNF;PAX2
prerank,peptide metabolic process (GO:0006518),-0.3405751571322688,-1.3594902804294962,0.03324808184143223,0.5321780184225952,1.0,24/75,24.52%,DMD;CPQ;NPEPPS;PCSK5;MME;SPCS2;PARL;MGAT3;TRHDE;ENPEP;ANPEP;AEBP1;GSTT1;CLN5;GSTP1;LNPEP;RHD;ABCB9;ACE;GSR;CPXM2;GSTZ1;SPCS1;GSTK1
prerank,platelet aggregation (GO:0070527),0.4307871252549566,1.3591745853297572,0.07495429616087751,0.6491407850616507,1.0,7/33,4.99%,P2RY12;FERMT3;PLEK;MYH9;PIK3CG;STXBP1;UBASH3B
prerank,regulation of cartilage development (GO:0061035),-0.4665474343266445,-1.3591485905868212,0.10927835051546392,0.5312162160140458,1.0,3/18,3.59%,TRPS1;ZBTB16;SOX5
prerank,keratan sulfate catabolic process (GO:0042340),0.5724568710186546,1.3590614837610195,0.1408199643493761,0.6475139244019191,1.0,3/11,6.37%,HEXB;PRELP;HEXA
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.542655891464481,1.3586338674850367,0.11904761904761904,0.6469991851696411,1.0,5/13,15.37%,ALG12;ALG6;ALG11;ALG2;ALG8
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.3833350642302907,1.3586169069343408,0.07032590051457976,0.6449521617516588,1.0,18/55,18.17%,TGFBR2;RAC1;COQ7;SIRT2;BCO2;RNF41;AATF;CBR1;PDGFB;DHRS4;BRCA1;PAX2;PDGFRB;PINK1;NOXO1;MAPK14;AGT;THBS1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.35061872092797297,1.3586126585456602,0.042833607907743,0.6428580537391997,1.0,27/92,19.11%,RREB1;SMOC2;ANXA3;ETS1;RAC1;MAP4K4;PRKCA;SRC;PIK3CG;SPARC;RHOB;PLCG2;PTK2B;PIK3CD;MTOR;PIK3CB;PDCD6;INSL3;ABL1;AKT1;PROX1;AGT;SCARB1;ROCK2;GATA3;THBS1;PPM1F
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5726015407070717,-1.358579597580933,0.12304250559284116,0.5308177927409596,1.0,4/10,13.24%,GPR35;CALM1;CBARP;GNB5
prerank,negative regulation of cell differentiation (GO:0045596),0.32130079769440395,1.3582758530251684,0.020864381520119227,0.6420188290820319,1.0,33/181,11.47%,TGFBR1;LDLRAD4;LRP5;SMAD3;NBR1;GREM1;SMAD7;SOX8;SKI;NELFB;SIRT2;CCDC85B;GPS2;EFEMP1;ITGAV;TRPM4;HOXB8;CTR9;PTK2B;SPRY2;SHH;ZFP36L2;OVOL2;GATA2;WNT10B;GPER1;ANKRD2;TWIST2;EID2B;NOTCH4;DTX1;DLL1;TRIO
prerank,T cell activation (GO:0042110),-0.34664231081798824,-1.3581709970679454,0.048223350253807105,0.5300747721753547,1.0,32/69,27.58%,CD74;CD44;DPP4;NCK2;PTPN22;IRF4;JAML;PTPN2;CD2;LFNG;ICOSLG;KIT;CTPS1;EIF2AK4;ITK;TNFRSF4;CD3E;FOXP3;MSN;CRTAM;DLL4;LCK;IL2;CD8B;CD4;NLRC3;RASGRP1;CCL19;CD276;CD8A;SLA2;SOX4
prerank,ventricular septum development (GO:0003281),0.4110523951396331,1.356803081133837,0.0821917808219178,0.6454937976092305,1.0,5/37,1.49%,TGFBR1;SALL1;TGFBR2;SMAD7;HEYL
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.5095436757021263,-1.356171240260763,0.10950413223140495,0.5338752780943458,1.0,4/14,7.84%,IRS1;SLC45A3;SIRT1;PTPN2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4626900068550845,-1.3559171094836533,0.10660980810234541,0.532669965080379,1.0,7/19,19.38%,CIITA;VIM;WNT4;SCX;RGCC;BMP4;SUCO
prerank,negative regulation of viral life cycle (GO:1903901),-0.49185367132756713,-1.3558127963938178,0.10786516853932585,0.5310225234064567,1.0,8/15,16.04%,GSN;CIITA;MID2;PPIA;IFITM3;LY6E;IFITM2;IFITM1
prerank,retinoid metabolic process (GO:0001523),-0.34486804665484283,-1.3554829569040716,0.060759493670886074,0.5300044275398997,1.0,35/71,34.69%,GPC6;SDC3;GPC5;APOE;RETSAT;NAPEPLD;HSPG2;RDH13;GPC3;RDH10;RBP4;DHRS9;ABCA4;GPC4;AGRN;DHRS13;RDH12;RBP1;GPC1;CYP2S1;RARRES2;UGT1A7;UGT1A8;UGT1A1;LRP2;SDC2;AKR1C1;OPN1MW;APOA2;RBP2;LRAT;STRA6;SCPEP1;SDC4;CYP26B1
prerank,gonad development (GO:0008406),0.40728890290553926,1.3554013318772236,0.07321131447587355,0.6483247222099716,1.0,7/41,8.69%,SALL1;BASP1;SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,regulation of stem cell population maintenance (GO:2000036),0.4947224582024838,1.354551351263097,0.11228070175438597,0.6491758448187265,1.0,7/18,24.03%,CNOT1;TAF6L;CNOT3;NCOA3;TAF5L;ELAVL1;CNOT2
prerank,peptide catabolic process (GO:0043171),-0.4493803309408007,-1.3542921963576624,0.08372093023255814,0.5316627952664433,1.0,6/23,9.99%,CPQ;NPEPPS;TRHDE;ENPEP;GGT7;ANPEP
prerank,negative regulation of cilium assembly (GO:1902018),0.5447211937567109,1.3541247074158376,0.11940298507462686,0.6486739333304734,1.0,5/12,24.58%,TBC1D7;MAP4;TBC1D30;CCP110;CEP97
prerank,translational elongation (GO:0006414),0.3447290368341584,1.353870916812207,0.04784688995215311,0.6475859009174151,1.0,54/101,32.97%,MRPL50;MRPS24;MRPL17;MRPL2;MRPL37;MRPL43;MRPS34;MRPL34;MRPL9;EEF1B2;MRPS5;MRPL30;EEF2K;MRPS21;CHCHD1;MRPL13;MRPS16;MRPS11;MRPS18B;NEMF;MRPS28;MRPS35;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;TUFM;DAP3;LTN1;MRPL47;MRPL36;GTPBP1;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;EEFSEC;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5601856794495186,-1.3531357513947881,0.1443089430894309,0.5330044229982541,1.0,4/10,14.23%,PARP14;PTPN2;PPP2R1A;INPP5F
prerank,gland development (GO:0048732),0.38205265835461644,1.3526270075768148,0.0738255033557047,0.6501673434722883,1.0,13/59,15.23%,TGFBR1;SALL1;PRKCSH;TG;FOXE1;NKX2-8;SHH;MET;LSR;NOTCH4;CEBPG;SOD1;PROX1
prerank,chloride transport (GO:0006821),-0.3462849406867203,-1.352578217619999,0.046632124352331605,0.532614671459708,1.0,29/74,22.99%,GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;SLC4A10;SLC12A8;ANO3;GABRA2;SLC12A4;SLC12A5;GABRG2;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;SLC4A8;ANO10;CFTR;GABRQ;SLC1A1;SLC12A1;SLC6A1;SLC26A8;SLC4A1;ANO2;SLC12A3
prerank,cellular transition metal ion homeostasis (GO:0046916),0.346979794254285,1.3514974033388105,0.052050473186119876,0.6524183384792509,1.0,24/91,16.13%,SLC30A5;FRRS1;SLC30A10;SLC40A1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;ISCU;ATP6V0A2;SLC30A8;HAMP;ANKRD9;TMPRSS6;MT2A;TMEM199;COX19;SOD1;CYB561A3;CCDC22
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5344083334043425,1.3510898187012805,0.12432432432432433,0.6518831695341064,1.0,11/13,35.85%,SART3;PRPF31;DDX20;USP4;PRPF3;CD2BP2;SRSF10;PRPF8;LSM2;PRPF19;PRPF6
prerank,protein homooligomerization (GO:0051260),-0.31716002386052994,-1.3509972397779189,0.03773584905660377,0.5351766684551891,1.0,29/114,15.21%,NLRC4;DISP1;HCN1;KCNC2;RYR3;B2M;EHD1;GLS;AQP4;ATL2;LETM1;TRMT61B;ALOX5AP;PKD2;SLC1A5;NINJ1;MLKL;SCARA5;ADCY8;AQP11;ACOT13;GNMT;SHMT1;SAMHD1;G3BP2;SOD2;MPP2;ALDH9A1;NACC2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4367169366665164,-1.3508400679558348,0.1050228310502283,0.5337207449513621,1.0,11/23,32.51%,PFKFB1;HDAC4;SIK1;TIGAR;CBFA2T3;C1QTNF3;CRY1;NCOR1;PPARA;C1QTNF12;GCK
prerank,endothelial cell proliferation (GO:0001935),-0.47637601944846575,-1.3503096485189339,0.12147505422993492,0.5333884677916274,1.0,9/17,25.26%,ERN1;SEMA5A;ITGB1BP1;HMOX1;ACVRL1;TEK;BMP4;ANGPT4;DLG1
prerank,glial cell differentiation (GO:0010001),-0.4234982579264578,-1.3498016092568685,0.08899297423887588,0.5328812935014738,1.0,7/28,4.37%,NFIB;FGF10;SLC8A3;TPPP;ADGRG6;MYRF;SOX11
prerank,regulation of interferon-gamma production (GO:0032649),0.37117936838556287,1.3497349004630586,0.06291390728476821,0.6548329749411502,1.0,18/71,11.73%,IL18;TLR7;SIRPA;LGALS9;SLC7A5;DDIT3;VSIR;CYRIB;TLR4;EBI3;C1QBP;CCR7;PDCD1LG2;IL12B;INHA;IL12RB2;AXL;HAVCR2
prerank,homotypic cell-cell adhesion (GO:0034109),0.4060621160728792,1.3487266953677013,0.08348134991119005,0.6566591940610299,1.0,19/39,28.65%,P2RY12;FERMT3;PLEK;MYH9;PIK3CG;STXBP1;UBASH3B;PIK3CB;TJP2;GNAS;DSC2;MYL12A;MEGF10;MEGF11;ITGB3;FIBP;RAP2B;TYRO3;CLIC1
prerank,regulation of macroautophagy (GO:0016241),0.3403811797951154,1.3486190555707671,0.04823151125401929,0.6549431248072827,1.0,37/105,23.83%,SCOC;EXOC7;UCHL1;ATP6V0B;PRKACA;VPS26B;ATP6V1D;ATP6V0A2;LAMTOR2;RPTOR;SH3GLB1;GAPDH;MTOR;USP36;MLST8;LAMTOR5;CLN3;RB1CC1;PINK1;ATG101;MAPK8;SNX5;RRAGA;AKT1;SNX32;ULK1;ATP6V0E2;VPS26A;VPS35;EXOC1;LARP1;SNX6;PIK3CA;SESN1;ATP6V0C;EXOC8;EXOC4
prerank,positive regulation of myelination (GO:0031643),-0.5562363372128905,-1.3481613116250553,0.12473118279569892,0.5354919320306611,1.0,4/11,13.36%,TPPP;MYRF;TENM4;PARD3
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.3597858562616655,-1.347906563210481,0.05200945626477541,0.53431123817585,1.0,18/54,17.28%,GPC6;HS3ST5;HS3ST2;HGSNAT;EXT1;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;GPC3;PXYLP1;NDST1;B3GAT2;GPC4;EXT2;AGRN;B4GALT7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.47914511666017284,1.346790293262459,0.10805860805860806,0.6596880729538727,1.0,6/20,5.85%,NUMB;MRAP;ABI3;PICALM;RHOQ;CSK
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5319019417055421,1.3467753546299261,0.12432432432432433,0.6577003858737375,1.0,7/13,23.86%,ITGAM;ITGB2;PRKCD;SOD1;MAPT;TGFB1;TYROBP
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3919113647337997,-1.346713242193292,0.07551487414187644,0.5359385046062062,1.0,9/39,7.31%,ANK2;FGF12;UTRN;YWHAE;NEDD4L;FXYD5;HOMER1;PTPN3;CHRM3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5304001483560365,-1.346496573034642,0.10874200426439233,0.5347612224747509,1.0,6/12,29.57%,NFIB;SPTBN4;EPHA4;EPHB2;CHRNB2;TSKU
prerank,negative regulation of phosphorylation (GO:0042326),-0.32605552330515536,-1.3455968623113044,0.03561643835616438,0.5352552817587475,1.0,23/85,15.49%,PID1;LRRK2;XDH;STAP1;SLIT2;PFKFB1;LRP6;NTRK3;PPIA;CADM4;SH3GL2;HDAC4;PRKN;SIRT1;MYADM;TIGAR;PAQR3;PTPN13;CDKN2A;CBFA2T3;CDKN1A;PRR5L;PLPP3
prerank,regulation of protein kinase B signaling (GO:0051896),0.31549267320768604,1.3454144100202925,0.01788375558867362,0.660839145730254,1.0,42/193,12.78%,CX3CR1;TGFBR1;IL18;P2RY12;RAC1;DDIT3;ARRB2;PIK3R1;GAB2;IGF1R;SRC;PIK3CG;RNF41;PKHD1;CCL3;FLCN;THEM4;SPRY2;PIK3AP1;PDPK1;PDGFB;MTDH;CD86;MET;C1QBP;GCNT2;CCR7;RASD2;GPER1;CALCR;GRM2;FRS2;PIK3CD;INPP5K;AXL;PIK3CB;PDGFRB;PPP2R5B;PINK1;ENG;PDCD6;PTPN11
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.42790636914290203,-1.3453187765670136,0.09684684684684684,0.5341125901069776,1.0,8/26,6.61%,ITPR1;RYR3;RYR2;HTR2C;SLC8B1;LETM1;HTR2B;PKD2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5400276957412762,1.3442641950318166,0.13018867924528302,0.6630874898508294,1.0,3/12,15.59%,FDXR;TSPO;FDX1
prerank,neuronal action potential (GO:0019228),-0.44575135132680327,-1.344222536231799,0.11161731207289294,0.5353208610207301,1.0,10/22,24.00%,ANK3;SCN2A;KCNMB2;SCN3A;KCNMB4;SCN9A;KCNMB3;CACNA1G;SCN1A;KCNA1
prerank,negative regulation of receptor binding (GO:1900121),-0.5579164364493753,-1.3439565657075516,0.12368972746331237,0.5341657137649992,1.0,3/10,10.17%,B2M;ATP2A2;ATP2A3
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5278910435231399,-1.3438106008540347,0.13232104121475055,0.5326988286076622,1.0,4/11,16.84%,ZFPM2;JAG1;HEY2;BMP4
prerank,focal adhesion assembly (GO:0048041),-0.45221762594903353,-1.3430487204956918,0.10606060606060606,0.5330572612961014,1.0,9/21,21.63%,SORBS1;CTTN;TRIP6;THSD1;ACTN2;THY1;RCC2;PTPRK;PEAK1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4820586238396947,-1.3429217048790387,0.10706638115631692,0.5315609973898313,1.0,7/15,14.70%,KCNN2;KCNJ3;YWHAE;KCND3;ATP1A1;KCNQ1;KCNIP2
prerank,negative regulation of hydrolase activity (GO:0051346),0.38521675029599906,1.342787041725881,0.08561643835616438,0.6666864149128807,1.0,11/49,13.72%,F11R;CST3;LRCH1;FICD;EGLN1;RASA4;ZCCHC9;GPATCH2;WNK1;SH2D4A;GMIP
prerank,regulation of fibroblast migration (GO:0010762),0.47211033197581087,1.3422935907298688,0.11070110701107011,0.6665755846810669,1.0,11/20,26.06%,GNA12;RAC1;RFFL;APPL1;DDR2;CLN3;THBS1;DMTN;TGFB1;APPL2;ARHGEF7
prerank,lipoprotein localization (GO:0044872),-0.5337184938082744,-1.342211571735789,0.16916488222698073,0.5317543062453549,1.0,5/11,10.48%,PPARG;CD36;ZDHHC17;VMP1;UNC119
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.40031419239917765,1.3416219706242094,0.07534246575342465,0.6670849993856987,1.0,9/43,10.78%,TMEM119;LRP5;MEF2C;NPNT;CTNNBIP1;IL6ST;IL6R;WNT7B;DDR2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5723560063857533,1.3411672720305554,0.1339622641509434,0.6669011463827339,1.0,4/10,17.58%,CX3CR1;SMARCD3;DRD2;KDM1A
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.553603449061181,-1.3408227816691827,0.13655462184873948,0.5337491361425917,1.0,3/11,7.08%,DAB2;MTMR2;PRKN
prerank,pre-miRNA processing (GO:0031054),-0.5007517230087574,-1.3404325198020208,0.11572052401746726,0.5328648457413597,1.0,9/14,37.30%,AGO4;TUT4;DROSHA;LIN28B;ADAR;AGO2;TARBP2;PRKRA;MRPL44
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.41202781506381436,-1.3402026156626246,0.10062893081761007,0.5316601940135147,1.0,8/29,11.26%,SORBS1;LDLR;CREBL2;ZBTB20;APOE;SLC45A3;ELOVL5;MFSD2A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.32077665610177175,1.3398051776608717,0.034055727554179564,0.6697093806453791,1.0,49/153,20.62%,TGFBR1;TGFBR2;ULK2;CSNK1E;RPS6KA1;PRKCA;PRKACA;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;CAMK1D;RPS6KA5;ULK3;PDPK1;PDGFB;PKN3;VRK3;MTOR;WNK1;PRKCB;GRK2;TAF1;PINK1;UHMK1;MARK2;MAP3K10;MAPK8;MAST3;MORC3;LATS2;AKT1;MAPK14;DYRK4;DYRK1A;STK39;AURKA;MASTL;ULK1;RPS6KA4;VRK2;ROCK2;CAMK1;CAMK1G;CSNK1G2;EIF2AK3;PRKCH
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5629290159815801,1.3390724060928463,0.1571969696969697,0.670514714970965,1.0,4/11,16.44%,LGALS9;VSIR;RUNX1;LGALS7
prerank,mitochondrial translational termination (GO:0070126),0.3468521097729979,1.3387840069509978,0.0738362760834671,0.6695539486541767,1.0,46/88,32.97%,MRPL50;MRPS24;MRPL17;MRPL2;MRPL37;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;MRPS21;CHCHD1;MRPL13;MRPS16;MRPS11;MRPS18B;MRPS28;MRPS35;MRPS10;MRPS18A;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;MRPL38;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;MRPL21;MRPL20;MRPL49;MRPS18C;MRPL45;OXA1L;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,mitochondrial translation (GO:0032543),0.3366085582631966,1.3381455671077507,0.05221518987341772,0.6700404436022436,1.0,53/104,32.97%,MRPL50;MRPS24;MRPL17;MRPL2;MRPL37;MRPL43;MRPS34;MRPL34;MRPL9;MRPS5;MRPL30;MRPS21;CHCHD1;MRPL13;MRPS16;MRPS11;MRPS18B;MRPS28;MRPS35;MTIF2;MRPS10;MRPS18A;IARS2;MRPL46;MRPL11;MRPL41;MRPL27;MRPL54;FASTKD2;MRPL38;TUFM;DAP3;MRPL47;MRPL36;MRPS25;MRPL28;NOA1;MRPL21;MRPL20;GATC;MRPL49;MRPS18C;MRPL45;OXA1L;TSFM;MRPL14;MRPL32;MRPL10;MRPL19;MRPL15;MRPS17;MRPS27;AURKAIP1
prerank,Golgi to lysosome transport (GO:0090160),0.554622689211036,1.338142821861841,0.13333333333333333,0.6680377690878295,1.0,10/11,33.47%,SORT1;CLN3;RBSN;AP4M1;CCDC91;ANKFY1;GAK;EHD3;LAPTM5;AP1G1
prerank,cytoplasmic translational initiation (GO:0002183),0.4985398474779833,1.3379561993048834,0.12098298676748583,0.6666815151335255,1.0,9/17,20.88%,EIF4A2;EIF4G1;EIF2B3;EIF4H;EIF2S2;EIF3D;EIF2D;EIF5;DHX29
prerank,sensory perception of pain (GO:0019233),-0.442084460855664,-1.337901293605238,0.11791383219954649,0.5365463098737304,1.0,7/21,16.77%,CCR2;MME;OPRM1;NIPSNAP1;CHRNA4;PTGES;SCN9A
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.32783640353615695,1.3377996497887068,0.047839506172839504,0.6651729451846531,1.0,36/136,17.58%,SUMO1;SMAD7;PRMT2;HEYL;DDIT3;IRAK2;ARRB2;PYDC1;OTULIN;ITCH;PHB2;PKHD1;ID1;CTNNBIP1;EGLN1;MDFI;NLRP3;NFKBIE;COMMD6;TBX6;HAVCR2;TAF1;FZD6;MAP3K10;CEBPG;NWD1;WWP2;ID3;PYCARD;PROX1;COMMD7;AIM2;TRIB1;ARRB1;HES6;KDM1A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.4603997014072411,-1.3363532376660123,0.11316397228637413,0.5390870255859058,1.0,8/20,10.95%,MCU;SLC8A3;SLC8B1;LETM1;PARL;MCUB;MICU2;MICU3
prerank,response to lipopolysaccharide (GO:0032496),0.32270988426595654,1.3355391779662646,0.03260869565217391,0.671548254656936,1.0,42/138,22.12%,CX3CR1;SIRPA;LGALS9;MEF2C;SBNO2;TLR4;OTUD5;CTR9;CASP1;SLPI;CD86;NLRP3;SELE;NOS2;PDCD1LG2;SELP;CXCL1;TAB2;AXL;PABPN1;TICAM2;CD180;SERPINE1;MAPK8;CCR5;PYCARD;MAPK14;TNIP2;TRIB1;SCARB1;HMGB2;TICAM1;SLC11A1;NOD2;IL1A;NOS1;GGT5;ADAM17;ACOD1;ZC3H12A;SHPK;CXCL10
prerank,regulation of leukocyte migration (GO:0002685),0.501332746168282,1.3352230800648675,0.1366906474820144,0.6707426493595795,1.0,4/16,10.24%,RAC1;RHOH;MIA3;NCKAP1L
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.35742438390148923,1.3346623011001904,0.07986688851913477,0.6708561271442347,1.0,20/72,18.67%,POLR2H;PCNA;POLR2J;RFC2;POLR2D;COPS4;GTF2H2;RPS27A;UBC;ERCC2;CUL4B;HMGN1;LIG1;POLD2;ERCC4;GPS1;COPS6;POLR2E;RFC1;CUL4A
prerank,positive regulation of viral transcription (GO:0050434),0.4471564729705187,1.334354780645232,0.10326086956521739,0.6700329459013178,1.0,6/25,6.85%,NELFB;POLR2H;CDK9;POLR2J;POLR2D;DHX9
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32231212582032776,1.3341614563132598,0.03067484662576687,0.6688224836501797,1.0,29/149,11.02%,CX3CR1;IL18;ARHGEF2;CAPN3;CFLAR;LGALS9;IRAK2;RIPK2;AGER;CRNN;TLR4;TRIM5;TRAF5;CLU;RPS6KA5;RPS27A;UBC;TRADD;DHX9;MTDH;NLRP3;FLOT2;EDA2R;TAB2;RNF31;RTKN2;PRKCB;RNF25;LAMTOR5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4028807306963167,1.3337551613293195,0.10229276895943562,0.6684223263396046,1.0,15/38,25.57%,ARHGEF2;CFLAR;TRADD;RFFL;BRCA1;SERPINE1;STX4;THBS1;PMAIP1;RNF34;DDX3X;BCL2L1;FADD;FAIM;MADD
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5446795875941403,1.3337031399501582,0.15213358070500926,0.6666313753941743,1.0,5/12,27.12%,TLR4;MUC6;NOD2;SOX9;TLR9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5724767315889944,1.333275070793133,0.14119922630560927,0.666366517684003,1.0,3/10,17.44%,EGR1;CLU;C5AR1
prerank,regulation of glycogen metabolic process (GO:0070873),0.5460651719549703,1.3330914059899528,0.11913357400722022,0.6650967383781942,1.0,5/12,19.36%,PPP1R3E;INPP5K;AKT1;KHK;PPP1R3F
prerank,action potential (GO:0001508),-0.36990485891199304,-1.3329101405224972,0.09259259259259259,0.5470967646306784,1.0,7/44,5.73%,KCND2;DMD;ANK3;AKAP6;SCN2A;KCNMB2;SCN3A
prerank,regulation of developmental growth (GO:0048638),-0.4118945220304069,-1.3314882913106754,0.0825,0.54934054193349,1.0,9/29,11.26%,PLCB1;NRCAM;APP;CTTN;LATS1;APOE;GSK3B;FGFR3;MFSD2A
prerank,negative regulation of transferase activity (GO:0051348),0.44259899642233247,1.3299401132723918,0.11754684838160136,0.6750140787056795,1.0,12/28,23.60%,SMAD7;EIF4A2;SRC;INPP5K;ERCC4;TERF1;ABL1;DTX3L;MAPT;PARK7;CDKN1B;TP53
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4872728554598019,1.3291068443852123,0.12727272727272726,0.6761490190487721,1.0,4/17,13.61%,BIN1;EGR2;SERPINE2;IL34
prerank,positive regulation of interleukin-12 production (GO:0032735),0.4236585018194454,1.3285061803734812,0.10652920962199312,0.676270724691575,1.0,7/31,8.32%,LGALS9;RIPK2;AGER;TLR4;PLCG2;CCR7;IL12B
prerank,protein tetramerization (GO:0051262),-0.34161524041849195,-1.328259796736763,0.05980861244019139,0.5566909879679458,1.0,16/67,15.03%,HCN1;GRIN2B;RYR3;B2M;GLS;AQP4;HOMER1;PKD2;ACOT13;GNMT;SHMT1;SAMHD1;SOD2;PKD1;SNCA;ALDH9A1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.43603814295304544,1.3279589402587035,0.14564831261101244,0.6763293642493172,1.0,6/26,9.12%,IRAK2;RIPK2;ITCH;RPS27A;UBC;TAB2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.51046044858149,1.3276380852057257,0.12571428571428572,0.675623674704585,1.0,7/14,21.10%,PSENEN;CLN3;PSEN2;DYRK1A;ADAM10;APH1B;ADAM17
prerank,sensory perception of sound (GO:0007605),-0.3205391992488815,-1.3275719026906019,0.04594594594594595,0.5567550572227598,1.0,43/88,30.85%,GRM7;PCDH15;ROR1;RIPOR2;USP53;NDUFB9;BIRC5;DCDC2;MYO3B;SPTBN4;CCDC50;TPRN;CLRN1;PAX3;KIT;LHFPL4;LHFPL3;KCNQ1;COL1A1;TIMM10;SNAI2;TSPEAR;EPS8L2;TMC1;LOXHD1;SLC26A4;PDZD7;MKKS;TMIE;COL4A3;LRP2;LHFPL5;CHRNB2;TIMM9;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.34582212747020236,-1.326965687415589,0.06149732620320856,0.5564902658630109,1.0,28/66,26.07%,MTSS1;ROBO1;NFIB;XDH;B2M;APOE;KLF9;ALOX5;CASK;CDC73;DUSP10;AQP11;MCC;SFRP1;RGCC;SNAI2;SFRP2;CDKN1C;PTPRK;TGFBR3;CAV2;GHRL;MARVELD3;NLRC3;TNMD;FBXW7;CNMD;BRCA2
prerank,reverse cholesterol transport (GO:0043691),0.5192360942181065,1.3268137237140436,0.12454873646209386,0.6768206312874367,1.0,4/13,8.30%,LIPC;CLU;APOM;LCAT
prerank,placenta development (GO:0001890),-0.52420470082827,-1.3267994705168722,0.13755458515283842,0.5551040469938139,1.0,8/12,33.78%,PPARG;CUL7;E2F7;PLAC1;PTK2;ADAM19;CITED1;E2F8
prerank,regulation of interferon-beta production (GO:0032648),0.38843359119474663,1.3267576540958834,0.08453237410071943,0.6751165125555918,1.0,12/46,16.20%,TLR7;POLR3G;SIRPA;RNF216;RIPK2;TLR4;DHX9;PTPN11;RELB;MAVS;PYCARD;IRF3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.35107527206214706,1.3260295548453758,0.060955518945634266,0.6759146831552348,1.0,25/86,20.75%,BIN1;NAV3;RAC1;BAIAP2L2;CDC42EP2;PLEK;CLU;NUMA1;PTK2B;MET;CCR7;NCKAP1L;TRPV4;WDR1;PYCARD;MAPRE1;PROX1;TENM1;FCHSD2;CDC42EP3;FES;VASP;CCL24;MAPT;FCHSD1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.491225398921153,1.3259944150329372,0.11876075731497418,0.6741145009289345,1.0,7/18,23.67%,SMAD3;FSCN1;DDR2;RUNX1;IER3IP1;BMP2;TGFB1
prerank,negative regulation of secretion (GO:0051048),-0.5404038527974742,-1.3254561843111923,0.13392857142857142,0.5570054726146553,1.0,8/10,37.84%,CD74;ERBB3;SPX;NRG1;PTGER3;VAMP3;VAMP8;EGF
prerank,macrophage activation (GO:0042116),0.4158649714407984,1.325364865402421,0.11484098939929328,0.6745022906094774,1.0,10/34,8.21%,ITGAM;AIF1;AGER;SBNO2;TLR4;ITGB2;CLU;PLCG2;C1QA;EDN2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.47571278249922727,1.3247680197789604,0.12730627306273062,0.6748296689944602,1.0,7/19,20.62%,F11R;PRKACA;TJP1;RUNX1;ROCK2;EPHA2;PRKCH
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.29916328593114316,-1.3235326552346056,0.014970059880239521,0.560838831894467,1.0,36/161,15.25%,DAB2;CCDC88C;SHISA6;CUL3;LIMD1;PSMD14;LATS1;HECW1;APC2;RBMS3;LRP6;APOE;GSK3B;PSMD8;MLLT3;IGFBP4;FRZB;PSMA2;PSMF1;PRKN;PSMD6;TLE4;AXIN1;PSME2;SOX13;PSMD5;TLE1;PSMD12;NPHP3;MCC;IGFBP2;PSMD11;SCYL2;NKD1;PSMD1;SFRP1
prerank,diterpenoid metabolic process (GO:0016101),-0.35333587236672603,-1.3229997654834353,0.0671462829736211,0.5605513162313726,1.0,25/55,32.49%,GPC6;SDC3;GPC5;APOE;NAPEPLD;HSPG2;GPC3;RDH10;RBP4;ALDH3A2;ABCA4;GPC4;AGRN;RDH12;RBP1;GPC1;RARRES2;LRP2;SDC2;AKR1C1;OPN1MW;APOA2;RBP2;LRAT;STRA6
prerank,regulation of chemotaxis (GO:0050920),0.43353091468078386,1.3228975472854085,0.11904761904761904,0.6797445608056251,1.0,11/30,23.67%,P2RY12;AIF1;CYRIB;ZSWIM8;PDGFB;PDGFRB;STX4;THBS1;PPM1F;ZSWIM4;TGFB1
prerank,heme catabolic process (GO:0042167),0.5117567481604374,1.322842306180196,0.13793103448275862,0.6761327539257845,1.0,1/14,0.06%,SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5117567481604374,1.322842306180196,0.13793103448275862,0.6761327539257845,1.0,1/14,0.06%,SLCO2B1
prerank,inositol lipid-mediated signaling (GO:0048017),0.3896049245879867,1.3228183961280144,0.08361774744027303,0.6743247127890475,1.0,13/50,11.76%,ADAP2;CSF1R;PI4KB;PLCL1;PIK3R1;GAB2;IGF1R;PIK3CG;PIK3C3;PIK3CD;PIK3CB;PDGFRB;PLCL2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5212515108958119,-1.3221474010644727,0.14038876889848811,0.5612632322467145,1.0,4/13,10.58%,RBPJ;ZFPM2;ERBB4;PIM1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3122776346393636,-1.3207722780768294,0.04945054945054945,0.5633655744946214,1.0,31/118,15.51%,LRRC4C;PID1;PDLIM5;ADGRB3;LRRK2;ARHGAP35;PPFIA2;HECW2;HECW1;NEDD4L;PDZD8;SP100;SHANK3;PLXND1;GSK3B;CHN1;PAK3;ABI2;LFNG;BCL9L;HTATIP2;SRCIN1;SH3D19;SARM1;ZDHHC15;EFNA5;HMOX1;VASH2;PAK1;SFRP1;DAG1
prerank,regulation of intracellular signal transduction (GO:1902531),0.28712283841219444,1.3205901112907354,0.006765899864682003,0.6805669482000304,1.0,85/420,14.20%,SRGAP3;SRGAP2;ARHGAP5;CHN2;NUAK1;FGD2;ARHGAP22;GNA12;ARHGAP45;OPHN1;ARHGAP39;ARHGEF2;PREX1;VAV2;CAPN3;RAC1;MAP4K4;PJA2;AGER;RHNO1;CRNN;ARAP3;CHEK2;LYN;ARHGAP25;TBCK;RFC2;ITGAV;AKAP5;CSNK2A2;CSNK2A1;RHOQ;NBN;ATM;TRAF5;SLC15A4;RHOB;RNF41;PKHD1;PLCG2;FLCN;ARHGAP30;ARHGAP28;NEK8;TAF12;RAD17;RHOH;RFFL;ARHGAP17;MDM4;PDPK1;TAF6;PIP4P1;BRCA1;BOP1;ARHGAP8;RASD2;FSHR;GRM2;POU4F1;EHMT2;AKAP13;CHD3;ARAF;AKAP12;MTOR;PRDM1;FGD3;MLST8;PRDM11;FBXL2;CEACAM1;TRIO;PPP2R5B;TAF1;EXO1;RAD1;BLM;TAOK2;OPTN;PIN1;TAF4;GMIP;PLK3;ARHGAP36
prerank,regulation of protein ubiquitination (GO:0031396),0.33462935559284585,1.3204174678007967,0.039473684210526314,0.6792232224661436,1.0,25/108,18.52%,TGFBR1;IVNS1ABP;SENP2;SMAD7;ARRB2;RIPK2;TBC1D7;NDFIP2;U2AF2;SPRY2;PTTG1IP;BRCA1;KLHL40;PINK1;GNL3L;UBE3A;AKT1;FANCI;USP4;XIAP;HDAC8;PHF23;ARRB1;SPOPL;STUB1
prerank,regulation of autophagy (GO:0010506),0.3055580439305504,1.3199245527807622,0.027737226277372264,0.6791971903434699,1.0,64/216,19.60%,EXOC7;PIM2;DDIT3;UCHL1;ATP6V0B;SIRT2;PRKACA;TRIM5;VPS26B;CPTP;GFAP;CSNK2A2;ATM;FLCN;EIF4G1;ATP6V1D;FOXK2;MTDH;MET;ATP6V0A2;LAMTOR2;RPTOR;TAB2;DRAM2;SH3GLB1;ACER2;GAPDH;MTOR;PIK3CB;USP36;MLST8;WDR24;LAMTOR5;TPCN1;FBXL2;RASIP1;BMF;RB1CC1;PINK1;MTMR4;KDM4A;ATG101;OPTN;ABL1;IL10RA;MAPK8;SNX5;RRAGA;AKT1;VDAC1;GPR137;SNX32;WDR6;ULK1;ATP6V0E2;CTSA;KAT5;TICAM1;TMEM59;HTRA2;VPS29;DCAF12;VPS26A;VPS35
prerank,protein localization to cell-cell junction (GO:0150105),0.48937628210276196,1.319471054194586,0.15356489945155394,0.6789891140290574,1.0,5/15,14.86%,F11R;DSP;LSR;TJP1;TJP2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.47468617000674007,1.3188527837604398,0.14473684210526316,0.679565705534245,1.0,4/19,7.40%,CX3CR1;PYDC1;CPTP;NLRP3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4604302113456098,1.3187237333503512,0.12078152753108348,0.6781857067984287,1.0,8/23,18.67%,DDB2;COPS4;RPS27A;UBC;CUL4B;GPS1;COPS6;CUL4A
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4998472733121779,-1.3186661844777907,0.13953488372093023,0.5678419513479825,1.0,6/14,14.75%,CD74;LILRB1;CAMK4;SIRT1;KIT;SEMA7A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.47957461814400953,-1.3175185195837675,0.11936936936936937,0.5693916586884542,1.0,2/16,1.64%,DPYD;DPYSL5
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4685441960425041,1.3173977595961694,0.1492007104795737,0.6811103175521966,1.0,3/19,6.25%,TGFBR2;HEYL;MDM4
prerank,insulin secretion (GO:0030073),-0.4444807940179092,-1.3171648962489437,0.15367483296213807,0.5686246413730378,1.0,3/19,4.06%,RIMS2;PTPRN2;SNX19
prerank,development of primary male sexual characteristics (GO:0046546),0.413909419837716,1.3166848111622798,0.09743589743589744,0.6818284283852053,1.0,6/34,8.69%,LHFPL2;SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30021236810316587,1.3164891729292219,0.017366136034732273,0.6806809851027629,1.0,78/241,25.41%,SRRM1;SNRNP70;NCBP1;DDX5;SNRPA;POLR2H;FUS;SRRT;POLR2J;CSTF2;POLR2D;HNRNPA3;RBM19;SF3B2;SF3B1;MAGOHB;MAGOH;U2AF2;HNRNPC;SNRPC;ZMAT2;RBM14;SART3;SNRPF;SNRPA1;PCBP2;HNRNPH1;CWC25;DHX9;SNRNP48;DHX38;HNRNPR;SRSF5;PABPN1;SRRM2;CPSF1;GEMIN6;RBM8A;TRA2B;RBM17;PRPF31;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;POLR2E;METTL14;CCAR1;PRPF3;PCF11;PRPF4;SNRPN;ZCCHC8;LSM7;RBMX;SNRNP40;HNRNPA2B1;SRSF9;HNRNPH3;WBP4;SNIP1;DDX39B;POLR2I;ELAVL1;HNRNPUL1;SNRNP25;LSM8;DDX46;NOVA2;HNRNPA1;SYF2;PNN;CD2BP2;CRNKL1
prerank,polyamine metabolic process (GO:0006595),0.5267350378467751,1.3162701117739115,0.15514018691588785,0.6796013839609693,1.0,9/13,34.70%,HDAC10;SMOX;DHPS;OAZ2;PAOX;HDAC6;SRM;ODC1;SAT2
prerank,dendritic spine morphogenesis (GO:0060997),-0.475573895156143,-1.3159809856507392,0.13390928725701945,0.5705075500553076,1.0,4/15,6.72%,CTNND2;SHANK3;CDC42;PAK3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5344215591694972,-1.3157666541915822,0.15611814345991562,0.5692729881493013,1.0,5/10,9.32%,RAPGEF2;GIPC1;ATP7A;ZEB2;MFSD12
prerank,exit from mitosis (GO:0010458),-0.5199747028251865,-1.3155064539620638,0.1561822125813449,0.5681021059546221,1.0,2/12,11.43%,EPS8;UBE2C
prerank,P-body assembly (GO:0033962),-0.5237987406003694,-1.3142177443457128,0.14346895074946467,0.5700981148887792,1.0,9/12,39.51%,LIMD1;LSM3;PATL1;ATXN2;DYNC1H1;LSM4;EIF4ENIF1;PATL2;EDC3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5277109028327474,1.3137099141356732,0.14954954954954955,0.687115142343839,1.0,3/12,2.91%,DOCK8;AIF1;JAM2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5354412398385113,-1.3134067894795873,0.15286624203821655,0.5705220884279503,1.0,4/11,9.42%,AGBL4;AGBL1;TTL;ATG7
prerank,positive regulation of T cell proliferation (GO:0042102),0.3728578778776294,1.3132585298011217,0.08945686900958466,0.6869208016216206,1.0,12/55,10.24%,IL18;CCDC88B;AIF1;AGER;EBI3;TNFRSF13C;IL6ST;CD86;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4855115124810259,-1.3129158275075894,0.15975103734439833,0.5700849850549363,1.0,4/15,6.27%,NLGN1;SYN3;ADRA1A;CNTNAP4
prerank,regulation of viral transcription (GO:0046782),0.39629797315256043,1.312812366589535,0.10207612456747404,0.6866941769907343,1.0,8/39,6.85%,NELFB;POLR2H;UBP1;TRIM11;CDK9;POLR2J;POLR2D;DHX9
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.44148710261985274,-1.312584892551166,0.11538461538461539,0.5693084121155906,1.0,6/23,5.23%,CD74;SLIT2;DPP4;MCU;RIPOR2;DNM1L
prerank,protein catabolic process (GO:0030163),0.36588591987875346,1.3120420225255898,0.09391304347826086,0.6876156186181566,1.0,10/59,11.33%,BAG6;CTSD;CAPN3;CHEK2;RNF41;SOCS6;PPT1;CUL4B;MTOR;CEACAM1
prerank,tRNA transport (GO:0051031),0.40658346667581396,1.3117701694717518,0.11149228130360206,0.6867418658554743,1.0,13/35,17.95%,TOMM20L;XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;TOMM20;NUP62;SEH1L;NUP107
prerank,7-methylguanosine mRNA capping (GO:0006370),0.41648709232125297,1.311425047914045,0.11504424778761062,0.6843268357372139,1.0,7/31,7.30%,NCBP1;POLR2H;POLR2J;POLR2D;GTF2H2;ERCC2;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.41648709232125297,1.311425047914045,0.11504424778761062,0.6843268357372139,1.0,7/31,7.30%,NCBP1;POLR2H;POLR2J;POLR2D;GTF2H2;ERCC2;RNMT
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3888112769809394,1.3113045718668592,0.10420168067226891,0.6829672541577098,1.0,23/47,23.86%,ITGAM;TGFBR2;TLR4;ITGB2;RNF41;PRKCD;PLCG2;CBR1;PDGFB;DHRS4;PDGFRB;SOD1;MAPK14;SLC5A3;RAB27A;AGT;THBS1;MAPT;ACOD1;ZC3H12A;TP53;TGFB1;TYROBP
prerank,response to hydroxyurea (GO:0072710),0.5423745957535326,1.3102383129203117,0.15370705244122965,0.6850699335353408,1.0,7/11,34.81%,SPIDR;BLM;NSMCE3;RTF2;DDX11;ATRX;DDI2
prerank,synaptonemal complex organization (GO:0070193),0.5078728161555512,1.3101928240179417,0.14389799635701275,0.6816016147621232,1.0,6/15,27.42%,BAG6;STAG3;TEX12;SYCE2;SYCP2;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),0.5078728161555512,1.3101928240179417,0.14389799635701275,0.6816016147621232,1.0,6/15,27.42%,BAG6;STAG3;TEX12;SYCE2;SYCP2;HORMAD1
prerank,regulation of protein processing (GO:0070613),-0.4371567553263384,-1.309670387816901,0.12035010940919037,0.5762069382829437,1.0,3/21,1.41%,LRRK2;NLRC4;CCBE1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5574186712360347,-1.3086309651167642,0.14775160599571735,0.577587001412129,1.0,6/10,12.75%,GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRA5
prerank,sulfation (GO:0051923),-0.5127364491875656,-1.3079547065595127,0.1510204081632653,0.5776628371701249,1.0,2/11,2.31%,HS3ST5;UST
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4179958506401039,-1.3058084622720065,0.11951219512195121,0.5821677363780643,1.0,8/27,13.52%,PID1;IRS1;PRKCZ;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.32573621829449423,1.3056494817156923,0.06606606606606606,0.6964450931711286,1.0,42/113,25.40%,ASAP1;SUMO1;CDC42EP2;TLR4;DDB2;PLEK;SRC;ATM;CLU;EIF4G1;FSCN1;GTF2H2;SPIDR;MTLN;ERCC2;CUL4B;SH3GLB1;RASIP1;BMF;ERCC4;GNL3L;TERF1;PSMC2;TAL1;MED25;GBP5;STUB1;CUL4A;SLF2;PIEZO1;USP50;DDX3X;RPA3;BCL2L11;PARK7;MYD88;TP53;TGFB1;BRK1;RHOC;AJUBA;ABCA1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.45295524922557295,1.3055512588413445,0.14473684210526316,0.6949525394343435,1.0,10/21,26.27%,RASAL3;CYRIB;ARHGAP25;SPRY2;CD2AP;SYNGAP1;LZTR1;CGNL1;MFN2;SH3BP1
prerank,artery morphogenesis (GO:0048844),0.4187653272280368,1.305208349998127,0.1307300509337861,0.6943823022788439,1.0,7/30,15.73%,TGFBR1;SMAD7;HPGD;LRP1;PDGFRB;ENG;NOG
prerank,mRNA metabolic process (GO:0016071),0.3372386569112772,1.3048777672056566,0.07178631051752922,0.693755849596235,1.0,26/90,20.57%,SON;NCBP1;DDX5;PRKACA;AKAP8L;SSB;DXO;SF3B2;U2AF2;DIS3L2;SNRPF;PCBP2;ZFP36L2;NANOS2;HNRNPR;SRSF5;LSM5;SF3A1;ALKBH5;RIDA;PRPF3;PCF11;GEMIN2;NUDT16;HNRNPA2B1;SRSF9
prerank,ganglioside metabolic process (GO:0001573),0.45232064099908936,1.3044070311840048,0.13768115942028986,0.6937579376163006,1.0,5/20,11.74%,HEXB;ST3GAL5;HEXA;NEU3;B4GALNT1
prerank,brain morphogenesis (GO:0048854),-0.5021050157151592,-1.3040416049661585,0.14775160599571735,0.5855134065768655,1.0,3/12,5.36%,CTNNA2;SHANK3;VPS51
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3817426526473449,1.3034096081398876,0.1097770154373928,0.6957594543210056,1.0,11/49,14.82%,TLR7;LGALS9;DDIT3;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;SERPINE1;MAVS;PYCARD
prerank,potassium ion transmembrane transport (GO:0071805),-0.2963529530954136,-1.3028681699472453,0.04011461318051576,0.586973074856534,1.0,23/135,8.20%,KCND2;KCNT2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;NALCN;KCNH1;SLC24A2;KCND3;KCNA6;KCNQ3;SLC12A8;KCNAB2;SLC12A4;PKD2;KCNH7;ATP1B3;KCNH5;SLC12A5
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4732995780896837,1.3027430898399897,0.14285714285714285,0.6964210940486113,1.0,8/19,21.58%,CSF1R;CAMK1D;AKIRIN1;IL34;CSF1;CXCL17;THBS1;MPP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.45371324237959776,1.302629034946315,0.1494661921708185,0.6949996729704404,1.0,6/20,14.44%,TMEM35A;CLU;PSMG1;HSPA4;NDUFAF1;BBS12
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3208304224245342,-1.3026162902266971,0.041666666666666664,0.5859515817899762,1.0,41/85,30.85%,GRM7;PCDH15;ROR1;RIPOR2;USP53;NDUFB9;BIRC5;DCDC2;MYO3B;SPTBN4;CCDC50;TPRN;CLRN1;PAX3;LHFPL4;LHFPL3;KCNQ1;COL1A1;TIMM10;SNAI2;TSPEAR;EPS8L2;PIEZO2;LOXHD1;SLC26A4;PDZD7;TMIE;COL4A3;LRP2;LHFPL5;CHRNB2;TIMM9;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,spindle assembly (GO:0051225),0.3622370610776263,1.3022613768293005,0.10210696920583469,0.6944700036009128,1.0,16/67,15.19%,KIF2A;KIF3B;GOLGA8B;CHEK2;NEK6;NUMA1;STARD9;TUBGCP5;HAUS7;NEK7;ABRAXAS1;CEP63;HAUS6;HAUS2;KASH5;MAPRE1
prerank,lipoprotein transport (GO:0042953),-0.5406462659877241,-1.301792271078758,0.16556291390728478,0.5865306878667226,1.0,5/10,10.48%,PPARG;CD36;ZDHHC17;VMP1;UNC119
prerank,thymus development (GO:0048538),0.5202845141350704,1.3017066983967724,0.15083798882681565,0.6946715607189473,1.0,3/13,6.91%,TGFBR1;FOXE1;SHH
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3561525954396545,-1.3006932487554785,0.0892018779342723,0.5879825614456309,1.0,11/48,13.67%,ROBO1;PPARG;STAP1;SLIT2;PARP14;NLRP2B;PTPN2;PELI3;TTLL12;SAMHD1;OAS3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3918316168677449,-1.300457326670906,0.12614678899082568,0.5869081805417963,1.0,6/33,8.52%,AKAP6;KCNJ3;YWHAE;NEDD4L;CHRM3;ANO6
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.34888912131988087,1.2999799266685679,0.08346456692913386,0.6991975459466651,1.0,18/72,15.58%,NAV3;SSH2;ARHGEF2;FGF13;TWF2;CYRIB;PRKCD;CLU;CAMSAP1;SSH1;CAMSAP2;CLIP3;PLEKHH2;HIP1R;CIB1;MAPRE1;DYRK1A;ATXN7
prerank,positive regulation of embryonic development (GO:0040019),-0.4491137669183844,-1.2995451187300655,0.1403118040089087,0.5879631925523938,1.0,7/19,20.37%,PLCB1;B4GALT5;WNT4;TENM4;SCX;NIBAN2;NR2C2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.33240690856004984,-1.2991610484532987,0.06598984771573604,0.5872545512412563,1.0,23/66,19.47%,PLCB1;EGFR;FGF10;KMT2E;ANKRD17;CCND2;UBE2E2;PKD2;KIF14;CDC73;PSME2;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;PKD1;MYO16;RGCC;RBL1;E2F1;CDK4;TFDP1
prerank,"wound healing, spreading of cells (GO:0044319)",-0.42243804263724777,-1.2983701877216038,0.11990407673860912,0.5876594285946763,1.0,8/24,15.41%,CD44;ARHGAP35;TMEFF2;TOR1A;MMP12;CD151;ACVRL1;COL5A1
prerank,regulation of autophagosome maturation (GO:1901096),-0.5114807585973441,-1.2980749122657242,0.18843683083511778,0.5867746593131925,1.0,5/13,9.54%,TBC1D25;UVRAG;IRGM;SMCR8;RUBCN
prerank,positive regulation of lyase activity (GO:0051349),0.5001753293588171,1.2976896826626814,0.16098484848484848,0.7057455689674984,1.0,7/14,22.95%,AKAP5;ISCU;NOS2;CACNA1D;ORAI1;NOS1;PARK7
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.40363133551821573,1.2973629364354808,0.1095890410958904,0.705154458952641,1.0,6/36,8.10%,BAG6;OPHN1;FHIT;UCHL5;USP25;KLHL40
prerank,adipose tissue development (GO:0060612),0.5375633256586553,1.2971089876906428,0.1809872029250457,0.7042123682507015,1.0,2/11,2.03%,LRP5;SOX8
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4090204773965972,1.2966346368103068,0.12302284710017575,0.7042375580967789,1.0,7/31,13.36%,SASH3;DNAJB9;PHB2;CD86;KMT5C;SHLD2;STX4
prerank,carbohydrate catabolic process (GO:0016052),0.3889843906443131,1.2966272283367446,0.11265164644714037,0.7024755491084499,1.0,9/38,13.15%,HK2;MAN2B1;PFKL;NEU3;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1
prerank,response to calcium ion (GO:0051592),-0.3140352540306135,-1.2962352712481426,0.0707070707070707,0.590410029833271,1.0,39/102,24.06%,NLGN1;IQGAP1;SYT1;RYR3;RYR2;KCNMB2;KCNH1;CARF;SYT10;CALM1;HOMER1;ALOX5AP;PKD2;CPNE8;CPNE4;RASGRP2;TRPC3;SLC25A24;ADCY8;KCNMB4;CHP2;KCNIP2;CRHBP;SYT3;SLC25A12;TRPV6;HPCA;CPNE2;ITPR3;ALOX15;CPNE6;KCNMB3;NEUROD2;PRKAA1;PPIF;SYT5;CASQ2;BRAF;KCNMB1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.49714418310729724,1.2962096421236513,0.1546572934973638,0.7023072247278482,1.0,6/14,22.69%,DNAJB9;FICD;BFAR;PTPN1;TMEM33;BCL2L11
prerank,"transcription, DNA-templated (GO:0006351)",0.2986572339623388,1.2955791519398048,0.03167420814479638,0.7030300803955891,1.0,45/207,16.41%,IVNS1ABP;POLR3G;RREB1;GTF3C2;NCBP1;ARRB2;DDX5;NELFB;POLR2H;TTF2;CDK9;POLR2J;DEAF1;NKX2-8;POLR2D;CTR9;GTF2H2;TAF12;GTF3A;TAF6;ERCC2;THAP1;RNMT;BRF1;PKNOX1;BRF2;PAX1;POLR3H;MEF2A;MBD1;MMS19;DTX1;SMARCA5;SMN1;NFYA;TAF1;HSF2BP;GTF3C6;MED4;TAF4;NELFE;POLR1C;RPAP1;TAF5L;POLR2E
prerank,heart looping (GO:0001947),0.3982273005943149,1.2951077270623044,0.12095400340715502,0.7030165604754782,1.0,11/39,17.57%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;NDRG4;ENG;CCDC40;SMO;VANGL2
prerank,protein alkylation (GO:0008213),0.44389919031023795,1.294946574842534,0.14760147601476015,0.7018073139734294,1.0,6/22,9.61%,FAM98B;PRMT2;ETF1;EEF2KMT;PRMT8;PRMT1
prerank,fatty acid oxidation (GO:0019395),0.3673857320255037,1.2948704227289016,0.08514190317195326,0.7003387597058269,1.0,18/57,23.62%,ABCD2;ACAD10;PPARD;ECHS1;MTLN;PHYH;ACADM;HAO1;CROT;ECI1;ECHDC2;HADHB;HSD17B10;ACAA2;HACL1;ABCD1;ADIPOR1;SCP2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.39405155813805914,-1.2942299636041206,0.11883408071748879,0.5946688715500751,1.0,7/34,5.30%,PDE4B;ANK2;PDE4D;ADRA1A;RYR2;ATP2A2;CALM1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.44938627047141827,1.2937280450724655,0.15080789946140036,0.7027528302793089,1.0,6/22,7.40%,DDB2;GTF2H2;RPS27A;UBC;ERCC2;CUL4B
prerank,regulation of osteoblast differentiation (GO:0045667),0.3413558004016292,1.2926510384303,0.07766990291262135,0.7051600174218946,1.0,16/82,10.78%,TMEM119;LRP5;NBR1;GREM1;MEF2C;DDX5;SKI;PRKACA;NPNT;TRPM4;CTNNBIP1;IL6ST;TWIST2;IL6R;WNT7B;DDR2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.33899756416678556,-1.292522095488439,0.08726415094339622,0.5979888297301009,1.0,20/59,18.62%,ROBO1;TENM3;KIRREL3;PTPRT;CNTN6;EMB;NPTN;PALLD;CDH4;NECTIN1;PLXNB2;CDH13;SDK1;OBSL1;CDH1;PECAM1;PKD1;ITGB1;BSG;PCDHB6
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.428052428702516,1.2921174968089768,0.14234234234234233,0.7054354435895259,1.0,10/26,26.21%,SPTLC3;ACER3;NOS2;ACER2;ASAH1;AKT1;NQO1;NOS1;SPR;ASAH2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.43799714091394715,-1.2919074484168693,0.1468682505399568,0.5979622158241953,1.0,5/21,8.96%,STAP1;RPS3;FOXP1;CD226;TESPA1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.45090270394137816,1.2912848583986756,0.14522058823529413,0.7068063265935619,1.0,9/22,22.37%,NFE2L2;ENC1;PSMB3;PSMA7;PSME4;PSMB9;PSMB5;PSMB7;PSMB8
prerank,mRNA export from nucleus (GO:0006406),0.33024082759440826,1.2905688951868906,0.06976744186046512,0.7075674059079108,1.0,38/102,26.82%,SRRM1;NCBP1;RANBP2;POLR2D;MAGOHB;MAGOH;U2AF2;NUP42;DHX38;SEC13;SRSF5;NUP50;PABPN1;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;HNRNPA2B1;SRSF9;DDX19B;DDX39B;NUP153;PCID2;NUP188;IWS1;NDC1;THOC3;ZC3H11A;THOC5
prerank,genitalia development (GO:0048806),0.5191039197680211,1.2897496662794712,0.16163410301953818,0.7089237464752722,1.0,4/12,12.78%,CHD7;SHH;LHCGR;PTPN11
prerank,positive regulation of natural killer cell activation (GO:0032816),0.509489566895893,1.2896014796460271,0.1625441696113074,0.7077490744097104,1.0,6/13,23.86%,IL18;IL12B;AXL;TICAM1;ZBTB1;TYROBP
prerank,DNA repair (GO:0006281),0.28755125836767564,1.289532812348269,0.029871977240398292,0.7062694948089484,1.0,90/284,24.20%,HERC2;SUMO1;CSNK1E;RHNO1;PCNA;EID3;CHEK2;MTA1;RAD51AP2;PRIMPOL;HPF1;RFC2;DDB2;FAM111A;NBN;ATM;REXO4;WDR48;MPG;GTF2H2;RPS27A;UBC;RAD17;FANCM;POLN;RAD51B;ERCC2;MGMT;SLX4;CUL4B;INTS3;BRCA1;FAAP24;EYA3;RNF8;LIG1;MMS19;SMARCA5;KMT5C;FANCG;TNKS1BP1;APTX;POLD2;DCLRE1B;UBE2V2;BAZ1B;EXO1;KDM4A;RAD1;ERCC4;UBE2U;BLM;ABRAXAS1;SETD2;DCLRE1C;ABL1;PRMT6;MAPK8;RPAIN;CIB1;FANCI;ALKBH5;PSME4;UBE2A;NEIL2;DTX3L;NABP1;KAT5;DCLRE1A;FANCA;FBH1;BABAM1;RAD9A;PARP4;UBE2T;FAAP100;PWWP3A;CDCA5;RFWD3;TOPBP1;RPA3;NSMCE3;ZBTB1;PARK7;TP53;SPRTN;UBXN1;RAD23B;RAD51C;WRNIP1
prerank,dendrite morphogenesis (GO:0048813),-0.37826327282298866,-1.2892964847255994,0.12993039443155452,0.603966697857983,1.0,8/35,10.16%,CTNND2;CTNNA2;MAP2;SHANK3;CDC42;PAK3;DCDC2;PHACTR1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3255246489935209,1.2891859690468537,0.06542056074766354,0.705784818721235,1.0,27/109,15.73%,INPP5D;CSF1R;MTMR10;PI4KB;PIK3R1;PLEK;PIK3CG;PLCG2;PLA2G4A;PIK3C3;RAB4A;PIP4P1;PLA2G5;INPP4B;PIK3CD;INPP5K;PIK3CB;INPP5E;MTMR14;PDGFRB;PLEKHA4;MTMR4;BMX;IMPA1;CDS1;PITPNM1;PIK3R3
prerank,regulation of mononuclear cell migration (GO:0071675),0.4449940066553967,1.288729837585476,0.12455516014234876,0.7057700024661057,1.0,8/23,18.17%,CSF1R;AIF1;LYN;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4100358417154355,-1.2878211279515075,0.12410501193317422,0.6068785102973909,1.0,6/24,5.95%,NLGN1;GPM6A;TENM2;PALM;RIPOR2;CDC42
prerank,microtubule-based transport (GO:0099111),-0.5127105204540566,-1.2877906540819448,0.15550755939524838,0.605127082459138,1.0,7/12,32.27%,HTT;DYNC1I2;SPA17;SPEF2;DYNC1I1;DNAAF4;ROPN1L
prerank,positive regulation of tissue remodeling (GO:0034105),0.5507300856192935,1.2868075901465705,0.17938931297709923,0.7110632158263854,1.0,3/10,17.76%,IL18;IL12B;ROCK2
prerank,regulation of protein localization (GO:0032880),0.3596007948104089,1.2864768684538934,0.09982788296041308,0.7105654312564365,1.0,16/58,19.63%,CTSD;SUMO1;CSNK1E;MMD;USP8;PICALM;TRIM5;PLEKHM2;ZDHHC7;MAPK8;VIP;KDM1A;VPS4A;CAMK1;PPM1F;ATCAY
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.48138178358316425,1.2864674747255496,0.16295025728987994,0.7088798660802392,1.0,5/17,8.32%,IL18;BACH2;TLR4;EBI3;IL12B
prerank,primary miRNA processing (GO:0031053),0.5305049815849245,1.2861623403206055,0.17190388170055454,0.7082852164823317,1.0,2/10,2.58%,SMAD3;SRRT
prerank,homeostasis of number of cells (GO:0048872),0.522008866174605,1.2858177408565659,0.16446124763705103,0.7078126231384888,1.0,2/12,5.09%,CX3CR1;LRRC19
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5083422985363153,-1.285541776888443,0.1759465478841871,0.6100314141532516,1.0,2/12,5.30%,PDE4D;CALM1
prerank,cilium assembly (GO:0060271),0.28601758579518144,1.2851954712345433,0.018571428571428572,0.708348031183612,1.0,76/296,19.56%,ASAP1;EXOC7;SDCCAG8;TUBA4A;CSNK1E;RILPL1;KIF3B;BBS9;PRKACA;EHD4;TTLL3;ODF2;CEP162;PKHD1;RP2;UBXN10;HYLS1;ATP6V1D;TUBB;CEP164;TUBG1;CFAP74;DYNLT2B;LRGUK;JHY;HAUS7;CFAP52;TTC36;NME8;AVIL;RAB1A;CFAP221;MKS1;TNPO1;CFAP46;CNTRL;INPP5E;NUDCD3;CCDC28B;IFT52;GALNT11;BBS2;KIF27;CDC14B;IFT20;TUBA1A;ATAT1;WDR90;CEP63;CEP57;CCDC40;HAUS6;HAUS2;PDE6D;CFAP20;SFI1;MAPRE1;KIF3A;TCTN1;TTC21B;ARL3;CCDC66;RSPH9;PTPN23;CEP135;ACTR1A;EXOC6;VANGL2;OFD1;B9D1;CPLANE2;SSX2IP;DCTN2;TMEM17;CEP43;RAB8B
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.34184446811750174,1.2842956513664792,0.0970873786407767,0.7098471204291708,1.0,29/77,26.62%,CX3CR1;TGFBR1;ITGA6;CFLAR;ITGAV;CSNK2A2;CSNK2A1;SRC;CLU;NDUFS3;ZMYND11;RTKN2;PINK1;TMBIM6;NDUFA13;AKT1;QARS1;THBS1;DDX3X;ACAA2;BCL2L1;OPA1;PARK7;ACVR1;AR;FZD9;ASAH2;SLC35F6;URI1
prerank,glycolytic process (GO:0006096),0.41752396614701887,1.2842593275146716,0.13924050632911392,0.7083091669415844,1.0,7/28,13.15%,HK2;PFKL;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1
prerank,organelle assembly (GO:0070925),0.2810711604996757,1.2842178710269703,0.017615176151761516,0.706773635661751,1.0,104/384,20.88%,HPS4;ASAP1;EXOC7;CAPN3;ULK2;BIN2;RILPL1;FLII;KIF3B;BBS9;GOLGA8B;ATG9A;EHD4;ATG14;NEK6;TTLL3;ATXN2L;CEP162;PKHD1;RP2;UBXN10;HYLS1;ATP6V1D;STARD9;EIF2S1;EIF2A;TUBGCP5;CEP164;PIK3C3;RBM14;STX12;DYNLT2B;MIS12;HAUS7;CFAP52;TTC36;NME8;AVIL;RAB1A;CFAP221;CD34;MKS1;G3BP1;INPP5E;NUDCD3;CCDC28B;IFT52;GALNT11;RB1CC1;BBS2;KIF27;CDC14B;AUP1;IFT20;BSCL2;NEK7;ATAT1;WDR90;ATG101;CEP63;VPS37D;POGZ;HAUS6;HAUS2;GABARAPL1;VPS37A;KASH5;PDE6D;CDS1;CFAP20;MAPRE1;RAB32;ATG9B;KIF3A;TCTN1;ARL3;VPS36;CCDC66;PTPN23;UBXN2A;ULK1;NUP62;EXOC6;ATG5;CHMP1A;DBNL;OFD1;B9D1;CPLANE2;VPS4A;SSX2IP;TMEM17;TP53INP2;IST1;TSG101;RAB8B;VPS37B;PACS2;CHMP2A;MAPT;EXOC1;RCC1;HGS;DHX29
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48900040760351365,-1.2837914614383872,0.1670235546038544,0.6136993942645187,1.0,7/12,23.57%,RIMS2;SYT1;UNC13C;UNC13B;RIMS1;DOC2B;SYT5
prerank,regulation of protein sumoylation (GO:0033233),0.4682790160148791,1.2833649915524523,0.14038461538461539,0.7081774370337489,1.0,7/17,16.75%,CAPN3;UBA2;EGR1;RASD2;GNL3L;PIAS3;ZMIZ1
prerank,dorsal/ventral pattern formation (GO:0009953),0.4497287767280174,1.2820341727169176,0.1595744680851064,0.7113051257652434,1.0,4/20,6.91%,GREM1;FBXL15;MDFI;SHH
prerank,intermediate filament organization (GO:0045109),0.4737558874978643,1.2814759198194132,0.1797752808988764,0.7116121960503917,1.0,3/17,5.07%,DSP;GFAP;KLHL24
prerank,protein heterotetramerization (GO:0051290),-0.49606435433930257,-1.2812498449722645,0.17494089834515367,0.6197274687145129,1.0,6/13,26.53%,GRIN2B;PKD2;PKD1;CBR4;KRT10;CPSF7
prerank,negative regulation of lyase activity (GO:0051350),-0.4553366486130317,-1.280669229170999,0.16705336426914152,0.6196769052943853,1.0,4/16,5.26%,CCR2;GABBR2;PALM;EDNRB
prerank,canonical glycolysis (GO:0061621),0.42874886319069533,1.2805893431035065,0.1436265709156194,0.7114126591619427,1.0,6/24,13.15%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.42874886319069533,1.2805893431035065,0.1436265709156194,0.7114126591619427,1.0,6/24,13.15%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.40550773928054157,-1.2805294393672773,0.13908872901678657,0.6182889379833417,1.0,8/28,13.52%,PID1;IRS1;PRKCZ;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,positive regulation of endopeptidase activity (GO:0010950),0.42792313295797724,1.2803387817206144,0.13333333333333333,0.7107013561579194,1.0,14/26,26.13%,VSIR;AGER;PICALM;LYN;PSENEN;PYCARD;AIM2;APH1B;ROCK2;USP50;EFNA1;EFNA3;MEFV;STAT3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4235737060541917,-1.2801724816585123,0.1434878587196468,0.617649161308523,1.0,6/22,11.52%,APOE;PTPN3;SNX9;ADRA2A;TIMP3;SH3D19
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5263205215684066,-1.2801108198049733,0.18064516129032257,0.6160535934233546,1.0,4/10,19.93%,PTPN22;NINJ1;LBP;LTF
prerank,regulation of immune response (GO:0050776),-0.2915045375240091,-1.279718203368361,0.04747774480712166,0.6154884061000844,1.0,53/135,26.97%,ITGA4;CLEC2D;LILRB1;RSAD2;B2M;PTPN22;CD40;DENND1B;FOXP1;ITGB7;CD226;ITGAL;SLAMF7;IRF4;CD300LF;JAML;CD300LD;VCAM1;SPN;FCGR2B;AHR;KLRD1;SAMHD1;COL1A1;CD300E;CD300LG;IFITM1;NPDC1;CD200R1;CD3E;ITGB1;KLRK1;TREML4;FOXP3;IRF7;CD96;FCRLB;CD300C;SELL;CD247;ICAM1;CRTAM;CD3D;CD19;RIPK3;CD8B;CD22;CD276;PLSCR1;CD8A;KLRC1;IRF1;SLA2
prerank,protein autoubiquitination (GO:0051865),0.35706993268468656,1.279027384095412,0.1024793388429752,0.713709001711928,1.0,18/61,18.52%,ITCH;DDB2;RNF41;KLHL24;RNF141;ASB4;BRCA1;RNF8;BFAR;UHRF2;RNF187;WWP2;UBE3A;RNF11;UBE2A;DTX3L;RNF4;STUB1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.530931079354422,1.2788492946449146,0.16636528028933092,0.7126577833181817,1.0,2/11,2.62%,RAC1;SIRT2
prerank,cell-matrix adhesion (GO:0007160),-0.3072291459759695,-1.2784774810867758,0.07352941176470588,0.6175150112833886,1.0,34/95,20.52%,SORBS1;ITGA4;LYVE1;CD44;MKLN1;PPFIA2;CTTN;SIGLEC1;ITGB7;FN1;ITGAL;TRIP6;THSD1;COL13A1;ACTN2;VCAM1;ITGA8;ITGB1BP1;ITGB6;THY1;PKD1;TIAM1;RCC2;ANGPTL3;ITGBL1;PARVG;ITGB1;ITGA11;TNN;CD96;ITGA10;CD63;PTPRK;TSC1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3484781160417425,1.2782024419799436,0.10286677908937605,0.7135039392094465,1.0,12/69,7.46%,NCBP1;POLR2H;SRRT;CDK9;POLR2J;POLR2D;INTS11;TAF8;ELL2;TAF6;RPAP2;INTS3
prerank,mRNA processing (GO:0006397),0.2851991892566064,1.2778207032068083,0.03207810320781032,0.7131979464474097,1.0,79/287,22.66%,SRRM1;SNRNP70;SON;NCBP1;DDX5;SNRPA;POLR2H;FUS;SRRT;PRKACA;AKAP8L;POLR2J;CSTF2;POLR2D;HNRNPA3;RBM19;SF3B2;SF3B1;GTF2H2;MAGOHB;MAGOH;U2AF2;HNRNPC;SNRPC;ZMAT2;RBM14;SART3;SNRPF;SNRPA1;PCBP2;HNRNPH1;ERCC2;CWC25;DHX9;SNRNP48;RNMT;DHX38;HNRNPR;SRSF5;PABPN1;SRRM2;CPSF1;GEMIN6;RBM8A;TRA2B;RBM17;PRPF31;LSM5;U2AF1L4;SLU7;SF3A1;FIP1L1;BUD13;ALYREF;TRA2A;ALKBH5;POLR2E;METTL14;CCAR1;PRPF3;PCF11;PRPF4;SNRPN;ZCCHC8;GEMIN2;LSM7;RBMX;SNRNP40;THOC6;HNRNPA2B1;SRSF9;HNRNPH3;WBP4;SNIP1;DDX39B;POLR2I;ELAVL1;HNRNPUL1;RPRD1B
prerank,negative regulation of cyclase activity (GO:0031280),-0.4749539583793785,-1.2773866415524167,0.1590909090909091,0.6191460549930824,1.0,4/14,5.26%,CCR2;GABBR2;PALM;EDNRB
prerank,regulation of ruffle assembly (GO:1900027),-0.4301508794130752,-1.2770322412766064,0.1489841986455982,0.6184520356861459,1.0,5/23,10.14%,NLGN1;EPS8;STAP1;FAM98A;KANK1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3895636702266671,1.2769172835986995,0.1289198606271777,0.7148992590152623,1.0,13/39,18.67%,PCNA;RFC2;DDB2;GTF2H2;RPS27A;UBC;ERCC2;CUL4B;POLD2;ERCC4;RFC1;NTHL1;CUL4A
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.471025404014361,1.2766872965878957,0.16,0.7140965213954615,1.0,4/16,18.86%,CLDN11;CLDN12;CLDN10;CLDN1
prerank,axonemal dynein complex assembly (GO:0070286),-0.4046201204530152,-1.2765763384660993,0.1267605633802817,0.6180440692992208,1.0,14/27,22.16%,ODAD2;DNAH8;DNAI4;DNAAF5;DNAI3;ODAD3;DNAH17;DNAAF3;DNAAF1;SPAG1;CCDC65;CCDC39;DNAL1;CFAP100
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4413216362096362,1.2744025206240144,0.16081330868761554,0.7209069864338615,1.0,5/24,3.71%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,positive regulation of chemotaxis (GO:0050921),0.38171341714897894,1.2742357112184974,0.12331081081081081,0.7198870297932967,1.0,11/43,13.36%,SMOC2;P2RY12;AIF1;LGMN;PDGFB;MET;EDN3;EDN2;IL6R;PDGFRB;STX4
prerank,fluid transport (GO:0042044),-0.506169351068906,-1.274158781498885,0.18181818181818182,0.6239663995702017,1.0,4/12,31.58%,AQP4;AQP11;AQP1;SLC4A11
prerank,ERK1 and ERK2 cascade (GO:0070371),0.44624295498168987,1.2740849985580975,0.16152450090744103,0.7187791707926171,1.0,5/21,7.83%,LGALS9;KARS1;ITGAV;ZFP36L1;ZFP36L2
prerank,cellular response to amino acid starvation (GO:0034198),0.3439639777045852,1.2738877777006132,0.10016420361247948,0.7178493400409637,1.0,21/71,17.68%,ATP6V0B;FLCN;ATP6V1D;IMPACT;EIF2S1;LAMTOR2;TCIRG1;SEC13;RPTOR;SH3GLB1;MTOR;MLST8;WDR24;LAMTOR5;GCN1;MAPK8;RRAGA;EIF2AK2;ATP6V0E2;CASTOR1;SEH1L
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.44064800055462255,1.2734535076622215,0.13736263736263737,0.7177675563200925,1.0,6/24,11.45%,PCNA;RFC2;RPS27A;UBC;LIG1;POLD2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.340292841795803,1.2730721509604022,0.12054329371816638,0.71762719375107,1.0,19/72,18.67%,RNASE1;PCNA;RFC2;DDB2;DXO;REXO4;GTF2H2;RPS27A;UBC;ERCC2;CUL4B;POLD2;DCP1B;RNASE6;ERCC4;ISG20;RFC1;FBH1;CUL4A
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3037681842977255,-1.2730530821141797,0.06515580736543909,0.6256674897213182,1.0,38/99,23.77%,AKAP6;CTNNA1;GABRB1;HCN1;SLIT2;HRH1;RYR3;RAPGEF2;CPEB3;GLRA1;RRAGB;GOLPH3;PKD2;GABRG2;GABRB3;ACTB;P2RY1;AHR;GLRA2;CDH1;KCNQ1;PDE2A;HCN2;CRHBP;TSHR;SFRP1;CFTR;NR1H4;LAMTOR3;CPEB4;SLC26A3;AQP1;HCN4;SLC5A5;EZR;FOLR1;WT1;CTNNB1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.372769893875364,1.272418295891712,0.1050080775444265,0.7184332743610585,1.0,15/51,15.24%,CSF1R;LGALS9;AIF1;VEGFB;LGMN;C1QBP;EDN3;CCR7;EDN2;IL6R;AKIRIN1;SERPINE1;IL34;CSF1;CXCL17
prerank,phosphatidic acid metabolic process (GO:0046473),0.3691935373255705,1.2723537586098057,0.12736660929432014,0.7170573115650936,1.0,9/48,9.13%,LIPH;PLD1;LPCAT4;PLA2G4A;PLA2G6;PLD2;DGKD;PLA2G4B;PLA2G5
prerank,positive regulation of cell killing (GO:0031343),0.49471515197388666,1.272323082881856,0.183206106870229,0.7155377120962586,1.0,4/13,14.61%,RAC1;NOS2;MAPK8;NOXO1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3467808695759096,1.2722320535180711,0.10050251256281408,0.7142329738171657,1.0,16/72,13.59%,IL18;PIK3R1;LYN;IGF1R;SRC;PIK3CG;PIK3AP1;PDGFB;SELP;GPER1;FSHR;PIK3CD;PIK3CB;PDGFRB;HCST;SEMA4D
prerank,actin filament organization (GO:0007015),0.3079670362103462,1.2714871751809829,0.08076358296622614,0.7153821619816954,1.0,38/151,16.56%,ELMO1;ARHGEF2;MYO1B;RAC1;BAIAP2L2;AIF1;RND1;MYO1F;FLII;PPP1R9B;DBN1;CDC42EP2;ARHGAP25;MYO1E;PPP1R9A;RHOB;RHOBTB1;RND2;MARCKS;RHOH;ARHGAP17;MYO7A;MPRIP;TLE6;AVIL;SHROOM2;FHOD1;SPIRE1;ERMN;MYO5B;HIP1R;TRPV4;KASH5;MYO15A;PROX1;CD2AP;WASL;MARCKSL1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.4398005246428034,1.271231741022326,0.15789473684210525,0.7146466026186402,1.0,10/22,26.19%,IL18;SLC7A5;IL12B;LY9;OSM;SLAMF6;NOD2;MYD88;TGFB1;CARD9
prerank,double-strand break repair (GO:0006302),0.30459980783097673,1.271045944770518,0.0704,0.7137193969443333,1.0,45/158,20.02%,ZFYVE26;HERC2;SUMO1;IFFO1;CHEK2;MTA1;RAD51AP2;HPF1;NBN;ATM;RNF138;SPIDR;RAD54B;POLN;RAD51B;SWSAP1;SLX4;BRCA1;EYA3;RNF8;SMARCA5;MORF4L1;TNKS1BP1;APTX;DCLRE1B;UBE2V2;BAZ1B;KDM4A;ERCC4;BLM;ABRAXAS1;DCLRE1C;MAPK8;CIB1;DTX3L;AP5Z1;NABP1;KAT5;DCLRE1A;HMGB2;FBH1;BABAM1;PALB2;XRCC6;KDM2A
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.47949200643026313,-1.2707085942459244,0.18805309734513273,0.631037981476434,1.0,4/14,7.59%,HTT;PKIA;RAPGEF2;SIRT1
prerank,sulfur compound transport (GO:0072348),-0.40091215820661696,-1.2703826907076632,0.13211845102505695,0.6302106199081723,1.0,11/27,22.21%,SLC25A30;SLC35F3;SLC25A19;RACGAP1;MGST1;SLC26A7;SLC5A6;SLC6A6;SLC26A8;SLC19A2;SLC26A4
prerank,negative regulation of protein modification process (GO:0031400),-0.3105880351192644,-1.2703583695077625,0.058823529411764705,0.6284856715057794,1.0,16/79,10.07%,PID1;DMD;LRRK2;XDH;SLIT2;TPPP;LRP6;NTRK3;PPIA;CADM4;GSK3B;SH3GL2;PRKN;SIRT1;MYADM;P3H1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.41899032486687554,1.270292383204419,0.1453900709219858,0.7148295716232277,1.0,8/29,12.77%,SSH2;TWF2;CYRIB;PRKCD;SSH1;TJP1;PLEKHH2;HIP1R
prerank,regulation of cytoskeleton organization (GO:0051493),0.3185575627889697,1.2702259637791926,0.09702660406885759,0.7134763530860508,1.0,25/108,13.83%,F11R;TWF2;RAC1;RND1;RHOQ;RHOB;PRKCD;RHOBTB1;FSCN1;TRIM36;RND2;PHLDB1;RHOH;ARHGAP17;TJP1;MTOR;LRP1;MLST8;CLN3;PDGFRB;HIP1R;MARK2;TAOK2;ABL1;SORBS3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5211719420889588,-1.2696306843318337,0.18485523385300667,0.6288635276203914,1.0,6/10,28.51%,DSE;PXYLP1;B3GAT2;CSGALNACT2;CSGALNACT1;DSEL
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4026303488346894,-1.2693631842499085,0.13716814159292035,0.627902950737052,1.0,6/26,8.78%,ANK2;YWHAE;NEDD4L;NETO1;ATP1B3;ACTN2
prerank,superoxide anion generation (GO:0042554),-0.4915881454468033,-1.2692304973417172,0.18029350104821804,0.6265207259772322,1.0,5/13,20.69%,CYBB;NCF2;CYBA;TAFA4;NOX4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5014313658961393,-1.269112771087495,0.16981132075471697,0.6251759150040928,1.0,5/12,20.04%,CD74;FOXP1;KLF4;OAS3;MAP2K5
prerank,protein homotetramerization (GO:0051289),-0.34611728703055133,-1.2690300970141855,0.12093023255813953,0.6237015619010687,1.0,12/49,15.03%,HCN1;RYR3;B2M;GLS;AQP4;PKD2;ACOT13;GNMT;SHMT1;SAMHD1;SOD2;ALDH9A1
prerank,purine nucleotide catabolic process (GO:0006195),-0.4882221677948321,-1.2690070458868472,0.19279661016949154,0.6220210247160699,1.0,3/13,6.44%,XDH;GDA;HINT1
prerank,neuron projection regeneration (GO:0031102),0.5384020794616999,1.2681567942333416,0.18923933209647495,0.7193841926445186,1.0,2/10,5.78%,RTN4RL1;NREP
prerank,C4-dicarboxylate transport (GO:0015740),-0.47847418865492497,-1.2680699694781608,0.18142548596112312,0.6230841168303868,1.0,6/14,17.06%,SLC25A30;SLC1A6;SLC25A12;SLC25A18;SLC13A5;SLC1A1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.49068757214543934,-1.2679627645272011,0.17987152034261242,0.6216705064467888,1.0,4/12,10.22%,ZW10;PLK2;BUB1B;BUB1
prerank,regulation of viral entry into host cell (GO:0046596),-0.38680436070510654,-1.2679453756511916,0.14285714285714285,0.6200095611371619,1.0,6/30,5.10%,CD74;HS3ST5;GSN;CIITA;MID2;IFITM3
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.4648006985811659,-1.2679330901534918,0.1857451403887689,0.6183471897508543,1.0,6/16,16.45%,FGF10;PTPN22;SOX11;IKZF3;AHR;TNFSF9
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.491218190391675,-1.2679222385357003,0.17543859649122806,0.6166807607331434,1.0,5/13,9.03%,GRIK2;SHISA9;SHISA6;SLC4A10;RAB3A
prerank,nuclear membrane organization (GO:0071763),0.45831212012432304,1.2675846571761415,0.14210526315789473,0.7197980222275128,1.0,8/19,19.78%,AKAP8L;GPER1;NEMP1;TARDBP;TOR1AIP1;UBXN2A;VPS4A;CHMP2A
prerank,L-amino acid transport (GO:0015807),0.41413456349501737,1.2674087514760795,0.14909090909090908,0.7188168813340645,1.0,5/28,7.10%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;ARL6IP5
prerank,cell chemotaxis (GO:0060326),0.35150173848409516,1.2671162521357056,0.10784313725490197,0.7182339814350251,1.0,8/60,8.12%,CX3CR1;DOCK4;BIN2;ARRB2;PRKCD;EGR3;PDGFB;CCR7
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4706176835784783,1.2670347452167965,0.1830188679245283,0.7169202056835714,1.0,6/17,21.25%,LIPC;LMF1;SORT1;APOH;NR1H2;FURIN
prerank,potassium ion export across plasma membrane (GO:0097623),-0.48461814572730005,-1.2667606281276858,0.15217391304347827,0.6184345735703929,1.0,6/13,19.63%,KCNT2;KCND3;KCNQ1;KCNIP2;KCNE3;KCNK5
prerank,mesonephros development (GO:0001823),-0.5081824574630486,-1.2667418243596165,0.18816067653276955,0.6168112113963621,1.0,2/11,1.82%,ZBTB16;FGF10
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5367018572009543,1.2659958894285375,0.18450184501845018,0.719093603654565,1.0,7/10,29.71%,IVD;ACADM;ETFDH;ETFB;ETFA;ACADVL;ACAD11
prerank,muscle cell differentiation (GO:0042692),-0.3845910412496153,-1.2656234249657508,0.1346153846153846,0.6185105156804894,1.0,5/32,7.73%,SGCZ;DMD;NEBL;SYNE1;NINJ1
prerank,oligodendrocyte development (GO:0014003),-0.45867559277143183,-1.2655482118990897,0.17516629711751663,0.6170814248864076,1.0,5/15,9.52%,B4GALT5;B4GALT6;TPPP;MYRF;CNTNAP1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.516582272761318,1.2654598746746089,0.1958174904942966,0.7195444541170632,1.0,4/11,11.45%,WNT2B;WNT10B;CD34;RUNX1
prerank,response to amino acid starvation (GO:1990928),0.3423543731492781,1.2654250043528468,0.1070840197693575,0.7180707759080045,1.0,26/72,23.45%,ATP6V0B;FLCN;ATP6V1D;IMPACT;EIF2S1;LAMTOR2;TCIRG1;SEC13;RPTOR;SH3GLB1;MTOR;MLST8;WDR24;LAMTOR5;GCN1;MAPK8;RRAGA;EIF2AK2;ATP6V0E2;CASTOR1;SEH1L;EIF2AK3;LARP1;SESN1;ATP6V0C;DEPDC5
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5356910840107331,1.2652239292845568,0.18785578747628084,0.7156241624163104,1.0,4/10,18.03%,PRKCD;PLA2G6;SMPD2;SMPD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5356910840107331,1.2652239292845568,0.18785578747628084,0.7156241624163104,1.0,4/10,18.03%,PRKCD;PLA2G6;SMPD2;SMPD3
prerank,snRNA transcription (GO:0009301),0.3426836621996112,1.264926468828354,0.10851419031719532,0.7150481575158654,1.0,12/70,7.46%,NCBP1;POLR2H;SRRT;CDK9;POLR2J;POLR2D;INTS11;TAF8;ELL2;TAF6;RPAP2;INTS3
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3953257317406081,-1.2647370790409762,0.1471264367816092,0.6161265403457369,1.0,9/29,17.22%,KNL1;CENPT;CENPP;MIS18BP1;CENPW;RBBP7;NASP;CENPS;NPM1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3953257317406081,-1.2647370790409762,0.1471264367816092,0.6161265403457369,1.0,9/29,17.22%,KNL1;CENPT;CENPP;MIS18BP1;CENPW;RBBP7;NASP;CENPS;NPM1
prerank,negative regulation of growth (GO:0045926),0.3153594238346178,1.2646410509771442,0.09238249594813615,0.7145264179690404,1.0,28/121,15.00%,SMAD3;PPP1R9B;CCDC85B;OSGIN2;AGTR2;FLCN;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SIPA1;NDUFS3;PPT1;APBB2;SOX17;MT2A;NME6;PRDM11;SMARCA2;OSGIN1;GJA1;TSPYL2;NDUFA13;DACT3
prerank,transferrin transport (GO:0033572),0.3943403490740228,1.2645176051959417,0.1445578231292517,0.7134277159615359,1.0,7/33,11.69%,DNM2;ATP6V0B;MCOLN1;ATP6V1D;ATP6V0A2;TCIRG1;ATP6V0A4
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.45382733355035737,1.2643197212547286,0.162748643761302,0.7110791951151966,1.0,7/19,21.74%,POLR2H;POLR2J;POLR2D;TERF1;POLR2E;ACD;POLR2I
prerank,regulation of DNA recombination at telomere (GO:0072695),0.45382733355035737,1.2643197212547286,0.162748643761302,0.7110791951151966,1.0,7/19,21.74%,POLR2H;POLR2J;POLR2D;TERF1;POLR2E;ACD;POLR2I
prerank,lipid translocation (GO:0034204),-0.4240206847822773,-1.2637711592954077,0.1564625850340136,0.6172206380217086,1.0,9/21,18.74%,ATP8B4;ATP11A;ATP11C;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1;ATP10A
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5005298989657366,1.2636391749777702,0.1686046511627907,0.7118553440434379,1.0,6/14,18.17%,CSF1R;AKIRIN1;IL34;CSF1;CXCL17;THBS1
prerank,negative regulation of GTPase activity (GO:0034260),0.4300584857002117,1.2634227109670162,0.16022099447513813,0.711136918580093,1.0,6/22,13.72%,F11R;LRCH1;FICD;RASA4;WNK1;GMIP
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3834860756719075,1.263289502098232,0.14333333333333334,0.7101417554649031,1.0,13/43,14.92%,IL18;AIF1;FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;JUN;IL6R;PDGFRB;LDLRAP1;GJA1;AKT1
prerank,microtubule anchoring (GO:0034453),-0.49780671580252644,-1.2632227252176647,0.20607375271149675,0.6172536103772694,1.0,5/12,28.72%,BICD1;SAXO2;DAG1;PEX14;GCC2
prerank,cellular response to interleukin-6 (GO:0071354),0.4206225152344695,1.2631855118286917,0.1532567049808429,0.7090068240994168,1.0,7/26,9.05%,ST3GAL6;SELPLG;SBNO2;SRC;CTR9;IL6ST;IL6R
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4433373850676608,-1.263106715507687,0.17278617710583152,0.615947702729574,1.0,6/17,13.84%,PID1;PFKFB1;HDAC4;FIS1;TIGAR;CBFA2T3
prerank,response to interleukin-6 (GO:0070741),0.5367154896637762,1.2624170879216878,0.20610687022900764,0.710203130665649,1.0,3/10,2.42%,ST3GAL6;SELPLG;SBNO2
prerank,pore complex assembly (GO:0046931),-0.42622658363480365,-1.2623114542462248,0.15704387990762125,0.6168199648539424,1.0,5/19,11.65%,AFDN;NUP98;RTN4;ANO6;NUP205
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3524616036374879,1.2623099074941018,0.10378912685337727,0.7090243823115898,1.0,14/63,10.24%,SASH3;IL18;CCDC88B;MEF2C;AIF1;TNFSF13B;TNFRSF13C;IL6ST;CD86;CD320;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4521572047990736,1.26217057304526,0.16545454545454547,0.7079717772261048,1.0,8/19,22.86%,CD27;RHOH;AXL;NCKAP1L;ZMIZ1;GATA3;XRCC6;ZBTB1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4975939749969709,1.262062162443217,0.1982142857142857,0.706851152265098,1.0,4/13,14.42%,NCBP1;CSTF2;CPSF1;FIP1L1
prerank,protein destabilization (GO:0031648),-0.38676367857340005,-1.261848673798256,0.14351851851851852,0.6165099542909198,1.0,9/32,8.02%,CCDC88C;HTT;GSN;CUL3;PRKN;CDC73;BTRC;SIRT1;IRGM
prerank,generation of neurons (GO:0048699),-0.2714661906691682,-1.2614979098624335,0.026785714285714284,0.6158817529194289,1.0,42/190,16.05%,AUTS2;PTPRD;ADGRL3;SPOCK1;NRCAM;CDKL5;NAV1;GPM6A;MAP1B;FUT9;TAFA1;IL1RAPL1;ASTN2;RAPGEF2;ACSL3;NTRK2;SNPH;MYT1L;SH3RF1;SOX11;RACGAP1;NR4A2;EML1;PER2;ERCC6;DCDC2;WNT4;PLXNB2;DDIT4;EN2;ASTN1;RUNX2;IRX5;TUBB2A;MDGA1;CX3CL1;HEY2;WNT9A;POU3F2;POMGNT2;RELN;MTPN
prerank,synaptic vesicle cycle (GO:0099504),-0.38907068702324726,-1.261239008888645,0.15898617511520738,0.6149965943088767,1.0,11/30,20.61%,NLGN1;SYT10;PCLO;SNAP25;CPLX2;SYNDIG1;RAB3A;SNCA;RIMS1;RAB5A;WNT7A
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.4319444266389857,-1.2610818919622186,0.16335540838852097,0.6138845201840791,1.0,10/19,27.02%,ALDH1L1;SLC46A1;SHMT1;MTHFD1L;FPGS;FOLR2;MTHFD2;MTHFD2L;SLC25A32;DHFR
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5032544398092326,-1.2609546336867872,0.1956043956043956,0.6126336386263929,1.0,6/11,38.12%,SIK1;C1QTNF3;CRY1;C1QTNF12;GCK;PGP
prerank,translesion synthesis (GO:0019985),0.3761439040589444,1.26072516557019,0.12216404886561955,0.709975697757391,1.0,16/42,25.34%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;UFD1;POLD2;PCLAF;POLDIP2;RFC1;RPA3;ZBTB1;SPRTN;POLD4;NPLOC4
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4569342569574249,1.2605102829141943,0.1827956989247312,0.709245022904384,1.0,3/18,4.25%,GSAP;PICALM;CLU
prerank,negative regulation of ossification (GO:0030279),0.4298663272095008,1.2600744994932858,0.16312056737588654,0.709292503118532,1.0,6/23,6.16%,GREM1;MEF2C;TRPM4;CCL3;PTK2B;BCOR
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5250427627416242,-1.2595499961549195,0.19661733615221988,0.615169258194231,1.0,5/10,26.94%,ZC3H8;BMP4;GLI3;CTLA4;IRF1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.529500334886228,1.2595155557881574,0.18888888888888888,0.7096665799163479,1.0,5/11,10.25%,LGALS9;MEF2C;LYN;PIK3CD;PIK3CB
prerank,mRNA destabilization (GO:0061157),0.3827942294288541,1.2594008760319293,0.1592775041050903,0.7085715927819689,1.0,14/38,22.27%,CNOT1;POLR2D;MOV10;DIS3L2;ZFP36L1;ZFP36L2;RBM24;DCPS;TARDBP;RIDA;METTL14;ROCK2;ZC3H12A;RC3H2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4203501120679927,-1.2584964365348845,0.17040358744394618,0.6164188891654382,1.0,8/23,13.76%,PPARG;JAK2;PARP14;PTPN2;IRGM;IFNGR1;PIAS1;TXK
prerank,endoderm formation (GO:0001706),0.39330193739719427,1.2584863081073765,0.1672473867595819,0.7103362461571565,1.0,10/35,15.53%,ITGB5;ITGB2;ITGAV;MMP2;SOX17;LAMA3;DUSP5;SETD2;ITGA7;COL11A1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.38720104565373265,1.2584140990220116,0.14480408858603067,0.7090712595079868,1.0,5/34,7.08%,SASH3;SLC7A5;DNAJB9;PHB2;CD86
prerank,regulation of signal transduction (GO:0009966),-0.27514100637375777,-1.257429465231648,0.03459119496855346,0.6180523214232374,1.0,53/190,19.87%,MDFIC;PLCB1;LRRK2;GRK5;CD36;SLC8A3;NCK2;APP;FRMPD1;SHARPIN;SEMA5A;RASGRP4;SP100;PPIA;KCTD8;HOMER1;DOK5;IGFBP4;NCAM1;SIRT1;RGS20;DCDC2;AXIN1;ZDHHC17;PTPN2;ERBB3;LFNG;PPP2R1A;INTU;RGS6;ITGB1BP1;LIFR;CD80;IFT81;DTNBP1;YJEFN3;UGCG;TMEM108;IGFBP2;NUCKS1;CD46;CX3CL1;CDC42SE2;TSPEAR;CD3E;VEPH1;FOXP3;IGFBP7;SNW1;SOCS2;RGS3;USP33;CD63
prerank,response to cAMP (GO:0051591),-0.36139966832691944,-1.2573786382053291,0.16129032258064516,0.6165976546620163,1.0,16/37,23.75%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;HCN2;CRHBP;CFTR;SLC26A3;AQP1;HCN4;SLC5A5;EZR;WT1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4207009704251677,-1.2573372053006084,0.15550755939524838,0.6150829407819267,1.0,5/22,4.61%,SORBS1;PPARG;CREBL2;ZBTB20;APOE
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.40693654423217934,1.2566637615002016,0.15316901408450703,0.7138368748715967,1.0,9/29,23.54%,LDLRAD4;SMAD7;SPRY2;OVOL2;HPN;GATA3;SPRED2;EFNA1;ADIPOR1
prerank,embryonic skeletal system development (GO:0048706),-0.37385521702196745,-1.2566514935642512,0.13615023474178403,0.615585137406181,1.0,10/35,15.54%,HOXC4;SULF2;PCSK5;HOXC9;SOX11;HOXB3;RBP4;COL1A1;WNT9A;HOXB4
prerank,protein ubiquitination (GO:0016567),0.2723746035098649,1.2564507745784748,0.022193211488250653,0.713095887343018,1.0,111/471,18.67%,HERC2;FBXL18;RNF38;NFE2L2;KLHL7;ARRB2;TRIM69;PJA2;FBXO22;SMURF1;PCNA;OTULIN;ITCH;TRIM11;VHL;TRIM5;FBXL20;DDB2;SPSB1;FBXL15;FBXO24;UNKL;RNF41;PEX10;CTR9;TRIM36;ENC1;KLHL24;UBE2H;RNF138;RPS27A;UBC;TRIM44;HLTF;FBXW4;RNF141;ZSWIM8;SPSB2;AKTIP;TRIM72;ARRDC1;CDC34;CUL4B;DTX4;ASB4;BRCA1;HECTD2;ANKRD9;OS9;ASB11;RNF31;CRBN;RNF8;RNF103;BFAR;PSMD3;MSL2;RNF20;RNF166;AREL1;MYLIP;KBTBD8;ASB5;RNF25;DTX1;FBXL8;FBXL2;USP5;MIB2;PSMB3;WSB1;TAF1;PINK1;UBE2V2;UHRF2;TRIM62;UBE2U;PSMA7;RNF187;ZNRF3;FBXO21;WWP2;KLHL18;UBE3A;PSMC1;PSMC2;RRAGA;RNF144B;DTX3;MKRN3;RNF7;FBXL22;PSME4;RNF11;CCDC22;UBE2A;FBXO11;PELI2;PSMB9;ANAPC11;DET1;DTX3L;ARRB1;UBE4A;TNFAIP1;RNF4;LZTR1;TRIM47;STUB1;FBH1;CUL4A
prerank,defense response to protozoan (GO:0042832),-0.49661491559338633,-1.256327965329288,0.18888888888888888,0.6149432552733197,1.0,5/12,11.94%,CD40;PF4;IRF4;GBP4;GBP2
prerank,membrane organization (GO:0061024),-0.2654964947816276,-1.2562614990571288,0.031446540880503145,0.6135266323689932,1.0,48/227,15.44%,SGCZ;DAB2;HIP1;ANK3;MYOF;DNM3;DNAJC6;ANK2;SPTBN1;TMCC1;EGFR;REEP3;ACTR3;SYT1;CTTN;AP2A2;ITSN1;LDLR;VAPA;SGIP1;PIK3C2A;DNM1L;SH3GL2;DNM1;PLEKHA3;TOR1A;CHRM2;SAR1B;SNX9;ACTB;MYADM;DMPK;CCDC88A;ARPC5;KIF20A;DYSF;REEP4;COX18;TOR1AIP2;EPS15;AP2B1;REPS1;OCRL;HSPA8;NUP155;IGF2R;CFTR;ATP10B
prerank,regulation of store-operated calcium entry (GO:2001256),0.5202270527180044,1.256233780393321,0.18317757009345795,0.7123665991441064,1.0,2/10,1.29%,SARAF;CD84
prerank,vasodilation (GO:0042311),0.4950473434509003,1.2561811058041072,0.1830188679245283,0.7110628397311434,1.0,5/13,20.49%,KCNMA1;AGTR2;GPER1;SOD1;NOS1
prerank,RNA export from nucleus (GO:0006405),0.3221262921607825,1.25611463642716,0.09582689335394126,0.7098416282464687,1.0,37/100,26.82%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;DHX38;SEC13;NUP62CL;SRSF5;NUP50;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;HNRNPA2B1;SRSF9;DDX19B;DDX39B;NUP153;XPO5;HNRNPA1;NUP188;NDC1;THOC3;ZC3H11A;THOC5
prerank,regulation of immunoglobulin production (GO:0002637),0.42339900697781996,1.255497964840328,0.15070921985815602,0.71060096720393,1.0,4/23,7.08%,SASH3;DNAJB9;PHB2;CD86
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5333822644133711,1.2553960253393694,0.18857142857142858,0.7094561756515272,1.0,2/10,1.04%,MLXIPL;ABCD2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4747701583680149,1.2552277255850806,0.19109461966604824,0.7086354847760005,1.0,7/14,26.97%,U2AF2;SFSWAP;C1QBP;RBMX;SRSF9;PCBP4;SRSF10
prerank,axoneme assembly (GO:0035082),0.40471189743341385,1.25512587697762,0.17739130434782607,0.707567458370732,1.0,9/30,16.67%,DRC1;TTLL3;CFAP74;LRGUK;JHY;CFAP46;TTC12;CCDC40;RSPH9
prerank,sphingolipid biosynthetic process (GO:0030148),0.335449443619001,1.2547804314504447,0.12987012987012986,0.7073286519810099,1.0,18/71,14.33%,LARGE1;ST3GAL5;ALOXE3;CERS3;DEGS2;SPTLC3;PPM1L;HACD3;ACER3;PNPLA1;SMPD2;ACER2;PLPP1;ASAH1;PLPP2;PRKD3;CERS2;VAPB
prerank,determination of heart left/right asymmetry (GO:0061371),0.37799768393558836,1.2543317635107971,0.15551839464882944,0.707414577131684,1.0,11/42,17.57%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;NDRG4;ENG;CCDC40;SMO;VANGL2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37788384304273365,1.2540695010403249,0.1478102189781022,0.7068370818872864,1.0,14/41,23.62%,DAGLB;PTGS1;ALOXE3;PLA2G4A;PLA2G4B;FADS1;GPX4;SCD5;PTGR1;SCD;DAGLA;ABCD1;ACOT8;SCP2
prerank,positive regulation of neurogenesis (GO:0050769),-0.32276946651310756,-1.2535634439201144,0.0966183574879227,0.6198456589287323,1.0,18/68,9.35%,ROBO1;PTPRD;CDKL5;SLIT2;PLXNC1;SLITRK1;MME;IL1RAPL1;NTRK2;NPTN;SOX11;SHANK3;PLXND1;PLXNA2;OPRM1;CUL7;LIG4;PLXNB2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.383762882842945,1.252919317189426,0.14686468646864687,0.7094124576668251,1.0,9/39,11.38%,MAML3;TSPAN14;BMP2K;SRC;IL6ST;JAG2;NOTCH4;MAML2;DLL1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.36962846582514935,1.252849030806286,0.13080895008605853,0.7082317661661707,1.0,12/46,13.82%,DDIT3;PLCL1;PCTP;TLR4;LAMA4;FLCN;ID1;TFE3;WNT10B;ABHD6;PLCL2;NRDC
prerank,positive regulation of protein binding (GO:0032092),-0.3384899238705562,-1.2523619037462905,0.09114583333333333,0.6219131373977814,1.0,18/56,19.79%,LRRK2;BDNF;APP;B2M;RAPGEF2;MARK3;APOE;GSK3B;PRKN;RAN;HIPK2;EPB41;PKD1;TIAM1;BMP4;ADD2;TERT;USP33
prerank,regulation of cell cycle (GO:0051726),0.2800659841284568,1.2520121068560992,0.04084507042253521,0.7097612113758343,1.0,62/271,18.21%,TGFBR1;BIN1;TTC28;MLXIPL;SON;SMAD3;PIM2;PPP1R9B;SIRT2;PRKACA;CDK9;NEK6;CSNK2A2;CSNK2A1;NBN;ATM;RHOB;HBP1;HPGD;AFAP1L2;SIPA1;PES1;MAEA;TAF6;THAP1;JUN;BRCA1;BOP1;APBB2;IL12B;CKS1B;GPER1;POU4F1;INHA;RNF20;PRDM11;FBXL8;LIN9;PCLAF;CDC14B;UHRF2;TARDBP;NEK7;UHMK1;CDK11B;E4F1;ABL1;TSPYL2;PROX1;FBXL22;MAP2K1;MED25;ADAM10;WDR6;MASTL;XIAP;RPRM;LIN37;GATA3;CHMP1A;THBS1;HTRA2
prerank,lipid droplet organization (GO:0034389),0.4346837208648884,1.2518785836721933,0.1843065693430657,0.7087626442881421,1.0,5/22,14.81%,RAB3GAP1;PPID;AUP1;BSCL2;CDS1
prerank,cellular response to alcohol (GO:0097306),-0.35451306615278755,-1.2518728168156412,0.12098765432098765,0.6218067211567068,1.0,15/42,15.40%,CTNNA1;ADCY2;LRP6;GLRA1;KLF9;GOLPH3;ADCY5;GNAI1;ADCY3;ADCY8;AHR;GLRA2;CDH1;SFRP1;CFTR
prerank,RNA splicing (GO:0008380),0.3236912705064351,1.2517970160495042,0.09657320872274143,0.7076197193217016,1.0,30/95,23.41%,IVNS1ABP;SRRM1;NCBP1;PPP1R9B;FUS;SF3B2;SF3B1;MAGOHB;MAGOH;HNRNPC;SNRPF;SNRPA1;SNRNP48;RBM8A;TRA2B;TARDBP;LUC7L3;SLU7;PRPF3;PRPF4;SNRPN;SCNM1;GEMIN2;SNRNP40;HNRNPH3;WBP4;DDX39B;DDX47;MPHOSPH10;SNRNP25
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4897261956731778,1.2509380779331012,0.20840950639853748,0.7091807500162219,1.0,3/13,12.88%,ENTPD1;NUDT15;ENTPD7
prerank,zinc ion transport (GO:0006829),0.4397899775004418,1.249927211481495,0.17765567765567766,0.7113058922310862,1.0,5/21,12.80%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4136643893732159,-1.2497770608967225,0.17787418655097614,0.626705182170806,1.0,5/21,8.62%,PPARG;PLTP;APOE;SIRT1;NFKBIA
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.40397971616318396,-1.249100321280432,0.19077568134171907,0.6269674317605323,1.0,8/25,15.83%,B3GALT1;NDST4;FUT9;EXT1;NDST1;B3GALT2;CSGALNACT2;EXT2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.4840145922215253,-1.2488514059398828,0.18201754385964913,0.6260729877692831,1.0,7/12,16.04%,GSN;CIITA;MID2;IFITM3;LY6E;IFITM2;IFITM1
prerank,activation of protein kinase activity (GO:0032147),0.316138795758264,1.2483409578697398,0.10161290322580645,0.715655909952356,1.0,25/106,14.92%,IL18;TGFBR2;MAP4K4;ADCY9;PRKACA;PHB2;PRKCD;STRADA;PTK2B;PDPK1;PDGFB;CD86;ZFP91;ADCY4;MTOR;MLST8;PRRC1;ADCY6;PINK1;MARK2;TAOK2;ABL1;CHRNA3;GHR;AKT1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3717755966440702,-1.2479357045003492,0.1336405529953917,0.6273316673685322,1.0,14/35,20.57%,NLGN1;CDH8;CDH22;CDH7;CDH20;CDH10;CDH11;CDH13;CDHR3;CDH5;PCDHB16;PCDHB13;PCDHB6;SELL
prerank,regulation of GTPase activity (GO:0043087),0.2968086286006338,1.2473564579200889,0.07633587786259542,0.7175935963896865,1.0,41/177,15.64%,SRGAP2;CHN2;DOCK8;FGD2;F11R;VAV2;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;PICALM;TBC1D10B;TGM2;RGS10;LRCH1;TBC1D7;SNX18;TBC1D15;CCL3;FLCN;FICD;RASA4;RAB3GAP1;SGSM2;RAB3GAP2;DOCK10;LIMS1;WNK1;FGD3;RASIP1;RAPGEF3;PIN1;SEMA4D;GMIP;EZH2;TBC1D30;SOD1;RTN4R;SNX13;ADAP1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4382637634513181,-1.246871734192345,0.16806722689075632,0.6289346498469613,1.0,7/18,14.13%,MCU;DNM1L;PRKN;DDHD1;FIS1;MFF;RALBP1
prerank,monocyte differentiation (GO:0030224),0.5428013506964606,1.2467321479469746,0.20772058823529413,0.7184019517125327,1.0,4/10,11.06%,CSF1R;MYH9;MT1G;PDE1B
prerank,carboxylic acid transmembrane transport (GO:1905039),0.38129852761517885,1.2458551011674608,0.15807560137457044,0.7201880049250543,1.0,18/40,25.23%,SLC7A8;SLC7A5;SLC36A1;SLC16A7;SLC38A10;SLC25A11;SLC38A1;SLC25A14;SLC23A2;SLC23A1;SLC19A1;SLC25A10;SLC38A7;SLC25A21;SLC38A11;SLC38A6;ABCC5;SLC7A7
prerank,icosanoid secretion (GO:0032309),0.5202220109535522,1.2457814423456557,0.2088724584103512,0.7190238031733834,1.0,5/12,17.98%,NOS2;PLA2G5;NMUR2;DRD2;BDKRB2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3688544219203105,1.2455515374823343,0.1465798045602606,0.7184401776158099,1.0,16/46,21.06%,SIRPA;CNKSR3;TLR4;LYN;FLCN;SPRY2;GPER1;RGS14;PTPN1;DUSP29;PIN1;DUSP6;TNIP1;WNK2;SYNJ2BP;SPRED2
prerank,cellular response to leucine (GO:0071233),0.5292955447949499,1.2454096876542369,0.21212121212121213,0.7160404188873737,1.0,7/10,38.77%,RPTOR;MTOR;SESN1;UBR2;SESN2;LARS1;SESN3
prerank,response to leucine (GO:0043201),0.5292955447949499,1.2454096876542369,0.21212121212121213,0.7160404188873737,1.0,7/10,38.77%,RPTOR;MTOR;SESN1;UBR2;SESN2;LARS1;SESN3
prerank,positive regulation of leukocyte migration (GO:0002687),0.40793022484770675,1.2454090321070685,0.16666666666666666,0.7146217484153022,1.0,7/27,15.22%,AIF1;MIA3;EDN3;EDN2;IL6R;NCKAP1L;CSF1
prerank,DNA double-strand break processing (GO:0000729),0.44681921899506855,1.2453997466578965,0.17953321364452424,0.7132433865715896,1.0,7/18,13.13%,NBN;ATM;RNF138;SLX4;BRCA1;UBE2V2;BLM
prerank,respiratory electron transport chain (GO:0022904),-0.472256744192858,-1.244973001135334,0.20085470085470086,0.6333813925807924,1.0,5/14,15.32%,GPD2;SDHA;ETFRF1;SLC25A12;SLC25A18
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.44279692731094594,1.2447565556178397,0.1882998171846435,0.7142410323267561,1.0,5/18,8.52%,CX3CR1;SELPLG;JAM2;SELE;SELP
prerank,regulation of protein localization to membrane (GO:1905475),-0.3883629946284552,-1.2445510287161543,0.1514476614699332,0.6330467830396377,1.0,9/28,15.95%,GPC6;SPTBN1;GSN;GPC5;PRKN;ACTB;GPC3;GPC4;MMP14
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44272266550090483,-1.2445287411246957,0.1995841995841996,0.6315295494375761,1.0,8/17,18.07%,DNM1L;GGCT;FIS1;MFF;BAK1;SOD2;BCL2;BOK
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.41271290225551,1.2445065097354877,0.18525179856115107,0.713706267794046,1.0,9/26,22.43%,NAV3;RAC1;NUMA1;MET;TRPV4;MAPRE1;FES;MAPT;KATNB1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.40109111309742623,1.2442406482125998,0.17335766423357665,0.713240550625226,1.0,11/30,18.26%,SMAD3;SMAD7;LTBP4;NREP;EID2;BCL9;ENG;LATS2;FST;XIAP;DKK3
prerank,energy reserve metabolic process (GO:0006112),-0.4286358746405647,-1.2441519845077655,0.1888111888111888,0.6310301013236127,1.0,6/19,13.39%,PID1;PRKAG2;GSK3B;GBE1;GFPT2;PYGM
prerank,mesenchyme development (GO:0060485),0.4708571010863072,1.2440065411123875,0.1808695652173913,0.7125863547604968,1.0,1/15,0.06%,TGFBR1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.37400589384946925,1.24384106998778,0.14680483592400692,0.7117447888980696,1.0,15/42,21.59%,KARS1;AARS2;CARS2;NARS1;SARS2;SARS1;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2;MARS2
prerank,heme biosynthetic process (GO:0006783),0.4237740805336937,1.2438405207044905,0.1875,0.7103519419530636,1.0,6/22,14.49%,HMBS;FECH;PPOX;NFE2L1;UROD;TSPO
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.49271365589949173,-1.2436638009414986,0.20869565217391303,0.6308049040352047,1.0,5/12,18.90%,ATF7IP;TET1;SETDB2;PPHLN1;DNMT1
prerank,positive regulation of response to external stimulus (GO:0032103),0.30628049199505847,1.2435657691029025,0.0892018779342723,0.7099145288920296,1.0,34/128,19.11%,IL18;TLR7;POLR3G;LY86;P2RY12;ETS1;AIF1;PRKCA;TLR4;ZCCHC3;SLC15A4;CCL3;AKIRIN2;TRADD;PDGFB;DHX9;CNTF;IL12B;DDT;CD180;PDGFRB;APOH;SERPINE1;IL33;OPTN;STX4;OSM;PLG;GBP5;GPR4;AGT;THBS1;SETD4;PPM1F
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5086033881498,-1.2435001606325293,0.21585903083700442,0.6296812709259768,1.0,5/10,18.98%,PPARG;RARG;RARA;RARB;SNW1
prerank,response to chemokine (GO:1990868),0.49609557089076944,1.243221355545742,0.2037735849056604,0.7096736722044215,1.0,4/13,15.56%,DOCK8;LRCH1;WNK1;STK39
prerank,acylglycerol metabolic process (GO:0006639),0.3849276278083233,1.24314444529675,0.15213675213675212,0.7085656458596976,1.0,10/37,14.67%,ABHD12;SEL1L;DGAT1;LMF1;DGKK;DGKD;GK5;ABHD6;APOH;PGS1
prerank,embryonic appendage morphogenesis (GO:0035113),0.5065957788397596,1.2430649309838218,0.19856887298747763,0.7075019419847921,1.0,3/12,6.91%,SKI;FBXW4;SHH
prerank,lysosome organization (GO:0007040),0.38345137922926975,1.2430425519708281,0.1542649727767695,0.7062146921756374,1.0,17/36,28.40%,HPS4;HOOK2;ARSB;AKTIP;MYO7A;MBTPS1;MTOR;CLN3;ACP4;ACP2;GAA;HOOK3;ABCA1;GNPTAB;VPS18;HPS1;TMEM106B
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4662566613397565,1.2426117308237017,0.19180633147113593,0.7062758604494995,1.0,5/16,8.81%,ETS1;ITGB2;SELE;SELP;FUT7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4427539234205388,-1.2423323386253915,0.1934782608695652,0.6315351608802878,1.0,6/17,16.59%,PRKG1;PPARG;TAFA5;SOD2;CDKN1A;APLN
prerank,ribosomal small subunit assembly (GO:0000028),-0.44180671076309996,-1.242311930489701,0.17249417249417248,0.6300405585970563,1.0,10/16,32.88%,RPS27;RPS14;MRPS7;ABT1;XRCC5;RPS5;RPS19;RPS15;RPSA;PWP2
prerank,T cell proliferation (GO:0042098),0.49022309791071594,1.241885600289623,0.21739130434782608,0.7074031024295597,1.0,3/13,3.90%,DOCK8;CADM1;PIK3CG
prerank,positive regulation of hydrolase activity (GO:0051345),0.30428573101368367,1.2417281954437345,0.09559939301972686,0.7065444206227441,1.0,29/137,15.26%,SRGAP2;DOCK8;F11R;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;ASAP3;PICALM;TGM2;RGS10;TBC1D7;SNX18;CCL3;FLCN;RAB3GAP1;SGSM2;DOCK10;LIMS1;RAPGEF3;PINK1;PIN1;SEMA4D;EZH2;TBC1D30;MAPK8;RTN4R;NDUFA13;SNX13
prerank,negative regulation of interleukin-10 production (GO:0032693),0.46906862154133794,1.240815605734365,0.1869328493647913,0.7084000516649352,1.0,6/16,11.38%,VSIR;AGER;TNFRSF21;PDCD1LG2;IL12B;DLL1
prerank,calcium ion import (GO:0070509),-0.3854372932482542,-1.2405889095374727,0.16241299303944315,0.6334819902468297,1.0,13/28,23.87%,CACNA1E;MCU;TRPC4;ATP2A2;CACNA1C;MCUB;MICU2;MICU3;CACNA1B;MS4A1;CACNA1G;SMDT1;ATP2A1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.45653828672975916,1.2403977128757009,0.18478260869565216,0.7084802909157176,1.0,5/17,15.38%,NCBP1;CDK9;CTR9;RNF20;NELFE
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.47117109073713026,-1.2403202020299962,0.20316027088036118,0.6327143677073997,1.0,3/14,3.90%,USP15;ANKRD17;DDX60
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3901314404554662,1.2400053346669309,0.16308243727598568,0.7084792830055822,1.0,11/33,19.13%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;PAX2;ABL1;MAPK7;ANKZF1;ECT2
prerank,cilium-dependent cell motility (GO:0060285),-0.410879093297136,-1.239708626013734,0.18322295805739514,0.6329005916258423,1.0,10/22,22.01%,RFX3;DNAH8;DNAH2;DNAI3;CFAP44;DNAH3;DNAH17;CCDC65;CCDC39;TEKT5
prerank,regulation of TOR signaling (GO:0032006),0.33840238636522757,1.2384428664563518,0.12944983818770225,0.7126357493755611,1.0,15/67,12.72%,GNA12;TBC1D7;TBCK;PKHD1;FLCN;RFFL;LAMTOR2;SEC13;RPTOR;TNFAIP8L1;ARAF;MLST8;WDR24;LAMTOR5;PDCD6
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4379113450503752,1.238394921086328,0.18584070796460178,0.7114468521130349,1.0,5/19,9.92%,POLR3G;CHD8;BRF2;RPTOR;MTOR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3205211085105217,1.2383680479297599,0.10835913312693499,0.7101977096366695,1.0,28/96,21.63%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;DHX38;SEC13;SRSF5;NUP50;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;HNRNPA2B1;SRSF9;DDX19B;DDX39B
prerank,leukocyte tethering or rolling (GO:0050901),0.44890070651396163,1.237935907029741,0.1836007130124777,0.7102816050654515,1.0,5/17,8.52%,CX3CR1;SELPLG;JAM2;SELE;SELP
prerank,cellular response to nitrogen compound (GO:1901699),0.4355423335931412,1.2378385689539673,0.19395017793594305,0.7092525539306535,1.0,11/20,34.81%,EPG5;SPIDR;BLM;ROCK2;NSMCE3;RTF2;ATP2B4;DDX11;ATRX;PDE12;DDI2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.38217355765923117,1.2377211526531418,0.16887417218543047,0.7083230343289502,1.0,5/36,3.69%,CX3CR1;TGFBR1;CRADD;CSNK2A2;CSNK2A1
prerank,protein polymerization (GO:0051258),-0.32978167098334976,-1.2370374280445313,0.14180929095354522,0.6393464938565082,1.0,11/55,8.94%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;TPPP;DIAPH3;JAK2;WASF1;PRKN;MSRB1;UBE2K
prerank,zinc ion transmembrane transport (GO:0071577),0.4273066070576229,1.2368942445311168,0.1828358208955224,0.709927502989254,1.0,5/22,12.80%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5003450980150492,1.2364516752546224,0.22448979591836735,0.7100579392634186,1.0,4/12,6.71%,DOCK4;MEF2C;ADAMTS1;PDGFB
prerank,negative regulation of protein polymerization (GO:0032272),0.4094009759968373,1.2361876422290865,0.17168141592920355,0.7096289684754465,1.0,9/27,15.20%,SSH2;TWF2;CYRIB;PRKCD;SSH1;CLIP3;HIP1R;MAPRE1;DYRK1A
prerank,RNA 3'-end processing (GO:0031123),0.33762729800037283,1.2359225205157194,0.1342062193126023,0.7091957992639517,1.0,20/69,22.66%,SRRM1;NCBP1;CSTF2;MAGOHB;MAGOH;U2AF2;DHX38;SRSF5;PABPN1;CPSF1;RBM8A;U2AF1L4;SLU7;FIP1L1;ALYREF;PCF11;THOC6;SRSF9;DDX39B;RPRD1B
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3951215107682346,1.235736917807667,0.16089965397923875,0.7085245141405749,1.0,9/32,10.80%,RREB1;TWF2;RAC1;PIK3R1;SRC;FSCN1;AVIL;AKIRIN1;CYFIP1
prerank,response to axon injury (GO:0048678),0.45270466323729425,1.2354909495780408,0.19708029197080293,0.7080757377813728,1.0,3/18,5.78%,RTN4RL1;P2RY12;NREP
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.37730607201052496,-1.235180294971642,0.16475972540045766,0.6432546197915423,1.0,4/32,4.32%,PID1;APP;PFKFB1;ZBTB20
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.42482080891276375,-1.2350042180555967,0.18906605922551253,0.6422400944735843,1.0,5/20,10.43%,PDE4D;ADRA1A;RAPGEF2;ZDHHC21;ADRA2A
prerank,negative regulation of autophagy (GO:0010507),0.3513879187822461,1.234964544333135,0.15041322314049588,0.708620616653659,1.0,18/54,17.65%,SNRNP70;SIRT2;CPTP;EIF4G1;FOXK2;MET;TAB2;MTOR;USP36;RASIP1;BMF;PINK1;KDM4A;IL10RA;RRAGA;AKT1;WDR6;CTSA
prerank,amino acid import across plasma membrane (GO:0089718),0.41917155121972904,1.2345612866898263,0.17647058823529413,0.7086866634426306,1.0,4/24,2.43%,SLC7A8;SLC1A3;SLC7A5;SLC36A1
prerank,regulation of protein secretion (GO:0050708),-0.2877160759785551,-1.2345189366797928,0.07123287671232877,0.6421009130264406,1.0,26/119,13.88%,STXBP5L;CACNA1E;ITPR1;DISP1;KCNC2;DPP4;RSAD2;RFX3;APOE;PPIA;SLC8B1;STXBP5;DNM1L;CACNA1C;ALOX5;GOLPH3;SNAP25;PER2;P3H1;ADRA2A;CLOCK;FFAR1;UNC13B;HMGCR;ACHE;CCL5
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3975854763390706,1.2345098574206457,0.16548042704626334,0.7075108737011204,1.0,6/29,8.32%,ITGAM;CADM1;CYRIB;RAET1E;NOS2;IL12B
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3825073591684977,1.2342866214254675,0.17750439367311072,0.7069772928820645,1.0,8/39,10.25%,PI4KB;PIK3R1;TMEM150A;PIK3CG;PIK3C3;SOCS6;PIK3CD;PIK3CB
prerank,proteasomal protein catabolic process (GO:0010498),0.2893197352298092,1.2341211923864426,0.0861812778603269,0.7061933243718677,1.0,67/201,24.08%,BAG6;NFE2L2;DDIT3;UCHL1;RNF216;ARRB2;SEL1L;SIRT2;SMURF1;ITCH;MTA1;SPSB1;RNF41;ENC1;RFFL;ERLEC1;ZSWIM8;SPSB2;SOCS6;MAEA;PCBP2;TRIM72;CDC34;CUL4B;ANKRD9;CRBN;BFAR;PSMD3;AREL1;KCTD2;PSMB3;UBE2U;PSMA7;RNF187;WWP2;DCAF11;PSMC1;PSMC2;FBXL22;PSME4;UBE2A;PSMB9;UBXN2A;ARRB1;SPOPL;TNFAIP1;RNF4;KAT5;STUB1;CUL4A;ZFAND2A;GID8;TRIM3;PSMD4;PSMB5;PMAIP1;TOPORS;SYVN1;RNF34;PSMB7;GID4;PSMB8;ATE1;ZNRF1;UBXN1;FBXW5;RAD23B
prerank,triglyceride biosynthetic process (GO:0019432),0.4515987389672943,1.2340671704811281,0.1797153024911032,0.7050687591276273,1.0,5/18,9.06%,AGMO;LPIN2;DGAT1;MOGAT1;MOGAT2
prerank,organelle disassembly (GO:1903008),0.38910254111042003,1.2338859817300474,0.17647058823529413,0.7043464560494308,1.0,12/33,18.73%,ULK2;PLK5;PELO;RB1CC1;KLC1;PLK3;UBA5;RETREG1;ULK1;EIF2D;MTIF2;STX5
prerank,Rac protein signal transduction (GO:0016601),0.4475407375718783,1.233760937892461,0.1875,0.7034518993135365,1.0,6/18,10.80%,ELMO1;RAC1;AIF1;RHOH;HACD3;CYFIP1
prerank,excitatory postsynaptic potential (GO:0060079),-0.43256229703127547,-1.2334067425900668,0.18013856812933027,0.6438908369956151,1.0,6/19,8.74%,GRID2;LRRK2;GRIN2B;GRIN2A;GSK3B;GRIN2D
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.37898178270899824,-1.2330871017920817,0.16864608076009502,0.643332752430629,1.0,10/32,12.82%,RIMS2;LRRK2;SYN1;MCTP2;GSK3B;CPLX2;RIMS4;MCTP1;KCNMB4;DTNBP1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.41637565556610606,1.2329369980110358,0.1895551257253385,0.7050884961626529,1.0,6/24,9.97%,F11R;PIK3R1;ARHGAP28;MET;TJP1;INPP5K
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4752885090722338,1.2328801006142827,0.2048417132216015,0.7027203514276508,1.0,8/15,20.49%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TOB1;TNRC6C;TNRC6B;NANOS1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4752885090722338,1.2328801006142827,0.2048417132216015,0.7027203514276508,1.0,8/15,20.49%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TOB1;TNRC6C;TNRC6B;NANOS1
prerank,regulation of astrocyte differentiation (GO:0048710),0.49593412404871806,1.2326266612014152,0.19548872180451127,0.7023147169925944,1.0,3/12,15.73%,BIN1;SERPINE2;NOG
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4910600177167003,1.2322826908565627,0.21161048689138576,0.7022327149772892,1.0,9/12,33.84%,ZCCHC3;DHX9;CGAS;MAVS;RALB;FLOT1;IFIT1;MUL1;COLEC12
prerank,establishment of mitotic spindle localization (GO:0040001),-0.37563643320399154,-1.2311918047451114,0.19376391982182628,0.6474189994913581,1.0,9/28,18.75%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;NUSAP1;GPSM2;ITGB1;NSFL1C
prerank,regulation of cardiac conduction (GO:1903779),-0.3353834856972376,-1.2308702082145915,0.1373873873873874,0.6469201278059792,1.0,12/54,11.25%,ANK2;ITPR1;SLC8A3;ATP2B1;RYR3;RYR2;ATP2A2;TMEM65;ATP1B3;DMPK;ATP2A3;ATP1A1
prerank,lipid droplet formation (GO:0140042),0.5229425974274099,1.2298370309874893,0.2209737827715356,0.7091915151715322,1.0,3/10,14.81%,AUP1;BSCL2;CDS1
prerank,regulation of microtubule polymerization (GO:0031113),0.36936276851688943,1.2295730444597432,0.1788756388415673,0.7088420069173115,1.0,10/40,15.20%,NAV3;RAC1;CAMSAP1;NUMA1;MET;CAMSAP2;CLIP3;ABL1;MAPRE1;DYRK1A
prerank,peptide biosynthetic process (GO:0043043),-0.27734508334736996,-1.2295033870000815,0.06285714285714286,0.6493810661057248,1.0,61/153,26.98%,DMD;PCSK5;RPL36A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;RPLP2;RPL7A;IGHMBP2;RPL41;RPL26;RPS27;RPL18A;RPS25;GGT7;EEF1A2;MRPL18;RPL38;RPL37;HBS1L;RPS6KB2;RPS14;MRPS7;RPS15A;RPL24;RPS9;RPLP1;RPL22;RPL8;MRPS33;RPLP0;RPS12;RPS10;RPL19;RHD;RPL13A;RPS6;RPS5;RPS19;RPL23A;YARS2;RPL29;PABPC4;RPS11;RPL18;ZAR1;MRPL24;RPS23;MRPL55;RPS15;RPL23;RPL17;MRPL23;EEF1A1;CARNS1;RSL24D1;GGTA1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4969424212263661,1.229121339346266,0.18773234200743494,0.709082091970367,1.0,7/12,29.75%,GINS4;MCM2;MCM3;MCMDC2;CDC7;MCM6;MCM7
prerank,negative regulation of metabolic process (GO:0009892),0.3453017715535522,1.2291052591944465,0.1480865224625624,0.7078438178017225,1.0,13/54,13.82%,DDIT3;PLCL1;PCTP;TLR4;LAMA4;FLCN;ID1;TFE3;WNT10B;ABHD6;PLCL2;ZDHHC7;NRDC
prerank,regulation of synapse maturation (GO:0090128),-0.5037595516882004,-1.228987372249366,0.20600858369098712,0.649393162884722,1.0,4/10,23.59%,NRXN1;RELN;NEUROD2;ARHGEF15
prerank,epithelial cell migration (GO:0010631),-0.36184895566286795,-1.2289778733154668,0.1366906474820144,0.6478598004526264,1.0,11/37,15.42%,DPP4;PLXND1;FSTL1;GIPC1;ZEB2;CDH13;KANK1;KIT;PLEKHG5;TNFSF12;STARD13
prerank,negative regulation of neuron projection development (GO:0010977),-0.32601934297471935,-1.228658773961621,0.1343612334801762,0.6472749165720393,1.0,13/56,15.91%,NLGN1;DCC;SPOCK1;BCL11A;LINGO1;APOE;RTN4;KANK1;PAQR3;STMN2;MINAR1;THY1;ARHGDIA
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5069795152698955,-1.2283999630087643,0.21861471861471862,0.6465849411503607,1.0,5/10,20.49%,RIC1;RGP1;ANXA2;CDK5RAP3;EPHA4
prerank,sodium ion import across plasma membrane (GO:0098719),0.4618851490953072,1.228215547184281,0.21723518850987433,0.7096753971297565,1.0,3/17,5.47%,SLC9A9;TRPM4;SLC8A1
prerank,negative regulation by host of viral process (GO:0044793),-0.5017743405673747,-1.228066537331582,0.21367521367521367,0.6460494027264736,1.0,6/10,29.77%,VAPA;PRKN;EIF2AK4;LTF;CCL8;CRP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.293525886895701,-1.2278396102752096,0.08398950131233596,0.6452354085114793,1.0,28/95,17.28%,GPC6;HS3ST5;B4GALT5;ST3GAL1;ST3GAL4;B4GALT6;CHSY3;UST;HS3ST2;EXT1;DSE;SDC3;GPC5;HS6ST2;HS3ST1;HSPG2;VCAN;B4GALT2;GPC3;PXYLP1;CSPG4;NDST1;GPC4;CSGALNACT2;EXT2;AGRN;LUM;B4GALT7
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.39345023978050714,-1.2277728974351434,0.1941031941031941,0.6438873959975504,1.0,4/25,1.66%,RIT2;ITPR1;LRRK2;HTT
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.5005057206699222,-1.2275272618090678,0.23478260869565218,0.6430505499788526,1.0,4/11,18.90%,ATF7IP;SETDB2;PPHLN1;DNMT1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.29850820155131674,1.2269192738262416,0.08964451313755796,0.712610982634108,1.0,32/148,15.05%,NUAK1;RHNO1;CHEK2;RFC2;CSNK2A2;CSNK2A1;NBN;ATM;TAF12;RAD17;RFFL;MDM4;PDPK1;TAF6;PIP4P1;BRCA1;BOP1;POU4F1;EHMT2;CHD3;MTOR;PRDM1;MLST8;TAF1;EXO1;RAD1;BLM;PIN1;TAF4;PLK3;AKT1;MAPK14
prerank,regulation of neutrophil migration (GO:1902622),0.5185141425477666,1.2267870911353893,0.2101313320825516,0.7117934289520348,1.0,3/10,10.24%,RAC1;RHOH;NCKAP1L
prerank,protein sumoylation (GO:0016925),0.3542109921201651,1.2256270859976763,0.16666666666666666,0.7143748326921971,1.0,15/49,17.95%,SUMO1;RANBP2;UBA2;TRPM4;STX1A;NUP42;EGR2;NUP50;NUP35;NUP88;PIAS3;PIAS2;NUP62;SEH1L;NUP107
prerank,positive regulation of dendrite development (GO:1900006),-0.5002701246119706,-1.2251805537492646,0.22863247863247863,0.6486553758159018,1.0,2/10,12.92%,ALK;ZDHHC15
prerank,filopodium assembly (GO:0046847),0.45659646548963084,1.22509826158573,0.2039355992844365,0.7149137501656672,1.0,5/16,11.62%,SRGAP2;FGD2;PPP1R9B;FGD3;SPATA13
prerank,RNA processing (GO:0006396),0.2896378459854324,1.22474193515668,0.06706408345752608,0.7148087508182552,1.0,53/176,22.75%,IVNS1ABP;SRRM1;SON;NCBP1;PPP1R9B;FUS;PRKACA;AKAP8L;SF3B2;SF3B1;MAGOHB;MAGOH;U2AF2;HNRNPC;CELF2;SNRPF;SNRPA1;HNRNPH1;RBM39;SNRNP48;TSEN2;HNRNPR;DDX17;SRSF5;PABPN1;RBM8A;TARDBP;DDX54;TSEN54;LUC7L3;DDX20;LSM5;SLU7;SF3A1;ALKBH5;DUSP11;PRPF3;PRPF4;SNRPN;SCNM1;ZCCHC8;GEMIN2;SNRNP40;HNRNPA2B1;SRSF9;HNRNPH3;WBP4;FASTKD2;DDX39B;HNRNPUL1;DDX47;RBPMS;MPHOSPH10
prerank,cellular lipid catabolic process (GO:0044242),0.4112863295600757,1.224665528767446,0.1989342806394316,0.7138213689228345,1.0,6/27,4.89%,ABHD12;SIRT2;PPARD;LPIN2;NUDT19;PLA2G15
prerank,positive regulation of secretion (GO:0051047),-0.4801552805592805,-1.2246294055143025,0.2055084745762712,0.6488929691659501,1.0,6/11,32.94%,ACSL3;AQP1;ABCB11;XBP1;SCIN;TRH
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2794678426016336,-1.2245514977249603,0.093841642228739,0.6475829036598268,1.0,35/125,17.93%,KNL1;CENPF;DYNC1I2;CENPT;CDCA8;CENPP;ZW10;SPDL1;NUP98;EML1;BIRC5;RAN;CENPE;NDC80;PLK2;RPS27;NUSAP1;BUB1B;SPC25;KNTC1;AURKB;DLGAP5;KIF11;BUB1;TTK;GPSM2;ERCC6L;NUP43;DCTN6;MAD1L1;RCC2;CENPS;CCNB1;KIF4A;SPC24
prerank,melanocyte differentiation (GO:0030318),0.5216683570094809,1.2239094037297351,0.2237354085603113,0.7152008510682227,1.0,2/11,1.71%,LRMDA;MEF2C
prerank,arachidonate transport (GO:1903963),0.5385930754837025,1.223771686163507,0.23277467411545624,0.7131085035419109,1.0,4/10,17.98%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.5385930754837025,1.223771686163507,0.23277467411545624,0.7131085035419109,1.0,4/10,17.98%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4051811240088875,1.2234785137584254,0.18641114982578397,0.7128004501633632,1.0,10/29,27.42%,BAG6;STAG3;KASH5;TEX12;MAJIN;PRDM9;SYCE2;SYCP2;ZCWPW1;HORMAD1
prerank,intracellular sterol transport (GO:0032366),0.48815861371470903,1.2233051430122512,0.2003577817531306,0.7121127731727005,1.0,6/13,25.40%,NPC1;NPC2;OSBP;VPS4A;SERAC1;ABCA1
prerank,rRNA transcription (GO:0009303),0.4580796346930877,1.2223469504994047,0.21364452423698385,0.7140604281717118,1.0,7/17,25.74%,GTF3C2;GTF3A;BRF1;GTF3C6;POLR1E;POLR1G;SPIN1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.47981408154287963,1.2221941233198876,0.2271880819366853,0.7132963517748757,1.0,4/13,12.68%,TGFBR2;SHH;NOTCH4;ENG
prerank,retina homeostasis (GO:0001895),-0.3953163115057845,-1.2218510949732397,0.1845102505694761,0.6542931130408706,1.0,8/23,20.74%,B2M;PRDX1;SLC28A2;POTEF;ACTB;JCHAIN;LTF;ACTG1
prerank,interstrand cross-link repair (GO:0036297),0.34814114005322633,1.2215509135289098,0.16981132075471697,0.7142627940476822,1.0,20/53,22.22%,RAD51AP2;WDR48;RPS27A;UBC;FANCM;POLN;SLX4;FAAP24;RNF8;FANCG;DCLRE1B;ERCC4;DCLRE1C;FANCI;DCLRE1A;FANCA;UBE2T;FAAP100;RFWD3;RPA3
prerank,Notch signaling pathway (GO:0007219),0.3389365518217574,1.22149209893274,0.15689655172413794,0.7132066270527054,1.0,19/59,17.68%,MAML3;HEYL;ITCH;DTX4;JAG2;NOTCH4;DTX1;POFUT1;MAML2;PSENEN;GALNT11;DLL1;NLE1;PSEN2;NOTCH3;DTX3;ADAM10;DTX3L;APH1B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4360531553943304,-1.221390692160052,0.2021978021978022,0.6541944916876961,1.0,3/17,3.86%,ANK2;RYR2;NEDD4L
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.2687699395953721,-1.2212986677261712,0.06521739130434782,0.6529350277148966,1.0,40/186,15.25%,DAB2;CCDC88C;SHISA6;CUL3;LIMD1;PSMD14;LATS1;HECW1;APC2;RBMS3;LRP6;APOE;GSK3B;TRABD2B;PSMD8;MLLT3;IGFBP4;FRZB;PSMA2;PSMF1;PRKN;PSMD6;TLE4;AXIN1;PSME2;SOX13;NLK;GRB10;NXN;PSMD5;TLE1;PSMD12;NPHP3;MCC;IGFBP2;PSMD11;SCYL2;NKD1;PSMD1;SFRP1
prerank,heart contraction (GO:0060047),-0.35337976094182466,-1.2212961463594698,0.16511627906976745,0.6514197446614429,1.0,4/41,3.15%,SGCZ;DMD;RYR2;SGCD
prerank,positive regulation of interferon-beta production (GO:0032728),0.38469031169527723,1.2209201145404232,0.19666048237476808,0.7137997148248995,1.0,8/33,16.20%,TLR7;POLR3G;RIPK2;TLR4;DHX9;PTPN11;MAVS;IRF3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.45048907828314155,1.2205117381359771,0.19264448336252188,0.7139796041889636,1.0,5/17,11.53%,DOCK4;AIF1;ADAMTS1;PDGFB;PDGFRB
prerank,transition metal ion homeostasis (GO:0055076),-0.3873262664183258,-1.220314060652351,0.17985611510791366,0.6527410148540876,1.0,9/28,15.42%,FTL;ABCB7;B2M;NEO1;PRKN;TFR2;HMOX1;FBXL5;CYBRD1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.37398758499088264,1.2202746840674301,0.17584369449378331,0.7135568328521056,1.0,16/38,26.62%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFAF1;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFB4
prerank,organelle transport along microtubule (GO:0072384),-0.3670292637309873,-1.2200832877942744,0.17579908675799086,0.6519344959449676,1.0,9/31,11.89%,BICD1;BORCS5;HTT;RAB6A;CDC42;COPG2;KIF5B;RHOT2;ARHGAP21
prerank,protein deacylation (GO:0035601),0.4105876555062332,1.219871420098622,0.20035460992907803,0.7137329080328386,1.0,5/23,7.04%,ABHD17C;SIRT2;HDAC10;PPT1;SIN3A
prerank,sulfate transport (GO:0008272),-0.4514146234972355,-1.219861126889546,0.21686746987951808,0.6511250474988912,1.0,6/14,22.21%,SLC25A30;RACGAP1;SLC26A7;SLC26A2;SLC26A8;SLC26A4
prerank,regulation of T cell migration (GO:2000404),0.4398502457514759,1.2195566763985926,0.2074468085106383,0.7136039013723677,1.0,3/18,2.61%,DOCK8;AIF1;LRCH1
prerank,myeloid leukocyte differentiation (GO:0002573),0.3348681929015656,1.2193752417223216,0.18196994991652754,0.7129430094207413,1.0,15/65,15.22%,TGFBR2;CSF1R;LGALS9;GAB2;SBNO2;MYH9;MT1G;CCR7;PIK3CD;PDE1B;RUNX1;OSTM1;MAPK14;OSCAR;CSF1
prerank,calcium ion transport (GO:0006816),-0.2844321036163815,-1.2189323950035769,0.1,0.6523824437232318,1.0,23/113,10.17%,ANK2;CACNA1E;ITPR1;SLC8A3;TRPC5;CCR1;RYR3;RYR2;NALCN;TRPC4;TRPM3;ATP2A2;SLC24A2;TPT1;CACNA1C;PKD2;GRIN3A;TMEM165;STIM2;ANO6;TRPC3;CHRNA4;ATP2A3
prerank,nuclear membrane disassembly (GO:0051081),0.4722149492707711,1.2185129775828556,0.21042830540037244,0.7147493641704912,1.0,4/14,10.51%,PRKCA;AKAP8L;NEK6;PRKCB
prerank,regulation of phagocytosis (GO:0050764),0.349506141204046,1.2184322398705525,0.15734265734265734,0.7138127838236447,1.0,12/53,18.06%,MERTK;SIRPA;TGM2;ITGAV;CAMK1D;GATA2;PLA2G5;PYCARD;SNX3;RAB27A;SCARB1;SLC11A1
prerank,tryptophan catabolic process (GO:0006569),-0.5038477989821949,-1.2182580830589367,0.2297872340425532,0.6528359089359786,1.0,3/11,19.96%,KMO;IDO2;KYAT1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.31244913196526614,1.2177125075011008,0.1126984126984127,0.7151712466968532,1.0,20/100,13.59%,IL18;PIK3R1;CRNN;LYN;IGF1R;SRC;PIK3CG;PIK3AP1;PDGFB;SELP;GPER1;FSHR;PIK3CD;PIK3CB;FBXL2;CEACAM1;PDGFRB;PPP2R5B;HCST;SEMA4D
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.25833857220489337,1.217675405564801,0.03830911492734478,0.7140728729176646,1.0,90/509,12.78%,CX3CR1;TGFBR1;IL18;TLR7;P2RY12;CFLAR;RAC1;PIM2;LGALS9;DDIT3;PIK3R1;RIPK2;GAB2;AGER;TMEM101;TGM2;ATP2C1;TLR4;LYN;TRIM5;MAP3K3;NEK6;IGF1R;ITGAV;SRC;ZCCHC3;PIK3CG;TRAF5;PHB2;CCL3;PLCG2;FLCN;CD27;RYK;CASP1;LRRC19;NDFIP2;THEM4;KSR1;TRADD;SPRY2;TRIM44;PIK3AP1;PDPK1;PDGFB;TMED4;MTDH;CD86;CGAS;MET;C1QBP;GCNT2;NOS1AP;LAMTOR2;SEC13;EPHA8;CCR7;IL12B;EDA2R;RASD2;SELP;GPER1;CALCR;FSHR;RPTOR;TAB2;AKAP13;LIMS1;RNF31;FRS2;GAPDH;PIK3CD;RTKN2;AXL;PIK3CB;CXXC5;TICAM2;PRKCB;MLST8;ZDHHC13;WDR24;LAMTOR5;MIB2;BMF;PDGFRB;PINK1;HCST;TRIM62;ENG;PTPN11
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.41057995821232907,1.217627134385251,0.21200750469043153,0.712964036750676,1.0,8/21,22.48%,MYH9;PSENEN;PSEN2;SPPL2B;ADAM10;RBMX;ADAM17;ERAP1
prerank,negative regulation of histone modification (GO:0031057),-0.45114665249851765,-1.217353643669599,0.21205357142857142,0.654094620123736,1.0,8/14,23.63%,JARID2;TAF7;SNCA;AASS;FOXP3;THAP7;NOC2L;SPHK2
prerank,sphingoid metabolic process (GO:0046519),0.48680263663199386,1.2171603522096843,0.22988505747126436,0.7132472704001831,1.0,4/12,11.56%,DEGS2;SPTLC3;PLPP1;PLPP2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.34688084492507304,1.2169987595548633,0.16507936507936508,0.7125754256279302,1.0,26/52,30.45%,EXTL3;PREB;HYOU1;PDIA5;DNAJB9;GFPT1;KLHDC3;CXXC1;PLA2G4B;PPP2R5B;VAPB;TSPYL2;EDEM1;SYVN1;HDGF;SEC31A;CTDSP2;SERP1;DNAJB11;FKBP14;SRPRB;DDX11;ACADVL;ZBTB17;MYDGF;ADD1
prerank,peptidyl-arginine modification (GO:0018195),0.4599105857145908,1.2169915583892694,0.2161654135338346,0.7113826615877854,1.0,4/15,9.61%,ART4;PADI2;PRMT8;PRMT1
prerank,vesicle transport along actin filament (GO:0030050),0.4348345763279912,1.2163465387045058,0.21858864027538727,0.7123807123548982,1.0,7/19,16.30%,MYO1B;MYO1F;MYO1E;MYO7A;MYO5B;MYO15A;WASL
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.40328481060870186,1.2159537957942104,0.20238095238095238,0.712546342790368,1.0,14/25,32.54%,SRRM1;SF3B1;TRA2B;SLU7;PRPF3;PRPF4;GEMIN2;SNRNP40;MPHOSPH10;SRSF10;SF3B3;TXNL4A;SF3B4;PRPF8
prerank,protein import into nucleus (GO:0006606),0.3359496442924984,1.2158419571446617,0.1445578231292517,0.7116526721318583,1.0,31/66,27.69%,SPRN;RANBP2;PHB2;FAM53A;PTTG1IP;SEC13;NUP62CL;APPL1;TNPO1;NUP50;NUP35;NUP88;IPO4;RPAIN;AKT1;TNPO3;CSE1L;NUP62;NUP107;E2F3;KPNA3;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;HIKESHI;RANBP17
prerank,negative regulation of chemokine production (GO:0032682),0.4665388143516016,1.2154751741652208,0.22803738317757008,0.7116128806299599,1.0,2/14,1.68%,SIRPA;LGALS9
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3716289773848928,1.2154268743911132,0.18491921005385997,0.7105532751762829,1.0,7/38,6.85%,POLR3G;LY86;PRKCA;ZCCHC3;SLC15A4;AKIRIN2;DHX9
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4724573126695273,-1.2153365839016157,0.2163355408388521,0.6588401680201117,1.0,5/13,18.33%,CD74;LILRB1;SIRT1;SEMA7A;IRAK3
prerank,neuron projection development (GO:0031175),-0.2699493049924822,-1.2152974859103343,0.06963788300835655,0.6574335280460223,1.0,29/168,9.52%,CNTNAP2;NLGN1;GRM7;CTNND2;FRY;NYAP2;LRRK2;GPM6A;BDNF;APP;CTTN;RAPGEF2;VAPA;DCLK1;EHD1;MAP2;SHANK3;APOE;STMN4;GSK3B;SH3GL2;CDC42;PAK3;TOR1A;ERCC6;LGI1;ATP7A;RASGRF1;CNTNAP1
prerank,myeloid cell differentiation (GO:0030099),-0.3389722609126704,-1.2152855847356596,0.15938303341902313,0.6559610175338793,1.0,11/47,12.98%,ZBTB16;KMT2E;JAK2;RASGRP4;FLVCR1;HIPK2;PTPN2;RPS14;CEBPA;KIT;KAT6A
prerank,presynapse organization (GO:0099172),-0.5093209677875564,-1.2151690952384802,0.22198275862068967,0.6548361883560246,1.0,2/10,8.97%,NLGN1;LRRTM3
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4227278356232431,1.2148795921931863,0.2068345323741007,0.7112370183863067,1.0,7/22,14.23%,SSH2;TWF2;CYRIB;PRKCD;SSH1;HIP1R;PFN4
prerank,macromolecule catabolic process (GO:0009057),0.4022850473398781,1.214674428462119,0.20034246575342465,0.7107652562896847,1.0,6/26,9.92%,CAPN3;SMURF1;LGMN;PPT1;SH3GLB1;MTOR
prerank,ventricular septum morphogenesis (GO:0060412),0.39863568041772124,1.2140395891465152,0.18388791593695272,0.711771739247842,1.0,4/27,1.49%,TGFBR1;TGFBR2;SMAD7;HEYL
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.49832664283972944,1.2138443336892375,0.2222222222222222,0.711208099612701,1.0,3/11,10.23%,MERTK;CCR7;AXL
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3071700970621481,1.2132570810678678,0.11483253588516747,0.7119244675670858,1.0,18/107,10.71%,BAG6;HYOU1;QRICH1;DDIT3;PIK3R1;SEL1L;DNAJB9;CREB3L2;FICD;EIF2S1;ERLEC1;ATF3;MBTPS1;USP19;JUN;OS9;MBTPS2;SCAMP5
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3030806576362941,-1.2129913169703899,0.12947658402203857,0.6601300751293606,1.0,14/80,9.47%,NLGN1;EPS8;AUTS2;GPM6A;ARHGAP35;HTT;ACTR3;TENM2;PALM;RIPOR2;CDC42;FAM98A;ABI2;CCDC88A
prerank,nucleic acid metabolic process (GO:0090304),0.3275203564101292,1.212842039155195,0.14871794871794872,0.7121544976773464,1.0,22/69,24.39%,NCBP1;POLR2H;POLR2J;POLR2D;HNRNPA3;DXO;HNRNPC;PCBP2;HNRNPH1;HNRNPR;MMS19;DDX54;POLR2E;DNASE2;METTL14;DUSP11;RBMX;HNRNPA2B1;POLR2I;TOPBP1;LSM8;HNRNPA1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.49534903127612595,-1.2127776205692264,0.24210526315789474,0.6592837489855965,1.0,6/10,22.64%,JARID2;SIRT1;DNMT3B;RIF1;DNMT1;MYB
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4440332730694042,-1.2123678865473362,0.2441860465116279,0.6590143668626753,1.0,7/15,16.58%,RBPJ;EGFR;PTPN12;MVB12A;CDH13;FER;WDR54
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.41843570983436185,-1.211920829440393,0.18043478260869567,0.6589064840089017,1.0,7/20,21.34%,ITGA4;GSN;CD40;ANO6;RGCC;PRKCI;PLA2R1
prerank,negative regulation of telomere maintenance (GO:0032205),0.4667789574677812,1.2106142678148915,0.23118279569892472,0.7184833445180558,1.0,5/15,13.39%,NBN;ATM;SLX4;ERCC4;TERF1
prerank,protein localization to plasma membrane (GO:0072659),-0.28099018131299897,-1.210526450454912,0.09703504043126684,0.6617209070861048,1.0,29/129,13.41%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;LRP6;EHD1;AFDN;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;CCDC88A;SPTBN4;P2RY1;ZDHHC23;ITGB1BP1;TESC;EFR3A;CDH1
prerank,protein glycosylation (GO:0006486),0.30196707738335005,1.2102362056653326,0.12996941896024464,0.7185627702272391,1.0,30/125,13.56%,ST3GAL6;LARGE1;MGAT4A;B3GNT2;ST3GAL5;TRAK1;ALG12;GFPT1;POMGNT1;MPI;GALNT10;TET3;ALG6;GALNT1;DPM3;GCNT2;B3GNT4;FUT7;MGAT2;POMT1;MAN1C1;MGAT5;ALG11;POFUT1;MGAT1;NPC1;EOGT;GALNT7;ALG2;ST3GAL3
prerank,regulation of hemopoiesis (GO:1903706),0.5140432824149902,1.2102314860461394,0.24118738404452691,0.7173724210497707,1.0,3/10,11.45%,MYSM1;PRKCB;RUNX1
prerank,neuromuscular process controlling balance (GO:0050885),-0.47608071411652814,-1.2101489195352906,0.2242798353909465,0.6613723954069225,1.0,2/12,0.80%,NRXN1;PCDH15
prerank,ncRNA 3'-end processing (GO:0043628),0.47435340720781977,1.2099868651578178,0.23713235294117646,0.7170436644497841,1.0,6/14,22.29%,INTS6L;TRNT1;SSB;INTS8;ELAC2;PTCD1
prerank,membrane fusion (GO:0061025),-0.3635144120837351,-1.2092263696050642,0.17571059431524547,0.662578770625777,1.0,5/33,6.42%,MYOF;DNM3;VAPA;DNM1L;DNM1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4078562959727572,-1.208632959856407,0.19957983193277312,0.6628030427553797,1.0,4/20,4.61%,NLGN1;CPEB3;SHANK3;APOE
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3524353439364605,-1.2083727126507946,0.17857142857142858,0.6621203264213755,1.0,14/40,16.84%,SORBS1;CD36;CREBL2;VIM;ZBTB20;APOE;WNT4;CYBA;MMP8;CCL5;SCX;RGCC;MTPN;BMP4
prerank,positive regulation of vacuole organization (GO:0044090),0.5092516437832935,1.2081248928621957,0.24705882352941178,0.7220998157524856,1.0,3/10,9.30%,RAB3GAP1;RAB3GAP2;SH3GLB1
prerank,base conversion or substitution editing (GO:0016553),-0.4903841365557743,-1.2079994491830208,0.22767857142857142,0.6617377002060607,1.0,7/11,37.79%,ADARB2;ADAR;AICDA;APOBEC2;ADAD1;APOBEC1;ADARB1
prerank,import into cell (GO:0098657),0.3686978472138172,1.2078406642780009,0.18425460636515914,0.7218314599151547,1.0,14/41,20.03%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC12A6;NEURL1B;SLC22A2;IL10RA;SLC29A1;LRRC8A;SLC5A3;SLC38A1;SLC19A1;LRRC8D
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4310934742719208,-1.2075152699844431,0.21231422505307856,0.6617917626611698,1.0,5/17,13.32%,NLGN1;SYT10;RAB3D;RAB3A;SLC4A8
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.5015713422328318,-1.2072644159266677,0.24074074074074073,0.6610817889160474,1.0,6/10,30.33%,ZBTB16;SOX5;ACVRL1;SOX6;BMPR1B;GDF6
prerank,lipoxygenase pathway (GO:0019372),0.4652600086870272,1.207089471916277,0.2387218045112782,0.723167383893386,1.0,5/14,13.41%,ALOXE3;HPGD;PON2;GPX4;PON3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.42369784705608227,-1.2070079374943858,0.1973392461197339,0.6603685880685067,1.0,8/16,26.82%,DPM2;PIGW;PIGX;PIGC;PIGP;PIGA;PIGB;PIGZ
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3512394482390917,1.206957550233298,0.19080068143100512,0.7223691528007555,1.0,8/46,9.13%,LIPH;PLD1;LPCAT4;PLA2G4A;PLD2;DGKD;PLA2G4B;PLA2G5
prerank,indolalkylamine catabolic process (GO:0046218),-0.5174801549328485,-1.2068348442005317,0.2346723044397463,0.6594446004873225,1.0,3/10,19.96%,KMO;IDO2;KYAT1
prerank,thyroid hormone generation (GO:0006590),0.5181626439775753,1.2067393061339016,0.21052631578947367,0.721950799701675,1.0,3/10,7.99%,TG;FOXE1;DUOX1
prerank,cellular response to calcium ion (GO:0071277),-0.3117997297414101,-1.206022738167859,0.14354066985645933,0.6604352944931681,1.0,26/67,23.74%,NLGN1;IQGAP1;SYT1;RYR3;KCNH1;CARF;SYT10;ALOX5AP;PKD2;CPNE8;CPNE4;RASGRP2;SLC25A24;ADCY8;CHP2;CRHBP;SYT3;HPCA;CPNE2;ALOX15;CPNE6;NEUROD2;PRKAA1;PPIF;SYT5;BRAF
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3265437889713345,1.205746432023242,0.14832535885167464,0.724146036596412,1.0,19/70,16.69%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;NCKAP1L;PIK3CB;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4098449798252129,1.2057381369570275,0.2103386809269162,0.7229776012426928,1.0,8/24,19.99%,NFE2L2;PDPK1;GATA2;SERPINE1;TNIP2;MAPK7;GATA3;KRIT1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4591179103077828,-1.205701290319747,0.2167381974248927,0.6599180145916992,1.0,3/12,4.61%,IAPP;LDLR;APOE
prerank,regulation of lipid kinase activity (GO:0043550),0.5055722851054091,1.2055695298542233,0.23475046210720887,0.7223095179602382,1.0,5/11,19.50%,PIK3R1;RBL2;PIK3R3;PPP2R5A;WDR81
prerank,protein import (GO:0017038),0.32061523394696917,1.2046498283934766,0.1440536013400335,0.7242292638165241,1.0,37/84,26.95%,ABCD2;SPRN;PHB2;CLU;FAM53A;PTTG1IP;HSPA4;SEC13;NUP62CL;APPL1;TNPO1;NUP50;NUP88;IPO4;RPAIN;AKT1;TNPO3;PXMP2;CSE1L;NUP62;NUP107;E2F3;RAB8B;LAMP2;IPO7;ABCD1;NUP153;IPO5;PRICKLE1;PEX3;NUP188;APPL2;STAT3;IPO9;SAMM50;HIKESHI;SNX33
prerank,cell-cell junction organization (GO:0045216),0.3184435910041396,1.2044675266146416,0.15141430948419302,0.723617436368693,1.0,23/79,15.77%,CADM1;CSF1R;SMAD3;DSP;CXADR;TLN2;NECTIN4;PKHD1;FLCN;FSCN1;CSK;DSG2;CDH18;CDH24;PKP3;LIMS1;TJP1;GJA4;TRPV4;NECTIN2;TJP2;CDH15;CDH3
prerank,regulation of mitochondrial fission (GO:0090140),-0.39065735806575097,-1.2042800362821635,0.21336206896551724,0.6626687810637647,1.0,7/24,9.61%,LRRK2;MCU;DNM1L;PRKN;DDHD1;FIS1;MFF
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.47433036705906273,1.2040455518025235,0.22393822393822393,0.7238293092852104,1.0,3/13,15.38%,NELFB;RNF8;NELFE
prerank,positive regulation of apoptotic process (GO:0043065),0.26838614339182537,1.2037388991022544,0.08321167883211679,0.7236659117103881,1.0,54/293,14.82%,TGFBR1;BIN1;FGD2;ARHGEF2;DNM2;CTSD;PREX1;VAV2;ITGA6;QRICH1;PRMT2;CALHM2;CRADD;DDIT3;IGFBP3;KCNMA1;TGM2;SIRT2;KLF11;ATM;RHOB;CCL3;CLU;FLCN;SUDS3;RPS27A;UBC;TRADD;ARL6IP5;C1QBP;JUN;WNT10B;PIP5KL1;GPER1;AKAP13;PPID;SLC27A4;CLIP3;FGD3;PRDM11;PSENEN;BMF;TRIO;APAF1;PSEN2;MAP3K11;HIP1R;MAP3K10;ABL1;DDX20;MAPK8;SOD1;LATS2;PYCARD
prerank,positive regulation of TOR signaling (GO:0032008),0.36295243190411924,1.2032905978637332,0.19022687609075042,0.7239159279782723,1.0,13/40,17.68%,FLCN;PIP4P1;LAMTOR2;GPR137C;SEC13;RPTOR;NCKAP1L;MLST8;WDR24;LAMTOR5;RRAGA;GPR137;SEH1L
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32516018254356066,1.2023670096632182,0.14903846153846154,0.725901772045818,1.0,19/71,16.69%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;NCKAP1L;PIK3CB;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,cell cycle G2/M phase transition (GO:0044839),0.2955952966330851,1.2015840385156689,0.13129770992366413,0.7273279172522905,1.0,36/129,19.36%,DNM2;SDCCAG8;TUBA4A;CSNK1E;AKAP8;PRKACA;CHEK2;AKAP8L;FBXL15;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;FBXL8;TUBA1A;OPTN;CEP63;CEP57;PLK3;HAUS6;PPP1CB;HAUS2;SFI1;MAPRE1;FBXL22;AURKA;MASTL;CEP135;ACTR1A;KDM8;OFD1;KHDRBS1;DCTN2;CEP43
prerank,endodermal cell differentiation (GO:0035987),0.3904679599783615,1.201105480600369,0.20112781954887218,0.72779635684492,1.0,9/31,15.53%,ITGB5;ITGB2;ITGAV;CTR9;MMP2;LAMA3;SETD2;ITGA7;COL11A1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3372182072762329,1.2006546872241521,0.18257956448911222,0.7281825763308181,1.0,12/54,14.99%,DST;HOOK2;CCDC88B;CAMSAP1;NUMA1;TUBGCP5;WDR73;CAMSAP2;CLIP3;TRPV4;PLK3;CIB1
prerank,mitochondrial transport (GO:0006839),-0.3207048985385016,-1.2004020997917582,0.17298578199052134,0.6730753713910851,1.0,19/53,19.14%,TOMM22;TIMM23;TIMM17B;FLVCR1;TOMM5;SLC25A24;SLC25A16;FIS1;MFF;BAK1;FBXO7;COX18;TIMM17A;MTX2;TIMM10;BCL2;AIP;SPG7;BCAP31
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3655895500471963,-1.2001998053786853,0.18181818181818182,0.6722321942608195,1.0,10/30,18.11%,CD74;CD44;RPS3;TPT1;SIRT1;CCAR2;MDM2;SNAI2;SFRP2;DDIAS
prerank,epidermal cell differentiation (GO:0009913),0.3656913309521534,1.1997827701278916,0.19658119658119658,0.729968951949338,1.0,7/41,10.75%,DSP;CERS3;ST14;ERCC2;OVOL2;SPRR1A;ASAH1
prerank,negative regulation of cell growth (GO:0030308),0.29743836323034684,1.199547190697243,0.12924071082390953,0.7296114381687063,1.0,32/121,19.70%,FGF13;SMAD3;ULK2;CDKL3;DIP2B;PPP1R9B;CCDC85B;OSGIN2;AGTR2;FLCN;SIPA1;NDUFS3;PPT1;APBB2;SEMA3G;SOX17;NME6;PRDM11;SMARCA2;OSGIN1;GJA1;RTN4R;TSPYL2;NDUFA13;DACT3;VGLL4;MAG;ULK1;PTPRJ;NAIF1;ADAM15;EI24
prerank,positive regulation of ERAD pathway (GO:1904294),0.46940176353732393,1.199504145731396,0.2476894639556377,0.7285859286773914,1.0,2/13,1.25%,BAG6;NFE2L2
prerank,postreplication repair (GO:0006301),0.3536499904076405,1.1994203425883114,0.203125,0.7276622839767096,1.0,16/45,24.61%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;BRCA1;POLD2;PCLAF;UBE2V2;UBE2A;RFC1;RPA3;ZBTB1;SPRTN;POLD4
prerank,cellular response to organic substance (GO:0071310),0.30060540778178013,1.1992625986021779,0.13186813186813187,0.7270134272152321,1.0,29/116,17.29%,TGFBR1;IL18;TGFBR2;CSF1R;SMAD3;TWF2;IL1RL2;CRNN;CDK9;CCL3;CASP1;PDGFB;ARL6IP5;CCR7;PLK5;POU4F1;INPP5K;DCPS;PTPN11;LDLRAP1;IL18BP;MAPK8;GHR;CIB1;NCOA3;ACVR2B;PTPN23;PTPN5;MAPK7
prerank,cytosolic transport (GO:0016482),0.3017955417213909,1.1989573433281944,0.1557377049180328,0.7268744258775773,1.0,37/108,23.42%,HOOK2;PHETA1;TBC1D17;TBC1D10B;AP2A1;VPS26B;SORT1;PIK3C3;AKTIP;YKT6;VPS54;CLN3;MON2;SNX5;DENND5A;RBSN;SNX32;PTPN23;DOP1B;VPS29;RAB6B;STX5;AP4M1;VPS13C;VPS26A;WDR81;VPS35;CCDC91;ANKFY1;PREPL;SNX6;STX8;STX16;RAB9A;SYS1;HOOK3;VPS52
prerank,cellular response to metal ion (GO:0071248),-0.2784262108422311,-1.198872799283842,0.10817941952506596,0.6748879819499846,1.0,29/123,14.97%,DLG2;NLGN1;ANK3;IQGAP1;LRRK2;EGFR;SYT1;RYR3;B2M;KCNH1;GLRA1;CARF;SYT10;ALOX5AP;PKD2;CPNE8;CPNE4;PRKN;RASGRP2;SLC25A24;TIGAR;ADCY8;GLRA2;TFR2;CDH1;CHP2;CRHBP;SYT3;SNCA
prerank,lipoprotein catabolic process (GO:0042159),0.48972660360497106,1.1984371105685199,0.23440453686200377,0.727468858293979,1.0,3/11,6.89%,CTSD;ABHD17C;PPT1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.4104929782786707,1.198352599759372,0.20877192982456141,0.7266342734908664,1.0,9/22,23.48%,GREM1;NBN;PDGFB;TNKS1BP1;TAOK2;GPNMB;DDX3X;RASSF2;CALM2
prerank,endothelial cell development (GO:0001885),-0.3818284789475532,-1.1981026203968326,0.19724770642201836,0.6757988062449425,1.0,10/25,25.77%,PDE4D;RAPGEF2;MYADM;PDE2A;PECAM1;MSN;ICAM1;EZR;TNMD;CNMD
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3365932627285675,-1.1979686654727348,0.16930022573363432,0.6747033572114512,1.0,13/45,13.67%,OAS2;CD44;CIITA;B2M;JAK2;SP100;IRF4;NCAM1;IFNGR1;VCAM1;PTAFR;GBP2;OAS3
prerank,regulation of ERAD pathway (GO:1904292),0.48795437513817674,1.1974236369953095,0.23440453686200377,0.728617197218858,1.0,3/11,7.38%,BAG6;USP25;USP19
prerank,protein phosphorylation (GO:0006468),0.2559015410025357,1.197376426690299,0.05620915032679739,0.7276081143877611,1.0,105/478,17.30%,TGFBR1;MERTK;NUAK1;TGFBR2;TLR7;ABI3;CSF1R;SMAD7;BMP2K;ULK2;CSNK1E;CDKL3;PIM2;MAP4K4;IGFBP3;RPS6KA1;PRKCA;PRKACA;TLR4;CHEK2;LYN;EFEMP1;CDK9;MAP3K3;TBCK;NEK6;IGF1R;CSNK2A2;CSNK2A1;SRC;ATM;MKNK1;PRKCD;MAP4K3;NEK3;CAMK1D;RYK;RPS6KA5;ULK3;STRADA;PTK2B;CSK;PDPK1;PDK1;PDGFB;NRBP1;CAMKK2;PKN3;VRK3;EPHA8;TSSK6;TSSK4;PIK3CD;MTOR;WNK1;PDK2;PRKCB;NUAK2;GRK2;DDR2;PDGFRB;PKDCC;EEF2K;MAP4K2;TAF1;PINK1;HCST;MUSK;MAP3K11;BAZ1B;NEK7;UHMK1;CDK11B;MARK2;MAP3K10;TAOK2;ABL1;BMX;MAPK8;MAST3;PXK;CCNE1;MORC3;LATS2;AKT1;MAPK14;DYRK4;DYRK1A;FAM20B;PICK1;STK39;PASK;MAP2K1;TEC;EIF2AK2;EIF2AK1;AURKA;LIPE;CDC42BPB;ACVR2B;ADAM10;MASTL;ULK1;RPS6KA4;TRIB1
prerank,Golgi to endosome transport (GO:0006895),0.442160654771683,1.1973070789004778,0.23639774859287055,0.7266319917858349,1.0,9/16,30.00%,AP2A1;SORT1;MON2;DOP1B;AP4M1;VPS13C;SYS1;GBF1;KIF16B
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2681099547661992,-1.1970648584995895,0.0782608695652174,0.6760634046270382,1.0,23/151,7.18%,CD74;CD44;CD36;EGFR;ADRA1A;FGF10;GAREM1;APP;DSTYK;CCR1;PTPN22;HTR2C;RAPGEF2;ROR1;NTRK2;PDGFD;NTRK3;APOE;PRKCZ;HTR2B;ERBB4;OPRM1;PDE8A
prerank,cell projection organization (GO:0030030),0.38545706804741803,1.1970530662670178,0.20173913043478262,0.7263102693850754,1.0,8/30,12.45%,P2RY12;RAC1;PLEK;RHOQ;RHOH;NCKAP1L;CYFIP1;CSPG5
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4659793628320054,1.1969943197586987,0.24635036496350365,0.7253640311356362,1.0,3/15,7.31%,SMOC2;LGMN;MET
prerank,regulation of cell development (GO:0060284),0.3657881829723042,1.196952911052588,0.2250453720508167,0.7243353469952951,1.0,3/36,2.47%,CX3CR1;HEYL;FBXO22
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4510976756749678,-1.1968459381393368,0.2281449893390192,0.6752083724735641,1.0,5/14,10.01%,CD74;RSAD2;DENND1B;PRKCZ;RARA
prerank,negative regulation of cation channel activity (GO:2001258),-0.38529389087759525,-1.1967103777262542,0.21153846153846154,0.6742019289401892,1.0,11/26,26.85%,GPR35;CALM1;CBARP;PKD2;GNB5;KCNE3;UBQLN1;EPHB2;CASQ2;CALM3;MMP9
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.46427610700975425,1.196305575953295,0.23679417122040072,0.7253102266170728,1.0,5/15,8.32%,EBI3;SHH;HSPH1;PNP;IL12B
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3894675381450836,1.1960946930076868,0.20640569395017794,0.7248206283079182,1.0,4/28,7.31%,NAV3;RAC1;NUMA1;MET
prerank,second-messenger-mediated signaling (GO:0019932),0.3181383732399325,1.1960812798521756,0.15737704918032788,0.7237159194169118,1.0,18/82,8.21%,CX3CR1;P2RY12;LAT2;PPP1R9B;PPP1R9A;TRPM4;AGTR2;CCL3;PLCG2;PDPK1;DGKD;CAMKK2;SELE;PLA2G4B;EDN3;CCR7;NOS2;EDN2
prerank,positive regulation of cytokine production (GO:0001819),0.2673274850094373,1.196066558820682,0.09396914446002805,0.7226032801155071,1.0,71/292,18.06%,IL18;TLR7;POLR3G;ARHGEF2;CADM1;CSF1R;CCDC88B;LGALS9;SLC7A5;DDIT3;AIF1;RIPK2;AGER;POLR2H;CYRIB;TLR4;EGR1;PIK3CG;PLCG2;EBI3;AFAP1L2;IL6ST;DHX9;CD86;CGAS;PNP;NLRP3;BRCA1;CCR7;NOS2;IL12B;ORM2;RAB1A;IL6R;POLR3H;GAPDH;PIK3CD;CD34;APPL1;IL12RB2;G3BP1;SCAMP5;LAMTOR5;LY9;RUNX1;HAVCR2;SERPINE1;IL33;ARNT;PTPN11;CEBPG;DRD2;MAVS;SOD1;PYCARD;MAPK14;CXCL17;POLR1C;POU2F2;OSM;EIF2AK2;IRF3;POLR2E;STAT6;GBP5;AGT;RAB7B;ROCK2;GATA3;TICAM1;SLC11A1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3725866921320707,1.1960228344449124,0.21621621621621623,0.7216164522869731,1.0,9/34,10.80%,ABI3;TWF2;RAC1;PIK3R1;CAPZB;FSCN1;AVIL;AKIRIN1;CYFIP1
prerank,potassium ion transport (GO:0006813),-0.27741314581173493,-1.1959999704047086,0.10164835164835165,0.6748382418950518,1.0,20/120,8.04%,KCND2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;NALCN;KCNMB2;KCNH1;SLC24A2;KCND3;KCNA6;KCNQ3;KCNAB2;PKD2;KCNH7;ATP1B3;KCNH5
prerank,positive regulation of cell division (GO:0051781),-0.3532350661114051,-1.1959217134795055,0.19413092550790068,0.6736042357747167,1.0,9/38,9.30%,CUL3;KIF23;RACGAP1;HTR2B;CDC42;GIPC1;KIF14;PKP4;AURKB
prerank,protein localization to chromatin (GO:0071168),-0.41549196566956303,-1.195657690456176,0.21940928270042195,0.6729836978774799,1.0,8/18,28.32%,MCM9;SGF29;PPHLN1;PIH1D1;MSH2;FAM47E;MCM8;PLK1
prerank,regulation of type I interferon production (GO:0032479),0.3162077284119687,1.1952914917991702,0.15924657534246575,0.7229509625745134,1.0,22/84,16.55%,POLR3G;RNF216;POLR2H;ITCH;OTUD5;UBA7;PCBP2;DHX9;CGAS;DTX4;POLR3H;GAPDH;UFD1;IRF8;G3BP1;PIN1;MAVS;NLRX1;POLR1C;IRF3;POLR2E;STAT6
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4308876136582026,1.1940794660690575,0.22711267605633803,0.7258985319124689,1.0,8/18,22.95%,EDN3;EDN2;GDNF;ABL1;AGT;NOD2;POR;PARK7
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3848813303635763,-1.1929210045318916,0.19817767653758542,0.6796935244422643,1.0,6/26,3.74%,DNAJC6;AP2A2;ITSN1;SNAP91;SIGLEC1;SGIP1
prerank,positive regulation of cartilage development (GO:0061036),-0.43012998355943466,-1.1927732959407567,0.2297872340425532,0.6787353033297201,1.0,9/17,32.22%,ZBTB16;SOX5;SCX;ACVRL1;BMP4;SOX6;BMPR1B;GDF6;BMP1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4572047152753786,1.192579525734655,0.23642732049036777,0.7297553428355947,1.0,5/15,12.97%,FAM98B;CSTF2;TSEN2;CPSF1;TSEN54
prerank,regulation of protein autophosphorylation (GO:0031952),0.3632973972541144,1.1922074309194057,0.22625215889464595,0.7297615713624396,1.0,13/36,23.48%,NBN;IMPACT;PDGFB;TNKS1BP1;PPP2R5B;ENG;TAOK2;GPNMB;PPP2R5A;DDX3X;ERRFI1;RASSF2;CALM2
prerank,regulation of dendrite extension (GO:1903859),-0.41585044830121065,-1.191952064998412,0.21875,0.6797471807930155,1.0,7/18,21.05%,RIMS2;SYT1;NEDD4L;SYT3;RIMS1;PLAA;CPNE6
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.39438030347668707,1.1913041622002838,0.2222222222222222,0.7316200936820443,1.0,9/29,15.24%,LGALS9;AIF1;AGER;JAM2;LGMN;C1QBP;CCR7;SERPINE1;CXCL17
prerank,actin filament-based transport (GO:0099515),0.4120548036504254,1.1907773119074343,0.22071307300509338,0.7321580128216953,1.0,8/21,16.30%,MYO1B;MYO1F;MYO1E;MYO7A;SUN2;MYO5B;MYO15A;WASL
prerank,ganglion development (GO:0061548),-0.4923816877822648,-1.1902605245830176,0.23736263736263735,0.6835865031635451,1.0,1/11,0.70%,UNC5C
prerank,negative regulation of locomotion (GO:0040013),-0.4689230755613317,-1.1900803185851754,0.24766355140186916,0.6827115067407927,1.0,3/12,7.84%,FRMD5;SPOCK3;PTPN2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.31762250600711217,-1.189723274094121,0.1710843373493976,0.6824690792337137,1.0,8/52,6.07%,RBFOX1;RBFOX2;NOVA1;KHDRBS2;PUF60;MBNL3;CELF6;RBFOX3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.25438934669336616,1.1893456736409305,0.054474708171206226,0.735959920400337,1.0,72/476,11.49%,TGFBR1;ZFHX3;SALL1;LRP5;MLXIPL;DNM2;RREB1;SMAD3;BICRAL;CAPN3;ETS1;QRICH1;PRMT2;HIVEP3;PIM2;YWHAH;MEF2C;DDIT3;LYL1;SOX8;KARS1;FLI1;RPS6KA1;PICALM;TGFB1I1;PPARD;ZFP90;FOXE1;CHEK2;VHL;TNNI2;DEAF1;EGR1;PAX6;ELK1;ATMIN;TFE3;CHD8;NFATC1;CREB3L2;CALCOCO1;FOXK2;TRIM44;AFAP1L2;ILF2;PDGFB;SHH;CAMKK2;JMJD6;FZD2;CXXC1;CD86;TRIM45;EGR2;BICRA;JUN;BRCA1;CNBP;SOX17;RXRB;INPP5K;KDM3A;NOTCH4;RNF20;MMS19;PRDM11;PITHD1;SMARCD3;NFYA;PAX2;RUNX1;SMARCA2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2700169367375381,1.1893317533055972,0.09278350515463918,0.7348631182306344,1.0,63/259,18.84%,SRGAP2;FGD2;OPHN1;ASAP1;EXOC7;P2RY12;RAC1;MAP4K4;AIF1;RILPL1;KIF3B;BBS9;PPP1R9B;EHD4;TTLL3;CEP162;PKHD1;RP2;UBXN10;HYLS1;FSCN1;ATP6V1D;CEP164;ARFIP2;DYNLT2B;CFAP52;TTC36;NME8;AVIL;RAB1A;CFAP221;MKS1;INPP5K;FGD3;INPP5E;NUDCD3;CYFIP1;CCDC28B;IFT52;GALNT11;SPATA13;BBS2;KIF27;CDC14B;IFT20;ATAT1;WDR90;PDE6D;CFAP20;KIF3A;TCTN1;PMP22;CD2AP;ARL3;CCDC66;PTPN23;EXOC6;VSTM5;OFD1;B9D1;CPLANE2;SSX2IP;TMEM17
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.38779664004928605,1.188983340789914,0.20869565217391303,0.734959396119001,1.0,5/27,3.48%,SIRPA;CCDC88B;ETS1;CYRIB;ITGB2
prerank,transepithelial transport (GO:0070633),0.4610431804609149,1.1884324301585407,0.23105360443622922,0.7356701433425518,1.0,6/15,24.88%,SLC1A3;CXADR;SLC23A2;SLC23A1;SLC26A6;GPLD1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.32505647238695984,1.1875768465962342,0.18927973199329984,0.7373819358361077,1.0,12/74,9.39%,TGFBR1;ARHGEF2;ITGA6;CFLAR;ITGAV;SRC;TRADD;RFFL;ZMYND11;BRCA1;GDNF;EYA3
prerank,long-term memory (GO:0007616),-0.408199623252915,-1.1875172967235623,0.23464912280701755,0.6877358775587262,1.0,9/19,24.15%,LDLR;CAMK4;CPEB3;APOE;RASGRF1;EIF2AK4;CALB1;SLC2A4;ARC
prerank,lymphocyte differentiation (GO:0030098),0.3249389575708831,1.1870957635298325,0.1830065359477124,0.7378018861564885,1.0,22/68,22.44%,BLNK;IKZF1;LYL1;GPS2;DNAJB9;CHD7;PLCG2;RHOH;JAG2;PIK3CD;AXL;CEBPG;RELB;HDAC5;TCF3;PTPRJ;GATA3;TPD52;CD79A;ADAM17;GPR89A;GPR89B
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4206677092948936,-1.1870249112484825,0.22894168466522677,0.6878980072433332,1.0,4/16,4.61%,CD36;KCNC2;GUCY1B1;APOE
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4119131149710811,1.1869673299343166,0.23062381852551986,0.7370654146208281,1.0,7/20,22.71%,DIP2B;RPS6KA5;BRCA1;RPS6KA4;ARRB1;NOS1;GLYR1
prerank,histone H2A monoubiquitination (GO:0035518),0.4408132080618412,1.186627403240684,0.2587800369685767,0.7370841588711973,1.0,9/17,27.60%,DDB2;BCOR;CUL4B;PCGF2;RNF2;KDM2B;RING1;PCGF3;PCGF1
prerank,positive regulation of cell development (GO:0010720),0.3826926561551399,1.186172043296094,0.21465968586387435,0.7374659892593471,1.0,5/31,10.43%,CX3CR1;NUMB;TGM2;GPER1;RGS14
prerank,DNA damage checkpoint signaling (GO:0000077),0.38810758500776776,1.185989156483215,0.23769100169779286,0.7369401819779157,1.0,8/28,13.62%,RHNO1;CHEK2;NBN;ATM;RAD17;USP28;RAD1;CEP63
prerank,pinocytosis (GO:0006907),0.5181106672761743,1.1858242624417314,0.2467289719626168,0.7363413670990807,1.0,6/10,26.95%,PPT1;RAB34;SNX5;PYCARD;DOCK2;SNX33
prerank,positive regulation of vasculature development (GO:1904018),0.3070215990205963,1.185684763705875,0.16638078902229847,0.7356698815809842,1.0,18/94,12.72%,SMOC2;HK2;ANXA3;ETS1;PRKCA;RHOB;VEGFB;PDPK1;MTDH;BRCA1;GATA2;PIK3CD;CD34;PRKCB;RAPGEF3;RUNX1;SERPINE1;PDCD6
prerank,regulation of pH (GO:0006885),0.48310819518416115,1.185506352900049,0.2495201535508637,0.7351128485044153,1.0,3/11,11.69%,ATP1A4;PDK2;ATP6V0A4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.39536498916539065,-1.1852923904848083,0.2112676056338028,0.6903505103009653,1.0,6/23,9.30%,DAB2;ING2;SDCBP;GIPC1;HIPK2;ZEB2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.39536498916539065,-1.1852923904848083,0.2112676056338028,0.6903505103009653,1.0,6/23,9.30%,DAB2;ING2;SDCBP;GIPC1;HIPK2;ZEB2
prerank,steroid metabolic process (GO:0008202),0.3211139631337327,1.1852096798831961,0.1531986531986532,0.7350617109392934,1.0,15/72,16.59%,FDXR;HSD3B2;HSD17B1;LGMN;DHRS4;SHH;CYP46A1;AKR1D1;SULT2A1;NPC1;CYP7B1;TSPO;FDX1;HSD17B10;CYP2R1
prerank,skin development (GO:0043588),0.32799656331668575,1.1846848625112758,0.18666666666666668,0.7357177199388166,1.0,10/65,11.38%,ITGA6;ALOXE3;DSP;CERS3;ST14;MET;SPRR1A;LSR;ASAH1;DLL1
prerank,response to progesterone (GO:0032570),0.43713068508553127,1.1843793069218855,0.22580645161290322,0.7356768437046417,1.0,7/18,23.67%,SRC;UBE3A;THBS1;ACOD1;WBP2;CATSPER2;TGFB1
prerank,rRNA methylation (GO:0031167),0.41544421552445376,1.183905506909581,0.23497267759562843,0.7361112240252784,1.0,9/22,21.23%,EMG1;BUD23;NSUN5;METTL5;FTSJ3;NSUN3;TFB1M;NSUN4;FBL
prerank,lipid modification (GO:0030258),-0.349213993190557,-1.1838479315078068,0.21064814814814814,0.6932883955379991,1.0,8/37,8.14%,PLA2G7;DGKB;PLPPR4;PLPP5;DGKI;PLPP4;ALOX5;PLPPR1
prerank,negative regulation of immune effector process (GO:0002698),-0.45344448697062656,-1.1838103716615553,0.24672489082969432,0.6919532085437383,1.0,2/13,1.72%,CD47;LILRB1
prerank,protein neddylation (GO:0045116),-0.44982599133222023,-1.183698761861741,0.2520833333333333,0.6908594699247469,1.0,4/13,16.63%,DCUN1D2;UBA3;DCUN1D3;UBE2M
prerank,regulation of TORC1 signaling (GO:1903432),0.3733059912845335,1.1836575283053563,0.22105263157894736,0.7358106764335245,1.0,12/33,23.59%,ATM;FLCN;PIP4P1;GPR137C;LAMTOR5;RRAGA;GPR137;CASTOR1;SEH1L;SESN1;DEPDC5;TELO2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.41094476272817093,1.1836416225319184,0.24725274725274726,0.7347534608507249,1.0,5/21,17.58%,CX3CR1;SMARCD3;DRD2;PROX1;KDM1A
prerank,regulation of mitochondrion organization (GO:0010821),-0.3246631760060193,-1.1835984931527295,0.18990384615384615,0.6897104329677213,1.0,11/47,10.02%,PID1;LRRK2;IAPP;DNM1L;GSK3B;PARL;GOLPH3;PRKN;FIS1;MFF;RHOT2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.44730701143868135,-1.183222077630283,0.23694779116465864,0.6894918539574094,1.0,3/13,8.98%,LRRK2;SCFD1;SMCR8
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3268527293727546,1.183173739876372,0.2012987012987013,0.7351919623640395,1.0,18/64,24.07%,DAGLB;ALOXE3;ACAD9;ACSL4;PLA2G4A;HPGD;PLA2G4B;SLC27A4;FADS1;GPX4;CPT1A;DAGLA;HACL1;ABCD1;ACOT1;ACOT8;SCP2;ACOT4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.292470172757659,-1.183155796242335,0.1717948717948718,0.6882530625340385,1.0,15/90,9.18%,ESRRG;CCR2;KSR2;CD36;FABP4;JAK2;PLAC8;IRF4;CEBPB;ADIPOR2;PER2;ZBTB7B;THRA;G0S2;GRB10
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.42483538346627747,-1.1829970995686157,0.24282560706401765,0.6873246959089863,1.0,6/16,19.38%,VIM;WNT4;SCX;RGCC;BMP4;SUCO
prerank,neurotransmitter uptake (GO:0001504),0.47984487373215556,1.1827806713540672,0.2495446265938069,0.7353695531596856,1.0,5/12,16.96%,SLC1A3;SLC22A2;SLC29A4;SLC29A1;SLC38A1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.447195503419407,1.182709001773786,0.24545454545454545,0.7345051752823782,1.0,7/16,17.68%,FLCN;PIP4P1;GPR137C;LAMTOR5;RRAGA;GPR137;SEH1L
prerank,central nervous system development (GO:0007417),-0.24498964929788017,-1.1824158373997449,0.05592105263157895,0.6875456614600478,1.0,54/250,15.77%,CNTNAP2;ZBTB16;NFIB;ADGRL3;SPOCK1;NRCAM;GRIN2B;GRIN2A;SLC8A3;GSN;POMK;TPPP;JARID2;ADAM22;WWP1;MYRF;CNTN6;IL1RAPL2;DCLK1;VIT;SOX11;ATP6AP2;POU6F2;NR4A2;COL4A1;SH3GL2;CDK5RAP2;EML1;PKD2;PRKN;PBX1;HSPG2;ECRG4;LIG4;VCAN;GRIN2D;PBX3;PLXNB2;ZFHX2;DDIT4;GRIK1;SERPINI1;MFSD2A;MAL;ALDH3A2;AHI1;MDGA1;PKD1;ZIC5;SCYL2;CYP26C1;AFF2;RELN;NKX2-2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.389210107765505,1.1823157535314892,0.24471830985915494,0.7347004167831487,1.0,6/25,13.15%,HK2;PFKL;FOXK2;PGK1;GAPDH;PGAM1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4650039362856867,-1.1821474735998558,0.23595505617977527,0.6869088511323495,1.0,2/12,2.37%,SORBS1;IRS1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5002740036327826,1.1821137501102068,0.2835249042145594,0.7342552861102929,1.0,2/11,2.90%,PJA2;LYN
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.29282980056160995,-1.1818911273083281,0.15135135135135136,0.6863436162901949,1.0,28/83,22.93%,POLA1;CDK14;TFDP2;CDK7;CUL3;LATS1;PLK2;PPP6C;CACUL1;USP29;BCAT1;CDK15;CDKN2A;DBF4;CDKN1A;GPR132;NASP;CDK2;SPDYA;E2F1;NPAT;CDK4;TFDP1;USP26;EIF4EBP1;RPS6KB1;CCNH;BACH1
prerank,glycerolipid catabolic process (GO:0046503),0.4232202927759485,1.181720125481519,0.21942446043165467,0.7344860644562033,1.0,4/19,10.94%,ABHD12;PLA2G4A;PLA2G4B;ABHD6
prerank,regulation of JNK cascade (GO:0046328),0.2999990351439057,1.1816727478390268,0.17142857142857143,0.733525794917196,1.0,24/101,15.96%,SIRPA;MAP4K4;PJA2;AGER;ITCH;GPS2;IGF1R;TRAF5;CD27;PTK2B;ZMYND11;KLHL31;CCR7;EDA2R;WNT7B;MAP4K2;PINK1;MAP3K11;MAP3K10;TAOK2;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.34087414386809106,-1.1816630818087317,0.21232876712328766,0.6855860387079532,1.0,13/38,21.66%,KNL1;CENPT;CENPP;MIS18BP1;ASF1A;CENPW;H3-3A;RBBP7;NASP;CENPS;NPM1;HAT1;OIP5
prerank,cytoskeleton organization (GO:0007010),0.2975597557315743,1.181548277039157,0.16908212560386474,0.7327745135995486,1.0,18/114,6.48%,BIN1;FGD2;DST;RAC1;RND1;ARAP3;ZRANB1;CAPZB;FMNL3;RANBP10;RHOB;CCL3;RHOBTB1;CAMSAP1;PLD2;RND2;RHOH;SIPA1
prerank,actin polymerization or depolymerization (GO:0008154),-0.3238821055892537,-1.1811866067896095,0.18097447795823665,0.6856537357928351,1.0,12/50,10.09%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;DIAPH3;JAK2;DSTN;MICAL3;WASF1;MSRB1;ABI2;VILL
prerank,regulation of establishment of protein localization (GO:0070201),0.4673741604099516,1.1807701125693273,0.2630597014925373,0.7342721661579177,1.0,5/13,19.41%,CTSD;SPIDR;CEP295;CEP135;PTP4A3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3214190194914848,1.1803419759531022,0.1794871794871795,0.7345957789346127,1.0,13/67,10.80%,ELMO1;VAV2;RAC1;PIK3R1;ITGAV;SRC;SHB;VEGFB;PTK2B;AXL;NCKAP1L;PIK3CB;CYFIP1
prerank,receptor metabolic process (GO:0043112),0.34199735431156375,1.1788410108113276,0.20032310177705978,0.7384989508586042,1.0,11/53,10.71%,DNM2;PHETA1;CD9;ARRB2;PICALM;SMURF1;ITGB2;LGMN;SH3GLB1;LRP1;GRK2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3321859534896955,-1.1786643605805949,0.2037037037037037,0.6921265261882364,1.0,9/40,9.03%,RIMS2;SYT1;UNC13C;SNPH;SYT10;PCLO;SNAP25;CPLX2;RAB3A
prerank,regulation of interleukin-4 production (GO:0032673),0.40617150992898604,1.1784380784707245,0.21808510638297873,0.7387151547072391,1.0,6/21,11.73%,LGALS9;SLC7A5;DDIT3;CD86;NLRP3;HAVCR2
prerank,copper ion transport (GO:0006825),-0.4684249884208249,-1.1776875800426803,0.2488479262672811,0.6936345824759556,1.0,5/11,26.56%,ATP7A;SLC31A2;STEAP4;CUTC;STEAP3
prerank,regulation of striated muscle contraction (GO:0006942),-0.3708567997045205,-1.177614934941571,0.20620842572062084,0.6924470868119049,1.0,5/27,5.30%,DMD;ANK2;SLC8A3;RYR2;CALM1
prerank,phospholipid metabolic process (GO:0006644),0.3226750839341635,1.1775739063148591,0.1941747572815534,0.7404687743105874,1.0,17/71,13.95%,ABHD12;LPCAT4;PLA2G4A;PLA2G15;PIP4P1;PLA2G4B;PLB1;LCAT;SMPD2;PLA2G5;PLPP1;PLPP2;MBOAT1;FADS1;GPX4;PLBD2;PLPPR2
prerank,regulation of microglial cell activation (GO:1903978),-0.44099759819792356,-1.1774160410211274,0.23399558498896247,0.6916984365025849,1.0,5/15,15.87%,STAP1;LDLR;MMP8;CX3CL1;TTBK1
prerank,keratan sulfate metabolic process (GO:0042339),0.38319182869145424,1.176849055058541,0.2396551724137931,0.7418286174863119,1.0,7/31,8.34%,ST3GAL6;HEXB;B3GNT2;PRELP;CHST1;HEXA;B3GNT4
prerank,N-terminal protein amino acid modification (GO:0031365),0.4542888408295681,1.176626070535278,0.2662835249042146,0.7414699788712886,1.0,6/14,24.31%,NAA11;NAA50;NAA40;METAP2;METAP1D;NAA60
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4192736111659927,1.1763827005773144,0.22852233676975944,0.741224184011919,1.0,8/21,15.32%,CHST11;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;CHSY1
prerank,negative regulation of cell adhesion (GO:0007162),-0.29617883606645096,-1.1759755985997293,0.18811881188118812,0.6947287915862954,1.0,23/72,16.08%,SPOCK1;PLXNC1;ADAM22;SEMA5A;RIPOR2;PLXND1;PLXNA2;ERBB3;PLXNB2;CDH13;SPN;ITGB1BP1;PODXL;JAM3;CDH1;JAG1;CBLL1;PLXNB1;ACVRL1;DACT2;CX3CL1;ARHGDIA;SNAI2
prerank,regulation of neurogenesis (GO:0050767),0.3283066088612911,1.1755123376371035,0.19439868204283361,0.7431119803003227,1.0,8/55,11.38%,CX3CR1;NUMB;HEYL;TGM2;PAX6;GPER1;RGS14;DLL1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.36649472190907667,-1.1753420374284609,0.21261682242990654,0.6953102715561792,1.0,8/29,9.03%,GRIK2;SHISA9;SHISA6;APP;APOE;SLC4A10;NETO1;RAB3A
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.32467931076179335,-1.1751319439952685,0.21271393643031786,0.6945739186144892,1.0,22/46,22.48%,ATRNL1;ITGA4;TMEFF2;ITGB7;FN1;KIF14;LAMB2;MEGF9;ITGA8;SRCIN1;NTNG1;NTNG2;FER;LAMA5;TEK;PARVG;LAMC3;RADIL;PARVB;PEAK1;NTN4;MICALL2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4818200488407295,1.1741812025718295,0.2646502835538752,0.7465513845739791,1.0,3/11,10.04%,DDIT3;ATF3;MBTPS2
prerank,positive regulation of cell motility (GO:2000147),0.27536267255803987,1.1741810197678468,0.13561847988077497,0.7454470186204672,1.0,51/205,19.73%,TGFBR1;NUMB;CSF1R;ITGA6;SEMA3B;MAP4K4;VSIR;AIF1;PRKCA;FERMT3;SEMA4C;IGF1R;ATM;CCL3;SEMA4G;TRADD;PTK2B;SPRY2;PDGFB;GCNT2;SUN2;DUOX1;CCR7;GPER1;SEMA3G;TWIST2;PIK3CD;TJP1;MGAT5;PDGFRB;STX4;SEMA4D;SMO;CIB1;CFAP20;MAPRE1;CSF1;GPNMB;PIK3R3;PDCD10;LAMC2;ADAM10;CCAR1;ROCK2;THBS1;MIEN1;CLDN1;PPM1F;SEMA3D;CEP43;CCL24
prerank,regulation of interleukin-10 production (GO:0032653),0.35433227998809086,1.1739441635875982,0.20840336134453782,0.7451617918815278,1.0,10/44,11.38%,LGALS9;VSIR;AGER;TLR4;PLCG2;TNFRSF21;PDCD1LG2;IL12B;CD34;DLL1
prerank,regulation of ion transport (GO:0043269),-0.3006155214724574,-1.1737806752714026,0.17783505154639176,0.6972809455301978,1.0,18/76,14.97%,NKAIN2;ANK3;SYT1;KCNJ3;B2M;NEDD4L;SYT10;TOR1A;PRKN;SPTBN4;SIK1;CHRNA4;ATP1A1;DTNBP1;NKAIN3;PER1;SYT3;SNCA
prerank,negative regulation of synaptic transmission (GO:0050805),-0.38602236174154547,-1.1735172185384573,0.23529411764705882,0.6968075604546604,1.0,7/23,15.92%,LRRK2;ATAD1;SLC24A2;MTMR2;PLK2;ACHE;GRIK3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.31636856230836785,1.1734681527995006,0.18940609951845908,0.7456419227208264,1.0,19/73,16.69%,ELMO1;VAV2;RAC1;PIK3R1;LYN;SRC;PRKCD;PLCG2;PLA2G6;PLD2;NCKAP1L;PIK3CB;CYFIP1;ARPC1A;ABL1;WIPF2;ARPC3;WASL;MYH2
prerank,regulation of hippo signaling (GO:0035330),-0.4155182981969485,-1.1732267572016837,0.2462526766595289,0.6963226123370191,1.0,4/17,4.37%,MOB3B;LIMD1;MARK3;SOX11
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4814198620622347,1.173169169461153,0.26394052044609667,0.7456182890821441,1.0,4/12,6.32%,BIN1;DSP;TRPM4;DSG2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.35675150443548004,1.1730226100007723,0.2065972222222222,0.7450082486706071,1.0,10/40,16.13%,GNA12;SMURF1;CSNK2A2;CSNK2A1;CLU;PTK2B;ARAF;TAF1;UBE3A;CCDC22
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4393763029155568,1.172668519764645,0.2591240875912409,0.7451187780658496,1.0,6/16,17.35%,ULBP1;RAET1E;TUBB;PLEKHM2;CEBPG;VAMP7
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.25852213639432897,-1.172096831514568,0.1232876712328767,0.6983286315617553,1.0,57/168,20.91%,SAMD4A;RPL36A;PPP2R2A;RPS29;RPL30;RPL35A;RPS3;RPS7;RPL4;RPS2;RPLP2;RPL7A;SMG7;RPL41;RPL26;XRN2;PABPC1;EIF3E;RPS27;TUT4;RPL18A;RPS25;EIF4A3;SMG6;MRTO4;SMG5;RPL38;RPL37;PPP2R1A;RPS14;ERI1;LSM1;RPS15A;RPL24;EXOSC7;HELZ2;RPS9;TENT2;CNOT10;RPLP1;RPL22;RPL8;RPLP0;RPS12;SMG1;TUT1;RPS10;RPL19;PATL1;RPL13A;RPS6;RPS5;RPS19;POLR2G;RPL23A;UPF1;RPL29
prerank,positive regulation of dendrite extension (GO:1903861),-0.4158636507301736,-1.171887483174503,0.2398190045248869,0.6975706199645164,1.0,7/17,21.05%,RIMS2;SYT1;NEDD4L;SYT3;RIMS1;PLAA;CPNE6
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.29076168483152803,1.1711831697477304,0.16463414634146342,0.7490261225081905,1.0,26/119,15.73%,INPP5D;PI4KB;PIK3R1;TMEM150A;PIK3CG;PLCG2;PIGV;PIK3C3;RAB4A;PGAP2;SOCS6;DPM3;INPP4B;PIK3CD;INPP5K;PIK3CB;INPP5E;MTMR14;PLEKHA4;PIGO;MTMR4;BMX;IMPA1;CDS1;PITPNM1;PIK3R3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.33040648505210884,1.1711775570657192,0.21926910299003322,0.7479445396196478,1.0,15/63,18.17%,TGFBR1;ITGA6;CFLAR;ITGAV;SRC;AGTR2;TRADD;ZMYND11;GPER1;STX4;PYCARD;BCL2L14;TNFRSF12A;AGT;THBS1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.40459715441329985,1.1711281810705387,0.23518850987432674,0.7470002049058357,1.0,4/21,7.34%,SNTA1;KCNA5;SCN4B;NOS1AP
prerank,regulation of pseudopodium assembly (GO:0031272),0.5042695906351781,1.1709903050721042,0.27090909090909093,0.7452790268927866,1.0,3/10,17.33%,CDC42EP2;CCR7;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5042695906351781,1.1709903050721042,0.27090909090909093,0.7452790268927866,1.0,3/10,17.33%,CDC42EP2;CCR7;CDC42EP3
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4560278533436248,1.1708885696584155,0.283495145631068,0.7445391960262349,1.0,8/14,26.13%,PIK3R1;LYN;PTPN1;GHR;STAT6;PXN;STAT5B;STAT3
prerank,positive regulation of heart rate (GO:0010460),-0.4271724688413183,-1.1707639904632248,0.24476987447698745,0.699587186624435,1.0,4/17,3.95%,PDE4D;ADRA1A;RYR2;ATP2A2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.380651301644936,-1.1706917049499552,0.23042505592841164,0.6984348096615665,1.0,6/23,9.47%,KIF5C;CCDC88C;KIF1B;DYNC1I2;KIF5B;CCDC88A
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3028010377840162,-1.1706907652039902,0.1855421686746988,0.6970528339780888,1.0,17/67,14.78%,CACNA1E;ITPR1;KCNC2;DPP4;HTR2C;RFX3;SLC8B1;CACNA1C;ALOX5;SNAP25;PER2;ADRA2A;CLOCK;TFR2;FFAR1;CCL5;CRHBP
prerank,lysosome localization (GO:0032418),0.35666100249584515,1.1705535379313554,0.22508591065292097,0.7445249634547901,1.0,8/37,10.13%,KXD1;MYH9;PIK3CG;FLCN;PIP4P1;PIK3CD;PLEKHM2;RAB34
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.36784090765985633,1.1703202407488988,0.24113475177304963,0.7442265992173155,1.0,9/35,13.42%,F11R;ABI3;CSF1R;BAIAP2L2;TRPM2;PTK2B;TJP1;RAPGEF3;ABL1
prerank,protein stabilization (GO:0050821),0.27807560431309764,1.1699331518122382,0.13818722139673106,0.7444622720412796,1.0,34/168,15.33%,HPS4;BAG6;SUMO1;SMAD7;PIM2;COA8;PIK3R1;SEL1L;CHEK2;VHL;PHB2;PRKCD;CLU;TRIM44;STX12;MDM4;SWSAP1;USP19;FLOT2;WNT10B;SOX17;GAPDH;USP36;PEX6;TAF1;PINK1;HIP1R;PIN1;CCT3;NAPG;MFSD1;MORC3;BAG4;TNIP2
prerank,positive regulation of angiogenesis (GO:0045766),0.29498890992125487,1.1693846748500094,0.17346938775510204,0.7452087849300526,1.0,20/108,12.72%,SMOC2;HK2;ANXA3;ETS1;PRKCA;RHOB;VEGFB;PDPK1;MTDH;BRCA1;GATA2;PIK3CD;CD34;TJP1;PRKCB;DLL1;RAPGEF3;RUNX1;SERPINE1;PDCD6
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4645305561786438,-1.1680738574090899,0.2835820895522388,0.7040081144884075,1.0,3/12,7.52%,DMD;ANK3;ATP1B3
prerank,aorta development (GO:0035904),-0.43000259743035996,-1.1679090970715609,0.25,0.703136382900227,1.0,8/14,28.92%,ROBO1;PKD2;JAG1;PDE2A;APLNR;ROBO2;TBX1;ADAMTS9
prerank,positive regulation of metabolic process (GO:0009893),-0.2802656565025954,-1.1679031195826572,0.1407035175879397,0.7017665592521983,1.0,21/103,14.89%,ESRRG;CCR2;KSR2;CD36;FABP4;JAK2;PLAC8;IRF4;CEBPB;ADIPOR2;PER2;ZBTB7B;THRA;G0S2;GRB10;PRDM16;JCHAIN;ACHE;ALMS1;TSHR;AGPAT1
prerank,regulation of endocytic recycling (GO:2001135),-0.4752129883826279,-1.167840422779406,0.2762312633832976,0.7005683468553594,1.0,4/11,17.37%,EHD1;ACTN2;INPP5F;EHD2
prerank,smooth muscle tissue development (GO:0048745),0.496724098648555,1.1675453075283322,0.2640449438202247,0.7502761811581935,1.0,5/10,23.20%,SHH;ENG;SMO;PROX1;PTCH1
prerank,regulation of cell projection organization (GO:0031344),0.46735468594190416,1.1675187840434293,0.2467289719626168,0.749285726437515,1.0,5/13,13.59%,SPRY2;MOV10;MACF1;ERMN;SEMA4D
prerank,cartilage development (GO:0051216),-0.32036445540933356,-1.1674717404456052,0.19809069212410502,0.7002665103759095,1.0,13/49,16.84%,ZBTB16;NFIB;CD44;SULF2;SOX5;SNX19;ATP7A;FGFR3;RUNX2;PKD1;SCX;CCN3;BMP4
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3438889437906731,-1.1674426095276556,0.2266355140186916,0.698991273482838,1.0,6/35,3.74%,HIP1;MKLN1;BICD1;B2M;SNAP91;SGIP1
prerank,positive regulation of protein processing (GO:0010954),-0.3957969965914775,-1.1661891933439676,0.22466960352422907,0.7013770159148309,1.0,3/19,1.94%,NLRC4;CCBE1;GSN
prerank,immunoglobulin mediated immune response (GO:0016064),-0.491393556959295,-1.1660223826220286,0.27313769751693,0.7005412537536841,1.0,5/10,22.59%,CD74;FCGR2B;TLR8;GAPT;CD19
prerank,glycine transport (GO:0015816),0.5008351238219528,1.1659122897843281,0.29980276134122286,0.7536659372672262,1.0,3/10,13.12%,SLC7A8;SLC36A1;SLC6A9
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3156451663243207,1.165816224412716,0.17520661157024794,0.7529032793848965,1.0,20/75,17.63%,LRP5;PKIG;UCHL1;INCA1;LYN;PRKCD;SLC8A1;SPRY2;CDK5RAP1;INPP5K;PIK3CB;RGS14;RASIP1;PTPN1;ABL1;LATS2;PYCARD;AKT1;AGT;PTPRJ
prerank,mRNA transport (GO:0051028),0.2990179888076401,1.1654583186199157,0.18195488721804512,0.7529793547785156,1.0,29/101,21.63%,SRRM1;NCBP1;RANBP2;MAGOHB;MAGOH;U2AF2;NUP42;DHX38;ZFP36L1;SEC13;SRSF5;NUP50;CPSF1;NUP35;RBM8A;NUP88;U2AF1L4;SLU7;FIP1L1;ALYREF;ALKBH5;NUP62;SEH1L;NUP107;THOC6;HNRNPA2B1;SRSF9;DDX19B;DDX39B
prerank,epidermis development (GO:0008544),0.3287533437075277,1.1642625602256156,0.19237147595356552,0.7559678186183649,1.0,18/56,25.77%,DSP;ATP2C1;CERS3;FLOT2;OVOL2;EDA2R;SPRR1A;DLL1;LAMA3;LAMC2;KRTDAP;SPINK5;TGM5;SVEP1;CRABP2;PTHLH;FGFR2;GRHL3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4234814893043801,1.1637000193976432,0.28,0.7567169359205217,1.0,3/18,2.02%,BAG6;DDIT3;PIK3R1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.31209543347746227,1.1636829331792158,0.20302013422818793,0.7556992322101742,1.0,14/76,9.79%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;LRRC19;TRADD;TRIM44;CD86;NLRP3;IL12B;LIMS1;RTKN2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.48352904353297355,-1.1635248374270792,0.2863157894736842,0.7071717812144269,1.0,3/10,7.40%,SH3RF1;IRF4;ZBTB7B
prerank,actin crosslink formation (GO:0051764),-0.46516533601774424,-1.1633925131636516,0.26143790849673204,0.706173053204421,1.0,3/12,3.38%,EPS8;GAS2;GAS2L3
prerank,vasculogenesis (GO:0001570),0.37626393907663924,1.1633913953264279,0.2538860103626943,0.7556266085340668,1.0,8/32,16.00%,TGFBR2;SHH;SOX17;WNT7B;RASIP1;PDGFRB;ENG;CCM2
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.37663525191055003,-1.1633614606051306,0.23766816143497757,0.7048838228761681,1.0,8/23,18.75%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;GPSM2;ITGB1;NSFL1C
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3938900618397002,-1.162738402402443,0.23851203501094093,0.7054461319411486,1.0,4/20,4.99%,RSAD2;B2M;DENND1B;PRKCZ
prerank,wound healing (GO:0042060),0.3246859188269825,1.1625779606107463,0.21510673234811165,0.757265323472364,1.0,9/62,7.48%,TGFBR1;DST;SMAD3;CFLAR;DSP;MYH9;TRIM72;MACF1;MIA3
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5068107694250881,1.1613860564766474,0.27184466019417475,0.7600766656795135,1.0,3/10,21.68%,IMPACT;ENG;ERRFI1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2363504619578343,1.1609527076850994,0.04171364148816235,0.7604334861338121,1.0,221/1082,18.52%,TGFBR1;MAML3;ZFHX3;SALL1;IL18;ETV5;ARHGEF2;LRP5;MLXIPL;DNM2;RREB1;SMAD3;BRD8;BICRAL;GREM1;SMAD7;ITGA6;CAPN3;ETS1;QRICH1;NFE2L2;PRMT2;HEYL;HIVEP3;PIM2;YWHAH;MEF2C;DDIT3;CEBPZ;LYL1;PIK3R1;SOX8;KARS1;FLI1;RIPK2;SKI;FOXJ2;RPS6KA1;SBNO2;PICALM;TGFB1I1;UBP1;SIRT2;PPARD;ZFP90;MLXIP;FOXE1;TLR4;CHEK2;KMT2D;AKAP8L;GPS2;VHL;CDK9;LPIN2;TNNI2;DEAF1;RHOQ;NKX2-8;EGR1;ATM;MEF2D;PAX6;ELK1;AATF;ATMIN;FLCN;MEIS3;TFE3;CHD8;NFATC1;CREB3L2;ELK3;MYSM1;CALCOCO1;RPS6KA5;AKIRIN2;RPS27A;UBC;MLX;FIZ1;PADI2;FOXK2;TRIM44;RBM14;ATF3;ZBTB18;AFAP1L2;TET3;ILF2;PDGFB;TAF6L;TAF6;DHX9;SHH;CAMKK2;JMJD6;FZD2;SIN3A;CXXC1;CD86;TRIM45;EGR2;MET;MED19;NLRP3;BICRA;JUN;BRCA1;CNBP;GATA2;ABRA;SPAG8;GDNF;GPER1;CITED4;SOX17;POU4F1;RPTOR;DPF2;TMPRSS6;AKIRIN1;MOSPD1;HMGN1;DDX17;RXRB;MEF2A;MTOR;INPP5K;NR2F1;BCL9;KDM3A;NOTCH4;RNF20;IRF8;FHOD1;MMS19;E2F2;PRDM11;CRTC1;MAML2;ZSCAN21;PITHD1;SMARCD3;SMARCA5;NRF1;NFYA;DLL1;PAX2;RUNX1;SMARCA2;SERPINE1;CCDC62;MAP3K2;DPF1;IL33;MED10;ENG;ARNT;RLF;MED4;BLM;E4F1;CEBPG;ABL1;PIN1;RNF187;POGZ;MAVS;SNX5;ZIC1;HDAC5;NFATC2IP;ZBTB48;PRDM2;TAL1;CSRNP2;AKT1;ALYREF;MLLT6;NCOA3;DYRK1A;PROX1;TNIP2;ZMIZ2;MAP2K1;NRIP1;POU2F2;TCF3;OSM;IRF3;WASL;MED25;AKNA;STAT6;ZMIZ1;DTX3L;HDAC8;AGT;RPS6KA4;FZD1;MAPK7;GLMP;NUP62;ARRB1;FANK1;KDM1A;POU2F1;GATA3;RNF4;KDM8;KAT5;HMGB2;SLC11A1;ARID1A;LPIN1;LMO1;EDRF1;SSBP4;PPRC1;MITF
prerank,retrograde axonal transport (GO:0008090),-0.42533605869420876,-1.1607785335570355,0.25327510917030566,0.7099019309433486,1.0,4/16,13.25%,DLG2;ACTR10;KIF5B;TMEM108
prerank,myeloid cell activation involved in immune response (GO:0002275),0.41733063251427366,1.1606560487582396,0.2936936936936937,0.7603940723537151,1.0,5/18,15.96%,KARS1;SBNO2;PLCG2;PYCARD;SLAMF1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3742893630839223,1.1605696747237657,0.2560747663551402,0.7596063781967703,1.0,5/28,8.42%,CX3CR1;SIRPA;RAC1;NOS1AP;AVIL
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2851093619924873,-1.160240850563994,0.15342465753424658,0.7101800816732406,1.0,20/93,12.59%,DMD;PDE4D;CD44;EGFR;NCK2;BDNF;APP;LATS1;CREBL2;NTRK3;NLRP2B;AXIN1;IRGM;INPP5J;SPTBN4;NSD1;OPRD1;DDIT4;PAQR3;RAF1
prerank,regulation of dendritic spine development (GO:0060998),-0.3994111468643871,-1.1602079474993736,0.26939655172413796,0.7089004621797119,1.0,6/19,6.86%,NLGN1;PPFIA2;CPEB3;SHANK3;APOE;GRIN3A
prerank,long-chain fatty acid import into cell (GO:0044539),-0.47138058599656824,-1.1601020963926547,0.2762312633832976,0.7078435043883519,1.0,6/10,30.89%,CD36;ACSL3;ACSL1;RPS6KB1;SPX;SLC27A5
prerank,proton transmembrane transport (GO:1902600),0.36060170574661166,1.1600960477590023,0.23793103448275862,0.7600951751578469,1.0,9/36,17.38%,SLC36A1;ATP1A4;HVCN1;SLC25A27;ATP6V0A4;ATP5PO;NNT;ATP6V0E2;SLC25A14
prerank,mitotic spindle organization (GO:0007052),-0.2599109618777968,-1.1595594213450209,0.12540192926045016,0.7082566077500346,1.0,39/153,17.93%,KNL1;CENPF;DYNC1I2;CENPT;KIF23;CDCA8;CENPP;ZW10;SPDL1;NUP98;EML1;TOGARAM2;TPX2;BIRC5;RAN;CENPE;NDC80;PLK2;RPS27;BUB1B;SPC25;KNTC1;AURKB;DLGAP5;MAP9;PRC1;KIF11;BUB1;TTK;GPSM2;ERCC6L;NUP43;DCTN6;MAD1L1;RCC2;CENPS;CCNB1;KIF4A;SPC24
prerank,dendritic cell migration (GO:0036336),-0.4187730814739976,-1.159444116653032,0.26096491228070173,0.7072858131850475,1.0,4/16,6.03%,EPS8;CCR2;CCR1;ALOX5
prerank,response to muramyl dipeptide (GO:0032495),0.4653352333270605,1.159412929257513,0.2900355871886121,0.7613813369477728,1.0,2/12,2.20%,ARHGEF2;RIPK2
prerank,sterol transport (GO:0015918),-0.3994117428098454,-1.1589715757052146,0.2662192393736018,0.7073277997215076,1.0,3/19,3.24%,MSR1;CD36;LDLR
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.35764068225460843,1.1585669245898282,0.22758620689655173,0.763074319285843,1.0,8/38,8.41%,BIN1;KCNA5;CACNB2;DSP;TRPM4;SCN4B;DSG2;KCNH6
prerank,tRNA aminoacylation (GO:0043039),0.3591980429337638,1.158333112650992,0.23769100169779286,0.7627829175946242,1.0,17/37,29.09%,KARS1;NARS1;SARS2;SARS1;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2;MARS2;AIMP1;TARS1;GATC;WARS1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.49162073830069736,1.1582208366054756,0.27984344422700586,0.7620931990561659,1.0,5/10,16.30%,LRCH1;PADI2;MIA3;AKT1;WASL
prerank,positive regulation of B cell proliferation (GO:0030890),-0.35353849764092476,-1.1578669044781926,0.23732718894009217,0.7093674314629898,1.0,4/29,3.28%,VAV3;CD38;CD74;CD40
prerank,regulation of calcium ion transport (GO:0051924),-0.31200881497101884,-1.1574311273109144,0.23529411764705882,0.7094016377012792,1.0,16/54,15.35%,ANK2;LILRB1;ATP2B1;CCR1;PLPP4;SLC8B1;HOMER1;PKD2;STIM2;IL16;ADRA2A;FFAR1;EPB41;LILRA5;CCL5;BCL2
prerank,response to alcohol (GO:0097305),0.3779106220081544,1.1574136254451854,0.2623239436619718,0.7636635366892748,1.0,7/27,14.34%,TGFBR1;TGFBR2;HSD3B2;CCL3;CCR7;CCR5;SOD1
prerank,positive regulation of cilium assembly (GO:0045724),-0.4044808027544795,-1.1571853473442268,0.27672955974842767,0.7088537920192373,1.0,4/18,9.47%,ARHGAP35;HTT;SEPTIN9;CCDC88A
prerank,sphingolipid catabolic process (GO:0030149),0.44607045760197156,1.1571024133929328,0.2820976491862568,0.763633055168104,1.0,5/15,10.75%,PPT1;ACER3;SMPD2;ACER2;ASAH1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3384717889492704,1.1570354066376016,0.2167235494880546,0.7627658287735247,1.0,8/49,9.05%,IL18;CSF1R;LYN;IL6ST;CNTF;IL12B;CTF1;IL6R
prerank,keratinocyte differentiation (GO:0030216),0.3813947764978833,1.1563404055775535,0.25,0.764042857116212,1.0,5/29,10.75%,DSP;CERS3;ST14;SPRR1A;ASAH1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23154275347202788,1.1562783778145995,0.029157667386609073,0.7632091911021011,1.0,433/1668,24.03%,MAML3;ZFHX3;SALL1;IKZF1;IL18;ARID3B;ETV5;ZSCAN26;ARHGEF2;LRP5;MLXIPL;RREB1;CSF1R;SALL3;SMAD3;BRD8;ZNF697;DNMT3A;SUMO1;GREM1;BACH2;SMAD7;ITGA6;ETS1;NFE2L2;PHF21A;HEYL;HIVEP3;TRAK1;HOXD9;MEF2C;DDIT3;CEBPZ;LYL1;PIK3R1;SOX8;FLI1;DDX5;RIPK2;SKI;FOXJ2;RPS6KA1;SBNO2;UBP1;FUS;SIRT2;PPARD;ZFP90;MLXIP;CNOT1;FOXE1;TLR4;MTA1;KMT2D;AKAP8L;KLF11;GPS2;VHL;CDK9;EPOP;LPIN2;ZNF83;CRY2;HDAC10;DEAF1;RHOQ;NKX2-8;EGR1;ATM;MEF2D;ERF;PAX6;ELK1;AATF;ATMIN;KLF3;FLCN;SKIL;ZNF568;CUX1;HBP1;SUDS3;ZXDB;ID1;HOXB8;MEIS3;TFE3;CTR9;CHD8;NFATC1;ZIM3;IMPACT;CREB3L2;ZBTB21;ELK3;MYCL;MYSM1;CALCOCO1;GTF2H2;RPS6KA5;AKIRIN2;RPS27A;UBC;MLX;FIZ1;GTF2IRD1;PHF14;FOXK2;RBM14;MOV10;ATF3;BCOR;ZBTB18;EGR3;MDM4;MDFI;ZBTB24;KDM5B;TET3;TAF6L;CCNL1;TAF6;DHX9;SHH;RPAP2;JMJD6;MTDH;THAP1;SIN3A;EGR2;SLTM;MET;C1QBP;MED19;NLRP3;TIAL1;ZNF569;ZFP91;JUN;BRCA1;CNBP;SARS1;PKNOX1;TAL2;OVOL2;GATA2;ABRA;HOXA6;BCL6B;BARHL1;LEFTY1;SPAG8;GDNF;BHLHE22;CRYM;ALX4;TLE6;GPER1;ZBTB32;PAX1;FOXO6;HAMP;DMRTB1;CITED4;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;ZNF319;DPF2;EHMT2;TMPRSS6;AKIRIN1;MIDEAS;KLF12;CHD3;MOSPD1;PATZ1;NPAS1;PPID;DDX17;RXRB;MEF2A;SRCAP;NR2F1;BCL9;KDM3A;PRDM1;NOTCH4;IRF8;CXXC5;FHOD1;LBX1;PRKCB;ACTL6A;E2F2;CRTC1;MAML2;ZSCAN21;SMARCD3;SMARCA5;NFE2L1;NRF1;RPL10;NFYA;DLL1;PAX2;RUNX1;SMARCA2;MYNN;TBX6;LIN9;TCF25;ZNF367;IRF2BP2;PCGF2;SERPINE1;TAF1;CCDC62;DPF1;BAZ1B;IL33;ETV3;MED10;ENG;TEF;ARNT;SMAD9;RLF;MED4;E4F1;CEBPG;ABL1;PIN1;MXI1;RELB;SEMA4D;BRMS1L;POGZ;DDX20;EZH2;MAVS;WWP2;MRGBP;SP9;ID3;ZIC1;PLK3;ZNF3;HDAC5;NFATC2IP;PIAS3;ZBTB48;OLIG2;SAFB;PRDM2;ZNF292;TAL1;CSRNP2;ZBTB8B;BRD9;MAPK14;HR;MLLT6;NCOA3;PROX1;TNIP2;MXD1;ZMIZ2;SP110;PIAS2;NOG;EED;NRIP1;POU2F2;ZBTB39;TTC21B;TCF7L1;TCF3;OSM;FST;IRF3;ACVR2B;WASL;ZEB1;TADA1;MED25;AKNA;TGIF1;STAT6;SIN3B;MYPOP;ZMIZ1;MED18;MAFG;UXT;HDAC8;SP140;ZBTB2;KANK2;RPS6KA4;LIN37;MAPK7;GLMP;ARRB1;HES6;ZFP62;KDM1A;POU2F1;GATA3;RNF4;KAT5;IRF9;HMGB2;SLC11A1;PROX2;CUX2;ARID1A;LPIN1;LMO1;SSBP4;PPRC1;MITF;MIER3;IRF2;CAMK1;EID1;ZNF740;ZNF260;ZKSCAN1;ZSCAN22;E2F3;KTI12;KDM7A;RNF2;NR1H2;DMTF1;TNRC6C;REPIN1;IL4I1;TOX2;RBMX;ZFP82;BRD3;XRCC6;BHLHA9;ZNF585B;ZNF585A;TNRC6B;KDM2A;KCNIP3;MGA;NOD2;ZNF394;CASZ1;TNIP1;NOS1;EPC1;CDK8;ZSCAN12;SETD3;PHF20;ZNF692;PAXBP1;GLIS1;CEBPD;THAP3;GZF1;ZNF513;EFNA1;PLAGL2;CBX8;NLRC5;DDX3X;KAT6B;HIVEP1;IRX1;E2F5;ZC3H12A;HDGF;KANSL3;MED7;DBX2;ZBTB45;CXCL10;TWIST1;ELP3;TFAP4;RFXANK;ZNF691;SMARCA4;DEK;SAFB2;ZBTB6;NFIA;MED12;RPRD1B;ATAD2;GLYR1;ARF4;ZBTB1;KDM2B;PARK7;FOXP4;LMO2;FGF1;MED20;PTCH1;BMP2;HDGFL2;SCRT1;TEAD3;WBP2;MNT;MSC;BRMS1;TP53;KMT5A;TGFB1;BATF3;TGIF2;SUFU;JUP;YY1;AGO1;DR1;DVL2;KLF15;PCGF3;CNOT2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.44196835412086166,1.1557692533527588,0.269811320754717,0.7638430073683306,1.0,5/15,18.77%,PRKCD;PLA2G6;SMPD2;SMPD3;ORMDL2
prerank,Ras protein signal transduction (GO:0007265),0.28373407283403723,1.1557557198445438,0.17917304747320062,0.7628380394925881,1.0,22/137,11.44%,ELMO1;ARHGAP5;GNA12;RASGRP3;RREB1;RAC1;PLD1;AIF1;USP8;CDC42EP2;RGL2;RHOB;KSR1;RHOH;HACD3;TAX1BP3;USP28;JUN;RRAS2;G3BP1;CYFIP1;RAPGEF3
prerank,regulation of cellular protein localization (GO:1903827),-0.32711583506965974,-1.1555117073758359,0.2278177458033573,0.7126505021797733,1.0,10/45,10.19%,GPC6;BDNF;GPC5;MAP2;VCPIP1;KCNAB2;TOR1A;TRIM67;TRIM46;GPC3
prerank,bone development (GO:0060348),0.3526260067905448,1.1552922970992852,0.24150268336314848,0.7633270833670928,1.0,17/39,26.01%,LRP5;SKI;TGM2;DYM;AKAP13;MBTPS2;GJA1;GNAS;SBDS;SFRP4;STC1;TP53;SH3PXD2B;FGFR2;PTPRC;SULF1;SLC10A7
prerank,primary neural tube formation (GO:0014020),0.3700530310086134,1.15527999249257,0.2605042016806723,0.7623184622993279,1.0,14/30,25.77%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4791490787213869,1.1552569774899948,0.2821011673151751,0.7613312492241452,1.0,4/11,16.13%,PRKCD;PDK1;ARL6IP5;PDCD10
prerank,histone monoubiquitination (GO:0010390),0.39179831942527227,1.1549399943215726,0.2634508348794063,0.7612886610601988,1.0,11/24,27.60%,DDB2;CTR9;BCOR;CUL4B;RNF20;DTX3L;RNF2;KDM2B;RING1;ATXN7L3;PCGF1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3711348622326943,-1.1545922681575558,0.2517321016166282,0.7140830663840655,1.0,5/25,8.78%,DMD;ANK3;ANK2;ATP1B3;ACTN2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.32765714736802226,-1.1543913152865801,0.22458628841607564,0.7133426502882972,1.0,14/39,20.10%,LTV1;RPS7;SNU13;RPS27;RPS25;RIOK3;RPS14;MRPS7;RIOK1;NOB1;NPM1;RPS6;RPS5;RPS19
prerank,negative regulation of MAPK cascade (GO:0043409),0.30118571548230694,1.1542317158566628,0.21417565485362094,0.7626749048085052,1.0,24/87,21.06%,SIRPA;UCHL1;CNKSR3;TLR4;LYN;PRKCD;FLCN;SPRY2;GPER1;INPP5K;PIK3CB;RGS14;PTPN1;PEBP1;DUSP29;PIN1;DUSP6;QARS1;AGT;PTPRJ;TNIP1;WNK2;SYNJ2BP;SPRED2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.45319748171552376,1.154150426987727,0.2777777777777778,0.7618822869280749,1.0,3/13,11.69%,DNAJB9;BFAR;PTPN1
prerank,heterochromatin assembly (GO:0031507),-0.39881934852930434,-1.1540329160527756,0.25727069351230425,0.7131228137287435,1.0,6/20,13.73%,SUV39H1;SIRT1;HELLS;H3-3A;BAHD1;CDKN2A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.25674581301104504,1.1540197060540047,0.13233287858117326,0.7612697765838051,1.0,97/341,22.37%,BAG6;MVB12B;NFE2L2;DDIT3;UCHL1;RNF216;ARRB2;FBXO22;TGFB1I1;SIRT2;SMURF1;ITCH;MTA1;ZRANB1;SPSB1;UBE2H;NDFIP2;RFFL;FBXW4;ZSWIM8;SPSB2;MAEA;PCBP2;TRIM72;ARRDC1;CDC34;ANKRD9;OS9;CRBN;RNF8;BFAR;PSMD3;UFD1;RNF20;RNF166;AREL1;MYLIP;KCTD2;ANAPC15;PSMB3;TAF1;PINK1;UBE2U;PSMA7;RNF187;ZNRF3;FBXO21;VPS37D;WWP2;DCAF11;VPS37A;PSMC1;PSMC2;KCTD6;RNF144B;RNF7;FBXL22;PSME4;RNF11;NTAN1;AURKA;UBE2A;FBXO11;PSMB9;ANAPC11;PTPN23;DTX3L;UBXN2A;ARRB1;UBE4A;SPOPL;TNFAIP1;RNF4;KAT5;STUB1;VPS4A;CUL4A;ZFAND2A;UBQLN4;WDR81;TSG101;VPS37B;GID8;TRIM3;PSMD4;PSMB5;TOPORS;SYVN1;RNF34;FBXL7;UBE2R2;PSMB7;GID4;KLHL3;ANAPC1;RC3H2;PSMB8
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3797017242322211,1.153939676081587,0.26048951048951047,0.7604926543884677,1.0,6/27,13.12%,SLC7A8;SLC1A3;SLC7A5;ARL6IP5;SLC22A2;SLC6A9
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4482634220589907,-1.1537838756439096,0.2696629213483146,0.7125098727766042,1.0,2/12,7.43%,GSS;GGCT
prerank,regulation of cilium assembly (GO:1902017),0.31772997053432683,1.1537830785122827,0.23214285714285715,0.7599291670249907,1.0,9/62,6.18%,TBC1D16;SDCCAG8;TBC1D17;TBC1D9B;TBC1D10B;TBC1D7;TBC1D8;TBC1D15;DYNLT2B
prerank,regulation of myelination (GO:0031641),0.38744860568934497,1.1536300489511653,0.2536231884057971,0.7593601424811974,1.0,6/25,7.25%,SIRT2;JAM2;TNFRSF21;NSUN5;KLK8;EGR2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.4889564172687252,1.1531580709307745,0.32748538011695905,0.7598231821550007,1.0,6/10,20.55%,NDFIP2;TERF1;WWP2;SNX3;PPM1F;MAPT
prerank,response to hydrogen peroxide (GO:0042542),0.3410075114292717,1.1528315971684224,0.24041811846689895,0.7598523955268364,1.0,14/45,19.13%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;PAX2;APTX;ABL1;SOD1;PDCD10;MAPK7;ANKZF1;ECT2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.40245530464119283,1.1528166866702225,0.2814159292035398,0.7588651443502347,1.0,5/22,17.11%,PDE3B;GPER1;CEACAM1;BSCL2;PPP2R5A
prerank,regulation of mitochondrial translation (GO:0070129),0.40746175971696286,1.1527746036281887,0.2737430167597765,0.7579679965417329,1.0,15/21,35.32%,C1QBP;RMND1;MPV17L2;FASTKD3;UQCC2;NSUN3;FASTKD2;NGRN;MTG1;TSFM;MTG2;MRPS27;RCC1L;ALKBH1;MALSU1
prerank,ether lipid biosynthetic process (GO:0008611),0.4902949308862292,1.1526660186052788,0.28909090909090907,0.7572900993397527,1.0,2/10,4.55%,LPCAT2;PLA2G4A
prerank,establishment of skin barrier (GO:0061436),0.45158822145536576,1.1526514258069556,0.28166351606805295,0.755274372955658,1.0,3/15,9.28%,ALOXE3;MET;LSR
prerank,regulation of water loss via skin (GO:0033561),0.45158822145536576,1.1526514258069556,0.28166351606805295,0.755274372955658,1.0,3/15,9.28%,ALOXE3;MET;LSR
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.43901666951623025,-1.1523577368443836,0.27912087912087913,0.7154343561984374,1.0,4/13,5.31%,ANK2;KCNN2;KCNJ3;CACNA1C
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3357526958487943,-1.1521806792871352,0.21377672209026127,0.7146519552240732,1.0,8/40,5.35%,ARHGAP6;EGFR;ADRA1A;BDNF;NTRK2;NTRK3;RASGRP4;HTR2B
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.24235871956743718,1.1520355545022538,0.08545918367346939,0.7562797498589362,1.0,117/572,17.24%,ZFHX3;SALL1;ETV5;RREB1;SMAD3;DNMT3A;SUMO1;SMAD7;PHF21A;HOXD9;MEF2C;DDIT3;SOX8;DDX5;SKI;SIRT2;PPARD;ZFP90;CNOT1;FOXE1;MTA1;KLF11;GPS2;VHL;CRY2;HDAC10;DEAF1;ERF;PAX6;FLCN;SKIL;ZNF568;CUX1;SUDS3;ID1;CTR9;CHD8;IMPACT;ZBTB21;RPS27A;UBC;MLX;GTF2IRD1;ATF3;BCOR;ZBTB18;MDM4;MDFI;PDGFB;SHH;MTDH;THAP1;SIN3A;C1QBP;JUN;CNBP;SARS1;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;HAMP;ANKRD2;POU4F1;DPF2;EHMT2;TMPRSS6;KLF12;CHD3;MOSPD1;PPID;MEF2A;NR2F1;PRDM1;NOTCH4;IRF8;CXXC5;RPL10;RUNX1;SMARCA2;TBX6;TCF25;IRF2BP2;PCGF2;TAF1;IL33;E4F1;MXI1;SEMA4D;BRMS1L;DDX20;EZH2;WWP2;ID3;PLK3;ZNF3;HDAC5;PRDM2;PROX1;MXD1;NOG;EED;NRIP1;TCF3;FST;ACVR2B;ZEB1;MED25;TGIF1;SIN3B;MYPOP;UXT;HDAC8;ZBTB2;KANK2;LIN37
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.38272964871782966,-1.1518777883495053,0.24780701754385964,0.71419592254361,1.0,7/21,11.70%,DMD;PDE4D;NCK2;NLRP2B;INPP5J;DDIT4;PAQR3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3093336916990436,-1.1517991951416122,0.23076923076923078,0.7130726121204269,1.0,14/51,15.06%,CNTNAP2;NYAP2;LRRK2;GPM6A;BDNF;CTTN;DCLK1;WASF1;ATP7A;CNTNAP1;DTNBP1;PLXNB1;MYO16;PAK1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.26311007417221716,-1.1514171336060524,0.1615598885793872,0.7129309274759674,1.0,44/138,21.87%,NEDD9;MTSS1;PTPRG;PTPRD;STAP1;PTPRT;EGFR;SHC3;BDNF;ROR1;NTRK2;JAK2;NTRK3;RASGRP4;ERBB4;GFRA2;RET;EPHA5;ALK;FRK;ERBB3;BCAR1;FGFR3;CLNK;LIFR;KIT;AHI1;FER;TEK;MPZL1;LMTK2;CD3E;STYK1;GUCY2F;GUCY2D;BLK;EPHA4;EFS;EPHB2;EPHA7;FLT3;FYN;TIE1;LTK
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3432446572988795,1.1512724657790456,0.22750424448217318,0.7577136370107291,1.0,10/45,8.60%,LGALS9;RIPK2;PYDC1;AGER;TLR4;EGR1;CCL3;CASP1;NLRP3;ORM2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4217572764861458,1.151197436245996,0.27598566308243727,0.7569358161632798,1.0,7/17,30.18%,COX7A2L;COX8A;COX5A;COX6B1;COX6A2;AFG1L;COX6A1
prerank,skeletal system morphogenesis (GO:0048705),0.34479102220719354,1.1511438881182505,0.21746293245469522,0.7560860970646611,1.0,4/42,2.25%,TGFBR1;LRP5;HOXD9;SKI
prerank,B cell mediated immunity (GO:0019724),-0.4737185332249151,-1.1510518661475113,0.28211009174311924,0.7127200837963251,1.0,6/10,26.97%,CD74;FCGR2B;TLR8;CD19;MSH2;SLA2
prerank,blood circulation (GO:0008015),-0.31930771045122136,-1.1509568356304287,0.22588235294117648,0.7117092244149503,1.0,8/49,11.44%,SGCZ;MYOF;SGCD;GUCY1B1;SERPING1;OLR1;MEOX2;ITGB1BP1
prerank,tRNA export from nucleus (GO:0006409),0.36470221522422985,1.150842708922945,0.2453151618398637,0.7550146341974889,1.0,11/32,17.95%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.36470221522422985,1.150842708922945,0.2453151618398637,0.7550146341974889,1.0,11/32,17.95%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,cholesterol homeostasis (GO:0042632),0.3164038183301072,1.1503442678244753,0.24874791318864775,0.7555491212985285,1.0,11/64,13.28%,IL18;LIPC;LRP5;CNBP;APOM;LCAT;NPC1;CYP7B1;TTC39B;NPC2;LDLRAP1
prerank,regulation of chromosome organization (GO:0033044),-0.3809710850857301,-1.1502764798709462,0.2494172494172494,0.7125232696028649,1.0,9/22,20.67%,LIG4;SMG6;SMG5;BUB1;XRCC5;SMG1;PIF1;SETMAR;UPF1
prerank,regulation of interleukin-13 production (GO:0032656),0.4476785813764449,1.150214016772348,0.3088512241054614,0.7549711154819315,1.0,3/13,4.60%,IL18;LGALS9;TNFRSF21
prerank,regulation of nervous system development (GO:0051960),0.3477920497930591,1.14967262468987,0.2658450704225352,0.755746937997642,1.0,4/37,5.72%,CX3CR1;HEYL;SIRT2;NSUN5
prerank,negative regulation of potassium ion transport (GO:0043267),0.4547208864848927,1.149145824825731,0.2857142857142857,0.7565830036562552,1.0,5/13,20.49%,BIN1;PTK2B;VIP;STK39;NOS1
prerank,positive regulation of cellular process (GO:0048522),0.24396200278323346,1.1491371327761883,0.10038119440914867,0.7555965036785025,1.0,101/565,16.26%,TGFBR1;ZFHX3;MERTK;TGFBR2;SIRPA;LRP5;MLXIPL;CSF1R;GREM1;ETS1;FAM98B;RAC1;NCBP1;AIF1;RIPK2;RPS6KA1;GAB2;TGM2;SIRT2;PRKCA;TLR4;LYN;KMT2D;VHL;TBC1D8;IGF1R;ITGAV;CSNK2A1;TRPM4;ATM;PKHD1;PRKCD;FLCN;EIF4G1;CAMK1D;MEIS3;TFE3;NUMA1;LGMN;PTK2B;MTLN;IL6ST;PDGFB;SHH;CD86;EGR2;C1QBP;GCNT2;TCIRG1;ZFP36L1;ACER3;CNBP;S1PR3;GATA2;EDN3;CNTF;CCR7;EDN2;GDNF;IL12B;GPER1;CALCR;CTF1;FUT7;NEUROD4;RPTOR;IL6R;PLA2G5;ACER2;PRMT1;RTKN2;TJP1;IL12RB2;LRP1;DLL1;TBX6;PDGFRB;DHPS;STX4;RNF187;IL34;EZH2;MAPK8;ADGRG1;HTR1A;NOXO1;TAL1;PYCARD;AKT1;CIB1;HPN;CSF1;PROX1;VIP;CDH3;SLAMF1;OSM;PDCD10;UBE2A;TSPAN31;LAMC2
prerank,regulation of response to oxidative stress (GO:1902882),-0.46914581039060393,-1.1490100929492904,0.2803347280334728,0.715079227600664,1.0,5/11,19.58%,ALOX5;PRKN;GGT7;MCTP1;STOX1
prerank,regulation of T cell activation (GO:0050863),0.34387450643882106,1.1489001041800082,0.2533783783783784,0.7553765452995311,1.0,10/42,17.02%,PAG1;SIRPA;CCDC88B;CYRIB;TNFAIP8L2;TNFSF8;ABL1;PYCARD;GPNMB;SPINK5
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24115372367137822,-1.1483706771884612,0.09646302250803858,0.7157102186521387,1.0,32/245,7.72%,CD74;IQGAP1;ROBO1;RIT2;LRRK2;CD44;CD36;EGFR;ADRA1A;TMEM106A;FGF10;GAREM1;APP;DSTYK;CCR1;PTPN22;IAPP;HTR2C;CD40;RAPGEF2;ROR1;NTRK2;PDGFD;NTRK3;APOE;PRKCZ;HTR2B;ERBB4;RET;OPRM1;PDE8A;TPD52L1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.44809508912426094,1.1482852648966608,0.287292817679558,0.7564249541254882,1.0,3/14,6.04%,PYDC1;GPS2;RFFL
prerank,bile acid metabolic process (GO:0008206),0.37593697091439016,1.1479970462206175,0.24640287769784172,0.756361531276107,1.0,8/27,16.98%,CH25H;OSBPL3;CYP46A1;AKR1D1;NPC1;CYP7B1;HSD17B10;OSBP
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.34981361792032256,-1.1478049613372072,0.25653206650831356,0.7161228979718398,1.0,10/33,23.20%,PTPN22;RPS3;CD226;PTPN2;TESPA1;UBASH3A;THY1;LCK;TRAT1;EZR
prerank,substrate-dependent cell migration (GO:0006929),0.4518434853833983,1.1474662755727427,0.2791519434628975,0.7571045175191488,1.0,3/14,8.05%,OPHN1;P2RY12;EPHA8
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.41765164558816353,1.1471353443989911,0.28597122302158273,0.7572670679247793,1.0,6/19,17.17%,BIN1;PICALM;CLU;FLOT2;PIN1;GGA3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.36678266958960265,-1.1466013235320842,0.25925925925925924,0.7185079024284097,1.0,3/26,2.94%,NCK2;APP;CBLB
prerank,regulation of defense response to virus by host (GO:0050691),0.36927109680382547,1.1464970847483844,0.25444839857651247,0.7583540291805965,1.0,9/30,16.81%,RNF216;TRIM44;DHX9;SIN3A;CGAS;IL12B;MAVS;AIM2;DTX3L
prerank,regulation of cell aging (GO:0090342),0.48327769859789627,1.146165492117191,0.3078393881453155,0.7584350055591692,1.0,2/11,3.55%,NUAK1;NEK6
prerank,endodermal cell fate commitment (GO:0001711),0.49180543079308114,1.146137956677118,0.28832116788321166,0.7575126364411996,1.0,2/10,8.81%,CTR9;SOX17
prerank,protein O-linked mannosylation (GO:0035269),-0.4111221320839037,-1.145864650361513,0.2693208430913349,0.7194201457410903,1.0,8/18,15.62%,DPM2;TMTC1;CRPPA;POMT2;TMTC4;FKTN;TMTC2;POMGNT2
prerank,vascular transport (GO:0010232),0.299275304485569,1.1456374234044946,0.22422258592471359,0.758094730581802,1.0,19/81,18.08%,SLCO2B1;SLC7A8;SLC1A3;SLC7A5;AGER;SLC24A3;ABCC9;SLC22A2;SLC29A4;ATP1A4;SLC27A4;LRP1;SLC16A7;SLC6A9;SLC29A1;SLC5A3;SLC38A1;SLC15A2;SLC19A1
prerank,regulation of MAPK cascade (GO:0043408),-0.25608372013746616,-1.1453923055150412,0.1569767441860465,0.7196864186251726,1.0,31/157,15.51%,CD74;IQGAP1;RIT2;LBH;EGFR;PAK5;ADRA1A;TMEM106A;FGF10;IAPP;ROR1;NTRK2;PHLPP1;NTRK3;FN1;ATP6AP2;PAK3;RET;ZDHHC17;STYX;FGFR3;ADRA2A;KIT;LILRA5;FAM83D;WWC1;MMP8;CX3CL1;PAK1;TEK;DAG1
prerank,multivesicular body organization (GO:0036257),0.3674519849386617,1.145236895770156,0.2649122807017544,0.7583804639325157,1.0,17/31,33.31%,VPS37D;VPS37A;VPS36;RAB27A;CHMP1A;VPS4A;IST1;TSG101;VPS37B;CHMP2A;HGS;PDCD6IP;VTA1;CHMP7;STAM2;RAB11A;CHMP5
prerank,integrin-mediated signaling pathway (GO:0007229),0.31168414088543084,1.1451298780601533,0.2222222222222222,0.7577535298081156,1.0,20/73,16.48%,ITGB5;DST;FYB1;FERMT3;FYB2;PLEK;ITGB2;ITGAV;MYH9;SRC;ADAMTS1;PTK2B;CEACAM1;LAMA3;ZYX;PTPRA;ABL1;TEC;CCM2;ADAM10
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.26283587958060284,-1.1451231485035616,0.17478510028653296,0.7192065846121867,1.0,29/129,15.25%,LRRK2;EGFR;FGF10;CSNK1G1;SEMA5A;PPM1A;PSMD14;GPC5;UBR5;ATP6AP2;PSMD8;PSMA2;PSMF1;PSMD6;AXIN1;PSME2;ZEB2;CCAR2;LGR5;KANK1;GPC3;PSMD5;TNKS2;PSMD12;LGR4;COL1A1;PSMD11;PSMD1;SFRP1
prerank,regulation of cell migration (GO:0030334),0.24804511560099163,1.1450123814489457,0.145578231292517,0.7571296133444977,1.0,89/382,19.73%,TGFBR1;SRGAP3;SRGAP2;LDLRAD4;NUMB;NAV3;GNA12;ABI3;CSF1R;KIF2A;SMAD7;ITGA6;SLURP1;ARSB;RAC1;SEMA3B;MAP4K4;VSIR;AIF1;PRKCA;CYRIB;FERMT3;SEMA4C;IGF1R;SRC;ATM;RHOB;RNF41;CCL3;FLCN;SEMA4G;TRADD;PTK2B;SPRY2;RFFL;PDGFB;SHH;MACF1;GCNT2;MIA3;SUN2;PIP5KL1;GPER1;SEMA3G;TWIST2;DOCK10;PIK3CD;TJP1;APPL1;MGAT5;DPEP1;RNF20;CLN3;CEACAM1;PDGFRB;SPATA13;SERPINE1;ENG;OSGIN1;STX4;SERPINE2;DRD2;SEMA4D;AKT1;SMO;CIB1;MAPRE1;CSF1;GPNMB;NOG;PIK3R3;PDCD10;LAMC2;ADAM10;ARHGAP4;CCAR1;PTPRJ;ROCK2;THBS1;MIEN1;MITF;CLDN1;FGF18;PPM1F;SEMA3D;CEP43;TBCCD1;ADAM15;CCL24
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3925864543572969,-1.1449784259790956,0.27358490566037735,0.7182794367488466,1.0,6/20,18.07%,DCC;GSK3B;ERBB3;BAK1;BCL2;BOK
prerank,B cell differentiation (GO:0030183),0.33923900109553834,1.144801079620505,0.253781512605042,0.7567901190884063,1.0,14/46,21.11%,BLNK;LYL1;GPS2;DNAJB9;PLCG2;IRF2BP2;CEBPG;HDAC5;TCF3;PTPRJ;TPD52;CD79A;ADAM17;SYVN1
prerank,histone H3-K4 methylation (GO:0051568),0.37927043053319415,1.1441086388033475,0.27549194991055453,0.7579395682372551,1.0,12/26,29.65%,KMT2D;CTR9;TET3;CXXC1;SETD4;PRDM9;DPY30;KMT2B;WDR5;KMT2A;PAXIP1;DYDC2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4278616046681862,-1.144074524215649,0.2894168466522678,0.719843803689133,1.0,2/15,2.15%,IQGAP2;ACTR3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3802710072040016,1.1439294778567484,0.25734024179620035,0.7575104107838453,1.0,10/26,20.73%,KMT2D;CTR9;TET3;EEF2KMT;KMT5C;ANTKMT;SETD2;SETD4;PRDM9;SETD3
prerank,positive regulation of cell differentiation (GO:0045597),0.26118648892716095,1.1431313346177694,0.14714285714285713,0.759109529620908,1.0,52/237,16.40%,TGFBR1;TMEM119;IL18;TGFBR2;ARHGEF2;LRP5;SMAD3;HEYL;MEF2C;MMD;IGFBP3;RPS6KA1;TGFB1I1;PPARD;NPNT;VHL;TRPM4;IMPACT;CTNNBIP1;IL6ST;SIN3A;GCNT2;ZFP36L1;ASB4;EDN3;GDNF;RBM24;NEUROD4;IL6R;PLA2G5;AKIRIN1;CD34;MEF2A;MTOR;WNT7B;DDR2;CEACAM1;PAX2;PKDCC;BNIP2;GJA1;ABL1;EZH2;LRRC8A;CDS1;AKT1;MAPK14;CSF1;CDH15;TCF3;ACVR2B;ZEB1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.43883972262929943,1.1430903013201203,0.3037974683544304,0.7582729017784606,1.0,7/15,21.84%,POP1;KHNYN;ZC3H12C;ZC3H12B;NUDT16;RNASEH1;ZC3H12A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.39130014249786754,-1.1425130057253159,0.27251732101616627,0.7234054304095955,1.0,4/18,8.98%,ACSL3;ELOVL7;HACD1;ELOVL5
prerank,regulation of actomyosin structure organization (GO:0110020),0.44994354518470603,1.1423959933082983,0.2937853107344633,0.7596061655505216,1.0,4/13,10.46%,RAC1;ASAP3;AKAP13;FHOD1
prerank,T cell migration (GO:0072678),0.4513754761951701,1.1423760816922983,0.27472527472527475,0.7586739625122544,1.0,3/13,9.67%,PIK3CG;CCL3;PIK3CD
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.4919829024803218,1.1423398166345613,0.31568998109640833,0.7578075084300057,1.0,5/10,17.23%,ATP5PO;ATP5PD;ATP5MC1;VPS9D1;ATP5F1D
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3151039764647474,1.1416961850699174,0.22126929674099485,0.7587769625999993,1.0,16/67,15.85%,ABI3;CSF1R;LYN;EFEMP1;IGF1R;SRC;PTK2B;PDGFB;DDR2;PDGFRB;PKDCC;ABL1;BMX;GHR;DYRK1A;TEC
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.30224912936270576,1.141647367836026,0.23902439024390243,0.7579327867739789,1.0,29/82,25.12%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;TUBA1A;CEP63;CEP57;HAUS6;HAUS2;SFI1;MAPRE1;AURKA;CEP135;ACTR1A;OFD1;DCTN2;CEP43;CEP70;CSNK1D;TP53;CCP110;DYNLL1;NDE1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.43450513729725415,1.1413955045400348,0.27353463587921845,0.7577482904058962,1.0,4/15,11.91%,SEL1L;OS9;UFD1;AUP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.4153700411370954,1.1413555847481254,0.3005366726296959,0.7568848668652713,1.0,5/19,14.92%,HK2;TAF8;PINK1;MORC3;AKT1
prerank,diacylglycerol metabolic process (GO:0046339),0.39293414246158803,1.140975505584062,0.28595317725752506,0.7572214760639764,1.0,8/23,16.11%,DGAT1;DGKK;PLA2G15;DGKD;MOGAT1;MOGAT2;PGS1;LIPE
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3837292763081027,1.1402529944636117,0.26956521739130435,0.7587280536485463,1.0,4/25,4.13%,ABI3;TBC1D7;CAPZB;PRKCD
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48486104924412454,1.139981387640324,0.3053435114503817,0.758643596517315,1.0,3/10,10.11%,SEC14L1;C1QBP;UFD1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.30720810367102896,1.1397946122840723,0.23887973640856672,0.7583180633704243,1.0,9/70,4.07%,SRGAP2;OPHN1;RAC1;MEF2C;RILPL1;PIK3R1;FERMT3;ITGAV;PKHD1
prerank,spermatid development (GO:0007286),0.3631638530616306,1.1396619297178574,0.28368794326241137,0.757789667715653,1.0,8/32,14.99%,JAM2;PIWIL1;RIMBP3;RNF8;IQCG;CEP57;NECTIN2;CIB1
prerank,modulation by host of symbiont process (GO:0051851),0.3698084621731174,1.1396516701188881,0.2549728752260398,0.7568517649558917,1.0,7/31,15.06%,CX3CR1;CCL3;LRRC19;JUN;INPP5K;TARDBP;HPN
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2946604393499034,-1.1394505945511633,0.2136150234741784,0.7317744485935517,1.0,21/65,20.52%,KCND2;SLC8A3;SCN2A;SUV39H1;NPEPPS;LMNA;HIPK2;SIRT1;OPRD1;TIGAR;HMOX1;AK4;SFRP1;EGLN3;RGCC;MDM2;SUV39H2;UBQLN1;TERT;CPEB4;TSC1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3008443077265417,1.1390582848221935,0.2082695252679939,0.7577621510422428,1.0,28/88,24.98%,SMAD3;SUMO1;PRKCA;CDC42EP2;PLEK;CLU;SPIDR;MTLN;SLX4;SH3GLB1;BMF;GNL3L;TAL1;SMPD3;VPS4A;TSG101;SLF2;CHMP2A;HGS;STX18;PDCD6IP;BCL2L11;PARK7;TGFB1;BRK1;CHGA;RHOC;AJUBA
prerank,lamellipodium assembly (GO:0030032),0.3841771496196715,1.1389045249077205,0.28460038986354774,0.7572457947774791,1.0,6/26,11.62%,SRGAP2;P2RY12;RAC1;ARFIP2;CYFIP1;SPATA13
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3525645154581981,1.1386817595839127,0.2469775474956822,0.7570208426560372,1.0,5/37,3.69%,BAG6;FHIT;UCHL5;CSNK2A2;CSNK2A1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.31106600357355146,-1.1369597705129386,0.23696682464454977,0.7381086935424134,1.0,18/50,27.47%,CDK7;CCND2;CCNF;ACTB;CCNJ;CDKN1A;CDC25C;TTBK1;PKMYT1;CCNB1;STOX1;CDKN1C;CDK5RAP3;CCNH;GTF2H1;HSP90AB1;SERTAD1;CCNT2
prerank,glucose transmembrane transport (GO:1904659),0.4108446591767761,1.136441447584771,0.3045045045045045,0.7632890209997947,1.0,4/18,16.65%,PPARD;SORT1;RAB4B;SLC5A3
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2757810728160499,-1.1362752644137573,0.21138211382113822,0.7389722072579644,1.0,15/91,9.84%,RIMS2;HIP1;RIT2;STXBP5L;LRRK2;RAB3C;SYT1;STXBP5;RAB5C;CPLX2;SCFD1;RAB3D;RAB8A;RAB3A;CDH13
prerank,positive regulation of T cell migration (GO:2000406),0.4073084443954723,1.1359199955377086,0.29328621908127206,0.7640186988518696,1.0,9/20,22.12%,DOCK8;AIF1;WNK1;PYCARD;STK39;ADAM10;TNFRSF14;ADAM17;CXCL10
prerank,regulation of biosynthetic process (GO:0009889),-0.4621928399751354,-1.135851659541377,0.2920168067226891,0.738989319764988,1.0,4/11,23.63%,ALOX5;SNCA;GSTP1;SPHK2
prerank,blood vessel morphogenesis (GO:0048514),0.32264138986403723,1.1355403656565572,0.22764227642276422,0.7642728207480564,1.0,11/54,16.00%,TGFBR1;TGFBR2;LRP5;SMAD7;ID1;SHH;SOX17;RASIP1;ENG;PROX1;CCM2
prerank,positive regulation of protein catabolic process (GO:0045732),-0.28011058162647573,-1.1352792945317787,0.19480519480519481,0.7393926083433835,1.0,22/84,15.44%,WWP1;HECW2;HECW1;APC2;NEDD4L;FAF1;APOE;GSK3B;BARD1;PRKN;PLK2;AXIN1;SNX9;ATG7;GPC3;ADRA2A;SH3D19;TIPARP;NKD1;TNFSF12;OAZ1;RILP
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3369625438355338,1.135225641762516,0.2542955326460481,0.7643088596484043,1.0,8/43,7.92%,SMAD3;ETS1;DDX5;PPARD;EGR1;PDGFB;JUN;GATA2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.37238778456539184,1.1349863558991409,0.29572649572649573,0.7640802717653102,1.0,11/27,21.84%,RNASE1;POP1;KHNYN;RNASE6;ZC3H12C;ZC3H12B;NHP2;PCF11;NUDT16;RNASEH1;ZC3H12A
prerank,phosphorylation (GO:0016310),0.24690762166810806,1.1347142696964303,0.1366120218579235,0.7640704598205875,1.0,87/384,17.76%,TGFBR1;MERTK;NUAK1;TGFBR2;BMP2K;CSNK1E;CDKL3;PIM2;MAP4K4;IGFBP3;PRKCA;PRKACA;CHEK2;LYN;CDK9;TBCK;NEK6;CSNK2A1;PIK3CG;ATM;MKNK1;DGKK;PRKCD;MAP4K3;NEK3;RYK;RPS6KA5;STRADA;PTK2B;CSK;PDPK1;PDK1;DGKD;PDGFB;NRBP1;CAMKK2;PKN3;PGK1;GK5;TSSK6;TSSK4;PIK3CD;MTOR;PIK3CB;WNK1;PDK2;PRKCB;NUAK2;GRK2;CERK;PANK2;XYLB;MAP4K2;TAF1;PINK1;HCST;MAP3K11;NEK7;CDK11B;MARK2;TAOK2;ABL1;BMX;MAPK8;PXK;CCNE1;MORC3;LATS2;AKT1;DYRK1A;FAM20B;PICK1;STK39;PASK;MAP2K1;TEC;EIF2AK2;AURKA;LIPE;CDC42BPB;ACVR2B;ADAM10;ULK1;RPS6KA4;TRIB1;VRK2;ROCK2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3617810241078678,1.1339414678769932,0.28146853146853146,0.7654863086020982,1.0,8/34,11.53%,P2RY12;PIK3R1;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.31479401066553203,1.1337913013797232,0.23235800344234078,0.7650184804382979,1.0,9/62,6.82%,NCBP1;NELFB;POLR2H;CDK9;POLR2J;POLR2D;CTR9;GTF2H2;ERCC2
prerank,protein localization to vacuole (GO:0072665),0.44312311281783673,1.133447186651412,0.29874776386404295,0.7651947585379476,1.0,4/13,17.36%,SH3GLB1;LAMTOR5;MFSD1;GLMP
prerank,sodium ion transport (GO:0006814),-0.2819652745460553,-1.1331115671585978,0.1956521739130435,0.7448462530726212,1.0,38/85,33.00%,HCN1;SLC8A3;SCN2A;NALCN;NEDD4L;SLC24A2;SCN3A;PKD2;ATP1B3;ANO6;SLC6A15;SLC4A8;HCN2;ASIC3;SCN9A;SLC12A1;SLC6A16;SLC5A6;SLC6A1;SLC6A6;SLC6A7;SCN1A;HCN4;SLC5A5;SLC12A3;SLC6A17;HCN3;SLC6A12;SLC5A1;SLC6A13;CATSPER4;SLC6A19;SLC6A14;SLC5A10;SLC4A11;SLC5A12;SCN4A;SLC24A4
prerank,ncRNA transcription (GO:0098781),0.45077722771363166,1.1324925015471607,0.3,0.7673060478933921,1.0,6/13,25.82%,GTF3A;RPAP2;BRF1;POLR1G;SPIN1;SNAPC2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3315805640235367,1.132486253317762,0.2625418060200669,0.7663609711789904,1.0,12/49,15.05%,RHNO1;CHEK2;NBN;ATM;RAD17;MDM4;USP28;ACER2;RAD1;ABL1;CEP63;MAPK14
prerank,regulation of endocytosis (GO:0030100),-0.2960225235463769,-1.132374904088364,0.22531645569620254,0.7458001605634521,1.0,17/61,15.27%,DAB2;HIP1;RIT2;LILRB1;NEDD4L;MTMR2;APOE;RAB5C;RUBCN;CDH13;GPC3;CD151;TFR2;MCTP1;CBLL1;SNCA;SNX12
prerank,positive regulation of telomerase activity (GO:0051973),-0.3333789298688905,-1.1323016445313852,0.24764150943396226,0.7446817045697741,1.0,14/33,25.19%,PARM1;CCT2;MAPKAPK5;AURKB;KLF4;WRAP53;PRKCQ;XRCC5;MAPK1;TCP1;GRHL2;CTNNB1;MAPK15;HSP90AB1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3108296896088446,1.1322718236962839,0.2495921696574225,0.7660835471794494,1.0,16/69,11.76%,CSF1R;PI4KB;NYAP1;PLCL1;PIK3R1;GAB2;SIRT2;IGF1R;PIK3CG;PIK3C3;C1QBP;ZFP36L1;PIK3CD;PIK3CB;PDGFRB;PLCL2
prerank,cation transmembrane transport (GO:0098655),0.33844532548576384,1.1322063335046522,0.2722602739726027,0.7653182811909587,1.0,7/44,8.82%,SLC7A8;SLC7A5;TRPM4;TRPM2;TRPM6;ABCC9;SLC29A4
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3439448164100247,-1.1321894898250517,0.2431818181818182,0.7437168619232312,1.0,6/32,5.70%,SORBS1;CREBL2;PRKAG2;ZBTB20;APOE;ADIPOR2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.36141427783670743,1.1321394822951059,0.26362038664323373,0.7645757658936181,1.0,10/30,17.39%,F11R;RAC1;ABRA;GPR55;AKAP13;GPR18;ADGRG1;RTN4R;GPR4;ARRB1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3604479550178603,1.1320438091230818,0.2775862068965517,0.7639195905624977,1.0,14/33,26.08%,KLK2;PRMT2;DDX5;RUNX1;UBA5;KCTD6;KDM1A;CARM1;SAFB2;PARK7;KLK3;PKN1;HDAC6;AR
prerank,regulation of postsynapse organization (GO:0099175),0.36928393530578046,1.1318677613963493,0.2766355140186916,0.7635259379571917,1.0,4/28,0.98%,TANC2;ARHGAP22;ABI3;ABHD17C
prerank,pharyngeal system development (GO:0060037),0.4359026684178843,1.131469343653357,0.308529945553539,0.7638954575175003,1.0,1/15,0.06%,TGFBR1
prerank,skeletal muscle contraction (GO:0003009),0.4026544330950692,1.1312601287249433,0.2937853107344633,0.7635662596677973,1.0,4/19,19.25%,TNNI2;CCDC78;RCSD1;MYH14
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.39596371079640863,1.1311944254999664,0.29357798165137616,0.7628357727291307,1.0,3/20,3.88%,TGFBR1;ITCH;EGR1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.48497332243232444,1.1309401717503387,0.3333333333333333,0.7627230927245466,1.0,7/10,30.65%,DCLRE1B;DCLRE1C;DCLRE1A;ACD;RTEL1;TFIP11;TERF2
prerank,cardiac ventricle development (GO:0003231),0.4038926833183641,1.1309309372550433,0.2903225806451613,0.7617852622111536,1.0,3/20,6.25%,SALL1;HEYL;MDM4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4505566247677235,-1.130778029452472,0.3080168776371308,0.7467978671212949,1.0,3/12,4.36%,TMEFF2;PF4;TAF7
prerank,limb development (GO:0060173),0.3741169514747364,1.1306171582356586,0.29238754325259514,0.7618558028395198,1.0,7/28,15.73%,SALL1;GREM1;CHD7;IQCE;LRP4;ZNRF3;NOG
prerank,cellular protein localization (GO:0034613),0.2502331654289418,1.129584562906745,0.17379310344827587,0.764153130092494,1.0,81/285,19.73%,TBC1D16;UNC93B1;ARHGEF2;HERC2;CAPN3;TBC1D17;YWHAH;TBC1D9B;ARFIP1;COPA;ARFGAP3;TBC1D10B;SMURF1;AP2A1;ATG9A;TBCK;VPS26B;TBC1D8;ARL5C;VIPAS39;TBC1D15;FAM91A1;STXBP1;AP3D1;ID1;STX1A;TMED9;ARFIP2;STX12;MYO7A;TMED4;SGSM2;CPE;RAB3GAP2;LAMTOR2;STX19;SEC13;RAB1A;PIGK;TM9SF1;MESD;TICAM2;SAR1A;TBC1D9;SNX31;RUNDC1;BBS2;SEC31B;PDCD6;GJA1;STX4;TBC1D30;RAB20;SLU7;NAPG;CROCC;TRAPPC8;SCG5;RRAGA;RAB32;ATG9B;SNX13;PICK1;USP4;ADPRH;GGA3;SGSM3;CTSA;EIF2D;ARL11;VPS29;CPLANE2;GRTP1;RAB6B;STX5;PIGU;ACD;AP4M1;VPS26A;VPS35;PACS2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3796973827287994,1.1294651147410062,0.2793594306049822,0.7635986440183639,1.0,8/27,13.19%,P2RY12;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB;AGAP2
prerank,negative regulation of axon extension (GO:0030517),0.3615703464371687,1.1291496335620796,0.263254113345521,0.7637321118515106,1.0,10/30,19.29%,SEMA3B;CDKL3;DIP2B;SEMA4C;SEMA4G;SEMA3G;SEMA4D;RTN4R;MAG;SEMA3D
prerank,respiratory system development (GO:0060541),0.35619820584606626,1.129141493813089,0.2951096121416526,0.7628027037713639,1.0,8/32,15.23%,BAG6;BASP1;CHD7;LOXL3;SHH;WNT7B;CCDC40;PROX1
prerank,cardiac muscle cell differentiation (GO:0055007),0.3979027511404343,1.1288087732878553,0.297153024911032,0.7629240274988549,1.0,4/21,9.16%,MEF2C;CXADR;SLC8A1;AKAP13
prerank,activation of phospholipase C activity (GO:0007202),-0.3483439261636406,-1.1286911577605203,0.2853932584269663,0.7519788404370739,1.0,7/29,5.35%,ARHGAP6;EGFR;ADRA1A;BDNF;NTRK2;RASGRP4;HTR2B
prerank,cell-cell junction maintenance (GO:0045217),0.4646496477132093,1.128595561500959,0.33879781420765026,0.7626960095260346,1.0,2/11,9.81%,CSF1R;TJP1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3170753035245578,1.1281831918213956,0.26138279932546377,0.7620707668709226,1.0,23/56,27.56%,NDUFB2;NDUFB8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;NDUFB3;NDUFAF1;TMEM126A;NDUFA13;BCS1L;NDUFS5;NDUFAF5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFAF7;NDUFB4;NDUFAF3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3170753035245578,1.1281831918213956,0.26138279932546377,0.7620707668709226,1.0,23/56,27.56%,NDUFB2;NDUFB8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;NDUFB3;NDUFAF1;TMEM126A;NDUFA13;BCS1L;NDUFS5;NDUFAF5;NDUFV3;NDUFV2;NDUFA9;NDUFB11;NDUFC2;NDUFV1;NDUFAF7;NDUFB4;NDUFAF3
prerank,inflammatory response (GO:0006954),0.26468635688022424,1.1281099586935759,0.21407185628742514,0.7613669756636007,1.0,35/195,14.22%,BLNK;IL18;F11R;CSF1R;RAC1;LGALS9;AIF1;RIPK2;PJA2;ITCH;TLR4;ITGB2;PIK3CG;AGTR2;CCL3;LOXL3;ADORA1;AFAP1L2;TAC4;NLRP3;SELE;PLA2G4B;CCR7;NOS2;VNN1;FUT7;CXCL1;PIK3CD;IL10RB;RELB;TBXA2R;CCR5;PXK;ABCF1;HDAC5
prerank,regulation of axon extension (GO:0030516),0.34352434092727113,1.1271538077221703,0.2685810810810811,0.7635655915906793,1.0,9/37,8.64%,DNM2;TWF2;CDKL3;DIP2B;DBN1;SIN3A;MACF1;GOLGA4;SEMA3G
prerank,positive regulation of proteolysis (GO:0045862),-0.30337730582524436,-1.1267144522420918,0.21291866028708134,0.7569053085039035,1.0,11/55,11.52%,NLRC4;CCBE1;CTSC;CYFIP2;APOE;RCN3;BTRC;SNX9;BAK1;ADRA2A;SH3D19
prerank,cellular response to unfolded protein (GO:0034620),-0.35766627903764786,-1.126351449547555,0.2775229357798165,0.7566751110096724,1.0,8/26,14.62%,ERN1;PRKN;BAG3;BAK1;HSPA8;HSPA2;HSPA1B;HSPA5
prerank,receptor internalization (GO:0031623),0.3412271097277121,1.1259237363650543,0.27399650959860383,0.766653326440505,1.0,10/44,13.28%,DNM2;CD9;ARRB2;PICALM;ITGB2;GTF2H2;LRP1;GRK2;CEACAM1;LDLRAP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.30718706345294006,1.1257370607971293,0.24503311258278146,0.7663132588692199,1.0,29/68,29.13%,TLR7;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;DHX9;NOS2;IL6R;IL33;PTPN11;MAVS;PYCARD;POU2F2;RAB7B;SETD4;NOD2;IL1A;TWIST1;MYD88;TYROBP;ISL1;STAT3;CARD9;TLR9;WNT5A;C1QTNF4;TLR6
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.22555308565532498,1.1257126707888145,0.0499457111834962,0.765439130693515,1.0,337/1646,19.13%,TGFBR1;ZFHX3;SALL1;IKZF1;ARID3B;ETV5;POLR3G;BASP1;ZSCAN26;LRP5;MLXIPL;DNM2;RREB1;SALL3;SMAD3;ZNF697;DENND4A;BICRAL;SUMO1;BACH2;SMAD7;CAPN3;ETS1;QRICH1;NFE2L2;PRMT2;HEYL;HIVEP3;TRAK1;PIM2;HOXD9;YWHAH;MEF2C;DDIT3;LYL1;SOX8;KARS1;FLI1;DDX5;PBXIP1;FOXJ2;RPS6KA1;SBNO2;PICALM;TGFB1I1;UBP1;FUS;SRRT;SIRT2;PCNA;PPARD;ZFP90;MLXIP;FOXE1;CHEK2;CCDC85B;KMT2D;KLF11;EFEMP1;VHL;EPOP;ZNF83;CRY2;TNNI2;HDAC10;DEAF1;NKX2-8;EGR1;PHB2;SAMD1;MEF2D;ERF;PAX6;ELK1;CHD7;AATF;ATMIN;KLF3;ZNF568;REXO4;CUX1;HBP1;SUDS3;ZXDB;ID1;HOXB8;MEIS3;TFE3;CTR9;CHD8;NFATC1;ZIM3;CREB3L2;ZBTB21;LOXL3;ELK3;MYCL;CALCOCO1;GTF2H2;RPS6KA5;MLX;GTF2IRD1;RHOH;PHF14;FOXK2;TRIM44;ATF3;BCOR;ZBTB18;EGR3;MDM4;AFAP1L2;ZBTB24;KDM5B;EID2;ILF2;PDGFB;TAF6L;CCNL1;DHX9;SHH;CAMKK2;JMJD6;MTDH;FZD2;THAP1;SIN3A;CXXC1;CD86;TRIM45;EGR2;SLTM;ZMYND11;BCL7A;TIAL1;BICRA;ZNF569;ZFP91;FOXN3;JUN;BRCA1;CNBP;APBB2;PKNOX1;BRF2;TAL2;OVOL2;SAMD11;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;SAMD13;PAX1;FOXO6;DMRTB1;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;ZNF319;DPF2;TMPRSS6;LIMS1;MIDEAS;KLF12;CHD3;PATZ1;NPAS1;DDX17;RXRB;MEF2A;SRCAP;INPP5K;NR2F1;EID2B;KDM3A;MBD1;PRDM1;NOTCH4;RNF20;IRF8;RGS14;LBX1;PRKCB;MMS19;ACTL6A;E2F2;POFUT1;PRDM11;ZSCAN21;NUP35;PITHD1;SMARCD3;SMARCA5;NFE2L1;NRF1;NFYA;PAX2;RUNX1;SMARCA2;MYNN;TBX6;LIN9;ZNF367;IRF2BP2;MAP3K2;DPF1;FADS1;BAZ1B;ETV3;ENG;KDM4A;TEF;ARNT;SMAD9;RLF;MED4;CDK11B;MAP3K10;BLM;E4F1;CEBPG;ABL1;MXI1;RELB;PRMT6;RNF187;HP1BP3;EZH2;GCLC;WWP2;TRAPPC2;MRGBP;SNX5;SP9;ID3;ZIC1;ZNF3;CCNE1;HDAC5;PIAS3;ZBTB48;OLIG2;SAFB;PRDM2;ZNF292;TAL1;CSRNP2;NDUFA13;AKT1;ZBTB8B;BRD9;MAPK14;HR;MLLT6;DYRK1A;PROX1;SPTY2D1;MXD1;ZMIZ2;SP110;PIAS2;EED;MAP2K1;POU2F2;ZBTB39;TTC21B;TCF7L1;TCF3;TENM1;TAF5L;IRF3;COMMD7;SCMH1;ACVR2B;VGLL4;ZEB1;TADA1;TGIF1;STAT6;MYPOP;ZMIZ1;DTX3L;MED18;MAFG;UXT;SP140;QARS1;ZBTB2;CCAR1;AGT;TSC22D4;RPS6KA4;FZD1;NUP62;ARRB1;FANK1;HES6;ZFP62;KDM1A;POU2F1;GATA3;RNF4;KDM8;KAT5;NUP107;IRF9;HMGB2;CHMP1A;CARM1;PROX2;CUX2;DKK3;ARID1A;ZBTB11;EDRF1;MITF;KHDRBS1;IRF2;EID1;ZNF740;WTIP;ZNF260;ZKSCAN1;ZSCAN22;TP53INP2;E2F3;PPM1F;KTI12;KDM7A
prerank,cilium organization (GO:0044782),0.26152191039161005,1.1257023954961487,0.2062314540059347,0.7645215752717053,1.0,69/209,26.35%,ASAP1;EXOC7;RILPL1;KIF3B;BBS9;EHD4;TTLL3;ODF2;CEP162;PKHD1;RP2;UBXN10;HYLS1;ATP6V1D;CEP164;DYNLT2B;CFAP52;TTC36;NME8;AVIL;RAB1A;CFAP221;MKS1;INPP5E;NUDCD3;CCDC28B;IFT52;GALNT11;BBS2;KIF27;CDC14B;IFT20;ATAT1;MNS1;WDR90;IQCG;PDE6D;CFAP20;KIF3A;TCTN1;ARL3;CCDC66;PTPN23;EXOC6;OFD1;B9D1;CPLANE2;SSX2IP;TMEM17;RAB8B;MARK4;TTC17;EXOC1;TTBK2;ARF4;EXOC8;PLA2G3;EXOC4;CCP110;ACTR2;TRAPPC14;DYNLL1;DYNC2H1;IFT122;CATIP;TCTN2;HDAC6;IFT140;ARMC2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34445046466375084,-1.125633656603105,0.26136363636363635,0.7576984070356576,1.0,9/31,14.62%,ERN1;UBE2W;PRKN;BAG3;BAK1;HSPA8;HSPA2;HSPA1B;HSPA5
prerank,chemical homeostasis (GO:0048878),-0.2953917458920657,-1.1256176098577526,0.26097560975609757,0.7564043078126121,1.0,21/61,25.21%,PPARG;NEDD4L;USF1;ZBTB20;TLCD3A;AQP4;SLC4A10;CEBPA;AQP11;SLC4A8;ANGPTL3;ABHD5;TLCD3B;RBP1;PNPLA3;EIF5A2;SLC4A1;TM6SF2;ABCB11;WNK4;FBXW7
prerank,protein localization to cell periphery (GO:1990778),-0.2577869794955316,-1.1254076220570708,0.20698924731182797,0.7557057936184192,1.0,25/133,11.89%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;LRP6;EHD1;RAB40B;RAB3D;ATP1B3;PIGW;ACTN2;RAB8A;MYADM;RAB3A;SPTBN4;P2RY1;ZDHHC23;ITGB1BP1;TESC
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.23294038184342572,1.1252681607608805,0.08960573476702509,0.7649844875319824,1.0,214/834,24.01%,MAML3;ZFHX3;SALL1;IL18;ETV5;ARHGEF2;LRP5;MLXIPL;RREB1;SMAD3;BRD8;GREM1;SMAD7;ITGA6;ETS1;NFE2L2;HEYL;MEF2C;DDIT3;CEBPZ;PIK3R1;SOX8;RIPK2;SKI;FOXJ2;RPS6KA1;SBNO2;UBP1;SIRT2;PPARD;MLXIP;TLR4;KMT2D;AKAP8L;GPS2;CDK9;LPIN2;RHOQ;NKX2-8;EGR1;ATM;MEF2D;PAX6;ELK1;AATF;ATMIN;FLCN;MEIS3;TFE3;CHD8;NFATC1;ELK3;MYSM1;CALCOCO1;RPS6KA5;AKIRIN2;RPS27A;UBC;MLX;FIZ1;FOXK2;RBM14;ATF3;ZBTB18;TET3;PDGFB;TAF6L;TAF6;DHX9;SHH;JMJD6;SIN3A;EGR2;MET;MED19;NLRP3;JUN;BRCA1;CNBP;GATA2;ABRA;SPAG8;GDNF;GPER1;CITED4;SOX17;POU4F1;DPF2;TMPRSS6;AKIRIN1;MOSPD1;DDX17;RXRB;MEF2A;NR2F1;BCL9;NOTCH4;IRF8;FHOD1;E2F2;CRTC1;MAML2;ZSCAN21;SMARCD3;SMARCA5;NRF1;DLL1;PAX2;RUNX1;SMARCA2;SERPINE1;CCDC62;DPF1;IL33;MED10;ENG;ARNT;SMAD9;RLF;MED4;E4F1;CEBPG;ABL1;PIN1;GCN1;POGZ;MAVS;HDAC5;NFATC2IP;PRDM2;TAL1;CSRNP2;NOTCH3;MLLT6;NCOA3;PROX1;TNIP2;ZMIZ2;NRIP1;POU2F2;TCF3;OSM;IRF3;WASL;MED25;AKNA;STAT6;ZMIZ1;HDAC8;RPS6KA4;MAPK7;GLMP;ARRB1;KDM1A;POU2F1;GATA3;RNF4;KAT5;HMGB2;SLC11A1;LPIN1;LMO1;SSBP4;PPRC1;MITF;IRF2;CAMK1;E2F3;NR1H2;IL4I1;TOX2;RBMX;XRCC6;NOD2;CASZ1;TNIP1;NOS1;EPC1;CDK8;SETD3;PAXBP1;GLIS1;THAP3;ZNF513;NLRC5;DDX3X;KAT6B;HIVEP1;E2F5;ZC3H12A;KANSL3;CXCL10;TWIST1;RFXANK;SMARCA4;NFIA;MED12;RPRD1B;ATAD2;GLYR1;ARF4;PARK7;LMO2;FGF1;BMP2;WBP2;TP53;TGFB1;JUP;YY1;AGO1;DR1;DVL2;KLF15
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4602700363334393,1.1251593074067323,0.310546875,0.7643892439946507,1.0,4/11,24.34%,UNC93B1;TNIP2;TICAM1;FADD
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4416228832350747,1.1250496843211815,0.3159851301115242,0.7638156387712581,1.0,3/14,8.32%,IL18;CD84;IL12B
prerank,sterol homeostasis (GO:0055092),0.31004146304602287,1.1244972338904784,0.2634228187919463,0.7646380137152018,1.0,11/65,13.28%,IL18;LIPC;LRP5;CNBP;APOM;LCAT;NPC1;CYP7B1;TTC39B;NPC2;LDLRAP1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4600216191090689,-1.124308231749123,0.3169734151329243,0.757810362241114,1.0,3/11,6.40%,ATL2;VCPIP1;RTN4
prerank,aerobic electron transport chain (GO:0019646),0.3091906136311707,1.1242608718487743,0.25675675675675674,0.7644970828155664,1.0,25/68,27.09%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;UQCRB;UQCRC2;NDUFS4;NDUFS3;NDUFB3;NDUFAF1;COX5A;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;COX6B1;NDUFB11;NDUFC2;COX6A2;NDUFV1;NDUFB4;UQCRC1;AFG1L
prerank,regulation of amyloid-beta formation (GO:1902003),0.35175003581681086,1.124204513038632,0.29471890971039183,0.7637319115293598,1.0,4/34,4.25%,BIN1;GSAP;PICALM;CLU
prerank,membrane protein proteolysis (GO:0033619),0.3425363106255232,1.1240930377517486,0.2806026365348399,0.7631706878651663,1.0,20/37,32.18%,MYH9;MBTPS1;TMPRSS6;MBTPS2;PSENEN;PSEN2;SPPL2B;ADAM10;APH1B;AFG3L2;RBMX;ADAM17;ERAP1;TGFB1;APH1A;TRAF6;NFKB1;SPPL3;ADAM9;CTSH
prerank,carbohydrate biosynthetic process (GO:0016051),-0.38615883316957034,-1.12404464132028,0.27069351230425054,0.7572624465916523,1.0,3/21,1.98%,B3GALT1;ST3GAL4;FUT9
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2313372838479164,1.1240396753452293,0.10386473429951691,0.7624152601827793,1.0,174/807,18.84%,ZFHX3;SALL1;IKZF1;ETV5;BASP1;MLXIPL;RREB1;SMAD3;DNMT3A;SUMO1;SMAD7;CAPN3;PRMT2;PHF21A;HEYL;HOXD9;MEF2C;DDIT3;SOX8;DDX5;PBXIP1;SKI;SBNO2;SIRT2;PPARD;ZFP90;CNOT1;FOXE1;MTA1;CCDC85B;KLF11;GPS2;VHL;CRY2;HDAC10;DEAF1;PHB2;SAMD1;ERF;PAX6;FLCN;SKIL;ZNF568;CUX1;SUDS3;ID1;CTR9;CHD8;IMPACT;ZBTB21;LOXL3;ELK3;RPS6KA5;RPS27A;UBC;MLX;GTF2IRD1;FOXK2;ATF3;BCOR;ZBTB18;MDM4;MDFI;EID2;PDGFB;SHH;MTDH;THAP1;SIN3A;C1QBP;ZMYND11;BCL7A;FOXN3;JUN;BRCA1;CNBP;SARS1;SAMD11;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;SAMD13;HAMP;ANKRD2;TWIST2;POU4F1;DPF2;EHMT2;TMPRSS6;LIMS1;MIDEAS;KLF12;CHD3;MOSPD1;PATZ1;NPAS1;PPID;MEF2A;INPP5K;NR2F1;EID2B;MBD1;PRDM1;NOTCH4;IRF8;CXXC5;PRDM11;RPL10;PAX2;RUNX1;SMARCA2;TBX6;TCF25;IRF2BP2;PCGF2;TAF1;DPF1;IL33;KDM4A;MAP3K10;E4F1;MXI1;PRMT6;SEMA4D;BRMS1L;DDX20;EZH2;GCLC;WWP2;ID3;PLK3;ZNF3;HDAC5;PRDM2;NDUFA13;PROX1;MXD1;NOG;EED;NRIP1;TCF3;FST;COMMD7;SCMH1;ACVR2B;VGLL4;ZEB1;MED25;TGIF1;SIN3B;MYPOP;UXT;HDAC8;QARS1;ZBTB2;KANK2;TSC22D4;LIN37;KDM1A;POU2F1;GATA3;KDM8;KAT5;HMGB2;CHMP1A;CUX2;DKK3;MITF;KHDRBS1;MIER3;IRF2;EID1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4750587801674728,1.1238823497153683,0.33826247689463956,0.7619972384706765,1.0,2/10,1.68%,IL18;LGALS9
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.45122614253297644,-1.123846884273442,0.33771929824561403,0.7566201690996156,1.0,5/12,23.10%,TNKS2;PARP12;TIPARP;PARP3;PARP10
prerank,chordate embryonic development (GO:0043009),0.31634154020198857,1.123574255268291,0.2691029900332226,0.7620592142250655,1.0,22/55,29.31%,TGFBR1;SOX8;DEAF1;CHD7;FLCN;ZNF568;BRCA1;WNT7B;PROX1;NOG;ADAM10;GATA3;PTCH1;BMP2;TGFB1;FGFR2;SULF1;ISL1;MBNL1;PTPRR;WNT5A;ALDH1A2
prerank,organophosphate ester transport (GO:0015748),0.3774968724406631,1.1233649100960206,0.30144404332129965,0.7618737195039963,1.0,11/24,24.53%,PCTP;PITPNC1;EPG5;NPC2;OSBPL5;PITPNM1;SCARB1;MTTP;PRELID2;SCP2;PITPNB
prerank,positive regulation of reproductive process (GO:2000243),0.3570574314006737,1.1231262714949668,0.28771929824561404,0.7617298440580272,1.0,6/31,15.34%,LHFPL2;SIRT2;TAC4;C1QBP;PGAM4;VIP
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.37955207572304,1.1229873932307322,0.2994652406417112,0.7613071965867867,1.0,4/23,5.31%,CADM1;LGALS9;ARRB2;RAET1E
prerank,endochondral bone morphogenesis (GO:0060350),0.4711038529214423,1.1229058818079334,0.31666666666666665,0.7606553252226981,1.0,2/11,1.71%,TMEM119;MEF2C
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.249562244849213,1.1228454950696651,0.1678224687933426,0.7598993659947288,1.0,86/327,24.27%,TGFBR1;ZFHX3;ZSCAN26;MLXIPL;DNM2;RREB1;DENND4A;MEF2C;DDIT3;LYL1;SBNO2;FUS;SRRT;CHEK2;KMT2D;EFEMP1;VHL;HDAC10;CHD7;REXO4;CTR9;RPS6KA5;MLX;GTF2IRD1;RHOH;FOXK2;TAF6L;THAP1;CXXC1;FOXN3;CNBP;APBB2;SOX17;CHD3;PATZ1;RNF20;POFUT1;ZSCAN21;NUP35;NFYA;SMARCA2;FADS1;ENG;CDK11B;ABL1;HP1BP3;EZH2;TRAPPC2;PRDM2;MLLT6;SPTY2D1;TCF7L1;TCF3;TAF5L;ACVR2B;ZMIZ1;CCAR1;RPS6KA4;HES6;NUP107;CARM1;ZBTB11;MITF;IRF2;WTIP;DMTF1;PTP4A3;SAP30L;CASZ1;GZF1;CRABP2;KAT6B;ZFPL1;NFIA;BNC2;BMP2;SCRT1;MSC;TP53;LIN54;TGIF2;SUFU;ACVR1B;DVL2;ZNF628;TAF5
prerank,epithelial structure maintenance (GO:0010669),0.4802603086738502,1.1225457031072847,0.32765151515151514,0.7598827194061438,1.0,4/11,27.12%,CXADR;MUC6;NOD2;TLR9
prerank,regulation of response to biotic stimulus (GO:0002831),-0.3493684068447916,-1.1224929929315304,0.2713004484304933,0.7596766262331273,1.0,6/28,14.67%,CD36;PTPN22;FOXP1;FCGR2B;SAMHD1;CX3CL1
prerank,tube closure (GO:0060606),0.3526664117232187,1.121986957399532,0.28452579034941766,0.7607019223271599,1.0,14/31,25.77%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,detection of mechanical stimulus (GO:0050982),-0.38737261447141924,-1.1219452083411818,0.3180873180873181,0.7600205171766395,1.0,9/19,34.64%,PKD2;PKD1;PIEZO2;CTNNB1;PTK2;LHFPL5;TTN;PKD1L1;PKD2L1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4318855257480477,-1.1218298011168302,0.3259423503325942,0.7590406954516933,1.0,5/13,16.08%,CD74;CD44;SIRT1;MDM2;SNAI2
prerank,cGMP metabolic process (GO:0046068),-0.44317578879469144,-1.1216958509376873,0.30042918454935624,0.7581230123355832,1.0,5/12,18.61%,PDE9A;GUCY1B1;PDE2A;GUCY2F;GUCY2D
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.32051612873599983,1.121673053335822,0.2762237762237762,0.7608366968387401,1.0,21/54,26.27%,ETS1;MEF2C;PRKCA;AGTR2;PDPK1;PDGFB;GATA2;AKT1;MAPK14;PRCP;THBS1;FGF18;EPHA2;ADAM17;ANGPT2;TGFB1;JUP;HIF1A;PLCG1;ATP2B4;SH3BP1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.46194331809953737,1.1216715313155587,0.32023575638506874,0.7599282758387578,1.0,3/11,3.41%,ABCD2;COA8;SLC30A10
prerank,regulation of cholesterol storage (GO:0010885),-0.409952472759808,-1.1215606463543588,0.3032967032967033,0.7571984848401812,1.0,3/15,4.09%,PPARG;MSR1;EHD1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.32105499847186153,1.1215324639977258,0.2590759075907591,0.7594631470281252,1.0,9/53,12.14%,GNA12;OPHN1;UCHL5;PRKACA;USP19;NUDT15;ECSCR;ARAF;PINK1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3572592972366231,-1.121463376350055,0.30995475113122173,0.756183565758897,1.0,6/27,10.47%,PPARG;PLTP;APOE;SIRT1;NFKBIA;ABCA5
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.379739406608162,1.1214603264285687,0.3087971274685817,0.7587695835808905,1.0,7/24,10.80%,TWF2;RAC1;PIK3R1;FSCN1;AVIL;AKIRIN1;CYFIP1
prerank,cardiac cell development (GO:0055006),0.4716745830598589,1.121446586022677,0.31868131868131866,0.7579272952644754,1.0,2/11,5.47%,CXADR;SLC8A1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.33862152718894817,1.1214356955229665,0.27871621621621623,0.7570636270894331,1.0,14/44,20.75%,BIN1;BAIAP2L2;CDC42EP2;PTK2B;CCR7;NCKAP1L;SPIRE1;PYCARD;TENM1;FCHSD2;CDC42EP3;VASP;CCL24;FCHSD1
prerank,modulation by symbiont of host process (GO:0044003),-0.4662477149461963,-1.1214144586360915,0.32489451476793246,0.7550036328447902,1.0,2/10,2.76%,MRC1;B2M
prerank,negative regulation of RNA splicing (GO:0033119),0.3938734506236944,1.1213281831162472,0.3074074074074074,0.7564811654239751,1.0,11/19,28.97%,U2AF2;SFSWAP;C1QBP;TMBIM6;RBMX;SRSF9;PTBP3;PCBP4;SRSF10;RPS26;RPS13
prerank,metal ion transport (GO:0030001),-0.2732319513653445,-1.121322943117002,0.22074468085106383,0.7539527360598658,1.0,24/86,17.16%,CACNA1E;ITPR1;SLC8A3;TRPC5;CCR1;RYR3;RYR2;TRPC4;TPT1;CACNA1C;PKD2;GRIN3A;TRPC3;CHRNA4;ATP2A3;NDFIP1;PANX1;MMGT1;CCL5;CACNA1B;SELENOK;CACNB3;MAGT1;TRPV6
prerank,negative regulation of cell development (GO:0010721),-0.36308297432786,-1.1211702520789433,0.29904306220095694,0.7531549271132983,1.0,9/25,25.21%,LILRB1;B2M;GSK3B;FBN1;LTF;WNT7A;REST;RFLNB;FBXW7
prerank,atrial septum development (GO:0003283),-0.4328759265009954,-1.1208160151515467,0.32603938730853393,0.7529790926920059,1.0,6/13,26.58%,ANK2;NPHP3;HEY2;GJA5;NOTCH2;ZFPM1
prerank,sodium ion transmembrane transport (GO:0035725),-0.2769460974805551,-1.1206896176419023,0.2418478260869565,0.7520763443845224,1.0,25/84,22.99%,HCN1;SLC8A3;SCN2A;NALCN;SLC24A2;SCN3A;PKD2;ATP1B3;ANO6;SLC6A15;ATP1A1;SLC4A8;HCN2;SLC9A4;ASIC3;SCN9A;SLC12A1;SLC6A16;SLC6A1;SLC6A6;SLC6A7;SLC9A2;SCN1A;HCN4;SLC12A3
prerank,RNA transport (GO:0050658),0.3068367995846467,1.1203446235515349,0.28452579034941766,0.7587115543287807,1.0,26/71,26.82%,SRRM1;TGFBR2;NCBP1;MAGOHB;MAGOH;U2AF2;DHX38;ZFP36L1;NUP62CL;SRSF5;RBM8A;U2AF1L4;SLU7;ALYREF;NUP62;THOC6;HNRNPA2B1;SRSF9;DDX39B;NUP153;XPO5;HNRNPA1;NUP188;THOC3;ZC3H11A;THOC5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3067459693580038,1.1201974325750734,0.2540983606557377,0.7582622374265339,1.0,23/62,22.95%,ARHGEF2;HYOU1;NFE2L2;SRC;CLU;NDUFS3;PTTG1IP;VNN1;RTKN2;PINK1;TMBIM6;NDUFA13;AKT1;ARMC10;MAPK7;TMEM161A;HTRA2;SYVN1;DDX3X;TXNDC12;BCL2L1;OPA1;PARK7
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33510236307572006,1.1200675448499806,0.2857142857142857,0.7577735532258492,1.0,11/43,17.57%,TGFBR2;MEF2C;SHH;SOX17;DLL1;TBX6;NDRG4;ENG;CCDC40;SMO;VANGL2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3576332826433778,-1.1200642557659217,0.29952830188679247,0.7527665552491867,1.0,6/26,11.43%,CUL3;HECW2;CDK5RAP2;CENPE;DLGAP5;UBE2C
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3248749439765208,1.1200001310434398,0.253781512605042,0.7570681804229366,1.0,10/51,8.60%,LGALS9;RIPK2;PYDC1;AGER;TLR4;EGR1;CCL3;CASP1;NLRP3;ORM2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4494659270365139,1.1199423989969557,0.33459357277882795,0.7563547017337832,1.0,8/12,26.12%,GART;PRPS1;PRPS1L1;MTHFD1;PRPSAP1;PRPSAP2;ADSL;AMPD2
prerank,positive regulation of programmed cell death (GO:0043068),0.24950905804197213,1.119453460102163,0.18077474892395984,0.7569481335744935,1.0,50/272,14.82%,BIN1;FGD2;ARHGEF2;DNM2;CTSD;PREX1;VAV2;ITGA6;QRICH1;PRMT2;CALHM2;CRADD;IGFBP3;KCNMA1;TGM2;KLF11;ATM;RHOB;CLU;FLCN;SUDS3;RPS27A;UBC;TRADD;ARL6IP5;C1QBP;JUN;WNT10B;NOS2;PIP5KL1;GPER1;AKAP13;PPID;SLC27A4;CLIP3;FGD3;PSENEN;BMF;TRIO;APAF1;PSEN2;MAP3K11;HIP1R;MAP3K10;ABL1;DDX20;MAPK8;SOD1;LATS2;PYCARD
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.43041185152774925,1.1190673972795582,0.3089983022071307,0.7572389374842807,1.0,4/15,10.78%,CST3;FSCN1;LRP1;DDR2
prerank,bile acid biosynthetic process (GO:0006699),0.37727954087277205,1.1186824365317798,0.2905525846702317,0.757485202809552,1.0,9/24,23.62%,CH25H;OSBPL3;CYP46A1;AKR1D1;CYP7B1;HSD17B10;OSBP;ACOT8;SCP2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.24964269405872946,1.118465880890619,0.17695473251028807,0.7572150278289045,1.0,108/314,27.76%,BAG6;FBXL18;NFE2L2;DDIT3;UCHL1;RNF216;ARRB2;SEL1L;SIRT2;SMURF1;ITCH;MTA1;DNAJB9;FBXL20;SPSB1;FBXL15;RPS27A;UBC;RFFL;FBXW4;ZSWIM8;SPSB2;MAEA;PCBP2;TRIM72;CDC34;USP19;CUL4B;ANKRD9;OS9;CRBN;RNF103;BFAR;PSMD3;UFD1;AREL1;KCTD2;FBXL8;FBXL2;ANAPC15;PSMB3;AUP1;TAF1;UBE2U;PSMA7;RNF187;WWP2;DCAF11;PSMC1;PSMC2;FBXL22;FBXO38;PSME4;AURKA;UBE2A;MAN1B1;EDEM1;NEMF;PSMB9;ANAPC11;UBXN2A;ARRB1;UBE4A;ANKZF1;SPOPL;TNFAIP1;RNF4;KAT5;STUB1;CUL4A;DCAF12;ZFAND2A;GID8;TRIM3;PSMD4;PSMB5;TOPORS;SYVN1;RNF121;RNF34;FBXL7;PSMB7;GID4;ANAPC1;PSMB8;LTN1;ZNRF1;ANAPC2;UBXN1;FBXW5;RAD23B;FBXL3;KCTD5;PSMD13;NPLOC4;FBXL14;DNAJB14;UBE2G2;CUL1;ECPAS;RHBDD2;TBL1X;FBXO2;FBXO17;ANAPC16;FBXL12;SGTA;PSMD2
prerank,positive regulation of cell death (GO:0010942),0.30818169293907216,1.1183802407166086,0.26517571884984026,0.7566088759415495,1.0,12/59,10.22%,ITGAM;RIPK2;PICALM;ITGB2;EGR1;CLU;EIF4G1;EIF2S1;C1QA;CALCR;ACER2;LRP1
prerank,negative regulation of proteolysis (GO:0045861),0.34333903104518626,1.1182065572211208,0.3126079447322971,0.7562687564614808,1.0,9/34,18.18%,BAG6;CST3;CLN3;SERPINE2;DNAJC1;AKT1;ACP4;GAS1;TMEM59
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.46537720631483537,-1.1180515252225318,0.3333333333333333,0.7577186124770946,1.0,6/10,31.18%,PRKN;SNCA;HP;ETFBKMT;GZMA;AOC3
prerank,glutathione biosynthetic process (GO:0006750),-0.4482680756807792,-1.1180138678439233,0.30180180180180183,0.7565139626671172,1.0,2/11,7.43%,GSS;GGCT
prerank,response to laminar fluid shear stress (GO:0034616),0.480731932604708,1.1178255100338677,0.3320388349514563,0.7565586490272257,1.0,2/10,1.25%,SMAD7;NFE2L2
prerank,myotube differentiation (GO:0014902),0.41319158622111163,1.1174530203796276,0.3104089219330855,0.7568454384354404,1.0,5/17,8.10%,MEF2C;SKI;JAM2;SORT1;KLHL40
prerank,neuromuscular process (GO:0050905),-0.4034599125523351,-1.1168664221394675,0.3063457330415755,0.7588882392631171,1.0,1/16,0.11%,NRXN1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.28340437193537193,1.1166695832077516,0.24013157894736842,0.7584172618169298,1.0,20/107,9.09%,SLC30A5;ATP13A1;ATP2C1;SLC24A3;SLC30A10;PKHD1;CCL3;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SLC8A1;EDN3;SLC30A8;EDN2;MT2A
prerank,regulation of neuron differentiation (GO:0045664),0.2987983202906157,1.1166211841714955,0.25412541254125415,0.7577069416302472,1.0,13/76,11.38%,BIN1;ZFHX3;ARHGEF2;HEYL;YWHAH;MEF2C;MMD;IMPACT;NREP;SIN3A;CDK5RAP1;DTX1;DLL1
prerank,epithelial to mesenchymal transition (GO:0001837),0.32560720215213196,1.1165936431685515,0.25126475548060706,0.7569101976380005,1.0,17/47,24.80%,TGFBR1;HEYL;DDX5;LOXL3;LIMS1;DDX17;NOTCH4;ENG;NOG;AKNA;ROCK2;TASOR;BMP2;DLG5;TGFB1;SOX9;HIF1A
prerank,regulation of transforming growth factor beta production (GO:0071634),0.41729670324923307,1.1165378757005162,0.3076923076923077,0.7562286122171457,1.0,4/18,9.70%,SMAD3;LGALS9;ITGAV;CD34
prerank,aminoglycan catabolic process (GO:0006026),-0.3465307239414808,-1.1161418625389685,0.2825112107623318,0.7598742351527833,1.0,13/28,25.67%,GPC6;HGSNAT;SDC3;GPC5;HSPG2;GPC3;GPC4;AGRN;FUCA1;GPC1;SGSH;IDUA;SDC2
prerank,positive regulation of defense response (GO:0031349),0.28944618243064113,1.1161331696252426,0.25326797385620914,0.7566633901875389,1.0,20/89,17.12%,IL18;TLR7;POLR3G;ETS1;MEF2C;TLR4;SLC15A4;CCL3;AKIRIN2;TRADD;DHX9;IL12B;DDT;SERPINE1;IL33;OPTN;OSM;GBP5;GPR4;AGT
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.47056722920575345,-1.1159620898949145,0.3508771929824561,0.7591313416730452,1.0,2/10,9.18%,PID1;GRB10
prerank,cellular response to ketone (GO:1901655),-0.3295443452785254,-1.1158138245234006,0.2857142857142857,0.7582567145998217,1.0,13/35,18.94%,ADCY2;KLF9;GOLPH3;ADCY5;SPP1;GNAI1;ADCY3;ADCY8;AHR;SFRP1;CFTR;NR3C1;MSN
prerank,cellular response to glucose starvation (GO:0042149),0.33540252368450896,1.1155516175715585,0.2925531914893617,0.7575841463775569,1.0,14/41,25.00%,NUAK1;ATG14;IMPACT;PIK3C3;SH3GLB1;NUAK2;PICK1;EIF2AK3;PMAIP1;ZC3H12A;SESN1;TP53;HNRNPA1;RRP8
prerank,glycogen metabolic process (GO:0005977),-0.35900942263910524,-1.1153504856597674,0.3195121951219512,0.7584737365249379,1.0,11/27,21.20%,PRKAG2;GSK3B;CALM1;GBE1;PER2;GYG1;PYGM;PHKG1;STBD1;UGP2;PGM2L1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3924434708413149,-1.1149815510485765,0.30752688172043013,0.7583701760821031,1.0,8/17,23.13%,ROBO1;SLIT2;JAG1;HEY2;BMP4;ROBO2;GJA5;NOTCH2
prerank,regulation of coagulation (GO:0050818),-0.4511620996124609,-1.114944593958603,0.34475374732334046,0.7571966567366477,1.0,1/11,0.65%,HS3ST5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.35717673781449566,-1.114668409209889,0.28929384965831434,0.7567784782340901,1.0,6/25,11.14%,HIP1;RBPJ;RTN4;DOK1;CCDC88A;PDE6H
prerank,regulation of humoral immune response (GO:0002920),0.3315983801715364,1.1144516520738603,0.2847571189279732,0.7600761318794805,1.0,7/44,8.12%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP;CCR7
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3408915812220645,1.1143755444896273,0.28619528619528617,0.7594204270507511,1.0,4/40,2.55%,TGFBR1;TGFBR2;SMAD3;TGFB1I1
prerank,regulation of translation (GO:0006417),0.26472249383656027,1.1143162001535958,0.20890937019969277,0.7587063342702655,1.0,47/173,20.49%,PLD1;NCBP1;EIF4A2;RPS6KA1;CNOT1;CTIF;ETF1;EIF4G1;IMPACT;ENC1;EIF2A;NSUN5;METTL5;DHX9;NANOS2;PKP3;GAPDH;MTOR;EIF4H;EIF2B4;CYFIP1;MIF4GD;RPL10;TOB1;RPS27L;MRPL13;IGF2BP2;SHFL;PASK;EIF2AK2;NEMF;RIDA;METTL14;EPRS1;EIF3D;FXR2;THBS1;NSUN3;MTIF2;EIF1B;EIF1;EIF5;CAPRIN1;TYMS;EIF2AK3;PCIF1;NANOS1
prerank,regulation of B cell proliferation (GO:0030888),0.327885014327864,1.1141499281874725,0.2953020134228188,0.7583326131020799,1.0,9/44,7.30%,SASH3;MEF2C;LYN;ATM;TNFRSF21;TNFSF13B;TNFRSF13C;CD320;TNFRSF13B
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2929396589726402,-1.113968929542171,0.26854219948849106,0.7577157761118122,1.0,18/56,19.58%,PLCB1;EGFR;FGF10;CUL3;KMT2E;ANKRD17;CCND2;UBE2E2;DLGAP5;UBE2C;CDC25C;RGCC;RCC2;CCNB1;CDK4;DTL;TFDP1;STOX1
prerank,metanephros development (GO:0001656),0.36662555809838804,1.113771632219662,0.2979094076655052,0.7585945571936138,1.0,6/26,11.39%,BASP1;SHH;GDNF;SOX17;WNT7B;PAX2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.35893312286647444,1.1129131545653983,0.3041958041958042,0.7603723904337896,1.0,3/31,1.66%,TGFBR1;TGFBR2;HOXD9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.32369226414110003,1.1129051725886523,0.2862190812720848,0.7595173766951284,1.0,7/49,4.87%,LDLRAD4;PMEPA1;PYDC1;CPTP;SRC;CLU;IMPACT
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.37941233739764724,1.112596734307326,0.28810408921933084,0.7595626031343251,1.0,5/25,7.34%,SMAD3;TLR4;AGTR2;CLU;NOS1AP
prerank,negative regulation of JNK cascade (GO:0046329),0.35349386888993434,1.1122347569461042,0.30303030303030304,0.7598540457935404,1.0,7/31,13.75%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31;PINK1;MAPK8IP1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.29501844296496804,1.1119739928348982,0.2586490939044481,0.7598548020394026,1.0,26/78,20.62%,NUMB;MRAP;ABI3;PIK3R1;PICALM;AKAP5;RHOQ;PDPK1;ZDHHC5;GPER1;CLIP3;APPL1;LRP1;CLN3;ZDHHC7;LDLRAP1;STX4;AKT1;CIB1;PPP2R5A;MRAP2;TMEM59;VPS4A;WNK3;EPHA2;PRKCH
prerank,response to ATP (GO:0033198),0.40063577699854563,1.1119386777404965,0.336283185840708,0.7591052378689835,1.0,4/18,12.06%,P2RY12;ABCC9;SSH1;TAF1
prerank,B cell activation (GO:0042113),0.30601650835865896,1.1118683097645126,0.26232114467408585,0.7584878419774022,1.0,12/68,10.51%,BLNK;MEF2C;LYL1;FCRL1;LAT2;GPS2;DNAJB9;PHB2;PLCG2;CD86;PIK3CD;PRKCB
prerank,regulation of hydrolase activity (GO:0051336),-0.2892105476124589,-1.1114449460254945,0.23573200992555832,0.7642968864273365,1.0,18/71,14.24%,ARHGAP15;VAV3;PRKG1;PLXNC1;NTRK2;FGD6;PLXND1;FGD5;PLXNA2;CHN1;EPHA5;PLXNB2;FGD4;ITGB1BP1;EFNA5;RALBP1;PLXNB1;OCRL
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.2886867195167835,-1.1113855405079047,0.24937027707808565,0.763171449505934,1.0,13/67,9.84%,NEDD9;DOCK5;UTRN;CD36;JAK2;VIT;FN1;GSK3B;CDC42;SKAP1;CARMIL1;MYADM;CDH13
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.44868131581765314,-1.1111085266611,0.3370288248337029,0.7627880281897327,1.0,6/11,28.38%,STK26;PRKN;UBQLN1;FYN;REST;LANCL1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.36018749339778505,-1.1109594820517186,0.28888888888888886,0.7619817661513496,1.0,7/24,10.68%,ITPR1;RYR3;RYR2;HTR2C;HTR2B;PKD2;ERO1A
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4382066888438487,-1.110305181566566,0.33263157894736844,0.7627591845354332,1.0,3/12,15.31%,BICD1;CEP19;CCDC120
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4644004727063684,-1.110285423977827,0.336283185840708,0.7615426067365257,1.0,2/10,11.64%,DPYD;UPP2
prerank,regulation of gene expression (GO:0010468),0.22833133629850216,1.1100501936754306,0.12914691943127962,0.7634697361370849,1.0,252/903,24.37%,TGFBR1;ZFHX3;TMEM119;SNRNP70;SIRPA;ZSCAN26;MLXIPL;DNM2;RREB1;SON;SMAD3;DENND4A;ETS1;FAM98B;NFE2L2;LGALS9;SLC7A5;MEF2C;DDIT3;VSIR;LYL1;AIF1;COQ7;CLK1;SBNO2;PICALM;CRNN;FUS;SRRT;TRIM11;TLR4;CHEK2;MTA1;LYN;KMT2D;EFEMP1;VHL;TRIM5;SLC24A3;ATG14;HDAC10;HNRNPDL;CIAO3;EGR1;ATM;CCL3;PAX6;CLU;CHD7;PLCG2;FLCN;REXO4;CTR9;LRRC19;RBL2;CALCOCO1;NDFIP2;RPS6KA5;SLC8A1;MLX;LGMN;SPRY2;GTF2IRD1;RHOH;SORT1;FOXK2;TRIM44;MOV10;SART3;PDGFB;TAF6L;PCBP2;HNRNPH1;SHH;THAP1;CXXC1;ADNP;GCNT2;NOS1AP;CLK4;FOXN3;ZFP36L1;FLOT2;BRCA1;CNBP;APBB2;OVOL2;GATA2;EDN3;CNTF;BCL6B;NOS2;GDNF;PKP3;IL12B;GPER1;CALCR;SLC22A2;SOX17;UTY;POU4F1;LIMS1;ZUP1;CHD3;PATZ1;PIK3CD;CD34;MTOR;C1D;PRDM1;PIK3CB;RNF20;PABPN1;USP36;ESRP1;POFUT1;PRDM11;ZSCAN21;NUP35;LAMTOR5;NFYA;RUNX1;TOB1;SMARCA2;HAVCR2;TCEAL1;ANKRA2;TAF1;TRA2B;PINK1;MUSK;FADS1;TARDBP;NFKBID;IL33;ENG;KDM4A;CDK11B;GJA1;ABL1;PIN1;RNF187;POGZ;HP1BP3;NWD1;EZH2;WWP2;MAPK8;TRAPPC2;HDAC5;IGF2BP2;PRDM2;AKT1;SMO;MAPK14;HPN;MLLT6;CSF1;PROX1;SPTY2D1;NOG;PIK3R3;MAP2K1;CDH3;TCF7L1;TCF3;TAF5L;AURKA;PDCD10;ACVR2B;LGALS7;ADAM10;ANXA7;RAB27A;CCAR1;RPS6KA4;HES6;ROCK2;GATA3;NUP107;TICAM1;SLC11A1;CARM1;CUX2;ZBTB11;MITF;IRF2;MBIP;WTIP;FGF18;PPM1F;DMTF1;TNRC6C;PTP4A3;VPS35;TDRD7;TNRC6B;EIF2AK3;CRKL;PRDM9;SAP30L;CASZ1;IL1A;NANOS1;FGFR4;MAPT;HNRNPH3;HGS;SFRP4;GZF1;ZNF513;RBM38;FGF20;CRABP2;DDX3X;KAT6B;ZC3H12A;SLC8A2;TWIST1;LARP1;RFXANK;ZFPL1;CLK3;NFIA;BNC2;PTHLH;PARK7;FGF1;IL36G;BMP2;SCRT1;MSC;MYD88;TP53;TGFB1;LIN54;TGIF2;SUFU;PLA2G3;YY1;AGO1;TYROBP;NOVA2;ACVR1B;DVL2;SETDB1;HNRNPLL;DNAJA4;ZNF628;TAF5;PTBP3;SOX9
prerank,positive regulation of type I interferon production (GO:0032481),0.2934659330778656,1.1099114855958405,0.2722602739726027,0.7630108349934883,1.0,17/73,16.55%,TLR7;POLR3G;RIPK2;POLR2H;TLR4;DHX9;CGAS;POLR3H;GAPDH;G3BP1;PTPN11;SETD2;MAVS;POLR1C;IRF3;POLR2E;STAT6
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.45517465500963106,-1.1094768488218383,0.326271186440678,0.7628845724926401,1.0,3/11,23.17%,LMNA;FOXO1;MLIP
prerank,modification-dependent protein catabolic process (GO:0019941),0.2605904677688095,1.1089136876860914,0.20937042459736457,0.7651918724433082,1.0,53/193,22.27%,BAG6;PCYOX1;FBXO22;SMURF1;ITCH;SPSB1;UBE2H;NDFIP2;RPS27A;UBC;RFFL;FBXW4;SPSB2;ARRDC1;CDC34;OS9;RNF8;BFAR;PSMD3;UFD1;RNF20;RNF166;AREL1;MYLIP;ANAPC15;TAF1;PINK1;ZNRF3;FBXO21;PSMC2;KCTD6;RNF144B;RNF7;RNF11;NTAN1;AURKA;UBE2A;FBXO11;ANAPC11;DTX3L;ARRB1;UBE4A;STUB1;UBQLN4;WDR81;TOPORS;SYVN1;RNF34;FBXL7;UBE2R2;KLHL3;ANAPC1;RC3H2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42410622882556537,-1.108825064746524,0.33766233766233766,0.7636726090143707,1.0,5/14,18.84%,ITGA4;CD40;ANO6;RGCC;PRKCI
prerank,amide biosynthetic process (GO:0043604),-0.30300449123895684,-1.1087157193967796,0.2744630071599045,0.7627244631937898,1.0,7/47,7.44%,DMD;PAM;PCSK5;SGMS1;SGMS2;SPTSSA;ASL
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4199626594602984,1.1084741918657968,0.31868131868131866,0.7655925713779096,1.0,9/15,34.82%,ENTPD1;CMPK1;ENTPD7;ENTPD6;AK8;ENTPD3;AK1;AK7;CMPK2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.38773774218106516,1.108343674865736,0.31099656357388317,0.7651210259077185,1.0,8/22,19.67%,MVB12B;VPS37D;VPS37A;VPS36;PTPN23;VPS4A;TSG101;VPS37B
prerank,actomyosin structure organization (GO:0031032),0.295393028186136,1.108237177053789,0.2585669781931464,0.7645586964555829,1.0,7/75,3.80%,EPB41L2;ITGB5;F11R;CAPN3;FLII;MYH9;SRC
prerank,regulation of lymphocyte activation (GO:0051249),0.4507360071946923,1.108094802314103,0.3410714285714286,0.764148226343874,1.0,1/12,0.03%,PAG1
prerank,negative regulation by host of viral transcription (GO:0043922),0.44502368410151244,1.1080810206697365,0.3357664233576642,0.7633286069779034,1.0,4/12,12.38%,CCL3;JUN;INPP5K;TARDBP
prerank,histone acetylation (GO:0016573),0.2992370450306624,1.1076879285520371,0.2644628099173554,0.7636915880764741,1.0,25/69,24.97%,BRD8;TAF12;TAF6L;TAF6;CPA4;ACTL6A;MORF4L1;MRGBP;NAA50;TAF5L;TADA1;KAT5;JADE2;MBIP;NAA40;MORF4L2;EPC1;PHF20;TAF10;KAT6B;DR1;TAF5;NAA60;WDR5;BRD1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.33649601014272085,-1.1075848023941313,0.2727272727272727,0.7650348585573166,1.0,8/31,12.91%,DCUN1D2;RPS2;UBE2N;BTRC;AXIN1;ARRDC3;UBE2C;DCUN1D3
prerank,DNA duplex unwinding (GO:0032508),0.31508964164905623,1.107244063996037,0.2894308943089431,0.7641873918685891,1.0,11/50,13.13%,DDB2;NBN;GTF2H2;RPS27A;UBC;MCM2;ERCC2;DHX9;CUL4B;SSBP1;BLM
prerank,lymphocyte migration (GO:0072676),-0.3381503395801625,-1.1069179594736902,0.30963302752293576,0.7659684112475419,1.0,13/32,32.58%,MYO1G;RET;CCL5;CCL14;CX3CL1;CCL7;MSN;TBX21;CRTAM;CCL19;CCL8;MSMP;CCL4
prerank,global genome nucleotide-excision repair (GO:0070911),0.36845765529330354,1.1065428211660089,0.32241379310344825,0.7655099826760539,1.0,6/26,7.40%,DDB2;GTF2H2;RPS27A;UBC;ERCC2;CUL4B
prerank,cellular response to amyloid-beta (GO:1904646),-0.3280621596606582,-1.1064538119736296,0.30414746543778803,0.7660730012149136,1.0,8/35,11.11%,ITGA4;GRM5;CD36;GRIN2A;APP;GSK3B;VCAM1;FCGR2B
prerank,positive regulation of interleukin-4 production (GO:0032753),0.40427468242776715,1.1061604437459278,0.3303411131059246,0.765821294241717,1.0,5/17,11.73%,LGALS9;SLC7A5;CD86;NLRP3;HAVCR2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2610099899524034,1.1060599482668565,0.2430858806404658,0.7652591286613964,1.0,35/170,15.23%,TBC1D16;SIRPA;AIF1;COQ7;CRNN;TRIM11;TRIM5;HNRNPDL;CIAO3;SLC8A1;SORT1;TRIM44;SART3;PCBP2;SHH;ADNP;ZFP36L1;EDN3;GDNF;UTY;ZUP1;C1D;PRDM1;PRDM11;TOB1;ANKRA2;MTMR4;TARDBP;NFKBID;PIN1;RNF187;POGZ;IGF2BP2;PRDM2;PROX1
prerank,peptidyl-lysine acetylation (GO:0018394),0.46854141906593716,1.1060417026033356,0.32710280373831774,0.7644566580207658,1.0,1/10,0.48%,BAG6
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.43300230076825985,1.1057196143177837,0.3441682600382409,0.7646049031329094,1.0,3/15,7.31%,SMOC2;LGMN;MET
prerank,neural tube closure (GO:0001843),0.3449380835964964,1.1056994239886422,0.3106312292358804,0.763815464893951,1.0,15/34,25.77%,SKI;SEMA4C;DEAF1;PAX2;MTHFD1;VANGL2;VASP;KDM2B;TGFB1;CELSR1;DVL2;PRICKLE1;IFT122;SCRIB;GRHL3
prerank,lung epithelium development (GO:0060428),-0.4666669178651005,-1.1055866796525855,0.3271604938271605,0.7675800052566757,1.0,5/10,22.66%,FGF10;RCN3;PKD1;BMP4;GRHL2
prerank,protein deacetylation (GO:0006476),0.33004558510373927,1.1054093751009164,0.29701230228471004,0.7638745408511557,1.0,17/41,26.90%,SIRT2;MTA1;HDAC10;SUDS3;RBM14;SIN3A;MIDEAS;MORF4L1;BRMS1L;HDAC5;SIN3B;MIER3;MORF4L2;BRMS1;HDAC6;HDAC11;TBL1X
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3475375541351929,-1.1053659724498612,0.2929061784897025,0.7669964318277991,1.0,5/26,7.18%,IQGAP1;EGFR;GAREM1;PTPN12;PDE8A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.4302671571964205,1.1052824933732217,0.3237410071942446,0.7634153286667924,1.0,6/14,12.54%,MEF2C;IGFBP3;AIF1;LRP1;SERPINE1;NDRG4
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.3868112848000177,-1.105009543435514,0.2873303167420814,0.7668137979379486,1.0,3/20,1.98%,B3GALT1;ST3GAL4;FUT9
prerank,striated muscle cell development (GO:0055002),0.431386100233422,1.1048670948859762,0.3339382940108893,0.7638309877096535,1.0,2/14,2.11%,CAPN3;FLII
prerank,response to glucose (GO:0009749),0.3248826530947974,1.1047663276394037,0.3079584775086505,0.7632789649510251,1.0,16/46,24.88%,PRKACA;PFKL;IGF1R;EIF2B3;SLC30A8;GPER1;EIF2B4;PAX2;TRA2B;KHK;THBS1;SELENOT;PCK2;KCNB1;EIF2B2;GPLD1
prerank,protein O-linked glycosylation (GO:0006493),0.2885663483907319,1.1046325754447925,0.28680981595092025,0.7628439693180742,1.0,22/96,13.56%,LARGE1;XXYLT1;B3GNT2;TRAK1;GALNT12;GALNT5;POMGNT1;GALNT10;TET3;GALNT1;DPM3;MUC6;B3GNT4;POMT1;POFUT1;GALNT11;EOGT;GALNT15;GALNT7;GXYLT2;GALNT3;ST3GAL3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3967195204473705,-1.1045570472721389,0.3078556263269639,0.7670396066792977,1.0,7/16,18.11%,RPS3;TPT1;CCAR2;NACC2;SNAI2;SFRP2;DDIAS
prerank,response to UV-B (GO:0010224),-0.4378565312876444,-1.1042367550994916,0.3237885462555066,0.7668401425828512,1.0,7/12,29.29%,MME;CRIP1;CDKN1A;MFAP4;MSH2;RELA;IL12A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.42125772564434566,-1.1042129007688515,0.32461873638344224,0.7656565915515687,1.0,4/13,9.84%,PPARG;CD36;LDLR;CDH13
prerank,regulation of translational initiation (GO:0006446),0.30379604858147624,1.1041704493472468,0.29769736842105265,0.7634242591353234,1.0,25/63,26.50%,NCBP1;EIF4A2;POLR2D;CTIF;EIF4G1;IMPACT;ATF3;EIF4H;MIF4GD;UHMK1;EIF4EBP2;KHDRBS1;MTIF2;EIF1B;EIF1;EIF5;EIF2AK3;BOLL;DDX3X;LARP1;EIF4G2;EIF2B2;HABP4;YTHDF3;RBM4
prerank,regulation of peptidase activity (GO:0052547),0.3966941014800545,1.1040663921152158,0.3190394511149228,0.7628976543319836,1.0,6/19,22.37%,CST3;PINK1;NRDC;NDUFA13;FURIN;PSMB8
prerank,regulation of protein phosphorylation (GO:0001932),-0.23139527706058424,-1.1039946539707395,0.17647058823529413,0.7651045497124719,1.0,52/256,15.49%,PID1;DAB2;CD74;LRRK2;XDH;CCDC88C;GRM5;SLIT2;EGFR;FGF10;APP;KDM4D;CD40;NTRK2;LRP6;NTRK3;NPTN;FN1;PPIA;CCND2;CADM4;CEBPB;SH3GL2;ERBB4;SLCO3A1;VEGFD;PRKN;PDE8A;SIRT1;AXIN1;IRGM;MOB1B;MYADM;PLXNB2;CCDC88A;SPTBN4;LIMCH1;NSD1;FGF7;P2RY1;FGF9;PAQR3;CDH5;EFNA5;PTPN13;PECAM1;RALBP1;FER;PAK1;PRR5L;TEK;PLPP3
prerank,ceramide biosynthetic process (GO:0046513),0.33072997762184625,1.1037558285324776,0.3069139966273187,0.7630415352714801,1.0,10/40,13.68%,ST3GAL5;ALOXE3;CERS3;DEGS2;SPTLC3;PNPLA1;SMPD2;ASAH1;B4GALNT1;CERS2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3606389327892128,1.1037287498623227,0.31413612565445026,0.7622733199873825,1.0,10/28,20.24%,SIRPA;CCDC88B;CYRIB;IL12B;NCKAP1L;PYCARD;TNIP2;TICAM1;XRCC6;NOD2
prerank,positive regulation of behavior (GO:0048520),-0.45754998982785366,-1.1034799089831986,0.36616702355460384,0.7654259034111448,1.0,2/10,3.74%,NLGN1;SGIP1
prerank,positive regulation of catabolic process (GO:0009896),-0.28508112522680706,-1.1034695918898656,0.2708860759493671,0.7642112683560147,1.0,19/65,16.98%,WWP1;HECW2;HECW1;APC2;NEDD4L;GSK3B;BARD1;PRKN;PLK2;AXIN1;ATG7;GPC3;TIPARP;NKD1;TNFSF12;OAZ1;RILP;ANGPTL3;FOXO1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.41882256778022164,1.1032254739256395,0.30700179533213645,0.7629656423023232,1.0,5/16,12.38%,MOV10;ZFP36L1;ZFP36L2;RBM24;TARDBP
prerank,dendritic spine organization (GO:0097061),-0.3431441117937221,-1.10306686054949,0.3039647577092511,0.7643013655293793,1.0,5/26,6.72%,CTNND2;MTMR2;SHANK3;CDC42;PAK3
prerank,regulation of cellular metabolic process (GO:0031323),0.32230339585971857,1.1028432474930598,0.30973451327433627,0.7633205863517175,1.0,16/45,22.72%,TBC1D16;COQ7;BCO2;RNF41;SSH1;PDK2;PANK2;PINK1;NPC2;PM20D2;STUB1;VPS35;RSPO1;ARF1;RNF34;ARF4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2720903842759593,1.1024796273985136,0.24228395061728394,0.7635610047785132,1.0,48/128,27.51%,DNM2;SDCCAG8;TUBA4A;CSNK1E;PRKACA;CHEK2;FBXL15;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;FBXL8;TUBA1A;OPTN;CEP63;CEP57;PLK3;HAUS6;PPP1CB;HAUS2;SFI1;MAPRE1;FBXL22;AURKA;MASTL;CEP135;ACTR1A;KDM8;OFD1;KHDRBS1;DCTN2;CEP43;CCNY;FBXL7;CEP70;CSNK1D;FBXL3;CCP110;DYNLL1;AJUBA;NDE1;CUL1;HAUS5;ENSA;FBXL12;CDC25A
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3027950564472544,1.1020724300833518,0.2910321489001692,0.7639615449180217,1.0,25/69,27.09%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;UQCRB;UQCRC2;NDUFS4;NDUFS3;NDUFB3;NDUFAF1;COX5A;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;COX6B1;NDUFB11;NDUFC2;COX6A2;NDUFV1;NDUFB4;UQCRC1;AFG1L
prerank,regulation of interleukin-6 production (GO:0032675),0.2822244430421611,1.1015940497148662,0.265625,0.7645526218546397,1.0,27/96,22.14%,TLR7;SIRPA;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;AFAP1L2;DHX9;NOS2;IL6R;NCKAP1L;IL33;PTPN11;MAVS;PYCARD;POU2F2;SLAMF1;ARRB1;RAB7B;SETD4;SYT11;NOD2;IL1A;ZC3H12A;TWIST1
prerank,regulation of acute inflammatory response (GO:0002673),0.40327535764687517,1.1013600459494446,0.329136690647482,0.7644473696372243,1.0,4/18,15.99%,F12;IL6ST;NLRP3;OSM
prerank,regulation of cytokine production (GO:0001817),0.27319826638051375,1.1009692604514951,0.26666666666666666,0.7648650357823931,1.0,30/126,18.06%,SIRPA;CADM1;CCDC88B;LGALS9;LYN;PIK3CG;LRRC19;RPS6KA5;AFAP1L2;DTX4;CCR7;BCL6B;NOS2;IL12B;GAPDH;PLD4;PIK3CD;IRF8;SCAMP5;IL33;SOD1;IGF2BP2;MAPK14;GPNMB;EIF2AK2;IRF3;AGT;RPS6KA4;GATA3;SLC11A1
prerank,anterograde axonal transport (GO:0008089),-0.326595568713596,-1.1006271295461363,0.30973451327433627,0.770843791510535,1.0,10/37,18.91%,DLG2;KIF5C;KIF1B;AP3M1;AP3S2;KIF5B;DTNBP1;RAB27B;KIF4A;BLOC1S3
prerank,negative regulation of double-strand break repair (GO:2000780),-0.33824024715314155,-1.099914001949772,0.308584686774942,0.7718714221796749,1.0,10/30,19.22%,UBR5;TRIP12;PARPBP;OGG1;ERCC6;RNF169;CYREN;SHLD3;RIF1;FANCB
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45947204079355897,-1.0996935385529107,0.3405639913232104,0.7713536104302969,1.0,5/10,21.15%,TAF7;SIRT1;SNCA;THAP7;NOC2L
prerank,positive regulation of organelle assembly (GO:1902117),0.32445627887175804,1.098623454706153,0.2973451327433628,0.7714110858922072,1.0,17/44,24.29%,ASAP1;CNOT1;FSCN1;NUMA1;RAB3GAP1;RAB3GAP2;SH3GLB1;G3BP1;CROCC;ENTR1;NUP62;MARK4;STX18;PDCD6IP;RALB;CNOT2;CCP110
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4245378380516404,1.0985090080268123,0.32075471698113206,0.7709174283269006,1.0,7/14,23.43%,C1QBP;RMND1;MPV17L2;FASTKD3;UQCC2;FASTKD2;NGRN
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4150072403151226,1.0980492453143647,0.33084112149532713,0.7714998213407692,1.0,7/17,23.78%,ATP5PO;ATP5PD;ATP5MC1;VPS9D1;ATP5F1D;STOML2;ATP5PF
prerank,modified amino acid transport (GO:0072337),-0.40531055192489907,-1.0977291038736552,0.34988713318284426,0.7762183244510438,1.0,8/15,29.45%,MGST1;SLC46A1;SLC1A4;SLC5A6;FOLR2;FOLR1;SLC25A32;SLC6A13
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.28571338914469213,1.0976756526362808,0.27377049180327867,0.7718133386503107,1.0,32/87,26.62%,NDUFB2;NDUFB8;COA8;ACAD9;NDUFB10;NDUFS4;NDUFS3;NDUFAF6;UQCC1;NDUFB3;COX19;NDUFAF1;TMEM126A;NDUFA13;SURF1;BCS1L;NDUFS5;FASTKD3;NDUFAF5;UQCC2;NDUFV3;COX16;NDUFV2;NDUFA9;LYRM7;COX17;NDUFB11;NDUFC2;NDUFV1;NDUFAF7;SAMM50;NDUFB4
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4157567189222705,-1.0972051196239252,0.33860045146726864,0.7765770551528858,1.0,2/13,2.37%,SORBS1;IRS1
prerank,glycine metabolic process (GO:0006544),-0.43195105159219904,-1.0971030407033184,0.32989690721649484,0.7756635173752088,1.0,6/12,23.37%,GCSH;SHMT1;AMT;GLDC;GLYAT;GCAT
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.40730391389264803,1.0970827767663285,0.3517110266159696,0.7728302257851255,1.0,3/17,3.07%,LY86;PRKCA;TRIM5
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.30268080335128567,1.0968469363355176,0.27288428324697755,0.7727621060926557,1.0,9/64,6.82%,NCBP1;NELFB;POLR2H;CDK9;POLR2J;POLR2D;CTR9;GTF2H2;ERCC2
prerank,positive regulation of cell migration (GO:0030335),0.2495458297371207,1.0965535207028239,0.23435225618631733,0.7727542868301891,1.0,58/253,19.73%,TGFBR1;NUMB;ARHGEF2;RREB1;CSF1R;ITGA6;SEMA3B;MAP4K4;VSIR;AIF1;PRKCA;FERMT3;SEMA4C;IGF1R;SRC;ATM;CCL3;PLCG2;SEMA4G;TRADD;PTK2B;SPRY2;PDGFB;C1QBP;GCNT2;MIA3;SUN2;GPER1;SEMA3G;TWIST2;PIK3CD;TJP1;MTOR;MGAT5;NCKAP1L;DDR2;PDGFRB;INSL3;STX4;SEMA4D;SMO;CIB1;MAPRE1;CSF1;GPNMB;PIK3R3;PDCD10;LAMC2;ADAM10;CCAR1;ROCK2;THBS1;MIEN1;CLDN1;PPM1F;SEMA3D;CEP43;CCL24
prerank,regulation of gluconeogenesis (GO:0006111),-0.340744519944053,-1.0964537482195664,0.32339449541284404,0.7763887748037409,1.0,12/27,33.70%,SIRT1;PTPN2;SIK1;GNMT;C1QTNF3;CRY1;PPARGC1A;SDHAF3;DDB1;C1QTNF12;GCK;ARPP19
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4024261230515621,1.0962241201189127,0.3377609108159393,0.7729392077242629,1.0,6/17,17.88%,DSPP;CEACAM1;DLL1;MAFG;AJAP1;GATA3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.34613462310796667,1.0962130351368176,0.3333333333333333,0.7721203992828194,1.0,8/32,14.82%,BAG6;FHIT;DDX5;USP28;POU4F1;PDK2;RPS27L;PYCARD
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4236034535574197,-1.0960981773659177,0.3480083857442348,0.7762572334568024,1.0,6/12,23.44%,DAB2;FOXP1;SIRT1;SFRP1;HDAC1;NCOR1
prerank,negative regulation of ion transport (GO:0043271),0.3584952237352767,1.0956424462822258,0.3221601489757914,0.7730578417865425,1.0,12/24,22.54%,PTK2B;INPP5K;WNK1;CD33;PXK;VIP;SYT11;WNK3;NOS1;WNK2;PLN;STC1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.32349080427927734,1.0952945782254142,0.30849220103986136,0.7732994482414632,1.0,11/44,17.63%,UCHL1;LYN;PRKCD;SPRY2;INPP5K;PIK3CB;RGS14;PTPN1;MAPK8IP1;AGT;PTPRJ
prerank,negative regulation of axonogenesis (GO:0050771),0.3540551067019626,1.094920192160146,0.34831460674157305,0.7735630993911896,1.0,9/27,16.97%,FGF13;ULK2;CDKL3;DIP2B;SEMA3G;LRP4;RTN4R;MAG;ULK1
prerank,T cell differentiation in thymus (GO:0033077),0.42814689242742854,1.0948668824672485,0.3453887884267631,0.7728712126653563,1.0,6/14,24.93%,SHH;ZFP36L1;ZFP36L2;ADAM17;FADD;PTPRC
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.46849880228259827,1.0942753315516254,0.35575221238938054,0.7738465332600194,1.0,4/10,10.23%,LGALS9;LYN;CCR7;AXL
prerank,protein targeting to lysosome (GO:0006622),0.39479218336490357,1.094026785355109,0.3425414364640884,0.7737610983440856,1.0,8/20,20.82%,CLU;GGA3;ZFYVE16;VPS4A;NCOA4;AP4M1;LAMP2;HGS
prerank,endoplasmic reticulum organization (GO:0007029),-0.27912381485848,-1.093588027233255,0.2832512315270936,0.7829415732751526,1.0,14/72,13.46%,LRRK2;TMCC1;REEP3;APP;VAPA;UBE2J2;DNM1L;ATL2;VCPIP1;RTN4;REEP4;TOR1AIP2;ALDH3A2;HMOX1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.34782584409861744,1.093550702802739,0.3298791018998273,0.7743692184600188,1.0,10/29,27.55%,SMAD7;MYL3;ENG;PROX1;NOG;BMP2;TGFB1;FGFR2;ISL1;TPM1
prerank,phospholipid biosynthetic process (GO:0008654),-0.31417039847214295,-1.0934924197734435,0.2984749455337691,0.7819944215547704,1.0,14/36,26.03%,SGMS1;SGMS2;AGPAT4;MVD;DPAGT1;SRD5A3;AGPAT3;HDHD5;CPNE6;GPAT2;SPHK2;SAMD8;FDPS;FAR1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.46285689979263805,1.0930774285166034,0.3578154425612053,0.7750231607984239,1.0,3/10,19.11%,NOTCH4;PLG;PPM1F
prerank,cellular response to insulin stimulus (GO:0032869),0.2716578371882009,1.0929308710492913,0.26810477657935283,0.7746137818125916,1.0,26/124,17.37%,PDE3B;PIK3R1;ATP6V0B;LPIN2;IRS4;IGF1R;RHOQ;ATP6V1D;PDPK1;ATP6V0A2;TCIRG1;ZFP36L1;TRARG1;SLC27A4;APPL1;INPP5K;PDK2;CEACAM1;ATP6V0A4;ZDHHC7;HDAC5;AKT1;PIK3R3;ATP6V0E2;EPRS1;RAB13
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2663220808958427,1.0927515253854292,0.27856025039123633,0.7743497869378945,1.0,42/132,25.45%,DAGLB;MLXIPL;ABCD2;PIM2;ITCH;CNOT1;TRIM5;PRKCD;DXO;FLCN;MTLN;MOV10;ZSWIM8;MTDH;PTTG1IP;SH3GLB1;PIK3CB;TPCN1;PTPN1;PHKG2;PFKFB2;ARNT;OPTN;NRDC;VGLL4;DTX3L;ULK1;KAT5;TICAM1;TMEM59;VPS35;SLC4A4;FURIN;ZC3H12A;TWIST1;ABCD1;HIF1A;TRIM14;GPLD1;MEFV;GTPBP1;TRIM65
prerank,rRNA metabolic process (GO:0016072),-0.24663565546430039,-1.092592050138984,0.23863636363636365,0.783764368123778,1.0,45/160,20.28%,RPL36A;RPL30;DEDD2;RPL35A;DDX10;RPS7;RPL4;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;EXOSC1;POP4;RPL41;RPL26;XRN2;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;RPL37;NOC4L;UTP14A;RPS14;RPL24;EXOSC7;WDR18;RPS9;RPLP1;RPL22;NOB1;RPL8;ESF1;RPLP0;RPL19;PIH1D1;RRP9;RPL13A;RPS6;RPS19;RPL23A
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3756952420999314,-1.0925771022076647,0.32150313152400833,0.7825533321950098,1.0,3/18,4.61%,CTSC;FAF1;APOE
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.47048487845271536,1.092461129444652,0.3605313092979127,0.7744242711953175,1.0,6/10,26.13%,LYN;PTPN1;GHR;STAT6;STAT5B;STAT3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3807951370305861,-1.091820216514985,0.3220338983050847,0.7836852176894546,1.0,8/19,21.70%,TMEM106A;APP;KLF2;KLF4;MTPN;SLCO1C1;MAP2K5;PAX8
prerank,regulation of activated T cell proliferation (GO:0046006),0.35350266682379466,1.0917691498713575,0.32869565217391306,0.775629686045366,1.0,5/30,8.32%,IL18;LGALS9;AGER;PDCD1LG2;IL12B
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4063903009158633,1.091450187584732,0.3596330275229358,0.7758254338329589,1.0,9/15,25.00%,PYDC1;TLR4;CPTP;EIF2AK2;GBP5;USP50;DDX3X;MYD88;MEFV
prerank,cellular response to superoxide (GO:0071451),-0.45208821936439947,-1.0914240652859875,0.3081761006289308,0.783670317507639,1.0,3/10,13.81%,PRDX1;ATP7A;SOD2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.29515815376857646,-1.0906871598817733,0.31435643564356436,0.7846638907536516,1.0,18/53,23.55%,CCR1;HRH1;HTR2C;HTR2B;CHRM2;OPRM1;CHRM3;HTR1D;OPRD1;HTR4;HTR6;CNR2;TSHR;HTR1F;XCR1;HRH3;ANXA1;PTGIR
prerank,protein K48-linked deubiquitination (GO:0071108),0.3675385674123145,1.0904336011183464,0.343804537521815,0.7781464449761577,1.0,6/23,12.63%,USP8;OTUD5;USP25;USP5;MINDY2;OTUB2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38510107369727636,1.089861317533058,0.3241758241758242,0.7791690197509871,1.0,7/20,19.19%,MRAP;PLEK;MET;RGS14;GRK2;MRAP2;MGRN1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.29310402048642514,1.0892956891300574,0.30877742946708464,0.7800591822555546,1.0,10/71,7.40%,BAG6;ZRANB1;RNF41;RPS27A;UBC;CTSS;LGMN;YME1L1;SOCS6;CUL4B
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.389545583993666,1.0892387995208535,0.33865248226950356,0.7793955587085011,1.0,6/19,19.11%,RAC1;MAP4K4;LIMS1;ABL1;PTPRJ;PPM1F
prerank,transport across blood-brain barrier (GO:0150104),0.28310474230666477,1.0887297427120415,0.2965964343598055,0.7801014442497531,1.0,19/83,18.08%,SLCO2B1;SLC7A8;SLC1A3;SLC7A5;AGER;SLC24A3;ABCC9;SLC22A2;SLC29A4;ATP1A4;SLC27A4;LRP1;SLC16A7;SLC6A9;SLC29A1;SLC5A3;SLC38A1;SLC15A2;SLC19A1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.35683236277182023,1.088389445166187,0.32304900181488205,0.7804086956511089,1.0,5/26,4.37%,ABCD2;COA8;TLR4;SLC30A10;PLCG2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.281981256643548,1.088330362972704,0.2841091492776886,0.7797490531354234,1.0,24/102,18.35%,PDE3B;PIK3R1;ADCY9;PRKACA;LPIN2;SLC30A10;RHOQ;SRC;PRKCD;PDPK1;ZFP36L1;TRARG1;GPER1;LHCGR;ADCY4;INPP5K;CEACAM1;ADCY6;HDAC5;AKT1;EPRS1;RAB13;ADCY7;LPIN1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3716681783625899,-1.0880799097190739,0.35714285714285715,0.7917349040232533,1.0,9/20,19.58%,EGFR;CCND2;CCNYL1;PKD2;PKD1;RGCC;TTBK1;SPDYA;STOX1
prerank,nucleotide catabolic process (GO:0009166),-0.4010118214325735,-1.0879001671732562,0.3283582089552239,0.7910203940225988,1.0,4/16,13.12%,XDH;GDA;NUDT3;SAMHD1
prerank,positive regulation of signal transduction (GO:0009967),-0.230571527208923,-1.0878703982405111,0.19594594594594594,0.7898656384356167,1.0,34/238,8.01%,NRXN1;NLGN1;RIMS2;RBPJ;CD74;SORBS1;ROBO1;LRRK2;CCBE1;HTT;BDNF;SULF2;DSTYK;IRS1;ERN1;RPS3;LMO3;JAK2;NTRK3;CD226;NPTN;SHANK3;ATP6AP2;PRKCZ;VWF;KLF2;HOMER1;PKD2;CDC73;ZBTB7B;SIRT1;TPD52L1;DCDC2;F7
prerank,regulation of lamellipodium organization (GO:1902743),0.4237456557189721,1.0878250490314316,0.3615819209039548,0.780486597515358,1.0,3/14,3.13%,TWF2;RAC1;CAPZB
prerank,multivesicular body assembly (GO:0036258),0.35064311838834994,1.087761044045513,0.3240901213171577,0.7798349210822337,1.0,16/30,33.31%,VPS37D;VPS37A;VPS36;CHMP1A;VPS4A;IST1;TSG101;VPS37B;CHMP2A;HGS;PDCD6IP;VTA1;CHMP7;STAM2;RAB11A;CHMP5
prerank,cellular response to osmotic stress (GO:0071470),0.3789369673283979,1.0871439793834203,0.33697632058287796,0.7808822621555869,1.0,9/21,21.64%,ARHGEF2;CAPN3;ZFP36L1;RCSD1;TRPV4;STK39;LRRC8D;WNK3;DDX3X
prerank,myeloid dendritic cell activation (GO:0001773),0.4328711860329616,1.0869603047722691,0.3493761140819964,0.78063868266433,1.0,5/12,24.63%,TGFBR2;PYCARD;SLAMF1;BATF3;DOCK2
prerank,negative regulation of developmental growth (GO:0048640),0.3451484598510529,1.0863905336079365,0.3114754098360656,0.7816586767163755,1.0,9/30,16.97%,FGF13;ULK2;CDKL3;DIP2B;SEMA3G;BBS2;RTN4R;MAG;ULK1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.2744180033456406,-1.0861979972891762,0.2810945273631841,0.7940162583721526,1.0,19/72,15.91%,EPS8;ARHGEF3;ROBO1;RIT2;ARHGAP35;CUL3;STARD8;RIPOR2;APOE;GPR35;HEG1;KANK1;RAF1;RALBP1;GPR174;STARD13;SCAI;LPAR4;ARHGDIA
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.25670812271116483,-1.0860323898013964,0.2784090909090909,0.793281824598869,1.0,21/108,10.75%,CTNND2;MDFIC;LRRK2;CDK14;SULF2;APP;ATP6AP2;TRABD2B;FRZB;PRKN;CDC73;BTRC;DCDC2;AXIN1;NLK;GRB10;NXN;KANK1;GPC3;TLE1;PPP2R1A
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4561848819405739,1.0860294509199717,0.35424354243542433,0.781908019421705,1.0,6/11,28.76%,SIRT2;ZC3H12A;BCL2L1;TP53;FZD3;FAP
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3199849544687605,-1.0859907661797157,0.3187066974595843,0.792166802688614,1.0,8/33,7.25%,PLCB1;EGFR;FGF10;KMT2E;ANKRD17;CCND2;UBE2E2;CDC73
prerank,calcium-mediated signaling (GO:0019722),0.28445482053486015,1.0859040997600413,0.3127035830618892,0.7814716622491467,1.0,18/93,8.52%,CX3CR1;P2RY12;LAT2;PPP1R9B;PRKACA;PPP1R9A;TRPM4;CCL3;TRPM2;PLCG2;SLC8A1;PDPK1;CAMKK2;SELE;PLA2G4B;CCR7;EDN2;SELP
prerank,cellular protein modification process (GO:0006464),0.22148528216778704,1.0858167181679064,0.18203033838973162,0.7809439518073169,1.0,197/982,17.76%,TGFBR1;GOLM1;MERTK;ST3GAL6;NUAK1;PTPRM;SSH2;TGFBR2;PPM1H;LARGE1;CST3;CTTNBP2NL;MGAT4A;FBXL18;BMP2K;B3GNT2;ST3GAL5;CSNK1E;PRKCSH;CDKL3;PIM2;MAP4K4;MAN2B1;MACROD1;IGFBP3;DAPP1;DSP;FBXO22;TGM2;ASB8;SIRT2;PRKCA;PRKACA;CHEK2;LYN;VHL;CDK9;TBCK;ART4;FBXL20;DDB2;NEK6;SPSB1;FBXL15;CSNK2A1;UBA7;ATM;MKNK1;COPS4;PRKCD;MAP4K3;NEK3;DCAF8;RYK;MPI;PPM1L;RPS6KA5;STRADA;PTK2B;DCAF10;GAD1;CSK;PIK3C3;FBXW4;PDPK1;PDK1;PORCN;SPSB2;SOCS6;SSH1;PDGFB;NRBP1;CAMKK2;MBTPS1;USP25;MAN2A2;PKN3;CPE;CDC34;GCNT2;CUL4B;MIA3;ASB4;PTPRE;AMBN;B3GNT4;TSSK6;TSSK4;ASB15;SPRR1A;RAB1A;FUT7;ANKRD9;PP2D1;RCE1;PIGK;ASB11;PIK3CD;ARAF;RABGGTA;MTOR;PSMD3;WNK1;KBTBD8;PDK2;PRKCB;ASB3;NUAK2;ASB5;GRK2;ILKAP;FBXL8;FBXL2;MGAT1;NPC1;PSMB3;MSLN;PTPN1;WSB1;PPP2R5B;JMJD7;CDC14B;MAP4K2;TAF1;PINK1;SLC35A1;HCST;PTPRA;MTMR4;MAP3K11;DUSP29;NEK7;DUSP5;CDK11B;MARK2;TAOK2;PSMA7;PPP4R2;ABL1;ST3GAL3;FBXO21;BMX;TIMM50;WWP2;MAPK8;PXK;GPS1;CCNE1;PPP1CB;MORC3;PTPRH;LATS2;DCAF11;PSMC1;PSMC2;PTPN21;AKT1;KCTD6;DYRK1A;FAM20B;CSF1;KCTD7;PICK1;RNF7;FBXL22;WDTC1;STK39;PASK;PARP8;MAP2K1;PSME4;TEC;EIF2AK2;AURKA;LIPE;CCDC22;CDC42BPB;ACVR2B;COPS6;FBXO11;ADAM10;ADPRH;PSMB9;DUSP6;PTPN5;DUSP11;TULP4;ULK1;PPP2R5A;RPS6KA4;TRIB1;RAB13;WSB2;PTPRJ;VRK2;ATG5;ROCK2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.38081347011718253,-1.0855989936481556,0.3232104121475054,0.792185576722361,1.0,9/17,33.47%,ANXA4;PTPN22;KLF4;MAP2K5;SSC5D;ANXA1;MAPKBP1;BCL3;CACTIN
prerank,positive regulation of wound healing (GO:0090303),0.333147876228101,1.085541665004871,0.35,0.7809178003220085,1.0,8/36,12.93%,RREB1;SMOC2;F12;DUOX1;MTOR;APOH;SERPINE1;INSL3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4267449693885162,-1.08540893945932,0.33189655172413796,0.7915268858457953,1.0,2/12,0.58%,MAGI2;IQGAP1
prerank,regulation of heart contraction (GO:0008016),-0.26672102006776705,-1.0854006419014848,0.26535626535626533,0.7903084017573571,1.0,20/90,16.79%,ANK2;ITPR1;PDE4D;SLC8A3;ATP2B1;RYR3;RYR2;ATP2A2;TMEM65;CALM1;ATP1B3;DMPK;ATP2A3;ATP1A1;KCNQ1;FXYD4;KCNIP2;S100A1;APLN;DES
prerank,protein autoprocessing (GO:0016540),0.39807164536557404,1.0852397712373294,0.35634328358208955,0.7810682051750734,1.0,7/17,23.63%,FAM111A;CASP1;F12;HTRA2;AFG3L2;PIDD1;SPRTN
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.293039096999135,1.0851549581921183,0.3076923076923077,0.7805097525010425,1.0,16/72,14.82%,SUMO1;CFLAR;IRAK2;OTULIN;TRADD;TRIM44;ABCE1;RNF31;CLIP3;AXL;RUNX1;PTPN1;PTPN11;SPPL2B;IFNGR2;PYCARD
prerank,cellular response to type I interferon (GO:0071357),-0.3126346670061255,-1.0851326631383553,0.315035799522673,0.7887207764477934,1.0,18/41,26.94%,OAS2;RSAD2;SP100;IFITM3;IRF4;GBP2;RNASEL;IFIT3;SAMHD1;IFITM2;OAS3;IFITM1;IRF7;BST2;OASL;ADAR;IP6K2;IRF1
prerank,type I interferon signaling pathway (GO:0060337),-0.3126346670061255,-1.0851326631383553,0.315035799522673,0.7887207764477934,1.0,18/41,26.94%,OAS2;RSAD2;SP100;IFITM3;IRF4;GBP2;RNASEL;IFIT3;SAMHD1;IFITM2;OAS3;IFITM1;IRF7;BST2;OASL;ADAR;IP6K2;IRF1
prerank,manganese ion transport (GO:0006828),-0.41242165586362456,-1.085013969574244,0.3684210526315789,0.7878392293394259,1.0,4/14,8.54%,TRPC5;TRPC4;TMEM165;TRPC3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4153665946918446,-1.0848417306614924,0.3289760348583878,0.7871580276236937,1.0,5/14,22.90%,RPS3;CD226;TESPA1;LCK;TRAT1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3084591636249901,1.0848389006612447,0.31239092495637,0.7806449558940519,1.0,11/54,14.82%,CFLAR;PYDC1;OTULIN;GPS2;CASP1;TRADD;RFFL;RNF31;CLIP3;SPPL2B;PYCARD
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3257168937260263,-1.084813073356254,0.2853881278538813,0.7860335575127846,1.0,10/30,22.29%,LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.30312274448339044,-1.084683320982471,0.3132832080200501,0.7852035785311637,1.0,8/43,13.25%,EGFR;CBLB;SH3GL2;CDC42;PTPN3;PTPN2;RNF126;EPS15
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4639931020855025,-1.0846386325450323,0.3771186440677966,0.7841094747414113,1.0,4/10,20.26%,EMC3;MMGT1;EMC2;EMC7
prerank,endothelial cell migration (GO:0043542),-0.3196589636999895,-1.0845400280020234,0.3213367609254499,0.7831838923866348,1.0,11/37,16.25%,DPP4;PLXND1;FSTL1;GIPC1;CDH13;CDH5;PLEKHG5;TNFSF12;STARD13;CCN3;CORO1B
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.33737257046838687,1.0838827354468314,0.3049645390070922,0.7826911622331083,1.0,8/32,13.18%,NBN;ATM;FOXN3;BRCA1;CDC14B;BLM;TAOK2;ABRAXAS1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3379896890922617,1.0836757383602424,0.33276740237691,0.7825148364003258,1.0,8/36,13.62%,RHNO1;CHEK2;NBN;ATM;RAD17;USP28;RAD1;CEP63
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3942966338189182,1.0835464133449948,0.368705035971223,0.7820749882591131,1.0,7/18,21.19%,PCNA;GINS4;LIG1;POLD2;GINS3;MCM3;MCMDC2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.39053577687357277,-1.0832726079887225,0.3443708609271523,0.7859685956670964,1.0,3/15,11.18%,CD36;SYT10;ADCY3
prerank,intracellular pH reduction (GO:0051452),0.3442541560879451,1.0830892682125048,0.32460732984293195,0.7826785535621007,1.0,12/33,22.90%,ATP6V0B;ATP6V1D;ATP6V0A2;TCIRG1;RAB39A;ATP6V0A4;RAB20;ATP6V0E2;SLC11A1;GPR89A;GPR89B;ATP6V0C
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4019471619629494,1.0829055231510492,0.34186471663619744,0.7823885413354609,1.0,4/17,11.91%,SEL1L;OS9;UFD1;AUP1
prerank,regulation of integrin activation (GO:0033623),0.4164955806523351,1.0826979136521988,0.3497164461247637,0.7821545792919269,1.0,6/15,19.68%,PLEK;SRC;SELP;RASIP1;FBLIM1;PIEZO1
prerank,positive regulation of catalytic activity (GO:0043085),0.3385732055037226,1.0826756602582503,0.3333333333333333,0.7813944580880765,1.0,12/37,20.52%,PSENEN;PSEN2;SSBP1;STX4;ABL1;MAPK8;SOD1;CIB1;MAPK14;SLC5A3;NOD2;FGFR4
prerank,negative regulation of B cell activation (GO:0050869),0.3835076395781888,1.0825603304953075,0.33865248226950356,0.7809233926712754,1.0,5/21,9.26%,LYN;ATM;TNFRSF21;TNFRSF13B;INHA
prerank,small GTPase mediated signal transduction (GO:0007264),0.2726528715907959,1.0825367324135193,0.29448818897637796,0.780175917038086,1.0,15/103,7.65%,RAPGEF5;RASGRP3;RREB1;RAC1;PLD1;USP8;RGL2;ARHGAP30;KSR1;PLD2;HACD3;ARFIP2;RGS19;USP28;JUN
prerank,negative regulation of TORC1 signaling (GO:1904262),0.431749841447577,1.082375064042536,0.3518850987432675,0.7798467584449786,1.0,4/13,23.45%,ATM;CASTOR1;SESN1;DEPDC5
prerank,neural crest cell development (GO:0014032),0.3211123809358984,1.0823032876580958,0.32,0.7791960563367679,1.0,10/44,13.59%,SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;GDNF;SEMA3G;KBTBD8;PDCD6;SEMA4D
prerank,organic substance transport (GO:0071702),0.27171791641232373,1.0822865478275052,0.2796208530805687,0.7784246569490573,1.0,26/121,18.08%,SLCO2B1;ABCD2;ABCA9;PCTP;MYH9;TAP2;NME4;PPT1;ARRDC1;ARL6IP5;CD320;MIA3;RD3;SLC22A2;SLC22A6;SLC29A4;SCAMP2;SCAMP5;ARRDC2;TOM1;PICK1;KIF3A;MFSD2B;SLC23A1;CHMP1A;SLC19A1
prerank,regulation of cytokinesis (GO:0032465),-0.2714967219981094,-1.0820993184449081,0.2814814814814815,0.7883353694226449,1.0,17/78,11.30%,CUL3;KIF23;RACGAP1;CALM1;CDC42;KLHL13;UVRAG;GIPC1;KIF14;PKP4;PLK2;AURKB;MAP9;PRC1;BECN1;E2F7;KIF20A
prerank,peptidyl-tyrosine modification (GO:0018212),0.3093828219247852,1.0813504588242255,0.32798573975044565,0.7805262479930364,1.0,14/56,15.85%,ABI3;CSF1R;LYN;EFEMP1;TPST2;SRC;PTK2B;PDGFB;DDR2;PDGFRB;PKDCC;ABL1;DYRK1A;TEC
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3377383337845024,-1.0811335417549806,0.3418803418803419,0.7901277071732996,1.0,9/28,16.38%,ITPR1;TMEM117;ERN1;CEBPB;BAK1;ATP2A3;ERO1A;BCL2;SELENOK
prerank,positive regulation of telomere capping (GO:1904355),-0.38479826220692603,-1.081017854378571,0.35357917570498915,0.7893138777296961,1.0,7/17,23.83%,MAPKAPK5;AURKB;TNKS2;PRKCQ;MAPK1;NABP2;MAPK15
prerank,protein insertion into membrane (GO:0051205),-0.322693713301626,-1.0808534054812051,0.32558139534883723,0.7886782206516656,1.0,7/32,13.46%,EGFR;APP;VAPA;UBE2J2;COX18;ALDH3A2;HMOX1
prerank,mitotic metaphase plate congression (GO:0007080),-0.2921006291401377,-1.0806923798900252,0.3105134474327628,0.7879973504724596,1.0,17/51,24.80%,CUL3;CDCA8;ZW10;SPDL1;KIF22;KIF14;CENPE;NDC80;BECN1;MAD1L1;CCNB1;RRS1;KIFC1;KIF2C;CHMP1B;NUF2;BOD1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2901214291566648,1.0803252899465334,0.3129251700680272,0.7827883656743642,1.0,36/76,31.89%,SENP2;SMAD7;RIPK2;TBC1D7;UBA2;WDR48;NDFIP2;PTTG1IP;BRCA1;KLHL40;RASD2;PINK1;PIAS3;UBE3A;FANCI;XIAP;PHF23;STUB1;TNIP1;ZC3H12A;DCUN1D1;NSMCE3;SPRTN;PRICKLE1;DCUN1D4;TSPYL5;UBE2D1;SAE1;TRAF6;PAXIP1;LAPTM5;DCUN1D5;BIRC2;BIRC3;PIAS4;UBE2L3
prerank,autophagy of nucleus (GO:0044804),0.4022917409102354,1.080218800446333,0.3706422018348624,0.7823020604821376,1.0,6/16,17.75%,ULK2;ATG9A;RB1CC1;ATG9B;ULK1;ATG5
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.30022522158958787,-1.0802025203912233,0.3211845102505695,0.7882545546343657,1.0,4/48,1.16%,DMD;AKAP6;ANK2;PDE4D
prerank,protein polyglutamylation (GO:0018095),-0.43667868258400816,-1.080021450640603,0.348643006263048,0.7876410731849145,1.0,3/11,6.96%,TTLL11;TTLL7;TTLL5
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3395214192031478,1.0795178071806404,0.32685512367491165,0.7836378959384962,1.0,6/33,7.92%,SMAD3;ETS1;EGR1;PDGFB;JUN;GATA2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2574786193784343,1.0794922825245823,0.2848297213622291,0.7829045707864661,1.0,39/158,19.13%,CFLAR;PIM2;LGALS9;RIPK2;TMEM101;ATP2C1;TRIM5;MAP3K3;NEK6;TRAF5;CASP1;NDFIP2;TRADD;TMED4;MTDH;CCR7;EDA2R;TAB2;AKAP13;RNF31;GAPDH;CXXC5;TICAM2;PRKCB;ZDHHC13;LAMTOR5;MIB2;PINK1;TRIM62;GJA1;MAVS;TNIP2;TNFRSF19;CCDC22;PELI2;NUP62;TICAM1;MAP3K14;ECT2
prerank,visual system development (GO:0150063),0.33155116062228,1.0792845692985782,0.34782608695652173,0.7827266676629729,1.0,5/37,6.40%,ITGAM;FREM2;PAX6;MEIS3;C1QA
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3685596901397894,-1.0792761164789129,0.3524027459954233,0.7888516994497747,1.0,4/19,5.02%,ROBO1;XDH;CCBE1;CADM4
prerank,regulation of feeding behavior (GO:0060259),-0.4348355731543826,-1.079043636396108,0.3690205011389522,0.7883724886631862,1.0,6/11,32.02%,SGIP1;EIF2AK4;AGRP;LEPR;GNB3;NR4A3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3897250422116645,-1.0789174841386389,0.3463114754098361,0.7875627055025756,1.0,9/15,31.91%,BDNF;NTRK2;BCAR1;DDIT4;NGFR;HAP1;NTRK1;NGF;NTF4
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.35463155522183293,-1.0788497817242586,0.36261261261261263,0.7853934693453332,1.0,7/23,19.47%,YWHAQ;TFDP2;YWHAE;PPP3CC;BCL2;E2F1;TFDP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.35463155522183293,-1.0788497817242586,0.36261261261261263,0.7853934693453332,1.0,7/23,19.47%,YWHAQ;TFDP2;YWHAE;PPP3CC;BCL2;E2F1;TFDP1
prerank,regulation of cellular localization (GO:0060341),-0.2997240554857114,-1.0786899517346422,0.32075471698113206,0.7846850798946499,1.0,15/46,16.55%,LRRK2;GSN;MAP2;ADCY5;PRKN;TTL;EPHA5;TRIM67;TRIM46;SPAG5;EFNA5;WWC1;FER;MAD1L1;NR1H4
prerank,regulation of mRNA catabolic process (GO:0061013),0.27315975929352626,1.078470277336919,0.30109204368174725,0.7844460715222293,1.0,46/121,27.76%,PRKCA;CNOT1;PRKCD;EIF4G1;RPS27A;UBC;MOV10;ZFP36L1;ZFP36L2;PKP3;RBM24;TNPO1;PSMD3;ANP32A;PSMB3;CSDC2;PSMA7;EXOSC5;IGF2BP2;PSMC1;PSMC2;AKT1;PSME4;DIS3;PSMB9;FXR2;EXOSC8;PSMD4;PSMB5;PSMB7;ZC3H12A;RC3H2;PSMB8;ELAVL1;PCID2;PCBP4;XPO1;PSMD13;GTPBP1;YTHDF3;PARN;SAMD4B;PUM1;ZC3H14;CARHSP1;PSMD2
prerank,regulation of lipase activity (GO:0060191),0.4264036270950027,1.0784116987593744,0.36900369003690037,0.7837988184865999,1.0,2/13,3.68%,LIPC;LMF1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.34834583352301174,-1.0782866970178036,0.328125,0.784736286293346,1.0,6/25,5.31%,CTNNA3;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,microtubule polymerization (GO:0046785),0.35341264283635176,1.077855787909171,0.35628227194492257,0.7846660232580894,1.0,13/28,33.22%,FGF13;TUBGCP5;TUBG1;TRPV4;PIN1;MAPT;CSNK1D;NDE1;TPPP3;AKAP9;CLASP1;NDEL1;TUBGCP3
prerank,striated muscle tissue development (GO:0014706),-0.3281217163372715,-1.0778553067497587,0.348993288590604,0.7849339531750048,1.0,2/29,3.15%,SGCZ;SGCD
prerank,rRNA processing (GO:0006364),-0.23986308489432803,-1.0776308768161431,0.26038781163434904,0.7844787726227527,1.0,48/172,20.28%,RPL36A;RPL30;RPL35A;DDX10;NSA2;RPS7;RPL4;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;EXOSC1;POP4;RPL41;RPL26;XRN2;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;RPL37;NOC4L;RIOK3;UTP14A;RPS14;ERI1;RPL24;EXOSC7;WDR18;RPS9;RIOK1;RPLP1;RPL22;NOB1;RPL8;ESF1;RPLP0;RPL19;PIH1D1;RRP9;RPL13A;RPS6;RPS19;RPL23A
prerank,regulation of B cell apoptotic process (GO:0002902),-0.42100808009963486,-1.0774547922536237,0.3652173913043478,0.7838701084709565,1.0,6/12,22.91%,FOXP1;BTK;AURKB;BLK;NOC2L;IL2
prerank,connective tissue development (GO:0061448),-0.32133234464934646,-1.0772989229437777,0.3301204819277108,0.7832155900310398,1.0,15/35,26.50%,ZBTB16;CD44;SULF2;SOX5;PGRMC2;ATP7A;PKD1;SCX;SLC39A13;SOX6;GHRL;ITGB8;RORC;HES5;XBP1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4173045728506344,1.0772259764713212,0.37254901960784315,0.7857740883087685,1.0,4/15,20.96%,ABHD12;DPEP1;ALDH4A1;GGT5
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3887637855585387,1.077183422290878,0.36279926335174956,0.7850719416899535,1.0,4/20,7.40%,IL18;ENTPD1;CASP1;NLRP3
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2634614200597546,-1.077019455987783,0.2944606413994169,0.782920880794573,1.0,23/85,25.84%,MTSS1;EGFR;FGF10;B2M;CDC73;DUSP10;FGF7;FGF9;AQP11;MCC;ACVRL1;SFRP1;NME2;SFRP2;BMP4;CDKN1C;TGFBR3;TIE1;MARVELD3;ZFP36;FGF16;NLRC3;ANGPT1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.35016021461889274,-1.0765531342224812,0.3511777301927195,0.7830708043772535,1.0,10/23,21.09%,ZW10;PLK2;BUB1B;PABIR1;AURKB;BUB1;CHEK1;SETMAR;CDK5RAP3;NABP2
prerank,protein autophosphorylation (GO:0046777),0.2581436705387898,1.0758939925922117,0.30757575757575756,0.7883684404157861,1.0,38/157,16.10%,CSF1R;ULK2;PIM2;CHEK2;LYN;MAP3K3;NEK6;IGF1R;SRC;ATM;MKNK1;ULK3;PTK2B;PDPK1;CAMKK2;EPHA8;MTOR;DDR2;PDGFRB;EEF2K;TAF1;PINK1;MUSK;MAP3K11;UHMK1;MARK2;MAP3K10;TAOK2;ABL1;BMX;AKT1;DYRK1A;STK39;PASK;TEC;EIF2AK2;EIF2AK1;AURKA
prerank,actin filament capping (GO:0051693),-0.376192795318913,-1.0758826476280938,0.3260340632603406,0.7829785970408534,1.0,3/18,1.94%,EPS8;ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),-0.376192795318913,-1.0758826476280938,0.3260340632603406,0.7829785970408534,1.0,3/18,1.94%,EPS8;ADD3;GSN
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.28388224358432385,1.0757304310768199,0.32463295269168024,0.7880625572927955,1.0,17/76,17.39%,PRMT2;DDIT3;IRAK2;ARRB2;PYDC1;OTULIN;ITCH;PKHD1;NLRP3;COMMD6;HAVCR2;NWD1;PYCARD;CCDC22;COMMD7;AIM2;ARRB1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.39427887006238993,-1.0755993270856596,0.3221476510067114,0.7815307053200304,1.0,5/16,17.60%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.39427887006238993,-1.0755993270856596,0.3221476510067114,0.7815307053200304,1.0,5/16,17.60%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.41931096355982805,1.0754501905300364,0.3719298245614035,0.7881245818129903,1.0,4/14,12.53%,IL18;CD86;NLRP3;NFKBID
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4006400431388448,-1.0747115097603277,0.3486973947895792,0.7832288477174886,1.0,3/14,8.93%,ADRA1A;CD40;MYADM
prerank,mRNA stabilization (GO:0048255),0.32859351758700067,1.0743944254822553,0.3475177304964539,0.7905261089857557,1.0,15/40,23.57%,FUS;TENT5C;HNRNPC;DHX9;GDNF;RBM24;TARDBP;MAPK14;VIP;SLC11A1;BOLL;LARP1;ELAVL1;AXIN2;MYD88
prerank,positive regulation of exocytosis (GO:0045921),-0.31740384682144274,-1.0743256281268383,0.3533487297921478,0.7832327589483021,1.0,8/35,15.90%,CADPS;STXBP5;SDCBP;RAB3D;RAB3A;SNCA;CFTR;RAB27B
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3578816081809306,1.0743110504173212,0.33089579524680074,0.7899576039491708,1.0,7/29,11.53%,P2RY12;ATG14;PTK2B;PDGFB;EPHA8;CCR7;PDGFRB
prerank,protein localization to lysosome (GO:0061462),0.3550832742265451,1.0741912898324186,0.3391915641476274,0.7895452164725478,1.0,9/28,20.82%,LAMTOR5;MFSD1;GGA3;GLMP;ZFYVE16;VPS4A;NCOA4;AP4M1;HGS
prerank,regulation of protein localization to centrosome (GO:1904779),-0.44526868355893373,-1.074161788399018,0.36401673640167365,0.782580811611669,1.0,2/10,5.28%,BICD1;GSK3B
prerank,positive regulation of ion transport (GO:0043270),-0.2972420123908935,-1.0737321878623496,0.3221957040572792,0.7827436966282747,1.0,12/48,13.88%,ANK3;ANK2;ATP2B1;CCR1;STIM2;ANO6;KIF5B;ACTN2;ADRA2A;FFAR1;LILRA5;CCL5
prerank,histone H2B ubiquitination (GO:0033523),0.4545870851704567,1.073677783867181,0.3774703557312253,0.790253234131991,1.0,4/10,16.81%,CTR9;RNF8;RNF20;DTX3L
prerank,purine nucleotide metabolic process (GO:0006163),0.36220183456756183,1.073129417911942,0.3471223021582734,0.7911917386112245,1.0,8/24,15.76%,FHIT;GUK1;PNP;NUDT15;GART;PRPS1;PRPS1L1;MTHFD1
prerank,regulation of synapse organization (GO:0050807),-0.34321218553754507,-1.0728364763226608,0.33874709976798145,0.7843560593874994,1.0,4/26,2.64%,PDLIM5;CTNNA2;CDKL5;IL1RAPL1
prerank,snRNA processing (GO:0016180),0.4158559597107767,1.0721741560220308,0.36981132075471695,0.7933958110012804,1.0,3/16,7.46%,INTS6L;INTS11;INTS3
prerank,iron ion transport (GO:0006826),0.31040319809644085,1.0720577595595508,0.3279742765273312,0.7929329704975191,1.0,7/47,7.50%,DNM2;ATP6V0B;MCOLN1;ATP6V1D;SLC40A1;ATP6V0A2;TCIRG1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.31708553642928017,1.0718535145879893,0.3407534246575342,0.7927466529778184,1.0,10/43,13.18%,NBN;ATM;RAD17;INTS3;FOXN3;BRCA1;CDC14B;BLM;TAOK2;ABRAXAS1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3783509410088711,1.0717399681271134,0.36524822695035464,0.7923033553148021,1.0,11/20,31.16%,CFLAR;FLOT2;ASAH1;STUB1;PDCD6IP;CDC37;FLOT1;BIRC2;CYLD;BIRC3;PELI1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.40314594633377604,-1.0713603684809887,0.38235294117647056,0.7877890348551508,1.0,4/14,14.70%,ANK2;ATP1B3;ACTN2;KCNIP2
prerank,metal ion export (GO:0070839),-0.3255856361111055,-1.0713598918283482,0.33496332518337407,0.7866253878317312,1.0,9/31,19.63%,KCNT2;KCND3;ATP1B3;ATP7A;ATP1A1;KCNQ1;KCNIP2;KCNE3;KCNK5
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3733528980203091,-1.071195961297233,0.3723404255319149,0.7859392787333485,1.0,4/19,5.23%,CD74;MCU;RIPOR2;DNM1L
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2353188853821136,1.0710296610563965,0.2598639455782313,0.7936933171309277,1.0,94/366,24.27%,TGFBR1;ZFHX3;ZSCAN26;MLXIPL;DNM2;RREB1;DENND4A;MEF2C;DDIT3;LYL1;SBNO2;FUS;SRRT;CHEK2;KMT2D;EFEMP1;VHL;HDAC10;CHD7;REXO4;CTR9;RPS6KA5;MLX;EIF2A;GTF2IRD1;RHOH;FOXK2;TAF6L;THAP1;CXXC1;FOXN3;CNBP;APBB2;PKP3;SOX17;EHMT2;CHD3;PATZ1;RNF20;EIF2B4;POFUT1;ZSCAN21;NUP35;CYFIP1;RPL10;NFYA;SMARCA2;FADS1;ENG;CDK11B;ABL1;HP1BP3;EZH2;TRAPPC2;PRDM2;MLLT6;SPTY2D1;TCF7L1;TCF3;TAF5L;ACVR2B;CCAR1;RPS6KA4;HES6;ORC3;NUP107;CARM1;ZBTB11;MITF;IRF2;WTIP;DMTF1;PTP4A3;SAP30L;CASZ1;PCIF1;DSCC1;GZF1;CRABP2;KAT6B;ZFPL1;NFIA;BNC2;BMP2;SCRT1;MSC;TP53;LIN54;TGIF2;SUFU;ACVR1B;DVL2;ZNF628;TAF5
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2547098998968256,1.0709505519017286,0.29790419161676646,0.7931236454286574,1.0,49/175,21.84%,ARHGEF2;NFE2L2;PYDC1;NPNT;TRAF5;CCL3;TNFRSF21;TNFSF13B;CD27;TRADD;TNFRSF25;PTK2B;TNFRSF13C;DHX9;TNFRSF13B;ZFP36L1;BRCA1;ZFP36L2;EDA2R;GPER1;LIMS1;INPP5K;PSMD3;ASAH1;TNFRSF17;PSMB3;TNFSF8;PSMA7;PSMC1;PSMC2;BAG4;PYCARD;AKT1;CIB1;PSME4;COMMD7;TNFRSF12A;AIM2;PSMB9;GATA3;MAP3K14;CCL24;PSMD4;PSMB5;TNFRSF14;ADAM17;PSMB7;ACOD1;ZC3H12A
prerank,positive regulation of cell cycle (GO:0045787),-0.27959736916323397,-1.0709346987278447,0.33602150537634407,0.7856155452310956,1.0,21/62,22.46%,EGFR;APP;ANKRD17;LRP6;CCND2;CCNYL1;PKD2;TTL;RARA;RPS15A;PKD1;CHEK1;RGCC;MDM2;SRPK2;CCNB1;SPDYA;CDK4;EIF4EBP1;TGM1;RPS6KB1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30517131251684837,-1.0706181429350687,0.3060240963855422,0.7853760174495409,1.0,11/39,14.20%,PTPRG;TENM3;CD47;DPP4;FUT9;AFDN;PODXL;EFNA5;CDH1;JAG1;MDGA1
prerank,regulation of mRNA stability (GO:0043488),0.2606976215376383,1.0704274038811779,0.29777777777777775,0.7938895299160834,1.0,52/145,27.76%,FUS;PRKCA;TENT5C;PRKCD;EIF4G1;RPS27A;UBC;ZFP36L1;ZFP36L2;GDNF;RBM24;TNPO1;PSMD3;ANP32A;PSMB3;CSDC2;PSMA7;EXOSC5;IGF2BP2;PSMC1;PSMC2;AKT1;VIP;PSME4;DIS3;PSMB9;RIDA;METTL14;ROCK2;FXR2;SLC11A1;FASTKD3;EXOSC8;PSMD4;PSMB5;PSMB7;LARP1;RC3H2;PSMB8;ELAVL1;AXIN2;PCID2;PCBP4;XPO1;PSMD13;YTHDF3;PARN;SAMD4B;PUM1;ZC3H14;CARHSP1;PSMD2
prerank,embryonic digit morphogenesis (GO:0042733),0.3882375333628615,1.0703888271118889,0.34854014598540145,0.7932031681248464,1.0,2/18,6.91%,SALL1;SHH
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.34782223221605013,1.0702680327501821,0.36116152450090744,0.7927585145252498,1.0,6/29,7.40%,DDB2;GTF2H2;RPS27A;UBC;ERCC2;CUL4B
prerank,protein mannosylation (GO:0035268),-0.3599266372189341,-1.0702188082493491,0.34688995215311,0.785442947272319,1.0,9/22,15.62%,DPY19L1;DPM2;TMTC1;CRPPA;POMT2;TMTC4;FKTN;TMTC2;POMGNT2
prerank,positive regulation of T cell differentiation (GO:0045582),0.33218527775893036,1.069796522029483,0.3551236749116608,0.7933672813472277,1.0,10/36,19.51%,VSIR;RHOH;SHH;PNP;IL12B;VNN1;NCKAP1L;ZMIZ1;GATA3;IL4I1
prerank,embryonic organ morphogenesis (GO:0048562),-0.30268332640366635,-1.0696214620324447,0.31678486997635935,0.7861287341066749,1.0,23/42,34.20%,HOXC4;RYR2;HOXC9;SOX11;RARG;FBN1;FBN2;HOXB3;RBP4;RBPMS2;HOXB4;DSCAML1;MFAP2;MEGF8;HOXD4;FUZ;ID2;TBX1;HOXA4;ALX1;NEUROD1;HES1;NIPBL
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3495271198130785,1.069615928926135,0.3712686567164179,0.7931055874647047,1.0,6/27,9.97%,F11R;PIK3R1;ARHGAP28;MET;TJP1;INPP5K
prerank,heart morphogenesis (GO:0003007),0.31294535776652505,1.069488947739609,0.3649122807017544,0.7927084197370334,1.0,6/50,8.81%,TGFBR1;HEYL;CHD7;MDM4;LEFTY1;SOX17
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4524123648628668,-1.0694450190212659,0.3686440677966102,0.7855003554698007,1.0,2/10,4.37%,LRP6;SOX11
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4108461875129216,-1.0693801278905732,0.3713646532438479,0.7845623869518067,1.0,4/13,17.36%,CDK5RAP2;NDC80;GEN1;CCNB1
prerank,coenzyme A metabolic process (GO:0015936),0.4141508569739919,1.068800119244974,0.3773946360153257,0.7939466453583915,1.0,5/14,16.67%,PPCDC;PANK4;CROT;PANK2;DCAKD
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.24782148906869542,-1.068224988328657,0.29155313351498635,0.7870408518201193,1.0,44/110,31.93%,ADGRB3;ADGRL3;ADGRE5;ADRA1A;ADCY2;ADGRG6;IAPP;RAPGEF2;PF4;ADCY5;LGR5;ADRA2A;GPR161;ADCY3;ADCY8;LGR4;CNR2;ADGRG5;TSHR;LPAR2;RXFP2;ADGRL4;S1PR2;ADM;GNAQ;ADRA1B;MC4R;PTGIR;GNA13;S1PR5;PTH1R;GPR65;PTGER1;PTGFR;S1PR4;ADGRG4;CXCL9;ADGRD1;DRD1;GPR12;GPR3;ADRA2C;GHRH;CALCB
prerank,regulation of viral release from host cell (GO:1902186),0.37143792948918647,1.068086418837671,0.3761467889908257,0.7953160033729275,1.0,7/21,19.78%,TRIM11;TRIM5;TRIM62;VPS4A;TSG101;VPS37B;CHMP2A
prerank,histone exchange (GO:0043486),-0.3106500404861473,-1.0677005883410404,0.35374149659863946,0.7875916269189489,1.0,12/37,21.66%,KNL1;CENPT;CENPP;MIS18BP1;ACTR6;CENPW;RBBP7;NASP;CENPS;NPM1;ANP32E;OIP5
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.37672965718377227,-1.0677003839975752,0.3716216216216216,0.7864466020363803,1.0,2/17,0.57%,ANK3;AKAP6
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4441994171518677,-1.0676374820555021,0.3761261261261261,0.7855057381179988,1.0,4/10,6.81%,APP;NPTN;SHANK3;NETO1
prerank,cholesterol biosynthetic process (GO:0006695),-0.32053487199457725,-1.067557117837775,0.32407407407407407,0.7846455934349205,1.0,10/31,22.29%,LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1
prerank,macroautophagy (GO:0016236),0.26828803152321135,1.067481486980677,0.3370429252782194,0.7962497372823812,1.0,35/118,21.01%,NBR1;ATG14;VIPAS39;HDAC10;CSNK2A2;CSNK2A1;SRC;EPG5;ULK3;PIK3C3;TCIRG1;LIX1;CLN3;MTMR14;RB1CC1;PINK1;ATG101;VPS37D;GABARAPL1;VPS37A;VDAC1;VPS36;ULK1;TOMM20;VAMP7;TOMM7;ATG5;VPS4A;TSG101;VPS37B;EI24;CHMP2A;LAMP2;HGS;VPS39
prerank,lymphocyte chemotaxis (GO:0048247),0.336237314395205,1.0666569408378113,0.3623931623931624,0.7979901458932956,1.0,9/34,24.58%,PIK3CG;CH25H;CCL3;PIK3CD;CYP7B1;CCL24;CXCL10;CCL25;CKLF
prerank,cellular glucan metabolic process (GO:0006073),-0.4272240258539155,-1.0662583001820143,0.37662337662337664,0.7874786658459546,1.0,5/11,19.92%,PRKAG2;GSK3B;GBE1;PYGM;UGP2
prerank,folic acid metabolic process (GO:0046655),-0.37224527720367784,-1.0660913689815066,0.33114035087719296,0.7868458883222422,1.0,10/18,27.02%,ALDH1L1;SLC46A1;SHMT1;MTHFD1L;FPGS;FOLR2;MTHFD2;MTHFD2L;SLC25A32;DHFR
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3264539060213323,-1.0657689089731666,0.3503184713375796,0.786722438088418,1.0,5/31,4.59%,NLGN1;PDLIM5;LRRK2;PPFIA2;SHANK3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39641977303972326,1.0657630222048446,0.37174721189591076,0.7998092704222739,1.0,5/16,23.04%,MLXIPL;COX7A2L;PINK1;UQCC2;ABCD1
prerank,regulation of angiogenesis (GO:0045765),0.24913378074624984,1.0654562639123488,0.29701492537313434,0.8000025425275469,1.0,53/192,23.84%,PDE3B;PTPRM;SMOC2;HK2;ANXA3;ETS1;FOXJ2;PRKCA;ADAMTS1;SPARC;RHOB;VEGFB;SPRY2;EGLN1;PDPK1;MTDH;PGK1;BRCA1;SARS1;GATA2;ECSCR;PIK3CD;CD34;PRKCB;CEACAM1;RAPGEF3;RUNX1;APOH;SERPINE1;PDCD6;GTF2I;SERPINF1;GPNMB;SPINK5;ROCK2;THBS1;FGF18;AGGF1;KRIT1;EPHA2;IL1A;SYNJ2BP;HGS;NAXE;TSPAN12;ZC3H12A;CXCL10;TWIST1;EFNA3;FGF1;KLK3;JUP;AGO1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.339324012627373,1.0649240867897847,0.35855855855855856,0.8008851957774339,1.0,9/33,19.99%,NFE2L2;PKHD1;PDPK1;GATA2;SERPINE1;TNIP2;MAPK7;GATA3;KRIT1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.291732077382583,-1.0647311058675573,0.3333333333333333,0.788863176443818,1.0,25/47,27.93%,ZBTB16;PPARG;CREBL2;LMO3;CEBPB;FRZB;ZBTB7B;NAPEPLD;SOX13;FNDC5;PIM1;SFRP1;SFRP2;VSTM2A;SYAP1;AAMDC;ASXL2;NOCT;ZFP36;RARRES2;CREB1;XBP1;ID2;CCDC71L;METRNL
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.39017718082483044,-1.064521657637142,0.3747323340471092,0.7884164092797953,1.0,4/15,11.52%,APOE;SNX9;ADRA2A;SH3D19
prerank,platelet degranulation (GO:0002576),0.2706619951595112,1.0644694343745513,0.327718223583461,0.8015024788851337,1.0,21/118,11.96%,LHFPL2;TUBA4A;CD9;CYRIB;FERMT3;LYN;PROS1;PLEK;SPARC;STXBP1;CLU;VEGFB;PDGFB;CYB5R1;SELENOP;SELP;ORM2;F8;ENDOD1;APOH;SERPINE1
prerank,negative regulation of anoikis (GO:2000811),-0.396381058438856,-1.0641944744436878,0.35714285714285715,0.7882636197335329,1.0,8/14,25.35%,TLE1;PTRH2;BCL2;SNAI2;ITGB1;PDK4;MCL1;PTK2
prerank,nucleocytoplasmic transport (GO:0006913),0.3282152046220879,1.0635881571898427,0.3617391304347826,0.8034320458503341,1.0,11/40,18.90%,BACH2;NCBP1;SNRPF;ANP32A;RGS14;GEMIN6;SMN1;SNUPN;DDX20;NEMF;GEMIN2
prerank,response to ionizing radiation (GO:0010212),0.29279141120631436,1.0631154771866818,0.3456998313659359,0.8041200974535849,1.0,22/70,22.07%,RHNO1;MTA1;ATM;RHOB;SPIDR;USP28;INTS3;BRCA1;EYA3;RNF8;TNKS1BP1;RAD1;BLM;ABRAXAS1;MAPK14;NABP1;KAT5;BABAM1;ECT2;RAD9A;RFWD3;TOPBP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.34824001395832826,1.0630146402736527,0.37653239929947463,0.8036324515702749,1.0,5/30,9.70%,LGALS9;TLR4;PLCG2;IL12B;CD34
prerank,cholesterol transport (GO:0030301),0.31709936313284226,1.0630069503032114,0.3395585738539898,0.802846039400499,1.0,13/45,19.60%,LIPC;CLU;STX12;APOM;LCAT;NPC1;NPC2;LDLRAP1;OSBPL5;OSBP;SCARB1;VPS4A;SERAC1
prerank,cognition (GO:0050890),-0.2977489644598008,-1.0629045595784967,0.34151785714285715,0.7910463912111174,1.0,13/42,20.00%,GRM5;ST3GAL4;APP;JAKMIP1;MGAT3;CHRNA4;SETD5;MFSD2A;RP9;MAGT1;PTCHD1;SLC1A4;METTL23
prerank,cell proliferation in forebrain (GO:0021846),0.45511076648803617,1.0627664710465217,0.3825242718446602,0.8027932925687576,1.0,1/10,0.19%,NUMB
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.343156290969222,1.062511981991345,0.38,0.802789133363584,1.0,8/30,18.34%,DPM3;MGAT2;MGAT5;NUDT14;MGAT1;OSTC;ALG8;ALG5
prerank,protein secretion (GO:0009306),-0.28191832233148284,-1.062389577977643,0.34532374100719426,0.7915290374194732,1.0,12/56,11.01%,RIMS2;OLFM2;RAB3C;PCSK5;SNX19;RCN3;GOLPH3;RAB3D;COPG2;RAB8A;RAB3A;ARL4D
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3913687692217611,-1.0623390125165606,0.3707093821510298,0.7905558802219471,1.0,4/15,11.43%,HECW2;CENPE;PTTG1;UBE2C
prerank,negative regulation of viral release from host cell (GO:1902187),0.4229034674087941,1.062333897130487,0.3717948717948718,0.8025222047311651,1.0,2/13,3.07%,TRIM11;TRIM5
prerank,motile cilium assembly (GO:0044458),-0.4090540541122172,-1.0621155049196405,0.3665158371040724,0.7901332234815968,1.0,5/12,25.24%,SPATA6;DNAAF3;DNAAF1;CCDC39;BBOF1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3966562714229994,1.061591375715757,0.3790035587188612,0.804020323559741,1.0,5/17,9.97%,SMAD7;SIRT2;EIF4G1;SPRY2;INPP5K
prerank,hepaticobiliary system development (GO:0061008),0.3754330841099161,1.0614429867280424,0.37222222222222223,0.8036837932332341,1.0,6/20,15.23%,PRKCSH;NKX2-8;MET;LSR;CEBPG;PROX1
prerank,sterol biosynthetic process (GO:0016126),-0.3111860935688666,-1.061419204498957,0.33793103448275863,0.7911730053971388,1.0,11/33,22.29%,PRKAG2;LBR;EBP;LSS;HMGCR;HMGCS1;MVD;DHCR7;MSMO1;ACLY;CYP51A1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4454694481029377,1.0612247425917567,0.3931947069943289,0.8035708838137074,1.0,5/11,20.45%,PADI2;ZMIZ2;ZMIZ1;ARID1A;ELOF1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3499634932528646,1.0611156266569612,0.37749546279491836,0.8030969081389397,1.0,6/30,9.64%,CSF1R;PLEK;ARMC6;SHH;TNFRSF13B;PLD4
prerank,N-glycan processing (GO:0006491),0.39108107394804564,1.0609684400510364,0.3743119266055046,0.8027899863023941,1.0,5/18,10.07%,MGAT4A;PRKCSH;GANAB;MAN2A2;MAN1C1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.32769191474573434,1.0608016402255496,0.36568457538994803,0.8025031373902787,1.0,10/37,13.32%,MEF2C;FOXJ2;ADAMTS1;MEF2D;MMP2;PDGFB;JUN;GPER1;LDLRAP1;GJA1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.33900390876300274,1.0605054293152425,0.36101083032490977,0.802672243420087,1.0,9/30,18.21%,HPS4;CSNK2A2;SH3GLB1;RNF31;USP36;LEPROT;PINK1;TOMM7;HTRA2
prerank,regulation of ossification (GO:0030278),-0.30941654808976,-1.0603242300255205,0.3333333333333333,0.793441745616733,1.0,5/36,4.37%,RBPJ;ZBTB16;SGMS2;LRP6;SOX11
prerank,metanephric mesenchyme development (GO:0072075),0.45708689863245133,1.0602165399903123,0.3774597495527728,0.8027459379403202,1.0,3/10,11.39%,BASP1;SHH;PAX2
prerank,positive regulation of innate immune response (GO:0045089),0.33793045736371036,1.0591538221612558,0.37122557726465366,0.805294118531088,1.0,8/30,16.57%,POLR3G;SLC15A4;AKIRIN2;DHX9;PLA2G5;TRIM62;MAVS;GBP5
prerank,neutrophil activation (GO:0042119),0.43613367555914617,1.0589608194233693,0.37662337662337664,0.8050936719420104,1.0,2/12,4.13%,PREX1;PRKCD
prerank,external encapsulating structure organization (GO:0045229),-0.2270041096699424,-1.058575326843139,0.24281150159744408,0.7976558919109457,1.0,62/205,19.11%,ITGA4;CD47;CD44;MMP16;APP;ADAMTS17;ITGB7;VIT;FN1;ITGAL;THSD4;VWF;COL4A1;ADAMTS19;FBN1;COL13A1;POSTN;HSPG2;VCAN;SPP1;TNC;FBN2;ATP7A;LAMB2;MMP12;MMP15;ST7;VCAM1;ADAMTSL1;LOX;ADAM12;COL14A1;TNR;ITGA8;ADAMTSL5;MMP19;ITGA2B;ITGB6;MMP8;JAM3;CDH1;SMOC1;PECAM1;COL1A1;COL23A1;LAMA5;COL5A1;DAG1;MMP14;ELN;AGRN;LUM;ITGB1;LAMC3;ITGA11;COL6A3;COL19A1;ADAMTSL4;BSG;ADAMTS10;ITGAD;LAMA1
prerank,fatty acid metabolic process (GO:0006631),0.2635594262661908,1.0582539436535439,0.334855403348554,0.8063980921334378,1.0,18/115,13.41%,LIPC;LIPH;ABCD2;ALOXE3;ACAD9;ACSL4;PPARD;LPIN2;NUDT19;PLA2G15;HPGD;THEM4;ACADM;SLC27A4;CROT;PON2;GPX4;PON3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2903457757168153,1.0581783971238996,0.3630252100840336,0.8058079672356391,1.0,14/69,14.53%,CX3CR1;MEF2C;SLC30A10;LGMN;PTK2B;PPT1;CNTF;GDNF;POU4F1;CLN3;PINK1;AGAP2;SOD1;RETREG1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.22331894362336677,1.0581412624940176,0.26947637292464877,0.8051305043970542,1.0,112/532,17.97%,INPP5D;IL18;ITGAM;CSF3R;CSF1R;IL1RL2;IRAK2;PIK3R1;RIPK2;PYDC1;GAB2;PRKACA;TRIM5;MAP3K3;ITGB2;HNRNPDL;SRC;EGR1;TRAF5;PRKCD;CCL3;TNFSF13B;FSCN1;CTR9;CD27;CASP1;STX1A;EBI3;RPS6KA5;RPS27A;UBC;MMP2;TRADD;TNFRSF25;PTK2B;TNFRSF13C;CSK;MID1;IL6ST;SOCS6;SNRPA1;PDGFB;CD86;TNFRSF13B;DUOX1;CNTF;NOS2;EDN2;IL12B;EDA2R;CTF1;CXCL1;IL6R;MT2A;TAB2;LMNB1;LIMS1;MAP3K8;PIK3CD;APPL1;PSMD3;IL12RB2;PIK3CB;IRF8;TNFRSF17;IL10RB;CEACAM1;PSMB3;IL33;TRIM62;PTPN11;TNFSF8;PSMA7;STX4;IL34;IL10RA;IL18BP;CCR5;IFNGR2;SOD1;GHR;PSMC1;PSMC2;BAG4;PYCARD;IL4R;AKT1;IL1RL1;CSF1;TNIP2;PSME4;IL1R2;TEC;OSM;IRF3;COMMD7;ZEB1;PELI2;STAT6;TNFRSF12A;AIM2;ISG20;PSMB9;TXLNA;RPS6KA4;CSF2RA;POU2F1;PTPRJ;GATA3;IL7R;IL20RA;IRF9
prerank,protein complex oligomerization (GO:0051259),-0.2624782094974343,-1.0580483802683804,0.3197969543147208,0.7981864379611203,1.0,25/85,21.26%,LRRC8C;NLRC4;KCNC2;MCU;HGSNAT;EHD1;DNM1L;ATL2;LETM1;TRMT61B;HOMER1;PKD2;NINJ1;ADCY8;AQP11;G3BP2;MPP2;SNCA;NACC2;BOK;TWNK;MS4A1;ATL1;CUTC;RNF213
prerank,negative regulation of biosynthetic process (GO:0009890),0.3895451786475962,1.0577442545762252,0.3843283582089552,0.8056058152440302,1.0,5/16,11.33%,ABCD2;COA8;SLC30A10;GPER1;CEACAM1
prerank,regulation of cellular component movement (GO:0051270),0.31310585479492536,1.0577205025690222,0.36717428087986465,0.8048892755967109,1.0,6/49,6.35%,TGFBR1;ETS1;CD9;LYN;PKHD1;ZSWIM8
prerank,protein-containing complex assembly (GO:0065003),-0.2220739832738864,-1.0577178598298462,0.2633333333333333,0.7981539321348765,1.0,60/259,18.07%,DMD;CD74;LRRK2;GRIA1;MCU;HGSNAT;CUL3;CTSC;CD40;GOSR2;FN1;SEC23A;ZW10;AFDN;DNM1L;GSK3B;RAB1B;WASF1;SCFD1;ST13;CDC73;TLE4;GEMIN5;AXIN1;SAR1B;PPP6C;SNX9;ANO6;TCF7;KNTC1;CDC123;PPIH;BCL9L;TLE1;PPP2R1A;TRAPPC1;ADCY8;SEC24D;ITGB1BP1;IL2RB;JCHAIN;PARD3;PYGO2;GPAA1;CX3CL1;IL1RAP;TMED2;SEC24B;TIAM1;MDM2;CD3E;TRAF1;RIMS1;ADD2;REPS2;LMAN1;WDR19;SPG7;CARD10;BOK
prerank,RNA methylation (GO:0001510),0.2966410423625502,1.0577153208116379,0.37018425460636517,0.8041061901961927,1.0,22/60,24.66%,TRMT6;BUD23;NSUN5;METTL5;NSUN6;TGS1;METTL6;BCDIN3D;FTSJ3;WDR6;METTL14;MTO1;NSUN3;TRMT61A;PCIF1;TFB1M;NSUN4;FBL;METTL8;THUMPD3;TRDMT1;FTSJ1
prerank,transcription by RNA polymerase II (GO:0006366),0.23592535589181576,1.0576646702111117,0.31059506531204645,0.8034695431521748,1.0,63/305,17.97%,MAML3;RREB1;NCBP1;ARRB2;DDX5;NELFB;POLR2H;SRRT;PPARD;TTF2;CDK9;POLR2J;HDAC10;CSTF2;DEAF1;NKX2-8;POLR2D;INTS11;CTR9;GTF2H2;TAF8;TAF12;ELL2;SNRPF;TAF6;NRBP1;ERCC2;RPAP2;RNMT;INTS3;PKNOX1;PAX1;RXRB;NR2F1;MBD1;NOTCH4;PABPN1;E2F2;DTX1;CPSF1;MAML2;NFYA;TAF1;HSF2BP;MED4;SETD2;TAF4;HDAC5;FIP1L1;GTF2I;NOTCH3;NELFE;RPAP1;POU2F2;TAF5L;POLR2E;INTS8;MED18;NABP1;C5AR1;POU2F1;PCF11;IRF9
prerank,mitotic nuclear division (GO:0140014),-0.26708771081603877,-1.0567054533057134,0.32904884318766064,0.8001467447655672,1.0,14/71,12.70%,EPS8;SMC4;CDCA8;ZW10;TOGARAM2;TPX2;RAN;NDC80;NUSAP1;MAP9;KIF11;SPAG5;UBE2C;KIF18B
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.37694219837382414,-1.05669028738891,0.3752913752913753,0.7990541657755769,1.0,4/17,8.52%,PLA2G7;CCR2;CCR1;ANO6
prerank,amino sugar metabolic process (GO:0006040),-0.43509576308374887,-1.0565157380721537,0.3689727463312369,0.7985048387382828,1.0,3/10,11.16%,ST3GAL1;EXTL2;GFPT2
prerank,negative regulation of apoptotic process (GO:0043066),0.22735631915161952,1.0564838857571226,0.30614973262032086,0.8062030144776404,1.0,77/444,15.34%,CX3CR1;MERTK;SON;GREM1;CAPN3;CFLAR;PIM2;MAP4K4;MEF2C;PIK3R1;SOX8;RIPK2;RPS6KA1;ITCH;PRKCA;VHL;SLC30A10;IGF1R;CSNK2A2;CSNK2A1;SRC;PHB2;PKHD1;PRKCD;AATF;CD27;RPS27A;UBC;LGMN;PTK2B;SPRY2;ATAD3A;EGR3;YME1L1;IL6ST;WDR73;MAEA;MGMT;PPT1;SHH;MTDH;CIAPIN1;CNTF;GDNF;POU4F1;ARAF;TJP1;BFAR;DPEP1;AXL;NCKAP1L;AREL1;NUAK2;LAMTOR5;CLN3;RPL10;DLL1;PAX2;APOH;PSEN2;PINK1;BNIP2;AGAP2;SEMA4D;GCLC;MAPK8;PLK3;TMBIM6;SOD1;RETREG1;BAG4;AKT1;CIB1;HPN;VDAC1;RNF144B;VIP
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.39763979025033375,1.056116057904516,0.3843283582089552,0.8064514462498203,1.0,8/16,29.75%,MCM2;SSBP1;BLM;MCMDC2;MCM6;RPA1;RECQL;MCM7
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.4549186674409589,1.0555206526198146,0.4,0.8075601622937988,1.0,4/10,22.27%,SMAD7;NFKBID;ZC3H12A;RC3H2
prerank,regulation of interleukin-2 production (GO:0032663),-0.30241161489054524,-1.055421720395873,0.3493670886075949,0.8006933576927883,1.0,7/43,6.99%,PDE4B;SPTBN1;PDE4D;CCR2;RPS3;IRF4;VSIG4
prerank,positive regulation of interferon-gamma production (GO:0032729),0.30949443008184735,1.0553310581435116,0.3593220338983051,0.8073303859699317,1.0,9/48,10.14%,IL18;TLR7;LGALS9;SLC7A5;CYRIB;TLR4;EBI3;IL12B;IL12RB2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4559182473399619,1.0550976315459868,0.4018018018018018,0.8072381905498455,1.0,1/10,0.93%,DNMT3A
prerank,positive regulation of macrophage differentiation (GO:0045651),0.44548867968249384,1.0550131706397752,0.40608228980322003,0.8066979124925618,1.0,5/11,24.34%,PRKCA;IL34;CSF1;TGFB1;FADD
prerank,positive regulation of developmental growth (GO:0048639),-0.28968426321602914,-1.054904248454721,0.34615384615384615,0.8011623487172012,1.0,6/49,3.86%,RIMS2;PLCB1;CDKL5;BDNF;SYT1;NEDD4L
prerank,histone deacetylation (GO:0016575),0.3129226127250402,1.054356911411899,0.375,0.8078956473443267,1.0,14/43,20.60%,SIRT2;MTA1;HDAC10;SUDS3;RBM14;SIN3A;MIDEAS;MORF4L1;BRMS1L;HDAC5;SIN3B;HDAC8;MIER3;MORF4L2
prerank,regulation of cellular component size (GO:0032535),-0.3225033969134758,-1.0542704745975635,0.3619489559164733,0.8020286976758435,1.0,5/30,5.66%,VAV3;EPS8;PEX11A;RAB22A;RARG
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.41097466126613225,1.0540643608425442,0.40252707581227437,0.8080273670849372,1.0,3/13,12.06%,DDIT3;SIN3A;TAF1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.23652633377062596,-1.0533633097458464,0.30903790087463556,0.8037617221519044,1.0,38/141,17.67%,AKAP6;LRRK2;CTNNA1;GABRB1;HCN1;EGFR;ADCY2;HRH1;RYR3;RAPGEF2;GOLPH3;PKD2;ADCY5;SPP1;GABRG2;GABRB3;ACTB;P2RY1;RIOK3;GNAI1;ADCY3;ADCY8;ATP1A1;AHR;LCOR;CDH1;KCNQ1;PDE2A;HCN2;CCL5;TIPARP;CRHBP;SFRP1;CFTR;NR3C1;NR1H4;SLC1A1;ADTRP
prerank,actin nucleation (GO:0045010),-0.3515620156589637,-1.0529730477115493,0.3640256959314775,0.8038080012251855,1.0,2/21,2.15%,IQGAP2;ACTR3
prerank,heart development (GO:0007507),-0.23839123477262625,-1.0527426297226363,0.31761006289308175,0.8034477285429836,1.0,34/150,16.87%,SGCZ;PDLIM5;ZFPM2;FGF12;PCSK5;FLRT2;SGCD;NTRK3;CACYBP;FN1;ZDHHC16;CACNA1C;HTR2B;PDLIM1;RBM20;ERBB4;FBN1;PKD2;HEG1;ERBB3;GPC3;RBP4;PDLIM4;CRIP1;MYBPC3;CDKN1A;PKD1;ACVRL1;TEK;SRF;FOXC2;APLN;BMP4;APLNR
prerank,skeletal system development (GO:0001501),-0.23881529796205042,-1.052696427165162,0.30303030303030304,0.8024689348794655,1.0,48/148,24.91%,TRPS1;ZBTB16;CD44;MMP16;SULF2;PCSK5;EXT1;SOX5;PRDX1;SOX11;PAPSS2;FBN1;FRZB;TLL1;COL13A1;VCAN;ATP7A;CDH11;P3H1;FGFR3;EBP;RBP4;GDF11;TEAD4;COL1A1;PKD1;PHEX;MMP14;EXTL1;COL19A1;SPEF2;GDF10;CHRD;TNFRSF11B;ACAN;SOX6;BGLAP;ALPL;NOTUM;GHRL;NPR3;PPIB;BPNT2;HAPLN4;SHOX2;RFLNB;ITGB8;PTH1R
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4121935908302818,1.0525538398212486,0.3798165137614679,0.8120046275167813,1.0,8/14,25.17%,MIA3;SEC13;RAB1A;SAR1A;SEC31B;SCAP;SEC31A;SEC24A
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.335982890189561,-1.0524333426739187,0.38534278959810875,0.8021893789835378,1.0,3/26,2.17%,CCR2;CCBE1;SULF2
prerank,negative regulation of T cell activation (GO:0050868),0.32357658570058584,1.051897021586481,0.3905429071803853,0.8131696146151869,1.0,8/35,11.73%,PAG1;TNFRSF21;CD86;PDCD1LG2;TNFAIP8L2;NCKAP1L;CEACAM1;HAVCR2
prerank,artery development (GO:0060840),0.35490561488022404,1.0516698796296429,0.38475177304964536,0.8130462138632213,1.0,2/23,1.07%,TGFBR1;SMAD7
prerank,peptidyl-asparagine modification (GO:0018196),0.3371942239772768,1.051592608090978,0.38954468802698144,0.81248741843919,1.0,8/31,18.34%,DPM3;MGAT2;MGAT5;NUDT14;MGAT1;OSTC;ALG8;ALG5
prerank,regulation of complement activation (GO:0030449),0.3205184576202337,1.0515638036586594,0.40847457627118644,0.8118056477446656,1.0,6/40,7.32%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.31437767706439645,-1.0514345221567019,0.372960372960373,0.8041740823945309,1.0,14/32,31.24%,POLA1;CDK14;TFDP2;E2F7;CDK15;ESRRB;E2F1;NPAT;TFDP1;BACH1;ID2;DHFR;GFI1;RRM2
prerank,protein hydroxylation (GO:0018126),0.39682203175830133,1.0513241895799894,0.4195933456561922,0.8117518961048577,1.0,4/15,11.82%,ASPH;VIPAS39;P3H2;JMJD7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3754381877507741,1.0512334135562647,0.4090909090909091,0.8111889894378875,1.0,2/20,1.49%,TGFBR1;HEYL
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3404464664645883,1.0511321838082759,0.379746835443038,0.8107319186029465,1.0,5/31,3.78%,LRP5;NBR1;GREM1;SKI;TRPM4
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.34107336739042154,-1.051131198368718,0.39211136890951276,0.8040535193516107,1.0,6/26,9.87%,RSAD2;PTPN22;RTN4;NINJ1;CYBA;LBP
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2698702564011838,1.050972725880195,0.3672496025437202,0.8104551227342278,1.0,10/100,4.25%,GNA12;BAG6;SUMO1;SMAD7;FHIT;UCHL5;CSNK1E;FBXO22;SIRT2;CLU
prerank,regulation of RNA splicing (GO:0043484),0.28639554343027657,1.050795015637164,0.36423841059602646,0.8102027574112656,1.0,11/69,7.49%,SNRNP70;SON;PIK3R1;QKI;CLK1;FUS;U2AF2;HNRNPH1;RBM39;JMJD6;CLK4
prerank,positive regulation of histone acetylation (GO:0035066),0.35888025311421295,1.0501856554368048,0.396709323583181,0.8112360214080918,1.0,10/23,31.04%,RPS6KA5;BRCA1;RPS6KA4;ARRB1;NOS1;GLYR1;WBP2;PAXIP1;MUC1;BRD7
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.33141700365115134,1.050158767762613,0.36318407960199006,0.810550122249015,1.0,9/33,10.25%,NYAP1;PIK3R1;SIRT2;IGF1R;PIK3CG;C1QBP;ZFP36L1;PIK3CD;PIK3CB
prerank,positive regulation of protein import (GO:1904591),0.34041254811223287,1.0500805379645286,0.38898756660746003,0.8100015549110343,1.0,11/30,23.79%,SMAD3;PIK3R1;PRKCD;MAVS;ZIC1;ECT2;ARHGEF5;ZC3H12A;TGFB1;IPO5;JUP
prerank,positive regulation of viral process (GO:0048524),0.29196498442067786,1.050064340966895,0.3652173913043478,0.8092655977286248,1.0,16/60,22.24%,NELFB;POLR2H;CDK9;POLR2J;POLR2D;HACD3;DHX9;PPID;AXL;VAPB;NELFE;POLR2E;VPS4A;DDX3X;POLR2I;LARP1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3685730715263734,1.0499297012806117,0.38392857142857145,0.8089135302445039,1.0,8/21,26.29%,UCHL5;ULK3;SHH;RAB34;SMO;TUBD1;DLG5;KIF7
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4370471854426332,1.0499060025190599,0.39488117001828155,0.8082176489272613,1.0,3/11,9.75%,EGLN1;P4HA1;P3H2
prerank,protein acylation (GO:0043543),-0.31075993918165806,-1.049555254555787,0.358974358974359,0.8078328967496131,1.0,11/38,16.98%,ZDHHC21;ZDHHC16;GTF2B;ZDHHC17;ZDHHC23;CLOCK;ZDHHC15;KAT6A;ZDHHC18;SELENOK;FOXO1
prerank,mRNA splice site selection (GO:0006376),0.33955002232542353,1.0490266222569473,0.3917525773195876,0.8100696867494375,1.0,9/30,16.45%,SNRPC;SFSWAP;CELF2;PRPF39;SRSF5;LUC7L3;SLU7;SF3A1;LUC7L
prerank,natural killer cell mediated immunity (GO:0002228),0.3988810907298332,1.048733714592679,0.4051094890510949,0.8101723484662512,1.0,5/15,13.22%,ULBP1;RAET1E;TUBB;PLEKHM2;CEBPG
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2690235704080857,1.0481732439872695,0.35126050420168065,0.8111414608750115,1.0,22/93,16.13%,PJA2;AGER;SEMA4C;TRAF5;CD27;PTK2B;MID1;ARL6IP5;CCR7;EDA2R;PRMT1;WNT7B;MAP4K2;MAP3K11;MAP3K10;TAOK2;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1;EIF2AK2;PDCD10
prerank,cellular response to mechanical stimulus (GO:0071260),0.3085560177967225,1.0480623899397135,0.37943262411347517,0.8106886980569307,1.0,5/46,4.91%,F11R;TLR7;CRADD;TLR4;CASP1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4271251922710909,-1.0479361262281228,0.4024640657084189,0.8117058552151653,1.0,6/11,37.89%,NECAB1;ITM2A;ABCA7;AGO2;SOAT1;BACE2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.30550146626805175,1.047898859836281,0.36348408710217756,0.8096184459767748,1.0,14/50,17.95%,POLR2H;POLR2J;RANBP2;POLR2D;EIF4G1;NUP42;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107
prerank,regulation of gene silencing by RNA (GO:0060966),0.30550146626805175,1.047898859836281,0.36348408710217756,0.8096184459767748,1.0,14/50,17.95%,POLR2H;POLR2J;RANBP2;POLR2D;EIF4G1;NUP42;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2862890951404239,1.0478663869775604,0.37756714060031593,0.808932439906926,1.0,23/76,22.73%,BIN1;BAIAP2L2;CDC42EP2;PLEK;NUMA1;PTK2B;CCR7;NCKAP1L;ABL1;SORBS3;WDR1;PYCARD;PROX1;TENM1;FCHSD2;CDC42EP3;NUP62;FES;VASP;CCL24;FCHSD1;EVL;KATNBL1
prerank,regulation of cell division (GO:0051302),0.28483777107912417,1.047825931420204,0.36649214659685864,0.8082791774433375,1.0,18/72,16.10%,ZFYVE26;SIRT2;FLCN;PIK3C3;SHH;TLE6;PLK5;SH3GLB1;DLL1;BLM;SETD2;PIN1;PLK3;ENTR1;TAL1;CIB1;NCOA3;AURKA
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3460128031743188,-1.0477952419451209,0.3763440860215054,0.8110276005333624,1.0,10/24,20.55%,B2M;SEC23A;TAP1;SAR1B;SEC24D;SEC24B;SEC24C;BCAP31;ABCB9;ACE
prerank,DNA alkylation (GO:0006305),-0.36557938971094983,-1.0477396879442042,0.37104072398190047,0.8089550847006772,1.0,9/19,25.37%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1;FOS
prerank,DNA methylation or demethylation (GO:0044728),-0.36557938971094983,-1.0477396879442042,0.37104072398190047,0.8089550847006772,1.0,9/19,25.37%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1;FOS
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3931608183789543,1.047610679238671,0.37547892720306514,0.808198351251749,1.0,6/16,15.05%,MEF2C;IGFBP3;RBM24;AKIRIN1;LRRC8A;MAPK14
prerank,cardiac ventricle morphogenesis (GO:0003208),0.31317461848896005,1.047289275330869,0.38235294117647056,0.8084059445992751,1.0,6/41,8.46%,TGFBR2;SMAD7;HEYL;MEF2C;CPE;MYL3
prerank,zymogen activation (GO:0031638),0.3155773392869561,1.0471967726642883,0.37050359712230213,0.8078912048701019,1.0,7/39,7.62%,KLK2;VSIR;RIPK2;ASPH;F12;LGMN;PGK1
prerank,female gonad development (GO:0008585),0.38180842300553275,1.0471585872337372,0.4079696394686907,0.8072433700293224,1.0,6/19,17.95%,FSHR;LHCGR;INHA;EIF2B4;SOD1;NUP107
prerank,response to purine-containing compound (GO:0014074),0.380566424851442,1.0471376502947676,0.40831758034026466,0.8065381021827367,1.0,4/17,7.99%,TRPM2;NDUFS4;ABCC9;DUOX1
prerank,regulation of cellular response to stress (GO:0080135),0.2618280582832701,1.0470242268099255,0.36089030206677264,0.8061096227791456,1.0,44/115,27.90%,NUAK1;RANBP2;NEK6;ATM;EIF4G1;ATF3;NUP42;HSPH1;USP19;SEC13;RPTOR;MTOR;MBTPS2;NUP50;MLST8;NUP35;CLN3;HSPB8;PINK1;NUP88;ABL1;BAG4;ARMT1;NUP62;SEH1L;ROCK2;NUP107;MAPT;DNAJC7;RPA3;ABCD1;NUP153;FKBP4;AJUBA;NUP188;CRYAB;CHORDC1;IER3;NDC1;BAG5;HIKESHI;CAMK2D;DNAJB1;RPA1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2772351604286008,1.0466586147772545,0.3572593800978793,0.8064372652547631,1.0,25/80,23.42%,PHETA1;TBC1D17;TBC1D10B;VPS26B;TMED9;YKT6;SGSM2;VPS54;SNX5;DENND5A;RBSN;SNX32;SNX3;RAB7B;VPS29;RAB6B;STX5;VPS26A;VPS35;ANKFY1;PREPL;SNX6;STX16;RAB9A;VPS52
prerank,regulation of cholesterol efflux (GO:0010874),-0.32265423638563334,-1.0457469434604285,0.3847926267281106,0.8139888855623606,1.0,7/30,12.88%,PPARG;PLTP;APOE;SIRT1;NFKBIA;ABCA5;YJEFN3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.32100334886364035,1.0457306959023307,0.3915171288743883,0.8084353177268228,1.0,15/34,31.49%,TLR4;LYN;GPS2;GPR108;TICAM2;RAB7B;TICAM1;ACOD1;GRAMD4;OTUD4;TLR9;TYRO3;TLR6;TREM2;TNFAIP3
prerank,lipid homeostasis (GO:0055088),-0.2763880426711399,-1.0457081874897491,0.3640661938534279,0.8129533880461497,1.0,21/57,27.96%,PPARG;USF1;ZBTB20;APOE;TLCD3A;RCN3;SIRT1;CEBPA;ANGPTL3;ABHD5;TLCD3B;RBP1;PNPLA3;POLD1;TM6SF2;PRKAA1;ABCB11;FBXW7;XBP1;DGAT2;ADCK1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.24922586942679875,-1.0455230460547442,0.34782608695652173,0.8124607323141496,1.0,27/98,21.67%,ANK3;SORBS1;DPP10;SPTBN1;YWHAQ;EGFR;TFDP2;YWHAE;PRKN;KIF5B;PLS1;MTCL1;FIS1;MFF;ITGB1BP1;PPP3CC;BCL2;ITGB1;PRKCE;E2F1;PRKCI;TCAF1;TFDP1;EPHB2;CNPY4;FYN;RANGRF
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.27105299769679003,-1.0454755624187775,0.3365617433414044,0.8114817374418268,1.0,16/67,15.14%,CYBB;CD36;B2M;PSMD14;NCF2;PSMD8;PSMA2;PSMF1;PSMD6;TAP1;PSME2;CYBA;PSMD5;PSMD12;PSMD11;PSMD1
prerank,mesenchymal cell development (GO:0014031),0.3879298722088381,1.0452202315769474,0.4041353383458647,0.8091633821484989,1.0,4/18,12.72%,HEYL;SOX8;KBTBD8;PDCD6
prerank,negative regulation of response to wounding (GO:1903035),0.37086212038662814,1.0451938982279154,0.4017391304347826,0.80846936202311,1.0,6/19,17.73%,RTN4RL1;KLK8;SERPINE1;CERS2;RTN4R;AJAP1
prerank,tRNA wobble uridine modification (GO:0002098),0.4095503399857161,1.0450443148471016,0.4007352941176471,0.8081276049996285,1.0,9/14,28.62%,TRMU;CTU2;MTO1;KTI12;ELP3;ELP1;MOCS3;ALKBH8;TRMT9B
prerank,melanosome organization (GO:0032438),0.3414022594593148,1.0446015430848006,0.38420107719928187,0.8086441098655812,1.0,13/26,34.10%,HPS4;AP3D1;SHROOM2;RAB32;KIF13A;TRAPPC6A;BLOC1S6;HPS1;RAB29;BLOC1S5;LYST;AP1G1;AP3B1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.31028470209335446,-1.0444500408358004,0.38765432098765434,0.8135991695173007,1.0,8/32,21.13%,RPL30;PF4;ROMO1;CAMP;RNASE3;LTF;RPS19;CXCL14
prerank,protein targeting (GO:0006605),-0.24229437425016784,-1.0443476748398923,0.3577023498694517,0.8128058259028891,1.0,34/118,20.32%,NLGN1;AKAP6;CHM;ZDHHC21;SPCS2;AP4S1;TOMM22;TIMM23;TIMM17B;SDCBP;GIPC1;PEX12;TOMM5;FIS1;MFF;ZFAND6;ZDHHC23;FBXO7;AQP11;TIMM17A;ZDHHC15;PARD3;ZDHHC18;TIMM10;AIP;AP4E1;RASSF9;VPS37C;PRKCI;ATG3;BCAP31;ZDHHC24;AP1S3;PEX19
prerank,endothelial cell differentiation (GO:0045446),-0.4114276261656368,-1.044303679197783,0.39019189765458423,0.811818540355228,1.0,4/12,21.52%,FSTL1;JAG1;ACVRL1;TIE1
prerank,cellular response to ATP (GO:0071318),0.4045907734385179,1.043737074175062,0.41012216404886565,0.8104618381619395,1.0,3/14,12.06%,P2RY12;SSH1;TAF1
prerank,spinal cord development (GO:0021510),-0.40893232601410845,-1.0436862486288565,0.4063157894736842,0.8126649581981319,1.0,5/12,15.68%,VIT;SOX11;PKD2;PKD1;RELN
prerank,negative regulation of cell migration (GO:0030336),0.2551536817982194,1.0435863424655167,0.37442218798151,0.8101036604230469,1.0,28/137,17.63%,SRGAP3;SRGAP2;LDLRAD4;NAV3;SMAD7;SLURP1;RAC1;IGFBP3;RHOB;RNF41;FLCN;SHH;MIA3;PIP5KL1;DPEP1;LRP1;RNF20;SERPINE1;NDRG4;ENG;GJA1;DRD2;ADGRG1;NOG;PTPN23;ARHGAP4;TRIB1;PTPRJ
prerank,ncRNA export from nucleus (GO:0097064),0.3223722755623156,1.0433858139298517,0.3884297520661157,0.8099572924261554,1.0,11/36,17.95%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP50;NUP35;NUP88;NUP62;SEH1L;NUP107
prerank,histone mRNA metabolic process (GO:0008334),0.3402650921241923,1.0426968256208393,0.3790035587188612,0.8113090542201258,1.0,4/27,6.59%,NCBP1;SSB;ATM;SNRPF
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30987705734772375,1.04252577008215,0.3737024221453287,0.8110757938746959,1.0,14/42,24.61%,PCNA;PRIMPOL;RFC2;RPS27A;UBC;POLN;POLD2;PCLAF;RFC1;RPA3;ZBTB1;SPRTN;WRNIP1;POLD4
prerank,negative regulation of cell population proliferation (GO:0008285),-0.21025669738712455,-1.0423414764147139,0.2835820895522388,0.8158153513251639,1.0,105/351,23.99%,MAGI2;MTSS1;PPARG;ADRA1A;NCK2;APP;B2M;ST18;RAPGEF2;LMNA;ZBTB7C;JAK2;DLG3;ACVR1C;SOX11;UTP20;S100A11;RARG;ERBB4;FRZB;PKD2;OPRM1;CDC73;PER2;TNS2;PTPN2;FRK;DUSP10;SLC16A2;CDH13;P3H1;MN1;E2F7;RERG;KLF4;ITGB1BP1;CTCF;TESC;CEBPA;AQP11;MCC;MINAR1;RBP4;RAF1;IFIT3;SMYD2;HMOX1;CDKN2A;SOD2;CBFA2T3;CDKN1A;PLXNB1;SULT2B1;HSPA1B;MYO16;ACVRL1;CGREF1;PAK1;FKTN;WNT9A;NACC2;SFRP1;RGCC;CCN3;NIBAN2;IFITM1;SFRP2;BMP4;SPEG;BNIPL;COPS8;NPM1;B4GALT7;PBRM1;TNN;TNFRSF8;E2F1;GSTP1;FOXP3;KLF10;IGFBP7;RPS6KA2;DNAJA3;TPTE;TFDP1;CDKN1C;AVPR2;BTG2;PTPRK;TSC1;DNAJB2;NOX4;TGFBR3;POU1F1;DLL4;ING4;EMD;PARP10;REST;IGFBP6;PTGIR;WT1;CTNNB1;OGN;NMI
prerank,xenobiotic transport (GO:0042908),0.3835078126690433,1.0421132526611967,0.4223826714801444,0.8115402731883413,1.0,5/17,17.98%,SLC7A5;SLC22A2;SLC29A4;GJA1;SLC15A2
prerank,acute-phase response (GO:0006953),-0.4046378466767798,-1.0420746222269708,0.39655172413793105,0.8155188116907217,1.0,6/12,33.55%,CEBPB;LBP;SIGIRR;PLSCR1;CRP;IL22
prerank,ESCRT III complex disassembly (GO:1904903),0.4469810839123652,1.0416642429815612,0.40823970037453183,0.811319481560932,1.0,7/10,33.31%,CHMP1A;VPS4A;IST1;CHMP2A;VTA1;CHMP7;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),0.4469810839123652,1.0416642429815612,0.40823970037453183,0.811319481560932,1.0,7/10,33.31%,CHMP1A;VPS4A;IST1;CHMP2A;VTA1;CHMP7;CHMP5
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3695377277289742,-1.0414513938819752,0.39211136890951276,0.8162546114337235,1.0,7/17,17.68%,EGFR;CCND2;CCNYL1;PKD2;PKD1;RGCC;SPDYA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.42783822646599995,-1.0414221695709254,0.42340425531914894,0.815228827427998,1.0,2/10,7.56%,ATF7IP;THRA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3141255059071097,-1.0411548349675381,0.37264150943396224,0.8149186303128315,1.0,7/34,8.78%,CTNNA1;LATS1;NEDD4L;RIPOR2;GSK3B;ILRUN;ACTN2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.36960256172228345,-1.0410352730059187,0.40421052631578946,0.8141986066039018,1.0,4/18,5.23%,CD74;MCU;RIPOR2;DNM1L
prerank,regulation of osteoclast differentiation (GO:0045670),0.32755437723388564,1.0405842607773046,0.4003466204506066,0.8137432719360391,1.0,10/33,16.89%,TLR4;CCL3;UBASH3B;GPR55;IL12B;POU4F1;MTOR;CSF1;GPR137;CARTPT
prerank,hippo signaling (GO:0035329),-0.32413878433758464,-1.0403211231749887,0.38826185101580135,0.8153488262062343,1.0,6/26,13.55%,LATS1;YWHAE;FAT4;MOB1B;WWC1;TEAD4
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.38737258797279106,-1.040285078024186,0.4034334763948498,0.8143792361840293,1.0,9/15,37.79%,PTPN2;TTLL12;SAMHD1;OAS3;DCST1;CACTIN;STAT2;USP18;YTHDF2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.38258394648138994,1.039996207040374,0.3978494623655914,0.8147490851907737,1.0,3/17,14.92%,PDE3B;BSCL2;AKT1
prerank,mRNA 3'-end processing (GO:0031124),0.27695159982232526,1.0399569965446818,0.39344262295081966,0.8141284448498183,1.0,16/78,14.94%,SRRM1;NCBP1;CSTF2;POLR2D;MAGOHB;MAGOH;U2AF2;DHX38;SRSF5;PABPN1;CPSF1;RBM8A;U2AF1L4;SLU7;FIP1L1;ALYREF
prerank,receptor catabolic process (GO:0032801),0.3537642431957395,1.0391507637692612,0.3996478873239437,0.8157572397706488,1.0,7/24,13.59%,SMURF1;AP2A1;LGMN;SH3GLB1;MYLIP;CLTA;ZNRF3
prerank,negative regulation of defense response to virus (GO:0050687),0.4413881478581041,1.0391163324918988,0.3950381679389313,0.8151051530556817,1.0,3/10,7.32%,ITCH;PCBP2;C1QBP
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3366213429688815,1.039069222326265,0.39892665474060823,0.8144782446639829,1.0,5/27,9.12%,IRAK2;TLR4;RPS27A;UBC;TAB2
prerank,autophagosome organization (GO:1905037),0.30548273343381044,1.0389941219241734,0.3739565943238731,0.8139703004314628,1.0,16/50,19.73%,ULK2;ATG9A;ATG14;ULK3;PIK3C3;STX12;RAB1A;RB1CC1;ATG101;GABARAPL1;ATG9B;UBXN2A;ULK1;ATG5;TP53INP2;PACS2
prerank,regulation of insulin secretion (GO:0050796),-0.25005809030092263,-1.0389453693572648,0.37228260869565216,0.8173555726425767,1.0,33/101,23.58%,CACNA1E;ITPR1;KCNC2;DPP4;MCU;IRS1;RFX3;SLC8B1;CACNA1C;ALOX5;SNAP25;ADCY5;PRKN;PER2;EPHA5;ADRA2A;CLOCK;FFAR1;RBP4;EFNA5;CCL5;SFRP1;CCN3;NR1H4;MYRIP;BLK;ITPR3;GHRL;INHBB;DOC2B;SLC2A2;REST;RFX6
prerank,vesicle transport along microtubule (GO:0047496),0.35426461821252075,1.0388314460214143,0.38333333333333336,0.8136996353321031,1.0,10/23,27.24%,TRAK1;KIF3B;BICDL2;RAB1A;CLN3;KIF3A;FYCO1;KIF13A;NDE1;KIF1A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.373359428664103,-1.0386597284344392,0.39748953974895396,0.8171236940796002,1.0,4/17,5.23%,CD74;MCU;RIPOR2;DNM1L
prerank,mitotic recombination (GO:0006312),-0.37874361472818807,-1.038589416226573,0.4090909090909091,0.8162113156683978,1.0,9/15,33.79%,SMC5;RAD51D;GEN1;DMC1;TPRKB;ERCC1;RAD51;RAD52;NSMCE2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.329005944070861,1.038475933292719,0.3862815884476534,0.8140173741498699,1.0,11/33,23.05%,EPN1;PDPK1;TJP1;PIK3CB;E2F2;CEACAM1;DLL1;THBS1;FGF18;SYNJ2BP;FGF1
prerank,sodium-independent organic anion transport (GO:0043252),0.4383434431057399,1.0382686934857648,0.41320754716981134,0.8138713238621103,1.0,1/10,0.06%,SLCO2B1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4006630876800038,1.0382106852351256,0.4181494661921708,0.8133152519876218,1.0,6/15,15.85%,IGF1R;PTK2B;ABL1;BMX;DYRK1A;TEC
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4238259158229172,1.0381846999923665,0.40540540540540543,0.8126420015972154,1.0,4/12,13.36%,TRPM4;PLA2G6;C2CD2L;STX4
prerank,regulation of protein export from nucleus (GO:0046825),-0.34868674653163545,-1.0380538604384397,0.3694690265486726,0.8167794905081878,1.0,5/23,7.39%,YWHAE;SP100;GSK3B;BARD1;BAG3
prerank,sensory perception of smell (GO:0007608),-0.41258662649638916,-1.0380448340451256,0.4118895966029724,0.8157047282319908,1.0,5/11,34.07%,SYT10;ADCY3;MKKS;SLC24A4;BBS4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2766552100403476,1.0373822886189805,0.3783783783783784,0.8143167187433046,1.0,35/80,30.98%,SENP2;SMAD7;RIPK2;TBC1D7;MTA1;NDFIP2;FANCM;PTTG1IP;BRCA1;KLHL40;PINK1;PDCD6;PIN1;UBE3A;FANCI;XIAP;PHF23;KDM1A;STUB1;TOPORS;DCUN1D1;NSMCE3;SPRTN;ARRDC4;PRICKLE1;DCUN1D4;TSPYL5;UBE2D1;TRAF6;PAXIP1;RBX1;LAPTM5;DCUN1D5;BIRC2;BIRC3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3024816747175104,-1.0373459749047724,0.38498789346246975,0.8167711683295692,1.0,9/36,14.89%,CD74;CD300LF;PARP14;PRKN;IRGM;UBE2K;TXK;HSPA1B;AGPAT1
prerank,regulation of fat cell differentiation (GO:0045598),0.27811997176053754,1.0370228327277868,0.369281045751634,0.8146971244936735,1.0,21/74,18.10%,LRP5;SMAD3;SIRT2;PPARD;CCDC85B;GPS2;TRPM4;TAF8;ZFP36L1;ZFP36L2;GATA2;WNT10B;GPER1;TRIO;BBS12;CDS1;AKT1;ANKRD26;MEDAG;GATA3;CARM1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.42748052700288264,1.0365452544454117,0.428842504743833,0.8154067027742853,1.0,2/12,8.32%,IL18;IL12B
prerank,cell cycle G1/S phase transition (GO:0044843),-0.27077539572316367,-1.036338172972657,0.3756476683937824,0.8188664040351066,1.0,21/61,22.91%,CDK7;CUL3;LATS1;PLK2;PPP6C;CACUL1;USP29;BCAT1;CDKN2A;DBF4;CDKN1A;GPR132;NASP;CDK2;SPDYA;E2F1;CDK4;USP26;EIF4EBP1;RPS6KB1;CCNH
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4198694987063255,1.0359936102578708,0.4168260038240918,0.816370461333774,1.0,5/11,18.04%,ITGAM;ITGB2;STX4;MAVS;TICAM1
prerank,autophagosome assembly (GO:0000045),0.30186628798037884,1.0359816356056766,0.39669421487603307,0.815648154767043,1.0,17/52,19.73%,ULK2;SMURF1;ATG9A;ATG14;PIK3C3;STX12;RAB1A;RB1CC1;ATG101;GABARAPL1;TRAPPC8;ATG9B;UBXN2A;ULK1;ATG5;TP53INP2;PACS2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4387180706206969,-1.0359288334270425,0.4256198347107438,0.8190125188002032,1.0,3/10,7.18%,LRRK2;STK26;PDE8A
prerank,membrane depolarization (GO:0051899),-0.31189742882470994,-1.0358202310423927,0.39950980392156865,0.8182410987568113,1.0,10/32,22.35%,CACNA1E;SCN2A;CACNG2;SCN3A;CHRNA4;CACNA1B;CACNB3;SCN9A;CACNA1G;SCN1A
prerank,nuclear pore complex assembly (GO:0051292),-0.4237589627215708,-1.0358095682762951,0.4074074074074074,0.8171702839011197,1.0,3/10,11.65%,NUP98;RTN4;NUP205
prerank,regulation of cell size (GO:0008361),0.3527176622043466,1.03570270868781,0.41605839416058393,0.815706452068768,1.0,6/23,11.02%,VAV2;RAC1;PLEK;RPTOR;MTOR;LAMTOR5
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.42568810880077457,1.0356313392609457,0.4157509157509158,0.8151859325660685,1.0,3/12,12.55%,IL18;CCL3;IL33
prerank,ameboidal-type cell migration (GO:0001667),0.3013470419996509,1.03507005893697,0.38372093023255816,0.8162069159167648,1.0,9/51,8.64%,SRGAP2;SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;PKN3;GDNF;SEMA3G
prerank,positive regulation of insulin secretion (GO:0032024),0.31621552710379847,1.0348307602585505,0.3981818181818182,0.8161577083910456,1.0,9/36,14.46%,ACSL4;TRPM4;PLA2G6;C2CD2L;TM7SF3;SLC30A8;GPER1;STX4;LRRC8A
prerank,neural crest cell migration (GO:0001755),0.32087358621526346,1.0341553195641775,0.40316901408450706,0.8174498480541584,1.0,7/36,8.64%,SEMA3B;SOX8;SEMA4C;SEMA4G;SHH;GDNF;SEMA3G
prerank,endothelial tube morphogenesis (GO:0061154),-0.42883138382858466,-1.0341318240369872,0.4172043010752688,0.8212202625626381,1.0,4/10,16.84%,RBPJ;ACVRL1;STARD13;BMP4
prerank,negative regulation of cell motility (GO:2000146),0.2572930085357162,1.0340545987618595,0.3573667711598746,0.8169956964538955,1.0,25/108,18.52%,SRGAP3;SRGAP2;LDLRAD4;NAV3;SMAD7;SLURP1;RHOB;RNF41;FLCN;SHH;MIA3;PIP5KL1;DPEP1;RNF20;CCDC125;SERPINE1;ENG;PIN1;DRD2;SPINT2;NOG;ARHGAP4;PTPRJ;GATA3;MITF
prerank,carboxylic acid metabolic process (GO:0019752),0.328827783573652,1.0338977686043074,0.41134751773049644,0.8167092548021357,1.0,9/33,17.99%,TBXAS1;PLA2G4A;HAO1;PON3;CARNMT1;AGXT;SLC23A2;SLC23A1;GNE
prerank,nucleotide-excision repair (GO:0006289),0.260666057163354,1.0337869573495346,0.3993759750390016,0.8163103019691156,1.0,21/101,16.41%,POLR2H;PCNA;POLR2J;RFC2;DDB2;POLR2D;COPS4;GTF2H2;RPS27A;UBC;ERCC2;SLX4;CUL4B;HMGN1;LIG1;MMS19;POLD2;ERCC4;GPS1;COPS6;POLR2E
prerank,positive regulation of protein phosphorylation (GO:0001934),0.22998220295388822,1.0333653975437598,0.3543091655266758,0.8168108252325981,1.0,100/348,24.60%,CX3CR1;TGFBR1;TMEM119;ARHGEF2;CSF1R;RAC1;CAMKK1;MMD;RIPK2;AGER;LYN;CDK9;ATG14;SRC;NBN;PLCG2;FLCN;EIF4G1;VEGFB;LCP2;RPS6KA5;PTK2B;SPRY2;AKTIP;PDGFB;CAMKK2;CCR7;LEFTY1;GPER1;CALCR;RPTOR;IL6R;TAB2;INHA;ARAF;CLIP3;DDR2;TNKS1BP1;RAPGEF3;RB1CC1;PINK1;MUSK;CCND3;ENG;PTPN11;TAOK2;AGAP2;ABL1;PIN1;SEMA4D;IL34;MAVS;GHR;CDK2AP1;AKT1;CIB1;CSF1;GPNMB;PIK3R3;TEC;TENM1;OSM;PDCD10;PELI2;AGT;RPS6KA4;ARRB1;PTPRJ;ROCK2;FXR2;FBH1;CAMK1;FGF18;RSPO1;XRCC6;WNK3;CRKL;NOS1;TNFRSF14;ADAM17;TNK2;EFNA1;FGF20;DDX3X;CSNK1D;RBPMS;RASSF2;PARK7;AXIN2;FGF1;BMP2;JTB;CALM2;TP53;TGFB1;RALB;DVL2;SOX9;DUSP19;ITGB3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.43020928720160045,1.0330699679474271,0.4202626641651032,0.816943742271413,1.0,3/11,11.91%,BAG6;UFD1;AUP1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.425171860044513,1.0329379421669138,0.40194174757281553,0.8166236353371971,1.0,1/11,0.13%,BIN1
prerank,neutrophil chemotaxis (GO:0030593),0.30054017878337874,1.0328626470540148,0.37181663837011886,0.8161070211275383,1.0,9/53,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,regulation of organelle organization (GO:0033043),0.27156690912802184,1.0327930637391598,0.3953098827470687,0.8155744689843755,1.0,24/80,21.42%,F11R;PREB;TMED9;PISD;CAMSAP2;ARMH3;TJP1;SAR1A;CLN3;MIEF2;PINK1;MARK2;PRMT6;MAVS;RBSN;PDCD10;CPLANE2;STX5;TMEM33;VPS35;SYT11;MAPT;ARHGEF5;STX18
prerank,regulation of T cell mediated immunity (GO:0002709),0.4415330016851682,1.032492905043824,0.4187380497131931,0.8157127107440174,1.0,3/10,8.81%,AGER;TRPM4;FUT7
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.33926739045040333,1.0322888512669244,0.4056437389770723,0.8155820785163731,1.0,12/30,25.33%,SRC;CTC1;HNRNPC;ERCC4;GNL3L;TERF1;EXOSC10;TEN1;ACD;TP53;HNRNPA1;STN1
prerank,cellular glucose homeostasis (GO:0001678),0.3029036189630275,1.0321663219022954,0.3954305799648506,0.8152384762749451,1.0,15/41,24.80%,HK2;PIK3R1;PRKACA;IGF1R;FOXK2;GPER1;PAX2;TRA2B;LRRC8A;CARTPT;LRRC8D;PCK2;KCNB1;HK3;HIF1A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3165467566946566,-1.0319074591726394,0.375,0.827227122788002,1.0,10/31,18.54%,PKD2;CDC73;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;MYO16;RBL1;CDK4
prerank,regulation of apoptotic process (GO:0042981),0.21452565928478412,1.0316006944439473,0.3650190114068441,0.8161791854824134,1.0,134/676,18.22%,BIN1;FGD2;ARHGEF2;DNM2;SON;CTSD;PREX1;VAV2;GREM1;ITGA6;CAPN3;QRICH1;PRMT2;CALHM2;CFLAR;PIM2;MAP4K4;CRADD;MEF2C;IGFBP3;KCNMA1;PIK3R1;SOX8;RIPK2;RPS6KA1;TGM2;ITCH;KLF11;VHL;IGF1R;SRC;ATM;RHOB;PHB2;PKHD1;CLU;AATF;FLCN;SUDS3;CD27;CASP1;PLSCR3;RPS27A;UBC;TRADD;TNFRSF25;PTK2B;SPRY2;ATAD3A;EGR3;YME1L1;IL6ST;WDR73;MGMT;PPT1;SHH;MTDH;ARL6IP5;C1QBP;JUN;CIAPIN1;WNT10B;GDNF;PIP5KL1;GPER1;PLK5;AKAP13;ACER2;PPID;ARAF;SLC27A4;CLIP3;RABGGTA;TJP1;BFAR;DPEP1;AXL;NCKAP1L;ANP32A;AREL1;USP36;FGD3;NUAK2;PSENEN;CLN3;BMF;RPL10;PAX2;TRIO;APAF1;PSEN2;PINK1;MAP3K11;TARDBP;HIP1R;OSGIN1;BNIP2;MAP3K10;ABL1;SEMA4D;DDX20;GCLC;MAPK8;PLK3;TMBIM6;SOD1;LATS2;BAG4;PYCARD;AKT1;CIB1;HPN;VDAC1;RNF144B;VIP;PDCD10;IRF3;FBXO11;ADAM10;BCL2L14;GAS1;TNFRSF12A;XIAP;DUSP6;CCAR1;AGT;NUP62;FANK1;API5;APH1B;NME1;THBS1;HTRA2;MIEN1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4338815442616055,-1.0315650944637131,0.41041666666666665,0.8272359199940696,1.0,6/10,20.53%,RACGAP1;CDC42;SPAG5;RCC2;CCNB1;KNSTRN
prerank,protein export from nucleus (GO:0006611),0.34155820588117225,1.0314916544404769,0.4144144144144144,0.8157693916912739,1.0,5/27,7.33%,SMURF1;STRADA;NUP42;EGR2;RANBP3
prerank,phospholipid dephosphorylation (GO:0046839),-0.2978348638055839,-1.0314614836738945,0.37471264367816093,0.8265110086413612,1.0,14/37,21.83%,PLPPR4;PLPP5;PLPP4;MTMR2;PLPPR1;INPP5J;MTMR1;INPP5F;OCRL;PLPP3;PLPPR3;TPTE;SACM1L;MTMR3
prerank,positive regulation of immune effector process (GO:0002699),-0.3259689037613338,-1.0314553143527507,0.4236111111111111,0.825436321494028,1.0,4/27,3.90%,CCR2;LILRB1;ANKRD17;DDX60
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.23852501316701272,1.0314492511330704,0.3911042944785276,0.81515517199574,1.0,51/208,20.48%,CAPN3;CFLAR;PIM2;LGALS9;RIPK2;TMEM101;ATP2C1;TRIM5;MAP3K3;NEK6;TRAF5;PLCG2;CASP1;NDFIP2;TRADD;RHOH;PDPK1;TMED4;MTDH;ZMYND11;CCR7;EDA2R;TAB2;AKAP13;RNF31;GAPDH;CXXC5;TICAM2;PRKCB;ZDHHC13;LAMTOR5;MIB2;PINK1;TRIM62;GJA1;OPTN;MAVS;PYCARD;NLRX1;TNIP2;TNFRSF19;CCDC22;PELI2;NUP62;TICAM1;MAP3K14;ECT2;PIDD1;NOD2;TFG;TNIP1
prerank,inner dynein arm assembly (GO:0036159),-0.4238015806307384,-1.0312256878774586,0.40835266821345706,0.8250936788439006,1.0,5/10,22.16%,DNAAF5;DNAI3;DNAAF1;CCDC39;CFAP100
prerank,activation of protein kinase B activity (GO:0032148),0.3353198015710546,1.0311675115203465,0.40545454545454546,0.8152939746481433,1.0,7/29,14.92%,IL18;PDPK1;PDGFB;MTOR;MLST8;PINK1;AKT1
prerank,regulation of protein neddylation (GO:2000434),-0.4199387433697477,-1.0311552762778946,0.4136460554371002,0.8242207059432245,1.0,2/10,12.91%,DCUN1D2;DCUN1D3
prerank,muscle tissue development (GO:0060537),0.40477516882301556,1.0308354386649063,0.41385767790262173,0.8155125835133235,1.0,7/13,30.50%,SHH;ENG;SMO;PTCH1;PGM5;CSRP2;POGLUT1
prerank,inorganic anion transport (GO:0015698),-0.27814440812024277,-1.0307315661716112,0.3826291079812207,0.8244656895191227,1.0,9/53,13.64%,SLC25A30;GLRA1;RACGAP1;SLC4A10;ANO6;SLC26A7;ANO5;XPR1;ANO10
prerank,cAMP metabolic process (GO:0046058),-0.3962609026496682,-1.0305413869595035,0.41721854304635764,0.8239228795569995,1.0,5/13,11.19%,PDE4D;ADCY2;ADCY5;ADCY3;ADCY8
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.24387637460179595,-1.0301911494220475,0.3909348441926346,0.8238587363600716,1.0,17/108,10.17%,HIP1;ROBO1;XDH;NLRC4;PPARG;GSN;DAP;ST18;RPS3;JAK2;ACVR1C;DIABLO;DAPK1;SIRT1;BEX3;FIS1;ATP2A3
prerank,bicarbonate transport (GO:0015701),-0.335743391525591,-1.030042917791522,0.4,0.823246096641956,1.0,14/25,31.65%,SLC4A10;SLC26A7;SLC4A8;CFTR;CYB5R2;CA4;SLC4A1;AQP1;RHAG;CYB5R4;CYB5RL;CA1;SLC4A11;CA3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4251010906992951,1.029985999393127,0.3935361216730038,0.8158782492034381,1.0,7/11,29.85%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.4251010906992951,1.029985999393127,0.3935361216730038,0.8158782492034381,1.0,7/11,29.85%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4251010906992951,1.029985999393127,0.3935361216730038,0.8158782492034381,1.0,7/11,29.85%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACAT1;ACOT7
prerank,blood vessel endothelial cell migration (GO:0043534),0.3607767780445366,1.0299365539590974,0.40978077571669475,0.8152895096913259,1.0,7/22,15.73%,GREM1;MYH9;ID1;EGR3;MIA3;AKT1;PIK3R3
prerank,response to organophosphorus (GO:0046683),0.3827671589992876,1.0298560948820692,0.412962962962963,0.814785232918176,1.0,3/16,7.99%,NDUFS4;ABCC9;DUOX1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4479911721208308,1.029791407784741,0.42226487523992323,0.814231864951428,1.0,6/10,20.31%,DGKD;CHRM1;PLPP1;PRKD3;PICK1;GAP43
prerank,negative regulation of receptor internalization (GO:0002091),-0.39798422572598857,-1.02950852329959,0.4188034188034188,0.8237625199320601,1.0,7/12,28.80%,MTMR2;SDCBP;UBQLN2;WDR54;ATXN2;ANKRD13A;RIN3
prerank,negative regulation of platelet activation (GO:0010544),0.3825119589139915,1.0294904841507708,0.4174573055028463,0.8144102766049528,1.0,5/16,13.46%,CD9;PRKCD;PDGFB;CEACAM1;SERPINE2
prerank,regulation of keratinocyte migration (GO:0051547),-0.4050345895291801,-1.029370305269437,0.4200426439232409,0.8230873116640749,1.0,3/12,9.77%,IQSEC1;FGF10;FGF7
prerank,apoptotic cell clearance (GO:0043277),0.3344535074000361,1.0293056956962459,0.4172661870503597,0.814232545034981,1.0,11/30,24.60%,RAC1;TGM2;ITGAV;RHOBTB1;RHOH;LRP1;SCARB1;THBS1;MEGF10;TYROBP;ITGB3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4388891849589374,-1.0292127633296615,0.44880174291938996,0.8225209100720229,1.0,4/10,17.21%,IRS1;SLC45A3;SNCA;PRKCE
prerank,positive regulation of actin nucleation (GO:0051127),-0.40885403998417214,-1.0291792863075122,0.408,0.8215573406827955,1.0,3/11,9.42%,GSN;WASF1;ABI2
prerank,oligosaccharide metabolic process (GO:0009311),-0.2871562222072683,-1.0290136097829343,0.3926829268292683,0.8209680498102234,1.0,13/46,16.76%,B3GALT1;ST3GAL4;FUT9;ST8SIA4;ST8SIA1;ST8SIA2;GLA;B3GALT4;B3GALT2;MANBA;NAGA;ST8SIA3;FUT4
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3292701668843142,1.0288158126732925,0.4122657580919932,0.8149268102146036,1.0,3/30,1.22%,BAG6;FHIT;UCHL5
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4339198113265053,1.0285887005370675,0.4552238805970149,0.8148845509554138,1.0,3/10,11.72%,CHDH;COMT;SMOX
prerank,bone morphogenesis (GO:0060349),0.4109957417444361,1.0284756197347609,0.4377358490566038,0.8145050118804193,1.0,2/14,2.25%,LRP5;SKI
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27717744585701926,1.028471290735781,0.3949152542372881,0.8137863344878842,1.0,30/73,26.26%,ARHGEF2;LGALS9;AGER;TLR4;CCL3;CLU;PLCG2;DHX9;CD86;IL12B;ORM2;DDT;HAVCR2;IL33;PTPN11;MAVS;PYCARD;PTPRJ;THBS1;SETD4;NOD2;IL1A;TWIST1;TYROBP;FADD;FZD5;PTPRC;ISL1;STAT3;MIF
prerank,establishment of spindle localization (GO:0051293),0.39380927527564225,1.0283878442841392,0.4071294559099437,0.8133201250576535,1.0,3/14,12.04%,TLE6;MAP4;LLGL1
prerank,positive regulation of vasculogenesis (GO:2001214),0.43605270656063155,1.0279463996757492,0.41044776119402987,0.813873297863157,1.0,3/10,11.33%,ASB4;CD34;CEACAM1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2896780528639733,1.0279233313220393,0.40266222961730447,0.813220478146795,1.0,8/57,9.05%,IL18;CSF1R;LYN;IL6ST;CNTF;IL12B;CTF1;IL6R
prerank,positive regulation of protein import into nucleus (GO:0042307),0.338455339106786,1.0277556164427346,0.4107142857142857,0.8130258019025467,1.0,10/28,23.79%,SMAD3;PIK3R1;PRKCD;MAVS;ZIC1;ECT2;ZC3H12A;TGFB1;IPO5;JUP
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.31882991920326925,-1.027639557119244,0.40311804008908686,0.8241920898346,1.0,7/29,14.71%,CCR2;JAK2;PKD2;STAT4;PIAS1;PKD1;FER
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3378338868155278,1.027285842626885,0.4227353463587922,0.8137006134392141,1.0,9/27,19.75%,GUK1;NME4;CMPK1;DUT;DCTD;AK2;NME1;NUDT13;TYMS
prerank,protein K48-linked ubiquitination (GO:0070936),0.29298278651870624,1.0272852803437353,0.38813559322033897,0.8129791560067586,1.0,19/54,21.94%,RNF216;ITCH;UBE2H;RFFL;CDC34;RNF8;BFAR;RNF187;UBE3A;FBXO38;UBE2A;DTX3L;RNF4;UBE2T;TOPORS;SYVN1;RNF34;UBE2R2;KLHL3
prerank,peptide cross-linking (GO:0018149),-0.3364423963004848,-1.0272736028700948,0.40941176470588236,0.8242823414737172,1.0,14/25,31.13%,F13A1;FN1;TGM4;EVPL;CD247;TGM1;KRT10;ABCA7;ANXA1;NDNF;TGM6;EPB42;TGM7;CD3G
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.398573675606814,1.026861166920241,0.42173112338858193,0.8134688577114437,1.0,4/14,14.42%,NCBP1;CSTF2;CPSF1;FIP1L1
prerank,regulation of wound healing (GO:0061041),-0.2903698111058884,-1.026608552554253,0.39901477832512317,0.8251930271136904,1.0,17/42,30.45%,CADM4;ALOX5;CASK;CD109;KANK1;ADRA2A;ITGB1;PRKCE;ACTG1;EPHB2;ANXA1;OCLN;PTK2;PLAU;VTN;HRG;FOXA2
prerank,mesonephric tubule development (GO:0072164),0.38990169830598953,1.026591062390974,0.4194690265486726,0.8135215333620652,1.0,2/15,3.01%,SALL1;NPNT
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2785236627398419,1.0264708243861338,0.43005181347150256,0.8131438266500612,1.0,11/70,9.87%,SMAD3;CRADD;ITGAV;RNF41;CD27;TRADD;SORT1;PDPK1;IL6R;SIVA1;APPL1
prerank,embryonic eye morphogenesis (GO:0048048),-0.4181511417553279,-1.026449591291501,0.4144736842105263,0.8245733354955296,1.0,4/11,8.84%,LRP6;RARG;FBN1;FBN2
prerank,regulation of cell morphogenesis (GO:0022604),0.33201104470166787,1.0262787080931566,0.4283246977547496,0.8130168840455713,1.0,6/30,7.06%,ZRANB1;CAPZB;SPARC;CAMSAP1;MOV10;MACF1
prerank,extracellular structure organization (GO:0043062),-0.2202494804987476,-1.0259707697495228,0.329073482428115,0.8250033795893885,1.0,63/204,19.11%,ITGA4;CD47;CD44;MMP16;APP;ADAMTS17;ITGB7;VIT;FN1;ITGAL;THSD4;VWF;COL4A1;ADAMTS19;FBN1;COL13A1;POSTN;HSPG2;VCAN;SPP1;TNC;FBN2;ATP7A;LAMB2;MMP12;MMP15;ST7;VCAM1;ADAMTSL1;LOX;ADAM12;COL14A1;TNR;ITGA8;ADAMTSL5;MMP19;ITGA2B;ITGB6;MMP8;JAM3;CDH1;SMOC1;PECAM1;COL1A1;TEX14;COL23A1;LAMA5;COL5A1;DAG1;MMP14;ELN;AGRN;LUM;ITGB1;LAMC3;ITGA11;COL6A3;COL19A1;ADAMTSL4;BSG;ADAMTS10;ITGAD;LAMA1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.304373366083259,1.0259017463980993,0.43315508021390375,0.8134473661966733,1.0,17/48,23.36%,POLR2H;SF3B1;PADI2;SMARCA5;BAZ1B;POLR1C;ZMIZ2;POLR2E;ZMIZ1;ARID1A;ELOF1;TBP;DEK;ATAD2;POLR1E;WBP2;POLR1G
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.31093361248131907,1.0258912153303368,0.4231464737793852,0.8127618499892882,1.0,11/42,18.27%,CHD8;HNRNPC;CHD3;RNF8;SRCAP;ACTL6A;SMARCA5;SMARCA2;INO80B;SPTY2D1;ARID1A
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.36176461758913875,-1.0258829390731758,0.4282511210762332,0.8242297755770187,1.0,3/17,5.70%,PPARG;PRKAG2;ADIPOR2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3809533213758978,1.0257884589818114,0.4141791044776119,0.81234882523022,1.0,7/17,19.24%,CACNB2;TRPM4;SLC8A1;SCN4B;SCN1B;KCNJ2;CACNA1D
prerank,protein heterooligomerization (GO:0051291),-0.364703143874257,-1.025553545675826,0.4178743961352657,0.8241837392826353,1.0,7/17,26.53%,KCNC2;GRIN2B;PKD2;PKD1;CBR4;KRT10;CPSF7
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.39003790395966176,-1.0255492849012593,0.4232456140350877,0.8231323016977191,1.0,7/14,23.77%,AUTS2;KMT2E;DNMT3B;DNMT1;SNW1;MYB;CTNNB1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.33378558295432004,-1.0253513118045525,0.4247787610619469,0.8226868611581515,1.0,2/24,0.69%,ROBO1;ZFPM2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.31311268868714,-1.0252968048490658,0.39545454545454545,0.8218012362225481,1.0,5/30,5.31%,ANK2;FGF12;RYR2;NEDD4L;CACNA1C
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2536631193994285,-1.0252738829116874,0.376657824933687,0.8208188482447744,1.0,26/88,20.33%,SH3BP5;PTPRT;SLC8A3;PPM1E;PRKAG2;LRP6;TAF7;PPIA;DBNDD1;SMCR8;DUSP10;DUSP26;ITGB1BP1;SRCIN1;DTNBP1;CDKN1A;THY1;SNCA;TAB1;NPM1;GSTP1;CDKN1C;CAMK2N2;GNAQ;DEPTOR;CDK5RAP3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.40324012248657737,1.02516911695159,0.4257246376811594,0.8134954692272938,1.0,3/14,22.95%,IL6ST;OSM;PARK7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.25810890704065803,-1.0250503340672792,0.4075,0.8204708493542436,1.0,8/73,4.80%,HIP1;ROBO1;XDH;NLRC4;PPARG;DAP;JAK2;DIABLO
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.34026682497810556,-1.024882343881091,0.4160919540229885,0.8199397431808476,1.0,4/23,14.26%,SH3BP5;CBLB;SRCIN1;THY1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2936402873835596,-1.0248247731616167,0.39851485148514854,0.819059735922019,1.0,8/39,13.25%,EGFR;PTPN12;SH3GL2;CDC42;PTPN3;PTPN2;RNF126;EPS15
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.20791067954277684,-1.0248166245543877,0.3413654618473896,0.8180304828421441,1.0,58/390,10.91%,VAV3;NEDD9;MTSS1;SORBS1;PTPRG;PLCB1;CYBB;STAP1;PTPRT;EGFR;GRIN2B;RBFOX2;FGF10;NCK2;SHC3;BDNF;ACTR3;SULF2;IRS1;AP2A2;ITSN1;FLRT2;RAPGEF2;ROR1;NTRK2;CYFIP2;JAK2;PDGFD;NTRK3;RASGRP4;ATP6V0D2;PIK3C2A;GSK3B;NCF2;CDC42;CHN1;ERBB4;DNM1;SDCBP;GFRA2;PAK3;VEGFD;RET;PTPN2;EPHA5;ALK;FRK;ACTB;ERBB3;CYBA;GRB10;BCAR1;FGF7;FGFR3;DDIT4;ARPC5;FGF9;CLNK
prerank,cardiac muscle cell contraction (GO:0086003),-0.35498973000280626,-1.0247850774809963,0.4138755980861244,0.8170838299222647,1.0,4/19,11.25%,FGF12;GSN;CACNA1C;ATP1A1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.25151856033866715,-1.0247797791755247,0.3929471032745592,0.8160535995686221,1.0,20/84,17.36%,CUL3;PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;ECRG4;PSME2;PTTG1;BUB1B;AURKB;PSMD5;UBE2C;PSMD12;ANAPC10;PSMD11;PSMD1;SKP2;CDK2;CCNB1
prerank,regulation of nuclear division (GO:0051783),-0.347946852727553,-1.024625615192421,0.40774487471526194,0.8155057703724252,1.0,9/20,32.43%,MKI67;CUL7;OBSL1;CDC25C;PKMYT1;CAV2;BORA;CCDC8;NEK2
prerank,MAPK cascade (GO:0000165),-0.21094864758875664,-1.02395429914006,0.3736654804270463,0.8164494958291,1.0,49/295,12.09%,DLG2;RIT2;LRRC7;SPTBN1;LRRK2;RASAL2;EGFR;GRIN2B;FGF10;SHC3;RGL1;IRS1;CUL3;PSMD14;RAPGEF2;YWHAE;MARK3;JAK2;DLG3;RASGRP4;SHANK3;CALM1;HTR2B;PSMD8;ERBB4;PTPN3;NCAM1;GFRA2;PSMA2;PSMF1;RET;BTRC;PSMD6;PSME2;SPTBN2;ACTN2;ERBB3;RASGRF1;SPTBN4;FGF7;IL3RA;PSMD5;FGFR3;NRG2;FGF9;PAQR3;IL2RB;KIT;PSMD12
prerank,positive regulation of neuron differentiation (GO:0045666),0.30855540943568466,1.0238872619766952,0.40569395017793597,0.8165075331465023,1.0,13/40,23.22%,ARHGEF2;HEYL;MEF2C;MMD;IMPACT;SIN3A;PROX1;TCF3;ZEB1;ECT2;PCP4;FGF20;BMP2
prerank,negative regulation of mRNA processing (GO:0050686),0.3805936766111755,1.023665656707842,0.4397810218978102,0.8164364055294883,1.0,7/15,26.97%,U2AF2;SFSWAP;C1QBP;RBMX;SRSF9;PCBP4;SRSF10
prerank,ncRNA catabolic process (GO:0034661),0.3298432434352194,1.0232358959149026,0.44014732965009207,0.8170022091902114,1.0,11/28,25.73%,POP1;DIS3L2;EXOSC5;EXOSC10;DIS3;ZCCHC8;EXOSC8;NUDT16;SND1;RBM7;PARN
prerank,retinoic acid metabolic process (GO:0042573),0.40693947155325716,1.0231961637798892,0.44874274661508706,0.8164132553015303,1.0,2/14,3.58%,BCO2;ALDH8A1
prerank,negative regulation of angiogenesis (GO:0016525),0.26714113911946785,1.022900069176092,0.383147853736089,0.8165207888009284,1.0,27/84,23.84%,PDE3B;PTPRM;EPN1;FOXJ2;ADAMTS1;SPARC;SPRY2;PGK1;SARS1;ECSCR;PIK3CB;E2F2;APOH;SERPINE1;GTF2I;SERPINF1;SPINK5;ROCK2;THBS1;KRIT1;SYNJ2BP;HGS;NAXE;CXCL10;EFNA3;KLK3;AGO1
prerank,negative regulation of programmed cell death (GO:0043069),0.22290918274063148,1.022833487140048,0.40360610263522884,0.8160002426378442,1.0,70/355,17.55%,SON;GREM1;CAPN3;CFLAR;PIM2;MAP4K4;PIK3R1;SOX8;RIPK2;RPS6KA1;ITCH;VHL;IGF1R;SRC;PHB2;PKHD1;AATF;CD27;RPS27A;UBC;PTK2B;SPRY2;ATAD3A;EGR3;YME1L1;IL6ST;WDR73;MGMT;PPT1;SHH;MTDH;MET;TM7SF3;CIAPIN1;GDNF;POU4F1;ARAF;TJP1;BFAR;DPEP1;AXL;NCKAP1L;AREL1;NUAK2;CLN3;RPL10;PAX2;PSEN2;DCPS;GPX4;BNIP2;SEMA4D;GCLC;MAPK8;PLK3;TMBIM6;BAG4;AKT1;CIB1;HPN;VDAC1;RNF144B;VIP;PDCD10;ADAM10;XIAP;KANK2;NUP62;FANK1;API5
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3773202208444165,-1.0227849343501934,0.42538975501113585,0.8190063533951009,1.0,5/14,14.35%,FAF1;PKD2;NFKBIA;G3BP2;PKD1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3127831883031281,-1.022774692399705,0.4166666666666667,0.8179911468935419,1.0,8/32,16.87%,AKAP6;HTT;CALM1;PKD2;THY1;CX3CL1;SNCA;APLNR
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3636200935336785,-1.0224369545844407,0.43013100436681223,0.817953926341015,1.0,6/16,18.50%,KDM4D;WRAP53;PARP3;SHLD3;RIF1;SETMAR
prerank,regulation of inflammatory response (GO:0050727),0.23754995473550383,1.022232737075709,0.4059561128526646,0.817008282194406,1.0,26/190,10.37%,IL18;TLR7;SIRPA;DAGLB;ETS1;IL1RL2;SBNO2;PPARD;OTULIN;TLR4;GPS2;PRKCD;CCL3;CASP1;LRRC19;TRADD;PIK3AP1;DHX9;NLRP3;SELE;BCL6B;IL12B;GPER1;DDT;TNFAIP8L2;AREL1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.33754015500270496,-1.0221604213587894,0.39601769911504425,0.8177826852747899,1.0,4/24,5.95%,CTNNA2;CTNNA1;OLFM2;CDC42
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3989589863827378,-1.0221336261019687,0.4256619144602851,0.8168252569320952,1.0,1/13,0.16%,PID1
prerank,organonitrogen compound catabolic process (GO:1901565),0.283855815718587,1.0217990342426233,0.4006514657980456,0.817589168347941,1.0,16/57,19.51%,LIPC;CAPN3;PLA2G4A;PLA2G6;PLA2G15;PPT1;MPST;SMPD2;PLA2G5;MTOR;AMDHD2;GADL1;NPL;RIDA;TXN2;IL4I1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.35550757952922196,-1.0216460155456555,0.40835266821345706,0.8173551595836506,1.0,8/19,20.05%,AMPD3;POLL;ADK;APRT;CDA;POLD1;TERT;POLD3
prerank,endocytic recycling (GO:0032456),0.29970031939714653,1.0215657101523943,0.4094903339191564,0.8175960353385712,1.0,17/50,21.01%,CCDC93;EHD4;ACAP2;TRARG1;SNX31;RAB35;DENND1C;ENTR1;SNX3;CCDC22;PTPN23;RAB13;VPS29;VPS26A;VPS35;CMTM6;VPS39
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4338055833697057,-1.021448974248234,0.4400871459694989,0.8169193297222099,1.0,5/10,16.47%,DPP4;SKAP1;PODXL;CCL5;CD3E
prerank,lymphocyte proliferation (GO:0046651),-0.33750233745567926,-1.0214055285380548,0.42081447963800905,0.8159993767532568,1.0,10/22,24.93%,CD40;HELLS;CR2;CTPS1;BCL2;TNFRSF4;MSN;MS4A1;FLT3;RASGRP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.32846657005256824,-1.021069497827894,0.4271356783919598,0.8160449140854353,1.0,3/24,5.28%,SORBS1;IRS1;GSK3B
prerank,cell junction maintenance (GO:0034331),0.3990759130003955,1.0210461719849289,0.45112781954887216,0.8183890642767643,1.0,4/14,19.16%,CSF1R;CBLN1;CLDN1;CBLN2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.38242305190401277,-1.0208668666012428,0.40997830802603036,0.8156317453294084,1.0,6/15,25.69%,LDLR;SIK1;MFSD2A;CNEP1R1;FBXW7;CTDNEP1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2843110174315566,-1.0207382736330528,0.41686746987951806,0.8150057164578917,1.0,9/48,8.93%,NEDD9;PTPRD;DOCK5;CDKL5;IL1RAPL1;CDC42;CARMIL1;CUL7;MYADM
prerank,termination of RNA polymerase II transcription (GO:0006369),0.32146134147740335,1.020366377635911,0.42132867132867136,0.8196752391686336,1.0,9/33,17.83%,NCBP1;TTF2;CSTF2;SNRPF;PABPN1;CPSF1;FIP1L1;MED18;PCF11
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.39249682817516296,1.0203410865420681,0.4254545454545455,0.8190322656654574,1.0,6/15,26.10%,ZFP36L1;ZFP36L2;GPER1;BCL2L11;SSTR2;ISL1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.26355391519664295,-1.0203097891728365,0.4365079365079365,0.8152345826832211,1.0,13/65,11.14%,HIP1;EGFR;PTPN12;SH3GL2;CDC42;PTPN3;DOK1;PTPN2;CCDC88A;MVB12A;CDH13;RNF126;PDE6H
prerank,neutrophil mediated immunity (GO:0002446),-0.20183654617905372,-1.019992443935681,0.3760330578512397,0.8151627185712901,1.0,77/432,14.32%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD47;CD44;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;B2M;KMT2E;PSMD14;CTSC;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;RAB5C;ATP11A;ALOX5;SNAP25;KCNAB2;SDCBP;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;ANO6;FRK;RAB3A;GPI;SLC44A2;CYBA;OLR1;ATG7;DNAJC3;ANPEP;PTAFR;ARPC5;TRAPPC1;APRT;PSMD12;AP1M1;RNASE3;GYG1;ALDOC;GLA;LAMP1;MMP8;MCEMP1;PECAM1;PSMD11;MANBA;HSPA8;HSPA1B
prerank,organelle organization (GO:0006996),0.22280451621287997,1.019953449561368,0.3978494623655914,0.8195000462074702,1.0,141/388,28.03%,BIN1;FGD2;DST;ABCD2;TMEM135;ARAP3;DYM;CXADR;GOLGA8B;GOLGA5;ZRANB1;CAPZB;FMNL3;RANBP10;IRAG2;ODF2;PHB2;MCOLN1;CCL3;PEX10;CAMSAP1;NUMA1;PLD2;ATAD3A;SORT1;TMED9;YME1L1;SIPA1;WDR73;RAB3GAP1;TMED4;MIA3;LMAN1L;RAB1A;PPID;PLEKHM2;RAB34;TICAM2;FGD3;NRF1;SAR1A;TJAP1;FANCG;MIEF2;PEX6;SEC31B;AUP1;SSBP1;PINK1;CSPG5;FMNL2;BSCL2;LYSMD3;MNS1;OPTN;STX4;IQCG;REEP6;NECTIN2;MAST3;TRAPPC11;VAPB;TRAPPC8;COG2;SPRYD3;RAB32;KIF3A;ATXN7;MTX1;HSD17B10;CDC42BPB;TMEM11;POLG2;WASL;TANGO2;UBXN2A;ARHGAP4;SEC61A1;GORASP1;DOP1B;BCS1L;ZFYVE16;PACSIN2;CHMP1A;PPRC1;VPS4A;WTIP;PEX1;VPS13C;WDR81;CCL24;CHMP2A;MARK4;EIF2AK3;NCKIPSD;TTC17;MYO18A;TFB1M;STOML2;PYROXD2;AGTPBP1;DMTN;REEP5;SEC31A;CSNK1D;PDCD6IP;OPA1;PARK7;ABCD1;VPS13D;MAST2;CHGA;MICAL1;PITPNB;DYNC2H1;AJUBA;CATIP;PEX3;NPLOC4;LONP1;YTHDF3;SPTBN5;GAK;COG7;ARHGEF7;BNIP1;ARMC2;LMAN2L;BAG5;GORASP2;PACSIN3;PTCD2;VPS18;AFG1L;ZMYM4;FBXW8;TPM1;DNAJC28;GBF1;TMED10;RAB2A
prerank,positive regulation of kinase activity (GO:0033674),-0.24274590438706384,-1.01931047850813,0.3994708994708995,0.8161950390481928,1.0,35/107,21.87%,CD74;IQGAP1;EGFR;DSTYK;RAPGEF2;PRKAG2;ROR1;NTRK2;NTRK3;ERBB4;RET;CENPE;LMO4;EPHA5;SNX9;ALK;ERBB3;CACUL1;EEF1A2;FGFR3;TIGAR;KIT;CDKN1A;TEK;RELN;XRCC5;LMTK2;SPDYA;MRE11;EPHA4;EPHB2;EPHA7;FLT3;TIE1;LTK
prerank,histone H4-K16 acetylation (GO:0043984),0.3665797838389995,1.0191558757726122,0.44283121597096187,0.8211682140440965,1.0,9/19,28.37%,KANSL2;MSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1;KMT2A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.27763555556681396,1.0190800805043552,0.44189852700491,0.8206647558675353,1.0,23/69,27.68%,BAG6;SEL1L;DNAJB9;USP19;OS9;RNF103;UFD1;AUP1;MAN1B1;EDEM1;UBE4A;ANKZF1;STUB1;SYVN1;RNF121;NPLOC4;DNAJB14;UBE2G2;ECPAS;RHBDD2;FBXO2;FBXO17;SGTA
prerank,cardiac conduction system development (GO:0003161),-0.329191089643491,-1.019063179214965,0.44594594594594594,0.8159201446054315,1.0,9/24,23.69%,HEY2;BMP4;SMAD1;GJA5;MSX1;CACNA1G;HCN4;NOTCH2;SHOX2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.24873245997426932,-1.0190400370794976,0.4189189189189189,0.8149722238840971,1.0,21/87,15.59%,PSMD14;PSMD8;PKD2;PSMA2;PSMF1;CDC73;PSMD6;PSME2;PSMD5;E2F7;KLF4;PSMD12;DCUN1D3;CDKN2A;CDKN1A;PSMD11;MYO16;GPR132;PSMD1;RGCC;RBL1
prerank,mitochondrion localization (GO:0051646),0.3585063809248595,1.0189316621310198,0.4234875444839858,0.820371144201692,1.0,5/19,13.88%,TRAK1;TLE6;MEF2A;MARK2;NECTIN2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3808946907143796,1.0187595152914473,0.42830540037243947,0.820151522363959,1.0,4/17,15.37%,ALG12;ALG6;ALG2;ALG8
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3888292553812549,-1.018667454345322,0.42887931034482757,0.8151313348638836,1.0,6/13,17.11%,ZBTB7B;NAPEPLD;SOX13;FNDC5;PIM1;VSTM2A
prerank,aggrephagy (GO:0035973),-0.31947809706380803,-1.0186201124040086,0.4230769230769231,0.8142658283777746,1.0,5/27,7.08%,DYNC1I2;VIM;ACBD5;UBE2N;PRKN
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3100798055507298,-1.0185997182908408,0.4223300970873786,0.8133223198083068,1.0,5/31,9.31%,DLG2;LRRC7;DLG3;CDC42;MTCL1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.36206390866862387,1.0185799266534288,0.4202626641651032,0.8199537695677517,1.0,9/18,28.40%,PSENEN;CLN3;PSEN2;LDLRAP1;ADAM10;APH1B;ADAM17;TMCC2;APH1A
prerank,negative regulation of cellular component organization (GO:0051129),-0.2580655887573785,-1.0184715394939252,0.4019607843137255,0.8126918442297314,1.0,19/74,16.55%,LILRB1;IAPP;TMEFF2;MTMR2;PRKCZ;GSK3B;CDC42;CARMIL1;RUBCN;OPRD1;RIOK3;MCTP1;RAF1;HSPA8;HSPA2;HSPA1B;HSPA5;XRCC5;NR1H4
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.23051522059484506,-1.0183726184049817,0.39090909090909093,0.8119996842278389,1.0,29/151,13.57%,DMD;GPHN;B4GALT5;PAM;ST3GAL4;PCSK5;SGMS1;SGMS2;SLC44A5;VAPA;ELOVL7;SLC44A1;APOE;MGST1;CHAT;GOLPH3;SPTSSA;ASL;HACD1;SGPL1;ELOVL5;SLC44A2;MFSD2A;CHKA;CERS1;CEPT1;ALDH3A2;ACHE;NMRAL1
prerank,response to interferon-gamma (GO:0034341),-0.2580826767883754,-1.0183456237657362,0.4223300970873786,0.8110648908571877,1.0,20/67,19.64%,CD74;CD47;CIITA;CD40;SP100;GBP3;AQP4;IFITM3;DAPK1;GBP4;GBP2;IFITM2;CCL5;CCL14;CX3CL1;SNCA;IFITM1;CCL7;NUB1;RPL13A
prerank,heterochromatin organization (GO:0070828),-0.37741833278671566,-1.0182411869993815,0.4355179704016913,0.8103812288748411,1.0,4/14,12.74%,SIRT1;PRDM16;BAHD1;SETDB2
prerank,positive regulation of lipid storage (GO:0010884),-0.337873861768722,-1.018056048553786,0.4168564920273349,0.8099120943501955,1.0,6/21,19.95%,MSR1;EHD1;PLIN2;IKBKE;VSTM2A;PLIN3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3259029446473525,1.0179553195845883,0.4110320284697509,0.8210471698928237,1.0,4/30,2.14%,KLK2;PRMT2;HEYL;DDX5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2416948325020477,1.017833672457387,0.4206471494607088,0.8206782758772431,1.0,52/184,22.37%,SDCCAG8;TUBA4A;CSNK1E;PPP1R9B;SIRT2;PRKACA;NEK6;ODF2;TUBB;RPS27A;UBC;CEP164;TUBG1;ERCC2;HAUS7;ZFP36L1;ZFP36L2;PLK5;APPL1;PSMD3;CNTRL;ANAPC15;PSMB3;CDC14B;TUBA1A;PSMA7;CEP63;CEP57;HAUS6;HAUS2;KLHL18;PSMC1;PSMC2;SFI1;MAPRE1;PSME4;AURKA;PSMB9;ANAPC11;CEP135;ACTR1A;OFD1;DCTN2;CEP43;PSMD4;PSMB5;CEP70;PSMB7;ANAPC1;TFAP4;CSNK1D;PSMB8
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2587982790429924,1.017780926272281,0.4240924092409241,0.820122495020871,1.0,14/95,7.67%,ZFYVE26;RAD51AP2;GINS4;NBN;RNF138;SPIDR;RAD54B;FANCM;POLN;RAD51B;MCM2;SWSAP1;SLX4;BRCA1
prerank,hyaluronan catabolic process (GO:0030214),0.37481669677685386,1.0174720909960384,0.41788321167883213,0.8203233772620526,1.0,3/18,6.37%,HEXB;GUSB;HEXA
prerank,substantia nigra development (GO:0021762),0.3067937904436209,1.0174423235740095,0.4230769230769231,0.8196957671507781,1.0,7/37,9.26%,BASP1;YWHAH;SIRT2;SUDS3;PADI2;NDUFS3;CKB
prerank,RNA biosynthetic process (GO:0032774),0.3345061943689933,1.0172465516846632,0.4194690265486726,0.8195359510974298,1.0,8/31,13.64%,TTF2;TAF12;TAF6;BRF1;BRF2;SMARCA5;SMN1;TAF4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3896868305961184,-1.0170780786606626,0.44370860927152317,0.8107991119166841,1.0,2/13,11.74%,PLCB1;IL2RB
prerank,cellular response to interleukin-15 (GO:0071350),-0.3896868305961184,-1.0170780786606626,0.44370860927152317,0.8107991119166841,1.0,2/13,11.74%,PLCB1;IL2RB
prerank,cell junction organization (GO:0034330),0.27398171294383245,1.0168996973217936,0.38808373590982287,0.8198382677142785,1.0,22/71,20.55%,OPHN1;SMAD3;PPFIA4;CXADR;PKHD1;C1QA;APBB2;LIMS1;TJP1;WNT7B;FLNC;LRP4;PIN1;FBLIM1;TJP2;CBLN1;CLDN1;VASP;CBLN2;RAB8B;PPFIBP2;MAPT
prerank,regulation of endothelial cell proliferation (GO:0001936),0.26488552418684697,1.0167241416090786,0.42424242424242425,0.8196519306105786,1.0,28/88,25.61%,TGFBR1;PTPRM;PRKCA;SPARC;VEGFB;EGR3;PDGFB;PIK3CD;APOH;ARNT;PDCD6;AKT1;PROX1;VIP;HMGB2;THBS1;FGF18;CCL24;AGGF1;KRIT1;SYNJ2BP;NRAS;BMP2;ITGB3;HIF1A;AIMP1;ATP5IF1;SULF1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.23728217534061455,-1.016530888126422,0.42597402597402595,0.8113985309575914,1.0,24/110,14.62%,CD36;GSN;TPPP;NAPB;IAPP;LATS1;ATF7IP;RPS3;FAF1;APOE;PRKCZ;GSK3B;TRABD2B;CDC42;IRGM;SAR1B;OPRD1;BAK1;RIOK3;CDH5;RAF1;SLF1;HSPA8;HSPA5
prerank,positive regulation of transferase activity (GO:0051347),-0.23239951611240592,-1.0164840035450329,0.4188034188034188,0.8105447498364441,1.0,51/142,25.99%,CD74;DCUN1D2;EGFR;DSTYK;PARM1;ROR1;NTRK2;CCT2;NTRK3;RPS2;UBE2N;ERBB4;RET;MAPKAPK5;LMO4;AXIN1;EPHA5;ALK;ARRDC3;ERBB3;AURKB;FGFR3;KLF4;WRAP53;KIT;DCUN1D3;PRKCQ;TEK;XRCC5;LMTK2;SERINC5;MRE11;MAPK1;TCP1;EPHA4;EPHB2;EPHA7;FLT3;TIE1;LTK;TRIB3;GRHL2;MAGEC2;CTNNB1;MAPK15;CD4;HSP90AB1;FBXW7;RFC4;EPHA3;DDR1
prerank,sensory perception of light stimulus (GO:0050953),0.26808969585000564,1.0161898709898396,0.43657331136738053,0.8205657080472589,1.0,14/87,11.70%,CDH23;CRYBB1;EFEMP1;WHRN;PAX6;RP2;TULP2;MYO7A;RD3;DRAM2;EYA3;RABGGTA;PAX2;BBS2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.30328890186025625,1.0157469069186646,0.4315068493150685,0.8211921048938674,1.0,8/41,15.96%,SIRPA;LGALS9;VSIR;TLR4;CD34;HAVCR2;CD33;SLAMF1
prerank,regulation of protein transport (GO:0051223),-0.3186395373851152,-1.0154029954623085,0.41333333333333333,0.8128304596024992,1.0,8/27,15.27%,STXBP5L;DISP1;STXBP5;SCFD1;P3H1;NDFIP1;HSPA8;SNX12
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.31149884909451564,-1.015227110954667,0.41067285382830626,0.812378298057856,1.0,8/28,18.50%,KDM4D;ERCC6;WRAP53;PARP3;CYREN;SHLD3;RIF1;SETMAR
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.4007849097300036,1.0149975789911874,0.427255985267035,0.822595176913599,1.0,5/14,27.65%,PES1;BOP1;FTSJ3;RPL7;WDR12
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2728374813149577,-1.014946011014161,0.44360902255639095,0.8122207654310237,1.0,12/56,11.65%,ANK3;SPTBN1;SEPTIN9;KIF23;RACGAP1;CUL7;SNX9;NUSAP1;AURKB;UNC119;KIF20A;ALKBH4
prerank,regulation of membrane depolarization (GO:0003254),-0.35240337409383415,-1.014920083928072,0.46304347826086956,0.8113007026742209,1.0,3/18,6.32%,LRRK2;NEDD4L;PTPN3
prerank,negative regulation of protein binding (GO:0032091),-0.25756913515426494,-1.0141383686216983,0.4110787172011662,0.8125583058796455,1.0,12/71,11.44%,DAB2;ITGA4;LRRK2;B2M;ATP2A2;MAP2;GSK3B;STYX;ACTB;AURKB;ATP2A3;ITGB1BP1
prerank,neutrophil degranulation (GO:0043312),-0.20123099724935012,-1.014090704279773,0.40160642570281124,0.811728166659741,1.0,76/425,14.32%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD47;CD44;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;B2M;PSMD14;CTSC;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;RAB5C;ATP11A;ALOX5;SNAP25;KCNAB2;SDCBP;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;ANO6;FRK;RAB3A;GPI;SLC44A2;CYBA;OLR1;ATG7;DNAJC3;ANPEP;PTAFR;ARPC5;TRAPPC1;APRT;PSMD12;AP1M1;RNASE3;GYG1;ALDOC;GLA;LAMP1;MMP8;MCEMP1;PECAM1;PSMD11;MANBA;HSPA8;HSPA1B
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3877722247588,1.014016759647918,0.437847866419295,0.8247108956516351,1.0,3/15,8.30%,LIPC;APOM;LCAT
prerank,recombinational repair (GO:0000725),0.26718855369185546,1.0133658808644521,0.42,0.8259137656552711,1.0,15/77,13.13%,ZFYVE26;RHNO1;RAD51AP2;NBN;RNF138;SPIDR;RAD54B;POLN;RAD51B;SWSAP1;SLX4;BRCA1;MORF4L1;ERCC4;BLM
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.42605238829771785,1.0131333906448003,0.4323308270676692,0.8258638166870689,1.0,4/10,13.46%,CD9;PRKCD;CEACAM1;SERPINE2
prerank,inorganic ion transmembrane transport (GO:0098660),0.4064078614025269,1.0130268705206593,0.44727272727272727,0.825475461225703,1.0,2/12,6.36%,TRPM4;ABCC9
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.26110381047528786,-1.012999693824852,0.4103194103194103,0.8139241097220324,1.0,16/70,15.14%,CYBB;CD36;B2M;PSMD14;NCF2;PSMD8;PSMA2;PSMF1;PSMD6;TAP1;PSME2;CYBA;PSMD5;PSMD12;PSMD11;PSMD1
prerank,nucleoside catabolic process (GO:0009164),-0.4168220046329354,-1.012921590991267,0.4656319290465632,0.8131493948080314,1.0,3/11,20.09%,DPYD;UPP2;DERA
prerank,response to amyloid-beta (GO:1904645),-0.2870831418104243,-1.0127899076186542,0.41379310344827586,0.8125649654763822,1.0,9/44,11.11%,ITGA4;GRM5;CD36;GRIN2A;APP;GSK3B;MMP12;VCAM1;FCGR2B
prerank,cellular response to hypoxia (GO:0071456),-0.2360071025513391,-1.012781643185937,0.39325842696629215,0.8116021205119425,1.0,27/126,16.01%,KCND2;SLC8A3;SCN2A;SUV39H1;NPEPPS;LIMD1;PSMD14;LMNA;PSMD8;PSMA2;PSMF1;PSMD6;HIPK2;SIRT1;PSME2;OPRD1;PSMD5;TIGAR;PSMD12;HMOX1;PSMD11;AK4;PSMD1;SFRP1;EGLN3;RGCC;MDM2
prerank,neural tube development (GO:0021915),-0.3655133573544492,-1.0126154075631308,0.39643652561247217,0.8111494000833892,1.0,7/15,27.58%,SOX11;PKD2;PKD1;GRHL2;HES5;STIL;SOX4
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.27595386894751783,-1.0126115523540755,0.43636363636363634,0.809189906710317,1.0,14/51,17.36%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;PPP2R1A;NUP205;REEP4;NUP43;NUP155;VRK1;BANF1;CCNB1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.27595386894751783,-1.0126115523540755,0.43636363636363634,0.809189906710317,1.0,14/51,17.36%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;PPP2R1A;NUP205;REEP4;NUP43;NUP155;VRK1;BANF1;CCNB1
prerank,positive regulation of histone modification (GO:0031058),0.3190642142860499,1.0123531693493033,0.4258289703315881,0.8267717176306965,1.0,6/33,7.67%,AKAP8;AKAP8L;CDK9;RPS6KA5;SART3;BRCA1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3821421419045954,-1.0123524661349126,0.43847874720357943,0.8089604135579295,1.0,9/14,36.89%,TNKS2;XRCC5;TERT;NABP2;BRCA2;ATR;TINF2;TERF2IP;PINX1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3794333602362264,1.0121945090122244,0.42830882352941174,0.826501475130862,1.0,7/16,18.92%,DDX5;PADI2;DDX17;DDX54;SAFB;ARID1A;NCOA4
prerank,protein insertion into ER membrane (GO:0045048),-0.2976707054391248,-1.0121730156239999,0.44987775061124696,0.8085200536429774,1.0,13/37,22.65%,APP;VAPA;UBE2J2;GET3;ALDH3A2;EMC3;HMOX1;MMGT1;EMC2;GET4;EMC7;TRAM2;EMD
prerank,ether lipid metabolic process (GO:0046485),0.3926663099572832,1.0121426855047424,0.43201376936316693,0.8259258063271059,1.0,3/14,4.82%,AGMO;TMEM86B;PLA2G6
prerank,response to molecule of bacterial origin (GO:0002237),0.2715979256420879,1.0121308195036003,0.42174629324546953,0.8252524753265221,1.0,10/69,9.12%,LGALS9;SIRT2;CYRIB;TLR4;OTUD5;SLPI;SELE;NOS2;SELP;TAB2
prerank,myotube cell development (GO:0014904),0.42895313664658424,1.0115415503584633,0.4438202247191011,0.8262444081890519,1.0,2/10,8.10%,SKI;KLHL40
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3455815246445266,1.0115308019261855,0.43956043956043955,0.8255649202366186,1.0,4/24,3.08%,TGFBR1;GREM1;EFEMP1;MBOAT2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3625959813373326,-1.011501595332443,0.44956140350877194,0.8094498620245636,1.0,7/17,26.26%,RFX3;VEZF1;AHI1;SULT2B1;BMP4;FOXN1;KDF1
prerank,regulation of Golgi organization (GO:1903358),0.376827506047166,1.0114313501351746,0.4581005586592179,0.825143117925451,1.0,7/17,21.42%,CAMSAP2;ARMH3;RBSN;MAP2K1;PDCD10;STX5;STX18
prerank,stem cell development (GO:0048864),0.38143272732867345,1.0112218469596879,0.43010752688172044,0.8250318866915294,1.0,4/16,12.72%,SOX8;SHH;KBTBD8;PDCD6
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2836481567387653,1.0111881275424937,0.43278688524590164,0.8244437447668865,1.0,26/62,27.02%,POLR2H;POLR2J;RANBP2;POLR2D;EIF4G1;NUP42;DHX9;SEC13;NUP50;NUP35;NUP88;POLR2E;NUP62;SEH1L;NUP107;WTIP;POLR2I;ELAVL1;NUP153;TGFB1;AGO1;AJUBA;NUP188;STAT3;NDC1;PUM1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.33908161874001874,1.0108259383617564,0.43486238532110094,0.8247933424797232,1.0,5/26,7.34%,SMAD3;TLR4;AGTR2;CLU;NOS1AP
prerank,BMP signaling pathway (GO:0030509),0.27822000634908867,1.010811971459672,0.4394904458598726,0.8241311068806646,1.0,19/62,26.54%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;ENG;SMAD9;USP9Y;NOG;ACVR2B;ZFYVE16;HIVEP1;TMEM100;BMP2;TGFB1;PDCD4;ACVR1;AMH;SMAD6
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2829960170728882,1.0100830465949378,0.4380165289256198,0.8255292479700068,1.0,15/63,16.59%,CST3;SIRT2;CPTP;EIF4G1;FOXK2;MET;TAB2;MTOR;RASIP1;BMF;KDM4A;IL10RA;RRAGA;AKT1;WDR6
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3294403562993279,-1.0100234694588806,0.4072289156626506,0.8128029096613946,1.0,4/24,2.36%,PLA2G7;CCR2;SLIT2;CCR1
prerank,regulation of protein acetylation (GO:1901983),0.3998971858722381,1.0099150908124732,0.43907156673114117,0.8253281341465172,1.0,6/12,22.95%,CEP295;RAPGEF3;KAT5;CAMK1;DDX3X;PARK7
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.30446627700169043,1.0095491514235042,0.43501805054151627,0.8256731773821328,1.0,13/38,14.99%,DDIT3;ARRB2;PKHD1;FLCN;THEM4;GPER1;INPP5K;PIK3CB;PPP2R5B;PDCD6;DRD2;AKT1;CIB1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3638516870467976,1.0088909342534569,0.43726937269372695,0.8268936929977121,1.0,3/18,11.73%,NAV3;CD34;HAVCR2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.35608949996313644,1.0084014598163822,0.43159922928709055,0.8275533015500582,1.0,5/20,13.59%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3343984932589555,1.0083812309211981,0.43265993265993263,0.8269173533410766,1.0,8/27,15.32%,CHST11;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;CHSY1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.20025517237208576,-1.0083689342220306,0.4309623430962343,0.8168191934978467,1.0,76/428,14.32%,IQGAP2;ATP8B4;IQGAP1;ARMC8;LRRC7;ADGRE5;PTPRN2;CYBB;ACTR10;AMPD3;CD47;CD44;CD36;LILRB3;FTL;CD93;GSN;CYSTM1;CLEC12A;MME;AP2A2;HGSNAT;B2M;PSMD14;CTSC;VAPA;CCT2;STOM;RAB6A;ITGAL;PPIA;PLAC8;ATP6AP2;S100A11;MGST1;RAB5C;ATP11A;ALOX5;SNAP25;KCNAB2;SDCBP;PSMA2;CNN2;CFP;PSMD6;RAB3D;TBC1D10C;CAMP;ANO6;FRK;RAB3A;GPI;SLC44A2;CYBA;OLR1;ATG7;DNAJC3;ANPEP;PTAFR;ARPC5;TRAPPC1;APRT;PSMD12;AP1M1;RNASE3;GYG1;ALDOC;GLA;LAMP1;MMP8;MCEMP1;PECAM1;PSMD11;MANBA;HSPA8;HSPA1B
prerank,basement membrane organization (GO:0071711),-0.3890944751286358,-1.0083387232896626,0.43805309734513276,0.815933339373783,1.0,8/14,25.76%,FLRT2;COL4A1;LAMB2;NTNG1;NTNG2;NTN4;NID2;NID1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.36337178234180595,1.0081136862657858,0.4621212121212121,0.8270214112252594,1.0,5/18,12.78%,SRC;CTR9;IL6ST;IL6R;PTPN11
prerank,regulation of spindle organization (GO:0090224),-0.35214530102907504,-1.007928719304785,0.4492099322799097,0.8161326997885971,1.0,10/18,30.67%,TPX2;MAP9;GNAI1;GPSM2;PARP3;BORA;SENP6;FSD1;DYNC1H1;PSRC1
prerank,cellular response to reactive oxygen species (GO:0034614),0.2825244674019234,1.0074825095708821,0.43842364532019706,0.8281201399839654,1.0,19/59,22.97%,SIRPA;NFE2L2;RHOB;PRKCD;TRPM2;IMPACT;CAMKK2;JUN;PDK2;PAX2;ABL1;MAPK8;AKT1;MAPK7;ANKZF1;ECT2;MAPT;PARK7;PXN
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.4212973100845337,-1.007480924440718,0.45454545454545453,0.8165380188735678,1.0,3/10,3.28%,BTLA;LILRB1;CD40
prerank,mesenchymal cell differentiation (GO:0048762),0.29109997512404384,1.0074520480989668,0.4565587734241908,0.8275044380038094,1.0,18/51,24.80%,TGFBR1;HEYL;MEF2C;DDX5;LOXL3;LIMS1;DDX17;NOTCH4;ENG;NOG;AKNA;ROCK2;BMP2;DLG5;TGFB1;SOX9;FGFR2;HIF1A
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4162623033822174,-1.0074320879332488,0.45726495726495725,0.8157052243396078,1.0,4/11,14.20%,PARP14;PARP12;TIPARP;PARP3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3271052932814237,1.0070546375677267,0.43661971830985913,0.827939373823701,1.0,10/29,22.98%,FUS;TENT5C;GDNF;PKP3;RBM24;VIP;SLC11A1;LARP1;ELAVL1;AXIN2
prerank,regulation of receptor internalization (GO:0002090),-0.2945944213833012,-1.0065634937259045,0.45524296675191817,0.8173963639015959,1.0,5/35,6.56%,MAGI2;MKLN1;ATAD1;MTMR2;SDCBP
prerank,cellular response to glucose stimulus (GO:0071333),0.3282106973560201,1.006165288044263,0.43302752293577984,0.8297423741625611,1.0,7/30,12.13%,MLXIPL;AGER;PRKACA;IGF1R;GPER1;PAX2;TRA2B
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3860097060756601,1.0061137429411404,0.4419475655430712,0.8291805964309247,1.0,7/16,20.57%,DDX5;DHX9;DDX17;RBM17;SLU7;SCNM1;SRSF9
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3601079015271783,-1.0060179583651816,0.4247787610619469,0.8180457786589389,1.0,6/17,16.08%,CD74;CD44;PRKN;SIRT1;MDM2;SNAI2
prerank,regulation of muscle contraction (GO:0006937),-0.3179286604769995,-1.0059818278274673,0.45560747663551404,0.8171751450288143,1.0,5/26,14.00%,KCNB2;CHRM2;TNNI1;MYL9;MYBPC3
prerank,vesicle organization (GO:0016050),0.2979285610617578,1.0058866498638364,0.4377104377104377,0.8291099002965339,1.0,21/46,30.09%,HOOK2;PHETA1;USP8;SORT1;AKTIP;CD34;SAR1A;LAPTM4B;WASL;ZFYVE16;USP50;WASHC4;DNAJC13;EXOC8;HOOK3;SNX33;VPS18;SNX11;SQSTM1;SRGN;ARFGEF2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.42147982911767407,1.0058572203530693,0.4277456647398844,0.8278104148112341,1.0,3/10,12.51%,AP2A1;MYLIP;CLTA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.42147982911767407,1.0058572203530693,0.4277456647398844,0.8278104148112341,1.0,3/10,12.51%,AP2A1;MYLIP;CLTA
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3909146933975415,-1.0058448782864522,0.43628509719222464,0.8166333143337767,1.0,2/13,2.52%,RBPJ;RYR2
prerank,positive regulation of developmental process (GO:0051094),-0.22145296825923555,-1.0058175567857963,0.43626062322946174,0.8157343833515543,1.0,36/164,17.17%,NRXN1;NLGN1;ZBTB16;PLCB1;B4GALT5;MCU;LMNA;SOX5;CPEB3;GRIP1;SHANK3;APOE;DNM1L;CEBPB;RTN4;PRKN;DDHD1;SIRT1;ALK;FIS1;MFF;MAP3K13;ENPP2;ZDHHC15;RALBP1;SCX;ESRRB;SHLD3;DAG1;SRF;RELN;NIBAN2;CORO1B;RIF1;BMP4;TFRC
prerank,regulation of protein catabolic process (GO:0042176),-0.23901870677757772,-1.005772602106226,0.45135135135135135,0.8148993529915756,1.0,28/99,18.95%,EGFR;WWP1;HECW2;HECW1;APC2;NEDD4L;FAF1;GSK3B;BARD1;PRKN;PLK2;AXIN1;ATG7;EEF1A2;GPC3;HMGCR;FAM83D;TIPARP;NKD1;TNFSF12;OAZ1;SNX12;RILP;MDM2;FOXO1;AZIN1;IRAK3;DTL
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.28410511463748694,-1.005703143205648,0.4343675417661098,0.81414398724724,1.0,11/41,16.47%,ANK3;CD47;CD44;AFDN;SKAP1;PODXL;CCL5;THY1;CX3CL1;PLPP3;CD3E
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.42485084794202443,-1.0052882987535998,0.4331065759637188,0.8144195479376832,1.0,3/10,8.78%,SEMA5A;CARMIL1;ACTN2
prerank,positive chemotaxis (GO:0050918),-0.3517821945454864,-1.0052268445046044,0.4479638009049774,0.813639196153296,1.0,4/17,14.67%,FGF10;SEMA5A;FGF7;CX3CL1
prerank,histone ubiquitination (GO:0016574),0.3478902412264175,1.00513668903666,0.41899441340782123,0.829256995676601,1.0,6/21,16.81%,CTR9;RNF8;RNF20;UBE2U;UBE2A;DTX3L
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4157911882138292,-1.00496144283853,0.46790890269151136,0.8134764811864013,1.0,3/10,9.77%,IQSEC1;FGF10;FGF7
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.22408896253774474,-1.004925543095005,0.45671641791044776,0.8126217876412322,1.0,33/152,18.40%,ADGRB3;ADGRL3;GRM8;ADGRE5;GRK5;ADCY2;ADGRG6;IAPP;GABBR1;PF4;GNAO1;ADCY5;CHRM2;HTR1D;LGR5;ADRA2A;GPR161;GNAI1;RGS1;ADCY3;ADCY8;LGR4;PDE2A;CNR2;ADGRG5;TSHR;LPAR2;HTR1F;ADCYAP1R1;RXFP2;ADGRL4;S1PR2;ADM
prerank,DNA metabolic process (GO:0006259),0.22570041617026554,1.0045037585111083,0.43204577968526464,0.8304430966845361,1.0,70/270,22.98%,SUMO1;CSNK1E;PCNA;EID3;PRIMPOL;RFC2;DDB2;NBN;ATM;REXO4;CTC1;MPG;RPS27A;UBC;RAD17;RAD51B;MCM2;MGMT;SLX4;CDC34;INTS3;BRCA1;CNBP;NUDT15;LIG1;MMS19;KMT5C;TOP3B;FANCG;TOP2B;POLD2;DCLRE1B;UBE2V2;PARG;UHRF2;EXO1;RAD1;ERCC4;UBE2U;BLM;TERF1;RPAIN;PSME4;UBE2A;DNASE2;NABP1;ORC3;KAT5;HMGB2;RFC1;NTHL1;FANCA;TOP3A;ACD;MCM3;TYMS;XRCC6;RAD9A;PARP4;TSN;LTO1;UBE2T;PWWP3A;RNASEH1;TOPBP1;RPA3;NSMCE3;ZBTB1;PARK7;AXIN2
prerank,negative regulation of blood pressure (GO:0045776),0.40427037929599363,1.0042983795161038,0.4505703422053232,0.8303423201716217,1.0,4/13,20.49%,NOS2;DRD2;PRCP;NOS1
prerank,endomembrane system organization (GO:0010256),-0.21936067198443382,-1.0042765978647203,0.44983818770226536,0.8136041521548338,1.0,31/178,13.29%,ATP8B4;ANK3;MYOF;SPTBN1;LRRK2;TMCC1;HTT;REEP3;SYNE1;VAPA;RAB22A;ZW10;STX17;DNM1L;ATL2;VPS51;CDC42;GOLPH3;DNM1;TOR1A;CUL7;VMP1;TMED1;DMPK;FAM174B;DYSF;ARHGAP21;REEP4;TOR1AIP2;ALS2CL;OBSL1
prerank,response to reactive oxygen species (GO:0000302),-0.26980490495532145,-1.0040427734956883,0.4198473282442748,0.8133365750811057,1.0,18/54,21.44%,EGFR;RPS3;ROMO1;APOE;STK26;PKD2;SIRT1;AGAP3;HMOX1;SOD2;ERCC6L2;FER;HP;GSTP1;CAT;MAPK1;PTPRK;FYN
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.37446423165087067,-1.0037111529060663,0.4279475982532751,0.8133800335268773,1.0,6/15,22.65%,YWHAE;GSK3B;BAG3;GTSE1;XPO4;EMD
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3396690502153038,1.0037059906080141,0.4486486486486487,0.8313876706104532,1.0,7/24,19.11%,RAC1;MAP4K4;PIK3R1;LIMS1;ABL1;PTPRJ;PPM1F
prerank,negative regulation of signal transduction (GO:0009968),0.22872454707638584,1.0033272009507954,0.4243641231593039,0.8317855971366748,1.0,58/249,18.26%,CX3CR1;IGFBP3;CNOT1;LYN;GPS2;SHISA2;PLEK;CSNK2A2;CSNK2A1;PRKCD;AGTR2;NFATC1;UBASH3B;CTNNBIP1;ULK3;LGMN;SPRY2;MDFI;TAX1BP3;ARRDC1;PTPRE;GATA2;IL12B;GPR108;SLC27A4;APPL1;INPP5K;LRP1;PIK3CB;RGS14;LEPROT;PRKCB;DLL1;PTPN1;NDRG4;PDCD6;DRD2;EZH2;WWP2;TMBIM6;MOSMO;AKT1;KCTD6;NOTCH3;DACT3;NOG;SLAMF1;VGLL4;CBLN1;QARS1;AGT;KANK2;TRIB1;ARRB1;PTPRJ;GATA3;THBS1;DKK3
prerank,dendritic cell chemotaxis (GO:0002407),0.39249018185866485,1.0033185940491254,0.4323308270676692,0.8311110695281777,1.0,5/14,13.98%,TRPM4;PIK3CG;TRPM2;CCR7;CCR5
prerank,regulation of phospholipase C activity (GO:1900274),-0.37400480781076395,-1.0030322942702643,0.452991452991453,0.8144010264593013,1.0,3/15,12.04%,BICD1;NTRK3;KIT
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.3912520872093209,-1.0018582680905241,0.4515366430260047,0.8169951011947247,1.0,4/12,11.49%,UST;DSE;VCAN;CSPG4
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3269208935292269,-1.001829095431771,0.45598194130925507,0.8161197239899961,1.0,6/23,8.94%,APP;PRKAG2;CALM1;AXIN1;IRGM;UBE2K
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24997922486935073,-1.001696516580207,0.4588859416445623,0.8155587313717091,1.0,21/78,20.33%,EGFR;CDK7;LATS1;CCND2;CCNF;CCNYL1;PKD2;ACTB;CCNJ;CEBPA;CDKN2A;CDKN1A;PKD1;CDC25C;RGCC;HEXIM2;PKMYT1;CCNB1;SPDYA;CDKN1C;CDK5RAP3
prerank,peptidyl-lysine modification (GO:0018205),0.25415482527744154,1.0015276996276772,0.453416149068323,0.8356228316337249,1.0,21/99,17.95%,SUMO1;SENP2;SIRT2;RANBP2;UBA2;VIPAS39;HDAC10;TRPM4;STX1A;LOXL3;NUP42;EGR2;NUP50;NUP35;NUP88;PIAS3;PIAS2;NUP62;SEH1L;KAT5;NUP107
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3788126998829166,-1.0014525838289468,0.4288888888888889,0.8152761037809596,1.0,3/14,16.32%,LDLR;CX3CL1;CD200R1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2731761841339395,1.001436069900111,0.4608843537414966,0.8351935507736995,1.0,29/69,26.26%,ARHGEF2;LGALS9;AGER;TLR4;CCL3;CLU;PLCG2;DHX9;IL12B;ORM2;DDT;HAVCR2;IL33;PTPN11;MAVS;PYCARD;PTPRJ;THBS1;SETD4;NOD2;IL1A;TWIST1;TYROBP;FADD;FZD5;PTPRC;ISL1;STAT3;MIF
prerank,natural killer cell activation (GO:0030101),0.34633512813867334,1.00076589818649,0.4369602763385147,0.8364904947255206,1.0,5/23,10.23%,BAG6;ULBP1;IL12B;PIK3CD;AXL
prerank,respiratory tube development (GO:0030323),0.3281641098352601,1.0003918076596272,0.45,0.8368345106771216,1.0,7/28,15.23%,BAG6;LOXL3;HECA;SHH;WNT7B;CCDC40;PROX1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.36660271182525983,1.0001082318801298,0.4627659574468085,0.8369389607096208,1.0,3/17,7.34%,SNTA1;SCN4B;NOS1AP
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.3518746568105218,-0.9999975642399439,0.4267241379310345,0.8185274235925928,1.0,5/18,10.14%,ARHGAP35;CUL3;RIPOR2;HEG1;KANK1
prerank,protein N-linked glycosylation (GO:0006487),0.27726355808319775,0.9995495858109406,0.469721767594108,0.8378221042442698,1.0,13/66,12.73%,MGAT4A;ALG12;GFPT1;ALG6;DPM3;MGAT2;MAN1C1;MGAT5;ALG11;NUDT14;MGAT1;OSTC;ALG2
prerank,catecholamine biosynthetic process (GO:0042423),-0.4009491465808952,-0.9995426017018774,0.43013100436681223,0.8189194970760723,1.0,3/11,17.95%,SNCA;DAO;MOXD1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2940773751704463,0.9993345156933556,0.4566787003610108,0.8377579445817901,1.0,15/48,25.59%,ETS1;PRKCA;MAP3K3;PDPK1;PDGFB;GATA2;AKT1;CIB1;MAPK14;THBS1;FGF18;ADAM17;TGFB1;HIF1A;PLCG1
prerank,regulation of dephosphorylation (GO:0035303),-0.37032864459402004,-0.9989327581240165,0.46875,0.8197820027732203,1.0,8/15,21.83%,MTMR2;SMG7;SMG6;SMG5;MTMR1;CDK5RAP3;PPP1R17;MTMR3
prerank,granulocyte chemotaxis (GO:0071621),0.289290906199973,0.9987960971820817,0.4467005076142132,0.838666287751502,1.0,9/55,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,cation transport (GO:0006812),0.23661329437326253,0.9987398584611616,0.4534711964549483,0.8381498904139624,1.0,22/167,8.96%,SLC7A8;FGF13;KCNA5;KCNMA1;SLC36A1;KCNK6;TRPM4;MCOLN1;TRPM2;KCNH4;KCNN1;CNGB3;NDFIP2;TRPM6;SLC8A1;SCN4B;ABCC9;KCNG2;SLC22A2;SLC29A4;ATP1A4;KCNS2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3321954954714723,0.9986684307060193,0.43826086956521737,0.8376428786760161,1.0,5/27,9.25%,LPIN2;PLA2G6;PLA2G15;PISD;CHKB
prerank,extracellular matrix assembly (GO:0085029),-0.3261430419536985,-0.9985416617398402,0.46320346320346323,0.819977770339666,1.0,15/23,41.85%,ATP7A;LAMB2;NTNG1;NTNG2;MFAP4;NTN4;TNXB;LAMB3;QSOX1;HAS1;EMILIN1;HAS2;RAMP2;MYH11;EFEMP2
prerank,response to exogenous dsRNA (GO:0043330),0.3642297290453964,0.9979781855048504,0.4752851711026616,0.8390067793756851,1.0,10/18,33.84%,ZCCHC3;DHX9;CGAS;MAVS;TICAM1;RALB;FLOT1;IFIT1;MUL1;COLEC12
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3753250368388714,0.9976928367777623,0.45796064400715564,0.8391199013863643,1.0,5/15,17.76%,PRKCA;IL6ST;MEF2A;AGT;ROCK2
prerank,phospholipid transport (GO:0015914),-0.27043471354253823,-0.9974152897188373,0.4595238095238095,0.8224157225636102,1.0,13/52,15.96%,ATP8B4;LDLR;PLTP;APOE;ATP11A;MFSD2A;OSBPL8;ATP11C;ATP9B;ABCA4;ATP10B;ATP8B2;ABCC1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.20187879673755688,-0.9971780023673869,0.4414715719063545,0.8221762863580667,1.0,83/348,20.06%,MAGI2;PID1;RIMS2;RBPJ;CD74;ANK3;ROBO1;ANK2;ATF2;STAP1;CD36;LILRB1;FGF10;GSN;APP;PTPN22;ATF7IP;NTRK2;PF4;RPS3;ATAD1;RBMS3;RPS7;NTRK3;UBR5;SOX11;FN1;AGO4;AFDN;GSK3B;KLF2;PRKN;ZBTB7B;FAM98A;TNRC6A;DNMT3B;FGF7;IFNGR1;TLE1;FGF9;KLF4;CTCF;TESC;CDH5;SETDB2;DTNBP1;MMP8;AHI1;PDE2A;INPP5F;HSPA1B;CD46;SCX;SCYL2;HEY2;SNCA;ANXA2;RGCC;POU3F1;TTBK1;MTPN;HMGN5;CD3E;RIMS1;BMP4;VSTM2A;TFRC;PPHLN1;SRPK2;ADTRP;E2F1;TADA3;FGF5;SMAD1;DNMT1;MSN;LEF1;ACTA1;STOX1;CD63;MAPK1;MAP2K5;AVPR2
prerank,microvillus organization (GO:0032528),-0.3871621058827305,-0.9961348596757785,0.4588744588744589,0.8242452008073174,1.0,3/13,4.69%,RAPGEF2;FXYD5;STK26
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3528432401830198,-0.9958923284021679,0.4590909090909091,0.8239740692693533,1.0,2/18,1.34%,ITGA4;PPARG
prerank,muscle organ development (GO:0007517),0.2835102830716105,0.9958194255775226,0.4527027027027027,0.8438551992755933,1.0,10/54,9.92%,LARGE1;CAPN3;MEF2C;MEF2D;SGCE;EGR3;TRIM72;CTF1;ANKRD2;MEF2A
prerank,positive regulation of heart contraction (GO:0045823),-0.3571373678535146,-0.9956348393861313,0.4535637149028078,0.8237548317643963,1.0,6/19,18.40%,ADRA1A;RYR2;ATP2A2;KCNQ1;APLN;ADM
prerank,response to tumor necrosis factor (GO:0034612),0.26092749582055763,0.9955825321765251,0.45641838351822506,0.8438357467735761,1.0,19/91,14.99%,ARHGEF2;NFE2L2;NPNT;MAP4K3;CCL3;TNFRSF21;TRADD;DHX9;ZFP36L1;BRCA1;ZFP36L2;SELE;GPER1;INPP5K;ASAH1;BAG4;PYCARD;AKT1;CIB1
prerank,positive regulation of viral life cycle (GO:1903902),0.3410698793478512,0.995538197366213,0.4584103512014787,0.8432683682893989,1.0,7/22,19.78%,LGALS9;TRIM11;AXL;VPS4A;TSG101;VPS37B;CHMP2A
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2469709899803193,0.9955069275699842,0.4669887278582931,0.8426730637131412,1.0,26/124,13.37%,PTPRM;OPHN1;CSF1R;RAC1;AGER;PPP1R9B;LYN;PPP1R9A;PLEK;ODF2;NPY;CAMSAP1;RYK;ARFIP2;EPHA8;CCR7;GDNF;POU4F1;PRMT1;MAP4;CYFIP1;RAB35;UHMK1;MNS1;GPRIN2;IQCG
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3886688983735518,0.995231626525684,0.4444444444444444,0.8427708285979949,1.0,2/14,4.71%,OPHN1;FSCN1
prerank,regulation of cellular pH (GO:0030641),0.32955683732171326,0.995148950159269,0.4802158273381295,0.8423243688543587,1.0,9/29,24.79%,SLC9A9;SLC9A8;ATP1A4;CLN3;SLC4A3;SLC4A4;SLC4A5;SLC26A6;SLC9A3
prerank,pyruvate metabolic process (GO:0006090),0.28736688431782714,0.9949916916979582,0.4684838160136286,0.8420894848373969,1.0,16/52,27.14%,HK2;PFKL;PGK1;GAPDH;PFKFB2;PGAM4;PGAM1;VDAC1;LDHAL6B;SDS;PCK2;LDHA;HK3;ME2;PDHB;SLC16A1
prerank,positive regulation of sodium ion transport (GO:0010765),0.40121867417404766,0.9947927389298182,0.4777777777777778,0.8419996627520998,1.0,5/12,20.49%,CNKSR3;SCN4B;SCN1B;WNK3;NOS1
prerank,negative regulation of protein processing (GO:0010955),0.40554518338817747,0.9947539406770237,0.49536178107606677,0.8414112221891907,1.0,6/12,18.18%,SERPINE1;SERPINE2;ACP4;GAS1;THBS1;TMEM59
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3618593698161574,-0.9937729331788979,0.4318181818181818,0.8281957356924112,1.0,5/17,17.60%,STAP1;NTRK3;CDC42;TEK;BCAS3
prerank,cellular senescence (GO:0090398),-0.30900787773707783,-0.9937288977127394,0.4632352941176471,0.8273617049247128,1.0,8/27,15.66%,MAPKAPK5;SIRT1;ECRG4;SMC5;KAT6A;CDKN2A;CDKN1A;SRF
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3037241581088398,-0.9937085437064351,0.4788732394366197,0.8264685234265082,1.0,12/32,19.10%,DNM1L;NDUFS1;ERBB4;GGCT;FIS1;CCAR2;MFF;BAK1;SOD2;BCL2;BOK;ATG3
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2775493535718747,-0.9934412574026819,0.43661971830985913,0.8263039895726235,1.0,15/45,21.09%,BRINP3;ZW10;PTPN3;BRINP2;PLK2;BUB1B;BUB1;TRIM35;CHEK1;RGCC;BMP4;FOXC1;CDKN1C;BTG2;NABP2
prerank,protein methylation (GO:0006479),0.298680268006745,0.9932990348618882,0.4711033274956217,0.8449465948092838,1.0,9/40,13.80%,FAM98B;PRMT2;ETF1;EEF2KMT;EHMT2;PRMT8;PRMT1;PRMT6;EZH2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.23755510778612743,0.9931043724618489,0.4786450662739323,0.8448107664227497,1.0,46/163,22.78%,PAG1;INPP5D;BLNK;FYB1;MEF2C;PIK3R1;RIPK2;LAT2;FYB2;PLCG2;TNFRSF21;EIF2B3;LCP2;CSK;PDPK1;TAB2;RNF31;PIK3CD;PSMD3;NCKAP1L;PIK3CB;WNK1;EIF2B4;PRKCB;PSMB3;NFKBID;PSMA7;BMX;PSMC1;PSMC2;PSME4;TEC;PSMB9;PTPRJ;GATA3;KHDRBS1;PSMD4;PSMB5;SH2B2;CD79A;STOML2;PSMB7;ZC3H12A;RC3H2;PSMB8;PIK3CA
prerank,response to iron ion (GO:0010039),-0.39553550851837804,-0.9929321728889716,0.47671840354767187,0.8268345550309845,1.0,4/12,15.35%,B2M;TFR2;SNCA;BCL2
prerank,autophagy of mitochondrion (GO:0000422),0.3041461635931195,0.9929098341469554,0.46492659053833607,0.8447139517032264,1.0,11/38,17.75%,ULK2;ATG9A;ATG14;PHB2;RB1CC1;PINK1;MARK2;GABARAPL1;ATG9B;ULK1;ATG5
prerank,ERBB signaling pathway (GO:0038127),-0.25840433033215177,-0.9928733732033576,0.4884910485933504,0.8260479977838395,1.0,11/64,10.64%,IQGAP1;EGFR;GAREM1;NCK2;SHC3;PTPN12;PIK3C2A;ERBB4;ERBB3;BCAR1;NRG2
prerank,negative regulation of dephosphorylation (GO:0035305),0.36534666076517625,0.9924628581487912,0.48545454545454547,0.8453461451298532,1.0,4/18,11.60%,ZCCHC9;GPATCH2;INPP5K;SH2D4A
prerank,protein modification process (GO:0036211),0.26582190548427165,0.9924410380017374,0.4769736842105263,0.8447110690828364,1.0,21/76,20.23%,ST3GAL6;CDKL3;MAN2B1;FBXO22;UBA7;USP25;CPE;CDC34;ARAF;RABGGTA;FBXL2;SLC35A1;PPP4R2;ABL1;WWP2;FBXO11;ADPRH;PHKA2;DUSP12;PARP4;TGM5
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.27808385979571226,0.9923602258420481,0.4601328903654485,0.8442637819059904,1.0,16/60,20.62%,SMOC2;GREM1;PCNA;RFC2;ATM;PDGFB;CHTF18;PDGFRB;NEK7;CCT3;NVL;POLG2;CCT8;ACD;FGFR4;DSCC1
prerank,renal filtration (GO:0097205),-0.4113943993503516,-0.9921963386055274,0.48812095032397407,0.8270905655286976,1.0,4/10,13.17%,TMEM63C;SULF2;XPNPEP3;JCHAIN
prerank,protein K63-linked ubiquitination (GO:0070534),0.2992089848150839,0.9918643784975747,0.4649910233393178,0.8449906170123396,1.0,11/41,20.66%,ITCH;TRIM5;TRAF5;ZFP91;RNF8;BFAR;UBE2V2;WWP2;RNF4;STUB1;UBE2T
prerank,negative regulation of cellular process (GO:0048523),0.2113329231993112,0.99180520700636,0.48429319371727747,0.8444682442117951,1.0,113/521,20.98%,SRGAP2;PDE3B;SIRPA;CTTNBP2NL;SMAD3;SLURP1;ETS1;ATP8A2;PIM2;CD9;IGFBP3;RND1;SKI;INCA1;PPP1R9B;TGFB1I1;SIRT2;LYN;JAM2;CCDC85B;KLF11;VHL;OSGIN2;MYH9;ADAMTS1;RHOB;RNF41;PKHD1;AGTR2;CLU;FLCN;TNFRSF21;IMPACT;HPGD;PTK2B;MDM4;GNRH1;SIPA1;KLK8;DIS3L2;TAF6;NDUFS3;PPT1;SHH;MIA3;LPXN;APBB2;PIWIL1;GPER1;SOX17;CXCL1;INHA;CD34;P3H2;NME6;PLPP1;NOTCH4;PRDM11;DLL1;TOB1;SMARCA2;CLMN;OSGIN1;BLM;CD33;GJA1;DRD2;SEMA4D;ADGRG1;TMBIM6;TSPYL2;NDUFA13;CIB1;DACT3;PROX1;GPNMB;MAP2K1;TENM1;SNX3;OSM;PLG;EIF2AK2;VGLL4;TMEM98;ADAM10;WDR6;KANK2;NUP62;PTPRJ;ATG5;NME1;GATA3;CHMP1A;HTRA2;CD164;NAIF1;NR1H2;VPS13C;NUDT6;ADAM15;VPS35;EI24;CHMP2A;SYT11;EIF2AK3;PLXNA4;IL1A;NOS1;WNK2;PTPN14;HGS;PLXNA3;SFRP4
prerank,glycoprotein metabolic process (GO:0009100),0.28390381687989136,0.991744412521245,0.44869565217391305,0.8439500788619466,1.0,7/53,7.03%,LARGE1;MGAT4A;PRKCSH;MAN2B1;GAL3ST4;GANAB;MAN2A2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2743815672660953,0.9916753535782623,0.4656616415410385,0.8434369491797273,1.0,14/59,23.62%,LIPC;LIPH;CH25H;OSBPL3;CYP46A1;AKR1D1;CYP7B1;HSD17B10;OSBP;GAMT;SDS;PARK7;ACOT8;SCP2
prerank,UV protection (GO:0009650),-0.4129821766476609,-0.9912546174080111,0.46184738955823296,0.8289290560931999,1.0,5/10,21.97%,XPA;MFAP4;CAT;FEN1;SCARA3
prerank,regulation of stem cell differentiation (GO:2000736),0.2579648091500038,0.9910410732691181,0.4470774091627172,0.8445357541413264,1.0,26/89,23.01%,NELFB;ITCH;ZFP36L2;GATA2;GDNF;RBM24;PSMD3;RUNX1;PSMB3;PSMA7;ABL1;PSMC1;PSMC2;TAL1;PSME4;TCF3;OSM;EIF2AK2;PSMB9;GATA3;LMO1;PSMD4;PSMB5;PSMB7;PSMB8;LMO2
prerank,lipid transport (GO:0006869),0.25475343188715854,0.9908277304851351,0.46645367412140576,0.844483401156045,1.0,17/97,17.48%,SLCO2B1;ABCD2;ABCA9;PCTP;PITPNC1;PPARD;CPTP;NME4;SLC27A4;CLN3;CEACAM1;NPC2;OSBPL5;PITPNM1;MFSD2B;OSBP;SCARB1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3252634545185701,0.990766051132277,0.4543828264758497,0.8439568685114682,1.0,5/25,8.56%,CAPN3;CACNB2;PDPK1;GPER1;CALCR
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27462092872956523,0.9907167181487806,0.48026315789473684,0.8434136388231435,1.0,18/58,20.02%,HERC2;SUMO1;IFFO1;NBN;ATM;BRCA1;RNF8;DCLRE1B;UBE2V2;ERCC4;ABRAXAS1;DCLRE1C;KAT5;DCLRE1A;HMGB2;BABAM1;XRCC6;KDM2A
prerank,regulation of tumor necrosis factor production (GO:0032680),0.24752071984314475,0.9906446809370191,0.47217806041335453,0.8429372616757277,1.0,28/112,20.44%,CX3CR1;SIRPA;ARHGEF2;LGALS9;VSIR;AGER;TLR4;CCL3;CLU;PLCG2;DHX9;IL12B;ORM2;DDT;CD34;HAVCR2;IL33;PTPN11;CD33;MAVS;PYCARD;SLAMF1;PTPRJ;THBS1;SETD4;SYT11;NOD2;IL1A
prerank,protein localization to organelle (GO:0033365),-0.22760222175706252,-0.990401474248273,0.4742547425474255,0.830499724506905,1.0,22/133,13.98%,ANK2;CNTLN;LRRK2;BICD1;APP;WDR35;LMNA;VAPA;YWHAE;UBE2J2;EHD1;RAB6A;XPA;TOR1A;MTCH2;PAQR3;GBP2;ALDH3A2;LAMP1;OBSL1;HMOX1;COL1A1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.37668589247321904,0.9902893100998855,0.496309963099631,0.8432034498001482,1.0,13/16,37.13%,NAA11;NAA25;NAA50;NAA20;NAA40;NAA60;KAT2B;EP300;NAA10;CREBBP;NAA80;NAA35;AANAT
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3213794121502671,-0.989987300061863,0.4755244755244755,0.8307371010970924,1.0,5/23,19.53%,CALM1;CAMKMT;GUCY2F;GUCY2D;PDE6A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4267073389367222,0.9898479555678071,0.47186932849364793,0.8437751892816093,1.0,1/10,0.53%,OPHN1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.36831082186726516,0.9895835521558245,0.4724264705882353,0.8438478317096757,1.0,3/16,4.72%,RREB1;FLCN;TFE3
prerank,regulation of B cell differentiation (GO:0045577),0.3740290759042706,0.9892837794701791,0.48035714285714287,0.8440710196866203,1.0,5/17,10.24%,CD27;ZFP36L1;ZFP36L2;INHA;NCKAP1L
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3134413534621296,0.9891827669478168,0.4663299663299663,0.8436966725000113,1.0,14/33,27.90%,PPP6R3;CTC1;TNKS1BP1;DCLRE1B;TERF1;ZBTB48;NHP2;RFC1;ACD;SHQ1;TELO2;STN1;RTEL1;RPA1
prerank,protein K63-linked deubiquitination (GO:0070536),0.31559788727824806,0.98871970776694,0.4875886524822695,0.8443102155060146,1.0,7/31,13.18%,USP8;OTUD5;ZRANB1;USP25;STAMBPL1;OTUB2;ABRAXAS1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.29330244226746305,-0.9886270559140076,0.48291571753986334,0.8339405615420468,1.0,8/34,13.72%,PTPRT;PTPN22;PTPN12;TNS2;PTPN2;DUSP10;DUSP16;PTPN13
prerank,digestive tract development (GO:0048565),0.31230152432691544,0.9884820183322357,0.43559322033898307,0.8442875294040576,1.0,6/32,14.97%,SALL1;NPY;CHD8;PKDCC;CCDC40;SMO
prerank,apoptotic nuclear changes (GO:0030262),-0.3228699846219303,-0.9881523272264234,0.45951859956236324,0.8343921779902784,1.0,3/24,4.29%,DEDD2;TOP2A;ACVR1C
prerank,T cell receptor signaling pathway (GO:0050852),0.24049468994210543,0.9877622411599986,0.481981981981982,0.8456513267819479,1.0,38/138,22.78%,PAG1;INPP5D;FYB1;PIK3R1;RIPK2;FYB2;PLCG2;TNFRSF21;EIF2B3;LCP2;CSK;PDPK1;TAB2;RNF31;PIK3CD;PSMD3;PIK3CB;WNK1;EIF2B4;PSMB3;NFKBID;PSMA7;PSMC1;PSMC2;PSME4;TEC;PSMB9;PTPRJ;GATA3;KHDRBS1;PSMD4;PSMB5;STOML2;PSMB7;ZC3H12A;RC3H2;PSMB8;PIK3CA
prerank,regulation of organelle assembly (GO:1902115),0.26483930132377453,0.9876304754767233,0.4779050736497545,0.8453399201865425,1.0,9/72,6.18%,TBC1D16;SDCCAG8;TBC1D17;TBC1D9B;TBC1D10B;TBC1D8;TBC1D15;ATXN2L;DYNLT2B
prerank,negative regulation of catabolic process (GO:0009895),0.2888270064846986,0.9875449014665242,0.4745762711864407,0.8449022725668586,1.0,9/47,15.96%,PDE3B;CST3;SIRT2;MDM4;BSCL2;ZDHHC7;AGAP2;PIN1;SNX3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.37802324832278195,0.9875301299419962,0.45907473309608543,0.8442724711887631,1.0,3/14,10.56%,FUS;WDR48;MMS19
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.4188939318654382,0.987026859027055,0.46502835538752363,0.8450107899512633,1.0,4/10,27.12%,TLR4;IL33;NOD2;TLR9
prerank,neutral amino acid transport (GO:0015804),0.3245500913130084,0.9869157707578766,0.49722735674676527,0.8446380907255431,1.0,3/28,2.43%,SLC7A8;SLC7A5;SLC36A1
prerank,negative regulation of cell cycle (GO:0045786),0.2653628756943071,0.9868010569523241,0.47594501718213056,0.8442750717154064,1.0,28/73,26.19%,SMAD3;INCA1;RHOB;HECA;HPGD;SIPA1;TAF6;GPER1;INHA;CDK5RAP1;LATS2;TSPYL2;GAS1;GATA3;CHMP1A;HTRA2;NUDT6;IPO7;TFAP4;BMP2;CDKN1B;TGFB1;IPO5;PDCD4;NPPC;SCRIB;GMNN;BTG1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2554669143797759,0.9864084153696425,0.4876847290640394,0.8446510634340313,1.0,26/94,22.69%,BAG6;FHIT;QRICH1;DDIT3;DDX5;CHEK2;ATM;PRKCD;PDK1;ARL6IP5;C1QBP;BRCA1;POU4F1;PDK2;APAF1;ABL1;PYCARD;HTRA2;CUL4A;PPM1F;EPHA2;PMAIP1;TOPORS;DDX3X;BCL2L1;BCL2L11
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3825877645630247,0.986307507246716,0.49371633752244165,0.8442663560553356,1.0,6/14,23.04%,ABCD2;MTLN;AKT1;TYSND1;TWIST1;ABCD1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3788890535659713,0.9860368583963619,0.4505703422053232,0.8443485015623445,1.0,5/15,14.38%,CRNN;PHB2;PLCG2;EZH2;KLHL18
prerank,histone lysine demethylation (GO:0070076),0.337931835056827,0.9858868907473988,0.48073394495412847,0.844111159317919,1.0,12/25,25.37%,KDM5B;UTY;KDM3A;KDM4A;HR;KDM1A;KDM8;KDM7A;KDM2A;KDM5A;KDM2B;PHF8
prerank,pulmonary valve development (GO:0003177),-0.35095011818678085,-0.9858610729909257,0.45555555555555555,0.8400180889661597,1.0,7/18,23.13%,ROBO1;SLIT2;JAG1;HEY2;BMP4;ROBO2;NOTCH2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.2596075644334827,-0.985755800135967,0.472289156626506,0.8393771814187401,1.0,7/61,4.89%,ARHGEF3;AUTS2;ROBO1;FGF10;JAK2;RASGRP4;GPR35
prerank,brain development (GO:0007420),-0.22351553453874357,-0.9857261261771475,0.4670487106017192,0.8384989493388012,1.0,22/136,11.26%,CNTNAP2;CTNNA2;NFIB;ADGRL3;GRIN2B;GRIN2A;POMK;CENPF;RAPGEF2;SHANK3;VPS51;COL4A1;CDK5RAP2;EML1;PBX1;HSPG2;GRIN2D;PBX3;PLXNB2;ZFHX2;DDIT4;MFSD2A
prerank,regulation of DNA repair (GO:0006282),-0.2793451451308796,-0.9856904701764984,0.4663677130044843,0.8376500727651565,1.0,11/44,11.77%,EGFR;FGF10;RPS3;UBR5;TRIP12;UBE2N;SIRT1;ERCC6;TIGAR;BABAM2;WRAP53
prerank,extracellular transport (GO:0006858),0.40462426444046284,0.9856048186939808,0.48428835489833644,0.8442434656106326,1.0,4/12,19.55%,ARRDC1;WWP2;CCDC40;TSG101
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.39601024407420327,-0.9854365753757091,0.4692982456140351,0.8364602584721013,1.0,2/11,6.61%,CALM1;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.39601024407420327,-0.9854365753757091,0.4692982456140351,0.8364602584721013,1.0,2/11,6.61%,CALM1;PKD2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24274262212124292,0.9852037442952903,0.4733637747336377,0.844699338703168,1.0,33/132,21.63%,NCBP1;POLR2D;SF3B1;SNRPC;COIL;CELF2;SART3;SNRPF;DHX9;BOP1;SRSF5;EIF4H;GEMIN6;SMN1;RPL10;NLE1;TGS1;SNUPN;RPS27L;LUC7L3;DDX20;EIF2S2;MRPS11;LUC7L;BRIX1;EIF2D;GEMIN2;EIF5;TRAF7;SRSF9;DHX29;SHQ1;DDX39B
prerank,regulation of lipid catabolic process (GO:0050994),0.3547973047332676,0.9849204275280914,0.5070175438596491,0.8448408188760327,1.0,1/19,0.09%,PDE3B
prerank,nitrogen compound transport (GO:0071705),0.24068459624529168,0.9847384721306414,0.4727272727272727,0.8447096801952512,1.0,33/141,20.17%,SLC7A8;SLC7A5;SLC36A1;SEC14L1;MYH9;SLC15A4;SLC25A45;PPT1;ARRDC1;ARL6IP5;CD320;MIA3;RD3;SLC52A3;SLC22A2;SLC29A4;SCAMP2;SCAMP5;SLC52A2;SLC52A1;ARRDC2;TOM1;PICK1;KIF3A;SLC38A1;SLC23A1;SLC15A2;SLC11A1;CHMP1A;CHMP2A;SLC6A8;LRRC8D;CMTM6
prerank,glycerophospholipid metabolic process (GO:0006650),0.2631441960666463,0.9841418768473692,0.47317073170731705,0.8456871330656374,1.0,12/75,11.53%,ABHD12;CSF1R;PLEK;PIGV;PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;LCAT;ABHD6;CLN3;PDGFRB
prerank,regulation of macrophage differentiation (GO:0045649),0.38321343904077565,0.9837133005800417,0.475,0.8462026650718372,1.0,4/15,15.22%,PRKCA;INHA;IL34;CSF1
prerank,cellular response to dsRNA (GO:0071359),0.36388444508117945,0.9835418364128585,0.4652014652014652,0.8460044580763733,1.0,4/15,13.86%,ZCCHC3;DHX9;CGAS;MAVS
prerank,tRNA modification (GO:0006400),0.27189158504113586,0.9830344676058542,0.4879310344827586,0.8467503737203559,1.0,27/62,29.93%,QTRT1;SSB;TRMT6;AARS2;ANKRD16;THUMPD1;CTU2;NSUN6;METTL6;BCDIN3D;WDR6;CDKAL1;TYW5;MTO1;QTRT2;OSGEP;TRMT61A;THUMPD3;TRDMT1;FTSJ1;MOCS3;ALKBH8;TRMT9B;PUS7;TRUB1;METTL2B;METTL2A
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2610299887484442,-0.9823742718997432,0.495,0.8444322982012011,1.0,23/57,28.87%,HTT;MCU;DNM1L;GSK3B;PRKN;DDHD1;ZNF205;FIS1;MFF;BAK1;FBXO7;RALBP1;BOK;CHCHD10;CIDEB;PPIF;PPARGC1A;HRK;BID;MMP9;ADCK1;PLAUR;BNIP3
prerank,establishment of endothelial barrier (GO:0061028),-0.3058181295989328,-0.9823631600777986,0.45642201834862384,0.8434966771867647,1.0,11/29,23.20%,PDE4D;RAPGEF2;AFDN;RAB1B;MYADM;PDE2A;PECAM1;MSN;RAPGEF6;ICAM1;EZR
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.28892376714394596,0.9821217543611517,0.4824120603015075,0.8485705537866125,1.0,13/46,19.83%,IL18;IGFBP3;AIF1;PDGFB;IL12B;IL6R;PDGFRB;NDRG4;AKT1;VIP;TRIB1;THBS1;XRCC6
prerank,positive regulation of cell population proliferation (GO:0008284),0.21383950479577843,0.9821033378741895,0.5184210526315789,0.8479561282831352,1.0,79/423,18.17%,TGFBR1;TMEM119;IL18;TGFBR2;LRP5;MLXIPL;CSF1R;GREM1;FAM98B;MEF2C;AIF1;SOX8;GAB2;LYN;KMT2D;MAP3K3;TBC1D8;IGF1R;ITGAV;CSNK2A1;TRPM4;PKHD1;MEIS3;LGMN;PTK2B;NDUFS4;IL6ST;PDGFB;DHX9;SHH;CD86;GCNT2;TCIRG1;ACER3;CNBP;S1PR3;EDN3;CNTF;EDN2;GDNF;GPER1;CTF1;IL6R;ACER2;PRMT1;RTKN2;TJP1;IL12RB2;DDR2;DLL1;PAX2;TBX6;PDGFRB;DHPS;GJA1;STX4;RNF187;IL34;EZH2;HTR1A;AKT1;CIB1;CSF1;PROX1;VIP;SLAMF1;OSM;PDCD10;UBE2A;TSPAN31;LAMC2;ADAM10;CCAR1;AGT;C5AR1;KDM1A;NME1;IL7R;THBS1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4015231151715303,0.9816261565205333,0.5231660231660231,0.8486660902805043,1.0,4/12,18.35%,PRKCA;NEK6;PRKCB;LPIN1
prerank,regulation of viral genome replication (GO:0045069),-0.2637036672464162,-0.9812478024888255,0.48931116389548696,0.8457583560269986,1.0,23/56,26.31%,OAS2;RSAD2;PPIA;IFITM3;PABPC1;PPIH;RNASEL;IFITM2;OAS3;CCL5;IFITM1;BANF1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;NR5A2;OASL;PPARA;ADAR;PLSCR1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3685217492919569,-0.9809909494289942,0.46284501061571126,0.845561203660138,1.0,5/13,14.41%,FSTL1;FBN1;FBN2;NRROS;CD46
prerank,positive regulation of DNA recombination (GO:0045911),0.3228585713045811,0.9809082864547748,0.5026737967914439,0.849949694093673,1.0,6/27,13.15%,FUS;WDR48;ERCC2;MMS19;KMT5C;SHLD2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2995461584039594,0.9808011884954222,0.4731182795698925,0.8495914278302723,1.0,10/37,22.59%,NCBP1;ENTPD1;NUDT15;RNASE6;ENTPD7;ISG20;NUDT16;SND1;RNASEH1;ENTPD6
prerank,ureteric bud development (GO:0001657),0.36415833760393546,0.9804797947216356,0.4740484429065744,0.8498035148108491,1.0,2/17,3.01%,SALL1;NPNT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4179387468466016,0.9803879507078891,0.49613899613899615,0.8487175051672438,1.0,3/10,15.69%,MPG;MGMT;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.4179387468466016,0.9803879507078891,0.49613899613899615,0.8487175051672438,1.0,3/10,15.69%,MPG;MGMT;ALKBH5
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.40640075480965765,-0.9801753763867843,0.48695652173913045,0.8470751572588069,1.0,4/10,25.04%,HSPA2;HSPA1B;DNAJB2;SACS
prerank,UV-damage excision repair (GO:0070914),-0.38476977669101076,-0.9801441156946051,0.4823008849557522,0.8462058318157434,1.0,7/12,28.93%,POLA1;XPA;SIRT1;POLD3;XPC;ERCC1;DDB1
prerank,regulation of T cell proliferation (GO:0042129),0.27212399574913654,0.9800704850367171,0.48817567567567566,0.8489517049829126,1.0,10/61,10.24%,CCDC88B;AIF1;TNFRSF21;TNFRSF13C;IL6ST;CD86;PNP;PDCD1LG2;IL12B;NCKAP1L
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.37419556633286266,-0.9798258176367377,0.4588744588744589,0.8461496311628616,1.0,1/13,0.63%,PLCB1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.32851773184993655,0.9796344248684903,0.4712041884816754,0.8495206516475848,1.0,10/24,26.10%,IL6ST;BRCA1;ARNT;CXCL17;EIF2AK3;IL1A;TGFB1;HIF1A;SULF1;ISL1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.23607181362764237,0.9795046060032138,0.49700598802395207,0.8492049531955093,1.0,19/150,6.37%,LDLRAD4;SIRPA;MLXIPL;GREM1;SMAD7;PMEPA1;IGFBP3;CNKSR3;PYDC1;SIRT2;LYN;ATG14;PRKCD;EIF4G1;PRKRIP1;IMPACT;UBASH3B;SPRY2;PDPK1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.35405883250690606,-0.9794867382318317,0.48826291079812206,0.8461681995633288,1.0,5/15,15.24%,UST;DSE;VCAN;CSPG4;CSGALNACT2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3791883550526033,0.9791689412259337,0.47971781305114636,0.8494609014227336,1.0,3/14,9.25%,LPIN2;PISD;CHKB
prerank,proteoglycan biosynthetic process (GO:0030166),0.3177119786741701,0.9789281158141135,0.46503496503496505,0.8494727862670638,1.0,3/31,2.39%,EXTL3;CHST11;GAL3ST4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2310645747352236,-0.9789043756572012,0.49740932642487046,0.8469333894569695,1.0,14/101,8.02%,ROBO1;LRRK2;EGFR;CD40;RAPGEF2;PDGFD;CCND2;CALM1;HTR2B;CCNYL1;PKD2;SIRT1;TPD52L1;IRGM
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2887769667895754,-0.978548408738303,0.514218009478673,0.8470341435882293,1.0,8/36,13.88%,ANK2;ATP2B1;CCR1;STIM2;TRPC3;FFAR1;LILRA5;CCL5
prerank,nuclear membrane reassembly (GO:0031468),-0.2609180860419138,-0.9783934664054713,0.486284289276808,0.8465611080020844,1.0,15/54,18.75%,REEP3;PPP2R2A;LMNA;LBR;NUP98;RAN;PPP2R1A;NUP205;REEP4;NUP43;NUP155;VRK1;BANF1;CCNB1;NSFL1C
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3773008460354281,0.9783757014427934,0.4756554307116105,0.8503687478643441,1.0,6/16,23.78%,ATP5PO;ATP5PD;ATP5MC1;ATP5F1D;STOML2;ATP5PF
prerank,cellular response to interferon-gamma (GO:0071346),-0.2378710646152445,-0.9781186253989683,0.47880299251870323,0.8464219014202558,1.0,21/88,14.67%,OAS2;CD47;CD44;CIITA;B2M;JAK2;SP100;GBP3;AQP4;IRF4;NCAM1;DAPK1;GBP4;IFNGR1;VCAM1;PTAFR;GBP2;OAS3;CCL5;CCL14;CX3CL1
prerank,cellular response to peptide (GO:1901653),-0.26426633662896765,-0.9778757839512248,0.4796954314720812,0.8461765117513385,1.0,8/56,5.28%,ITGA4;GRM5;CD36;GRIN2A;APP;PTPN22;VIM;GSK3B
prerank,cellular response to oxygen-containing compound (GO:1901701),0.21721973981943513,0.9777723209884011,0.526536312849162,0.851367566482078,1.0,64/291,18.21%,CX3CR1;SIRPA;TWF2;P2RY12;MEF2C;SBNO2;TGM2;TLR4;LYN;EGR1;ATM;PRKCD;CTR9;IMPACT;CASP1;PTK2B;SSH1;PDGFB;CAMKK2;CD86;NLRP3;LAMTOR2;ZFP36L1;JUN;WNT10B;PDCD1LG2;GPER1;CXCL1;POU4F1;RPTOR;MTOR;INPP5K;DPEP1;AXL;PABPN1;TICAM2;PDK2;WNT7B;LAMTOR5;CD180;PAX2;RAPGEF3;SERPINE1;ADCY6;TAF1;CCDC62;MAPK8;CCR5;PYCARD;NDUFA13;RRAGA;AKT1;MAPK14;NCOA3;TNIP2;NRIP1;ABCB4;ROCK2;KAT5;HMGB2;TICAM1;FES;GNB1;HTRA2
prerank,regulation of stress fiber assembly (GO:0051492),0.2612403041224156,0.9775819471624444,0.4867549668874172,0.8512252922341932,1.0,13/74,13.83%,TGFBR1;F11R;RAC1;ASAP3;PIK3R1;ARHGAP28;MET;TJP1;INPP5K;FHOD1;RAPGEF3;ABL1;SORBS3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2540520918183602,0.9774395504673128,0.495114006514658,0.850958967399103,1.0,19/86,17.29%,NFE2L2;DDIT3;VHL;IMPACT;RPS27A;UBC;EGLN1;ATF3;ANKRD2;PSMD3;PSMB3;ARNT;PSMA7;GCN1;PSMC1;PSMC2;PSME4;PSMB9;MAPK7
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.36985001943645557,0.9772990522837978,0.45886654478976235,0.850702735413176,1.0,4/16,11.33%,AGER;CYRIB;IL12B;CEACAM1
prerank,hyaluronan metabolic process (GO:0030212),0.3356392800526239,0.9771747265862263,0.47731397459165154,0.8503937273524956,1.0,3/23,6.37%,HEXB;GUSB;HEXA
prerank,regulation of phosphorylation (GO:0042325),-0.22707106859364629,-0.9771658139903568,0.5223463687150838,0.8472651318573416,1.0,25/120,14.71%,CCDC88C;GRM5;STAP1;EGFR;APP;KDM4D;PRKAG2;FN1;CADM4;NUP98;BARD1;SDCBP;SIRT1;PLXNB2;CCDC88A;NUP205;CDH5;NUP210;CDKN2A;NUP43;CCL5;CDKN1A;NUP54;NUP155;FER
prerank,entry into host (GO:0044409),0.3968934560764399,0.9768445743215739,0.5121951219512195,0.8506431217791015,1.0,4/13,13.98%,ITGAV;SRC;MET;CCR5
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3904529368521825,-0.975389986765746,0.4967741935483871,0.8515261458940622,1.0,3/12,7.01%,LRRK2;ATP6AP2;TMEM165
prerank,protein monoubiquitination (GO:0006513),-0.2840476120890313,-0.9752408580351011,0.501187648456057,0.8510475176574609,1.0,7/36,11.08%,CUL3;UBE2W;WAC;PRKN;CDC73;PEX12;RNF126
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.3937053857268298,0.9752202820325067,0.476280834914611,0.8546046654305561,1.0,3/11,10.44%,PICALM;TAX1BP3;LEPROT
prerank,dicarboxylic acid transport (GO:0006835),-0.30220771400379065,-0.9750936723764801,0.4490238611713666,0.8505410433007975,1.0,14/28,25.00%,SLC1A6;GIPC1;SLC13A3;SLC26A7;SLC46A1;SLC25A12;SLC25A18;SLC13A5;SLC1A1;ABCC2;SLC26A8;FOLR2;FOLR1;SLC25A32
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.32716357807370605,0.9747747354211764,0.49825783972125437,0.8552225561279126,1.0,7/26,16.89%,TLR4;CCL3;GPR55;INHA;CEACAM1;GPR137;CARTPT
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.39558656849021157,0.9747194681226562,0.47358490566037736,0.8547125990988607,1.0,3/13,8.81%,ETS1;ITGB2;FUT7
prerank,regulation of phosphate metabolic process (GO:0019220),-0.3468927048511651,-0.9745394970131507,0.4649122807017544,0.8511663848872861,1.0,5/16,10.98%,BARD1;SMG7;SMG6;SMG5;TIGAR
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3708480515932403,-0.9744455520023158,0.4717832957110609,0.8504749833703283,1.0,8/13,29.49%,NFIB;PPARG;SRF;BMP4;REST;PPARA;RELA;NFATC4
prerank,cellular response to starvation (GO:0009267),0.23450615560366803,0.9744210940915127,0.5030769230769231,0.854823823657606,1.0,31/147,17.75%,NUAK1;ATP6V0B;ATG14;FLCN;ATP6V1D;IMPACT;EIF2S1;PIK3C3;LAMTOR2;TCIRG1;SEC13;RPTOR;EHMT2;SH3GLB1;MTOR;NUAK2;MLST8;WDR24;LAMTOR5;FADS1;GCN1;MAPK8;GABARAPL1;RRAGA;PICK1;EIF2AK2;CARTPT;ATP6V0E2;CASTOR1;SEH1L;ATG5
prerank,ribosome biogenesis (GO:0042254),-0.2147122885068083,-0.9742016921624881,0.50920245398773,0.8501757639808332,1.0,53/187,21.15%,RPL36A;RPL30;RPL35A;DDX10;LTV1;RPS7;RPL4;UTP20;RPS2;SNU13;RPLP2;RPL7A;LAS1L;EXOSC1;POP4;RPL41;RPL26;RAN;XRN2;DCAF13;RPS27;RPL18A;RPS25;MRTO4;RPL38;RPL37;NOC4L;UTP14A;RPS14;RPL24;EXOSC7;WDR18;RPS9;RIOK1;RPLP1;RPL22;NOB1;RPL8;ESF1;RPLP0;NPM1;NOP16;RPL19;RRS1;PIH1D1;RRP9;RPL13A;RPS6;RPS19;RPL23A;TSC1;RPL29;NOC2L
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.22812021820364164,-0.9741491164773812,0.5165745856353591,0.8493974432261083,1.0,27/124,16.78%,PLCB1;CCDC88C;PRICKLE2;AP2A2;PSMD14;GNAO1;AGO4;CALM1;PSMD8;CDC42;FRZB;PSMA2;PSMF1;PSMD6;PSME2;WNT4;TNRC6A;NLK;PSMD5;PSMD12;AP2B1;PSMD11;PSMD1;SFRP1;TIAM1;DAAM1;SFRP2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.31827756104494775,-0.9738048928006471,0.4727272727272727,0.849439807495371,1.0,8/24,18.90%,MTF2;JARID2;DNMT3B;H3-3A;AEBP2;RBBP7;PPHLN1;DNMT1
prerank,regulation of cell growth (GO:0001558),0.22592723802141612,0.9736324734400589,0.5230312035661219,0.8563559239034704,1.0,37/204,15.06%,TGFBR1;SMAD3;NCBP1;RPS6KA1;PPP1R9B;ITCH;CCDC85B;OSGIN2;LTBP4;CSNK2A1;AGTR2;FLCN;EIF4G1;ATAD3A;SIPA1;NDUFS3;PPT1;LAMTOR2;APBB2;PAPPA2;SOX17;RPTOR;MTOR;NME6;PRDM11;CEACAM1;SMARCA2;OSGIN1;CDK11B;TAOK2;GJA1;TSPYL2;NDUFA13;AKT1;CIB1;DACT3;HPN
prerank,neuron differentiation (GO:0030182),0.23176865261085736,0.9734108454444109,0.5060240963855421,0.8563463005481705,1.0,23/165,11.45%,TGFBR1;OPHN1;ATP8A2;MEF2C;ACSL4;EPOP;PAX6;RYK;WNT2B;MYO7A;ERCC2;PPT1;SHH;FZD2;MET;WNT10B;BHLHE22;CTF1;NEUROD6;NEUROD4;WNK1;WNT7B;RUNX1
prerank,neutrophil migration (GO:1990266),0.275244727058634,0.9731639517732291,0.4809917355371901,0.856369520849598,1.0,9/58,10.24%,CXADR;ITGB2;PIK3CG;CCL3;EDN3;EDN2;CXCL1;PIK3CD;NCKAP1L
prerank,steroid hormone biosynthetic process (GO:0120178),0.3147114158754025,0.9731386283720923,0.4869109947643979,0.8557702441090278,1.0,5/29,15.59%,FDXR;HSD3B2;HSD17B1;TSPO;FDX1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.39669096371951507,0.9730435247069713,0.5067437379576107,0.8553813551154554,1.0,4/11,14.86%,F11R;RAB1A;TJP1;TJP2
prerank,response to light stimulus (GO:0009416),0.27781594211859634,0.9729947980794488,0.5060034305317325,0.8548612607878006,1.0,12/55,16.18%,PRIMPOL;CRY2;DDB2;MAP4K3;FECH;GTF2H2;ERCC2;PCLAF;ERCC4;DRD2;MAPK8;UBE2A
prerank,lipid phosphorylation (GO:0046834),-0.4055057116265744,-0.9729166758234978,0.49344978165938863,0.8509958415576614,1.0,3/10,12.07%,DGKB;DGKI;DGKH
prerank,regulation of protein kinase A signaling (GO:0010738),-0.33054891671137554,-0.9729075081684473,0.47045454545454546,0.8500906231736599,1.0,3/20,2.80%,AKAP6;LRRK2;IAPP
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3560127516943779,0.9728617721297541,0.497196261682243,0.8545710610884478,1.0,9/18,22.89%,KMT2D;ASH1L;EHMT2;SETD2;SETD4;PRDM9;SETD3;SETD7;KMT2B
prerank,muscle cell migration (GO:0014812),-0.40981609262478846,-0.9723444772341732,0.47761194029850745,0.8507477093809802,1.0,6/10,30.99%,ITGB1BP1;PLAT;CCN3;DDR1;ROCK1;THBS4
prerank,positive regulation of binding (GO:0051099),-0.23948469293998656,-0.9722624108257634,0.5259067357512953,0.8500377324346894,1.0,23/84,19.79%,LRRK2;PPARG;APP;KDM4D;B2M;RAPGEF2;MARK3;APOE;GSK3B;PRKN;RAN;HIPK2;RARA;EPB41;MMP8;PKD1;TIAM1;BMP4;CLN5;ADD2;FOXC1;TERT;USP33
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.35616419915790054,0.9722345956799116,0.5112359550561798,0.8556890770235539,1.0,5/18,17.21%,CAMK1D;RPS6KA5;TSSK4;CRTC1;RPS6KA4
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.2508176274670876,-0.9718752184417923,0.461734693877551,0.8502274283294078,1.0,10/66,12.04%,ROBO1;LRRK2;EGFR;CD40;RPS3;PDGFD;HTR2B;TPD52L1;ADRA2A;KIT
prerank,positive regulation of transport (GO:0051050),-0.23581138199388763,-0.9715516769353955,0.5130890052356021,0.8502432072039795,1.0,29/85,23.50%,DAB2;CD47;ACSL3;NEDD4L;APOE;GSK3B;SGK2;ZNF205;ACTB;CYBA;BAK1;GPC3;SPAG5;CD151;FCGR2B;TFR2;IL2RB;CBLL1;SNCA;ANXA2;BOK;PLAA;CHCHD10;SYNGR3;FPR2;LYAR;DOC2B;ABCA7;ANXA1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4068277222455411,-0.971403765097218,0.4880694143167028,0.8497443121454805,1.0,2/10,8.52%,STAP1;ANO6
prerank,clathrin coat assembly (GO:0048268),-0.351463796555933,-0.9710619933076569,0.4906832298136646,0.8497996446662878,1.0,3/15,4.51%,HIP1;SGIP1;PIK3C2A
prerank,secondary alcohol metabolic process (GO:1902652),0.2915976972194962,0.9701393996000525,0.49575551782682514,0.860892300157589,1.0,8/42,15.59%,PPARD;CH25H;PIP4P1;LCAT;SULT2A1;LDLRAP1;OSBPL5;FDX1
prerank,secretion (GO:0046903),0.3734825153495456,0.9698992420882819,0.5083487940630798,0.8609238272385612,1.0,4/14,19.15%,SLC22A2;SLC22A6;VIP;TPD52
prerank,myeloid cell development (GO:0061515),-0.3374717895764858,-0.9697926156138141,0.50418410041841,0.8525689620584981,1.0,8/18,28.46%,APP;FOXP1;NRROS;KIT;ANXA2;LYAR;THPO;MED1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.31959297143227344,0.9688118842990859,0.4991482112436116,0.8632056969220098,1.0,7/27,16.00%,RPS27A;UBC;MAP3K8;TAOK2;MAPK8;TNIP2;CCM2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.307355543891202,0.9688051124687102,0.5190972222222222,0.8625611119135904,1.0,6/32,9.25%,PCTP;LPIN2;CSNK2A2;CSNK2A1;LCAT;CHKB
prerank,circulatory system development (GO:0072359),0.2431443910220133,0.9686208845084059,0.5227272727272727,0.8624053601831333,1.0,16/118,10.26%,TGFBR1;ADAP2;SALL1;TGFBR2;MEF2C;CXADR;BCOR;PDGFB;SHH;SOX17;UTY;POU4F1;TAB2;AKAP13;MEF2A;NOTCH4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.343340213126105,0.9685004498393488,0.501779359430605,0.8620807446608937,1.0,3/20,8.83%,KCNMA1;SLC8A1;ATP1A4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.3519679701281967,0.9683565221426026,0.49642857142857144,0.8617978807022713,1.0,3/18,8.32%,IL18;AGER;IL12B
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2927374801348615,-0.9683381633181526,0.49502487562189057,0.8559241396957971,1.0,11/33,18.54%,PKD2;CDC73;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;MYO16;NACC2;RBL1;CDK4
prerank,regulation of cell motility (GO:2000145),-0.22553535127243907,-0.9682361735366672,0.5202312138728323,0.855267594296243,1.0,24/121,14.23%,FRMD5;EGFR;SPOCK3;FGF10;PLXNC1;SLK;LMNA;PLXND1;CADM4;PLXNA2;ERBB4;KIF14;LMO4;MGAT3;ERBB3;PLXNB2;FGF7;NRG2;FGF9;SRCIN1;RAF1;ENPP2;PLXNB1;INPP5F
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2731155908327231,0.9681788504105282,0.4991568296795953,0.8616208800944517,1.0,12/52,14.99%,EPB41L2;PIK3R1;AKAP5;NUMA1;PDPK1;ZDHHC5;GPER1;CLIP3;LRP1;STX4;AKT1;CIB1
prerank,regulation of interleukin-8 production (GO:0032677),0.2635591597631747,0.967715506939405,0.5041876046901173,0.8622322749207243,1.0,12/69,14.82%,TLR7;LGALS9;DDIT3;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;SERPINE1;CD33;MAVS;PYCARD
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2671769771131202,-0.9675942779223432,0.5081206496519721,0.8561321849561854,1.0,6/47,6.15%,ANK3;EXOC6B;SPTBN1;EXOC2;STXBP6;GOLPH3
prerank,positive regulation of inflammatory response (GO:0050729),0.2515864340056124,0.9673667192677793,0.5216666666666666,0.8625910414090556,1.0,17/86,17.35%,IL18;TLR7;ETS1;KARS1;TLR4;CCL3;TRADD;IL6ST;DHX9;IL12B;DDT;SERPINE1;IL33;OSM;GPR4;AGT;VAMP7
prerank,positive regulation of peptidase activity (GO:0010952),0.3441848368142756,0.9673446135915023,0.5071428571428571,0.8619962613173259,1.0,5/20,17.68%,VSIR;PSENEN;PINK1;NDUFA13;APH1B
prerank,anion transport (GO:0006820),0.3057617056627668,0.9673111888623436,0.5017605633802817,0.8614308428780995,1.0,10/33,23.49%,SLCO2B1;SLC22A6;SLC17A8;LRRC8A;TSPO;VDAC1;SLC19A1;LRRC8D;VDAC2;SLCO1B1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3245717246612636,0.9672926551402007,0.5081967213114754,0.8608291771527432,1.0,11/26,24.75%,LARGE1;GAL3ST4;ALG6;GK5;ALG11;ALG2;ALG8;TNIP1;GBGT1;GCNT1;TKT
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.32376382793640757,-0.9672627252341639,0.5054945054945055,0.8561235357532365,1.0,9/22,29.80%,LRRK2;TAFA1;SLC16A2;SHCBP1;DLL4;NES;ID2;TOX;RASSF10
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.412310327603693,0.9670397682858014,0.5130597014925373,0.8608667752947724,1.0,4/10,18.76%,BRCA1;RAPGEF3;HDAC5;CAMK1
prerank,sulfur amino acid catabolic process (GO:0000098),0.4120189504321171,0.9670058605436289,0.49814126394052044,0.8602995766233527,1.0,3/10,18.22%,MPST;GADL1;TXN2
prerank,lamellipodium organization (GO:0097581),-0.3064941138813496,-0.9669415381114913,0.5,0.8561379761846953,1.0,12/29,20.71%,CTTN;ABLIM1;GOLPH3;WASF1;CARMIL1;CCDC88A;CDH13;KIT;ABLIM2;ITGB1;PARVB;SNX2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3398504100961543,-0.9663823624294227,0.5033860045146726,0.8567788048373286,1.0,3/18,3.90%,USP15;ANKRD17;DDX60
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3026714280964977,0.966043234378156,0.5034246575342466,0.8623000434992985,1.0,8/32,13.15%,PICALM;PRKCD;EIF2A;PKP3;EIF2B4;CYFIP1;RPL10;PGAM1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3339140944601775,0.9659644502753995,0.5093632958801498,0.8618758947167013,1.0,11/23,26.45%,HSPA4;TIMM8B;BMF;TIMM29;NDUFA13;TIMM10B;MAIP1;PMAIP1;BCL2L11;TIMM13;SAMM50
prerank,regulation of MAP kinase activity (GO:0043405),0.2517706657200259,0.9657441927083756,0.5237341772151899,0.861860660665056,1.0,25/92,20.82%,UCHL1;LYN;PIK3CG;PRKCD;KSR1;SPRY2;PDGFB;EDN3;INPP5K;PIK3CB;RGS14;PDGFRB;PTPN1;IL34;EZH2;DIRAS2;TENM1;PDCD10;AGT;TRIB1;PTPRJ;FGF18;TSG101;NOD2;HGS
prerank,dermatan sulfate metabolic process (GO:0030205),-0.36568186289200305,-0.9656503726272445,0.514018691588785,0.8579288704024683,1.0,4/13,11.49%,UST;DSE;VCAN;CSPG4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.40531528516528703,0.9656133636663998,0.5239043824701195,0.8615396795450339,1.0,5/11,20.53%,EPN1;PIK3CB;E2F2;THBS1;SYNJ2BP
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.35880839288134914,0.9655766247608444,0.4879852125693161,0.860976485898002,1.0,4/16,15.17%,IGF1R;ETF1;CLN3;SHFL
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3206401167032348,0.9654088758997331,0.5114235500878734,0.8607955846009205,1.0,3/25,3.69%,OPHN1;CSNK2A2;CSNK2A1
prerank,myelination (GO:0042552),-0.27257176857126997,-0.9654087892442875,0.5257009345794392,0.8576789411856252,1.0,7/46,3.13%,B4GALT5;B4GALT6;SLC8A3;SCN2A;TPPP;ADGRG6;MYRF
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.318230040597789,0.9653389146286138,0.5099818511796733,0.860339687842999,1.0,12/29,27.03%,CNOT1;KMT2D;BRCA1;RUNX1;UBA5;KCTD6;KANK2;CARM1;WBP2;CNOT2;ISL1;VPS18
prerank,metal ion homeostasis (GO:0055065),0.291399819438829,0.9651109452936074,0.5051903114186851,0.8603358673956544,1.0,5/40,5.73%,SLC7A8;SLC12A6;CNNM2;SLC8A1;SLC12A9
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3027373904835725,-0.9650423890343895,0.4796380090497738,0.8578398891918916,1.0,6/27,10.47%,PPARG;MSR1;CD36;PF4;NFKBIA;ABCA5
prerank,proteasome assembly (GO:0043248),0.402814103708128,0.9646730318015023,0.5199240986717267,0.8609733751625064,1.0,2/11,4.87%,OTUD6B;PSMG1
prerank,epithelial tube morphogenesis (GO:0060562),-0.2898139244953345,-0.9646320944676167,0.49528301886792453,0.8580839249280935,1.0,11/32,16.84%,MTSS1;SLIT2;FGF10;RYR2;COL4A1;PKD2;PODXL;PKD1;ACVRL1;PAK1;BMP4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3256614510921169,-0.9645860781452269,0.49653579676674364,0.8572793419222198,1.0,10/21,28.75%,CDC25C;RCC2;NPM1;CCNB1;CDK4;DTL;STOX1;ATAD5;CDC25B;MECP2
prerank,positive regulation of ossification (GO:0045778),-0.28227578005391357,-0.9645560495062706,0.5275779376498801,0.8564275909489646,1.0,7/39,8.84%,ZBTB16;ATP2B1;SOX11;ALOX5;ANO6;WNT4;FBN2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33832699009577766,0.9643873250852414,0.5017667844522968,0.8610567149744411,1.0,7/21,21.68%,ZFP36L1;DLL1;RUNX1;MAFG;ROCK2;SFRP4;ERRFI1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2743594393524797,0.9642200116849171,0.5160744500846024,0.8608537649288555,1.0,14/54,19.43%,CRADD;PCNA;CNOT1;CHEK2;ATM;RBL2;MDM4;PRMT1;TNKS1BP1;CNOT3;PLK3;AURKA;CARM1;PIDD1
prerank,regulation of neuron death (GO:1901214),0.2505141346746541,0.964143619786974,0.49363057324840764,0.8604011148012513,1.0,12/82,9.80%,ITGAM;MEF2C;RILPL1;PICALM;ITGB2;EGR1;CLU;EIF4G1;EIF2S1;C1QA;CD34;RRAS2
prerank,visual perception (GO:0007601),0.25395956781436363,0.9641282451786825,0.5299837925445705,0.8597922333150265,1.0,21/84,23.23%,CRYBB1;EFEMP1;PAX6;RP2;TULP2;MYO7A;RD3;DRAM2;EYA3;RABGGTA;PAX2;BBS2;REEP6;COL11A1;ATXN7;CRYBA1;OPA3;CACNA2D4;OAT;OPA1;EYA4
prerank,bile acid and bile salt transport (GO:0015721),0.329022843046942,0.9640603686691814,0.5133689839572193,0.8593317109847793,1.0,1/24,0.06%,SLCO2B1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.27856564201822626,-0.9638259932852009,0.4781609195402299,0.8576506086595724,1.0,14/37,26.12%,RPS3;RPS7;DNM1L;FIS1;BECN1;EIF5A;NACC2;BCL2;BOK;BCAP31;MSX1;LCK;RACK1;BID
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3685067331514055,-0.9638062446210884,0.5194274028629857,0.8567784919403505,1.0,3/13,8.98%,ELOVL7;HACD1;ELOVL5
prerank,positive regulation of glucose import (GO:0046326),-0.3243185791303662,-0.9635191536826252,0.5,0.8567018202677922,1.0,3/21,3.39%,SORBS1;IRS1;CREBL2
prerank,regulation of immune effector process (GO:0002697),0.29133324394552756,0.9631195581841242,0.5233333333333333,0.8612750884387114,1.0,6/41,7.32%,C1QB;PROS1;PHB2;CLU;C1QA;C1QBP
prerank,selective autophagy (GO:0061912),0.2733633504175176,0.9630447609073447,0.5196078431372549,0.8608406244775428,1.0,19/56,25.93%,NBR1;ULK2;ATG14;ATM;PHB2;RPS27A;UBC;RB1CC1;AUP1;UBA5;RETREG1;ULK1;ATG5;WDR81;KLHL3;PARK7;DYNLL1;HDAC6;UFC1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.23554059829368978,-0.962787792056681,0.5481283422459893,0.857927833060161,1.0,19/86,16.78%,CD74;BANK1;CD44;EGFR;FGF10;APP;JAK2;PRKCZ;CADM4;FGF7;CSPG4;CD80;ENPP2;CLEC6A;EFNA5;PECAM1;SFRP1;RELN;SFRP2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.2857654780033972,0.9626945207178699,0.5295109612141653,0.8611937023606903,1.0,8/45,6.67%,PIK3R1;EFEMP1;SLC30A10;SRC;RPS6KA5;PTK2B;PDPK1;DGKD
prerank,regulation of histone acetylation (GO:0035065),0.30355950004910404,0.9626058290815815,0.5205724508050089,0.8607786212954621,1.0,15/33,29.14%,FLCN;RPS6KA5;BRCA1;RAPGEF3;HDAC5;RPS6KA4;ARRB1;CAMK1;NOS1;GLYR1;PARK7;IWS1;KMT2A;SPI1;PAXIP1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31114187619448186,0.9622265055967875,0.5174216027874564,0.8611545278937804,1.0,4/29,3.80%,TGM2;LYN;ITGAV;SRC
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.37112313960442467,-0.9619112085283611,0.5043668122270742,0.8595486770183003,1.0,4/13,10.04%,NLRC4;GRIN2A;CYFIP2;BAK1
prerank,engulfment of apoptotic cell (GO:0043652),0.36307911878812255,0.9618132632064187,0.5152671755725191,0.861616066589865,1.0,3/15,5.91%,RAC1;RHOBTB1;RHOH
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.35417781792505704,-0.9612240626331692,0.48306997742663654,0.8606314605893411,1.0,5/15,19.95%,PPARG;PLIN2;OSBPL8;ABHD5;PLIN3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.2861124973676177,-0.9610081611740519,0.5456730769230769,0.8603289053971301,1.0,7/37,12.95%,BICD1;TPPP;STMN4;GSK3B;SKA3;STMN2;EFNA5
prerank,actin filament depolymerization (GO:0030042),-0.3873072469768638,-0.9608120775285146,0.49223946784922396,0.8599929529304771,1.0,3/11,6.32%,GSN;DSTN;MICAL3
prerank,male meiosis I (GO:0007141),0.364615018309697,0.9608111593466206,0.5298372513562387,0.8637018115659748,1.0,3/16,12.18%,FOXJ2;ZSCAN21;HSF2BP
prerank,cellular response to fluid shear stress (GO:0071498),-0.37820410165131074,-0.960631142663312,0.5031847133757962,0.8595969139781772,1.0,4/12,11.41%,MTSS1;KLF2;PKD2;KLF4
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.36535882469341846,-0.9605006429932219,0.5227765726681128,0.8590349391864027,1.0,7/14,21.54%,MEOX2;KLF4;ITGB1BP1;STARD13;CARD10;MAP2K5;DLL4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.28493577348937127,0.9604454320035267,0.5207612456747405,0.8640265955384139,1.0,8/43,15.96%,SIRPA;LGALS9;VSIR;TLR4;CD34;HAVCR2;CD33;SLAMF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.25813846747347363,0.9603199041454251,0.5252854812398042,0.8637519608547488,1.0,22/72,25.35%,NCBP1;POLR2H;POLR2J;POLR2D;HNRNPH1;TIAL1;FRS2;ESRP1;PTPN11;GALNT3;CEP57;NOG;POLR2E;FGF18;FGFR4;SPRED2;FGF20;POLR2I;FGF1;HNRNPA1;FGFR2;FIBP
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.22477074574191575,-0.9602501892031255,0.5817694369973191,0.8588104682616773,1.0,25/121,13.88%,NEDD9;CD74;BANK1;GRM5;CD44;FGF10;CD40;JAK2;DLG3;PARP14;ERBB4;ERBB3;FGF7;FGFR3;UNC119;SRCIN1;CSPG4;KIT;CD80;LILRA5;ENPP2;CLEC6A;EFNA5;PECAM1;CCL5
prerank,stress fiber assembly (GO:0043149),0.36624005667948273,0.9602335648662351,0.5145985401459854,0.8627002828394891,1.0,6/15,17.91%,ITGB5;SRC;ZYX;PDCD10;ARRB1;TNFAIP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.36624005667948273,0.9602335648662351,0.5145985401459854,0.8627002828394891,1.0,6/15,17.91%,ITGB5;SRC;ZYX;PDCD10;ARRB1;TNFAIP1
prerank,regulation of neuroinflammatory response (GO:0150077),0.3409702680248483,0.9598697922123731,0.5108303249097473,0.8630534471033616,1.0,1/19,0.36%,IL18
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29427606208839796,0.959703266538097,0.5205724508050089,0.8628637942721795,1.0,10/35,20.39%,RASAL3;FLCN;SPRY2;MET;RASIP1;CCDC125;SYNGAP1;TNFAIP1;LZTR1;ARHGAP24
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.33485094629719414,0.9591322031208871,0.5294117647058824,0.8637527850001504,1.0,4/23,13.00%,ALOXE3;HPGD;FADS1;GPX4
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3745355088803581,-0.9588137568858214,0.5260869565217391,0.8619376507254143,1.0,2/12,2.52%,ANK2;RYR2
prerank,regulation of interleukin-12 production (GO:0032655),0.2793125490025346,0.9587674142451971,0.541095890410959,0.8641120817600421,1.0,8/47,8.32%,LGALS9;RIPK2;AGER;TLR4;PLCG2;C1QBP;CCR7;IL12B
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.34507999406434564,-0.9587463561086957,0.5262008733624454,0.861209751270461,1.0,2/17,5.30%,MAGI2;CALM1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31072066073483895,-0.9585833249731385,0.4964871194379391,0.8607858239461289,1.0,10/25,18.99%,CTNNA3;ITGA4;ITGB7;NINJ1;CD2;VCAM1;JAM3;CD200R1;ITGB1;ITGAD
prerank,regulation of response to stress (GO:0080134),-0.3996605130954821,-0.95843041685479,0.49588477366255146,0.8602839498180394,1.0,4/10,19.58%,OPRM1;ADCY8;CRHBP;STOX1
prerank,protein dephosphorylation (GO:0006470),0.2348984092383395,0.9583819294947441,0.5522620904836193,0.8645278770074193,1.0,32/135,17.63%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;UBASH3B;PPM1L;SSH1;RPAP2;PTPRE;PP2D1;EYA3;ILKAP;PTPN1;PPP2R5B;CDC14B;PTPRA;MTMR4;DUSP29;PTPN11;DUSP18;DUSP5;PPP4R2;TIMM50;PPP1CB;PTPRH;PTPN21;DUSP6;PTPN5;DUSP11;PPP2R5A;PTPRJ
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2121119305376935,-0.9583174880483849,0.5833333333333334,0.8596961945361447,1.0,67/182,26.14%,ROBO1;XDH;MSR1;APP;CCR1;PTPN22;LDLR;RBMS3;FOXP1;SOX11;MTMR2;APOE;AGO4;SH3GL2;PARP14;SDCBP;PRKN;SIRT1;TET1;WNT4;TNRC6A;MYADM;SMCR8;REL;OPRD1;NDFIP1;PTRH2;KLF4;SETDB2;MMP8;TIPARP;CD46;ACVRL1;HEY2;SFRP1;SNX12;RBL1;TTBK1;CD3E;WDR54;APLN;SFRP2;BMP4;APLNR;ATXN2;ABCC2;DNMT1;TERT;STOX1;DLL4;NR0B2;PRKAA1;TRAT1;PGR;HDAC1;NOCT;PARP10;NOTCH2;REST;ITGB8;RACK1;OCLN;HSP90AB1;FBXW7;ANKRD13A;CITED2;SFMBT2
prerank,regulation of anoikis (GO:2000209),-0.33199436316718756,-0.9581734296212294,0.5275779376498801,0.8591740687153916,1.0,9/19,25.35%,SIK1;TLE1;PTRH2;BCL2;SNAI2;ITGB1;PDK4;MCL1;PTK2
prerank,negative regulation of signaling (GO:0023057),0.32314396713599686,0.9580470124923227,0.5043177892918825,0.8647512758942806,1.0,5/25,15.99%,IGFBP3;UBASH3B;PTPN1;OPTN;OSM
prerank,defense response to virus (GO:0051607),0.2459160621531113,0.9578681789651777,0.5538720538720538,0.8646164748216695,1.0,29/100,22.41%,TLR7;RNASE1;SERINC3;TRIM5;PHB2;ATAD3A;MOV10;ABCC9;CGAS;ZMYND11;ABCE1;G3BP1;RNASE6;SETD2;EXOSC5;MAVS;TTC4;PYCARD;SHFL;EIF2AK2;IRF3;ISG20;MAP3K14;IRF2;PMAIP1;NLRC5;ACOD1;CXCL10;BCL2L1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.20537023797615037,0.9577778576318924,0.5868421052631579,0.8642296329178379,1.0,83/417,18.26%,SALL1;IKZF1;BASP1;MLXIPL;SUMO1;CAPN3;PRMT2;HEYL;DDIT3;SOX8;PBXIP1;EIF4A2;SBNO2;SIRT2;PPARD;FOXE1;CCDC85B;CRY2;HDAC10;DEAF1;PHB2;SAMD1;ZNF568;SUDS3;ID1;CHD8;ZBTB21;LOXL3;ELK3;RPS6KA5;MLX;FOXK2;BCOR;ZBTB18;EID2;PDGFB;SIN3A;ZMYND11;BCL7A;FOXN3;JUN;BRCA1;SAMD11;SAMD13;TWIST2;DPF2;TMPRSS6;LIMS1;MIDEAS;PATZ1;NPAS1;INPP5K;EID2B;MBD1;PRDM11;PAX2;SMARCA2;DPF1;KDM4A;MAP3K10;PRMT6;EZH2;GCLC;WWP2;ID3;HDAC5;NDUFA13;PROX1;EED;COMMD7;SCMH1;VGLL4;ZEB1;QARS1;TSC22D4;KDM1A;POU2F1;GATA3;KDM8;KAT5;HMGB2;CHMP1A;DKK3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25045704607867025,0.9567581738359531,0.5316045380875203,0.8663708233423306,1.0,19/85,19.29%,BAG6;SUMO1;SMAD7;CSNK1E;FBXO22;SIRT2;CLU;KLHL40;ECSCR;USP5;TAF1;ZYG11B;PSMC2;RNF144B;DET1;TRIB1;ZER1;STUB1;TMEM259
prerank,regulation of defense response (GO:0031347),0.2546250831238169,0.9566645557688196,0.5351629502572899,0.8659740360761493,1.0,29/76,31.13%,DAGLB;IL1RL2;SBNO2;CASP1;LRRC19;PIK3AP1;SELE;BCL6B;APPL1;AREL1;NLRP6;AKNA;XIAP;NOD2;CASP12;SHPK;ERAP1;PARK7;MYD88;NR1D2;APPL2;HCK;BCL6;WNT5A;SETD6;BIRC2;CYLD;BIRC3;TREM2
prerank,positive regulation of histone deacetylation (GO:0031065),0.38924175478105766,0.9564216699286894,0.5348399246704332,0.8659975597567199,1.0,2/12,2.94%,AKAP8;AKAP8L
prerank,regulation of transmembrane transport (GO:0034762),-0.2906630254511898,-0.9563731274342757,0.5054229934924078,0.8632465609015524,1.0,15/31,31.19%,KCNJ3;NEDD4L;ACTB;PIM1;SNCA;BCL2;FFAR4;KCNJ10;TRIB3;OCLN;KCNJ8;KCNJ16;CLTRN;ACE2;KCNJ14
prerank,sensory perception (GO:0007600),-0.2674834416233875,-0.9562438212273794,0.5625,0.8626707871058316,1.0,11/45,16.77%,PCDH15;CCR2;TMEM150C;MME;OPRM1;NIPSNAP1;CHRNA4;CLRN1;PTGES;ASIC3;SCN9A
prerank,positive regulation of macrophage activation (GO:0043032),0.3556747278445644,0.9561348955134815,0.5166051660516605,0.8661322259911041,1.0,6/17,18.17%,KARS1;TLR4;CCL3;IL33;TNIP2;THBS1
prerank,ovarian follicle development (GO:0001541),0.3821348236231414,0.9561152946677748,0.5235404896421846,0.8655250377533716,1.0,4/13,14.34%,LHCGR;INHA;EIF2B4;SOD1
prerank,plasma membrane repair (GO:0001778),-0.3702059381439961,-0.9560472354763295,0.49435665914221216,0.8623050512394591,1.0,4/13,11.60%,MYOF;RAB3A;AHNAK2;DYSF
prerank,renal system development (GO:0072001),0.2778261076009843,0.9559726505679407,0.5131147540983606,0.8652288207389931,1.0,3/52,0.48%,TGFBR1;SALL1;BAG6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2732625077388636,0.9558614194189107,0.5435540069686411,0.864856540129732,1.0,18/55,26.25%,TGFBR1;CRADD;DDIT3;AGTR2;GPER1;BMF;PYCARD;TNFRSF12A;AGT;TRAF7;PMAIP1;BCL2L1;BCL2L11;TP53;FADD;TRIM39;S100A8;S100A9
prerank,positive regulation of coagulation (GO:0050820),0.409651909241611,0.9553604786912989,0.4934086629001883,0.8649898279020356,1.0,5/10,22.04%,F12;APOH;SERPINE1;THBS1;DMTN
prerank,positive regulation of hemostasis (GO:1900048),0.409651909241611,0.9553604786912989,0.4934086629001883,0.8649898279020356,1.0,5/10,22.04%,F12;APOH;SERPINE1;THBS1;DMTN
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.24083339432473874,0.9550372136771703,0.5450310559006211,0.8652246388480107,1.0,32/113,24.80%,TGFBR1;RREB1;CRNN;PRKCA;PKHD1;VEGFB;EGR3;PDGFB;PIK3CD;PAX2;ARNT;PDCD6;AKT1;HPN;PROX1;VIP;CDH3;C5AR1;NME1;HMGB2;CLDN1;CCL24;AGGF1;NOD2;NRAS;FGF1;BMP2;STXBP4;SOX9;FGFR2;ITGB3;HIF1A
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.31563112954160766,0.9549977681761099,0.5044404973357016,0.8646932820744443,1.0,14/27,30.73%,DDX5;EIF4G1;DHX9;MAP2K1;WTIP;TNRC6B;TP53;TGFB1;AJUBA;STAT3;EIF4E2;PUM1;DDX6;FXR1
prerank,regulation of fibrinolysis (GO:0051917),0.3810725914030057,0.954896025960857,0.5265151515151515,0.864344878291846,1.0,5/13,18.17%,F12;APOH;SERPINE1;PLG;THBS1
prerank,plasma membrane organization (GO:0007009),-0.24914230731052142,-0.9546758974976708,0.5216284987277354,0.865265385352168,1.0,12/61,13.18%,ANK3;MYOF;ANK2;SPTBN1;SNX9;ANO6;RAB3A;AHNAK2;PLSCR4;PLSCR2;DYSF;UGCG
prerank,regulation of cell-substrate adhesion (GO:0010810),0.27940508160712274,0.9545874026622332,0.519434628975265,0.8645027194813345,1.0,7/42,10.25%,RAC1;NPNT;PKHD1;PDGFB;GCNT2;LIMS1;PIK3CB
prerank,positive regulation of protein metabolic process (GO:0051247),-0.22713684746961318,-0.9543466772766791,0.5773480662983426,0.8653682940458586,1.0,27/110,16.05%,PAEP;APP;WWP1;HECW2;HECW1;APC2;NEDD4L;APOE;GSK3B;RAB1B;KLF2;BARD1;PRKN;PLK2;AXIN1;NFKBIA;ATG7;GPC3;KLF4;TFR2;CD80;TIPARP;NKD1;TNFSF12;OAZ1;RILP;MTPN
prerank,regulation of necroptotic process (GO:0060544),0.32373830692822425,0.9543448851228277,0.5305755395683454,0.864572803438057,1.0,12/23,31.16%,ARHGEF2;CFLAR;FLOT2;STUB1;PDCD6IP;FZD9;CDC37;FLOT1;BIRC2;CYLD;BIRC3;PELI1
prerank,V(D)J recombination (GO:0033151),0.39633480215917255,0.9538126120366974,0.5185873605947955,0.865401019714006,1.0,3/11,18.02%,LIG1;TCF3;HMGB2
prerank,negative regulation of reproductive process (GO:2000242),-0.33899685852935346,-0.9537245076589945,0.5320088300220751,0.8662193188291731,1.0,2/17,4.29%,PAEP;ACVR1C
prerank,myofibril assembly (GO:0030239),0.28650332171238535,0.9534866880449298,0.5202108963093146,0.8656861654741553,1.0,3/42,2.11%,CAPN3;CFLAR;FLII
prerank,regulation of cell population proliferation (GO:0042127),0.19904931817062876,0.9528631581118162,0.6462668298653611,0.8667325656003511,1.0,125/691,18.17%,TGFBR1;NUAK1;TGFBR2;ARHGEF2;LRP5;MLXIPL;CSF1R;GREM1;SLURP1;ETS1;FAM98B;ATP8A2;PIM2;IGFBP3;AIF1;SKI;GAB2;INCA1;PPP1R9B;TGFB1I1;SIRT2;LYN;KMT2D;KLF11;VHL;TBC1D8;IGF1R;ITGAV;CSNK2A1;TRPM4;ADAMTS1;RNF41;PKHD1;CLU;MEIS3;KSR1;LGMN;PTK2B;MDM4;IL6ST;GNRH1;DIS3L2;EID2;PDGFB;SHH;CD86;GCNT2;TCIRG1;ZFP36L1;ACER3;JUN;CNBP;S1PR3;EDN3;CNTF;BCL6B;AMBN;EDN2;GDNF;CHRM1;GPER1;CTF1;CXCL1;IL6R;LIMS1;INHA;ACER2;JAG2;PRMT1;P3H2;RTKN2;TJP1;IL12RB2;PLPP1;DLL1;RUNX1;TOB1;SMARCA2;TBX6;PDGFRB;DHPS;CLMN;ENG;OSGIN1;CD33;STX4;RNF187;DRD2;IL34;HP1BP3;EZH2;ADGRG1;HTR1A;TSPO;AKT1;CIB1;CSF1;PROX1;VIP;GPNMB;MAP2K1;TENM1;SLAMF1;OSM;PLG;EIF2AK2;PDCD10;UBE2A;TSPAN31;LAMC2;ADAM10;STAT6;WDR6;XIAP;CCAR1;AGT;KANK2;NUP62;PTPRJ;NME1;GATA3;IL7R;HMGB2;FES;THBS1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.35743538683725273,0.9527309052731617,0.5066162570888468,0.8664593243615982,1.0,4/16,12.09%,SNRPC;SFSWAP;PRPF39;DCPS
prerank,positive regulation of DNA repair (GO:0045739),0.2818517699395615,0.9523523009144943,0.5201401050788091,0.8668552871936007,1.0,11/46,13.22%,PCNA;HDAC10;SPIDR;DHX9;MGMT;BRCA1;EYA3;RNF8;SPIRE1;ABRAXAS1;CEBPG
prerank,glucose metabolic process (GO:0006006),0.2653799136444707,0.9518674799843895,0.5420240137221269,0.8675120815746427,1.0,13/58,21.36%,LRP5;PPARD;GALM;PGK1;GAPDH;GDPGP1;SORD;PGAM1;SLC25A11;MDH1;SLC25A10;PCK2;GAA
prerank,microvillus assembly (GO:0030033),-0.36261269737964674,-0.9516738476079583,0.5173913043478261,0.871051720408146,1.0,3/14,4.69%,RAPGEF2;FXYD5;STK26
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.39351447426863984,0.9514625676913396,0.5276292335115864,0.8679490902340303,1.0,2/11,3.80%,RREB1;SRC
prerank,regulation of cellular response to heat (GO:1900034),0.2527739111011488,0.9514581700980486,0.5358306188925082,0.8673262050857701,1.0,31/77,27.90%,RANBP2;ATM;NUP42;HSPH1;SEC13;RPTOR;CD34;MTOR;NUP50;MLST8;NUP35;HSPB8;NUP88;BAG4;NUP62;SEH1L;NUP107;MAPT;DNAJC7;RPA3;NUP153;FKBP4;NUP188;CRYAB;CHORDC1;NDC1;BAG5;HIKESHI;CAMK2D;DNAJB1;RPA1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2833675613275458,0.9511358267937545,0.5296108291032149,0.8675479896700126,1.0,14/44,21.84%,CNOT1;MOV10;ZFP36L1;ZFP36L2;NANOS2;RBM24;TOB1;RIDA;METTL14;ROCK2;TNRC6C;TNRC6B;NANOS1;ZC3H12A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.21295855529867672,-0.9505463084708419,0.5778443113772455,0.8733418445250326,1.0,31/152,15.25%,LRRK2;EGFR;FGF10;CSNK1G1;SULF2;SEMA5A;PPM1A;PSMD14;GPC5;UBR5;ATP6AP2;PSMD8;PSMA2;PSMF1;CDC73;PSMD6;AXIN1;PSME2;ZEB2;CCAR2;LGR5;KANK1;GPC3;PSMD5;TNKS2;PSMD12;LGR4;COL1A1;PSMD11;PSMD1;SFRP1
prerank,maturation of LSU-rRNA (GO:0000470),-0.3073745141788512,-0.9504982538187325,0.5365296803652968,0.8725703983008218,1.0,4/26,5.80%,NSA2;SNU13;RPL7A;LAS1L
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.22285680216185902,-0.950492037926872,0.5909090909090909,0.87166913506415,1.0,17/122,9.35%,SORBS1;SAMD4A;EGFR;TMEM106A;CIITA;IRS1;EIF3C;VIM;CPEB3;FAF1;JAK2;RPL26;PRR16;SIRT1;EIF3E;EIF4A3;PLXNB2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3832003006671513,0.949942789657203,0.532608695652174,0.8701364281758263,1.0,2/12,5.80%,CHEK2;RAD17
prerank,response to glucocorticoid (GO:0051384),0.32136923473102535,0.9492268125995026,0.5397923875432526,0.871482963050201,1.0,4/26,8.56%,HSD3B2;ZFP36L1;ZFP36L2;CALCR
prerank,somite development (GO:0061053),0.3992060183771799,0.9492075744091177,0.5182341650671785,0.8708940169298262,1.0,4/11,15.76%,LOXL3;SHH;SMO;MTHFD1
prerank,protein localization to cilium (GO:0061512),0.29529397880071184,0.948995608274172,0.5288966725043783,0.8708373905398143,1.0,13/32,27.12%,BBS9;ATP6V1D;TULP2;IFT20;INVS;TCTN1;TTC21B;ARL3;CSNK1D;IFT122;TCTN2;IFT140;ARL6
prerank,positive regulation of JNK cascade (GO:0046330),0.257222249992089,0.9487505638766869,0.565,0.8708674753073797,1.0,16/70,15.96%,PJA2;AGER;TRAF5;CD27;PTK2B;CCR7;EDA2R;WNT7B;MAP4K2;MAP3K11;MAP3K10;TAOK2;MAPK8IP1;PYCARD;TNFRSF19;SLAMF1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3718843342223347,0.9487274925641953,0.5177935943060499,0.8702975823997595,1.0,2/13,6.11%,CNOT1;MOV10
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.33619288885146575,0.9484385889411374,0.5327272727272727,0.8704446067935475,1.0,10/21,22.95%,DDIT3;TMBIM6;EIF2AK3;PMAIP1;SYVN1;TXNDC12;BCL2L1;OPA1;BCL2L11;PARK7
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34431852032061383,0.9482469079575884,0.5445736434108527,0.8703275904237141,1.0,2/18,8.65%,BIN1;HAMP
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.1962928615495616,-0.948170386164942,0.6725352112676056,0.8773511527871282,1.0,108/306,27.93%,B4GALT5;THRB;POLA1;ST3GAL4;FUT9;RPL36A;EXT1;RPS29;RPL30;RPL35A;RBMS1;CREBL2;RPS3;MCM9;POLL;RPS7;RPL4;APOE;RPS2;NR4A2;RPLP2;RPL7A;BARD1;IGHMBP2;GOLPH3;POLE2;RBBP8;RPL41;RPL26;RPS27;RPL18A;RPS25;EEF1A2;MRPL18;RPL38;RPL37;HBS1L;RPS6KB2;HUS1;RPS14;MRPS7;RPS15A;RPL24;DBF4;SCX;CHEK1;RPS9;EXT2;RPLP1;TOP1;RPL22;POLR2K;RPL8;CDK2;MRPS33;RPLP0;RPS12;E2F1;RPS10;POLR2F;PIF1;MCM5;MRE11;RPL19;POLD1;TERT;RPL13A;RPS6;RPS5;POLD3;RPS19;POLR2G;RPL23A;CLSPN;UPF1;YARS2;PTMS;RPL29;FEN1;PABPC4;TIPIN;PAX8;ING4;RPS11;BRIP1;RPL18;ZAR1;PTMA;MRPL24;RAD9B;RPS23;MRPL55;RNPS1;RFC4;RPS15;EEF1G;KIN;RPL23;RPL17;MRPL23;RECQL4;EEF1A1;RSL24D1;MRRF;B3GNT6;MCM8;GRWD1;AGO2
prerank,carboxylic acid transport (GO:0046942),0.2683730009881359,0.9481077533093827,0.5313028764805414,0.8700785520882748,1.0,11/55,17.78%,SLC7A8;SLC16A6;SLC7A5;SLC36A1;SLC15A4;CLN3;SLC16A7;SLC6A9;SLC38A1;SLC23A2;SLC23A1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.32804526135849665,-0.948054869656624,0.5396825396825397,0.876766602068244,1.0,7/18,26.12%,GSK3B;ZNF205;BAK1;BOK;CHCHD10;MPV17L;BID
prerank,regulation of transport (GO:0051049),-0.2762537601418348,-0.9478313515276635,0.5700934579439252,0.8764654948660335,1.0,9/36,15.95%,LRRK2;SCFD1;PRKN;ACTB;EPB41;WWC1;MYO6;SNCA;ICA1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.23574551495014223,-0.9470558024164205,0.5756097560975609,0.8777568569672555,1.0,13/82,8.80%,VAV3;GRIN2B;NCK2;ACTR3;AP2A2;ITSN1;CDC42;CHN1;DNM1;SDCBP;PAK3;EPHA5;ACTB
prerank,establishment of spindle orientation (GO:0051294),-0.29635234217658063,-0.946923343807693,0.5471264367816092,0.8772380903511166,1.0,8/28,18.75%,HTT;ZW10;SPDL1;CDK5RAP2;NDC80;GPSM2;ITGB1;NSFL1C
prerank,nucleic acid-templated transcription (GO:0097659),0.2840652565336878,0.9468444727256237,0.5478260869565217,0.8728440730722132,1.0,8/42,10.67%,POLR2H;POLR2J;NKX2-8;POLR2D;THAP1;MEF2A;MMS19;DTX1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.34461672276531324,0.9467999475595426,0.5391459074733096,0.8723310654913942,1.0,5/17,14.99%,MAML3;HEYL;NOTCH4;MAML2;NOTCH3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3556817136377352,0.9466672669200002,0.515370705244123,0.8720256537513372,1.0,5/16,26.02%,KLK2;DRD2;PRCP;KLK3;DDAH1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3540434051181687,0.9466590845855616,0.5245009074410163,0.8714158793160726,1.0,5/16,21.31%,MAU2;POGZ;NAA50;DSCC1;CDCA5
prerank,fatty acid elongation (GO:0030497),-0.368034743514429,-0.9462975152593373,0.5476190476190477,0.8780738032511098,1.0,3/13,8.98%,ELOVL7;HACD1;ELOVL5
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2989896739744012,0.9462898059518035,0.5181975736568457,0.8717880992975323,1.0,7/31,15.73%,TGFBR1;SMAD7;DSP;MYL3;ENG;PROX1;NOG
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3723184922181766,0.9458779597421755,0.5525846702317291,0.8722465265879806,1.0,5/13,20.17%,CLU;USP19;MBTPS2;NR1H2;EIF2AK3
prerank,regulation of protein modification process (GO:0031399),-0.2588447536676331,-0.9457385316615158,0.5487179487179488,0.8787531987396602,1.0,12/50,15.10%,CCDC88C;GRM5;KDM4D;FN1;CADM4;PLXNB2;ATG7;CCDC88A;CCAR2;CDH5;FER;FKTN
prerank,protein polyubiquitination (GO:0000209),0.21264539552971046,0.9455239022256192,0.5988700564971752,0.8725413816778542,1.0,78/297,22.37%,FBXL18;RNF216;TRIM69;FBXO22;SMURF1;ITCH;TRIM5;FBXL20;DDB2;SPSB1;FBXL15;UNKL;TRAF5;RNF41;TRIM36;UBE2H;RPS27A;UBC;RFFL;FBXW4;AKTIP;CDC34;ZFP91;BRCA1;HECTD2;RNF31;RNF8;BFAR;PSMD3;RNF20;RNF166;AREL1;MYLIP;FBXL8;MIB2;PSMB3;WSB1;TAF1;UBE2V2;TRIM62;UBE2U;PSMA7;RNF187;FBXO21;WWP2;UBE3A;PSMC1;PSMC2;RNF144B;MKRN3;FBXL22;ANKRD39;FBXO38;PSME4;UBE2A;FBXO11;PELI2;ANAPC13;PSMB9;ANAPC11;DTX3L;UBE4A;RNF4;STUB1;TRIM3;PSMD4;PSMB5;UBE2T;TOPORS;SYVN1;RNF34;FBXL7;UBE2R2;PSMB7;KLHL3;ANAPC1;RC3H2;PSMB8
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.344724360539851,-0.9454375089398507,0.5405982905982906,0.8787263139723595,1.0,2/16,1.79%,AMPD3;PPAT
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.28090716285056183,-0.9452293970804804,0.5521327014218009,0.8784180357922244,1.0,6/36,5.35%,NOSTRIN;EGFR;ZDHHC21;APOE;CALM1;HTR2B
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2740932091039267,-0.9447927257917215,0.5294117647058824,0.8787367481860859,1.0,14/38,26.16%,OTUD7A;PPM1A;SIRT1;USP10;TLE1;RIOK3;PER1;NR1H4;TRIM59;GSTP1;CARD19;TNIP3;NLRC3;MAPKBP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.254277571523027,0.944588242508171,0.5723905723905723,0.873831237965505,1.0,22/78,18.82%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;AP1S1;ACTR1A;DCTN4;DCTN2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.254277571523027,0.944588242508171,0.5723905723905723,0.873831237965505,1.0,22/78,18.82%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;AP1S1;ACTR1A;DCTN4;DCTN2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.24652160385820837,-0.9445601674219556,0.5476772616136919,0.8784660833685966,1.0,15/61,17.26%,PSMD14;PRKAG2;PSMD8;PSMA2;PSMF1;PSMD6;SIRT1;PSME2;PSMD5;PSMD12;PSMD11;PSMD1;OAZ1;NR1H4;AZIN1
prerank,autonomic nervous system development (GO:0048483),-0.33138476818058304,-0.9438605731322587,0.5615212527964206,0.8794969922245255,1.0,3/17,5.26%,SOX11;FN1;EDNRB
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3730362078558005,-0.943840425677805,0.5350877192982456,0.878647587470276,1.0,3/12,8.98%,UVRAG;IRGM;SMCR8
prerank,cellular response to heat (GO:0034605),0.297566772691716,0.9433751264296808,0.5565529622980251,0.8763702317131058,1.0,11/35,20.55%,SUMO1;PRKACA;POLR2D;PDCD6;TRPV4;SLU7;THBS1;HTRA2;STUB1;IL1A;MAPT
prerank,lung development (GO:0030324),-0.27764463891966656,-0.9433263665695708,0.5545454545454546,0.8792118447054263,1.0,12/33,20.63%,FGF10;SOX11;RCN3;FGF7;FGF9;CEBPA;NPHP3;RBP4;PKD1;BMP4;DNAAF1;CCDC39
prerank,regulation of microtubule nucleation (GO:0010968),-0.3957467797366758,-0.9428672802192409,0.5273109243697479,0.8796534966594678,1.0,4/10,28.75%,HSPA1B;PAK1;RANGRF;MECP2
prerank,regulation of receptor recycling (GO:0001919),0.34951728539798416,0.9426930950882183,0.533213644524237,0.8775822206173125,1.0,1/16,0.31%,TBC1D16
prerank,stem cell differentiation (GO:0048863),-0.2760018997336446,-0.9424027147058268,0.539906103286385,0.8800345732149882,1.0,14/39,23.03%,GPM6A;MTF2;JARID2;LRP6;HTR2B;MLLT3;KIT;PSMD11;SFRP1;HOXB4;ACE;WNT7A;SP7;FBXL17
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.21047353877745942,-0.9423442239724688,0.6090651558073654,0.8792834864390932,1.0,25/166,9.35%,SORBS1;SAMD4A;CD36;EGFR;IRS1;EIF3C;LDLR;VIM;CPEB3;FAF1;KLF2;PKD2;GIPC1;RPL26;SLC45A3;PRR16;SIRT1;PTPN2;EIF3E;ZNF205;EIF4A3;ATP7A;ELOVL5;ZEB2;PLXNB2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3186117992499519,0.9422840490052288,0.5374280230326296,0.8780337294207479,1.0,5/24,13.59%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2834414472332406,0.9418213434391166,0.5628227194492255,0.8785961928284406,1.0,11/42,19.18%,FUS;WDR48;SPIDR;CGAS;MMS19;SHLD2;PPP4R2;SETD2;KDM1A;FBH1;UBQLN4
prerank,glycoprotein biosynthetic process (GO:0009101),0.25014614745198444,0.9417449893675083,0.565,0.8781548534032462,1.0,12/79,11.35%,ST3GAL6;LARGE1;B3GNT2;ST3GAL5;CHST11;GAL3ST4;MPI;GCNT2;B3GNT4;FUT7;MGAT1;NPC1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3198540707354341,0.9413955541262254,0.5446735395189003,0.8784118002674828,1.0,7/24,21.68%,NUMA1;ZFP36L1;RUNX1;NCOA3;ROCK2;PRKCH;ERRFI1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3522635761072185,0.9406336129170391,0.558766859344894,0.8798495923327062,1.0,6/17,18.21%,NFE2L2;VNN1;SOD1;AKT1;MAPK7;HTRA2
prerank,odontogenesis (GO:0042476),-0.2776854924692792,-0.9404365099410978,0.5817757009345794,0.8838118785083209,1.0,12/35,31.02%,LRP6;EDA;TUFT1;BMP4;FOXC1;WNT6;MSX1;AQP1;HDAC1;TBX1;AMELX;PITX2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.37970265559955996,0.9403943547906067,0.5500945179584121,0.8798838625088669,1.0,8/12,31.58%,FADS1;ABCD1;ACOT8;SCP2;FADS2;ELOVL1;HSD17B4;ACOX1
prerank,modulation by host of viral genome replication (GO:0044827),-0.3548852947300601,-0.9401458461556057,0.514161220043573,0.8837235719381175,1.0,4/13,14.25%,VAPA;PRKN;NUCKS1;EIF2AK4
prerank,collagen fibril organization (GO:0030199),0.2452230661223819,0.9399625948195754,0.5636363636363636,0.8803977482123212,1.0,5/88,1.07%,TGFBR1;DST;COL27A1;GREM1;ITGA6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.3817829921083453,0.9397994528508433,0.5615671641791045,0.8802285863538366,1.0,8/12,35.13%,UHMK1;KHDRBS1;PTPN14;TGFB1;RBM4;SIRT7;NUP214;NEDD4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.34840052728762894,0.9397043719634122,0.539568345323741,0.879862006798873,1.0,8/18,19.83%,ZFP36L1;ZFP36L2;NCKAP1L;PRDM1;ABL1;SPINK5;IL4I1;XRCC6
prerank,negative regulation of cellular component movement (GO:0051271),-0.3440396414259893,-0.9396803686641793,0.5661252900232019,0.8840959044489692,1.0,3/15,4.55%,FRMD5;SPOCK3;SP100
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.23574686894373936,0.9395073719506962,0.5914149443561209,0.8797726279039273,1.0,32/114,22.37%,PYDC1;TRAF5;TNFSF13B;CD27;TRADD;TNFRSF25;PTK2B;TNFRSF13C;TNFRSF13B;EDA2R;LIMS1;PSMD3;TNFRSF17;PSMB3;TNFSF8;PSMA7;PSMC1;PSMC2;BAG4;PYCARD;PSME4;COMMD7;TNFRSF12A;AIM2;PSMB9;MAP3K14;PSMD4;PSMB5;TNFRSF14;ADAM17;PSMB7;PSMB8
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.2731661987280145,0.9393969560165275,0.5417376490630323,0.8794460811098085,1.0,15/46,23.79%,SMAD3;PIK3R1;PRKCD;DHX9;RAPGEF3;MAVS;ZIC1;KHDRBS1;CAMK1;ECT2;ZC3H12A;TP53;TGFB1;IPO5;JUP
prerank,regulation of filopodium assembly (GO:0051489),0.28762016590073175,0.9393821426847061,0.5752508361204013,0.8788629312750736,1.0,8/38,8.12%,PIK3R1;CAPZB;RHOQ;PRKCD;TRPM2;FSCN1;ABITRAM;CCR7
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.25222167599279954,0.9393378028456957,0.573109243697479,0.8783536968379333,1.0,22/79,18.82%,DNM2;CTSD;KIF2A;KIF3B;AP2A1;CAPZB;CTSS;LGMN;ACTR1B;SEC13;AP1M2;CTSF;CLTA;AP1S2;KLC1;CTSE;KIF3A;DCTN5;AP1S1;ACTR1A;DCTN4;DCTN2
prerank,neuron remodeling (GO:0016322),-0.3903155429353664,-0.93925509098222,0.5315682281059063,0.8844338361626748,1.0,4/10,14.67%,ADGRB3;APP;SCARF1;CX3CL1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25449218659453865,0.9391223739451972,0.5814332247557004,0.878275243023921,1.0,22/70,23.01%,ITCH;GATA2;PSMD3;RUNX1;PSMB3;PSMA7;ABL1;PSMC1;PSMC2;TAL1;PSME4;TCF3;OSM;EIF2AK2;PSMB9;GATA3;LMO1;PSMD4;PSMB5;PSMB7;PSMB8;LMO2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.34374919958619254,0.9389017684882136,0.5500945179584121,0.878244814582045,1.0,2/18,2.90%,BAG6;LYN
prerank,receptor recycling (GO:0001881),0.4047581570153318,0.9386975503829843,0.5384615384615384,0.8781753899327535,1.0,1/10,1.00%,PHETA1
prerank,negative regulation of histone methylation (GO:0031061),-0.3945363573174832,-0.9384812031841134,0.5508849557522124,0.8856732893957124,1.0,5/10,18.90%,MTF2;JARID2;DNMT3B;AASS;DNMT1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3935912511570342,0.9383628637734088,0.5369649805447471,0.8784107983178387,1.0,3/11,18.17%,LGALS9;CD34;THBS1
prerank,positive regulation of phagocytosis (GO:0050766),0.27586512975277844,0.9383494139122837,0.5894736842105263,0.8778227938586953,1.0,10/47,18.06%,MERTK;SIRPA;CAMK1D;GATA2;PLA2G5;NCKAP1L;PYCARD;RAB27A;PTPRJ;SLC11A1
prerank,axonal transport of mitochondrion (GO:0019896),-0.38370496249173325,-0.9383199417757341,0.5843881856540084,0.8852083052838595,1.0,2/11,3.32%,ACTR10;SYBU
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.39644985015351375,0.9383066580508647,0.5490909090909091,0.8773319161007771,1.0,2/11,4.37%,CCL3;PLCG2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3459527534626593,-0.9379345490735905,0.5280665280665281,0.8853517508188532,1.0,5/15,18.40%,PPARG;IRS1;SLC45A3;PRKCE;ADM
prerank,regulation of calcium ion import (GO:0090279),0.32991220487849987,0.9379201225416753,0.5213358070500927,0.8777760197975301,1.0,7/21,22.54%,CCL3;PDGFB;PDGFRB;PSEN2;WNK3;PLN;STC1
prerank,actin filament bundle assembly (GO:0051017),-0.2784737685441925,-0.9378590421812648,0.5490196078431373,0.884649646192578,1.0,5/33,8.72%,EPS8;NEDD9;PAWR;PLS1;SHROOM1
prerank,insulin receptor signaling pathway (GO:0008286),0.25487709628048416,0.9378272649979905,0.56738768718802,0.8773666118654995,1.0,14/69,17.01%,PIK3R1;ATP6V0B;IRS4;IGF1R;RHOQ;ATP6V1D;ATP6V0A2;TCIRG1;APPL1;PDK2;ATP6V0A4;AKT1;PIK3R3;ATP6V0E2
prerank,regulation of mast cell activation (GO:0033003),0.3973673652092997,0.9377161754594137,0.5380434782608695,0.8770340657954281,1.0,2/10,2.90%,CD84;LYN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.26197189336084603,0.9372082420619522,0.5663430420711975,0.8777508170018158,1.0,22/57,26.19%,CTSD;RIPK2;ASPH;CASP1;LGMN;ARL6IP5;NLRP3;GPER1;PDCD6;PYCARD;NDUFA13;AIM2;HTRA2;PPM1F;USP50;PMAIP1;DDX3X;GRAMD4;FADD;MEFV;PERP;CARD9
prerank,positive regulation of axon extension (GO:0045773),0.3203462384534188,0.9371375783919657,0.5329861111111112,0.8773188627981182,1.0,4/22,7.82%,TWF2;DBN1;MACF1;GOLGA4
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3388571443685122,0.9370002588526312,0.5405405405405406,0.8770756178671404,1.0,7/20,17.30%,IGFBP3;PDGFB;LRP1;PDGFRB;SERPINE1;NDRG4;TRIB1
prerank,catecholamine metabolic process (GO:0006584),0.3627497780683611,0.9365314358866821,0.5790441176470589,0.877686958894332,1.0,3/14,13.57%,SNCAIP;COMT;DRD2
prerank,regulation of phospholipase activity (GO:0010517),0.407536567186468,0.9363703191360642,0.5444234404536862,0.8774964192563524,1.0,3/10,10.22%,PDPK1;PLA2G5;LRP1
prerank,cellular defense response (GO:0006968),0.2830478193300858,0.9363176344735339,0.5445205479452054,0.8770140161838821,1.0,5/40,7.63%,CX3CR1;IL1RL2;PTK2B;TCIRG1;ADORA2B
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.27033497062659306,-0.9362126792006418,0.5799522673031027,0.8883047676915576,1.0,10/39,16.16%,SPOCK1;CASK;KANK1;SPRY4;ITGB1BP1;EFNA5;JAG1;CDKN2A;CX3CL1;RCC2
prerank,glycogen catabolic process (GO:0005980),0.3611869120393969,0.9361641112687326,0.5472370766488414,0.8768161950383878,1.0,7/15,21.36%,PYGB;PHKB;AGL;RB1CC1;PHKG2;PHKA2;GAA
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2816081021957618,-0.936010491293852,0.5522727272727272,0.8879353395760203,1.0,3/30,6.15%,ANK3;SPTBN1;GOLPH3
prerank,negative regulation of phosphatase activity (GO:0010923),0.32135376938761384,0.9359258821390057,0.5464285714285714,0.876793685905276,1.0,6/25,16.73%,CRY2;ZCCHC9;GPATCH2;SH2D4A;SEMA4D;MASTL
prerank,intestinal absorption (GO:0050892),-0.36143230087287564,-0.9357908793060657,0.5194805194805194,0.8876265771150276,1.0,5/13,13.53%,CD36;ADRA2A;SLC46A1;UGCG;KCNQ1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3416446800804497,-0.9352547487285958,0.5542452830188679,0.8881739802442702,1.0,3/16,9.11%,AUTS2;CADM4;RASGRF1
prerank,regulation of transferase activity (GO:0051338),0.34843148108928224,0.935225880014487,0.5431192660550459,0.8779649572504116,1.0,9/17,32.92%,ATM;PPP1R3F;PARP4;NLRC5;JMJD8;BAG5;HMBOX1;FEM1A;EMP2
prerank,B cell activation involved in immune response (GO:0002312),-0.3656538767960983,-0.9351959739172527,0.5323275862068966,0.8874137717753403,1.0,6/13,22.72%,LIG4;FCGR2B;MSH6;GAPT;CD19;MSH2
prerank,regulation of embryonic development (GO:0045995),-0.2780141101375718,-0.9350176733963373,0.5485327313769752,0.887029136641108,1.0,8/34,16.02%,PLCB1;B4GALT5;TRIP12;RACGAP1;CCSAP;NPHP3;DAG1;NIBAN2
prerank,embryonic hemopoiesis (GO:0035162),0.37998089629939763,0.9342678750001356,0.5425330812854442,0.8799582455897977,1.0,1/12,0.45%,TGFBR2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.33073915475719196,0.9341723524825534,0.5571428571428572,0.8795711432342966,1.0,6/20,14.99%,HOXB8;CTR9;PTK2B;ZFP36L1;PRMT1;CIB1
prerank,inner mitochondrial membrane organization (GO:0007007),0.2761244439929011,0.9341000379880605,0.5759717314487632,0.8791358620786306,1.0,20/47,27.39%,TIMM8B;MICOS13;DNAJC11;TIMM29;ATP5PO;ATP5PD;NDUFA13;ATP5MC1;MTX1;TMEM11;TIMM10B;ATP5F1D;AFG3L2;MAIP1;OPA1;ATP5PF;CHCHD6;TIMM13;SAMM50;MICOS10
prerank,protein targeting to membrane (GO:0006612),-0.22923084329287063,-0.9339544715828856,0.6010362694300518,0.8890289563517813,1.0,26/83,25.33%,CHM;ATAD1;ZDHHC21;ACBD5;SDCBP;PEX12;SEC62;GET3;FIS1;ZDHHC23;AQP11;ZDHHC15;ALDH3A2;PARD3;ZDHHC18;SRP19;VPS37C;PRKCI;ATG3;ZDHHC24;PEX19;NACA;SSR2;ZDHHC19;PEX14;PEX16
prerank,regulation of biomineral tissue development (GO:0070167),0.31189209327129536,0.9338403706620779,0.5482142857142858,0.8791975504013022,1.0,7/26,24.37%,NBR1;BMP2K;DDR2;ROCK2;TWIST1;TGFB1;SOX9
prerank,nuclear transport (GO:0051169),-0.33622362787516985,-0.9338127552673355,0.5563380281690141,0.8885222968224215,1.0,8/16,29.74%,NUP98;RSRC1;NUP205;BANF1;NPM1;NXT2;AAAS;CITED1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.39441315656013987,0.9336896359641829,0.539047619047619,0.8789824633584464,1.0,8/10,31.13%,TLR4;MIA3;AKT1;TICAM1;MYD88;CD68;TLR6;TREM2
prerank,cellular protein catabolic process (GO:0044257),0.26408752377619166,0.9336562666485544,0.5851979345955249,0.8784570775562734,1.0,10/59,12.51%,AP2A1;CHEK2;CTSS;LGMN;YME1L1;PISD;TCIRG1;MYLIP;CTSF;CLTA
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.29402412677399614,0.9336111019350732,0.5647058823529412,0.8779418587380048,1.0,7/35,11.53%,NUAK1;PPP6R3;CRY2;AGTR2;PPP6R1;MTOR;PDGFRB
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3937481922341471,0.9328278746902238,0.539568345323741,0.8793702429579863,1.0,2/10,8.26%,LGALS9;PDCD1LG2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.36691013908377074,0.9327349824905256,0.53125,0.8789861822188476,1.0,2/13,8.67%,TPST2;SULT2A1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3679292317747024,0.9327269419322196,0.5512104283054003,0.8783899029672454,1.0,1/13,0.06%,TGFBR1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.24986661337013014,-0.9326022277119976,0.5833333333333334,0.8909489528908997,1.0,11/55,11.49%,GPC6;LYVE1;CD44;HGSNAT;SDC3;GPC5;HMMR;HSPG2;VCAN;GPC3;CSPG4
prerank,nuclear envelope organization (GO:0006998),-0.3141534926479689,-0.9324571283914863,0.5526932084309133,0.8904452724803379,1.0,9/20,29.17%,REEP3;TOR1A;DMPK;REEP4;NUP155;EMD;CTDNEP1;NUP93;SUN3
prerank,DNA strand elongation (GO:0022616),0.33799847943873385,0.9323750602147409,0.5523465703971119,0.8786998551294144,1.0,7/18,21.19%,GINS4;NBN;POLD2;DCLRE1B;GINS3;MCM3;MCMDC2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.2898495142361091,0.9323643913891713,0.5651376146788991,0.8781176206905282,1.0,6/35,8.64%,RAC1;SEMA3B;SEMA4C;SEMA4G;MET;SEMA3G
prerank,potassium ion homeostasis (GO:0055075),0.3206078049009531,0.9322470961636999,0.5545927209705372,0.8778344481764797,1.0,4/23,8.83%,KCNMA1;SLC12A6;SLC12A9;ATP1A4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3051736784390176,0.9319966459148151,0.5477031802120141,0.8779009456983501,1.0,7/27,21.84%,SIRPA;TLR4;NCKAP1L;SLAMF1;ARRB1;SYT11;ZC3H12A
prerank,regulation of dopamine secretion (GO:0014059),-0.30434380948831863,-0.9318928729471334,0.5521327014218009,0.8910472949356494,1.0,7/25,14.97%,SYT1;SYT10;PRKN;CHRNA4;DTNBP1;SYT3;SNCA
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2423055151119577,0.9318903082914901,0.603225806451613,0.877559188118539,1.0,24/88,22.24%,BAG6;CST3;CNOT1;ENC1;NANOS2;GAPDH;CLN3;TOB1;SERPINE2;MRPL13;DNAJC1;IGF2BP2;AKT1;EIF2AK2;RIDA;EPRS1;FXR2;CAPRIN1;TYMS;EIF2AK3;PCIF1;NANOS1;DDX3X;LARP1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.25202458241692194,0.9317321409820412,0.5744,0.8773490631894203,1.0,22/75,25.59%,TGFBR1;PRKCA;VEGFB;EGR3;PDPK1;PDGFB;GATA2;PIK3CD;ARNT;PDCD6;AKT1;PROX1;VIP;HMGB2;CCL24;AGGF1;ADAM17;NRAS;BMP2;ITGB3;HIF1A;PLCG1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2987568153069585,-0.9317310141422779,0.5354691075514875,0.8905970869174552,1.0,4/24,6.96%,AGBL4;TTLL11;TTLL7;TTLL5
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3193916839815135,-0.9315180551601953,0.5852017937219731,0.8893886251501938,1.0,3/20,4.32%,APP;PFKFB1;ZBTB20
prerank,positive regulation of glycolytic process (GO:0045821),-0.3193916839815135,-0.9315180551601953,0.5852017937219731,0.8893886251501938,1.0,3/20,4.32%,APP;PFKFB1;ZBTB20
prerank,kidney development (GO:0001822),0.2564326351533049,0.9314746363269569,0.5733113673805601,0.8774373642901321,1.0,14/65,17.88%,TGFBR1;SALL1;BAG6;SHH;GDNF;SOX17;PAX2;LRP4;PROX1;ARL3;AGT;KANK2;VANGL2;GATA3
prerank,cellular response to UV (GO:0034644),0.25223817301258267,0.9310805866726408,0.5779967159277504,0.8778882323484762,1.0,13/76,12.75%,RHNO1;PCNA;DDB2;PRKCD;IMPACT;MMP2;EIF2S1;USP28;CUL4B;PPID;BMF;TAF1;ERCC4
prerank,positive regulation of phosphorylation (GO:0042327),0.21417450645909294,0.9309107518217394,0.6375739644970414,0.877710678161792,1.0,69/240,24.80%,MERTK;TMEM119;MLXIPL;CSF1R;ITGA6;RAC1;AGER;LYN;ATG14;IGF1R;NBN;FLCN;VEGFB;RYK;AKTIP;CAMKK2;KCTD20;MET;EPHA8;GPER1;CLIP3;AXL;NCKAP1L;DDR2;PDGFRB;RB1CC1;PINK1;MUSK;CCND3;PFKFB2;ENG;ARNT;ABL1;PIN1;SEMA4D;IL34;MAVS;CDK2AP1;AKT1;CIB1;GPNMB;PIK3R3;PELI2;ARRB1;ROCK2;FXR2;THBS1;FBH1;FGF18;RSPO1;CRKL;EPHA2;FGFR4;SLC4A4;ADAM17;VAC14;EFNA1;FGF20;CSNK1D;AXIN2;FGF1;BMP2;TGFB1;RALB;DVL2;SOX9;FGFR2;ITGB3;HIF1A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25204954982242095,0.9308746754245415,0.5737976782752903,0.8771891526689196,1.0,23/73,23.01%,ITCH;GATA2;PSMD3;RUNX1;PSMB3;PSMA7;ABL1;PSMC1;PSMC2;TAL1;PSME4;TCF3;OSM;EIF2AK2;PSMB9;METTL14;GATA3;LMO1;PSMD4;PSMB5;PSMB7;PSMB8;LMO2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.24527328574807986,0.9307772723476953,0.611965811965812,0.8768593737316138,1.0,34/88,23.83%,DNM2;CCDC93;MYO1B;AP2A1;RP2;SORT1;AP1M2;SCAMP2;ACBD3;LLGL1;CLTA;MON2;STX4;OSBPL5;AP1S2;ARL3;CCDC22;DOP1B;VAMP7;ARRB1;AP1S1;EXOC6;AP4M1;VPS13C;CHMP2A;CLINT1;EXOC1;HGS;ARF1;AP1B1;SYS1;EXOC8;BLOC1S6;EXOC4
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.35769800337401236,-0.9306734177275093,0.5387931034482759,0.8908275381202492,1.0,7/12,26.43%,EXTL2;GMDS;GFPT2;UGP2;SLC35A3;FUT8;CSGALNACT1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.21637246709651534,0.9305620422288998,0.6362359550561798,0.8768020317183934,1.0,55/214,21.20%,SIRPA;CSF1R;LGALS9;CNKSR3;ARRB2;AGER;PRKCA;TLR4;LYN;NPNT;SLC30A10;PHB2;PKHD1;CCL3;FLCN;PTK2B;SPRY2;PDGFB;GCNT2;GPR55;CCR7;ARHGAP8;GPER1;CALCR;FSHR;DDT;PLA2G5;RGS14;CEACAM1;PDGFRB;PTPN1;NDRG4;DUSP29;PTPN11;PIN1;PYCARD;CIB1;GPNMB;MAP2K1;SLAMF1;DUSP6;ARRB1;C5AR1;CCL24;TRAF7;CRKL;NOD2;EPHA2;TNIP1;WNK2;FGFR4;SYNJ2BP;SPRED2;ARHGEF5;P2RY6
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.22952417538044553,-0.9301561368719682,0.6005221932114883,0.891350534393459,1.0,19/80,17.71%,HTT;KIF23;RAB6A;RACGAP1;ZW10;RAB1B;GOLPH3;KIF22;SCFD1;UVRAG;CENPE;COPG2;KIF11;ARF3;ATP9B;TMED2;PLPP3;KIF4A;RER1
prerank,post-translational protein modification (GO:0043687),0.2052254685779665,0.9299694948507908,0.6808219178082192,0.8777480199290839,1.0,97/332,27.40%,GOLM1;CST3;MGAT4A;FBXL18;PRKCSH;IGFBP3;FBXO22;ASB8;VHL;FBXL20;DDB2;SPSB1;FBXL15;COPS4;DCAF8;DCAF10;FBXW4;SPSB2;SOCS6;MBTPS1;CUL4B;MIA3;ASB4;AMBN;ASB15;RAB1A;ANKRD9;ASB11;RABGGTA;PSMD3;KBTBD8;ASB3;ASB5;FBXL8;PSMB3;MSLN;WSB1;PSMA7;FBXO21;GPS1;DCAF11;PSMC1;PSMC2;KCTD6;CSF1;KCTD7;RNF7;FBXL22;WDTC1;PSME4;CCDC22;COPS6;FBXO11;ADAM10;PSMB9;TULP4;RAB13;WSB2;ATG5;EVA1A;CUL4A;DMP1;PENK;PSMD4;PSMB5;DSCC1;SUMF2;UBXN7;FBXL7;DCAF5;PSMB7;DCUN1D1;KLHL3;PSMB8;RCN1;MXRA8;CAND1;FBXW5;KLHL41;FBXL3;HIF1A;WDR5;KLHL9;PSMD13;CHGB;ICMT;FBXL14;APLP2;FBXO41;SOCS3;ASB7;CUL1;FBXO2;FBXO17;KEAP1;FBXW8;FBXL12
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3242273771661798,0.9299515757706994,0.5460992907801419,0.8771834886646371,1.0,3/22,8.00%,LGMN;CBR1;RLBP1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.33796056446367556,-0.9299417493174928,0.5315126050420168,0.8910252592109095,1.0,4/17,14.26%,PTPN22;PTPN2;UBASH3A;THY1
prerank,B cell proliferation (GO:0042100),-0.3325587311373539,-0.9297328455139436,0.5473441108545035,0.8907248215941114,1.0,8/17,24.93%,CD40;CR2;CTPS1;BCL2;MS4A1;GAPT;CD19;RASGRP1
prerank,protein depolymerization (GO:0051261),-0.2927593709396534,-0.9295622446858818,0.5711009174311926,0.890311932377804,1.0,8/27,15.80%,GSN;DSTN;STMN4;MICAL3;KIF14;STMN2;KIF18B;NCKAP5
prerank,regulation of cholesterol transport (GO:0032374),0.32847659484062885,0.9295395967697435,0.5580110497237569,0.8776495268566421,1.0,6/20,21.33%,LRP1;TTC39B;TSPO;ABCB4;NR1H2;NAXE
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.39071960703511904,0.9293439908665622,0.5216606498194946,0.8775610235055766,1.0,1/11,1.07%,SMAD7
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.24778365949533596,0.929342822163175,0.5993537964458805,0.8769541744281196,1.0,22/80,22.37%,GSAP;PLD1;PICALM;PRKCD;CLU;PLA2G6;NSUN5;METTL5;SMPD2;MTOR;RPS27L;PASK;METTL14;EIF3D;ROCK2;FXR2;SMPD3;THBS1;PCIF1;EFNA1;DDX3X;ELAVL1
prerank,positive regulation of exosomal secretion (GO:1903543),0.3555777258977774,0.9293000199094338,0.54673721340388,0.8764532180966879,1.0,6/15,22.44%,SMPD3;VPS4A;TSG101;CHMP2A;HGS;PDCD6IP
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23507734434119257,0.9290496132441826,0.6305031446540881,0.8764678495041622,1.0,22/109,16.68%,VAV2;RAC1;PIK3R1;GAB2;LAT2;LYN;PLCG2;NFATC1;LCP2;PDPK1;JUN;TAB2;PSMD3;PIK3CB;PSMB3;PSMA7;MAPK8;PSMC1;PSMC2;PSME4;TEC;PSMB9
prerank,iron ion homeostasis (GO:0055072),-0.24320275352481027,-0.9289652406611423,0.5964912280701754,0.8910785351898773,1.0,14/58,17.17%,FTL;ABCB7;B2M;NEO1;FLVCR1;SCARA5;NDFIP1;TFR2;SLC46A1;HMOX1;ATP6V1A;FBXL5;CYBRD1;TFRC
prerank,telomere maintenance (GO:0000723),0.2702904296425089,0.9288662800593984,0.576,0.8763390183379184,1.0,19/50,27.90%,PCNA;NBN;ATM;CTC1;POLD2;DCLRE1B;ERCC4;BLM;TERF1;ZBTB48;TEN1;ACD;XRCC6;LTO1;RPA3;POLD4;STN1;RTEL1;RPA1
prerank,nucleus organization (GO:0006997),0.27559089557992544,0.928495135433212,0.5888501742160279,0.8767409486796806,1.0,12/47,19.78%,BIN1;IRAG2;NUMA1;WDR73;SUN2;USP36;NUP35;ATXN7;SEH1L;CHMP1A;VPS4A;CHMP2A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3628567579851605,0.9284947606857631,0.5526802218114603,0.8761346271384083,1.0,6/14,21.10%,CCL3;PTK2B;WNK1;STK39;ADAM10;ADAM17
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3667855064399514,0.9284129591282266,0.5488029465930019,0.8757370954550368,1.0,5/13,20.45%,PADI2;ZMIZ2;ZMIZ1;ARID1A;ELOF1
prerank,Golgi organization (GO:0007030),-0.2185199446331011,-0.9283530484688824,0.6527777777777778,0.891847454509241,1.0,15/112,8.17%,ATP8B4;LRRK2;HTT;SYNE1;GOSR2;ZW10;STX17;ATL2;VPS51;VCPIP1;CDC42;GOLPH3;CUL7;VMP1;TMED1
prerank,negative regulation of hemostasis (GO:1900047),0.37548204355642023,0.9281969883870119,0.5694444444444444,0.8757066238956255,1.0,4/12,13.46%,CD34;APOH;SERPINE1;SERPINE2
prerank,regulation of neuron migration (GO:2001222),0.313607164777278,0.9281319039431438,0.5716878402903811,0.8752665542604561,1.0,2/26,0.66%,SRGAP2;ARHGEF2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2803261365674671,-0.927982453957419,0.5958429561200924,0.8919761048037704,1.0,7/33,14.51%,PTPRG;SLIT2;SP100;APOE;DUSP10;MCC;ACVRL1
prerank,regulation of RNA metabolic process (GO:0051252),-0.2423276401309795,-0.9278362009712183,0.5979643765903307,0.891486623477235,1.0,11/59,10.68%,AHNAK;OAS2;PTBP2;NOVA1;MBNL3;RBM20;GRSF1;PCBP3;PRX;SRRM4;AHNAK2
prerank,organic cation transport (GO:0015695),-0.3160318201946809,-0.9278220264362376,0.5257009345794392,0.8906337314386459,1.0,8/20,19.94%,SLC25A19;SLC44A1;SLC5A7;SLC44A2;SLC47A1;RALBP1;SLC22A18;SLC22A5
prerank,activation of protein kinase A activity (GO:0034199),0.3435780488894692,0.927623672264785,0.5649819494584838,0.8759400326583106,1.0,5/16,11.99%,ADCY9;PRKACA;ADCY4;PRRC1;ADCY6
prerank,cellular response to leucine starvation (GO:1990253),0.39696932906277055,0.927607882820277,0.5315487571701721,0.8753768338452526,1.0,3/10,13.60%,IMPACT;MTOR;GCN1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2999398426611113,-0.9275844573066467,0.5764966740576497,0.8903809340851382,1.0,6/24,7.99%,PSMD14;CTSC;LATS1;USP14;APOE;PSME2
prerank,negative regulation of defense response (GO:0031348),0.2464405315042338,0.9273371842449748,0.6112084063047285,0.8754517316318633,1.0,12/77,9.78%,SIRPA;SIRT2;PPARD;OTULIN;ITCH;GPS2;PRKCD;PCBP2;C1QBP;NLRP3;GPER1;TNFAIP8L2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.30710856879035364,-0.9272942885275957,0.5585585585585585,0.8902917628673879,1.0,4/23,7.08%,PDE4B;LRRK2;RYR2;PRKN
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2892671178482108,0.9271364589325383,0.5482142857142858,0.8753605681514417,1.0,8/35,18.32%,PCNA;RFC2;MPG;LIG1;POLD2;PARG;RFC1;NTHL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.24522101017924036,0.9270076840694922,0.6060606060606061,0.8750980161523328,1.0,19/80,19.11%,CTSD;RPS6KA1;CSNK2A1;SRC;CASP1;ARL6IP5;NLRP3;GPER1;DPEP1;LAMTOR5;PAX2;PDCD6;PYCARD;NDUFA13;AKT1;XIAP;THBS1;HTRA2;PPM1F
prerank,presynaptic endocytosis (GO:0140238),-0.29586674237798244,-0.9262820633639762,0.5766423357664233,0.8921525093713866,1.0,2/24,2.39%,NLGN1;SYT1
prerank,cellular response to oxygen levels (GO:0071453),0.3958081785841102,0.926101827294916,0.5599284436493739,0.8768430001217098,1.0,3/10,15.26%,ATP6V0A2;TMEM199;PICK1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3783358100295717,-0.9259557789021258,0.5197368421052632,0.8921910264444497,1.0,5/11,17.22%,CCNF;CDK5RAP2;TRIM37;MDM1;NPM1
prerank,positive regulation of double-strand break repair (GO:2000781),0.2804970118357747,0.9259358388865894,0.5846153846153846,0.8766555211137458,1.0,8/39,13.15%,FUS;WDR48;SPIDR;MGMT;MMS19;SPIRE1;KMT5C;SHLD2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2064604738545303,0.9258689658022793,0.6808510638297872,0.8762412638962958,1.0,59/308,18.35%,TGFBR1;TMEM119;IL18;TGFBR2;RREB1;CADM1;SMAD3;CCDC88B;SOX8;TGFB1I1;TRPV2;IGF1R;TRPM4;PIK3CG;RBM19;NUMA1;HCRT;PDGFB;SHH;C1QBP;GCNT2;GDNF;IL12B;TLE6;GAPDH;PIK3CD;MTOR;INPP5K;KDM3A;LRP1;SCAMP5;KMT5C;PAX2;SERPINE1;IL33;PTPN11;BSCL2;SHLD2;GJA1;TBXA2R;EZH2;CNOT3;SOD1;GHR;IL4R;SMO;NCOA3;VIP;NOG;EIF2AK2;FST;GNAS;STAT6;AGT;VAMP7;KDM1A;SLC11A1;SCD;LPIN1
prerank,mitochondrial gene expression (GO:0140053),0.2787172055406942,0.9255184525584684,0.5742904841402338,0.8765308317631896,1.0,12/42,23.50%,MRPS24;MRPL2;MRPS34;MRPS21;MRPS16;MRPS11;MRPS18B;MRPS28;MRPS18A;IARS2;FASTKD2;MRPL47
prerank,retinal metabolic process (GO:0042574),0.37104011716486274,0.9253718228888063,0.5395948434622467,0.8763298260836118,1.0,2/12,3.58%,BCO2;ALDH8A1
prerank,mitochondrial transcription (GO:0006390),-0.38746063278670784,-0.925069063714557,0.5412026726057907,0.8938299632546077,1.0,3/10,18.54%,POLRMT;MRPL12;TWNK
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.19657677518383362,0.9250351778233799,0.7114882506527415,0.8765949386555226,1.0,98/497,18.26%,SALL1;IKZF1;BASP1;MLXIPL;SUMO1;CAPN3;PRMT2;HEYL;DDIT3;SOX8;PBXIP1;SBNO2;SIRT2;PPARD;CNOT1;FOXE1;CCDC85B;CRY2;HDAC10;DEAF1;PHB2;SAMD1;ZNF568;SUDS3;ID1;CHD8;ZBTB21;LOXL3;ELK3;ENC1;RPS6KA5;MLX;RAD17;FOXK2;BCOR;ZBTB18;EID2;PDGFB;SIN3A;ZMYND11;BCL7A;FOXN3;JUN;BRCA1;SAMD11;NANOS2;SAMD13;TWIST2;DPF2;TMPRSS6;LIMS1;MIDEAS;PATZ1;GAPDH;NPAS1;INPP5K;EID2B;MBD1;PRDM11;PAX2;TOB1;SMARCA2;DPF1;KDM4A;MAP3K10;TERF1;PRMT6;EZH2;GCLC;WWP2;ID3;HDAC5;MRPL13;IGF2BP2;TSPYL2;NDUFA13;PROX1;PASK;EED;EIF2AK2;EIF2AK1;COMMD7;SCMH1;VGLL4;ZEB1;RIDA;EPRS1;QARS1;TSC22D4;KDM1A;POU2F1;FXR2;GATA3;KDM8;KAT5;HMGB2;CHMP1A;DKK3
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2866844198333501,0.9247502370939289,0.5545774647887324,0.8767073349829239,1.0,8/34,20.44%,LRP5;PDGFB;EDN3;PDGFRB;AURKA;ANAPC11;NUP62;IL1A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.31116181079024374,0.9247256836940991,0.5530434782608695,0.8761795673791477,1.0,5/26,8.34%,ST3GAL6;B3GNT2;PRELP;CHST1;B3GNT4
prerank,embryonic limb morphogenesis (GO:0030326),0.29287788943750337,0.9246897131148647,0.5799648506151143,0.875668721892504,1.0,4/34,6.91%,SALL1;SKI;FBXW4;SHH
prerank,cell-cell junction assembly (GO:0007043),0.2537100839172205,0.9246175184562213,0.6089743589743589,0.8752606389268027,1.0,15/63,14.05%,SMAD7;CD9;PRKCA;TLN2;FLCN;FSCN1;CDH18;CDH24;PKP3;CLDN11;TJP1;GJA4;GJA1;TRPV4;WDR1
prerank,cellular potassium ion homeostasis (GO:0030007),0.36597853022893534,0.9245745208332219,0.5503472222222222,0.8747616692994601,1.0,2/13,8.83%,KCNMA1;ATP1A4
prerank,myelin maintenance (GO:0043217),0.39763849980270366,0.9245137509514728,0.5434380776340111,0.8743203180331587,1.0,3/10,14.34%,ABCD2;CLU;SOD1
prerank,regulation of vasculogenesis (GO:2001212),-0.34470350882657774,-0.9245009329502385,0.5567685589519651,0.8944210444877605,1.0,2/14,3.36%,XDH;RAPGEF2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.34761552106499266,0.9243848846755348,0.5749063670411985,0.8740432404048901,1.0,6/15,18.81%,RAB3GAP1;RAB3GAP2;EDEM1;SEC61A1;SRP14;ZFAND2A
prerank,regulation of neuroblast proliferation (GO:1902692),0.35221734165326063,0.924226161774805,0.5480769230769231,0.873828314166289,1.0,4/15,17.58%,CX3CR1;SMARCD3;DRD2;KDM1A
prerank,modulation by symbiont of entry into host (GO:0052372),0.3470351768857719,0.9241282712692267,0.5593525179856115,0.8734754853835738,1.0,4/16,13.88%,EXOC7;TRIM5;TRIM62;NECTIN2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3768844007761806,0.9240904158939397,0.5627450980392157,0.8729962518275239,1.0,2/12,5.66%,ABCD2;MTLN
prerank,regulation of lymphocyte migration (GO:2000401),0.3991496442192882,0.9239651544033622,0.5522388059701493,0.8727131217629004,1.0,4/10,16.30%,JAM2;MIA3;AKT1;WASL
prerank,camera-type eye morphogenesis (GO:0048593),-0.3831576293716422,-0.9237273776447357,0.5291666666666667,0.8955809404436972,1.0,2/10,4.02%,TENM3;LRP6
prerank,Golgi localization (GO:0051645),-0.3736083134303907,-0.9235563052059891,0.5668103448275862,0.8951523448524967,1.0,3/11,11.89%,CDC42;UVRAG;ARHGAP21
prerank,regulation of exit from mitosis (GO:0007096),0.2790868994131082,0.9234378371818428,0.6104347826086957,0.8734524765261491,1.0,19/38,32.61%,PPP1R9B;SIRT2;PHB2;RPS27A;UBC;ANAPC15;CDC14B;ANAPC11;CDCA5;ANAPC1;ANAPC2;ANAPC16;ANLN;UBE2D1;BUB3;ANAPC7;CDC14A;MAD2L1;CDC23
prerank,regulation of sodium ion transport (GO:0002028),-0.2751639505826905,-0.9233519033790241,0.5681293302540416,0.8947893951476935,1.0,8/34,14.74%,NKAIN2;ANK3;FGF12;SPTBN4;SIK1;ATP1A1;NKAIN3;PER1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.23279430072624405,-0.9231983622752507,0.6259541984732825,0.8942881856617649,1.0,14/76,10.49%,GRM5;ADRA1A;GRM1;HRH1;HTR2C;GPR35;HTR2B;HOMER1;CHRM2;OPRM1;ACTN2;OPRD1;ADRA2A;P2RY1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3521676723992011,0.9230072882354633,0.5634057971014492,0.8739410725973106,1.0,5/15,16.11%,LARGE1;CHST1;CHST7;AMDHD2;CHST2
prerank,carbohydrate derivative transport (GO:1901264),0.331584942240261,0.9224653891027389,0.5851851851851851,0.8747058567209459,1.0,8/18,21.55%,CPTP;SLC15A4;CLN3;NPC2;SLC29A1;SCARB1;SLC15A2;SLC28A1
prerank,positive regulation of protein kinase activity (GO:0045860),0.22388640691440703,0.9222968439887634,0.6501547987616099,0.8745215429628727,1.0,47/148,24.93%,TGFBR2;CSF1R;CAMKK1;MAP4K4;MMD;SRC;EGR1;PRKCD;CLU;LCP2;STRADA;PTK2B;PDGFB;CCR7;IL12B;RPTOR;IL6R;TAB2;DDR2;PTPN1;DLG4;MARK2;TAOK2;AGAP2;IL34;EZH2;CIB1;CSF1;MAP2K1;PDCD10;AGT;SLC11A1;CAMK1;ECT2;XRCC6;EFNA1;DDX3X;SLC8A2;RASSF2;MINK1;JTB;CALM2;TELO2;RALB;DUSP19;ITGB3;PTPRC
prerank,macrophage migration (GO:1905517),0.363155306637827,0.9219940584187001,0.566420664206642,0.8746879609874013,1.0,4/13,15.24%,P2RY12;CCL3;EDN2;CXCL17
prerank,cellular response to lipid (GO:0071396),0.21515466807323896,0.9217485030783649,0.6480938416422287,0.8747425218757173,1.0,42/191,18.21%,CX3CR1;SIRPA;TWF2;MEF2C;SBNO2;TLR4;LYN;ATM;CTR9;CASP1;PTK2B;CD86;NLRP3;WNT10B;PDCD1LG2;GPER1;CXCL1;POU4F1;AXL;PABPN1;TICAM2;WNT7B;CD180;PAX2;SERPINE1;ADCY6;CCDC62;MAPK8;CCR5;PYCARD;NDUFA13;MAPK14;NCOA3;TNIP2;NRIP1;ABCB4;ROCK2;KAT5;HMGB2;TICAM1;FES;HTRA2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.37789797012305637,-0.9211812858367854,0.5511482254697286,0.8988338367951884,1.0,4/10,22.40%,KLF4;IRAK3;MAP2K5;SIGIRR
prerank,phospholipid homeostasis (GO:0055091),-0.36677861995840877,-0.9211027925022001,0.5714285714285714,0.8981538594353566,1.0,4/11,31.51%,RCN3;ANGPTL3;ABCB11;LIPG
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3601205402304082,-0.9204412933184454,0.5863539445628998,0.8990345863359998,1.0,2/12,1.55%,PLCB1;SLIT2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3413585034620379,-0.9196566589502266,0.6008869179600886,0.9003117976594214,1.0,3/15,3.63%,MSR1;CD36;PF4
prerank,muscle tissue morphogenesis (GO:0060415),-0.3348303323997684,-0.9194287829885939,0.5816993464052288,0.9000984066842557,1.0,6/16,28.52%,HEY2;BMP4;TGFBR3;ZFPM1;TTN;TBX1
prerank,myoblast fusion (GO:0007520),-0.3572867507377399,-0.9192380856106188,0.5851063829787234,0.8997169979380293,1.0,3/12,10.71%,ADGRB3;KCNH1;ADAM12
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2620786312564238,-0.919124201871119,0.610738255033557,0.8991293085802919,1.0,9/39,11.01%,OLFM2;RAB3C;RCN3;GOLPH3;RAB3D;COPG2;RAB8A;RAB3A;ARL4D
prerank,glial cell development (GO:0021782),-0.2898738394440601,-0.9190743064732001,0.5747863247863247,0.8983916685961856,1.0,4/25,4.37%,TPPP;APP;MYRF;SOX11
prerank,Fc receptor signaling pathway (GO:0038093),0.23259504005977655,0.9187170287891202,0.6534181240063593,0.8819672876255816,1.0,22/110,16.68%,VAV2;RAC1;PIK3R1;GAB2;LAT2;LYN;PLCG2;NFATC1;LCP2;PDPK1;JUN;TAB2;PSMD3;PIK3CB;PSMB3;PSMA7;MAPK8;PSMC1;PSMC2;PSME4;TEC;PSMB9
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2412648786908134,0.918613919086622,0.6296900489396411,0.8816162186948686,1.0,10/85,9.16%,RASAL3;OPHN1;ARHGEF2;DENND4A;LYN;FLCN;SPRY2;ARHGAP17;RALGPS1;AKAP13
prerank,telomere organization (GO:0032200),0.2764163403375767,0.9183070288385055,0.6037414965986394,0.8817732155345255,1.0,17/43,27.90%,PCNA;NBN;ATM;CTC1;POLD2;DCLRE1B;ERCC4;BLM;TERF1;ACD;XRCC6;LTO1;RPA3;POLD4;STN1;RTEL1;RPA1
prerank,defense response to bacterium (GO:0042742),0.23444967207718878,0.9182878565989,0.665144596651446,0.8812279237410259,1.0,26/105,21.10%,ANXA3;LYZL4;TLR4;PRKCD;PLA2G6;SLPI;NOS2;IL12B;SELP;HAMP;RAB1A;IL6R;GBP6;SERPINE1;RNASE6;OPTN;MAVS;PYCARD;HMGB2;SLC11A1;GBP7;RPL39;LPO;NOD2;TNFRSF14;ADAM17
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2706687252073463,-0.9177556145642761,0.5868544600938967,0.9010077106060981,1.0,6/36,9.04%,PLCB1;GNAO1;AGO4;CALM1;TNRC6A;NLK
prerank,Notch signaling involved in heart development (GO:0061314),-0.374992941314528,-0.9177245009646435,0.5726315789473684,0.9001989821478872,1.0,6/11,23.13%,RBPJ;JAG1;HEY2;SNAI2;DLL4;NOTCH2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.34367367052657005,0.9170851249633999,0.5761467889908257,0.8836420598710507,1.0,7/18,23.70%,COA8;COX19;SURF1;BCS1L;FASTKD3;COX16;COX17
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3298156093728129,0.9170513376615563,0.5625,0.8831184793183319,1.0,5/19,17.29%,IRAK2;DHX9;RUNX1;MAVS;MAPK7
prerank,negative regulation of nuclear division (GO:0051784),0.38424440669689647,0.9167561848687116,0.552536231884058,0.8832566804894807,1.0,2/11,10.11%,NANOS2;NME6
prerank,regulation of hormone secretion (GO:0046883),0.3477697046626816,0.916546477327967,0.590339892665474,0.8831865135183067,1.0,5/15,22.39%,EDN3;SCG5;NMB;OSM;SNX6
prerank,regulation of actin filament depolymerization (GO:0030834),0.37100069059116797,0.91648183232991,0.5586206896551724,0.8827551415215842,1.0,6/12,27.18%,PLEK;PLEKHH2;WDR1;PIK3CA;SH3BP1;LIMA1
prerank,gene expression (GO:0010467),0.20152532183581856,0.916436712986364,0.7119784656796769,0.8822675231664207,1.0,96/348,23.42%,SRRM1;TSPAN14;NCBP1;POLR2H;POLR2J;RANBP2;LMF1;NKX2-8;POLR2D;EIF4G1;MRPL37;MAGOHB;MAGOH;RPS27A;U2AF2;RRBP1;CELF2;NUP42;MRPL43;HNRNPH1;RBM39;THAP1;DHX38;MRPL34;SARS1;SEC13;MRPL9;DDX17;MEF2A;SRSF5;NUP50;PABPN1;RPL15;MMS19;MRPS5;DTX1;CPSF1;NUP35;ASMT;RPL10;RBM8A;DHPS;NUP88;RPS8;DDX54;MRPS21;GSPT2;DDX20;U2AF1L4;ABCF1;SLU7;RPS24;FIP1L1;MRPL13;ALYREF;MRPS16;MRPS11;MRPS18B;ALKBH5;POLR2E;DUSP11;NUP62;EIF4EBP2;SEH1L;PRPF4;NUP107;STUB1;RPL9;MRPS18A;RPL39;SNRNP40;THOC6;MRPL11;TNIP1;HNRNPA2B1;SRSF9;MRPL41;MRPL27;GALNT2;EPC1;HNRNPH3;TOPORS;FASTKD2;DDX19B;ANGPT2;DDX39B;POLR2I;RPL28;HNRNPUL1;RBPMS;MPHOSPH10;LMF2;RPL34;RPL31;MED20;NUP153
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3499143013382805,0.9162998207477081,0.5791505791505791,0.8820070211094609,1.0,5/15,26.47%,SMAD7;ABL1;DTX3L;PARK7;BAG5
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3021296540601889,0.9159917827600939,0.6027164685908319,0.8822167884670293,1.0,3/26,3.44%,RAC1;ASAP3;PLEK
prerank,negative chemotaxis (GO:0050919),-0.2772589217632939,-0.9155310271834799,0.6050420168067226,0.9052281344326469,1.0,4/33,4.74%,ROBO1;UNC5C;SLIT2;SEMA4A
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3442566065162256,-0.9152820546749273,0.558891454965358,0.9050189137131753,1.0,4/14,17.60%,RARA;CRHBP;SFRP1;BCAS3
prerank,negative regulation of cell junction assembly (GO:1901889),-0.292862966262885,-0.9152252653386083,0.5676274944567627,0.9042950941491403,1.0,7/25,21.18%,ARHGAP6;ITGB1BP1;ACVRL1;RCC2;BCAS3;ACE;ROBO2
prerank,positive regulation of protein modification process (GO:0031401),0.21324306329970732,0.9151510073728285,0.6573529411764706,0.883704372096789,1.0,60/203,24.60%,TMEM119;CSF1R;RAC1;AGER;LYN;ATG14;PRKCD;FLCN;VEGFB;AKTIP;RAB3GAP1;CAMKK2;RAB3GAP2;NOS1AP;GPER1;CEP295;CLIP3;RAPGEF3;RB1CC1;PINK1;MUSK;CCND3;ENG;ABL1;PIN1;SEMA4D;IL34;MAVS;CDK2AP1;AKT1;CIB1;DYRK1A;GPNMB;PIK3R3;PELI2;PPP2R5A;ARRB1;ROCK2;FXR2;KAT5;FBH1;CAMK1;FGF18;RSPO1;CRKL;ADAM17;EFNA1;FGF20;DDX3X;CSNK1D;AXIN2;FGF1;BMP2;CALM2;BRMS1;TGFB1;RALB;DVL2;SOX9;ITGB3
prerank,carbohydrate homeostasis (GO:0033500),-0.23705187114380144,-0.9150980046177567,0.6190476190476191,0.903734177956306,1.0,12/67,12.58%,PPARG;MCU;IRS1;USF1;SLC8B1;ADIPOR2;ALOX5;PTPN2;ADRA2A;ADCY8;CEBPA;RBP4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.35064718064773565,-0.9150569005177269,0.5502283105022832,0.9029698831972974,1.0,6/13,20.80%,APP;SHANK3;ADCY8;EIF2AK4;RELN;EPHB2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3336216342172219,0.914809133156351,0.5866425992779783,0.883938983284609,1.0,4/17,13.88%,CADM1;RAET1E;IL12B;NECTIN2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.37491273082628307,-0.9145558494348976,0.58719646799117,0.9034271119025888,1.0,1/10,0.45%,ANK3
prerank,mitotic cytokinesis (GO:0000281),-0.25462461874126324,-0.9145421190465021,0.6148148148148148,0.9025822286433494,1.0,10/47,11.30%,ANK3;SPTBN1;KIF23;RACGAP1;CUL7;SNX9;NUSAP1;CNTROB;UNC119;KIF20A
prerank,negative regulation of cellular senescence (GO:2000773),0.36502384022469864,0.9142544911105186,0.5904936014625228,0.8847216833079036,1.0,2/13,3.41%,MAP3K3;SLC30A10
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3420337000410089,0.913976136456926,0.5931899641577061,0.8848324393684199,1.0,7/16,29.06%,BRCA1;CEACAM1;WDTC1;SOX9;APPL2;ERLIN2;ACADVL
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.36516562565315946,0.9137319618810138,0.5830188679245283,0.8848761404720645,1.0,3/13,14.35%,UBA2;UBA7;UBA5
prerank,limb morphogenesis (GO:0035108),0.32566121576634594,0.9133739918578808,0.5754884547069272,0.88519481313569,1.0,4/20,12.83%,SKI;FBXW4;SHH;IQCE
prerank,negative regulation of cell activation (GO:0050866),-0.34609876789294414,-0.9133333765159075,0.5496828752642706,0.9049589443013436,1.0,2/14,4.61%,LDLR;APOE
prerank,negative regulation of blood coagulation (GO:0030195),0.27733434238248866,0.9132550997443214,0.5963636363636363,0.8849110157543293,1.0,8/38,16.05%,F12;PDGFB;CD34;F8;APOH;SERPINE1;SERPINE2;PLG
prerank,positive regulation of DNA metabolic process (GO:0051054),0.25536923470098927,0.9132011232972118,0.6247848537005164,0.8844513729141465,1.0,12/61,13.22%,SMOC2;PCNA;NBN;PDGFB;DHX9;BRCA1;STPG4;EYA3;RNF8;PDGFRB;ABRAXAS1;CEBPG
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.32325495359432066,0.9131486545941329,0.5592592592592592,0.8833881857346549,1.0,5/21,12.75%,DDB2;GTF2H2;ERCC2;CUL4B;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.32325495359432066,0.9131486545941329,0.5592592592592592,0.8833881857346549,1.0,5/21,12.75%,DDB2;GTF2H2;ERCC2;CUL4B;ERCC4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.3814378285343989,-0.9129622191212423,0.5636743215031316,0.9050513240667543,1.0,2/10,4.54%,LILRB1;FN1
prerank,RNA metabolic process (GO:0016070),0.2225009447496592,0.9129022676760135,0.678343949044586,0.8834230568606495,1.0,40/127,24.39%,RNASE1;NCBP1;POLR2H;POLR2J;POLR2D;HNRNPA3;HNRNPC;CELF2;PCBP2;HNRNPH1;DHX9;RBM39;HNRNPR;DDX17;PABPN1;DDX54;RNASE6;DDX20;POLR2E;ISG20;METTL14;DUSP11;PRPF4;RBMX;SNRNP40;SND1;HNRNPA2B1;HNRNPH3;RNASEH1;FASTKD2;DDX39B;DDX3X;POLR2I;ZC3H12A;HNRNPUL1;RBPMS;MPHOSPH10;LSM8;AGO1;HNRNPA1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.33290222492059734,-0.9126703694567824,0.5883720930232558,0.9049596448043148,1.0,3/15,11.25%,NEDD4L;ATP1B3;ATP1A1
prerank,regulated exocytosis (GO:0045055),0.2204711639179755,0.912421429065796,0.6982248520710059,0.8840833221474466,1.0,26/173,11.96%,LHFPL2;TUBA4A;CD9;SYNGR1;CYRIB;FERMT3;LYN;PROS1;PLEK;MYH9;SPARC;STXBP1;CLU;VEGFB;STX1A;RIMS3;ARHGAP17;PDGFB;CYB5R1;SELENOP;SELP;ORM2;F8;ENDOD1;APOH;SERPINE1
prerank,innate immune response (GO:0045087),0.21287789980114322,0.9124158040563273,0.6909361069836553,0.8835063815310881,1.0,20/217,5.78%,CX3CR1;COLEC11;RIPK2;PJA2;PYDC1;AGER;SERINC3;OTULIN;TRIM11;TLR4;LYN;TRIM5;SRC;PIK3CG;PHB2;PLCG2;SLPI;F12;PTK2B;ATAD3A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.21325228326064624,0.9124108132099104,0.7042682926829268,0.8829281517452969,1.0,54/190,23.54%,PDE3B;DDIT3;ARRB2;TBC1D7;CYRIB;LYN;ARHGAP25;PLEK;SRC;PKHD1;FLCN;THEM4;RHOH;RFFL;DGKD;NDUFS3;CDC34;ZMYND11;NLRP3;GPER1;TNFAIP8L1;RTKN2;INPP5K;PIK3CB;PPP2R5B;PEBP1;PINK1;PDCD6;DRD2;PYCARD;NDUFA13;AKT1;CIB1;NLRX1;MAPK14;CD2AP;CCDC22;VGLL4;PTPRJ;THBS1;WTIP;MGRN1;EPHA2;TNIP1;RNF34;PPM1B;DDX3X;ZC3H12A;CGNL1;TWIST1;BCL2L1;DLG5;DEPDC5;ADIPOR1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.23267048580851465,-0.9123986125806682,0.6526315789473685,0.9048075318585788,1.0,15/73,17.17%,CD44;EGFR;BDNF;APP;LATS1;CREBL2;NTRK3;AXIN1;IRGM;OPRD1;RAF1;SNCA;PAK1;SFRP2;TFRC
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.3233965285368901,-0.9122368405762056,0.5686274509803921,0.9043501543836429,1.0,7/17,16.78%,SKAP1;RET;PODXL;CCL5;FOXC2;CD3E;SFRP2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3080540806418877,0.9117457053431716,0.5982300884955752,0.8840170328653911,1.0,7/24,16.81%,TRIM44;SIN3A;CGAS;IL12B;MAVS;AIM2;DTX3L
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2926408382015926,-0.9116798071284901,0.5876777251184834,0.9050300262324003,1.0,5/23,11.94%,ACSL3;ELOVL7;HACD1;ELOVL5;FAR2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.25246990770684347,-0.911601469134959,0.6169154228855721,0.9043799253862805,1.0,17/45,28.07%,GLS;ASPA;THAP4;KMO;ATP7A;SRR;GNMT;SLC25A12;GPT;PYCR3;DDAH2;KYAT1;NOX4;RIMKLB;GOT1;ASNS;ALDH18A1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23802938225201184,0.9114520961498362,0.6351791530944625,0.8841746195864973,1.0,15/84,12.13%,SON;NCBP1;DDX5;QKI;MAGOH;U2AF2;SFSWAP;CELF2;RBM39;JMJD6;C1QBP;RBM24;DDX17;RBM8A;TRA2B
prerank,response to UV-A (GO:0070141),-0.3483228126648247,-0.9113604066992472,0.5824175824175825,0.9041342169386769,1.0,2/14,2.55%,EGFR;MME
prerank,positive regulation of RNA splicing (GO:0033120),0.29739098328171454,0.9112619088310334,0.6114180478821363,0.8840897677189783,1.0,10/29,24.66%,NCBP1;PIK3R1;U2AF2;TRA2B;TRA2A;DYRK1A;RBMX;DAZAP1;HNRNPLL;HABP4
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3524666055038006,0.9109321486113329,0.5650557620817844,0.884326418941381,1.0,6/14,23.62%,ACOX3;CROT;CRAT;ABCD1;ACOT8;SCP2
prerank,regulation of protein metabolic process (GO:0051246),-0.2584234315189931,-0.910581963583894,0.62877030162413,0.905273531748094,1.0,8/44,6.15%,APP;LDLR;NEDD4L;FAF1;APOE;KLF2;PARL;SPOP
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3450325991239471,0.910141579401001,0.5828677839851024,0.8856902938289634,1.0,2/17,4.25%,BIN1;CLU
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3342360288264865,0.91010922335221,0.5738963531669866,0.8851894010705497,1.0,8/18,26.11%,CCT3;EXOSC10;NHP2;CCT8;SHQ1;CCT7;PARN;CCT5
prerank,cellular response to BMP stimulus (GO:0071773),0.24784205770165219,0.9100731924843245,0.6332794830371568,0.884707597922419,1.0,19/66,26.54%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;ENG;SMAD9;USP9Y;ACVR2B;ZFYVE16;HIVEP1;TMEM100;BMP2;TGFB1;PDCD4;SOX9;ACVR1;AMH;SMAD6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.24547175507060554,0.9098357268136237,0.624561403508772,0.8847195180057923,1.0,18/72,19.43%,CRADD;PCNA;CNOT1;CHEK2;NBN;ATM;RBL2;MDM4;ACER2;PRMT1;TNKS1BP1;RPS27L;CNOT3;PLK3;AURKA;KAT5;CARM1;PIDD1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.2494095256603612,-0.909714609638308,0.6175771971496437,0.9067230725040791,1.0,13/47,19.82%,NEDD9;DOCK5;CDC42;CARMIL1;MYADM;KANK1;SPRY4;ITGB1BP1;EFNA5;RCC2;S100A10;OLFM4;DOCK1
prerank,histone H3-K36 demethylation (GO:0070544),0.39691741879914544,0.9097104985817019,0.599624060150376,0.8844819756600947,1.0,6/10,25.37%,KDM4A;KDM8;KDM7A;KDM2A;KDM2B;PHF8
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.22763375776174233,0.9095442176299898,0.6610942249240122,0.8842999162375453,1.0,24/117,18.20%,KARS1;ADCY9;PRKACA;LYN;MYH9;SRC;PLCG2;HRH2;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;ADCY6;INSL3;MAPK14;VIP;ADORA2A;ADCY7;GPR84;GNB1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3163997251560785,-0.909399281155762,0.575,0.9066758708312037,1.0,6/18,23.20%,RIC1;FAF1;RGP1;MSN;CDK5RAP3;EZR
prerank,DNA recombination (GO:0006310),0.27889440018548883,0.9093629091940922,0.5887372013651877,0.884169826558761,1.0,13/37,28.25%,RHNO1;HDAC10;RAD54B;RAD51B;EXO1;BLM;RPAIN;FBH1;TSN;RAD51C;RTEL1;RPA1;RECQL
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2763167148699432,0.9093335831060375,0.635593220338983,0.8836692003481804,1.0,11/42,18.06%,TLR4;NOS2;IL12B;SELP;IL6R;SERPINE1;RNASE6;OPTN;PYCARD;HMGB2;SLC11A1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.33293656174377456,0.9092528037246421,0.5790441176470589,0.8832725565906681,1.0,4/18,10.71%,GNA15;RGS10;CHRM1;GRK2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.30620422772467665,0.9082867708233404,0.5863970588235294,0.8850644671446138,1.0,4/25,15.38%,NELFB;ZMYND11;RNF8;NELFE
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2702057969052938,0.908182819922208,0.6146010186757216,0.8847434585179409,1.0,12/40,23.60%,CLU;PLSCR3;GPER1;BMF;PINK1;PYCARD;AKT1;PMAIP1;BCL2L1;OPA1;BCL2L11;TP53
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3060113391970505,0.908069608399261,0.6025878003696857,0.8844391543286437,1.0,4/25,6.47%,RAC1;PICALM;ITGAV;NEU3
prerank,regulation of response to external stimulus (GO:0032101),0.2251048126038517,0.9078848956575929,0.6848673946957878,0.884309486557742,1.0,13/121,10.37%,DAGLB;P2RY12;IL1RL2;SBNO2;CYRIB;TRIM5;CASP1;LRRC19;PIK3AP1;SELE;BCL6B;APPL1;AREL1
prerank,Rap protein signal transduction (GO:0032486),-0.37259343814389995,-0.9078376776536188,0.5857142857142857,0.9098793272176512,1.0,2/10,7.79%,RAPGEF2;PLK2
prerank,regulation of cell junction assembly (GO:1901888),0.29434320777486145,0.9078250493697945,0.5773381294964028,0.8838574919472508,1.0,5/27,11.45%,F11R;MEF2C;PRKACA;TJP1;RUNX1
prerank,cellular response to oxidative stress (GO:0034599),-0.2150116649062548,-0.9077108804151766,0.7089337175792507,0.9093226017363885,1.0,34/118,21.34%,LRRK2;CYBB;EGFR;MSRA;PRDX1;RPS3;ROMO1;PPIA;NCF2;PKD2;DAPK1;MGAT3;AGAP3;SLC25A24;CYBA;ERO1A;HMOX1;PYROXD1;SOD2;HSPA1B;ERCC6L2;FER;SNCA;PRR5L;ZFAND1;FOXO1;GSTP1;TXNRD1;CYCS;CAT;MAPK1;PTPRK;NOX4;PLA2R1
prerank,apoptotic process (GO:0006915),0.21181405620612664,0.9075344433968563,0.6998491704374057,0.8839788927403207,1.0,39/203,16.50%,ELMO1;TGFBR2;BAG6;HK2;CAPN3;CFLAR;PPARD;ITGB2;RHOB;PRKCD;TNFRSF21;CASP1;PLSCR3;TRADD;TNFRSF25;PTK2B;MCM2;ERCC2;NLRP3;DPF2;GAPDH;MTOR;PDE1B;BMF;APAF1;DPF1;BNIP2;CDK11B;MAP3K10;TAOK2;PLK3;PYCARD;AKT1;CIB1;VDAC1;TNFRSF19;ADORA2A;IRF3;BCL2L14
prerank,epithelial cell morphogenesis (GO:0003382),0.33729189508896085,0.9073584536686436,0.5898876404494382,0.8838450462157468,1.0,3/17,7.31%,RILPL1;PKHD1;MET
prerank,regulation of cellular component organization (GO:0051128),0.22238036782088122,0.9073323219810332,0.6714285714285714,0.8833313612079996,1.0,27/135,13.76%,OPHN1;PICALM;SNCAIP;ITCH;LTBP4;GFAP;ATAD3A;RAB4A;KLK8;LAMTOR2;CAMSAP2;PAPPA2;RPTOR;TJP1;MTOR;ERMN;CEACAM1;PTPN1;ANKRA2;PINK1;HIP1R;PTPN11;CDK11B;TAOK2;ABL1;SEMA4D;RAB4B
prerank,positive regulation of lipid transport (GO:0032370),-0.3566522710878814,-0.9072097959349952,0.565121412803532,0.9097486448776696,1.0,2/12,8.39%,APOE;SPP1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2594637478094985,0.9067725446849901,0.6161790017211703,0.8841225248751972,1.0,5/51,4.51%,GREM1;SMAD7;SKI;SMURF1;SKIL
prerank,muscle contraction (GO:0006936),-0.20908300874446878,-0.906543397718747,0.7018469656992085,0.9106813138272629,1.0,11/126,5.30%,DMD;SORBS1;MYOF;UTRN;DTNA;ADRA1A;TMOD3;VIM;GNAO1;GLRA1;CALM1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3128151228173265,-0.9065180588766666,0.5869565217391305,0.9098691782870063,1.0,5/18,12.65%,ROMO1;TIMM23;TIMM17B;DNAJC15;TIMM17A
prerank,positive regulation of cellular component organization (GO:0051130),0.2303515104324019,0.9061624437200736,0.6578538102643857,0.8850598660539786,1.0,19/107,13.40%,TGFBR1;ASAP1;SUMO1;CDC42EP2;IGF1R;CLU;SPIDR;MTLN;TMED9;SH3GLB1;CLIP3;PLEKHM2;LRP1;BMF;DLL1;RAPGEF3;RUNX1;GNL3L;LRP4
prerank,dopamine metabolic process (GO:0042417),-0.312484323853968,-0.9059839133811876,0.6108695652173913,0.9104094982046039,1.0,7/18,18.72%,PRKN;ATP7A;SNCA;DAO;MAOA;MOXD1;MAOB
prerank,protein-containing complex subunit organization (GO:0043933),-0.2157475417329591,-0.9059072331699546,0.6910112359550562,0.9097472963502569,1.0,28/109,17.78%,CD74;CD40;ZW10;DNM1L;NUP98;WASF1;ST13;GEMIN5;SNX9;KNTC1;PPIH;PPP2R1A;NUP205;IL2RB;JCHAIN;PARD3;NUP54;GPAA1;IL1RAP;MDM2;CD3E;TRAF1;RIMS1;ADD2;REPS2;WDR19;SPG7;CARD10
prerank,amyloid fibril formation (GO:1990000),0.26040877894701797,0.905871728635314,0.6273504273504273,0.8851875053097364,1.0,6/51,5.46%,TSPAN14;CST3;SERF1A;SNCAIP;RPS27A;UBC
prerank,oligodendrocyte differentiation (GO:0048709),0.3263270996086577,0.9058548719657384,0.599647266313933,0.8846547285173031,1.0,5/19,10.47%,SOX8;EIF2B3;NSUN5;SHH;EIF2B4
prerank,DNA methylation (GO:0006306),-0.30047375388924874,-0.9058192633037133,0.6105769230769231,0.9090937158220246,1.0,9/23,25.37%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;DNMT1;EHMT1;FOS
prerank,cell-substrate junction assembly (GO:0007044),-0.2758391400730543,-0.9056647004865537,0.6161137440758294,0.9085919730990939,1.0,7/33,10.46%,SORBS1;CTTN;FN1;TRIP6;THSD1;ACTN2;CD151
prerank,actin filament bundle organization (GO:0061572),-0.26564167516446,-0.9051379879637577,0.6144578313253012,0.9090653996885076,1.0,5/33,8.72%,EPS8;NEDD9;PAWR;PLS1;SHROOM1
prerank,protein localization to cell junction (GO:1902414),-0.3098086538749436,-0.9047902222973377,0.6282608695652174,0.9090870240910736,1.0,6/22,14.78%,NLGN1;PCLO;NECTIN1;HEG1;JAM3;MPP4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.3766559148483031,0.9047719701157257,0.5764925373134329,0.8867228269833454,1.0,1/11,0.66%,ARHGEF2
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.27675117510002734,-0.9046054923152582,0.6139088729016786,0.9087020876914212,1.0,7/32,17.81%,MAGI2;PPIA;CALM1;DUSP26;CDH5;PPP1R7;CNEP1R1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.36218299768391277,-0.9044773832150529,0.5884861407249466,0.9081962285441451,1.0,6/12,24.80%,CENPE;NDC80;MAD1L1;KIF2C;NUF2;BOD1
prerank,negative regulation of vascular permeability (GO:0043116),-0.3627536002620819,-0.9044651273001498,0.578125,0.9073522980880758,1.0,3/12,13.66%,SLIT2;SH3GL2;PDE2A
prerank,negative regulation of transport (GO:0051051),0.2632247732112856,0.9043136405210863,0.6164623467600701,0.887276820639779,1.0,13/51,20.05%,SIRPA;CTTNBP2NL;ITGAV;NDFIP2;ARL6IP5;HAMP;SCAMP5;WWP2;PXK;SNX3;PPM1F;NR1H2;SYT11
prerank,atrial septum morphogenesis (GO:0060413),-0.3768359178367538,-0.9042045378340232,0.5711252653927813,0.907156357106561,1.0,4/10,27.58%,HEY2;NOTCH2;ZFPM1;SOX4
prerank,purine-containing compound salvage (GO:0043101),-0.3560171455803949,-0.903695201921846,0.5659090909090909,0.9075490952175925,1.0,3/12,11.20%,AMPD3;ADK;APRT
prerank,mitotic chromosome condensation (GO:0007076),0.30040042724691807,0.9036022425213969,0.5789473684210527,0.8884500065887907,1.0,10/26,25.37%,AKAP8L;CSNK2A2;CSNK2A1;NCAPH2;CHMP1A;NCAPH;CDCA5;KMT5A;MCPH1;PHF8
prerank,defense response to tumor cell (GO:0002357),0.38041515886177035,0.9032733803283741,0.6148007590132827,0.888661115679076,1.0,2/10,8.76%,ABI3;PLK5
prerank,pancreas development (GO:0031016),0.3650312588397665,0.902825668086148,0.5896980461811723,0.8891361286574356,1.0,6/12,28.12%,MET;CCDC40;PROX1;SELENOT;ISL1;TCF7L2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.35017078458895956,-0.9027164630676132,0.5855855855855856,0.9092769608758106,1.0,2/13,4.07%,PTPRT;JAK2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.31241213826251685,-0.9024405859805543,0.5846501128668171,0.9091152560720366,1.0,4/19,13.33%,SLC5A7;APOE;CHRNA4;ACHE
prerank,receptor signaling pathway via STAT (GO:0097696),-0.29487055751330055,-0.9023324376452996,0.6230248306997742,0.9085209312632074,1.0,6/25,14.35%,CCR2;JAK2;PKD2;STAT4;PIAS1;PKD1
prerank,negative regulation of developmental process (GO:0051093),-0.22924605768376372,-0.9022406142454102,0.6579634464751958,0.9079204628832254,1.0,25/69,28.87%,NFIB;DCC;BCL11A;GRIN3A;PRKN;HOPX;KANK1;FGFR3;PARP3;THY1;HEY2;SFRP1;BMP4;TFRC;FOXC1;NEUROD2;VAT1;ARHGEF15;KLF7;FUZ;RPS6KA6;ROCK1;ADCK1;TBX1;BNIP3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.34617174995176814,0.9021936075219866,0.6056603773584905,0.8901136808767315,1.0,2/15,2.63%,MLXIPL;PPARD
prerank,heterocycle biosynthetic process (GO:0018130),-0.3352500380043799,-0.9021886415891837,0.6044444444444445,0.9072149194069458,1.0,2/14,6.03%,GPHN;ALOX5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.38545275467461193,0.9017605209500064,0.6011342155009451,0.8905824292961999,1.0,2/10,7.29%,PDE3B;CDC34
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.35705937107952834,-0.9017575781402036,0.5946502057613169,0.9074847531455547,1.0,4/11,15.25%,DAB2;MLLT3;NKD1;SFRP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3617663084988641,0.901456878642555,0.6,0.890744637392668,1.0,4/13,22.39%,GPRC5A;TSG101;ERRFI1;SNX6
prerank,positive regulation of vascular permeability (GO:0043117),0.36161821958930046,0.9013611644195146,0.586073500967118,0.8903970828682229,1.0,4/12,23.67%,TJP1;TRPV4;TJP2;TGFB1
prerank,RNA stabilization (GO:0043489),0.28253584680102783,0.9010338858589317,0.6191335740072202,0.890626203205634,1.0,11/33,25.73%,FUS;TENT5C;GDNF;RBM24;VIP;SLC11A1;LARP1;ELAVL1;AXIN2;TRDMT1;PARN
prerank,positive regulation of cell cycle process (GO:0090068),-0.2206883879044491,-0.9005877523272731,0.6915167095115681,0.90969035788207,1.0,22/91,17.36%,CUL3;KIF23;RACGAP1;CDC42;GIPC1;KIF14;PKP4;NDC80;NUSAP1;AURKB;SPAG5;E2F7;GPSM2;WIZ;GEN1;DBF4;NPM2;RGCC;RCC2;PRKCE;CEP120;CCNB1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3725522823179195,0.9003690965591458,0.5892857142857143,0.8916317516631341,1.0,3/11,17.12%,LIPC;PLA2G5;AGT
prerank,regulation of lipid metabolic process (GO:0019216),0.23362990738171502,0.9001909486652899,0.6776315789473685,0.8914689853303704,1.0,24/88,25.85%,CHD9;PPARD;GPS2;SIN3A;C1QTNF2;PLPP1;GGPS1;SMARCD3;PANK2;NFYA;TGS1;NPC2;CERS2;IDI1;SIN3B;CARM1;SCD;FGFR4;OPA3;THRSP;ADIPOR1;MVK;NR1D2;MID1IP1
prerank,response to unfolded protein (GO:0006986),0.26126068143558717,0.9000181292615902,0.6327212020033389,0.8913284980790188,1.0,10/48,16.23%,HSPB3;DDIT3;HSPH1;HSPA4;TM7SF3;HSPB8;PTPN1;OPTN;TMBIM6;HSPA13
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2385663643866002,0.899745776872257,0.6661157024793388,0.8913846698793723,1.0,17/78,18.52%,SUMO1;SMAD7;NFE2L2;CSNK1E;FBXO22;SIRT2;CLU;KLHL40;USP5;TAF1;ZYG11B;PLK3;RNF144B;DET1;TRIB1;ZER1;STUB1
prerank,glucan catabolic process (GO:0009251),0.3472214993836101,0.8995040068107275,0.602112676056338,0.8913906797122259,1.0,7/15,21.36%,PYGB;PHKB;AGL;PHKG2;PHKA2;MGAM;GAA
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.28539664051010094,0.899218492123348,0.6338028169014085,0.8915007997333034,1.0,9/33,18.14%,PRKCA;CTNNBIP1;ZFP36L1;IL12B;POU4F1;RUNX1;IL34;CSF1;FES
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.21911573363304396,0.8989218811351075,0.6731927710843374,0.8916407917953575,1.0,44/145,25.30%,SDCCAG8;TUBA4A;CSNK1E;PRKACA;ODF2;TUBB;CEP164;TUBG1;RAD51B;HAUS7;PSMD3;CNTRL;PSMB3;TUBA1A;PSMA7;CEP63;CEP57;HAUS6;HAUS2;PSMC1;PSMC2;SFI1;MAPRE1;PSME4;AURKA;PSMB9;CEP135;ACTR1A;OFD1;DCTN2;CEP43;PSMD4;PSMB5;FBXL7;CEP70;PSMB7;CSNK1D;PSMB8;RAD51C;CCP110;DYNLL1;NDE1;PSMD13;CDC7
prerank,histone H3 deacetylation (GO:0070932),-0.3336373426828438,-0.8980004113219155,0.5950782997762863,0.9156412199738541,1.0,4/15,14.74%,HDAC4;PER2;SIRT1;PER1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2962542274978155,0.8978850971242258,0.6131386861313869,0.8935816464828072,1.0,12/25,26.12%,GMPR2;PNP;GART;PRPS1;PRPS1L1;MTHFD1;PAICS;DGUOK;PRPSAP1;PRPSAP2;ADSL;AMPD2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3000889082119193,0.8977821675970455,0.6072072072072072,0.8932538224458165,1.0,6/24,17.29%,NFE2L2;DDIT3;ATF3;MBTPS2;GCN1;MAPK7
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.19894140881530323,-0.8975116564188185,0.7803468208092486,0.9160569955332564,1.0,21/173,8.59%,ANK3;ANK2;SPTBN1;ACTR10;GRIA1;CUL3;DYNC1I2;CTSC;VAPA;GOSR2;SEC23A;ZW10;STX17;ATL2;RAB1B;SCFD1;F7;SPTBN2;SAR1B;TMED1;COPG2
prerank,negative regulation of histone acetylation (GO:0035067),-0.3623056936514266,-0.8974607094440177,0.5941422594142259,0.915333559585993,1.0,5/11,21.15%,TAF7;SIRT1;SNCA;THAP7;NOC2L
prerank,inorganic cation transmembrane transport (GO:0098662),0.20304953372088566,0.8973533489994329,0.7310924369747899,0.8937438994624913,1.0,43/268,13.87%,SLC30A5;SLC1A3;KCNA5;SLC9A9;SLC36A1;ATP2C1;KCNK6;SLC9A8;TRPV2;SLC24A3;SLC30A10;ITGAV;TRPM4;MCOLN1;TRPM2;KCNH8;KCNH4;KCNN1;SLC40A1;TRPM6;SLC8A1;SCN4B;ABCC9;ABCB8;LRRC55;KCNG2;SLC30A8;KCNH6;LRRC38;ATP1A4;KCNS2;KCNK13;HVCN1;SLC25A27;ATP6V0A4;SLC39A2;KCNA2;SLC6A9;ATP5PO;NNT;KCND1;TRPV4;KCNAB3
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.2792539184685422,-0.8973122455598528,0.6059225512528473,0.9148543015689193,1.0,3/27,4.77%,RIMS2;SYT1;SYT10
prerank,response to UV (GO:0009411),0.23283500360496973,0.897145204506753,0.6677067082683308,0.8936572211607032,1.0,20/95,17.71%,RHNO1;PCNA;PRIMPOL;DDB2;PRKCD;MAP4K3;GTF2H2;EIF2S1;USP28;ERCC2;IL12B;BMF;PCLAF;TAF1;ERCC4;MAPK8;AKT1;UBE2A;KDM1A;TMEM161A
prerank,negative regulation of DNA binding (GO:0043392),-0.2845723192303367,-0.8969245490607811,0.6136363636363636,0.9149594195900217,1.0,6/28,8.62%,JAK2;SOX11;SP100;PER2;ILRUN;NFKBIA
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2604006482999703,0.8966286482994937,0.6523972602739726,0.8943611486666784,1.0,13/46,17.70%,HK2;TOMM20L;PITRM1;TIMM8B;TIMM44;PINK1;TIMM50;TSPO;AKT1;TIMM10B;TOMM20;GRPEL1;TOMM7
prerank,positive regulation of gene expression (GO:0010628),0.19365710421059165,0.896512929585439,0.800275482093664,0.8940655592139591,1.0,121/442,24.37%,TGFBR1;TMEM119;CADM1;SMAD3;CCDC88B;ETS1;FAM98B;NFE2L2;PLD1;LGALS9;MEF2C;VSIR;PIK3R1;DDX5;POLR2H;TLR4;SLC24A3;EGR1;PIK3CG;ATM;CCL3;PAX6;CLU;SF3B1;PLCG2;CALCOCO1;U2AF2;NSUN5;SPRY2;METTL5;MOV10;PDGFB;NOS1AP;BRCA1;OVOL2;GATA2;CNTF;PKP3;GPER1;CALCR;SLC22A2;RBM24;POU4F1;LIMS1;GAPDH;PIK3CD;CD34;MTOR;PIK3CB;SCAMP5;SMARCA5;LAMTOR5;MUSK;BAZ1B;IL33;RPS27L;GJA1;NWD1;MAPK8;SOD1;AKT1;SMO;MAPK14;HPN;DYRK1A;CSF1;POLR1C;PASK;NOG;PIK3R3;MAP2K1;CDH3;EIF2AK2;PDCD10;POLR2E;LGALS7;RAB27A;METTL14;AGT;EIF3D;ROCK2;FXR2;TICAM1;SLC11A1;CUX2;THBS1;MITF;MBIP;FGF18;PPM1F;TNRC6C;VPS35;TNRC6B;EIF2AK3;IL1A;PCIF1;FGFR4;HGS;SFRP4;FGF20;DDX3X;ZC3H12A;TBP;TWIST1;ELAVL1;DEK;POLR1E;PARK7;FGF1;IL36G;BMP2;WBP2;POLR1G;MYD88;TP53;TGFB1;AGO1;TYROBP;HNRNPLL;DNAJA4;SOX9
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.23963542117809417,0.896320062901589,0.6650082918739635,0.893956265797738,1.0,17/76,18.52%,SUMO1;SMAD7;CSNK1E;FBXO22;SIRT2;SMURF1;CLU;KLHL40;USP5;TAF1;ZYG11B;RNF144B;CCDC22;DET1;TRIB1;ZER1;STUB1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.23643125916814037,0.8962821374418497,0.6781045751633987,0.8934708774302033,1.0,23/84,22.24%,BIN1;CNOT1;CLU;ENC1;NANOS2;GAPDH;TOB1;PIN1;MRPL13;IGF2BP2;EIF2AK2;RIDA;EPRS1;GGA3;FXR2;ORMDL2;CAPRIN1;TYMS;EIF2AK3;PCIF1;NANOS1;DDX3X;LARP1
prerank,histone H4-K8 acetylation (GO:0043982),0.33989071829619416,0.8961904581154553,0.6070110701107011,0.8925490253887693,1.0,7/15,26.89%,KANSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1
prerank,histone H4-K5 acetylation (GO:0043981),0.33989071829619416,0.8961904581154553,0.6070110701107011,0.8925490253887693,1.0,7/15,26.89%,KANSL2;JADE2;PHF20;KANSL3;WDR5;KANSL1;MCRS1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.24835861553156346,0.8961886782565265,0.6565143824027073,0.8919833550713988,1.0,20/63,25.09%,CRADD;PCNA;CNOT1;CHEK2;ATM;RBL2;MDM4;PRMT1;TNKS1BP1;RPS27L;CNOT3;PLK3;AURKA;CARM1;PIDD1;RFWD3;CDKN1B;TP53;CNOT2;PCBP4
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.2580504548644878,-0.8961305943318142,0.6439393939393939,0.9161572162974905,1.0,9/42,18.38%,CCR2;CCR1;PF4;GPR35;CCL5;CCL14;CX3CL1;CCL7;FOXC1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.255983816073527,0.8958819614158806,0.6470588235294118,0.8921868196025127,1.0,25/57,28.68%,EMG1;GTF3A;PES1;CUL4B;BOP1;SDAD1;NIP7;TGS1;NOP14;RPS24;NOM1;NVL;CUL4A;LTO1;SHQ1;BYSL;MRPL36;RRP36;DDX31;XPO1;RPL7;URB2;WDR12;PAK1IP1;RBIS
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3088216229496318,-0.8956523824938708,0.6044444444444445,0.9165804590092548,1.0,9/20,23.27%,CWC27;PPIA;PPIH;PPIC;PPIL3;PPWD1;PPIG;PPIF;PPIB
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.30004309689257,0.8955011213086849,0.6180422264875239,0.8925044495621235,1.0,4/27,5.71%,SNTA1;YWHAH;FXYD1;SCN4B
prerank,cell projection assembly (GO:0030031),0.31445262001424135,0.8953637101713988,0.6035714285714285,0.89228031201121,1.0,5/22,10.80%,RAC1;RHOQ;RHOH;NCKAP1L;CYFIP1
prerank,regulation of DNA metabolic process (GO:0051052),-0.25341004197939676,-0.8951595785447692,0.6357308584686775,0.9169390594533277,1.0,15/44,22.66%,UBE2N;KDM1B;SMG6;SMG5;WDR18;NUCKS1;WDR70;XRCC5;SMG1;PIF1;STOX1;USP1;UPF1;POLH;GRHL2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.32541269891214,-0.8949112826710676,0.5868131868131868,0.9167417532080415,1.0,6/16,16.70%,SYN1;MCTP2;CPLX2;MCTP1;KCNMB4;RIMS1
prerank,L-serine metabolic process (GO:0006563),-0.3754916567488673,-0.8948561763867354,0.6178343949044586,0.9160152331010035,1.0,4/10,17.18%,PSAT1;SRR;SHMT1;SERINC5
prerank,negative regulation of cell projection organization (GO:0031345),-0.2428927902395893,-0.8948321555031334,0.6590389016018307,0.9152201237396193,1.0,9/48,12.47%,DCC;SPOCK1;GRIN2B;RAPGEF2;APOE;KANK1;PAQR3;STMN2;MINAR1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3253118174640908,-0.8947765991776282,0.6009389671361502,0.9145017566346813,1.0,1/15,0.06%,MAGI2
prerank,regulation of protein kinase activity (GO:0045859),0.22757388935506537,0.8947042377340723,0.6563517915309446,0.893319486073782,1.0,28/106,19.83%,CAMKK1;MMD;PYDC1;PRKRIP1;UBASH3B;LCP2;PTK2B;PDPK1;CAMKK2;CCR7;TAB2;SMG8;INPP5K;DDR2;CEACAM1;AGAP2;SOD1;TSPYL2;AKT1;CEP85;CSF1;QARS1;TRIB1;C5AR1;PPM1F;ECT2;CEP43;XRCC6
prerank,myelin assembly (GO:0032288),-0.36721407390209376,-0.8946110148271045,0.5881104033970276,0.9140532556794944,1.0,3/10,9.52%,TPPP;TENM4;CNTNAP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.34599454487521875,-0.894238323010702,0.6008771929824561,0.9142118936813649,1.0,3/12,13.52%,CCR2;CLEC6A;PRKCQ
prerank,negative regulation of myotube differentiation (GO:0010832),0.35775025800204463,0.8935157789088639,0.6086142322097379,0.8956723562099467,1.0,1/12,0.28%,TMEM119
prerank,negative regulation of leukocyte activation (GO:0002695),-0.32824455748110243,-0.8932871864532379,0.6057268722466961,0.9158068549009374,1.0,3/15,11.11%,LRFN5;CD300LF;FCGR2B
prerank,Wnt signaling pathway (GO:0016055),0.22948159807545906,0.893171191841309,0.6886035313001605,0.8959156902921642,1.0,34/92,27.12%,LRP5;CSNK1E;ZRANB1;PLCG2;RYK;RPS27A;UBC;WNT2B;PORCN;FZD2;CPE;WNT10B;BCL9;WNT7B;FZD6;TCF7L1;SNX3;FZD1;VPS29;VPS26A;VPS35;CSNK1G2;RAC3;SFRP4;DDX3X;WLS;DVL2;FZD5;FZD9;FZD3;FZD10;CUL1;WNT5B;ARL6
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3352159084343589,-0.8930391133728761,0.5895196506550219,0.9155351240464885,1.0,1/14,0.38%,DPYD
prerank,negative regulation of gene expression (GO:0010629),-0.18261028257176187,-0.8929007663418271,0.8770764119601329,0.9150026129053722,1.0,64/302,17.19%,ROBO1;SAMD4A;XDH;MSR1;PTBP2;ATP2B1;MTF2;JARID2;APP;CCR1;PTPN22;ERN1;RPS3;CPEB3;RBMS3;FOXP1;NPTN;SOX11;APOE;AGO4;SH3GL2;PARP14;PRKN;DAPK1;SIRT1;ZC3H12D;EIF4A3;WNT4;TNRC6A;MYADM;SMCR8;REL;DNMT3B;OPRD1;HELLS;NDFIP1;PTRH2;FCGR2B;KLF4;H3-3A;SETDB2;AEBP2;SHMT1;LGR4;MMP8;RBBP7;TIPARP;HSPA1B;CD46;ACVRL1;HEY2;SFRP1;SNX12;CNOT10;RGCC;RBL1;TTBK1;FFAR4;CD3E;APLN;SFRP2;BMP4;APLNR;PPHLN1
prerank,embryonic organ development (GO:0048568),0.24780785959003612,0.89275671351985,0.6560402684563759,0.8962998052688115,1.0,9/61,12.54%,SALL1;TGFBR2;FOXE1;GDNF;SOX17;WNT7B;RPL10;PKDCC;NDRG4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.22843769538137415,-0.8924158902391051,0.6527093596059114,0.9153148022184724,1.0,14/65,15.14%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PABIR1;AURKB;PSMD5;PSMD12;PSMD11;CHEK1;GPR132;PSMD1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2534288812983053,-0.8923599133870254,0.6481927710843374,0.9146090229471199,1.0,14/46,21.65%,PLCB1;JAK2;PPIA;CDC42;CNN2;STAT4;PSME2;SOD2;ANXA2;AIP;RPLP0;MSN;TCP1;SERPINB2
prerank,L-glutamate transmembrane transport (GO:0015813),0.3837495852374573,0.892190322061407,0.6218181818181818,0.8971374029397031,1.0,2/10,7.10%,SLC1A3;ARL6IP5
prerank,regulation of centriole replication (GO:0046599),-0.32178705480507647,-0.8921205465307573,0.5887640449438202,0.91443811959346,1.0,7/17,17.22%,CDK5RAP2;TRIM37;PLK2;CEP76;ALMS1;MDM1;NPM1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.28589939089337724,0.8920736668251159,0.6265060240963856,0.8968571700488108,1.0,7/29,19.58%,COPA;GOLGA5;NAPG;COG2;COG6;RAB6B;COG5
prerank,glutamine family amino acid metabolic process (GO:0009064),0.28277602868067,0.8920087646148384,0.637478108581436,0.896432524804051,1.0,8/33,18.42%,ART4;DGLUCY;NIT2;GCLC;ALDH4A1;RIMKLA;PYCR2;PYCR1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.29007923629543203,-0.8919457472047017,0.6311111111111111,0.9140347572277365,1.0,7/25,24.00%,ANK3;PRKN;SNCA;TMTC2;TRPV6;TRPM7;KCNA1
prerank,positive regulation of neuron migration (GO:2001224),0.36282848409635293,0.8914401241477503,0.6018518518518519,0.8972145088236708,1.0,1/11,0.66%,ARHGEF2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.19992551431349628,-0.8913046199941101,0.7851002865329513,0.914745234453248,1.0,21/142,11.19%,CCR2;CD36;ADRA1A;TRPC5;ATP2B1;CCR1;RYR2;IAPP;TRPC4;YWHAE;NPTN;SLC8B1;GPR35;CACNA1C;ADCY5;TRPC3;HCRTR2;FIS1;CD52;P2RY1;ADCY8
prerank,mitotic sister chromatid segregation (GO:0000070),-0.21434395652795346,-0.8912490122334472,0.7365591397849462,0.9140434775640073,1.0,25/98,20.53%,CUL3;SMC4;KIF23;CDCA8;ZW10;SPDL1;KIF22;KIF14;RAN;CENPE;NDC80;NUSAP1;DLGAP5;PRC1;SPAG5;BECN1;KIF18B;TEX14;NCAPD3;PDS5A;CCNB1;NCAPG2;RRS1;KIFC1;KNSTRN
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.27717098601705314,0.8908926571587605,0.6319444444444444,0.8979205737885319,1.0,5/36,7.92%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31
prerank,positive regulation of B cell activation (GO:0050871),-0.2445098240396403,-0.8907158888259535,0.6691919191919192,0.9145931555819642,1.0,11/50,17.17%,VAV3;CD38;CD74;CD40;BTK;BCL2;SHLD3;MMP14;TNFRSF4;RIF1;TFRC
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2887947594229596,-0.8906577907627526,0.6357758620689655,0.9138901782082832,1.0,7/26,13.81%,LRRK2;PPIA;PRKN;PDE8A;SIRT1;FBXO7;SOD2
prerank,response to insulin (GO:0032868),0.23675801327550863,0.8905807935100858,0.672,0.8980878290536366,1.0,18/80,20.41%,PDE3B;PIK3R1;LPIN2;RHOQ;SORT1;PDPK1;ZFP36L1;TRARG1;INPP5K;CEACAM1;HDAC5;AKT1;EPRS1;KHK;RAB13;LPIN1;RAB8B;PCK2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3455294495894073,-0.8904385385689965,0.6047516198704104,0.9135634660648125,1.0,4/13,14.08%,LRRK2;RAN;AK3;AK4
prerank,Rho protein signal transduction (GO:0007266),-0.23899261434553004,-0.8902944343376751,0.675392670157068,0.9131012892848294,1.0,3/53,0.29%,EPS8;ARHGAP6;ARHGEF3
prerank,sterol metabolic process (GO:0016125),0.2494132615613081,0.8902795848543513,0.6612111292962357,0.8982220527526917,1.0,11/60,15.59%,PPARD;FDXR;CH25H;CYP46A1;PIP4P1;LCAT;SULT2A1;CYP7B1;LDLRAP1;OSBPL5;FDX1
prerank,positive regulation of leukocyte activation (GO:0002696),0.32016477372216456,0.8902294274292143,0.6131386861313869,0.8977624688010565,1.0,6/18,18.17%,KARS1;TLR4;IL33;NECTIN2;TNIP2;THBS1
prerank,telomere maintenance via recombination (GO:0000722),-0.3490062903732376,-0.8898530918178614,0.6065573770491803,0.9133726326584087,1.0,6/11,33.79%,SMC5;RAD51D;TPRKB;ERCC1;RAD51;NSMCE2
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.2921898171896343,-0.889849551523205,0.6396396396396397,0.9125437188334774,1.0,9/22,24.37%,FGF10;KLF9;CASK;FGF7;SNAI2;PTPRK;TGM1;NOTCH2;ZFP36
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.2696862261949232,-0.8897225366447369,0.6437659033078881,0.9120255981842013,1.0,9/32,17.60%,ARHGAP6;CASK;MMP12;ITGB1BP1;JAG1;CDKN2A;ACVRL1;RCC2;BCAS3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2926986373842805,0.8894829217800304,0.6398601398601399,0.8989468957164918,1.0,13/27,30.80%,MTA1;CRY2;CRTC1;FBXL8;PPP1CB;FBXL22;TP53;FBXL3;RBM4;PPP1CC;FBXL12;PPP1CA;PDE6B
prerank,cellular response to interleukin-12 (GO:0071349),-0.2482180455443348,-0.88933083399603,0.6541176470588236,0.912229398118524,1.0,8/48,7.99%,PLCB1;CD47;JAK2;PPIA;CDC42;CNN2;STAT4;PSME2
prerank,dephosphorylation (GO:0016311),0.21637625225670357,0.88904136982877,0.710077519379845,0.8994222890055732,1.0,33/147,17.63%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;PPM1L;SSH1;PTPRE;PP2D1;INPP5K;PLPP1;ILKAP;PLPP2;PTPN1;PPP2R5B;CDC14B;PTPRA;MTMR4;DUSP29;DUSP18;DUSP5;PPP4R2;TIMM50;PLPPR2;PPP1CB;PTPRH;PTPN21;ACP4;DUSP6;PTPN5;DUSP11;PPP2R5A;PTPRJ
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.29151033083342004,-0.888982422327557,0.6361702127659574,0.9122428528280422,1.0,3/22,8.56%,CCR2;LILRB1;BTK
prerank,neural crest cell differentiation (GO:0014033),0.3284040269303912,0.8887984960902264,0.6209386281588448,0.8994243833860646,1.0,4/18,12.72%,MEF2C;SOX8;KBTBD8;PDCD6
prerank,regulation of telomerase activity (GO:0051972),-0.2434164812100481,-0.8887161696625144,0.6674937965260546,0.912087573867646,1.0,18/45,25.19%,PARM1;CCT2;MAPKAPK5;SMG6;AURKB;KLF4;WRAP53;CERS1;PRKCQ;XRCC5;PIF1;MAPK1;TCP1;NABP2;GRHL2;CTNNB1;MAPK15;HSP90AB1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.26224163773529907,-0.8887032013670217,0.6947115384615384,0.9112882085702159,1.0,11/36,25.21%,CCR2;JAK2;SHANK3;ADRA2A;BUD31;RELN;ITGB1;EPHB2;HDAC1;ARC;FBXW7
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.29571741965894793,-0.8883537690313275,0.6111111111111112,0.9112963470980693,1.0,3/22,7.63%,SCAF8;CDC73;ERCC6
prerank,anion transmembrane transport (GO:0098656),0.2439125342623135,0.8882670175299284,0.6612377850162866,0.900105624313351,1.0,18/67,20.28%,SLC7A8;SLC1A3;SLC25A42;SLC7A5;ARL6IP5;SLC35A1;SLC16A7;SLC6A9;LRRC8A;SLC25A11;SLC25A14;SLC35B4;SLC23A2;SLC23A1;SLC19A1;SLC6A8;LRRC8D;SLC25A10
prerank,response to metal ion (GO:0010038),0.24025040542461099,0.8882031718050705,0.6840390879478827,0.8996750736044727,1.0,16/67,20.55%,SLC30A5;CAPN3;KCNMA1;MT1A;MT1X;SLC30A8;HAMP;MT2A;HVCN1;PDCD6;ALG2;KHK;ATP5F1D;THBS1;IL1A;MAPT
prerank,positive regulation of intracellular protein transport (GO:0090316),0.21303162729124836,0.8877585496098594,0.7488372093023256,0.900140957849417,1.0,37/144,23.79%,ITGAM;HPS4;SMAD3;YWHAH;PIK3R1;ITGB2;AKAP5;CSNK2A2;PRKCD;SH3GLB1;RNF31;USP36;LEPROT;SAR1A;MIEF2;RAPGEF3;PINK1;MAVS;MAPK8;ZIC1;PLK3;CIB1;TENM1;PDCD10;OAZ2;TOMM7;HTRA2;CAMK1;ECT2;PMAIP1;KIF20B;ZC3H12A;KCNB1;TP53;TGFB1;IPO5;JUP
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.29208896173306403,-0.887370805121702,0.6094117647058823,0.9129483823109116,1.0,10/25,27.47%,SCAF8;ERCC6;CCAR2;SETD5;TCEA2;ZNF326;SUPT4H1;ELL;HTATSF1;CCNT2
prerank,mesoderm development (GO:0007498),0.32742815432181643,0.8871819484841869,0.6148007590132827,0.9009543232382002,1.0,4/18,13.83%,IKZF1;MESD;TBX6;BMX
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.35039401589549235,-0.8869586444592502,0.611336032388664,0.9131563529974498,1.0,3/12,10.47%,PPARG;NFKBIA;ABCA5
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.359490711086598,-0.8864171575366889,0.5807127882599581,0.913664837148988,1.0,3/11,7.25%,PAPOLA;BARD1;CDC73
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3493550610824804,0.8855439591668792,0.5971223021582733,0.9043562896984314,1.0,2/13,3.90%,DDX5;ATM
prerank,epithelial cell differentiation (GO:0030855),-0.21694934335391672,-0.8855395828668777,0.7291666666666666,0.9149807445077474,1.0,33/88,32.47%,DAB2;PPARG;ANXA4;LATS1;FSTL1;ERBB4;TST;E2F7;TAGLN;ALDOC;JAG1;DHRS9;BMP4;CNN3;PIH1D1;CTSB;GRHL2;DEUP1;HDAC1;ANXA1;WT1;GSTK1;CASP6;TBX1;PTER;CITED1;AKR1C1;CDHR2;IRF6;OVOL1;GLI1;GSTA2;CCNO
prerank,regulation of B cell activation (GO:0050864),-0.2838528131298051,-0.8848724459203858,0.6622516556291391,0.9157808766342662,1.0,4/25,11.60%,BANK1;IKZF3;FCGR2B;AHR
prerank,mitotic cell cycle phase transition (GO:0044772),0.20681166020093222,0.8847729996743842,0.7708333333333334,0.9056048988123486,1.0,66/203,27.51%,DNM2;SDCCAG8;TUBA4A;CSNK1E;PIM2;PRKACA;CHEK2;FBXL15;ODF2;TUBB;CEP164;TUBG1;CCNG2;CDC34;CUL4B;HAUS7;CNTRL;FBXL8;TUBA1A;CCND3;OPTN;CEP63;CEP57;PLK3;HAUS6;CCNE1;PPP1CB;HAUS2;LATS2;SFI1;MAPRE1;FBXL22;AURKA;MASTL;CEP135;ACTR1A;KDM8;OFD1;KHDRBS1;CUL4A;DCTN2;E2F3;CEP43;CHMP2A;RCC1;CCNY;FBXL7;CEP70;ANAPC1;CSNK1D;CDKN1B;ACVR1B;FBXL3;CCP110;DYNLL1;AJUBA;NDE1;CDC7;PHF8;ACVR1;CUL1;HAUS5;CRLF3;ENSA;FBXL12;CDC25A
prerank,mitotic DNA replication (GO:1902969),0.38066820367404336,0.8847572804611363,0.5932203389830508,0.9050672910661177,1.0,6/10,26.40%,MCM2;LIG1;GINS3;MCM3;MCMDC2;MCM6
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2424220871688479,0.8845233847008798,0.6763698630136986,0.9050501731961509,1.0,20/68,23.91%,NCBP1;POLR2H;TTF2;CSTF2;GTF2H2;SNRPF;ERCC2;PABPN1;CPSF1;SMN1;FIP1L1;POLR1C;POLR2E;MED18;PCF11;UBTF;TBP;POLR1E;POLR1G;MTERF2
prerank,hexose transmembrane transport (GO:0008645),-0.3006413225707939,-0.8843839961443268,0.6152125279642058,0.9162463344741316,1.0,11/21,35.50%,SLC45A3;SLC2A12;SLC2A8;SLC2A2;SLC2A4;SLC50A1;SLC5A1;SLC5A10;SLC2A3;SLC2A6;SLC45A1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22787710796118074,0.8840642474112314,0.7142857142857143,0.90558380583202,1.0,27/94,22.37%,IRAK2;RIPK2;MAP3K3;EGR1;RPS6KA5;RPS27A;UBC;TAB2;MAP3K8;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;TNIP2;PSME4;IL1R2;PELI2;PSMB9;RPS6KA4;PSMD4;NOD2;PSMB5;IL1A;IRAK4;PSMB7;PSMB8
prerank,regulation of chromosome segregation (GO:0051983),0.3350256086519228,0.8837563103770185,0.6268382352941176,0.9057680598178703,1.0,3/16,4.91%,CSNK2A2;CSNK2A1;NUMA1
prerank,extracellular matrix organization (GO:0030198),0.19944619820569687,0.883493130225942,0.7776203966005666,0.9058409042310357,1.0,34/276,11.96%,TGFBR1;ITGB5;ITGAM;F11R;DST;COL27A1;SMOC2;KLK2;GREM1;ITGA6;DSPP;JAM2;NPNT;ITGB2;ITGAV;ADAMTS1;SPARC;LAMA4;LOXL3;CTSS;SH3PXD2A;MMP2;MATN4;PDGFB;TMPRSS6;P4HA1;BGN;P3H2;ADAMTS4;DDR2;MFAP5;BCAN;LAMA3;SERPINE1
prerank,ion transport (GO:0006811),0.22295647566252444,0.8833215477981203,0.75,0.9056648031474852,1.0,16/111,10.35%,SLC1A3;SLC9A9;SLC36A1;SLC12A6;SLC9A8;SLC20A2;SLC24A3;SLC15A4;MCOLN1;KCNN1;CNGB3;SLC8A1;ATP1A4;SLC32A1;SLC17A8;WNK1
prerank,microtubule depolymerization (GO:0007019),-0.3172684476224744,-0.8827113799116497,0.6456521739130435,0.9194405163557965,1.0,9/17,25.03%,STMN4;KIF14;CCSAP;STMN2;KIF18B;NCKAP5;KIF24;KIF2C;STMN3
prerank,cellular response to growth factor stimulus (GO:0071363),0.21528519793630588,0.8825713766154776,0.7386541471048513,0.9068596785830336,1.0,21/151,9.97%,TGFBR1;TGFBR2;SMAD3;TWF2;SMAD7;MEF2C;SIRT2;MT1G;LGMN;SPRY2;ACAP2;EGR3;PDPK1;PDGFB;ZFP36L1;ZFP36L2;OVOL2;PLK5;LIMS1;APPL1;INPP5K
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2747412534094843,0.8823816082808779,0.6348920863309353,0.906727933919059,1.0,7/33,13.80%,CRNN;PHB2;PLCG2;PLK5;APPL1;TAF1;EZH2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3339458787387335,0.8822545000148697,0.6094674556213018,0.9064666507381915,1.0,3/15,11.38%,PDPK1;TJP1;DLL1
prerank,positive regulation of response to stimulus (GO:0048584),-0.25691613399887225,-0.8819990809304334,0.6544117647058824,0.9203685140461192,1.0,9/40,13.73%,RSAD2;B2M;HOMER1;NSMCE4A;SIRT1;FCGR2B;CD80;IER5;CDKN2A
prerank,sprouting angiogenesis (GO:0002040),-0.23897475607660676,-0.8817736203387307,0.6649616368286445,0.9200830168140508,1.0,14/51,17.67%,ROBO1;CCBE1;SLIT2;SEMA5A;VEGFD;CDH13;E2F7;ITGB1BP1;YJEFN3;ACVRL1;TEK;SRF;BMP4;ADTRP
prerank,regulation of intracellular transport (GO:0032386),-0.25786220104728097,-0.881637847210979,0.6399026763990268,0.9195816204682642,1.0,9/38,14.23%,LRRK2;MAP2;SCFD1;SPAG5;NEFH;LAMP1;WWC1;MYBPC3;INPP5F
prerank,negative regulation of viral genome replication (GO:0045071),-0.248734200477014,-0.8811963119267507,0.6502242152466368,0.9198018665170968,1.0,17/40,26.31%,OAS2;RSAD2;IFITM3;RNASEL;IFITM2;OAS3;CCL5;IFITM1;BANF1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;OASL;PLSCR1
prerank,cholesterol efflux (GO:0033344),0.3130249673005535,0.8810895657444294,0.605072463768116,0.9086626956821298,1.0,5/20,17.48%,STX12;APOM;NPC1;NPC2;SCARB1
prerank,regulation of ATP metabolic process (GO:1903578),0.2522618483966655,0.8810239006546723,0.6688963210702341,0.9082418368058357,1.0,20/54,26.44%,RANBP2;COX7A2L;NUP42;SEC13;NUP50;NUP35;PINK1;NUP88;PGAM1;NUP62;SEH1L;NUP107;UQCC2;ABCD1;NUP153;HIF1A;NUP188;ATP5IF1;JMJD8;NDC1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3757103331389473,0.8810210266316035,0.611764705882353,0.9076791007347015,1.0,2/10,4.47%,DIP2B;FLCN
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.21923385645968635,-0.8810053720823273,0.71875,0.9194456477062659,1.0,33/86,31.77%,DAB2;RBPJ;JAK2;SOX11;ING2;SDCBP;GIPC1;HIPK2;ZEB2;TTK;CDH5;GDF1;GDF11;ACVRL1;SH2B1;BMP4;GDF10;SNW1;CDKN1C;INHBB;TWSG1;HSP90AB1;ZNF423;CITED2;HES5;BMPR1B;NUP93;SMAD2;BMP8B;CITED1;GDF6;BMP15;INHBC
prerank,negative regulation of viral transcription (GO:0032897),0.3511402590329327,0.8808252542107509,0.6091549295774648,0.9075944784006035,1.0,3/13,12.68%,UBP1;TRIM11;TRIM62
prerank,response to interleukin-4 (GO:0070670),-0.36985323654252533,-0.8804305124591845,0.6291390728476821,0.920046137919156,1.0,7/10,36.81%,TCF7;LEF1;DCSTAMP;XBP1;CITED1;RUFY4;JAK3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3586665714389936,0.8797225990092126,0.6155268022181146,0.909644017248879,1.0,2/12,8.32%,IL18;IL12B
prerank,positive regulation of autophagy (GO:0010508),0.22787554241037153,0.8795450914226858,0.7084690553745928,0.9094988295477122,1.0,17/81,18.18%,SCOC;PIM2;TRIM5;PHB2;FLCN;CAMKK2;MTDH;SH3GLB1;PIK3CB;TPCN1;PINK1;OPTN;PLK3;ULK1;KAT5;TICAM1;TMEM59
prerank,aortic valve morphogenesis (GO:0003180),-0.2719981779145718,-0.8793300346631499,0.6388888888888888,0.9218527539950296,1.0,10/30,21.54%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;ROBO2;TIE1;DLL4
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3552696752048504,-0.8789282160904647,0.6423982869379015,0.9220251661280537,1.0,4/11,34.64%,RTP4;RTP2;TAS1R3;PKD2L1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2329748386276801,0.8783639122048342,0.7050243111831442,0.9116795534038183,1.0,23/75,23.84%,PDE3B;PTPRM;FOXJ2;ADAMTS1;SPARC;SPRY2;PGK1;SARS1;ECSCR;APOH;GTF2I;SERPINF1;SPINK5;ROCK2;THBS1;KRIT1;SYNJ2BP;HGS;NAXE;CXCL10;EFNA3;KLK3;AGO1
prerank,regulation of monooxygenase activity (GO:0032768),-0.2918551647853947,-0.8783622659003949,0.6712962962962963,0.9225741650961211,1.0,4/23,5.30%,NOSTRIN;EGFR;ZDHHC21;CALM1
prerank,acute inflammatory response (GO:0002526),-0.28786602733104144,-0.8778847050000592,0.6357615894039735,0.9228639397224554,1.0,10/23,33.55%,CEBPB;ANO6;LBP;HPR;HP;SIGIRR;PLSCR1;CRP;CD6;IL22
prerank,negative regulation of DNA recombination (GO:0045910),0.2620691391022576,0.8778696579711097,0.66723259762309,0.9123127626988823,1.0,11/43,19.18%,POLR2H;POLR2J;POLR2D;CGAS;BLM;SHLD2;TERF1;POLR2E;FBH1;ACD;UBQLN4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.23451637443702902,0.8778387655675639,0.6844660194174758,0.9118056956354738,1.0,9/75,8.83%,SLC9A9;SLC12A6;TRPV2;TRPM4;TRPM2;SLC8A1;SLC12A9;ABCC9;ATP1A4
prerank,male gonad development (GO:0008584),0.2741464506313197,0.8774975980905927,0.6521739130434783,0.9120345983865213,1.0,5/34,8.69%,SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,epithelium development (GO:0060429),0.2236020851680634,0.8774454028803559,0.7251552795031055,0.9115759996791925,1.0,20/107,17.16%,SALL1;SOX8;PCNA;LOXL3;CBR1;SHH;PGK1;SOX17;CD34;WNT7B;DLL1;PAX2;NDRG4;SMO;VDAC1;PROX1;MTHFD1;ANXA7;SPINK5;KANK2
prerank,mammary gland epithelium development (GO:0061180),-0.33164601738875926,-0.8769360708160008,0.6163793103448276,0.9244009306997503,1.0,4/14,8.58%,LATS1;JAK2;ERBB4;WNT4
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.36131340977805315,0.8768655615635675,0.6007462686567164,0.9122965168127869,1.0,3/11,8.92%,GREM1;PADI2;DDT
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.35156072354233026,0.8768515659058913,0.6065573770491803,0.9117649956143007,1.0,4/13,16.11%,LARGE1;CHST1;CHST7;CHST2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3490400976476623,0.8765955615271158,0.6502835538752363,0.9117985666729718,1.0,6/12,31.60%,NBN;BLM;WRNIP1;GMNN;METTL4;TICRR
prerank,cellular protein metabolic process (GO:0044267),0.19059705380356207,0.8765705094153532,0.8552278820375335,0.9112795828871272,1.0,83/396,20.59%,GOLM1;ST3GAL6;CST3;CCDC59;MGAT4A;PRKCSH;CDKL3;MAN2B1;IGFBP3;FBXO22;CHEK2;FDXR;UBA7;EIF4G1;MRPL37;RPS27A;MMP2;LGMN;RRBP1;YME1L1;MRPL43;MBTPS1;USP25;CPE;CDC34;MIA3;ADORA2B;MRPL34;SARS1;AMBN;PAPPA2;MRPL9;ARAF;RABGGTA;RPL15;MRPS5;ASMT;PSENEN;GALNT11;FBXL2;RPL10;PSEN2;MSLN;DHPS;SLC35A1;RPS8;MRPS21;PPP4R2;ABL1;GSPT2;WWP2;ABCF1;RPS24;MRPL13;MRPS16;CSF1;MRPS11;MRPS18B;FDX1;ADORA2A;PLG;FBXO11;ADAM10;ADPRH;CSF2RA;EIF4EBP2;APH1B;HTRA2;EVA1A;RPL9;AFG3L2;MRPS18A;PHKA2;DMP1;RPL39;PENK;DUSP12;PARP4;TGM5;MRPL11;TNIP1;MRPL41;MRPL27
prerank,regulation of cellular catabolic process (GO:0031329),-0.2300708859862016,-0.8764296852838461,0.7127937336814621,0.9247764789197715,1.0,10/62,8.98%,ITPR1;LRRK2;DRAM1;RRAGB;PRKN;DAPK1;USP10;USP13;RAB8A;SMCR8
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3130119440166285,0.8764177005418353,0.6354961832061069,0.9110520974838194,1.0,2/19,1.71%,TGFBR1;MEF2C
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3093598285042156,0.8761869920132334,0.6453382084095064,0.9110007093624332,1.0,3/18,14.22%,TMEM119;FRS2;HDAC5
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19371026868321062,0.8761849023180464,0.83008356545961,0.9104357378587167,1.0,88/336,24.17%,HERC2;SUMO1;CSNK1E;DDIT3;MACROD1;EID3;CHEK2;LYN;HPF1;RFC2;DDB2;FAM111A;UBA7;NBN;ATM;AATF;REXO4;WDR48;SPIDR;RAD17;RAD51B;USP28;AKTIP;MGMT;CGAS;SLX4;CUL4B;INTS3;BRCA1;RBM24;PLK5;ACER2;RNF8;LIG1;MMS19;KMT5C;FANCG;APTX;PCLAF;TAF1;BAZ1B;EXO1;RAD1;ERCC4;UBE2U;BLM;TAOK2;ABL1;CEP63;RPAIN;PLK3;CIB1;MAPK14;PSME4;UBE2A;IRF3;MASTL;XIAP;DTX3L;NABP1;HTRA2;GNL1;FANCA;FBH1;CUL4A;UBQLN4;PIDD1;SLF2;RAD9A;PARP4;EPHA2;UBE2T;PWWP3A;TOPORS;SETD7;ZC3H12A;RFWD3;TOPBP1;BCL2L1;NSMCE3;BCL2L11;ZBTB1;PARK7;TP53;SPRTN;YY1;STXBP4;RAD51C
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.2823539835940536,-0.8761796205478511,0.6628440366972477,0.9245518603694596,1.0,4/24,11.16%,PID1;NDUFS1;SDHAF4;GFPT2
prerank,cellular protein-containing complex assembly (GO:0034622),0.21024543156498054,0.8755853498824775,0.7563150074294205,0.9112755907043278,1.0,27/159,14.44%,BIN1;SMAD3;PICALM;DRC1;OTUD6B;TMEM35A;SRC;STXBP1;CLU;VAMP1;COX7A2L;PSMG1;CLTB;EID2;DHX9;MIS12;HSPA4;EIF4H;TTC12;CLTA;HIP1R;NDUFAF1;GPX4;POGZ;CCDC40;CHRNA3;BBS12
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.28803281028320893,0.8751090717925928,0.643979057591623,0.9118831933613357,1.0,6/29,15.49%,UTP6;WDR46;TBL3;NOP14;RPS8;MRPS11
prerank,myoblast differentiation (GO:0045445),0.3379260357743753,0.8748456637412912,0.6177536231884058,0.9119306264237558,1.0,2/14,9.80%,DDX5;DDX17
prerank,membrane raft organization (GO:0031579),0.33748395205037673,0.8746606350956377,0.6577946768060836,0.911807209937237,1.0,4/15,11.35%,PPT1;FLOT2;CLN3;NPC1
prerank,regulation of telomere maintenance (GO:0032204),-0.2694149139083354,-0.8744527843229063,0.6577181208053692,0.9279592389362082,1.0,12/26,28.97%,SMG6;SMG5;XRCC5;SMG1;PIF1;MRE11;UPF1;PPP1R10;PML;ERCC1;GNL3;TINF2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.2699545621785241,0.8744238239363334,0.6428571428571429,0.9117811153982386,1.0,11/39,19.99%,NFE2L2;PDPK1;GATA2;GPER1;ECSCR;SERPINE1;TNIP2;MAPK7;GATA3;THBS1;KRIT1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.33452749446274577,0.8743456049579478,0.6268656716417911,0.9114036734688077,1.0,6/15,16.30%,BMP2K;NEU3;DGKD;PIK3CB;HIP1R;WASL
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.31234655180724646,-0.8742938098011386,0.6359649122807017,0.9275206611196406,1.0,7/16,23.37%,APOE;IFNGR1;HMGCR;SRF;CYP51A1;HDAC1;ABCA7
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.23408630644474193,-0.8737361095551536,0.6811594202898551,0.928047555334549,1.0,5/52,3.48%,SORBS1;DPP10;SPTBN1;EGFR;ACSL3
prerank,macrophage chemotaxis (GO:0048246),0.368521666505735,0.873733504112773,0.6132596685082873,0.9122238425617746,1.0,3/10,15.24%,CCL3;EDN2;CXCL17
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.24074157030647253,-0.8731860834166632,0.7086419753086419,0.9285168619468982,1.0,12/50,17.26%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;PSMD1;OAZ1;AZIN1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.31012805935504706,0.873177425904095,0.6535714285714286,0.9129568550180612,1.0,9/19,25.70%,CSNK2A2;CAMKK2;USP36;PINK1;VDAC1;HTRA2;PARK7;FZD5;HDAC6
prerank,COPII vesicle coating (GO:0048208),-0.2311582427716954,-0.8730638224994951,0.7388059701492538,0.9263461196420889,1.0,11/61,11.35%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2311582427716954,-0.8730638224994951,0.7388059701492538,0.9263461196420889,1.0,11/61,11.35%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D
prerank,vesicle coating (GO:0006901),-0.2311582427716954,-0.8730638224994951,0.7388059701492538,0.9263461196420889,1.0,11/61,11.35%,GRIA1;CUL3;CTSC;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D
prerank,regulation of stem cell proliferation (GO:0072091),0.324132277681781,0.8730417239831277,0.6325088339222615,0.912699908922939,1.0,5/17,18.02%,ZFP36L1;GJA1;EIF2AK2;KDM1A;HMGB2
prerank,positive regulation of protein deacetylation (GO:0090312),0.343847866488143,0.8729742522800327,0.6164122137404581,0.912297340794163,1.0,2/14,2.94%,AKAP8;AKAP8L
prerank,early endosome to late endosome transport (GO:0045022),0.3091477469601993,0.8726005378342954,0.6577060931899642,0.9126060484449681,1.0,7/20,23.24%,HOOK2;PIK3C3;AKTIP;PTPN23;WDR81;STX8;HOOK3
prerank,negative regulation of cellular metabolic process (GO:0031324),0.26589688100193476,0.8724720020485413,0.6735395189003437,0.9123230619572563,1.0,8/37,13.34%,SIRT2;ITGAV;AATF;BRCA1;PAX2;DLG4;PINK1;OPTN
prerank,mucosal immune response (GO:0002385),-0.32545206162066875,-0.8722025649509915,0.6318289786223278,0.9275413330119242,1.0,3/15,19.93%,CAMP;RNASE3;LTF
prerank,regulation of cell killing (GO:0031341),0.32598808357204623,0.8721843216322115,0.6336448598130842,0.9124290890878071,1.0,5/16,24.00%,RAC1;MAPK8;NOXO1;CFH;DVL2
prerank,apical junction assembly (GO:0043297),-0.23628153308503771,-0.8720356974294486,0.7071428571428572,0.9271272220390793,1.0,20/53,30.12%,CTNNA1;AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;MICALL2;GRHL2;PARD6G;MARVELD3;OCLN;STRN;DLG1;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,carboxylic acid catabolic process (GO:0046395),0.3525137706065238,0.872006933353308,0.6291512915129152,0.9122304758632018,1.0,6/12,24.07%,AMDHD2;PON3;NPL;IL4I1;ACOT8;ACOT4
prerank,phosphate-containing compound metabolic process (GO:0006796),0.20356917715822834,0.8714501980383887,0.7638483965014577,0.9130175002591965,1.0,37/198,15.18%,INPP5D;HK2;LPCAT4;PFKL;GFPT1;PIK3CG;PLCG2;PLA2G4A;PLA2G15;PIP4P1;PGK1;GK5;PLA2G4B;PLB1;LCAT;PLA2G5;INPP4B;PLD4;PIK3CD;MTOR;INPP5K;PLPP1;PIK3CB;CERK;NUDT14;PANK2;PLPP2;XYLB;PFKFB2;DUSP18;GPX4;DUSP5;INPP1;PLPPR2;IMPA1;AKT1;ACP4
prerank,carnitine metabolic process (GO:0009437),0.35486113419442367,0.8714159623652795,0.6301115241635687,0.9125247939164419,1.0,5/12,22.76%,ACADM;CROT;CRAT;CPT1A;CPT1C
prerank,chondrocyte differentiation (GO:0002062),-0.2634095133287801,-0.8713392433197663,0.6986301369863014,0.9279550938191008,1.0,11/32,21.19%,NFIB;SULF2;SOX5;SNX19;FGFR3;RUNX2;SCX;CCN3;BMP4;WNT7A;SOX6
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3125499053401706,0.8709957365139576,0.6368515205724508,0.9129299408833366,1.0,5/19,17.33%,NFATC1;EDN3;EDN2;NMUR2;GPR62
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3577923502912659,0.8704429442475398,0.6306818181818182,0.9136047389988192,1.0,5/11,30.33%,MTOR;SMARCA4;IPPK;DDX11;SIRT7
prerank,protein import into peroxisome membrane (GO:0045046),-0.2926745398694348,-0.8702301719198322,0.6495327102803738,0.9297521143536838,1.0,5/22,13.00%,ATAD1;ACBD5;PEX12;FIS1;ALDH3A2
prerank,negative regulation of cell aging (GO:0090344),0.3306480500234114,0.8700846719287959,0.6321626617375231,0.9138439447052659,1.0,2/16,3.41%,MAP3K3;SLC30A10
prerank,sulfur compound biosynthetic process (GO:0044272),0.22379132018416853,0.8698819098247178,0.716012084592145,0.9137674356660679,1.0,20/104,16.11%,ST3GAL6;HPGDS;B3GNT2;PRELP;CHST11;CHST1;B3GNT4;MPST;BGN;CHPF;CHPF2;CHST7;BCAN;CSPG5;ST3GAL3;GCLC;PAPSS1;CHSY1;GSTA3;CHST2
prerank,mitotic spindle assembly (GO:0090307),-0.2450494393468735,-0.8698415824890415,0.6724565756823822,0.9298279876845319,1.0,8/42,10.03%,KIF23;RACGAP1;TOGARAM2;TPX2;AURKB;MAP9;PRC1;KIF11
prerank,negative regulation of cell death (GO:0060548),0.2292422886586476,0.8698109151440162,0.7233333333333334,0.9133947832406463,1.0,19/88,19.78%,SRGAP2;CLU;EIF4G1;IMPACT;TM7SF3;POU4F1;CD34;PAX2;DCPS;PINK1;AKT1;CSF1;GPNMB;KANK2;NUP62;ATG5;HTRA2;VPS35;CHMP2A
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.22838885670879222,-0.8696092761131038,0.727735368956743,0.9295435823693302,1.0,15/64,16.47%,UTRN;CD36;SLK;GSK3B;SKAP1;CASK;LIMCH1;CDH13;EFNA5;JAG1;CDKN2A;THY1;CX3CL1;SFRP1;CD3E
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.36597462754644944,0.8694585678281203,0.6332116788321168,0.9136153319861977,1.0,2/11,6.13%,UQCRB;UQCRC2
prerank,response to ketone (GO:1901654),0.3022238070298048,0.8690453832776746,0.6655172413793103,0.914020847409523,1.0,8/24,23.67%,HSD3B2;CCR7;UBE3A;ABCB4;THBS1;WBP2;CATSPER2;TGFB1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3074046413592825,0.8688487585224507,0.6606498194945848,0.9139185128607941,1.0,9/22,29.73%,CYRIB;IL12B;FBXO38;ZBTB1;FADD;FZD5;TRAF6;STX7;IL12RB1
prerank,regulation of lipid storage (GO:0010883),-0.29103482605883035,-0.8685802221120293,0.6531049250535332,0.9311149477979623,1.0,9/22,29.77%,SIRT1;PTPN2;NFKBIA;IKBKE;VSTM2A;FBXW7;ALKBH7;PLA2G10;CRP
prerank,regulation of neuron projection arborization (GO:0150011),-0.31761966755028437,-0.8680243687092303,0.6590389016018307,0.9315999121736863,1.0,5/15,14.17%,GRIP1;MFSD2A;MAP3K13;NTNG1;NTNG2
prerank,mitochondrial protein processing (GO:0034982),0.3645233306836655,0.8679588978387701,0.6295620437956204,0.9153955211910165,1.0,5/11,21.67%,YME1L1;PMPCA;MIPEP;AFG3L2;STOML2
prerank,androgen metabolic process (GO:0008209),0.3137353399106509,0.867951913546041,0.6403508771929824,0.9148488436037556,1.0,4/18,15.95%,HSD3B2;SHH;AKR1D1;HSD17B10
prerank,positive regulation of cell growth (GO:0030307),-0.20931414180874736,-0.8677169491950235,0.7520891364902507,0.9315201866631785,1.0,23/96,17.41%,RIMS2;AKAP6;CDKL5;EGFR;BDNF;SYT1;NEDD4L;CDC42;SDCBP;LGI1;PABIR1;MFSD2A;H3-3A;MAP3K13;SEMA7A;SYT3;SFRP1;BCL2;MMP14;MTPN;RIMS1;SFRP2;USP47
prerank,protein targeting to mitochondrion (GO:0006626),0.248254686385863,0.8675078850365604,0.6935201401050788,0.9153226148616108,1.0,15/52,17.70%,TOMM20L;PITRM1;HSPA4;TIMM8B;PMPCA;TIMM44;TIMM29;TIMM50;MIPEP;TSPO;NDUFA13;TIMM10B;TOMM20;GRPEL1;TOMM7
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.36740689375640856,-0.8673477859963467,0.614406779661017,0.9315093219759852,1.0,3/10,15.78%,ST3GAL1;RENBP;GNPDA2
prerank,glycolipid biosynthetic process (GO:0009247),0.2643699464971637,0.8672667157329272,0.703150912106136,0.9153149061331933,1.0,5/38,7.26%,LARGE1;ST3GAL5;PIGV;PGAP2;DPM3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.2738594636814803,0.86689255387713,0.6518650088809946,0.9156234118919773,1.0,8/33,17.30%,MEF2C;IGFBP3;AIF1;IL12B;GPER1;NDRG4;VIP;TRIB1
prerank,Golgi inheritance (GO:0048313),0.3577452958855721,0.866747781825863,0.6325411334552102,0.9153952018094073,1.0,4/11,18.73%,PLK5;PLK3;PDCD10;STX5
prerank,bicellular tight junction assembly (GO:0070830),-0.2444943558219854,-0.8666120410393093,0.6997635933806147,0.9323681588534931,1.0,19/46,30.12%,AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;MICALL2;GRHL2;PARD6G;MARVELD3;OCLN;STRN;DLG1;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,maintenance of blood-brain barrier (GO:0035633),0.27454835132337185,0.866600845726265,0.6708407871198568,0.9151785945580371,1.0,10/30,20.84%,F11R;JAM2;LSR;TJP1;GJA1;TJP2;CLDN12;CLDN1;WNK3;LAMA2
prerank,synaptic vesicle transport (GO:0048489),-0.3559129552542378,-0.8663637980824309,0.647191011235955,0.9321456879360925,1.0,3/11,8.61%,KIF5C;TOR1A;KIF5B
prerank,SNARE complex assembly (GO:0035493),0.3691648664450463,0.8662815693955216,0.6309963099630996,0.9153539551618672,1.0,2/10,4.32%,STXBP1;VAMP1
prerank,regulation of cell cycle process (GO:0010564),-0.2047001854438156,-0.8661358590307102,0.7692307692307693,0.9318423791110829,1.0,26/104,16.90%,MKI67;RACGAP1;CALM1;CDC42;KLHL13;UVRAG;TTL;CUL7;PLK2;AURKB;MAP9;PRC1;KIF11;BUB1;SPAG5;BECN1;KIF20A;DCUN1D3;OBSL1;DBF4;CHEK1;IHO1;SFRP1;CDC25C;MAD1L1;PKMYT1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.30351585107682977,-0.8659965975727233,0.6585903083700441,0.9313629154890843,1.0,6/19,15.68%,PTPRD;CDKL5;IL1RAPL1;CUL7;OBSL1;RELN
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3158212300567072,-0.8656037588834128,0.6630196936542669,0.931464576708288,1.0,6/16,16.40%,B4GALT6;ST8SIA4;ST8SIA1;ST8SIA2;B3GALT4;ST8SIA3
prerank,ncRNA processing (GO:0034470),-0.18870757214164577,-0.8653029908113999,0.8463855421686747,0.9313525483330986,1.0,53/200,20.28%,RPL36A;RPL30;RPL35A;DDX10;RPS7;RPL4;UTP20;RPS2;AGO4;SNU13;RPLP2;RPL7A;LAS1L;EXOSC1;POP4;RPL41;RPL26;XRN2;DCAF13;RPS27;TUT4;RPL18A;RPS25;MRTO4;RPL38;RPL37;NOC4L;UTP14A;RPS14;RPL24;EXOSC7;INTS9;WDR18;POP7;RPS9;DROSHA;RPLP1;RPL22;NOB1;RPL8;ESF1;RPLP0;INTS7;TUT1;RPL19;SMAD1;AARS1;PIH1D1;RRP9;RPL13A;RPS6;RPS19;RPL23A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2130269085705904,-0.8652942329897042,0.7803030303030303,0.9305501569191802,1.0,17/85,16.65%,MAGI2;PRICKLE2;AP2A2;PSMD14;PSMD8;CDC42;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;AP2B1;PSMD11;PSMD1;TIAM1;DAAM1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.30843601777843527,-0.8650919808299221,0.6569506726457399,0.9302243073543193,1.0,6/17,19.38%,VIM;WNT4;SCX;RGCC;BMP4;SUCO
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3006730034778561,-0.8648728423024181,0.6527196652719666,0.9299192301415597,1.0,6/18,23.20%,DAB2;MTMR2;SNX12;MSN;MAPK1;EZR
prerank,negative regulation of cell communication (GO:0010648),0.3057901597053019,0.864798060108766,0.6566371681415929,0.9180865036923118,1.0,4/21,15.99%,IGFBP3;UBASH3B;PTPN1;OSM
prerank,defense response to symbiont (GO:0140546),0.22547811907009208,0.864508449629678,0.742320819112628,0.9182002212602731,1.0,26/92,22.41%,TLR7;RNASE1;SERINC3;TRIM5;MOV10;ABCC9;CGAS;ZMYND11;ABCE1;G3BP1;RNASE6;SETD2;EXOSC5;MAVS;TTC4;PYCARD;SHFL;EIF2AK2;IRF3;ISG20;MAP3K14;IRF2;PMAIP1;NLRC5;ACOD1;BCL2L1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3584582804769169,0.8644327590403574,0.6319845857418112,0.9178129843800655,1.0,4/11,25.73%,EXOSC5;EXOSC10;FBL;PARN
prerank,superoxide metabolic process (GO:0006801),-0.2697863233401844,-0.864397913458865,0.6901709401709402,0.9301714015983242,1.0,8/29,16.26%,CYBB;PRDX1;NCF2;ATP7A;CYBA;NRROS;SOD2;TAFA4
prerank,inhibitory synapse assembly (GO:1904862),-0.34388984192533906,-0.8643339615208381,0.6589958158995816,0.9295056098887032,1.0,5/11,18.69%,GABRA2;GABRG2;GABRB3;PLXNB1;CBLN4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2655442657196302,-0.8642235282674965,0.6886792452830188,0.9289526348181688,1.0,4/28,6.72%,ARHGAP35;CTTN;LATS1;PAK3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.23155360670890096,-0.864166744308136,0.6897374701670644,0.928274813647092,1.0,6/52,3.91%,YWHAQ;NPEPPS;TFDP2;ATG13;YWHAE;UBE2J2
prerank,regulation of muscle cell differentiation (GO:0051147),0.27672691599426424,0.8641185604071259,0.680140597539543,0.9179919595161128,1.0,10/31,20.27%,MEF2C;CDK9;MEF2A;BNIP2;ABL1;MAPK14;CDH15;TCF3;CAMK1;MEGF10
prerank,cAMP biosynthetic process (GO:0006171),-0.3541909712459606,-0.8638192188956124,0.6247288503253796,0.9282342334205576,1.0,4/10,11.19%,ADCY2;ADCY5;ADCY3;ADCY8
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.25519136819723426,-0.8637065997447161,0.6741293532338308,0.9276821407553384,1.0,6/35,11.94%,PAM;ALOX5;ALOX5AP;HMGCLL1;GGT7;FAR2
prerank,positive regulation of translational initiation (GO:0045948),0.31772659908857553,0.8633119235061834,0.6318681318681318,0.9192576321705211,1.0,9/18,25.59%,POLR2D;MTOR;UHMK1;KHDRBS1;BOLL;DDX3X;LARP1;HABP4;YTHDF3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2372374202687748,0.8630628085391471,0.7212020033388982,0.9192438195297605,1.0,11/57,13.18%,CHEK2;NBN;ATM;RAD17;FOXN3;BRCA1;CDC14B;RPS27L;BLM;TAOK2;ABRAXAS1
prerank,mitochondrion organization (GO:0007005),0.20296267064461146,0.8624666492135785,0.8289085545722714,0.9200439065716505,1.0,46/165,23.14%,DNM2;HK2;TRAK1;CXADR;PHB2;COX7A2L;MIGA2;ATAD3A;PITRM1;YME1L1;PISD;TIMM8B;MEF2A;NRF1;FANCG;MIEF2;TIMM44;SSBP1;PINK1;TIMM50;TSPO;RAB32;MTX1;HSD17B10;TMEM11;POLG2;TIMM10B;TOMM20;ATP5F1D;BCS1L;TOMM7;PPRC1;AFG3L2;MYH14;VPS13C;WDR81;ATCAY;TFB1M;MTFR1L;STOML2;PYROXD2;AGTPBP1;BCL2L1;OPA1;PARK7;VPS13D
prerank,negative regulation of response to external stimulus (GO:0032102),0.2161624084359247,0.8623713996646611,0.7736156351791531,0.9196980209741819,1.0,23/105,17.88%,SIRPA;RTN4RL1;SIRT2;PPARD;OTULIN;ITCH;GPS2;PRKCD;KLK8;PCBP2;C1QBP;NLRP3;GPER1;TNFAIP8L2;SERPINE1;DRD2;CERS2;RTN4R;CXCL17;MAPK7;TRIB1;AJAP1;GATA3
prerank,cellular response to arsenic-containing substance (GO:0071243),0.33296589915495073,0.8619026252462284,0.6466302367941712,0.9202117228129055,1.0,8/15,33.18%,ATF3;DDX3X;ZC3H12A;HNRNPA1;CPEB2;GSTO2;VCP;GSTO1
prerank,cellular response to chemokine (GO:1990869),0.25664708255850943,0.86163295088187,0.7095158597662772,0.9202461092231226,1.0,6/46,10.35%,DOCK8;LRCH1;CCL3;PTK2B;CXCL1;WNK1
prerank,steroid biosynthetic process (GO:0006694),0.24173946433868815,0.861576823276605,0.7107438016528925,0.9198214126146205,1.0,10/56,16.98%,FDXR;HSD3B2;CH25H;HSD17B1;OSBPL3;CYP46A1;AKR1D1;CYP7B1;HSD17B10;OSBP
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.23261946534635683,-0.8615335624622509,0.7573529411764706,0.9320374263390828,1.0,12/53,17.26%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;PSMD1;OAZ1;AZIN1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3443197210335548,-0.8614889484079498,0.6453744493392071,0.9313241749626032,1.0,2/11,5.42%,LRP6;NR4A2
prerank,organelle fusion (GO:0048284),-0.2794449199601746,-0.8613402877854641,0.6761487964989059,0.9308501692712072,1.0,6/22,17.41%,EEA1;MIGA1;FIS1;MFF;CYP26C1;SPG7
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.33780478829054617,-0.8613318619555645,0.6681222707423581,0.928444404695915,1.0,2/12,9.50%,CUL3;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.33780478829054617,-0.8613318619555645,0.6681222707423581,0.928444404695915,1.0,2/12,9.50%,CUL3;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.33780478829054617,-0.8613318619555645,0.6681222707423581,0.928444404695915,1.0,2/12,9.50%,CUL3;DLGAP5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3043277307953784,0.8612014919037402,0.6775862068965517,0.9200850633439951,1.0,9/22,30.02%,CRY2;MGAT5;NCKAP1L;MASTL;ROCK2;IKBKB;FKBP1B;BOD1L1;STYXL1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.26664689176844647,0.8609073705350115,0.6945898778359512,0.9201437917867842,1.0,8/37,11.22%,SMAD7;RIPK2;SIRT2;EIF4G1;SPRY2;RPTOR;INPP5K;TNKS1BP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3730420528127546,0.8605053056010066,0.6273408239700374,0.9204761272870611,1.0,2/10,9.24%,ERLEC1;OS9
prerank,positive regulation of receptor internalization (GO:0002092),-0.27961854211910536,-0.86046660266648,0.6745283018867925,0.9296073276630359,1.0,2/22,3.66%,MAGI2;ATAD1
prerank,positive regulation of cell aging (GO:0090343),-0.3491652758020338,-0.8597525248467467,0.6063157894736843,0.9304996658173927,1.0,4/11,13.73%,B2M;LMNA;SIRT1;CDKN2A
prerank,neurogenesis (GO:0022008),0.2608771539555794,0.8596492874100294,0.676126878130217,0.9218759440329186,1.0,3/43,4.86%,DAGLB;TRAK1;RYK
prerank,response to nitric oxide (GO:0071731),-0.3300894467375454,-0.8591837453377608,0.6263736263736264,0.9310232610427116,1.0,6/13,25.40%,KCNC2;GUCY1B1;CDK2;FOXO1;AQP1;CCL19
prerank,smooth muscle cell differentiation (GO:0051145),-0.33814876196887655,-0.8587357312739257,0.6412037037037037,0.9311815604208002,1.0,7/12,32.25%,EDNRB;HEY2;BMP4;APLNR;MRTFB;MYOCD;TBX18
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.23495928244734687,-0.8585026878888012,0.728110599078341,0.9309017009323323,1.0,14/48,18.61%,AMPD3;ADCY2;GUCY1B1;PAPSS2;ADCY5;SLC25A16;ADCY3;ADCY8;SLC26A2;ADSS2;SLC35B3;PPCS;GUCY2F;GUCY2D
prerank,positive regulation of DNA replication (GO:0045740),0.32557465939886376,0.8582819666332776,0.6604127579737336,0.92440855420581,1.0,3/16,6.85%,PCNA;CTC1;DHX9
prerank,leukocyte cell-cell adhesion (GO:0007159),0.29061329194241003,0.8579941479541261,0.6704331450094162,0.9244775979357958,1.0,5/24,8.52%,F11R;FERMT3;ITGB2;SELE;SELP
prerank,polarized epithelial cell differentiation (GO:0030859),0.3457501986872555,0.8579324485781769,0.671559633027523,0.9240428131396633,1.0,1/13,0.53%,OPHN1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.23924220248804542,0.8578518457831055,0.7140549273021002,0.9236651122743256,1.0,12/62,13.52%,MEF2C;LYN;KMT2D;HOXB8;CTR9;PTK2B;MOV10;SIN3A;PRMT1;PRKCB;RUNX1;PRMT6
prerank,regulation of fibroblast proliferation (GO:0048145),-0.23916989790141335,-0.8577413804681426,0.7342995169082126,0.9318867865717146,1.0,15/45,24.85%,CD74;FN1;CDC73;LIG4;CDKN1A;SFRP1;B4GALT7;E2F1;GSTP1;CDK4;AQP1;EMD;PARP10;CTNNB1;NLRC3
prerank,iron ion transmembrane transport (GO:0034755),-0.3545991959159025,-0.8576535135292137,0.6205450733752621,0.9312913727901966,1.0,3/10,10.18%,ABCB7;SLC25A28;SCARA5
prerank,protein ADP-ribosylation (GO:0006471),0.2786650279010008,0.8570235904165286,0.684981684981685,0.9248985291906098,1.0,3/28,3.37%,SIRT2;ART4;HPF1
prerank,regulation of DNA binding (GO:0051101),0.25389592381973597,0.8569856817737627,0.7199312714776632,0.9244251672031774,1.0,11/44,18.02%,SUMO1;SKI;SIRT2;MDFI;JUN;CEBPG;MAPK8;SMO;KDM1A;NME1;HMGB2
prerank,respiratory chain complex IV assembly (GO:0008535),0.3075644963869149,0.8566739957158616,0.6666666666666666,0.924538662611498,1.0,7/21,23.70%,COA8;COX19;SURF1;BCS1L;FASTKD3;COX16;COX17
prerank,cellular component assembly (GO:0022607),-0.18066719363863415,-0.8563374185802201,0.8970588235294118,0.9334713582752503,1.0,49/253,17.78%,NLGN1;EPS8;NEDD9;CD74;ANK3;SPTBN1;GSN;CD40;ZW10;PCLO;DNM1L;VCPIP1;CDC42;WASF1;RTN4;ST13;PAWR;GEMIN5;VMP1;SNX9;PLS1;SHROOM1;ACTB;LRRTM3;KNTC1;PPIH;PPP2R1A;DNAJB13;CFAP206;IL2RB;RHOU;NEFH;JCHAIN;PARD3;GPAA1;IL1RAP;MDM2;CORO1B;CD3E;TRAF1;RIMS1;PARVG;RSPH1;ADD2;REPS2;WDR19;SPG7;TRIP13;CARD10
prerank,regulation of leukocyte activation (GO:0002694),0.33568496219363003,0.8562575643641412,0.6715867158671587,0.9249409585361282,1.0,6/14,22.00%,PJA2;LYN;GPER1;CD33;MYO18A;SHPK
prerank,positive regulation of macroautophagy (GO:0016239),0.24681896523768337,0.8561122834979956,0.7195767195767195,0.9246970809215732,1.0,13/48,23.73%,SCOC;RAB3GAP1;RAB3GAP2;SH3GLB1;HSPB8;PINK1;OPTN;VDAC1;FYCO1;LARP1;SESN1;VPS13D;RALB
prerank,regulation of T cell cytokine production (GO:0002724),0.32212428272077986,0.8560536225237745,0.675,0.9242639932471879,1.0,2/15,3.78%,SMAD7;TRPM4
prerank,regulation of DNA replication (GO:0006275),-0.23464045016932197,-0.8555649499283073,0.7434052757793765,0.9344401145687388,1.0,12/49,17.07%,EGFR;ANKRD17;FAF1;S100A11;CCDC88A;PPP2R1A;NUCKS1;NPM2;ACVRL1;ESCO2;GMNC;PDS5A
prerank,RNA destabilization (GO:0050779),0.31396811539764374,0.8551044053182353,0.6851520572450805,0.925799589800321,1.0,5/18,17.76%,DXO;RBM24;RIDA;METTL14;ROCK2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3357453342826126,-0.8542585606857784,0.660377358490566,0.9357876691615632,1.0,1/12,0.57%,AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3357453342826126,-0.8542585606857784,0.660377358490566,0.9357876691615632,1.0,1/12,0.57%,AKAP6
prerank,cardiac muscle contraction (GO:0060048),-0.26081553929336476,-0.8539473845255114,0.6959619952494062,0.9356737010450357,1.0,3/34,2.52%,DMD;GSN;RYR2
prerank,histone methylation (GO:0016571),0.28474076715029234,0.8537598451889579,0.6813996316758748,0.9281139504726906,1.0,9/26,22.71%,PRMT2;EHMT2;PRMT8;PRMT1;PRMT6;EZH2;CARM1;FBL;SMYD1
prerank,organophosphate catabolic process (GO:0046434),0.35269032244405685,0.8537364068384954,0.632688927943761,0.9276153020864174,1.0,3/11,13.24%,ABHD12;NUDT15;PLBD2
prerank,positive regulation of phosphatase activity (GO:0010922),0.2924129622983598,0.8534717227764534,0.6743362831858407,0.9276275596309022,1.0,5/21,11.53%,MEF2C;PLEK;AGTR2;MTOR;PDGFRB
prerank,ERBB2 signaling pathway (GO:0038128),-0.255948689679755,-0.8531851766581748,0.7043879907621247,0.9366034717554215,1.0,5/31,10.64%,EGFR;PTPN12;ERBB4;ERBB3;NRG2
prerank,innate immune response in mucosa (GO:0002227),-0.3569376832978366,-0.8528169676784735,0.6365638766519823,0.9366206677458797,1.0,3/10,19.93%,CAMP;RNASE3;LTF
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2821080732727368,0.8525970883389786,0.7078039927404719,0.9289926051296242,1.0,14/29,33.38%,TLR4;RPS27A;UBC;TICAM2;IRF3;TICAM1;FADD;UBE2D1;IKBKB;TLR6;BIRC2;BIRC3;TBK1;CD14
prerank,B cell receptor signaling pathway (GO:0050853),0.27542491158473537,0.8523104483330712,0.6962457337883959,0.9290533885776635,1.0,9/32,15.85%,BLNK;MEF2C;LAT2;PLCG2;PIK3CD;NCKAP1L;PRKCB;BMX;TEC
prerank,cellular response to purine-containing compound (GO:0071415),-0.3580125851934623,-0.852260806562994,0.6440329218106996,0.937059633941096,1.0,3/10,10.49%,RYR3;RYR2;P2RY1
prerank,protein deneddylation (GO:0000338),0.3618948152658604,0.8517178837273469,0.6353790613718412,0.9297745819388429,1.0,3/10,16.32%,COPS4;GPS1;COPS6
prerank,regulation of mitotic spindle organization (GO:0060236),-0.24896955434035073,-0.8516009418298952,0.6980676328502415,0.9377213012778276,1.0,14/35,32.56%,TPX2;CCSAP;MAP9;GNAI1;GPSM2;PARP3;HSPA1B;CHMP1B;BORA;FSD1;DYNC1H1;PLK1;PSRC1;DRG1
prerank,negative regulation of protein transport (GO:0051224),0.2882290003827468,0.8507511911401006,0.6904761904761905,0.9312924414841488,1.0,8/25,19.11%,NDFIP2;CSK;IL12B;PKDCC;DRD2;WWP2;SNX3;PPM1F
prerank,protein import into peroxisome matrix (GO:0016558),0.3431984158414634,0.8506208915942344,0.6502835538752363,0.9310061877372443,1.0,3/12,18.97%,PEX10;PEX6;PEX1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.2719798086329112,-0.8498605978756189,0.7228637413394919,0.9407679454471379,1.0,3/26,3.39%,SORBS1;IRS1;CREBL2
prerank,TOR signaling (GO:0031929),0.28542918081552465,0.849535435714021,0.696113074204947,0.9328471462578942,1.0,8/26,17.88%,FLCN;RPTOR;MTOR;MLST8;PINK1;AKT1;EIF4EBP2;GATA3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.26200561560268837,-0.8488234066997379,0.7165532879818595,0.9422421451068232,1.0,12/29,26.82%,CDC73;TLE4;TCF7;BCL9L;TLE1;PYGO2;LEF1;TERT;HDAC1;CTNNB1;RBBP5;ASH2L
prerank,negative regulation of neuron differentiation (GO:0045665),-0.28122781316862333,-0.8486887633965831,0.6772009029345373,0.9417062651289073,1.0,10/22,34.04%,B2M;GSK3B;EIF2AK4;REST;CNTN4;HES5;MED1;SOX3;POU4F2;HES1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.30616110116139733,-0.8481548715136271,0.6722338204592901,0.9421373819268986,1.0,5/16,21.92%,SOX5;HOXB4;FOXC1;SOX6;SP7
prerank,positive regulation of monooxygenase activity (GO:0032770),0.27983418036730756,0.8469739092057614,0.6939890710382514,0.9378186295477163,1.0,10/26,24.80%,AGTR2;NOS1AP;GDNF;PIK3CB;AKT1;CDH3;SCARB1;POR;PARK7;HIF1A
prerank,regulation of macrophage activation (GO:0043030),-0.2626045387127375,-0.8469073540957253,0.6658767772511849,0.9440442822707712,1.0,6/30,13.27%,CD74;LRFN5;LBP;FCGR2B;CEBPA;MMP8
prerank,calcium ion import across plasma membrane (GO:0098703),0.33499461324715685,0.8465421226506652,0.6871508379888268,0.9381954996775744,1.0,3/14,5.47%,TRPV2;TRPM2;SLC8A1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.3558676156539728,0.8465165836892555,0.6654205607476635,0.9376852102186541,1.0,3/11,12.56%,SLC19A3;DCTD;ERH
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.22711896251348052,-0.8463937175842384,0.7675,0.944395845138087,1.0,12/55,17.41%,PSMD14;PSMD8;PSMA2;PSMF1;PSMD6;PSME2;PSMD5;PSMD12;PSMD11;GPR132;PSMD1;USP47
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.25609048064598067,0.8460829077812106,0.7132987910189983,0.9381132971303904,1.0,15/41,26.44%,RANBP2;NUP42;SEC13;NUP50;NUP35;NUP88;PGAM1;NUP62;SEH1L;NUP107;NUP153;HIF1A;NUP188;JMJD8;NDC1
prerank,positive regulation of cellular senescence (GO:2000774),0.361334306049641,0.8457821088092213,0.6705202312138728,0.9381996242390002,1.0,2/10,7.25%,ABI3;CGAS
prerank,replication fork processing (GO:0031297),0.2605415974498447,0.8456174620057016,0.7014388489208633,0.9379969402714448,1.0,5/38,6.02%,PCNA;CDK9;PRIMPOL;FAM111A;FANCM
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3557682607753143,0.8448849807171698,0.6666666666666666,0.939004002745671,1.0,1/10,0.13%,BIN1
prerank,regulation of double-strand break repair (GO:2000779),0.2589919639280733,0.8447311779067409,0.747008547008547,0.9387753496633521,1.0,20/39,32.64%,SPIDR;MGMT;SPIRE1;OTUB2;SHLD2;PPP4R2;SETD2;KDM1A;SLF2;TWIST1;DEK;ACTR2;ZCWPW1;RTEL1;DDX11;SIRT7;FOXM1;USP51;MRNIP;RPA2
prerank,regulation of kinase activity (GO:0043549),0.21850426875009912,0.8445033750890394,0.7942583732057417,0.9386963695110528,1.0,16/89,14.77%,MERTK;CSF1R;IGF1R;NBN;RYK;RBL2;CAMKK2;MET;EPHA8;SMG8;AXL;DDR2;PDGFRB;MUSK;SOD1;TSPYL2
prerank,regulation of isotype switching (GO:0045191),0.3293279692045505,0.844485493859593,0.6917148362235067,0.9381719934317834,1.0,3/14,13.15%,SLC15A4;KMT5C;SHLD2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.26465567948164687,-0.8444772818398648,0.7114093959731543,0.9478458957246049,1.0,9/25,28.74%,RBPJ;SOX11;CDH5;ACVRL1;BMP4;ZNF423;HES5;BMPR1B;SMAD2
prerank,glycerol metabolic process (GO:0006071),-0.3450543894685576,-0.8444667662706274,0.6724511930585684,0.9470611184726747,1.0,8/10,42.30%,COQ2;GK;ANGPTL3;GOT1;TPI1;PGP;COQ3;PDXP
prerank,alanine transport (GO:0032328),-0.3475370014765775,-0.84444072394307,0.6573875802997858,0.9463070232325567,1.0,7/10,31.54%,SLC36A2;SLC1A4;SLC6A6;SLC36A3;SLC6A17;SLC6A14;SLC38A3
prerank,DNA-dependent DNA replication (GO:0006261),0.2075459274153125,0.8444311929956091,0.816923076923077,0.9377320252956225,1.0,38/128,26.40%,PRIMPOL;RFC2;GINS4;RPS27A;UBC;MCM2;CDC34;PSMD3;POLD2;PSMB3;SSBP1;GINS3;BLM;PSMA7;RPAIN;PSMC1;CDK2AP1;PSMC2;PSME4;POLG2;PSMB9;ORC3;RFC1;MCM3;PSMD4;PSMB5;MCMDC2;PSMB7;TOPBP1;RPA3;PSMB8;WRNIP1;POLD4;PSMD13;CDC7;ORC2;GMNN;MCM6
prerank,negative regulation of lymphocyte activation (GO:0051250),0.2986140597209087,0.8442930716831394,0.7158273381294964,0.9374594395433694,1.0,1/21,0.03%,PAG1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2845402458741191,0.8436352826093585,0.714548802946593,0.9383184678727039,1.0,7/25,18.52%,BAG6;YME1L1;UFD1;AUP1;ZYG11B;ZER1;STUB1
prerank,mitochondrion disassembly (GO:0061726),0.2661238756886539,0.8436164422694719,0.6985172981878089,0.9377943372934514,1.0,9/34,17.75%,ULK2;ATG9A;RB1CC1;PINK1;MARK2;GABARAPL1;ATG9B;ULK1;ATG5
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.347181685319894,-0.8435395446882046,0.6590389016018307,0.9474113681501135,1.0,2/10,5.02%,XDH;CADM4
prerank,hexose metabolic process (GO:0019318),0.2569894014480372,0.8434967708944167,0.7456140350877193,0.9375124368164175,1.0,12/39,29.75%,PPARD;CHST1;GALM;GDPGP1;SORD;KHK;GAA;CHST15;PMM1;HECTD4;GALK1;OMA1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.29796933179140717,0.8432527407213475,0.6427255985267035,0.9374857512527779,1.0,5/19,20.44%,TJP1;NOTCH4;PLG;PPM1F;DENND6A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2913315982790477,0.843159972754286,0.6792792792792792,0.937114784392173,1.0,8/22,30.10%,MTOR;UBTF;EIF2AK3;SMARCA4;PHF8;IPPK;DDX11;HEATR1
prerank,protein maturation (GO:0051604),0.21720209497524656,0.8427523335978285,0.7796052631578947,0.9373892326934561,1.0,25/95,23.20%,TSPAN14;LMF1;F12;CTSS;PITRM1;CPE;NAA11;MMS19;PSENEN;CLN3;PSEN2;NAA50;ADAM10;CCS;APH1B;STUB1;NAA40;METAP2;AFG3L2;GALNT2;ADAM17;FURIN;TYSND1;LMF2;PTCH1
prerank,regulation of urine volume (GO:0035809),0.35688528313704737,0.8426707254415342,0.6841121495327103,0.9370041526781906,1.0,2/10,11.99%,INPP5K;ADCY6
prerank,liver development (GO:0001889),0.2699328201194445,0.8425552696857004,0.715034965034965,0.9367046926717213,1.0,8/32,16.10%,PRKCSH;NKX2-8;MET;LSR;CEBPG;CCDC40;PROX1;AURKA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.27873147044639335,-0.842156558440176,0.70917225950783,0.9496931125922415,1.0,5/21,11.11%,STAP1;PTPN22;FOXP1;PAX5;FCGR2B
prerank,aorta morphogenesis (GO:0035909),-0.2967384418231627,-0.841995225002069,0.6877828054298643,0.9492517718779282,1.0,4/17,14.90%,RBPJ;JAG1;ACVRL1;HEY2
prerank,negative regulation of protein catabolic process (GO:0042177),0.25425294698319334,0.8413373211680844,0.7234401349072512,0.9387748262783542,1.0,8/40,17.65%,SNRNP70;CST3;SIRT2;MDM4;AGAP2;PIN1;SNX3;CTSA
prerank,potassium ion import across plasma membrane (GO:1990573),-0.23889319510986767,-0.841227729046246,0.7139364303178484,0.950137137239407,1.0,11/41,22.99%,KCNJ3;SLC12A8;SLC12A4;ATP1B3;SLC12A5;ATP1A1;HCN2;SLC12A1;KCNJ10;HCN4;SLC12A3
prerank,gliogenesis (GO:0042063),0.32160747190900496,0.841224537642265,0.6905982905982906,0.938451586324836,1.0,5/15,22.24%,CD9;PAX2;METRN;METTL14;MMP24
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3011966945829619,0.8411740650629832,0.6697416974169742,0.938015779076517,1.0,4/18,10.51%,CLIP3;APPL1;INPP5K;PRKCB
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.2830660926724403,-0.8411124171757371,0.6781609195402298,0.9495735877560794,1.0,8/21,27.80%,SLK;LIMCH1;EFNA5;ACTG1;PEAK1;PTK2;EPHA3;ROCK1
prerank,urogenital system development (GO:0001655),0.3432274758764866,0.8404362655103365,0.6691176470588235,0.9390552303414194,1.0,5/11,30.44%,SHH;PAX2;SOX9;AMH;OSR1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.2901383173548905,0.8402020614001781,0.6994906621392191,0.9389932056498437,1.0,8/23,23.67%,GREM1;MEF2C;RBM24;MAPK14;PROX1;PIEZO1;SMYD1;TGFB1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.28588876672794294,0.8401360812026402,0.7129798903107861,0.9385911886105862,1.0,4/23,12.71%,MLXIPL;PDGFB;PFKFB2;ARNT
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3601141606598596,-0.8397301658957851,0.6856540084388185,0.9508797823262011,1.0,3/10,20.04%,MYADM;KLF4;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3601141606598596,-0.8397301658957851,0.6856540084388185,0.9508797823262011,1.0,3/10,20.04%,MYADM;KLF4;MAP2K5
prerank,negative regulation of response to stimulus (GO:0048585),-0.22142763295032913,-0.839441015883706,0.7586206896551724,0.9507138015978318,1.0,18/60,20.04%,SLIT2;ALOX5;CASK;SIRT1;ERBB3;GGT7;ADRA2A;PIM3;FCGR2B;KLF4;AQP11;MCTP1;THY1;RBL1;FOXP3;FCRLB;TERT;MAP2K5
prerank,regulation of phosphatase activity (GO:0010921),0.2864378108724203,0.8393236531691072,0.7054794520547946,0.939698137728197,1.0,5/24,11.60%,PPP6R3;ZCCHC9;GPATCH2;PPP6R1;SH2D4A
prerank,ribosome assembly (GO:0042255),0.24597932314094342,0.839185735548232,0.7512520868113522,0.9394142445372675,1.0,14/47,21.64%,EIF2A;C1QBP;BOP1;MPV17L2;RPL10;NLE1;RPS27L;MRPS11;BRIX1;SBDS;TRAF7;DHX29;EFL1;DDX3X
prerank,response to interleukin-1 (GO:0070555),0.22852552031236845,0.8389706989341684,0.7586750788643533,0.9393418678598983,1.0,6/73,4.18%,SIRPA;LGALS9;IRAK2;PRKCA;SRC;CCL3
prerank,nuclear pore organization (GO:0006999),-0.31115895609072125,-0.8385616597710039,0.6827133479212254,0.9517624839265201,1.0,7/14,28.87%,NUP98;RTN4;NUP205;NUP54;AHCTF1;NUP93;NUP133
prerank,ubiquinone metabolic process (GO:0006743),0.31882844757289464,0.8385506668555222,0.6846689895470384,0.939643314157123,1.0,2/15,3.32%,COQ7;FDXR
prerank,cholesterol metabolic process (GO:0008203),0.22847546731793536,0.8384731024756642,0.7828947368421053,0.9392584135417362,1.0,12/68,15.59%,PPARD;CH25H;CYP46A1;PIP4P1;LCAT;AKR1D1;SULT2A1;GGPS1;LDLRAP1;OSBPL5;IDI1;FDX1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.32850193690072693,-0.8382600630259781,0.6455142231947484,0.9515782551297254,1.0,1/12,1.34%,PPARG
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2453543904962227,0.838250887182931,0.7383015597920277,0.9391403480530027,1.0,18/49,24.95%,MEF2C;KMT2D;MOV10;SIN3A;PRMT1;PITHD1;RUNX1;PRMT6;CIB1;RAB7B;HMGB2;THBS1;TNRC6C;TNRC6B;DPY30;KMT2B;AGO1;WDR5
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.320259999060077,-0.8381404818318063,0.6756152125279642,0.9510203772305575,1.0,3/12,14.26%,CD44;SKAP1;THY1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3181893171698518,-0.8378204131806611,0.6794871794871795,0.9508596786919069,1.0,4/13,16.84%,CAMK4;TESPA1;ZC3H8;BMP4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.33018747447889296,-0.8377678636076895,0.6778947368421052,0.9501751357925075,1.0,4/12,13.27%,CD36;ZNF205;CYBA;MMP8
prerank,endoderm development (GO:0007492),0.3331871247723931,0.8377123511992257,0.6845018450184502,0.9397015735512358,1.0,2/13,13.03%,SOX17;DUSP5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.25468802308660027,-0.8374616681434923,0.7552941176470588,0.9500347524686186,1.0,13/32,26.20%,PIK3C2A;MEOX2;KLF4;ITGB1BP1;HMOX1;STARD13;FOXC2;CARD10;MAP2K5;DLL4;ANXA1;RHOJ;AKT3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.30808679523123844,0.8371584490843086,0.6924460431654677,0.9402591251877516,1.0,6/16,17.63%,PDGFB;RGS14;PDGFRB;PTPN1;ABL1;PTPRJ
prerank,regulation of monocyte differentiation (GO:0045655),-0.313374012879045,-0.8371411978446215,0.6904231625835189,0.9499308286526127,1.0,2/14,3.95%,CD74;FOXP1
prerank,protein processing (GO:0016485),0.21168621874253618,0.8371031666472892,0.831973898858075,0.9398114517170568,1.0,27/102,23.63%,KLK2;VSIR;FAM111A;CASP1;F12;CTSS;LGMN;PITRM1;YME1L1;CPE;RCE1;PSENEN;CLN3;PSEN2;ADAM10;APH1B;HTRA2;METAP2;AFG3L2;PIDD1;ADAM17;FURIN;STOML2;TYSND1;PTCH1;KLK3;SPRTN
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2528053877287159,0.8369458975385506,0.7426086956521739,0.9395884809980051,1.0,5/40,6.02%,PCNA;CDK9;PRIMPOL;FAM111A;FANCM
prerank,maturation of 5.8S rRNA (GO:0000460),0.3049721274391337,0.8365956893956248,0.6897810218978102,0.9397741167047821,1.0,5/17,19.48%,PES1;C1D;EXOSC10;FTSJ3;MPHOSPH6
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2564139918418485,0.8364485970140134,0.7323943661971831,0.939537583926322,1.0,15/41,26.44%,RANBP2;NUP42;SEC13;NUP50;NUP35;NUP88;PGAM1;NUP62;SEH1L;NUP107;NUP153;HIF1A;NUP188;JMJD8;NDC1
prerank,rRNA catabolic process (GO:0016075),0.30635998541759824,0.836377282255118,0.6894639556377079,0.9391352921284055,1.0,5/16,19.16%,PELO;EXOSC5;EXOSC10;DIS3;EXOSC8
prerank,response to cytokine (GO:0034097),0.20739261487862307,0.8363264029755966,0.828393135725429,0.9386979974289476,1.0,28/141,16.86%,CSF1R;SMAD3;IL1RL2;LGALS9;IRAK2;CRNN;PRKCA;CDK9;SRC;MAP4K3;CASP1;IL6ST;SELE;CCR7;SELP;POU4F1;IL6R;PTPN11;LDLRAP1;SETD2;RELB;IL18BP;MAPK8;SHFL;EIF2AK2;ADAM10;PTPN23;PTPN5
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3522007234425011,0.8360349290429114,0.6913123844731978,0.9387461189783679,1.0,2/10,8.07%,PRKACA;APOM
prerank,fat cell differentiation (GO:0045444),0.233939464042957,0.8358590276837783,0.7774193548387097,0.9385960111798828,1.0,10/57,12.83%,SENP2;ALOXE3;SOX8;BBS9;OSBPL11;TMEM120B;EGR2;CLIP3;BBS2;BSCL2
prerank,negative regulation of hormone secretion (GO:0046888),0.3489981033084776,0.8357617018753758,0.6721014492753623,0.9382720273978354,1.0,2/10,15.99%,GJA1;OSM
prerank,vacuolar acidification (GO:0007035),0.2934947012389264,0.8357392226204846,0.6892138939670932,0.937773871431404,1.0,8/21,18.06%,PPT1;ATP6V0A2;TCIRG1;CLN3;TMEM199;ATP6V0A4;ATP6V0E2;SLC11A1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.31230505067239817,0.8357038069168531,0.6817325800376648,0.9373146615810792,1.0,5/16,22.56%,NCBP1;TRA2B;TRA2A;RBMX;DAZAP1
prerank,organic anion transport (GO:0015711),0.22295519979500292,0.8345701407728446,0.7713815789473685,0.9390997218048626,1.0,18/76,20.68%,SLCO2B1;SLC25A42;CPTP;CYB5R1;SLC52A3;SLC22A6;SLC52A2;SLC35A1;SLC52A1;LRRC8A;SLC17A9;SLC35B4;SLC23A1;SLC19A1;LRRC8D;SLC4A3;SLC4A4;SLC4A5
prerank,secretory granule organization (GO:0033363),-0.3486781999136335,-0.8344939766899001,0.6695278969957081,0.9546681743532894,1.0,5/10,35.70%,DTNBP1;BLOC1S3;VPS33B;BLOC1S2;F2R
prerank,cellular response to alkaloid (GO:0071312),0.3054243542473164,0.8344724024497286,0.6996336996336996,0.938762426403028,1.0,3/17,5.50%,TGM2;SLC8A1;SPIDR
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3324420642088103,-0.8340704250798916,0.678082191780822,0.9547421640984933,1.0,3/12,14.62%,SEC62;GET3;HSPA5
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3342180946700325,0.8336937764555328,0.6963636363636364,0.9397875553817975,1.0,5/13,26.02%,GAD1;NOS2;ALDH4A1;NOS1;DDAH1
prerank,vitamin transport (GO:0051180),-0.25531567955497525,-0.8333323467165378,0.7624190064794817,0.955500951603985,1.0,11/29,25.00%,SLC35F3;SLC46A1;TCN2;SLC5A6;SLC2A8;SLC19A2;SLC2A2;FOLR2;FOLR1;CUBN;SLC25A32
prerank,negative regulation of interferon-beta production (GO:0032688),0.35794285017768795,0.833327696345937,0.7024952015355086,0.9400022850214043,1.0,5/10,23.81%,SIRPA;RELB;PYCARD;PPM1B;YY1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.20970315076628657,0.8332251109380591,0.8410493827160493,0.9396626620784652,1.0,23/116,18.20%,ADCY9;PRKACA;LYN;MYH9;SRC;PLCG2;HRH2;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;ADCY6;INSL3;MAPK14;VIP;ADORA2A;ADCY7;GPR84;GNB1
prerank,cellular response to estradiol stimulus (GO:0071392),0.3048768901340732,0.8332121176003437,0.6857142857142857,0.9391436179505497,1.0,6/18,17.95%,GPER1;POU4F1;CCDC62;NCOA3;NRIP1;KAT5
prerank,chromatin organization (GO:0006325),-0.1892521754693366,-0.8332057164894139,0.8763736263736264,0.9549884534305747,1.0,29/132,20.10%,SUV39H1;MTF2;JARID2;KDM4D;BAZ2B;HDAC4;SIRT1;SMARCE1;MPND;MTA2;MCM3AP;PADI4;SETD5;PRDM16;KDM4C;SETDB2;HMG20A;NUCKS1;NPM2;PAK1;CBX3;TOP1;SUV39H2;NPM1;PBRM1;FOXP3;SUPT4H1;PIH1D1;KDM6A
prerank,homocysteine metabolic process (GO:0050667),0.346129432068268,0.8326343262573108,0.6666666666666666,0.939751800593264,1.0,3/11,20.95%,MPST;DPEP1;MMUT
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2421380720227823,0.8322729318315433,0.740418118466899,0.939924284586545,1.0,14/48,23.60%,BAG6;CHEK2;ATM;USP28;BRCA1;RPS27L;ABL1;PYCARD;HTRA2;EPHA2;TOPORS;BCL2L1;BCL2L11;TP53
prerank,mesoderm formation (GO:0001707),-0.2971318671344482,-0.8320570962209765,0.6680942184154176,0.9565714303328099,1.0,7/17,34.38%,ITGA8;SCX;ITGB1;SMAD2;EOMES;SNAI1;ITGA3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.26806794369198206,0.8319816598594315,0.7252747252747253,0.9399868396763283,1.0,6/31,8.26%,LYN;ATM;TNFRSF21;CD86;TNFRSF13B;PDCD1LG2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.31539274388336447,0.8319260416739483,0.6946983546617916,0.9395522502238227,1.0,4/16,13.39%,ATM;SLX4;ERCC4;TERF1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.2913220249573416,0.831901592874895,0.7271062271062271,0.9390603836530856,1.0,5/22,17.76%,PRKCA;IL6ST;MEF2A;AGT;ROCK2
prerank,vasoconstriction (GO:0042310),-0.3440071864525047,-0.8318082388557596,0.6751054852320675,0.9563039834878707,1.0,3/11,5.35%,PIK3C2A;EDNRB;HTR2B
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2781289822406816,0.8315464182557568,0.7177121771217713,0.9392644205244861,1.0,4/26,7.05%,LRP5;TRPM4;PLA2G6;C2CD2L
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3380469735073436,-0.8315225077566757,0.7136752136752137,0.9560641921908047,1.0,2/11,2.37%,PLCB1;IRS1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.28537582608696943,-0.831273860917932,0.7329059829059829,0.9557792227476659,1.0,5/20,15.86%,AMPD3;PPAT;AK3;AK4;ADSS2
prerank,phasic smooth muscle contraction (GO:0014821),0.35946130282317124,0.8311092326679941,0.6848030018761726,0.9396252958373318,1.0,4/10,13.57%,EDN3;EDN2;GDNF;DRD2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2775177146129392,0.8310548308305202,0.705244122965642,0.9392038107823542,1.0,4/26,7.32%,SIRT2;ITCH;PCBP2;C1QBP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.27675464006518535,0.8307503067561111,0.7376146788990826,0.9392713192464007,1.0,4/24,8.47%,PDE3B;CGAS;CDC34;RASD2
prerank,sodium ion homeostasis (GO:0055078),-0.27319249592878997,-0.830586687266853,0.726457399103139,0.956423101608935,1.0,5/21,22.99%,NEDD4L;ATP1B3;ATP1A1;SLC12A1;SLC12A3
prerank,activation of adenylate cyclase activity (GO:0007190),0.2605371032891877,0.8303242874612649,0.7442680776014109,0.9395994933623116,1.0,7/35,11.99%,ADCY9;ADORA2B;CALCR;FSHR;LHCGR;ADCY4;ADCY6
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.27546918277476107,-0.8301098993582964,0.691764705882353,0.9566244602685129,1.0,5/22,14.26%,MAP1B;MAP2;APOE;AEBP1;HSPA8
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2384768545504434,0.830107948636107,0.7829861111111112,0.9395117648154461,1.0,18/49,26.79%,DDIT3;SRC;NDUFS3;RTKN2;BMF;PINK1;PYCARD;NDUFA13;EIF2AK3;PMAIP1;DDX3X;BCL2L1;BCL2L11;TP53;S100A8;S100A9;URI1;PTPMT1
prerank,intracellular cholesterol transport (GO:0032367),0.31610870309204164,0.8299936475891275,0.7031802120141343,0.9392064090973322,1.0,6/15,19.60%,NPC1;NPC2;LDLRAP1;OSBP;VPS4A;SERAC1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.261561668238843,0.829868298421894,0.7290209790209791,0.9389191924703215,1.0,2/29,2.58%,SMAD3;SRRT
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.330586480122649,0.8298239209000753,0.699812382739212,0.9384740866403427,1.0,3/12,11.38%,PTK2B;DOCK10;DLL1
prerank,membrane lipid biosynthetic process (GO:0046467),0.23357800557954925,0.8291071730825527,0.7757166947723441,0.9393549298722307,1.0,12/58,14.33%,CERS3;DEGS2;SPTLC3;PPM1L;HACD3;ACER3;ACER2;PLPP1;PLPP2;PRKD3;CERS2;VAPB
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3360507158869877,0.8288527895595162,0.6930147058823529,0.9393321110388804,1.0,3/12,19.08%,MBTPS1;MBTPS2;CLCN2
prerank,regulation of myotube differentiation (GO:0010830),0.2814457488819003,0.8287187531846281,0.7290552584670231,0.939049031134227,1.0,5/24,15.05%,TMEM119;FBXO22;RBM24;HDAC5;MAPK14
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2770095986555998,0.82859597822253,0.7228260869565217,0.9387461744808963,1.0,5/26,14.80%,SMOC2;PRKCA;LGMN;KLHL18;TAL1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2589006752028462,-0.8283811631464894,0.7420814479638009,0.9593499402447969,1.0,5/28,12.23%,MAP1B;MAP2;STMN4;SKA3;STMN2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.23537453109677606,0.8283293414369054,0.7738693467336684,0.9387556516704315,1.0,17/50,26.29%,UCHL5;ULK3;SHH;RAB34;ZIC1;MOSMO;KCTD6;SMO;GAS1;MGRN1;TUBD1;PTCH1;DLG5;SUFU;FGFR2;IFT122;KIF7
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2741596846597496,-0.8280660869949321,0.7093023255813954,0.9591978737403409,1.0,7/21,26.23%,LRP6;GSK3B;AXIN1;WNT8B;FRAT1;CTNNB1;CSNK1A1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3230453849218501,-0.8277385809169188,0.7177242888402626,0.9590898557219446,1.0,4/12,14.97%,MAP2;STMN2;CDH5;SNCA
prerank,negative regulation of neuron death (GO:1901215),0.2152167260454206,0.8275464307336322,0.8032,0.9397430604593575,1.0,27/93,24.38%,MEF2C;SLC30A10;EIF4G1;LGMN;PTK2B;PPT1;CNTF;GDNF;POU4F1;CD34;CLN3;PINK1;AGAP2;SOD1;RETREG1;AKT1;CSF1;GPNMB;MAG;HTRA2;VPS35;FGF20;SNX6;KDM2B;PARK7;PLA2G3;CHGA
prerank,positive regulation of RNA metabolic process (GO:0051254),0.24619111069113492,0.8273375227662294,0.7739130434782608,0.9396032237410331,1.0,5/45,5.56%,PIK3R1;DDX5;DXO;BUD23;U2AF2
prerank,cellular response to misfolded protein (GO:0071218),-0.28353230192524903,-0.8273197639450907,0.720620842572062,0.9591379607753074,1.0,5/20,11.08%,CUL3;UBE2W;TOR1A;POMT2;RNF126
prerank,regulation of vasculature development (GO:1901342),-0.2608088289927462,-0.8272080981724218,0.7433414043583535,0.9585746517647018,1.0,6/26,15.25%,SP100;PLXND1;HTATIP2;HMOX1;VASH2;SFRP1
prerank,renal absorption (GO:0070293),-0.350189831429893,-0.8271210985220161,0.7203579418344519,0.9579455529197337,1.0,2/10,13.53%,GSN;KCNQ1
prerank,cellular response to light stimulus (GO:0071482),0.23147189416567718,0.8269355660219363,0.804635761589404,0.9398528605826691,1.0,16/66,23.81%,RHNO1;PCNA;PRKCD;EIF2S1;USP28;BMF;TAF1;ERCC4;KDM1A;TMEM161A;GNB1;GPR52;NSMCE3;ZBTB1;TP53;YY1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.213861821769396,0.8269284979830749,0.8336025848142165,0.9393281570132246,1.0,22/98,18.17%,TGFBR2;GREM1;ARRB2;PPARD;RNF41;EIF4G1;CBR1;PDGFB;DHRS4;SELE;RAB1A;IL10RB;PDGFRB;AKT1;MAPK14;HPN;CSF1;PICK1;AGT;ARRB1;GATA3;THBS1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.27872637427677777,0.8268215695162575,0.724907063197026,0.9390114498681599,1.0,4/23,11.61%,UBASH3B;PTK2B;NOS1AP;PSEN2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.28555100222267066,-0.8268012677444067,0.6962616822429907,0.9578063881325395,1.0,8/19,31.29%,LRP6;NR4A2;CTNNB1;PHOX2A;FOXA2;EN1;WNT2;CDNF
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2588265155787509,-0.8267217415905592,0.7085427135678392,0.9571829290597154,1.0,10/28,20.80%,APP;SHANK3;APOE;GSK3B;ADCY8;EIF2AK4;RELN;CALB1;EPHA4;EPHB2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.33181897284483997,-0.8265249653226083,0.658,0.9567847339359952,1.0,4/11,25.69%,LDLR;MFSD2A;CNEP1R1;CTDNEP1
prerank,COPII-coated vesicle budding (GO:0090114),-0.21557800805854022,-0.8262705127566237,0.8383838383838383,0.956501199772541,1.0,12/68,11.35%,GRIA1;CUL3;CTSC;VAPA;GOSR2;SEC23A;RAB1B;SCFD1;SAR1B;PPP6C;TRAPPC1;SEC24D
prerank,positive regulation of chromosome organization (GO:2001252),0.30778097776516855,0.8261426339521721,0.722735674676525,0.9397956797029813,1.0,2/15,4.52%,NBN;SHCBP1L
prerank,nitric oxide metabolic process (GO:0046209),0.31737880021918286,0.8261040148503908,0.6888045540796964,0.9393342910357091,1.0,5/14,24.54%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,cellular response to hexose stimulus (GO:0071331),0.2819839701094674,0.825788522207542,0.7089552238805971,0.9394127951542425,1.0,5/23,12.13%,PRKACA;IGF1R;GPER1;PAX2;TRA2B
prerank,positive regulation of isotype switching (GO:0045830),-0.3048143973587426,-0.8256535731883136,0.6923076923076923,0.957003636701073,1.0,4/15,17.17%,CD40;SHLD3;RIF1;TFRC
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3184926482194027,-0.8250941295265593,0.6784140969162996,0.9573060677913436,1.0,2/13,4.77%,SYT1;SYT10
prerank,eye morphogenesis (GO:0048592),-0.2849968776144709,-0.8246086027398621,0.707983193277311,0.9574429456516449,1.0,6/19,15.41%,TENM3;RARG;FBN1;FBN2;NKD1;COL5A1
prerank,antibacterial humoral response (GO:0019731),0.31129528114152716,0.8246049560775249,0.7120418848167539,0.9413070782046454,1.0,4/16,19.54%,PLA2G6;SLPI;RNASE6;RPL39
prerank,regulation of BMP signaling pathway (GO:0030510),0.22356218972127134,0.8242655929514036,0.8064516129032258,0.9414325442864565,1.0,7/73,4.91%,GREM1;SMAD7;SKI;SMURF1;FBXL15;SKIL;NUMA1
prerank,histone H4 acetylation (GO:0043967),0.23967422472746694,0.8242221895811231,0.7834179357021996,0.9409747976111306,1.0,16/47,28.37%,BRD8;KANSL2;MSL2;ACTL6A;MORF4L1;JADE2;NAA40;MORF4L2;EPC1;PHF20;KANSL3;NAA60;WDR5;KANSL1;MCRS1;KMT2A
prerank,regulation of establishment of planar polarity (GO:0090175),0.21768289545053834,0.8241121359792956,0.8096026490066225,0.9406654573914517,1.0,26/88,25.14%,RAC1;ARRB2;SMURF1;AP2A1;PKHD1;FZD2;PSMD3;PSMB3;FZD6;PSMA7;PSMC1;PSMC2;PSME4;VANGL1;PSMB9;FZD1;VANGL2;PSMD4;PSMB5;PSMB7;PSMB8;CELSR1;DVL2;PRICKLE1;FZD5;PSMD13
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.23409985942234746,0.8240089688066677,0.761986301369863,0.9403259706893284,1.0,16/53,21.06%,DDX5;PCNA;ATM;PRKCD;DHX9;BRCA1;EYA3;RNF8;ABRAXAS1;CEBPG;TMEM161A;FXR2;FBH1;BABAM1;PMAIP1;SPRED2
prerank,response to prostaglandin E (GO:0034695),0.34511738324811664,0.823894169892222,0.7140255009107468,0.9400167652855755,1.0,3/10,18.20%,CCR7;ADCY6;GNB1
prerank,nucleotide biosynthetic process (GO:0009165),0.29875285679350255,0.8238771231885987,0.7196969696969697,0.9395192694330489,1.0,8/18,25.42%,PNP;GART;PRPS1;PRPS1L1;MTHFD1;PRPSAP1;PRPSAP2;ADSL
prerank,aortic valve development (GO:0003176),-0.24695487740760808,-0.823820744842778,0.7551487414187643,0.9582424333997638,1.0,10/34,21.54%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;ROBO2;TIE1;DLL4
prerank,cardiac muscle cell development (GO:0055013),-0.2787546381118027,-0.8238124691044179,0.7024608501118568,0.9574708214182424,1.0,8/20,30.23%,PDLIM5;OBSL1;HEY2;FHOD3;SORBS2;TTN;MYH6;ALPK3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2714915914056589,-0.823800532567875,0.722707423580786,0.9567067788002008,1.0,12/22,31.47%,RPS7;RPL37;EIF5A;CDK5RAP3;PLA2R1;MSX1;SPRED1;RPS15;RPL23;SPRED3;ATR;HIC1
prerank,ear morphogenesis (GO:0042471),0.291011771893239,0.8237107111503417,0.7084078711985689,0.9393309036938141,1.0,6/20,24.55%,CHD7;PAX2;ZIC1;NOG;TWIST1;FGFR2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.29088965383522014,0.8236164188093605,0.7022058823529411,0.9390081606177857,1.0,3/20,5.76%,SMOC2;SHISA2;SPRY2
prerank,negative regulation of translation (GO:0017148),0.2171677467390494,0.8234154862342935,0.8282504012841091,0.938867086545612,1.0,36/87,30.73%,CNOT1;ENC1;NANOS2;RBM24;GAPDH;TOB1;MRPL13;IGF2BP2;EIF2AK2;RIDA;METTL14;EPRS1;EIF4EBP2;ROCK2;FXR2;CAPRIN1;TYMS;EIF2AK3;PCIF1;NANOS1;DDX3X;CPEB1;LARP1;YTHDF3;CPEB2;SAMD4B;RBM4;EIF4E2;PUM1;ILF3;UNK;CALR;PUS7;CNOT8;DDX6;FXR1
prerank,regulation of DNA recombination (GO:0000018),0.2646968926665307,0.8229842634780328,0.7513513513513513,0.9392101514103655,1.0,8/32,17.92%,SPIDR;BLM;SHLD2;PPP4R2;SETD2;ALYREF;KDM1A;IL7R
prerank,establishment of protein localization to membrane (GO:0090150),-0.21600516933481922,-0.8228684877737165,0.8393782383419689,0.9577851273417717,1.0,22/66,27.14%,CHM;EGFR;FRMPD1;ZDHHC21;AFDN;SDCBP;ZDHHC23;AQP11;COX18;ZDHHC15;PARD3;ZDHHC18;VPS37C;PRKCI;ATG3;ZDHHC24;NACA;ZDHHC19;BRAF;RFTN1;BID;SYNE3
prerank,response to retinoic acid (GO:0032526),-0.2129677543526077,-0.8228022668739577,0.8259803921568627,0.9571258979055128,1.0,18/59,22.27%,BRINP3;RORB;RARG;BRINP2;RET;HSD17B2;RARA;TESC;RBP4;ZNF35;WNT9A;SNW1;ASXL1;TRIM16;WNT6;WNT8B;LTK;AQP1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2211998891312117,0.8227674790311041,0.8189233278955954,0.9390848957527964,1.0,8/79,5.76%,GREM1;SMAD7;SKI;SMURF1;SHISA2;AGTR2;SKIL;SPRY2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2435896804625969,0.8227362153367839,0.75,0.938614140911663,1.0,18/48,27.17%,RANBP2;NUP42;SEC13;NOS2;NUP50;NUP35;NUP88;PGAM1;KHK;NUP62;SEH1L;NUP107;NUP153;HIF1A;NUP188;JMJD8;NDC1;NOA1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.200191126619505,-0.8226862737261593,0.8771929824561403,0.9565966289969823,1.0,19/91,17.36%,PSMD14;PSMD8;PSMA2;PSMF1;BTRC;PSMD6;PSME2;BUB1B;PSMD5;MN1;UBE2C;PSMD12;ANAPC10;DBF4;CDKN1A;PSMD11;PSMD1;GTSE1;CCNB1
prerank,negative regulation of inflammatory response (GO:0050728),0.19321449239473562,0.8226690423226284,0.9036144578313253,0.9382104407814609,1.0,23/182,10.20%,SIRPA;PPARD;OTULIN;ADCY9;PRKACA;LYN;GPS2;MYH9;SRC;PRKCD;PLCG2;HRH2;NLRP3;ADORA2B;MC2R;GPER1;CALCR;FSHR;LHCGR;NPS;ADCY4;TNFAIP8L2;DPEP1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.1968498406127036,0.82238794163322,0.8759571209800919,0.9382428423037131,1.0,22/166,10.87%,MAML3;POLR2H;PPARD;CDK9;POLR2J;HDAC10;POLR2D;GTF2H2;TAF8;TAF12;TAF6;NRBP1;ERCC2;BRF1;BRF2;POLR3H;RXRB;NR2F1;NOTCH4;E2F2;MAML2;SMARCA5
prerank,peripheral nervous system development (GO:0007422),0.2837378576460853,0.8223314901909279,0.7276051188299817,0.9378293173327464,1.0,4/23,8.24%,SOX8;ARTN;EGR2;GDNF
prerank,histone H3 acetylation (GO:0043966),0.24618400559235531,0.8222520079932654,0.7610921501706485,0.937450046802603,1.0,18/40,30.87%,TAF12;PHF14;TAF6L;TAF5L;TADA1;JADE2;MBIP;TAF10;KAT6B;DR1;TAF5;NAA60;WDR5;BRD1;YEATS2;SPI1;KAT2B;SUPT7L
prerank,autophagosome maturation (GO:0097352),-0.2500828806283156,-0.8218594744327695,0.7703349282296651,0.9574769018332911,1.0,6/32,8.15%,ATP2A2;SNX14;STX17;CALM1;UVRAG;VMP1
prerank,positive regulation of bone mineralization (GO:0030501),0.25652058208749223,0.8206044114773517,0.7603448275862069,0.9400509245614495,1.0,3/35,5.47%,TMEM119;MEF2C;SLC8A1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.2999231038858133,-0.8199792356344169,0.7117903930131004,0.9603108906790881,1.0,2/14,7.08%,LRRK2;PRKN
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2092941683505215,-0.819649508185522,0.81,0.9601762024683768,1.0,15/72,17.78%,PSMD14;PSMD8;PSMA2;PSMF1;BTRC;PSMD6;PSME2;REL;NFKB2;PSMD5;PSMD12;PSMD11;PSMD1;COPS8;CARD10
prerank,peptidyl-proline modification (GO:0018208),-0.26271864471224904,-0.8192564138826101,0.7426636568848759,0.9601137970128548,1.0,10/25,23.27%,CWC27;PPIA;PPIH;PPIC;PPIL3;PPWD1;PPIG;NTMT1;PPIF;PPIB
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.32107300893602114,-0.8191120403803258,0.7177777777777777,0.959613990326203,1.0,1/13,0.60%,ITGA4
prerank,microtubule bundle formation (GO:0001578),0.2429309934994544,0.8190719138533588,0.7750865051903114,0.9425191069671927,1.0,9/42,16.67%,TTLL3;NUMA1;CFAP74;LRGUK;JHY;CFAP46;CCDC40;CCDC66;RSPH9
prerank,eye photoreceptor cell development (GO:0042462),-0.30360659309336074,-0.8190551591060321,0.6916299559471366,0.9589374808803346,1.0,3/15,14.47%,RORB;THY1;RPGRIP1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3381561770755044,0.8190222896800624,0.6819047619047619,0.9420988682978908,1.0,3/11,8.68%,NOS1AP;LRRC55;LRRC38
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.28216013384189675,-0.8190210283081593,0.7184265010351967,0.9582347249996838,1.0,2/20,4.39%,RBPJ;CARF
prerank,quinone biosynthetic process (GO:1901663),0.3192520952929294,0.818546085004246,0.7137809187279152,0.9425247770504841,1.0,2/14,3.32%,COQ7;FDXR
prerank,embryonic digestive tract development (GO:0048566),0.2971031419675464,0.8184426032976149,0.7103321033210332,0.9422055031353624,1.0,1/18,0.18%,SALL1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.2530350767439308,-0.8184058313320178,0.76,0.9586394249351798,1.0,5/29,8.84%,DCUN1D2;RPS2;UBE2N;AXIN1;ARRDC3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.3230719930620423,0.8183289143624864,0.7236842105263158,0.941907489266726,1.0,8/13,33.45%,PLEK;SOD1;DKK3;SCAP;BMP2;ERLIN2;NFKB1;BMP5
prerank,steroid catabolic process (GO:0006706),-0.341506583998347,-0.8177443521758636,0.6848072562358276,0.9591472211594447,1.0,6/10,31.36%,SPP1;HSD17B11;HSD11B1;HSD17B14;FGF23;CYP19A1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.28065583461126864,0.817618253045334,0.7198515769944341,0.9427836305087902,1.0,8/23,27.55%,SMAD7;DSG2;MYL3;PROX1;TGFB1;FGFR2;ISL1;TPM1
prerank,icosanoid biosynthetic process (GO:0046456),0.3555257903918587,0.8175114096021181,0.7080152671755725,0.9424589508303898,1.0,3/10,12.31%,PLA2G4A;PLA2G5;FADS1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29526592210043434,0.8173466600161992,0.7364620938628159,0.9422250515286149,1.0,5/20,18.23%,ACSL4;DGAT1;PPT1;SCD5;SCD
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.19741911389440744,-0.8171473419892871,0.8760330578512396,0.9595583170575024,1.0,16/101,11.41%,SAMD4A;EIF3C;VIM;CPEB3;CYFIP2;FAF1;BTRC;RPL26;PRR16;EIF3E;EIF4A3;NFKBIA;PLXNB2;ATG7;BAK1;KLF4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.2489644768381886,0.8167094184953192,0.7619893428063943,0.942933868846279,1.0,10/38,18.21%,HPS4;CSNK2A2;SH3GLB1;RNF31;USP36;LEPROT;PINK1;BAG4;TOMM7;HTRA2
prerank,proteolysis (GO:0006508),0.18671891127713638,0.816635223639609,0.9160739687055477,0.9425459693334566,1.0,59/252,23.77%,CTSD;CAPN3;VHL;FAM111A;ST14;CAPN9;NAALAD2;CASP1;F12;CTSS;MMP2;LGMN;CAPN5;PITRM1;YME1L1;MBTPS1;USP25;CPE;CPA4;PRSS38;PAPPA2;CPB1;TMPRSS6;PSENEN;FBXL2;CLN3;DPP7;PSEN2;CTSF;RNPEP;SPPL2B;PM20D2;UBE3A;MIPEP;ATG4C;HPN;CTSE;PLG;ADAM10;PRCP;CTSA;APH1B;HTRA2;CPA6;METAP2;AFG3L2;RNF123;PSMB5;GGT5;ADAM17;FURIN;TYSND1;MMP24;MMP25;ERAP1;PTCH1;KLK3;SPRTN;SUFU
prerank,positive regulation of growth (GO:0045927),-0.20995243055356638,-0.816249240527663,0.8290816326530612,0.9605746841947297,1.0,15/64,17.41%,AKAP6;PLCB1;EGFR;CDC42;SDCBP;LGI1;PABIR1;MFSD2A;H3-3A;SFRP1;BCL2;MMP14;MTPN;SFRP2;USP47
prerank,motor neuron axon guidance (GO:0008045),-0.3044758647481861,-0.8161848793785853,0.7292929292929293,0.9599255903253641,1.0,3/15,9.40%,SLIT2;CHN1;TMEFF1
prerank,glycerolipid metabolic process (GO:0046486),-0.324833571113162,-0.8158051040664155,0.6941431670281996,0.9598809498441695,1.0,1/11,1.14%,DGKB
prerank,nitric oxide biosynthetic process (GO:0006809),0.3173941992593548,0.8156076060130151,0.6962264150943396,0.9439516118107873,1.0,5/13,24.54%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.35195394662296287,0.8155113768440377,0.7167300380228137,0.9436237179973195,1.0,3/11,10.14%,EBI3;IL6ST;IL12RB2
prerank,negative regulation of kinase activity (GO:0033673),-0.21279692814791867,-0.8154863748289203,0.8427518427518428,0.9597004154981492,1.0,17/62,20.20%,PPM1E;PRKAG2;LRP6;TAF7;PPIA;DBNDD1;SMCR8;ITGB1BP1;DTNBP1;THY1;SNCA;TAB1;GSTP1;CDKN1C;CAMK2N2;GNAQ;DEPTOR
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.27795959012265004,-0.8154822947660761,0.7394209354120267,0.9589394852686913,1.0,4/20,9.32%,LIMD1;AGO4;TNRC6A;HELZ
prerank,gluconeogenesis (GO:0006094),-0.23421971729850757,-0.8153938899266551,0.7837837837837838,0.958302344861688,1.0,7/39,15.00%,PFKFB1;SLC37A4;PER2;GPI;RBP4;ALDOC;SLC25A12
prerank,protein localization to cell surface (GO:0034394),-0.2575153780605523,-0.8143017193675275,0.7678958785249458,0.959641103753051,1.0,10/26,25.84%,ANK2;FGF10;FGF7;JAM3;PTPRK;CD177;RIC3;CTNNB1;FLNA;ANGPT1
prerank,DNA replication (GO:0006260),0.20771011303883108,0.813740160617955,0.8693548387096774,0.9464564719994731,1.0,32/105,26.40%,RHNO1;RFC2;FAM111A;NBN;ATM;RAD17;MCM2;BRCA1;DUT;POLD2;PCLAF;EXO1;RAD1;BLM;RPAIN;CDK2AP1;POLG2;ORC3;KAT5;RFC1;TOP3A;MCM3;RAD9A;TOPBP1;RPA3;DONSON;WRNIP1;POLD4;CDC7;NT5M;ORC2;MCM6
prerank,regulation of response to interferon-gamma (GO:0060330),-0.31100077577724605,-0.8136971147905719,0.7229166666666667,0.9599980335485992,1.0,4/14,12.83%,JAK2;PTPN2;IFNGR1;PIAS1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21581787520010703,0.8126895072948871,0.8303715670436187,0.9479262973156725,1.0,31/88,27.76%,FBXL18;FBXL20;FBXL15;FBXW4;CUL4B;PSMD3;FBXL8;FBXL2;PSMB3;PSMA7;PSMC1;PSMC2;FBXL22;FBXO38;PSME4;PSMB9;CUL4A;PSMD4;PSMB5;FBXL7;PSMB7;PSMB8;FBXW5;FBXL3;PSMD13;FBXL14;CUL1;FBXO2;FBXO17;FBXL12;PSMD2
prerank,negative regulation of organelle assembly (GO:1902116),-0.24271179284402813,-0.8122109159330082,0.8116591928251121,0.9620598794558366,1.0,5/35,8.98%,LRRK2;CDK5RAP2;TRIM37;SCFD1;SMCR8
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28081739750789436,0.8120750068050328,0.7409420289855072,0.9485290858841396,1.0,2/20,2.53%,RAP1GDS1;TGM2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.30849484095954216,-0.8119973134947225,0.7095343680709535,0.9616882566797106,1.0,5/13,19.31%,LTV1;NOP9;RAN;NPM1;RRS1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2502290812625765,0.8114219644840523,0.784070796460177,0.9492217865881666,1.0,16/36,29.16%,RILPL1;MACF1;GOLGA4;TRARG1;RAB34;BBS2;OPTN;GGA3;GORASP1;KIF13A;PREPL;SYS1;GORASP2;RAB26;NECTIN3;GOLPH3L
prerank,photoreceptor cell development (GO:0042461),-0.30678373014471005,-0.8113763929023164,0.6937901498929336,0.9620990737031804,1.0,3/14,13.39%,RORB;MFSD2A;AHI1
prerank,neuron projection organization (GO:0106027),0.3122167235876716,0.8112558619974385,0.7279279279279279,0.9489968141343074,1.0,5/15,23.04%,ABCD2;LGMN;PICK1;ARF1;ABCD1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.27216698470471534,-0.8109640599623532,0.7669683257918553,0.9620800260793931,1.0,5/23,13.88%,JAK2;ERBB4;OCIAD2;KIT;CCL5
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.25759868569938615,-0.810649465265609,0.7733333333333333,0.9618944021331418,1.0,11/26,24.31%,DAB2;FOXP1;STRN3;SIRT1;CLOCK;PER1;SFRP1;CRY1;HDAC1;NCOR1;CNOT9
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2237712542999876,0.8101575945271351,0.8207236842105263,0.9505443475010437,1.0,20/66,26.89%,SMAD3;PIK3R1;PRKCD;LAMTOR5;CCT3;MAVS;ZIC1;AKT1;DTX3L;CCT8;ECT2;EIF2AK3;ZC3H12A;PARK7;TGFB1;IPO5;JUP;CCT7;CCT5;MCRS1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2327271683108582,-0.8100988943016559,0.7720588235294118,0.9621853744850747,1.0,13/40,29.77%,ROMO1;CAMP;GBP4;LBP;GBP2;RNASE3;DROSHA;PGLYRP2;RARRES2;PGLYRP1;MPEG1;IL12A;CRP
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.33514664048164367,-0.8098177895783967,0.70625,0.9619183343626427,1.0,5/10,32.99%,DLGAP1;DLGAP2;NPTX1;NPTXR;CACNG5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.31270892053816923,-0.8095706263501231,0.6905263157894737,0.9615747752512802,1.0,1/13,0.23%,B3GALT1
prerank,regulation of programmed cell death (GO:0043067),0.19329588953765175,0.8093658598029667,0.9156626506024096,0.9514628643133768,1.0,34/161,17.81%,CRADD;IGFBP3;TGM2;ATM;CLU;CASP1;PLSCR3;TNFRSF25;ACER3;TM7SF3;PLK5;POU4F1;ACER2;RABGGTA;ANP32A;USP36;ASAH1;PAX2;APAF1;DCPS;PINK1;TARDBP;OSGIN1;ABL1;AKT1;IRF3;FBXO11;BCL2L14;GAS1;AGT;KANK2;NUP62;FANK1;NME1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.23591246137691524,0.809326871502351,0.785958904109589,0.9510009803760877,1.0,14/47,20.46%,EIF4G1;EIF2A;SSH1;PKP3;EIF2B4;CYFIP1;RPL10;PM20D2;AKT1;CSF1;AGT;NR1H2;VPS35;PCIF1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.2859790948961018,0.8089798020438421,0.7425925925925926,0.9511385801187134,1.0,1/21,0.06%,TGFBR1
prerank,tyrosine metabolic process (GO:0006570),-0.3326667165918044,-0.8089213063070982,0.724669603524229,0.962011386948377,1.0,5/11,31.34%,THAP4;DCT;GSTZ1;TAT;TH
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.33767074964388477,-0.808899868642483,0.7098214285714286,0.9612818784139938,1.0,2/10,5.30%,PDE4B;CALM1
prerank,phospholipid catabolic process (GO:0009395),0.27686811474794876,0.8086902849740982,0.7437275985663082,0.9511431882753905,1.0,4/24,13.24%,ABHD12;PLA2G4A;PLA2G4B;PLBD2
prerank,cochlea morphogenesis (GO:0090103),0.3425103603821551,0.8085179891541726,0.6960431654676259,0.9509311159638585,1.0,4/10,24.37%,PAX2;HPN;POU3F4;SOX9
prerank,negative regulation of peptidase activity (GO:0010466),0.2396409008846323,0.808341920308815,0.7906976744186046,0.950729619550857,1.0,9/47,17.12%,CST3;GAPDH;LRP1;SERPINE1;SERPINE2;AKT1;SERPINF1;SPINK5;AGT
prerank,canonical Wnt signaling pathway (GO:0060070),-0.20545791150691667,-0.8082286597462593,0.871859296482412,0.9617318431192049,1.0,21/68,21.76%,LRRK2;LRP6;GSK3B;NR4A2;RARG;FRZB;AXIN1;WNT4;TCF7;BCL9L;SCYL2;WNT9A;SFRP1;PLPP3;SFRP2;LEF1;RAB5A;WNT7A;WNT6;WNT8B;FRAT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2942681425845704,-0.8081512597422089,0.7632183908045977,0.9611149411292564,1.0,3/17,10.43%,ADRA1A;RAPGEF2;ADRA2A
prerank,regulation of endopeptidase activity (GO:0052548),0.22861826057601303,0.8080986666728847,0.7982905982905983,0.9506311106951071,1.0,12/59,17.68%,VSIR;PICALM;GAPDH;PSENEN;SERPINE1;SERPINE2;NRDC;AKT1;SERPINF1;PSMB9;AGT;APH1B
prerank,regulation of cell communication (GO:0010646),-0.2360187969640199,-0.8079413906930147,0.7855530474040632,0.9607542357510646,1.0,11/35,23.64%,ANK2;GRK5;RYR2;UGCG;CDC42SE2;VEPH1;IGFBP7;SOCS2;GJA5;ANXA1;CASQ2
prerank,digestive tract morphogenesis (GO:0048546),-0.3008764019592115,-0.8079159005840342,0.718816067653277,0.9600303567323384,1.0,7/14,37.13%,SOX11;RBPMS2;ID2;GLI1;STRA6;NIPBL;PDGFRA
prerank,cellular response to chemical stress (GO:0062197),-0.1954634928659318,-0.8078828755862221,0.8715846994535519,0.9593221705982464,1.0,25/96,20.69%,LRRK2;CYBB;MSRA;PRDX1;PPIA;NCF2;PKD2;MGAT3;SLC25A24;CYBA;ATG7;ERO1A;PYROXD1;SOD2;HSPA1B;SNCA;PRR5L;ZFAND1;FOXO1;GSTP1;TXNRD1;CYCS;STOX1;CAT;NOX4
prerank,glucose homeostasis (GO:0042593),0.21340801210769034,0.8075433706675265,0.8493377483443708,0.9511214052948771,1.0,11/83,10.48%,MLXIPL;HK2;PIK3R1;CRY2;IGF1R;PAX6;FOXK2;SLC30A8;MTNR1B;INPP5K;PDK2
prerank,monosaccharide transmembrane transport (GO:0015749),-0.29324842253800787,-0.8074108610411339,0.7538461538461538,0.959453079361162,1.0,8/16,35.01%,SLC45A3;SLC2A12;SLC2A8;SLC2A2;SLC50A1;SLC5A1;SLC5A10;SLC2A6
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3098579032392368,0.8068846706759399,0.7158878504672898,0.951796380596909,1.0,5/14,21.06%,SPRY2;NOTCH4;DLL1;ZEB1;SPRED2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3368593909714205,0.8068825046695091,0.6853932584269663,0.9512693091971628,1.0,2/11,2.90%,PRKCA;LYN
prerank,eye development (GO:0001654),0.23213798729230578,0.806794549312604,0.7979966611018364,0.9509077955629787,1.0,8/54,11.39%,SKI;FREM2;EFEMP1;PAX6;MEIS3;RAB3GAP1;SHROOM2;PAX2
prerank,camera-type eye development (GO:0043010),0.2719007621246167,0.8066486235703589,0.7450980392156863,0.9506554587122976,1.0,5/25,11.39%,SKI;EFEMP1;RAB3GAP1;SHROOM2;PAX2
prerank,glutathione metabolic process (GO:0006749),0.24809765636523,0.8064808974066804,0.788135593220339,0.9504503210580056,1.0,9/38,22.95%,HPGDS;DPEP1;GCLC;SOD1;GSTA3;GGT5;CTNS;GSTM5;PARK7
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.29016587697260976,-0.8062172986530375,0.744920993227991,0.9608809821748635,1.0,3/16,8.54%,AKAP6;PDE9A;TRPC3
prerank,regulation of G0 to G1 transition (GO:0070316),0.25025926294690726,0.8058772446091365,0.789198606271777,0.9510025605129205,1.0,14/38,25.30%,RHNO1;BRCA1;EHMT2;APAF1;PCGF2;EZH2;EED;UXT;RNF2;MGA;EPC1;RING1;PHC1;CDC7
prerank,regulation of innate immune response (GO:0045088),0.227127183731686,0.8057574473587954,0.8165289256198347,0.9506997231962736,1.0,10/57,16.74%,POLR3G;SLC15A4;AKIRIN2;DHX9;ABCE1;APPL1;PTPN1;PTPN11;GBP5;XIAP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.32761683018399923,0.8053957868084679,0.7024952015355086,0.9508125066529042,1.0,2/12,5.48%,BRD8;CTSS
prerank,ubiquinone biosynthetic process (GO:0006744),0.3051590455804299,0.8053936679367645,0.7446428571428572,0.9502885952945461,1.0,5/15,20.81%,COQ7;FDXR;PDSS2;NDUFA9;COQ8B
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3368544661361398,-0.8053311440014056,0.7112970711297071,0.9617440231526785,1.0,3/10,17.91%,PTPN22;DUSP10;GSTP1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.23353748619709788,0.8052673695508121,0.7870216306156406,0.9499963565346796,1.0,18/51,26.67%,SRC;ATM;CTC1;HNRNPC;NEK7;GNL3L;TERF1;CCT3;EXOSC10;TEN1;CCT8;ACD;HNRNPA1;CCT7;STN1;PARN;CCT5;HMBOX1
prerank,calcium ion import into cytosol (GO:1902656),0.3151568878659897,0.8052415234642165,0.7406716417910447,0.9495208101751006,1.0,3/15,5.47%,TRPV2;TRPM2;SLC8A1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3087585766842326,0.8052176175642815,0.7367458866544789,0.9490315406787048,1.0,3/14,15.22%,IL12B;POU4F1;CSF1
prerank,nucleosome assembly (GO:0006334),0.25786846552712944,0.8051697218716066,0.782608695652174,0.9485872449878007,1.0,10/31,24.37%,UBN1;SART3;SMARCA5;IPO4;SPTY2D1;HMGB2;CHAF1B;KAT6B;NAA60;SOX9
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2577931806812071,-0.8049458731250246,0.7566371681415929,0.9617064162681972,1.0,5/24,11.44%,ANK3;MTCL1;FIS1;MFF;ITGB1BP1
prerank,protein localization to nucleus (GO:0034504),0.20412291015854628,0.8045469724518826,0.8540031397174255,0.9491830505954978,1.0,33/102,27.80%,SPRN;PHB2;FAM53A;TAF8;PTTG1IP;SEC13;NUP62CL;APPL1;TNPO1;NUP50;TOR1AIP1;NUP88;IPO4;RPAIN;MORC3;AKT1;TNPO3;CSE1L;NUP62;NUP107;E2F3;TOPORS;IPO7;NUP153;IPO5;PRICKLE1;NUP188;APPL2;STAT3;IPO9;HIKESHI;RANBP17;BANP
prerank,"phototransduction, visible light (GO:0007603)",-0.30210771151019256,-0.8042724433668448,0.7580993520518359,0.9621802641769013,1.0,3/14,20.19%,ABCA4;PDE6A;GNAQ
prerank,GTP metabolic process (GO:0046039),-0.2996335287790939,-0.8042019882441731,0.7272727272727273,0.96156893580762,1.0,4/15,14.08%,LRRK2;RAN;AK3;AK4
prerank,negative regulation of multicellular organismal process (GO:0051241),0.1876979944306487,0.8041368158842929,0.9290882778581766,0.949414592411478,1.0,50/199,24.51%,LDLRAD4;SMAD7;MEF2C;DDIT3;PLCL1;PCTP;AGER;TLR4;LAMA4;FLCN;ID1;TFE3;RPS6KA5;SPRY2;SHH;OVOL2;WNT10B;APOM;ABHD6;BBS2;PLCL2;GJA1;LRP4;NRDC;HPN;CHSY1;GPNMB;PROCR;ACVR2B;PTPN23;RPS6KA4;ROCK2;GATA3;SLC11A1;NR1H2;SYT11;SPRED2;ADAM17;EFNA1;IP6K1;STC1;EVL;PTCH1;BMP2;ADIPOR1;TGFB1;NOVA2;SOX9;LRPAP1;WDR77
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2946849844077959,-0.8039179137871239,0.7233560090702947,0.9613458903465821,1.0,7/16,23.77%,AUTS2;DNMT3B;DNMT1;SNW1;PIH1D1;MYB;CTNNB1
prerank,photoperiodism (GO:0009648),0.2628331240862318,0.8035776629387126,0.7807017543859649,0.9499217025958884,1.0,13/28,30.80%,MTA1;CRY2;CRTC1;FBXL8;PPP1CB;FBXL22;TP53;FBXL3;RBM4;PPP1CC;FBXL12;PPP1CA;PDE6B
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.24218908571309972,-0.8032568487125753,0.8109339407744874,0.9618120545697437,1.0,12/33,23.94%,PPARG;APOE;MEOX2;KLF4;ITGB1BP1;ACVRL1;STARD13;RGCC;CARD10;MAP2K5;DLL4;ANGPT4
prerank,positive regulation of protein sumoylation (GO:0033235),0.32752060820810147,0.8031912492913392,0.7416974169741697,0.9500684590405454,1.0,3/10,14.30%,UBA2;RASD2;PIAS3
prerank,cellular response to glucagon stimulus (GO:0071377),0.2900322473323781,0.8030463900429453,0.7570921985815603,0.949802626062774,1.0,5/17,17.38%,ADCY9;PRKACA;ADCY4;ADCY6;ADCY7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.26311754022441824,0.8028502756246917,0.779783393501805,0.9496466654551862,1.0,14/30,33.38%,TLR4;RPS27A;UBC;TICAM2;IRF3;TICAM1;FADD;UBE2D1;IKBKB;TLR6;BIRC2;BIRC3;TBK1;CD14
prerank,negative regulation of protein metabolic process (GO:0051248),0.23337223111463587,0.8027809132994054,0.8092105263157895,0.9492519774333046,1.0,10/48,16.06%,CD84;SIRT2;ITGAV;CLU;MDM4;FLOT2;AGAP2;PIN1;SNX3;EIF2AK1
prerank,regulation of metal ion transport (GO:0010959),-0.2951386854467577,-0.8024194424056916,0.7602591792656588,0.9626451874763967,1.0,4/16,15.35%,ANK2;IL16;EPB41;BCL2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.29527256767034943,-0.8023281855462061,0.7207392197125256,0.9620786959331116,1.0,1/16,0.16%,PID1
prerank,negative regulation of viral process (GO:0048525),-0.2153848768727958,-0.8017522248316641,0.8480392156862745,0.9623580955307456,1.0,22/57,27.12%,OAS2;RSAD2;MID2;PPIA;IFITM3;TRIM35;RNASEL;IFITM2;OAS3;CCL5;IFITM1;BANF1;SRPK2;IFIH1;LTF;ZC3HAV1;PARP10;BST2;ZFP36;OASL;PLSCR1;PML
prerank,regulation of protein polymerization (GO:0032271),0.25326989974332326,0.8016408198698529,0.7926829268292683,0.9507593582645731,1.0,16/35,30.71%,DBN1;CAMSAP1;ARHGAP28;ABITRAM;CAMSAP2;ABL1;FCHSD2;DBNL;MAPT;FCHSD1;ESAM;PLEKHG2;TPPP3;COTL1;RASA1;MAPRE3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2266008463946706,-0.8015039997009585,0.819047619047619,0.9620458725195032,1.0,11/42,17.48%,UTRN;CD36;GSK3B;SKAP1;CDH13;THY1;CX3CL1;SFRP1;TEK;CD3E;S100A10
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3298748958087675,0.8014123095193479,0.7380952380952381,0.9506581114870548,1.0,2/12,7.83%,NELFB;ZFP36L2
prerank,negative regulation of heart contraction (GO:0045822),0.328821589172253,0.8013165180896494,0.7329545454545454,0.9502901448303802,1.0,5/11,21.84%,PIK3CG;AGTR2;GRK2;PLN;ZC3H12A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2925630338977259,0.8013092161838591,0.7513321492007105,0.9497815964118583,1.0,1/17,0.48%,BAG6
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3295521070112551,0.800728740793297,0.7333333333333333,0.95026336281033,1.0,4/11,17.05%,TIMM8B;TIMM29;NDUFA13;TIMM10B
prerank,establishment of vesicle localization (GO:0051650),-0.28217130046239225,-0.8006523464203166,0.7477678571428571,0.9628837638921135,1.0,3/18,8.61%,KIF5C;TOR1A;KIF5B
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2975216156675569,-0.8006136507525715,0.7310924369747899,0.9621970378394095,1.0,3/14,18.54%,POLRMT;MRPL12;TWNK
prerank,negative regulation of hippo signaling (GO:0035331),-0.31744248006658915,-0.8004789758817022,0.7398720682302772,0.9616747187941906,1.0,3/12,13.22%,LIMD1;MARK3;WWC1
prerank,response to peptide hormone (GO:0043434),0.23723071044036842,0.8003655329275657,0.7919463087248322,0.950383189775003,1.0,10/43,17.76%,SRC;EIF2B3;SORT1;ZFP36L1;GPER1;EIF2B4;AKT1;STAT6;KHK;ROCK2
prerank,histone H3-K9 demethylation (GO:0033169),0.3364292502161289,0.800359960395783,0.7279549718574109,0.9498742966490672,1.0,5/11,19.13%,KDM3A;KDM4A;HR;KDM1A;KDM7A
prerank,positive regulation of phospholipid transport (GO:2001140),-0.33351461250046055,-0.7999518513984196,0.7333333333333333,0.9618233840397867,1.0,1/10,4.61%,APOE
prerank,regulation of cholesterol metabolic process (GO:0090181),0.2874810915178364,0.7995646340097295,0.7550644567219152,0.9507264035812514,1.0,5/20,17.25%,MBTPS1;MBTPS2;TTC39B;LDLRAP1;FMO5
prerank,regulation of actin nucleation (GO:0051125),0.32011300240200324,0.7993709985916737,0.7220216606498195,0.9505493343665129,1.0,4/12,21.32%,ARFIP1;ARFIP2;PICK1;ARF1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.29371194963861114,0.7991699275570119,0.7730769230769231,0.9504147852561999,1.0,9/18,26.47%,NFE2L2;VNN1;PINK1;AKT1;MAPK7;HTRA2;PARK7;HIF1A;BAG5
prerank,chromosome condensation (GO:0030261),0.24449283662681254,0.7989770937253985,0.7869718309859155,0.9502437208397032,1.0,13/36,27.41%,AKAP8L;CSNK2A2;CSNK2A1;GPER1;NCAPH2;CHMP1A;NCAPH;CDCA5;KMT5A;MCPH1;PHF8;ACIN1;DFFB
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2732267984166408,0.7989362893839234,0.7671480144404332,0.9498073261032354,1.0,4/23,11.69%,SLC12A6;SLC12A9;PDK2;ATP6V0A4
prerank,negative regulation of binding (GO:0051100),0.2118014387643672,0.7986816248975906,0.8649921507064364,0.9497314359622061,1.0,24/81,24.66%,SUMO1;CSNK1E;PRKCD;ARHGAP28;SLPI;CTNNBIP1;MDFI;PDGFB;JUN;GNL3L;PIN1;MAPK8;TMBIM6;AKT1;SMO;AURKA;KDM1A;CAMK1;PLN;TFAP4;PARK7;RALB;LRPAP1;HABP4
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.19489460685253449,0.79793699053352,0.8989280245022971,0.9505447877891657,1.0,18/138,10.74%,MAML3;POLR2H;PPARD;CDK9;POLR2J;HDAC10;POLR2D;GTF2H2;TAF8;TAF12;TAF6;NRBP1;ERCC2;RXRB;NR2F1;NOTCH4;E2F2;MAML2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.253887250921853,0.7975384635951391,0.8122807017543859,0.9506672489090104,1.0,7/31,18.42%,FDXR;HSD3B2;HSD17B1;MOCS2;MOCS1;PYCR2;PYCR1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.30677973139749004,0.7971032129054246,0.7414104882459313,0.950935826474397,1.0,6/14,23.57%,HNRNPC;TARDBP;MAPK14;BOLL;ELAVL1;MYD88
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3266250774303914,0.7970055493543938,0.7279549718574109,0.9505840113950964,1.0,3/12,15.48%,BRCA1;CEACAM1;WDTC1
prerank,leukotriene metabolic process (GO:0006691),0.29039150579433004,0.7967647127425045,0.7424812030075187,0.9504972288042904,1.0,6/19,20.96%,PLA2G4A;PLA2G5;DPEP1;ABCC10;PTGR1;GGT5
prerank,regulation of chromatin binding (GO:0035561),0.34099253772205806,0.7962727313728415,0.7240704500978473,0.9508272338320082,1.0,7/10,28.86%,MED25;DTX3L;GMNN;HMBOX1;BTAF1;DDX11;WAPL
prerank,cellular response to drug (GO:0035690),-0.2564859872534302,-0.7960264691405466,0.7911832946635731,0.9679985255801947,1.0,6/25,17.17%,PDE4B;PPM1E;CERS1;KCNQ1;CRHBP;TFRC
prerank,gastrulation (GO:0007369),0.3018183907681271,0.7960123459559967,0.7431693989071039,0.9507757736286946,1.0,1/15,0.67%,LRP5
prerank,phosphate ion transport (GO:0006817),-0.28845920774992445,-0.7959866515619635,0.7458677685950413,0.9673031488586018,1.0,3/16,11.35%,SLC25A30;SLC37A4;XPR1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.30426677607704666,-0.7958384626927167,0.7313769751693002,0.9668146402844698,1.0,2/12,5.02%,XDH;CADM4
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.2688046962578782,-0.7955792559275724,0.7916666666666666,0.9665325127271535,1.0,7/21,18.61%,ADCY2;GUCY1B1;ADCY5;ADCY3;ADCY8;GUCY2F;GUCY2D
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.27575838591419416,0.7954061371924713,0.7831775700934579,0.9513481675308015,1.0,6/23,27.41%,REXO4;DNASE2;HMGB2;FBH1;EXOG;DFFB
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.29808564860992603,0.7952405642859294,0.7425044091710759,0.9511400545624887,1.0,5/17,15.73%,GREM1;EGR3;MIA3;AKT1;PIK3R3
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3199673622222069,-0.7950496795460639,0.7417943107221007,0.9667701041857266,1.0,4/11,32.53%,PRDX1;CAT;GPX3;PRDX4
prerank,neurotransmitter biosynthetic process (GO:0042136),0.31385234389146643,0.7948471570308507,0.7385496183206107,0.9512947204681442,1.0,4/14,20.49%,DAGLB;SLC22A2;DAGLA;NOS1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23012235199636746,0.7947618090514859,0.8082191780821918,0.950925006899065,1.0,8/47,17.76%,SIRPA;PLEK;BRCA1;CD34;CEACAM1;PROX1;WDTC1;ROCK2
prerank,positive regulation of secretion by cell (GO:1903532),-0.20460179089971367,-0.7944639841863288,0.8787878787878788,0.9670118351526459,1.0,14/70,15.90%,CADPS;SOX11;PPIA;STXBP5;DNM1L;GOLPH3;RAB3A;UNC13B;DTNBP1;ACHE;SNCA;CFTR;RGCC;RAB27B
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.19835681731755161,-0.7940572190920354,0.8982630272952854,0.9669706626603379,1.0,17/75,21.08%,PLCB1;GRK5;FRMPD1;RASGRP4;CALM1;KCTD8;RGS20;RGS6;PDE6H;CCL5;CAMKMT;GUCY2F;GUCY2D;PDE6A;RGS3;USP33;CRY1
prerank,regulation of cell death (GO:0010941),0.2052533782951521,0.7939365397029765,0.8689320388349514,0.9518565555059639,1.0,11/94,10.22%,SRGAP2;RILPL1;RIPK2;CLU;EIF4G1;IMPACT;ACER3;CALCR;ACER2;RRAS2;LRP1
prerank,negative regulation of cholesterol transport (GO:0032375),0.33783670807776756,0.7938894405217369,0.7523992322456814,0.9514237208637257,1.0,1/10,6.91%,SHH
prerank,protein localization to phagophore assembly site (GO:0034497),0.31997145609156635,0.7938531183772207,0.7377938517179023,0.9509611621939582,1.0,6/11,26.16%,ATG9A;TRAPPC8;ATG9B;PACS2;WDR45B;MFN2
prerank,glutamate metabolic process (GO:0006536),0.2799902074791658,0.7934328216220854,0.7548845470692718,0.9511691543769034,1.0,3/19,13.81%,DGLUCY;GAD1;GCLC
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.20577562072852226,0.7930916887066167,0.8817204301075269,0.9512233233895026,1.0,14/87,13.71%,NCBP1;POLR2H;POLR2J;POLR2D;EGR3;HNRNPH1;TIAL1;ZFP36L1;ZFP36L2;FRS2;ESRP1;PTPN11;GALNT3;CEP57
prerank,negative regulation of phagocytosis (GO:0050765),-0.27977916715674955,-0.7930113647748547,0.8004640371229699,0.9680452552543227,1.0,4/17,11.60%,CD47;CD300LF;FCGR2B;DYSF
prerank,positive regulation of ATPase activity (GO:0032781),-0.22619575106836565,-0.7929810490470881,0.7970660146699267,0.9673333918457303,1.0,12/41,23.87%,FGF10;RYR2;ATP1B3;VMP1;TOR1AIP2;MYBPC3;MSH6;SETMAR;DNAJB2;CHTOP;MSH2;ATP2A1
prerank,neuropeptide signaling pathway (GO:0007218),-0.20965372201258425,-0.7928507791495103,0.8561151079136691,0.9668085501638816,1.0,13/58,21.95%,SORCS1;RAPGEF2;GLRA1;OPRM1;HCRTR2;OPRD1;GALR1;GLRA2;NTS;NTSR1;AGRP;NXPH2;PNOC
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.27836856896064666,-0.7925269582176108,0.734375,0.9666148588001433,1.0,3/18,6.50%,LILRB3;LILRB1;FBN1
prerank,heart trabecula morphogenesis (GO:0061384),0.28867384571953925,0.7922328585038272,0.7562724014336918,0.952175074856625,1.0,1/18,0.06%,TGFBR1
prerank,regulation of centrosome duplication (GO:0010824),-0.24247731864272964,-0.7920660174991562,0.7879464285714286,0.9666512484732319,1.0,8/29,17.22%,CCNF;SIRT1;PLK2;CEP76;GEN1;ALMS1;CEP120;NPM1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.21362007664216826,-0.7919316270747689,0.856492027334852,0.9661229305172265,1.0,21/52,30.64%,ALDH1L1;SDHA;L2HGDH;SLC46A1;SHMT1;ME1;IDH2;MTHFD1L;ACLY;FPGS;FOLR2;MTHFD2;MTHFD2L;SLC25A32;GOT1;DHFR;HOGA1;ALDH18A1;SDHAF3;TAT;MDH1B
prerank,axonal transport (GO:0098930),0.24353805545620869,0.7915415546696435,0.7955801104972375,0.952885884841789,1.0,4/36,6.87%,DST;KIF3B;AP3D1;AP3B2
prerank,response to peptide (GO:1901652),0.24897721737031975,0.7915269218638946,0.7932773109243697,0.9523931167977716,1.0,12/33,27.98%,AGER;EIF2B3;MMP2;CALCR;EIF2B4;CACNA1A;STAT6;NOD2;STAT5B;EIF2B2;STAT3;IRF5
prerank,cellular component maintenance (GO:0043954),0.3166763555932964,0.7909618408171555,0.7276119402985075,0.9528015251155012,1.0,3/12,18.86%,IGF1R;PICK1;CLDN1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28257759758919704,0.7908807449007039,0.7850953206239168,0.9524212979306451,1.0,6/20,18.20%,RGS10;LYPD1;CHRM1;GRK2;CHRNA3;GNB1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.31143984827092264,0.7902929432567933,0.7572463768115942,0.9529060780123804,1.0,4/13,13.86%,TRIM44;DHX9;AXL;MAVS
prerank,positive regulation of chromatin organization (GO:1905269),0.32075773658746193,0.7902759168956508,0.7601410934744268,0.9524149197847608,1.0,4/12,19.17%,SIN3A;TERF1;TAL1;ACD
prerank,angiogenesis involved in wound healing (GO:0060055),0.327991407729881,0.7896772101025534,0.7382671480144405,0.952894731064702,1.0,5/11,27.13%,GATA2;CD34;PRCP;ITGB3;MCAM
prerank,T cell differentiation (GO:0030217),0.23803669255757362,0.7896511749417202,0.8152542372881356,0.952416892786144,1.0,7/40,9.67%,CHD7;RHOH;SHH;ZFP36L1;ZFP36L2;JAG2;PIK3CD
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.32814319662186564,-0.7896226328917703,0.7219917012448133,0.9692893370550641,1.0,2/10,7.25%,CPEB3;CDC73
prerank,negative regulation of immune response (GO:0050777),0.19129517761449258,0.7896166523812974,0.9409984871406959,0.9519595686376333,1.0,29/154,18.20%,SIRT2;ADCY9;ITCH;PRKACA;LYN;MYH9;SRC;PLCG2;PCBP2;HRH2;C1QBP;ADORA2B;MC2R;CALCR;FSHR;LHCGR;NPS;ADCY4;DPEP1;HAVCR2;ADCY6;INSL3;MAPK14;VIP;ADORA2A;SPINK5;ADCY7;GPR84;GNB1
prerank,inositol phosphate metabolic process (GO:0043647),-0.2187028973922524,-0.7893704537121566,0.8470873786407767,0.9689419875818346,1.0,13/46,19.67%,PLCB1;CALM1;PLCH1;PLCB4;INPP5J;NUDT3;PLCH2;OCRL;PLCD1;ISYNA1;ITPKC;IPMK;ITPK1
prerank,ceramide transport (GO:0035627),-0.3100575798768016,-0.789091737338977,0.740174672489083,0.9686891916123704,1.0,3/12,16.52%,PLTP;PLEKHA3;CERT1
prerank,sulfur amino acid metabolic process (GO:0000096),0.2627477310205483,0.7889951811802823,0.7814113597246127,0.9524988141963189,1.0,8/24,24.13%,MPST;DPEP1;GCLC;GADL1;MTHFD1;TXN2;MMUT;CDO1
prerank,myelination in peripheral nervous system (GO:0022011),0.315042052420201,0.7887565937047751,0.7386569872958257,0.9523959824234182,1.0,2/13,2.62%,SKI;SIRT2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.322257519998461,0.7887427780087067,0.7074569789674953,0.9519055755644895,1.0,5/11,26.35%,VHL;LEPROT;HGS;ADIPOR1;SOCS3
prerank,fatty acid transmembrane transport (GO:1902001),-0.27120878809796534,-0.7887424937856646,0.7584745762711864,0.9685180542635201,1.0,4/19,14.52%,CD36;PRKAG2;ABCD4;CPT1B
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.22024206430089377,-0.7877495562414594,0.8429951690821256,0.9694497511650026,1.0,12/44,17.48%,CD47;PPM1E;ARHGEF10L;CDC42;CARMIL1;CCDC88A;LIMCH1;ITGB1BP1;PAK1;SFRP1;RGCC;S100A10
prerank,negative regulation of chemotaxis (GO:0050922),-0.24274854035781834,-0.7873258120441652,0.8333333333333334,0.9693921826308073,1.0,5/31,7.84%,ROBO1;SLIT2;SEMA5A;SEMA4A;PTPN2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3216049048337,0.7873041878464838,0.7427007299270073,0.9537610699372305,1.0,4/11,23.67%,DDX5;MAP2K1;TP53;TGFB1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3127090584697635,-0.7872703987231863,0.7395833333333334,0.968728487021125,1.0,1/12,0.23%,B3GALT1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.30199406358452785,-0.7872552765301412,0.7595744680851064,0.9680048733002712,1.0,6/13,32.02%,ANO6;AZIN1;ACSL1;BRAF;C2CD5;NR4A3
prerank,negative regulation of macroautophagy (GO:0016242),-0.250234554600714,-0.7871159168556752,0.7863436123348018,0.9675007253767851,1.0,4/26,9.54%,LRRK2;SCFD1;SMCR8;RUBCN
prerank,metallo-sulfur cluster assembly (GO:0031163),0.275943038583577,0.7869668466376263,0.7553956834532374,0.9537940174528046,1.0,4/22,10.56%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,mitochondrion distribution (GO:0048311),-0.30818072401882,-0.7868882290450877,0.7672955974842768,0.9671138666359517,1.0,2/12,5.23%,LRRK2;DNM1L
prerank,cellular copper ion homeostasis (GO:0006878),-0.29414521608841393,-0.7866823064853198,0.7617021276595745,0.9667120338093368,1.0,3/14,9.22%,APP;ATP7A;SLC31A2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.27477501905841,-0.7866603187583912,0.7844444444444445,0.9660048084762823,1.0,8/18,28.75%,CDC25C;RCC2;CCNB1;CDK4;DTL;STOX1;CDC25B;MECP2
prerank,macrophage differentiation (GO:0030225),0.30846986040984525,0.7866081313728388,0.7625482625482626,0.9539011300592214,1.0,1/13,0.78%,CSF1R
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.2747023544800536,0.7865863918582945,0.7741935483870968,0.953420376796521,1.0,4/22,10.35%,AGER;GCNT2;FLOT2;WNK1
prerank,regulation of neuron apoptotic process (GO:0043523),0.20143913641615235,0.7860877879756822,0.9130434782608695,0.9537327901398398,1.0,15/96,14.53%,MEF2C;DDIT3;SLC30A10;CCL3;LGMN;PTK2B;PPT1;CNTF;GDNF;POU4F1;CLN3;PINK1;AGAP2;SOD1;RETREG1
prerank,tRNA 5'-leader removal (GO:0001682),0.31570963779453687,0.7860580850334807,0.7481481481481481,0.9532780738357012,1.0,3/13,12.42%,POP1;SSB;RPP21
prerank,ribosomal large subunit assembly (GO:0000027),0.26448431813236,0.7858932827818438,0.7808471454880295,0.9530349182825599,1.0,11/24,29.37%,BOP1;RPL10;NLE1;BRIX1;TRAF7;FASTKD2;DHX30;MRPL20;NOP2;MDN1;RPL6
prerank,erythrocyte differentiation (GO:0030218),0.23257243845210118,0.7857809931111465,0.842809364548495,0.9527009018784823,1.0,7/44,14.80%,IKZF1;LYN;INHA;NCKAP1L;CEBPG;UBA5;TAL1
prerank,blood vessel diameter maintenance (GO:0097746),-0.23467462508147102,-0.7854948514719008,0.8039647577092511,0.9672014513672302,1.0,7/34,12.23%,KCNMB2;EDNRB;HTR2B;KLF2;PER2;ITGB1BP1;KCNMB4
prerank,regulation of intracellular protein transport (GO:0033157),0.25042749313727447,0.7854926194747546,0.7860869565217391,0.9526697149123944,1.0,17/32,36.03%,PTPN1;UHMK1;PLK3;TENM1;PDCD10;OAZ2;PTPN14;KIF20B;TGFB1;SIRT7;RAB29;LCP1;NDEL1;B3GAT3;RIPOR1;VAMP2;ATP13A2
prerank,regulation of protein targeting to membrane (GO:0090313),0.252839926206597,0.7854446527384815,0.7989031078610603,0.9522391594647557,1.0,5/28,14.99%,ITGAM;ITGB2;INPP5K;MIEF2;CIB1
prerank,response to organic cyclic compound (GO:0014070),0.22337176767472602,0.785131146560752,0.8154859967051071,0.9522512593854989,1.0,5/52,7.10%,IL18;PAQR7;CCL3;TRPM2;ARL6IP5
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2649152060997315,-0.7848751070491174,0.8021978021978022,0.9675188352429465,1.0,3/20,5.83%,SYNE1;SP100;BARD1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.32209355185851707,0.7848612476980114,0.7440944881889764,0.9521834412102379,1.0,2/12,7.58%,PICALM;FLOT2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2789614551189739,-0.7847980461501546,0.7662337662337663,0.9668895037961668,1.0,4/17,10.51%,CTNNA2;WASF1;ABI2;DNAI3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.31856729418756524,-0.7847861004218889,0.7655913978494624,0.9661621594896812,1.0,2/11,3.05%,GSN;ST18
prerank,epithelial cell development (GO:0002064),0.28014276851115805,0.7844791500421118,0.7791741472172352,0.9522919436895062,1.0,3/20,10.58%,RILPL1;PKHD1;WNT7B
prerank,negative regulation of endothelial cell migration (GO:0010596),0.24300323346495856,0.7844507983611185,0.8084358523725835,0.9518294811559764,1.0,13/36,25.99%,PTPRM;MEF2C;AGTR2;APOH;THBS1;KRIT1;SYNJ2BP;ANGPT2;STC1;TGFB1;JUP;DNAJA4;ATP2B4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.32750819279466703,0.7843893242439062,0.7397504456327986,0.9509093361214577,1.0,1/10,4.85%,NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.32750819279466703,0.7843893242439062,0.7397504456327986,0.9509093361214577,1.0,1/10,4.85%,NFATC1
prerank,regulation of protein binding (GO:0043393),0.19628061193794377,0.7839943801570289,0.9039039039039038,0.9510518122828254,1.0,24/114,17.58%,CSNK1E;RIPK2;PRKACA;PRKCD;SLPI;CTNNBIP1;AKTIP;PDGFB;PRMT8;LRP1;TAF1;HIP1R;MARK2;GNL3L;LDLRAP1;PIN1;MAPK8;HDAC5;TMBIM6;AKT1;NVL;AURKA;DTX3L;KDM1A
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.21382739970979522,-0.7838765918525968,0.8671875,0.9669793054474497,1.0,15/54,21.15%,RPL35A;NSA2;SNU13;RPL7A;LAS1L;RPL26;MRTO4;PPAN;RPL24;RPLP0;NPM1;NOP16;RRS1;RPL23A;NOC2L
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2633862953124616,0.7836167776289793,0.7898423817863398,0.9511749107863892,1.0,2/24,0.90%,FGF13;KIF2A
prerank,regulation of mitotic cell cycle (GO:0007346),0.18752755479711347,0.7836068840655741,0.9431643625192012,0.950676942275269,1.0,30/171,16.82%,TTC28;SMAD3;SMOC2;PIM2;PRKCA;CDK9;NEK6;HECA;LGMN;AFAP1L2;MAEA;ERCC2;THAP1;CKS1B;PSMD3;RNF20;ANAPC15;PSMB3;NEK7;CDK11B;PSMA7;PIN1;PSMC1;PSMC2;TAL1;PSME4;GAS1;PSMB9;ANAPC11;RPRM
prerank,negative regulation of cell cycle process (GO:0010948),0.22220267362042254,0.783440317511611,0.8455008488964346,0.9504395985744003,1.0,20/61,25.30%,BRCA1;NANOS2;GPER1;EHMT2;NME6;APAF1;PCGF2;TERF1;EZH2;EED;UXT;VPS4A;RNF2;CHMP2A;MGA;EPC1;RING1;PHC1;CCP110;CDC7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.24628350255072445,0.7831380607016263,0.8208695652173913,0.950429557740073,1.0,4/32,8.56%,CAPN3;PDPK1;GPER1;CALCR
prerank,negative regulation of endocytosis (GO:0045806),-0.25291171503693943,-0.7828845266206248,0.8106235565819861,0.9678128960557565,1.0,5/24,12.15%,LILRB1;MTMR2;RUBCN;UNC119;MCTP1
prerank,positive regulation of protein secretion (GO:0050714),0.2126475165352271,0.7827946376882328,0.8662207357859532,0.9504962670209255,1.0,26/69,31.64%,FRMD4A;ACSL4;TLR4;TM7SF3;SLC30A8;GPER1;PPID;CD33;LRRC8A;CD2AP;PTPN23;IL1A;EXOC1;MYO18A;IER3IP1;TGFB1;WLS;MYOM1;ISL1;TMED10;TCF7L2;GOLPH3L;NNAT;TREM2;ADAM9;ABCG1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.30019622497314835,-0.782598284428089,0.7692307692307693,0.9675146969704796,1.0,6/13,30.40%,ADRA1A;SMTNL2;AVPR2;ADRA1B;OXTR;AVPR1A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.29338673907942564,0.7824576207007643,0.7711864406779662,0.9505311302228644,1.0,2/15,11.72%,ASMT;SMOX
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.2823720284313092,0.7824490279597378,0.7712765957446809,0.9500370169864374,1.0,7/20,23.67%,PAX6;POU4F1;LAMTOR5;GATA3;TWIST1;PARK7;TGFB1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.2766299559186034,-0.782410029256052,0.7847533632286996,0.9670829303226453,1.0,7/17,23.13%,RBPJ;JAG1;HEY2;SNAI2;BMP4;DLL4;NOTCH2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3056049827130762,-0.7823085903775322,0.7404255319148936,0.9665031866420074,1.0,2/13,4.07%,OAS2;JAK2
prerank,cellular response to acid chemical (GO:0071229),-0.24813332022833895,-0.781832313626309,0.8259911894273128,0.9665588729355759,1.0,4/27,5.74%,CPEB3;GLRA1;KLF2;RRAGB
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.203624077825524,-0.7817377366247317,0.8716049382716049,0.9659752753625855,1.0,18/68,24.64%,LRRK2;AMPD3;PDE9A;HINT1;RAN;AK3;ACOT13;ACOT11;AK4;SULT2B1;ADSS2;BPNT1;GLYAT;ACLY;ACOT12;ACSM3;BPNT2;ACSL6
prerank,peptidyl-methionine modification (GO:0018206),0.31385426658003124,0.7815795262279711,0.7897727272727273,0.9509356720332012,1.0,5/12,24.31%,NAA25;NAA20;METAP2;METAP1D;NAA60
prerank,programmed necrotic cell death (GO:0097300),-0.2679727890225323,-0.7809902811053412,0.7739872068230277,0.9664152402220072,1.0,7/18,23.15%,DNM1L;MLKL;IPMK;ITPK1;TRPM7;RIPK3;PPIF
prerank,regulation of protein import into nucleus (GO:0042306),0.24156998472105462,0.7807613819061456,0.7898423817863398,0.9517699239898149,1.0,11/36,23.79%,SMAD3;PIK3R1;PRKCD;MAVS;ZIC1;ECT2;ZC3H12A;TGFB1;IPO5;SUFU;JUP
prerank,regulation of myoblast fusion (GO:1901739),-0.31531229638411107,-0.7806180224014505,0.7618025751072961,0.9662559248621939,1.0,2/11,4.45%,EHD1;RIPOR2
prerank,translation (GO:0006412),0.18175080402370258,0.7806030057387984,0.9638728323699421,0.9515214014581564,1.0,56/208,22.95%,KARS1;ETF1;MRPS24;EIF4G1;MRPL2;MRPL37;RPS27A;RRBP1;NARS1;MRPL43;MRPS34;ABCE1;MRPL34;SARS2;SARS1;MRPL9;EEF1B2;RPL15;MRPS5;ASMT;RPL10;DHPS;RARS1;EEF2K;RPS8;MRPS21;GSPT2;ABCF1;FARSA;RPS24;MRPL13;MRPS16;IARS1;MRPS11;MRPS18B;DARS2;EPRS1;QARS1;WARS2;MRPS28;EIF4EBP2;RPL9;MRPS18A;IARS2;RPL39;TMA7;MRPL11;TNIP1;MRPL41;MRPL27;FASTKD2;MARS2;RPL28;TUFM;RPL34;RPL31
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.23711274558191345,0.7794571591380113,0.838475499092559,0.9528620591208248,1.0,11/39,23.67%,MIA3;NOTCH4;WNK1;AKT1;SPINT2;PLG;AKNA;MAPK7;PPM1F;BMP2;TGFB1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.2893543263651503,-0.7792748354955447,0.7443762781186094,0.9677329696104394,1.0,3/15,10.43%,LILRB1;CBARP;ADRA2A
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.21707245533839667,-0.7789420841942545,0.8508557457212714,0.9675186889753166,1.0,17/47,29.85%,SPOCK1;SPOCK3;SERPING1;SERPINI1;TIMP3;SERPINH1;LTF;SERPINB2;ANXA8L1;ANXA8;SERPINE3;TIMP4;VTN;SERPINA2;SERPINB5;HRG;SERPINA10
prerank,regulation of DNA biosynthetic process (GO:2000278),0.2576576605732071,0.7781106336838315,0.800718132854578,0.9544901856198944,1.0,4/27,11.53%,SMOC2;ATM;PDGFB;PDGFRB
prerank,replicative senescence (GO:0090399),-0.30765907074201765,-0.7775310674711892,0.7898230088495575,0.9690759548236029,1.0,6/12,21.34%,MME;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,smoothened signaling pathway (GO:0007224),0.24479114925629547,0.7775203820010885,0.7950963222416813,0.9549147001622341,1.0,11/32,26.98%,ULK3;SHH;MAP3K10;SMO;B9D1;TMEM17;TTBK2;DISP2;PTCH1;TCTN2;CC2D2A
prerank,regulation of cholesterol esterification (GO:0010872),-0.32330979583190866,-0.7765724769046167,0.7396313364055299,0.9698556146644391,1.0,1/10,4.61%,APOE
prerank,cellular component disassembly (GO:0022411),-0.21100344483760314,-0.7765599622826586,0.8873563218390804,0.9691374206796557,1.0,14/53,21.95%,CD44;MMP16;GSN;TLL1;MMP12;MMP15;MMP19;MMP8;MMP14;BSG;CAPNS2;TLL2;SCUBE3;KLKB1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.330109048682535,0.776416033349998,0.7841584158415842,0.9561445089839762,1.0,5/10,23.66%,SETD2;SETD4;SETD3;SETD7;KMT5A
prerank,regulation of histone deacetylation (GO:0031063),0.3135365478528509,0.776306917528424,0.7458866544789763,0.9557994578068364,1.0,2/13,2.94%,AKAP8;AKAP8L
prerank,aromatic amino acid family metabolic process (GO:0009072),0.33177779398889756,0.7762702375038923,0.7730627306273062,0.9553446916152897,1.0,1/10,1.62%,QDPR
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.270848223843922,0.7759668715728315,0.7978910369068541,0.9553125193872649,1.0,10/22,31.77%,LYN;APPL1;TICAM2;RAB7B;ACOD1;APPL2;FLOT1;TREM2;TNFAIP3;NR1H3
prerank,peroxisome organization (GO:0007031),0.2616901228808699,0.7751417699788129,0.8189964157706093,0.9560985760511466,1.0,3/25,4.28%,ABCD2;TMEM135;PEX10
prerank,gene silencing by miRNA (GO:0035195),0.24442659671475997,0.7750767473674602,0.8321678321678322,0.9557134713182462,1.0,12/32,27.02%,CNOT1;MOV10;NOTCH4;WTIP;TNRC6C;TNRC6B;SNIP1;AGO1;XPO5;AJUBA;RBM4;PUM1
prerank,cellular response to retinoic acid (GO:0071300),0.22899097580639044,0.7750170684624036,0.8544839255499154,0.9553070210291096,1.0,7/42,11.39%,TWF2;LYN;ATM;PTK2B;WNT10B;WNT7B;PAX2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.2845601848319872,0.774775745871125,0.784452296819788,0.9551836263314932,1.0,2/17,7.76%,F11R;S1PR3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.25007239015127836,-0.7747176582913416,0.8088888888888889,0.9713339690386138,1.0,2/25,2.94%,PPARG;CBLB
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.20992242069209488,-0.7745839701739718,0.8858560794044665,0.9707981637855402,1.0,12/51,15.50%,CD47;PPM1E;ARHGEF10L;CDC42;CARMIL1;CCDC88A;LIMCH1;ITGB1BP1;CX3CL1;PAK1;SFRP1;RGCC
prerank,regulation of axon guidance (GO:1902667),0.3368129576148805,0.7744042299537018,0.7527675276752768,0.955228761991302,1.0,4/10,32.66%,ZSWIM8;ZSWIM4;TUBB2B;ZSWIM5
prerank,organic hydroxy compound transport (GO:0015850),0.23929264035439524,0.7738670090716216,0.8316326530612245,0.9555778967386551,1.0,5/36,16.98%,SLCO2B1;CEACAM1;NPC2;SLC5A3;OSBP
prerank,positive regulation of biomineral tissue development (GO:0070169),0.23383831942715833,0.7738640359690382,0.8644366197183099,0.9550779520883347,1.0,3/40,5.47%,TMEM119;MEF2C;SLC8A1
prerank,response to gamma radiation (GO:0010332),-0.24560185117291475,-0.7738477962517563,0.8288288288288288,0.9712351005984683,1.0,7/24,22.73%,RPL26;LIG4;DCUN1D3;MDM2;XRCC5;TLK2;PRKAA1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2868943566126008,0.7738377809224504,0.7792207792207793,0.9546159571515784,1.0,2/16,5.31%,CADM1;RAET1E
prerank,determination of left/right symmetry (GO:0007368),-0.22625365552668641,-0.7737501742605014,0.8450363196125908,0.9706564696227535,1.0,18/36,31.02%,RFX3;ODAD2;PKD2;CFAP53;NPHP3;ODAD3;DNAAF1;CCDC39;MEGF8;MKKS;CITED2;STIL;DNAH11;ODAD4;TBX1;DNAAF4;PKD1L1;PITX2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.23875703010144747,-0.773581632770819,0.8363228699551569,0.9701682633595303,1.0,8/26,20.04%,PF4;RET;HSPA1B;EYA2;BCL2;SNAI2;TERT;MAP2K5
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.24543546033426633,-0.7731626047821253,0.8374164810690423,0.9700852705421148,1.0,6/27,18.54%,CD74;FN1;LIG4;CDKN1A;E2F1;CDK4
prerank,amino sugar biosynthetic process (GO:0046349),0.3150236176509242,0.7730142679781447,0.7912885662431942,0.9553784730854848,1.0,3/12,11.99%,GFPT1;UAP1L1;AMDHD2
prerank,cellular response to interleukin-1 (GO:0071347),0.1873411958090644,0.7729251103279041,0.9444444444444444,0.9550094535081451,1.0,39/143,25.14%,SIRPA;IRAK2;RIPK2;MAP3K3;EGR1;CCL3;RPS6KA5;RPS27A;UBC;TAB2;MAP3K8;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;PYCARD;TNIP2;PSME4;IL1R2;PELI2;PSMB9;RPS6KA4;RBMX;CCL24;PSMD4;NOD2;PSMB5;IL1A;IRAK4;PSMB7;ACOD1;ZC3H12A;PSMB8;CCL25;MYD88;SOX9;HIF1A;PSMD13
prerank,regulation of vacuole organization (GO:0044088),-0.26088796771161304,-0.7728499429543109,0.8115631691648822,0.969828669918313,1.0,6/20,23.23%,RAB1B;UBQLN2;ANXA2;RAB5A;MTMR3;NPRL3
prerank,protein-DNA complex assembly (GO:0065004),0.19173222268926834,0.7721917510295225,0.9262672811059908,0.9556572433618997,1.0,38/116,28.13%,DDB2;GTF2H2;RPS27A;UBC;SART3;MCM2;ERCC2;CUL4B;PSMD3;SMARCA5;PSMB3;PSMA7;PSMC1;PSMC2;SPTY2D1;PSME4;PSMB9;ORC3;HMGB2;CUL4A;MCM3;CHAF1B;PSMD4;PSMB5;KAT6B;PSMB7;RPA3;PSMB8;RAD23B;NAA60;SOX9;PSMD13;ORC2;GMNN;MCM6;PSMD2;RPA1;TCF4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2461128243185053,0.7719130408318253,0.8310104529616724,0.9555839763028742,1.0,8/31,18.97%,TOMM20L;PEX10;TIMM44;PEX6;TIMM50;TOMM20;GRPEL1;PEX1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.23033280936042153,0.7717826009216957,0.8536585365853658,0.9552765568118199,1.0,15/40,23.04%,BCO2;MTLN;ARL6IP5;PIP5KL1;PINK1;ABL1;SOD1;AKT1;PYCR1;MAPT;PMAIP1;STOML2;BCL2L1;PARK7;ABCD1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.32852923804027495,0.7714647660430703,0.75,0.9552916942006933,1.0,1/10,0.70%,CST3
prerank,regulation of protein localization to cell surface (GO:2000008),-0.23035949674784362,-0.7714488580022413,0.7893518518518519,0.9712779706820425,1.0,11/33,25.19%,BDNF;NEDD4L;KCNAB2;TOR1A;ACTN2;LEPROTL1;RANGRF;RIC3;ABCA7;CTNNB1;HSP90AB1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2446066505224213,-0.7714145135584124,0.8293838862559242,0.9705897196346598,1.0,14/27,31.53%,CD74;CD44;SIRT1;SMYD2;MDM2;SNAI2;PLA2R1;MSX1;SPRED1;YJU2;SPRED3;ATR;HIC1;SNAI1
prerank,chromatin remodeling (GO:0006338),0.19694117034475847,0.7711958915176096,0.9199346405228758,0.9551809076256234,1.0,16/100,14.22%,INO80C;CHD8;MYSM1;HNRNPC;KDM5B;TAF6L;CHD3;SRCAP;ACTL6A;SMARCD3;SMARCA5;SMARCA2;BAZ1B;KDM4A;INO80B;HDAC5
prerank,positive regulation of response to wounding (GO:1903036),-0.24941041790089513,-0.7704912866043213,0.8153526970954357,0.9712587644706082,1.0,10/24,28.18%,SCARF1;KANK1;ADRA2A;ITGB1;PRKCE;ACTG1;ANXA1;OCLN;PTK2;VTN
prerank,mitochondrial genome maintenance (GO:0000002),0.32770032960632656,0.7704535188788406,0.7632575757575758,0.9558506742293786,1.0,4/11,25.52%,MEF2A;TOP3A;OPA1;LONP1
prerank,transition metal ion transport (GO:0000041),0.23644780658891684,0.770445888110248,0.8344827586206897,0.9553645416216161,1.0,4/35,7.99%,SLC30A5;ATP2C1;SLC30A10;SLC30A8
prerank,amino acid transport (GO:0006865),0.22392645423922758,0.7698306011936218,0.8604651162790697,0.9557961178635495,1.0,4/49,5.86%,SLC7A8;SLC7A5;SLC36A1;SLC25A45
prerank,tight junction assembly (GO:0120192),-0.21258154169199764,-0.7697575593861866,0.8920863309352518,0.9716550277260606,1.0,20/49,30.12%,AFDN;PATJ;FRMPD2;CDH5;PARD3;PECAM1;PRKCI;ACTG1;MICALL2;GRHL2;PARD6G;MARVELD3;OCLN;STRN;DLG1;CLDN5;CLDN18;POF1B;CLDN16;PARD6B
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.32319590462708525,-0.7695891751419593,0.7505376344086021,0.9711831305478393,1.0,3/10,13.90%,E2F7;WIZ;DBF4
prerank,lipid biosynthetic process (GO:0008610),0.20547312475166038,0.7693068890576761,0.8934426229508197,0.9560978231564043,1.0,8/77,12.31%,LIPC;LIPH;FDXR;HSD3B2;HSD17B1;GGPS1;MBOAT1;FADS1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.19531287354861793,0.7688247361296059,0.9171974522292994,0.9563313032756355,1.0,33/117,25.71%,ACSL4;PPARD;BCO2;ALDH8A1;THEM4;VNN1;CKB;SLC27A4;CROT;NPC1;PANK2;ALDH4A1;VDAC1;MCCC2;AGXT;GAMT;PTGR1;LDHAL6B;CPT1A;SLC6A8;GGT5;AASDHPPT;CPT1C;LDHA;HACL1;ACOT1;SCP2;ME2;ACOT4;GNPAT;ABAT;AASDH;PDHB
prerank,chromatin assembly (GO:0031497),-0.22124177316201177,-0.7686430196364699,0.8865740740740741,0.9718791593644482,1.0,7/38,12.46%,NAP1L2;ASF1A;SIRT1;PADI4;CTCF;H3-3A;BAHD1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.3122434681601272,0.7683279943571837,0.7926605504587156,0.9566232557653671,1.0,3/13,10.16%,CALCOCO1;GPER1;PLPP1
prerank,cellular iron ion homeostasis (GO:0006879),-0.2042950401662799,-0.7683063731259544,0.9134860050890585,0.9716587146903559,1.0,12/55,17.17%,FTL;ABCB7;FLVCR1;SCARA5;NDFIP1;TFR2;SLC46A1;HMOX1;ATP6V1A;FBXL5;CYBRD1;TFRC
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.28491610841072357,-0.7682145813533189,0.7756410256410257,0.971080944907163,1.0,4/14,17.17%,CD226;SHLD3;RIF1;TFRC
prerank,tRNA 5'-end processing (GO:0099116),0.2952624800611111,0.7681773429864519,0.7887067395264117,0.9563522733482619,1.0,4/15,15.95%,POP1;SSB;RPP21;HSD17B10
prerank,GPI anchor biosynthetic process (GO:0006506),0.24381518350230055,0.7677440904987133,0.8078994614003591,0.9564980792917159,1.0,5/30,11.96%,PIGV;PGAP2;DPM3;PIGK;PIGO
prerank,synaptic vesicle recycling (GO:0036465),-0.23042822167595717,-0.7672541150124964,0.8571428571428571,0.9717545415597031,1.0,2/31,2.39%,NLGN1;SYT1
prerank,positive regulation of protein depolymerization (GO:1901881),0.31926311711775174,0.7670233100429024,0.780952380952381,0.9570686264403704,1.0,3/11,14.05%,PLEK;TRPV4;WDR1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2957821777905402,-0.7669294031880195,0.778705636743215,0.9715534456068755,1.0,4/13,14.40%,CBLB;KPNA4;RGPD1;NUP54
prerank,striated muscle contraction (GO:0006941),0.21918755683285832,0.7668379146874041,0.875,0.9568494414510473,1.0,14/53,24.12%,TNNI2;CCDC78;SLC8A1;SCN4B;SMPX;MYL3;GRK2;RCSD1;SCN1B;MYH14;NOS1;GAA;PIK3CA;KLHL41
prerank,mismatch repair (GO:0006298),0.2543262034109305,0.7667944987954117,0.8028419182948491,0.9564080515457439,1.0,6/27,13.42%,PCNA;LIG1;POLD2;EXO1;SETD2;ABL1
prerank,cellular amide metabolic process (GO:0043603),-0.18194034069099188,-0.7663984842410626,0.9552631578947368,0.9716438998869918,1.0,31/102,27.52%,ST3GAL1;MME;ALDH1L1;NAPEPLD;HLCS;SGPL1;AEBP1;PPP2R1A;ACOT13;SLC46A1;SHMT1;ACOT11;PLPP3;BTD;SLC5A6;MTHFD1L;ABCB9;GLYAT;ACOT12;ACSM3;CPXM2;FPGS;FOLR2;MTHFD2;MTHFD2L;ACSL6;SLC25A32;NAAA;PPP2CA;DHFR;MCCC1
prerank,regulation of glycolytic process (GO:0006110),-0.19919232672850246,-0.7661849959359401,0.915,0.9712472483545082,1.0,13/68,14.58%,APP;PRKAG2;PFKFB1;ZBTB20;NUP98;HDAC4;TIGAR;NUP205;NUP210;NUP43;CBFA2T3;NUP54;NUP155
prerank,regulation of p38MAPK cascade (GO:1900744),-0.22662888715175794,-0.7655900993038526,0.8382687927107062,0.9714025812709255,1.0,5/35,9.05%,XDH;PTPN22;PHLPP1;RELL1;DUSP10
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.18679950228609413,0.7654933074924982,0.9479326186830015,0.9579588507248046,1.0,26/140,18.92%,CX3CR1;GNA15;TRPM4;SLC8A1;TAC4;S1PR3;GPR55;CCR7;EDN2;GPER1;CALCR;GPR18;DLG4;NMUR2;ABL1;TRPV4;DRD2;TBXA2R;CCR5;CACNA1A;GPR4;C5AR1;BDKRB2;SELENOT;GPR157;P2RX5
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.29329945084135484,0.7653914515066321,0.7884615384615384,0.957618246002651,1.0,6/15,26.11%,CCT3;NHP2;CCT8;SHQ1;CCT7;CCT5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2536260820391461,0.7653394296160085,0.8192982456140351,0.9571991392335587,1.0,6/27,18.49%,GNA15;GPR55;GPR18;DRD2;GPR4;GPR157
prerank,oogenesis (GO:0048477),0.28980013160503537,0.7653035223161375,0.7912087912087912,0.95675205205993,1.0,2/15,8.18%,KMT2D;NANOS2
prerank,determination of bilateral symmetry (GO:0009855),-0.2508091165138061,-0.7651113267361132,0.8198614318706697,0.9713670695071689,1.0,12/24,31.02%,ODAD2;PKD2;CFAP53;NPHP3;ODAD3;MKKS;CITED2;STIL;DNAH11;TBX1;DNAAF4;PITX2
prerank,regulation of primary metabolic process (GO:0080090),0.1898621122126276,0.7649601948379348,0.9461172741679873,0.9567716471600743,1.0,36/126,25.51%,CHD9;PPARD;GPS2;SIN3A;C1QTNF2;PSMD3;PLPP1;GGPS1;SMARCD3;NFYA;PSMB3;TGS1;PSMA7;CERS2;PSMC1;PSMC2;IDI1;PSME4;SIN3B;PSMB9;OAZ2;ROCK2;NQO1;CARM1;SCD;PSMD4;PSMB5;FGFR4;OPA3;PSMB7;PSMB8;ADIPOR1;OAZ3;MVK;PSMD13;NR1D2
prerank,toxin transport (GO:1901998),-0.31834772744613316,-0.7647998776429228,0.7761194029850746,0.9711016106223002,1.0,2/10,7.25%,ANTXR2;RAB40B
prerank,stabilization of membrane potential (GO:0030322),-0.2700224023015663,-0.7647510520868258,0.8155555555555556,0.9704422501831178,1.0,5/16,23.28%,KCNK10;KCNK12;KCNK5;CHCHD10;KCNK2
prerank,leukotriene biosynthetic process (GO:0019370),-0.28657189949388495,-0.7644920869873567,0.7789473684210526,0.970119748364028,1.0,7/14,29.95%,ALOX5;ALOX5AP;GGT7;MGST3;GGTA1;LTA4H;MGST2
prerank,regulation of cytoplasmic translation (GO:2000765),0.2987297769637274,0.7643269223431866,0.7885304659498208,0.9572239894474281,1.0,3/14,8.63%,DHX9;CNBP;RBM24
prerank,smooth muscle contraction (GO:0006939),-0.2895115167891637,-0.7642205484112264,0.8296460176991151,0.9697719115899601,1.0,7/14,29.87%,ADRA1A;PIK3C2A;EDNRA;ACTA2;CHRNB2;ROCK1;NMUR1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.31294877822470835,0.7635114028329101,0.7714285714285715,0.9579692199650904,1.0,5/12,23.60%,PLK5;RPS27L;PLK3;RFWD3;TP53
prerank,RNA catabolic process (GO:0006401),0.22452760121414012,0.7626912337746838,0.8846153846153846,0.9586890644467457,1.0,12/46,20.93%,NCBP1;DXO;DIS3L2;ZFP36L2;NANOS2;RNASE6;LSM5;ISG20;RIDA;NUDT16;SND1;RNASEH1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2832261909995564,0.7625920057459634,0.7953736654804271,0.9583338097460741,1.0,8/17,31.21%,GJA1;CCNE1;LTBP3;KDM1A;PTPRC;N4BP2L2;PDCD2;HMGA2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.31620086332878033,0.762392967023477,0.7794117647058824,0.9581312538441357,1.0,3/11,11.99%,GFPT1;UAP1L1;AMDHD2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2503773805703328,-0.7620833068857115,0.8269662921348314,0.9721978513759563,1.0,5/22,17.98%,PPM1A;PPM1E;DUSP10;DUSP16;DUSP2
prerank,regulation of cilium movement (GO:0003352),-0.32131461869651523,-0.7620742272090094,0.7598152424942263,0.971480923420551,1.0,5/10,20.63%,ODAD2;CFAP206;DNAAF1;CCDC65;CCDC39
prerank,snRNA 3'-end processing (GO:0034472),0.2734397909794799,0.7619821613894437,0.8087431693989071,0.9582585186815409,1.0,4/19,19.16%,INTS6L;EXOSC5;INTS8;EXOSC8
prerank,iron-sulfur cluster assembly (GO:0016226),0.2639368833657381,0.7614979227146962,0.7967332123411979,0.9584737514615776,1.0,4/24,10.56%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.2400143676255545,0.7613817947294483,0.8282312925170068,0.9581540321800701,1.0,4/34,6.20%,VEGFB;MT1G;SPRY2;EGR3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.2922938979593116,0.7607547348591304,0.7635009310986964,0.9585648487460763,1.0,6/15,26.67%,CSNK1E;RSPO3;ZNRF3;SFRP4;CSNK1D;WNT5B
prerank,negative regulation of coagulation (GO:0050819),-0.28753026327619524,-0.7604735022493184,0.7741273100616016,0.9730876917047989,1.0,2/14,4.61%,HS3ST5;APOE
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.1951824538064706,0.7604388523782245,0.9409937888198758,0.9585231632685969,1.0,18/105,16.68%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.26019197801612837,-0.7603150506375619,0.8259023354564756,0.9725820946964382,1.0,4/19,10.01%,GRM5;RYR2;FIS1;VCAM1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.20273087294140044,-0.7601422679672964,0.9192708333333334,0.9721094017541724,1.0,21/60,28.75%,ATF7IP;AGO4;CEBPB;MED15;TNRC6A;RUNX2;CDKN2A;CDKN1A;HEY2;SRF;CCNB1;CDK4;LEF1;MED6;HNF1B;CTNNB1;MED14;MED16;MED1;RELA;MECP2
prerank,non-motile cilium assembly (GO:1905515),-0.23334642063520483,-0.7600286600045622,0.8851351351351351,0.9715367469741625,1.0,5/30,18.94%,TBC1D32;TMEM216;TMEM107;RPGRIP1;IFT57
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.24402548362072407,-0.7598727925290061,0.8119469026548672,0.9710519793956981,1.0,9/23,30.22%,PPM1A;TSPAN6;CCN3;C1QTNF3;NMI;NLRC3;UACA;RELA;NLRP12
prerank,response to lipid (GO:0033993),-0.17827875858006953,-0.7597448814421754,0.9688385269121813,0.9705137534650654,1.0,29/105,23.77%,PPARG;CD36;PTPN22;FOXP1;JAK2;RARG;STRN3;SPP1;HSD17B2;GGT7;LBP;RARA;SRR;FFAR1;RBP4;FER;SNCA;FOXO1;IRAK3;ASXL1;SOCS2;TRIM16;BGLAP;ALPL;WNT8B;PAQR8;NOCT;ANXA1;CTNNB1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2563136767229566,0.7597169032539257,0.8490909090909091,0.9590985426755645,1.0,12/23,32.16%,MAP3K11;MAP3K10;ARHGEF5;DVL2;DUSP19;FZD10;TLR9;TRAF6;TLR6;TAOK3;DVL3;MAP3K4
prerank,polyol metabolic process (GO:0019751),-0.2104644251509255,-0.7595376960671213,0.8866995073891626,0.9700960011259121,1.0,13/46,19.67%,PLCB1;CALM1;PLCH1;PLCB4;INPP5J;NUDT3;PLCH2;OCRL;PLCD1;ISYNA1;ITPKC;IPMK;ITPK1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.30392672020057343,-0.7594596568117428,0.7732181425485961,0.9694710173231902,1.0,5/12,20.24%,KLF2;CYP26C1;SNW1;ASXL1;TRIM16
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2878048938876046,-0.7594388209448064,0.8151260504201681,0.9687779648073084,1.0,2/14,4.66%,PPAT;ADK
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.1951929830009127,0.759297507833675,0.9438377535101404,0.9587198644847109,1.0,18/104,16.68%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,cellular response to lectin (GO:1990858),0.1951929830009127,0.759297507833675,0.9438377535101404,0.9587198644847109,1.0,18/104,16.68%,PRKACA;LYN;SRC;PRKCD;PLCG2;RPS6KA5;PDPK1;MUC6;TAB2;CLEC4E;PSMD3;PSMB3;PSMA7;RELB;PSMC1;PSMC2;PSME4;PSMB9
prerank,monocarboxylic acid transport (GO:0015718),0.21656400857437652,0.7592594829799685,0.8805970149253731,0.9582765184490685,1.0,2/51,1.13%,SLCO2B1;SLC16A6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.20296012647560488,0.7592305191809925,0.9065108514190318,0.9578182096498213,1.0,14/74,16.68%,NFE2L2;SIRT2;VHL;RPS27A;UBC;EGLN1;PSMD3;PSMB3;ARNT;PSMA7;PSMC1;PSMC2;PSME4;PSMB9
prerank,dicarboxylic acid catabolic process (GO:0043649),0.2975779805634825,0.758863848056872,0.7996289424860853,0.9578599459888685,1.0,4/13,24.07%,GAD1;PM20D2;ACOT8;ACOT4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.27452801679778566,-0.7588037553252963,0.8098434004474273,0.9689544937250596,1.0,8/16,34.52%,PRKAG2;PDK4;ABCB11;PPARGC1A;PPARA;NR4A3;MLYCD;SIRT4
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2673759460054702,0.758775197475605,0.839572192513369,0.9574910324736104,1.0,4/22,9.97%,PLEK;PRKRIP1;INHA;INPP5K
prerank,T-helper cell differentiation (GO:0042093),-0.2861743421631644,-0.7584682621630259,0.795131845841785,0.9687166921021902,1.0,5/14,26.58%,FOXP1;ATP7A;LEF1;RORC;ZFPM1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.30603941770127063,-0.7580728780842134,0.7875,0.9685764730005343,1.0,1/11,1.00%,LRRK2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.24837598908861655,0.7580552778633928,0.8508604206500956,0.958030359285178,1.0,3/28,5.92%,CRADD;TRADD;SORT1
prerank,regulation of T cell chemotaxis (GO:0010819),0.31492914305460895,0.7580401670732654,0.7703435804701627,0.9575630390935812,1.0,7/11,30.44%,WNK1;STK39;ADAM10;ADAM17;CXCL10;WNT5A;OXSR1
prerank,copper ion homeostasis (GO:0055070),0.28173125844293023,0.7575454943280058,0.7947761194029851,0.9577708253691853,1.0,6/17,21.32%,ANKRD9;MT2A;COX19;CCDC22;XIAP;ARF1
prerank,regulation of epithelial cell migration (GO:0010632),0.21766389545254713,0.7574648358151566,0.8752136752136752,0.9573942352897642,1.0,15/51,25.70%,RREB1;ARSB;SRC;PLCG2;MACF1;CEACAM1;INSL3;PTPN23;PPM1F;EVL;ADIPOR1;SOX9;HIF1A;PLCG1;HDAC6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.30608097114891,-0.7572724029461295,0.7863247863247863,0.9690456544434488,1.0,2/11,8.24%,NOVA1;PCBP3
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.22611292343958783,0.7571755450295213,0.8564102564102564,0.9572998969803505,1.0,7/45,11.34%,ATG14;EIF2A;GCNT2;PKP3;EIF2B4;CYFIP1;RPL10
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.23130696514329785,0.7555734281179121,0.8358714043993232,0.9590871406850269,1.0,12/35,25.61%,PTPRM;MEF2C;SPARC;IL12B;APOH;PDCD10;THBS1;KRIT1;SYNJ2BP;AIMP1;ATP5IF1;SULF1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.26044626501454265,0.7553425803113143,0.828996282527881,0.9589322215653224,1.0,3/22,9.61%,PJA2;AGER;PRMT1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.31514866566112054,-0.7547125619441247,0.7851063829787234,0.9719207696586971,1.0,5/10,27.02%,SHMT1;MTHFD1L;MTHFD2;MTHFD2L;DHFR
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2108050396643193,-0.7544214789045518,0.8875305623471883,0.9716255376709564,1.0,14/44,23.54%,CD44;YWHAE;SH3RF1;CAST;BEX3;KLF4;RAF1;SNCA;USP47;LTF;MAP2K5;SIAH2;AQP1;NGFR
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.2541175878159926,0.754402487667769,0.8134991119005328,0.9597391918653405,1.0,4/25,10.24%,ITGA6;SRC;KCTD20;NCKAP1L
prerank,diol metabolic process (GO:0034311),0.26628551679922624,0.7539735591207678,0.7851985559566786,0.9598749004095173,1.0,4/19,14.92%,DEGS2;PLPP1;PLPP2;AKT1
prerank,negative regulation of TOR signaling (GO:0032007),0.2376894530614448,0.753790049039204,0.8701754385964913,0.9596305055640836,1.0,5/36,12.72%,TBC1D7;ATM;FLCN;TNFAIP8L1;PDCD6
prerank,negative regulation of neurogenesis (GO:0050768),-0.22606175618429117,-0.7536915710290436,0.8862144420131292,0.9718932989549958,1.0,4/34,6.40%,LINGO1;B2M;RAPGEF2;RTN4
prerank,pre-replicative complex assembly (GO:0036388),0.20927226162305348,0.7534531428735756,0.9098360655737705,0.9596055605851198,1.0,20/64,26.40%,RPS27A;UBC;MCM2;PSMD3;PSMB3;PSMA7;PSMC1;PSMC2;PSME4;PSMB9;ORC3;MCM3;PSMD4;PSMB5;PSMB7;PSMB8;PSMD13;ORC2;GMNN;MCM6
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2707328763190271,0.7533935503284703,0.8178571428571428,0.9587104515419794,1.0,6/20,16.25%,ECHS1;IVD;ACAD8;BCKDHA;HSD17B10;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2707328763190271,0.7533935503284703,0.8178571428571428,0.9587104515419794,1.0,6/20,16.25%,ECHS1;IVD;ACAD8;BCKDHA;HSD17B10;MCCC2
prerank,actin-myosin filament sliding (GO:0033275),-0.22132786065053536,-0.7531876092132875,0.8677494199535963,0.9711409603874852,1.0,15/38,33.50%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;ACTA1;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1;TNNT3
prerank,muscle filament sliding (GO:0030049),-0.22132786065053536,-0.7531876092132875,0.8677494199535963,0.9711409603874852,1.0,15/38,33.50%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;ACTA1;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1;TNNT3
prerank,cellular response to ionizing radiation (GO:0071479),0.22217505688140626,0.7524471066587956,0.868824531516184,0.9595187490963304,1.0,12/47,19.97%,RHNO1;ATM;RHOB;SPIDR;TNKS1BP1;RAD1;BLM;MAPK14;KDM1A;ECT2;XRCC6;RAD9A
prerank,sensory organ development (GO:0007423),0.219032466999457,0.752285446600877,0.8724489795918368,0.9592561854994182,1.0,6/51,10.19%,FREM2;PAX6;CHD7;MEIS3;MYO7A;SHROOM2
prerank,regulation of glucose metabolic process (GO:0010906),-0.22469936821541436,-0.7522415596617198,0.8752886836027713,0.9716817315372117,1.0,6/34,12.44%,IRS1;PRKN;SLC45A3;SIRT1;FOXK1;GNMT
prerank,regulation of focal adhesion assembly (GO:0051893),-0.20237335725089198,-0.751847998735382,0.9025,0.9714872416773185,1.0,15/54,21.63%,ARHGAP6;SLK;LIMCH1;ITGB1BP1;EFNA5;THY1;ACVRL1;SFRP1;TEK;RCC2;S100A10;BCAS3;TSC1;ACTG1;PEAK1
prerank,regulation of blood coagulation (GO:0030193),0.24714796186088606,0.7516654586110897,0.8324225865209471,0.9596698273540286,1.0,8/27,22.90%,F12;CD34;APOH;SERPINE1;SERPINE2;THBS1;DMTN;TFPI
prerank,response to organonitrogen compound (GO:0010243),-0.21797275098984925,-0.7507400469925883,0.8714285714285714,0.9723625533791032,1.0,8/38,18.33%,GLRA1;RCN3;PRKN;HLCS;GLRA2;UBXN6;NR1H4;IRAK3
prerank,cGMP biosynthetic process (GO:0006182),-0.3139971626145204,-0.7507160933325179,0.7618025751072961,0.9716796289156489,1.0,5/10,30.73%,GUCY1B1;GUCY2F;GUCY2D;GUCY1A1;NPPA
prerank,peptide hormone secretion (GO:0030072),-0.2417788679663395,-0.7507031231361423,0.8355855855855856,0.970990666684757,1.0,13/26,32.54%,RIMS2;SNX19;FFAR4;GHRL;PTPRN;MAFA;ANXA1;GAL;CYB5R4;EXOC3L1;EDN1;GHRH;NEUROD1
prerank,chromosome organization (GO:0051276),-0.1820886065417553,-0.7505127552314169,0.9750692520775623,0.970529935357426,1.0,17/99,14.58%,SUV39H1;MTF2;LATS1;TOP2A;CENPT;CDCA8;XPA;NDC80;SIRT1;LIG4;PADI4;CENPW;H3-3A;BAHD1;HMG20A;NUCKS1;NUP155
prerank,cellular response to inorganic substance (GO:0071241),-0.2534374359501318,-0.7504442961849899,0.8283062645011601,0.9699180409694809,1.0,2/21,3.60%,KCNC2;GUCY1B1
prerank,membrane depolarization during action potential (GO:0086010),0.248799060225995,0.7498197387352351,0.8268551236749117,0.9616822449582562,1.0,7/26,19.24%,YWHAH;SLC8A1;SCN4B;SCN1B;SCN7A;KCNJ2;CACNA1D
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.2800164123551827,0.7492609693532106,0.8114602587800369,0.9619494919670593,1.0,5/16,17.48%,AGTR2;NOS1AP;PIK3CB;AKT1;SCARB1
prerank,cell differentiation in hindbrain (GO:0021533),0.31049750593820435,0.7483863572227822,0.8108614232209738,0.9626341372764681,1.0,4/11,16.48%,OPHN1;PROX1;NOG;CBLN1
prerank,intracellular lipid transport (GO:0032365),0.2641448626946482,0.748163146051665,0.835820895522388,0.9624489931047315,1.0,7/21,26.01%,ABCD2;NPC2;CPT1A;THRSP;ABCD1;MID1IP1;SLC25A20
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.30694705095108576,-0.7480530310025031,0.8114035087719298,0.9724609966091265,1.0,1/10,1.00%,LRRK2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.23583903561389305,-0.7471648734714189,0.8925,0.9729688584378655,1.0,10/29,31.10%,KMO;SARDH;DAO;IDO2;KYAT1;GSTZ1;HOGA1;ACADSB;TAT;OTC
prerank,positive regulation of protein transport (GO:0051222),0.20493223440217004,0.7471336600693413,0.9178743961352657,0.9633597004357685,1.0,17/67,23.67%,FRMD4A;ATP2C1;PPID;CLN3;CD33;PLK3;CD2AP;TENM1;PDCD10;OAZ2;IL1A;EXOC1;MYO18A;ARHGEF5;KIF20B;IER3IP1;TGFB1
prerank,regulation of catecholamine secretion (GO:0050433),-0.23421285640274264,-0.7470071844163697,0.8782816229116945,0.9724687491195031,1.0,7/29,14.97%,SYT1;SYT10;PRKN;CHRNA4;DTNBP1;SYT3;SNCA
prerank,piRNA metabolic process (GO:0034587),-0.26126323987260225,-0.7468720091193665,0.8056872037914692,0.9719308209011731,1.0,7/19,29.56%,TDRD12;GPAT2;TDRD9;MYBL1;PIWIL2;MOV10L1;PIWIL4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2356564635496939,0.7467623233983112,0.8614564831261101,0.9633986483315838,1.0,10/32,23.36%,POLR2H;GTF2H2;ERCC2;TAF1;POLR1C;POLR2E;UBTF;TBP;POLR1E;POLR1G
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.24658119236462117,-0.7466450652501122,0.8264642082429501,0.9715127440678698,1.0,7/21,23.54%,GRIN2B;BEX3;TTBK1;LTF;EPHA7;FYN;NGFR
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2433731977435814,0.7464321985067254,0.843859649122807,0.9633199649937857,1.0,10/29,25.84%,AGTR2;GPER1;PYCARD;TNFRSF12A;AGT;THBS1;HTRA2;PMAIP1;FADD;PPP2R1B
prerank,regulation of adaptive immune response (GO:0002819),0.2713519684545825,0.7463750721169522,0.8302919708029197,0.9629039829020355,1.0,5/18,19.51%,SASH3;IL6ST;PYCARD;ADCY7;IL4I1
prerank,cellular response to gamma radiation (GO:0071480),0.2770526909592882,0.7463698249103023,0.8279569892473119,0.9624249684172154,1.0,7/17,27.94%,ATM;KDM1A;XRCC6;TP53;CRYAB;TSPYL5;TMEM109
prerank,oxoacid metabolic process (GO:0043436),-0.2350225932625682,-0.7463418072134507,0.8514412416851441,0.971223354775372,1.0,9/27,24.42%,PPA1;THAP4;GNMT;SULT2B1;DAO;BPNT1;GRHPR;BPNT2;LIPT2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.31591077805422896,0.7457226897962226,0.7985212569316081,0.962811831409236,1.0,1/10,3.35%,PIH1D2
prerank,necroptotic process (GO:0070266),-0.26617218818129196,-0.7455324990421963,0.8389830508474576,0.9715896949431873,1.0,6/16,22.62%,DNM1L;MLKL;IPMK;ITPK1;TRPM7;RIPK3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.307311963608651,-0.7447570449087408,0.8145833333333333,0.9719093768214421,1.0,3/10,20.16%,CCT2;WRAP53;TCP1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.2939602327822973,0.7446428092543999,0.8186915887850468,0.9637572967408174,1.0,3/13,20.24%,TLR4;IL33;NOD2
prerank,regulation of transposition (GO:0010528),-0.2863264999690319,-0.7442693688749528,0.8183856502242153,0.9718221537988926,1.0,7/13,29.56%,SPOCD1;TDRD9;MYBL1;PIWIL2;SMYD5;AICDA;PIWIL4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3137045551549625,0.7441541912640552,0.819366852886406,0.9639153111691353,1.0,7/11,30.73%,DHX9;WTIP;XPO5;AJUBA;STAT3;PUM1;FXR1
prerank,regulation of protein localization to nucleus (GO:1900180),0.22509408495120747,0.7437036164642377,0.8606965174129353,0.9639925672545312,1.0,13/43,23.67%,FLCN;SHH;SIN3A;LAMTOR5;PIN1;LATS2;AKT1;NVL;DTX3L;EIF2AK3;BYSL;PARK7;TGFB1
prerank,regulation of intracellular pH (GO:0051453),-0.2227149342220562,-0.7436831438678538,0.875,0.9719123094854529,1.0,10/34,21.94%,LRRK2;SLC4A10;TMEM165;SLC4A8;SLC9A4;CFTR;SLC9B1;SLC26A3;SLC4A1;SLC9A2
prerank,aerobic respiration (GO:0009060),0.26411173676181043,0.7436603430896431,0.8372093023255814,0.9635565868134183,1.0,9/20,29.85%,UQCRB;UQCRC2;ATP5F1D;SURF1;SLC25A14;MTFR1L;UQCRC1;SIRT3;OXA1L
prerank,regulation of chromatin organization (GO:1902275),-0.2821299600960818,-0.7432135650946546,0.8163716814159292,0.9718119617493042,1.0,4/14,11.65%,MKI67;MLLT3;SETD5;ALKBH4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.28101303744172934,0.7428553582678645,0.821917808219178,0.9641175656807972,1.0,4/16,12.75%,FANCM;SLX4;TOP2B;ERCC4
prerank,regulation of mitotic nuclear division (GO:0007088),0.21219902381867373,0.7421688898169848,0.8951747088186356,0.9645222508134831,1.0,12/55,21.58%,LRP5;PDGFB;EDN3;NME6;ANAPC15;PDGFRB;PIN1;AURKA;NUP62;IL1A;RCC1;KIF20B
prerank,protein targeting to peroxisome (GO:0006625),-0.2267427426688527,-0.7420438670910098,0.8627002288329519,0.9726259985152192,1.0,6/29,13.00%,ATAD1;ACBD5;PEX12;FIS1;ZFAND6;ALDH3A2
prerank,extracellular matrix disassembly (GO:0022617),-0.20106062679705153,-0.7419682147790292,0.9187935034802784,0.972016962979739,1.0,14/53,21.95%,CD44;MMP16;GSN;TLL1;MMP12;MMP15;MMP19;MMP8;MMP14;BSG;CAPNS2;TLL2;SCUBE3;KLKB1
prerank,fatty acid biosynthetic process (GO:0006633),0.20357061306884724,0.7418282785414553,0.914572864321608,0.9644778686893076,1.0,4/63,5.94%,LIPC;LIPH;HPGD;HACD3
prerank,amino acid transmembrane transport (GO:0003333),0.2214072436085568,0.7414421648651803,0.8843537414965986,0.9644658978234789,1.0,3/45,2.43%,SLC7A8;SLC7A5;SLC36A1
prerank,renal water homeostasis (GO:0003091),0.25674477484414737,0.740912730757757,0.8468634686346863,0.9647064770376479,1.0,5/23,11.99%,ADCY9;PRKACA;ADCY4;MYO5B;ADCY6
prerank,positive regulation of organelle organization (GO:0010638),0.23344303864752736,0.7408657011395149,0.8693284936479129,0.9642860613737806,1.0,10/32,22.73%,SHCBP1L;TMED9;RAB3GAP1;RAB3GAP2;PLA2G5;SORBS3;HTRA2;STX18;FYCO1;KATNBL1
prerank,relaxation of cardiac muscle (GO:0055119),0.29573351494423983,0.7407944024016999,0.8065693430656934,0.9638926545012432,1.0,8/13,32.90%,SLC8A1;KCNJ2;PLN;PIK3CA;CHGA;CAMK2D;ATP1B1;ATP1A2
prerank,response to thyroid hormone (GO:0097066),0.2974938625418082,0.7407435785357988,0.8065764023210832,0.9634730753661244,1.0,2/13,5.48%,BRD8;CTSS
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.23743571310356826,-0.7400837596918022,0.864693446088795,0.9737808532494974,1.0,2/26,5.28%,AKAP6;GSK3B
prerank,response to glucagon (GO:0033762),0.26042492911393594,0.7394388469090059,0.8497316636851521,0.9646264886855801,1.0,4/19,11.99%,ADCY9;PRKACA;ADCY4;ADCY6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.27209364734341646,-0.7394188781908849,0.8376068376068376,0.9739547864949196,1.0,4/14,16.20%,AK3;AK4;ME1;NME2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.26507538448717627,0.7393669529990187,0.8671726755218216,0.9642517218771959,1.0,9/18,31.13%,CEP295;CCT3;CEP135;CCT8;PTP4A3;CCT7;CCT5;CORO2B;TREM2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.21770819257715507,-0.7393581916018114,0.8755760368663594,0.9733287415486981,1.0,10/36,19.47%,TFDP2;E2F6;RBBP8;CBX5;RBBP7;CHEK1;CBX3;PCGF6;E2F1;TFDP1
prerank,regulation of rRNA processing (GO:2000232),0.27800469616151857,0.7391606381292893,0.8280961182994455,0.9640209065072279,1.0,7/16,30.33%,BUD23;USP36;NUDT16;SHQ1;KAT2B;HEATR1;SIRT7
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2818086662926862,0.7387226072549155,0.8074074074074075,0.9640814847650193,1.0,1/15,1.07%,SMAD7
prerank,DNA catabolic process (GO:0006308),0.300016713312834,0.7386817139910888,0.814176245210728,0.9636472783159877,1.0,3/11,18.62%,REXO4;ISG20;FBH1
prerank,cellular amino acid catabolic process (GO:0009063),-0.18049729260863454,-0.7386098479382622,0.9620253164556962,0.9735499631165734,1.0,17/87,17.15%,HIBADH;GLS;ASPA;GCSH;HMGCLL1;HAL;KMO;AUH;BCAT1;SHMT1;SARDH;HIBCH;DAO;AMT;AASS;GLDC;BCKDHB
prerank,positive regulation of blood coagulation (GO:0030194),-0.26813908717923995,-0.7386098017737092,0.8034557235421166,0.972846022434638,1.0,3/17,8.52%,ST3GAL4;USF1;ANO6
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3113882747626896,0.7384370042653139,0.8046594982078853,0.9630075629799618,1.0,4/11,19.57%,INPP5K;INPP1;IMPA1;IMPA2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3113882747626896,0.7384370042653139,0.8046594982078853,0.9630075629799618,1.0,4/11,19.57%,INPP5K;INPP1;IMPA1;IMPA2
prerank,positive regulation of DNA binding (GO:0043388),0.2397359900635931,0.7376569659879612,0.8627787307032591,0.9634815600682299,1.0,10/31,23.67%,SKI;SIRT2;POU4F1;CEBPG;NME1;GATA3;HMGB2;TWIST1;PARK7;TGFB1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2981161567478295,0.7374118064465843,0.7935606060606061,0.9632964307258802,1.0,4/12,16.24%,IMPDH1;GART;ATIC;PAICS
prerank,regulation of telomere capping (GO:1904353),-0.23927185670941503,-0.736825190719109,0.8396436525612472,0.9743616714806542,1.0,8/23,23.83%,MAPKAPK5;SMG6;AURKB;TNKS2;PRKCQ;MAPK1;NABP2;MAPK15
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.24011628270855778,0.7367419959815867,0.8612521150592216,0.9636142974565383,1.0,7/28,17.39%,ARRDC1;GATA2;DLL1;WWP2;AKT1;NOTCH3;ARRB1
prerank,protein localization to chromosome (GO:0034502),-0.22035348506265362,-0.7358485477221693,0.9002375296912114,0.9748858087267328,1.0,13/34,28.97%,MCM9;CTCF;TNKS2;SLF1;PARP3;XRCC5;MSH2;FAM47E;BOD1;MCM8;PLK1;ATR;TINF2
prerank,proteoglycan metabolic process (GO:0006029),-0.23257311601163314,-0.7357605598298811,0.8650602409638555,0.97429596567966,1.0,10/26,27.26%,SULF2;HS3ST4;CHST10;CSGALNACT2;B4GALT7;ADAMTS12;CNMD;CSGALNACT1;CHST14;BMPR1B
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3079527344075718,-0.7357479181713267,0.8235294117647058,0.9736128877755242,1.0,3/10,11.26%,MTMR2;MTMR1;MFSD2A
prerank,tRNA wobble base modification (GO:0002097),0.28682148125148366,0.7351296566979467,0.8130841121495327,0.9651037868345808,1.0,7/14,28.62%,CTU2;MTO1;KTI12;ELP3;MOCS3;ALKBH8;TRMT9B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2964997270326023,0.7347390609597383,0.8097014925373134,0.9651081685549506,1.0,2/12,11.15%,DGAT1;APOC4
prerank,DNA conformation change (GO:0071103),0.26820003211571214,0.7347301797131176,0.8198529411764706,0.9646322320144294,1.0,5/17,18.89%,TOP3B;TOP2B;ABL1;HMGB2;TOP3A
prerank,peroxisomal membrane transport (GO:0015919),-0.2335423220686541,-0.7346151488992556,0.8758949880668258,0.9743168624705285,1.0,6/27,13.31%,ATAD1;ACBD5;PEX12;FIS1;ALDH3A2;ABCD4
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.311787917177022,0.7341687775496342,0.8147448015122873,0.964855154998813,1.0,4/10,35.16%,GNB1;PDE6B;SAG;PDE6G
prerank,lipoprotein biosynthetic process (GO:0042158),0.3032257467175326,0.7339728370683404,0.8275862068965517,0.9646233583681649,1.0,2/11,6.46%,PIK3C3;PORCN
prerank,aromatic amino acid family catabolic process (GO:0009074),0.28125816787176233,0.7332888801612422,0.848816029143898,0.964987665651263,1.0,3/15,19.51%,QDPR;FAH;IL4I1
prerank,transcription by RNA polymerase I (GO:0006360),0.22886021702731288,0.7330949416873483,0.8814159292035398,0.9647446710564122,1.0,10/34,23.36%,POLR2H;GTF2H2;ERCC2;TAF1;POLR1C;POLR2E;UBTF;TBP;POLR1E;POLR1G
prerank,snRNA metabolic process (GO:0016073),0.2749381397806738,0.7321635399466047,0.8402903811252269,0.9653749545769035,1.0,6/17,28.46%,INTS11;INTS3;INTS8;ZCCHC8;RBM7;INTS5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2435713379602183,-0.7319536270173524,0.8530701754385965,0.976851156070067,1.0,5/22,14.26%,PTPN22;PTPN2;FCGR2B;UBASH3A;THY1
prerank,acidic amino acid transport (GO:0015800),-0.25732635958073524,-0.7318678892657736,0.8482142857142857,0.9762512418258206,1.0,7/17,20.50%,SLC1A6;GIPC1;SLC25A12;SLC25A18;SLC1A1;SLC6A1;SLC6A6
prerank,response to X-ray (GO:0010165),-0.27306994816466523,-0.7317136144206456,0.8230088495575221,0.9757260003465567,1.0,6/14,23.50%,LIG4;IKBIP;NUCKS1;XRCC5;MSH2;ANXA1
prerank,protein prenylation (GO:0018342),-0.30343255193761176,-0.7315182250638158,0.8144104803493449,0.975248387243283,1.0,1/10,1.06%,CHM
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.2640765334097947,0.730839603401328,0.8220973782771536,0.9665464326114068,1.0,6/18,21.58%,CYRIB;PTK2B;LLGL1;ROCK2;KRIT1;KIF20B
prerank,positive regulation of viral genome replication (GO:0045070),-0.22886896031823287,-0.730796260952321,0.8615384615384616,0.975420332596681,1.0,9/29,25.79%,TOP2A;PPIA;PABPC1;PPIH;CCL5;SRPK2;NR5A2;PPARA;ADAR
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.284685227204725,-0.7296846361805962,0.8347280334728033,0.976054589293507,1.0,3/12,14.97%,CBLB;F7;SNCA
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.26084443084116304,0.7291133197533287,0.8381818181818181,0.9681272879285737,1.0,4/19,11.99%,GFPT1;MPI;UAP1L1;AMDHD2
prerank,endosome organization (GO:0007032),0.22103286012093937,0.729007996722716,0.8969072164948454,0.9677764987647821,1.0,12/41,23.24%,HOOK2;PHETA1;USP8;AKTIP;LAPTM4B;SNX3;RAB27A;USP50;WASHC4;DNAJC13;EXOC8;HOOK3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.21848569018204606,0.72850862719399,0.8688212927756654,0.9678825723169205,1.0,11/37,26.06%,KIF3B;TNPO1;IFT52;IFT20;KIF3A;TTC21B;SSX2IP;DYNLL1;DYNC2H1;IFT122;IFT140
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2496821059428982,0.7272582896710629,0.8581436077057794,0.9688769027479612,1.0,4/23,12.36%,MTMR10;PIP4P1;INPP5K;MTMR4
prerank,regulation of establishment of cell polarity (GO:2000114),-0.2669148786382419,-0.7261258694741984,0.8535564853556485,0.9795720371408557,1.0,5/16,17.60%,GSN;RIPOR2;KANK1;CDH5;BCAS3
prerank,positive regulation of translation (GO:0045727),0.1881553306085238,0.7260604062053877,0.956661316211878,0.9698352378111847,1.0,26/94,22.37%,PLD1;POLR2D;NSUN5;METTL5;DHX9;C1QBP;CNBP;RMND1;MTOR;MPV17L2;RPS27L;UHMK1;PASK;METTL14;EIF3D;FXR2;FASTKD3;THBS1;UQCC2;KHDRBS1;PCIF1;BOLL;FASTKD2;DDX3X;LARP1;ELAVL1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.26884971643826644,0.7260580206515627,0.8321167883211679,0.9693541333518582,1.0,3/17,13.32%,PRKACA;SLC8A1;GJA1
prerank,regulation of centrosome cycle (GO:0046605),0.253942430985695,0.7255920110989423,0.8591304347826086,0.9694021292913578,1.0,7/21,24.06%,PKHD1;AURKA;CHMP1A;CHMP2A;MARK4;PDCD6IP;FBXW5
prerank,cristae formation (GO:0042407),0.24181545266661317,0.7253480340329608,0.8664259927797834,0.9691977202608394,1.0,11/27,28.85%,MICOS13;DNAJC11;ATP5PO;ATP5PD;ATP5MC1;ATP5F1D;AFG3L2;ATP5PF;CHCHD6;SAMM50;ATP5F1A
prerank,negative regulation of DNA replication (GO:0008156),0.27743055468262257,0.7240377151516384,0.8385899814471243,0.9702433698853081,1.0,3/13,14.77%,RAD17;TERF1;TSPYL2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.2771671207354482,-0.7240108122771581,0.8398169336384439,0.9813791445423354,1.0,2/13,11.25%,ATP1B3;ATP1A1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.26582306711649095,-0.7238447859029411,0.8660508083140878,0.9808861440389379,1.0,1/17,1.04%,PLBD1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.23667997237978233,-0.7230451548681185,0.8637362637362638,0.9811172732605173,1.0,8/23,24.58%,HERC4;BTRC;GPC3;GPR161;GLI3;PTCH2;MEGF8;RACK1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.2991371382734725,0.7225483643506331,0.823076923076923,0.9714635785681817,1.0,4/11,23.22%,EGR1;ASAH1;FGFR4;BMP2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.23501373906651707,0.7225270239285251,0.8791018998272885,0.9710059550475457,1.0,5/28,16.13%,SMURF1;CLU;ECSCR;PSMC2;CCDC22
prerank,microtubule nucleation (GO:0007020),-0.25274447228665575,-0.7224877937547926,0.8690476190476191,0.9810840119836751,1.0,2/19,6.62%,TPPP;TPX2
prerank,isotype switching (GO:0045190),-0.2966055405363138,-0.7224618496464819,0.8140043763676149,0.9804168213302055,1.0,3/10,22.72%,LIG4;MSH6;MSH2
prerank,protein lipidation (GO:0006497),-0.18868938231653112,-0.7219222741359951,0.9386189258312021,0.9803471233755513,1.0,15/59,20.62%,DPM2;ZDHHC21;ZDHHC16;ZDHHC17;PIGW;ATG7;ZDHHC23;ZDHHC15;UGCG;ZDHHC18;SELENOK;PIGC;PGAP4;PIGP;PIGA
prerank,cellular response to nutrient levels (GO:0031669),0.19825919393433228,0.7207462565614149,0.9354838709677419,0.9726128666805098,1.0,11/62,16.97%,ATG14;FLCN;EIF4G1;RPTOR;EHMT2;MTOR;PDK2;FADS1;RRAGA;CARTPT;ULK1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.22601749757872713,0.7206931607644786,0.8911917098445595,0.972197679746385,1.0,8/33,17.36%,AFAP1L2;NEU3;DGKD;GPER1;HIP1R;AKT1;AGT;NUP62
prerank,cellular response to radiation (GO:0071478),0.2203518424249278,0.7206812489945666,0.9020979020979021,0.9717306376534367,1.0,12/40,23.60%,RHNO1;RHOB;SPIDR;TNKS1BP1;RAD1;BLM;MAPK14;ECT2;RAD9A;GPR52;NSMCE3;TP53
prerank,regulation of small molecule metabolic process (GO:0062012),-0.22411884949308677,-0.7202372896090782,0.8820861678004536,0.9815737835733417,1.0,11/28,25.62%,APOE;PRKN;SIRT1;FOXK1;NR1H4;PDK3;PDK4;ABCB11;EPHX2;PPARA;RORC
prerank,regulation of T cell differentiation (GO:0045580),0.22506478872808616,0.7200233308174131,0.8726968174204355,0.9719990344106876,1.0,9/33,18.39%,RHOH;PRDM1;RUNX1;ABL1;SOD1;ZMIZ1;SPINK5;GATA3;FANCA
prerank,protein localization to mitochondrion (GO:0070585),0.2965841751101787,0.72000033279043,0.8248031496062992,0.9715427934845493,1.0,4/11,19.89%,HK2;PINK1;AKT1;MAIP1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2657674780445781,-0.7197591778275864,0.8513513513513513,0.9814472793185622,1.0,2/15,4.45%,EHD1;RIPOR2
prerank,carbohydrate transport (GO:0008643),-0.28526522039104985,-0.719624966099974,0.8449781659388647,0.980884244921817,1.0,5/11,29.34%,AQP11;AQP1;SLC2A2;SLC50A1;SLC5A1
prerank,cardiac myofibril assembly (GO:0055003),0.2679826234137431,0.7191905252570152,0.8370883882149047,0.9720003344359888,1.0,4/15,19.70%,MEF2A;PDGFRB;PROX1;NEB
prerank,ATP transport (GO:0015867),-0.2986685922782638,-0.7189667397266156,0.8272727272727273,0.9809250492081037,1.0,2/10,8.90%,CD47;SLC25A24
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2585664436775234,0.7189598281459709,0.8560885608856088,0.9717578057101215,1.0,4/19,14.82%,BAG6;USP28;RPS27L;PYCARD
prerank,acyl-CoA biosynthetic process (GO:0071616),0.26878348715530537,0.7186494134796697,0.842391304347826,0.9716111047310793,1.0,4/16,18.23%,PPT1;ACSS1;SCD5;SCD
prerank,2-oxoglutarate metabolic process (GO:0006103),0.28919051454280226,0.7180167719468266,0.83203125,0.9718513063951794,1.0,2/13,13.09%,PHYH;ADHFE1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.29073652699470415,-0.7179932726712321,0.8307692307692308,0.9813199899153917,1.0,4/11,24.58%,PRKN;FBXO7;REST;RACK1
prerank,glutathione derivative metabolic process (GO:1901685),0.26044802894174773,0.7179643379473425,0.8546099290780141,0.9709421929669287,1.0,1/20,0.46%,HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.26044802894174773,0.7179643379473425,0.8546099290780141,0.9709421929669287,1.0,1/20,0.46%,HPGDS
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.22769374366132397,0.7179438707291551,0.8920863309352518,0.9704819344746353,1.0,10/34,22.04%,RREB1;RAC1;C1QBP;LIMS1;CSPG5;ABL1;CIB1;CRKL;RAC3;DMTN
prerank,protein localization to Golgi apparatus (GO:0034067),0.23607660916493126,0.7176780492810039,0.8974358974358975,0.9703153219847733,1.0,12/27,28.01%,ARL5C;IFT20;OPTN;GBP5;VPS13C;CSNK1D;SYS1;VPS13D;GAK;COG7;GBF1;TMED10
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2666688258564407,-0.7175587496002577,0.837953091684435,0.9810937760083723,1.0,7/15,27.78%,ATF2;EME1;HUS1;MRE11;TIPIN;RAD9B;EME2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.27126165536957114,0.7175570148540774,0.8324022346368715,0.9699664216017848,1.0,3/16,10.48%,FOXK2;PDK1;PDK2
prerank,regulation of multicellular organismal development (GO:2000026),-0.23013809080150704,-0.7167188302909095,0.8991228070175439,0.9813387904043028,1.0,4/25,9.01%,OAS2;TRIP12;RACGAP1;CCSAP
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.19417637354511247,0.7162848378275806,0.9489291598023064,0.9708679152696318,1.0,27/73,30.35%,DNMT3A;POLR2H;MTA1;SF3B1;SMARCA5;BAZ1B;EZH2;HDAC5;POLR1C;EED;POLR2E;EPC1;TASOR;TBP;DEK;POLR1E;WBP2;POLR1G;HDAC6;TFAP2C;MYO1C;POLR1A;GLMN;SUZ12;SPI1;KAT2B;EP300
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.27073373195940703,0.7162764713472173,0.822463768115942,0.9703963836985566,1.0,4/16,18.17%,GATA2;IL12B;PDCD10;THBS1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.2917854662410093,-0.7159871444305899,0.8530020703933747,0.9807552777385964,1.0,1/12,5.28%,GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.2917854662410093,-0.7159871444305899,0.8530020703933747,0.9807552777385964,1.0,1/12,5.28%,GSK3B
prerank,phosphate ion transmembrane transport (GO:0035435),-0.28848766642717605,-0.7157765559276384,0.8145833333333333,0.9803077331508059,1.0,3/12,11.35%,SLC25A30;SLC37A4;XPR1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.28398314736838787,0.7154784389809922,0.8451730418943534,0.9707899208681644,1.0,3/13,11.99%,GFPT1;UAP1L1;AMDHD2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.24282945428528774,0.7154141633673112,0.8705035971223022,0.9703829816855031,1.0,10/24,24.04%,CLU;USP25;TMBIM6;NR1H2;SYVN1;TXNDC12;BCL2L1;OPA1;PARK7;UBXN1
prerank,T cell mediated immunity (GO:0002456),-0.280264058746026,-0.714286610074201,0.8679245283018868,0.9811879946862901,1.0,4/13,14.41%,MYO1G;BTN3A3;JAG1;CD46
prerank,cellular response to UV-A (GO:0071492),0.30121456402113805,0.7142021786045669,0.8571428571428571,0.9712585966754848,1.0,2/11,9.62%,MMP2;PPID
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2988965022832376,-0.7140524480778723,0.7960088691796009,0.9807550378951808,1.0,6/10,37.30%,DROSHA;TERT;AGO2;TARBP2;PRKRA;MRPL44
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.18205836668146602,0.7136450530718401,0.9676425269645609,0.971387403655513,1.0,27/104,23.73%,LRP5;CSF1R;SRC;SLC8A1;KSR1;CCNG2;RPTOR;CCND3;BLM;ABL1;EZH2;CCNE1;PYCARD;AKT1;CIB1;MAP2K1;PDCD10;TRIB1;CAMK1;TSG101;HGS;DDX3X;SLC8A2;CDKN1B;CALM2;TELO2;RALB
prerank,regulation of blood circulation (GO:1903522),0.22148293102626881,0.7127058478113986,0.9064748201438849,0.9719442316794784,1.0,4/34,7.80%,AGER;FXYD1;CELF2;KCNG2
prerank,tRNA methylation (GO:0030488),-0.2110614593613201,-0.712619263623594,0.9140271493212669,0.9816127015959818,1.0,10/34,23.01%,TRMO;TRMT13;TRMT61B;TRMT12;TRMT112;TRMT1;TRMT10C;LCMT2;GTPBP3;TRMT5
prerank,ion homeostasis (GO:0050801),-0.22275817515669422,-0.712398307781149,0.9272300469483568,0.9811508976706766,1.0,10/30,26.25%,UNC80;NEDD4L;SLC4A10;SLC12A5;SLC4A8;SLC4A1;RANGRF;HCN4;WNK4;RHAG
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23297918213225738,-0.7114797805018102,0.8784403669724771,0.9813999085524303,1.0,5/22,13.72%,UTP20;NOP9;ERI1;EXOSC7;ABT1
prerank,negative regulation of wound healing (GO:0061045),-0.21896786859025358,-0.7110253978283919,0.8995433789954338,0.9811982580389488,1.0,4/28,10.12%,APOE;ALOX5;CASK;CD109
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2882555984022528,0.71101934976639,0.8213592233009709,0.9733030835295604,1.0,3/13,16.35%,ERLEC1;OS9;EDEM1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.27729581291460925,-0.7107217393174626,0.8484848484848485,0.9808290752388753,1.0,7/13,27.93%,CPEB3;PABPC1;TNRC6A;POLR2G;BTG2;ZFP36;AGO2
prerank,histone mRNA catabolic process (GO:0071044),0.27244618286874767,0.7107091795065535,0.8458646616541353,0.9731435131324083,1.0,2/15,3.90%,SSB;ATM
prerank,Golgi ribbon formation (GO:0090161),0.28561249622350515,0.7104547632091301,0.8444444444444444,0.9729257791181344,1.0,6/13,32.98%,OPTN;MYO18A;STX16;STX6;VTI1A;TRIP11
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.267831181828398,0.7102202771220091,0.8718446601941747,0.9726910251507245,1.0,1/16,0.65%,DAGLB
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.2346881648316097,-0.7101831013193219,0.8835164835164835,0.9799990192153283,1.0,8/21,24.05%,PF4;HSPA1B;EYA2;BCL2;SNAI2;TERT;MAP2K5;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.2346881648316097,-0.7101831013193219,0.8835164835164835,0.9799990192153283,1.0,8/21,24.05%,PF4;HSPA1B;EYA2;BCL2;SNAI2;TERT;MAP2K5;MCL1
prerank,base-excision repair (GO:0006284),0.20813814662110058,0.7099928756452757,0.9094138543516874,0.9724342099569366,1.0,10/48,18.32%,PCNA;RFC2;MPG;LIG1;POLD2;PARG;PRMT6;NEIL2;RFC1;NTHL1
prerank,body fluid secretion (GO:0007589),-0.2616640774434109,-0.7098922294292952,0.8605664488017429,0.9796280835118432,1.0,3/15,16.59%,ERBB4;ZBTB7B;APLN
prerank,response to estradiol (GO:0032355),-0.21546873660931135,-0.7097160124548136,0.9128440366972477,0.9791112429549257,1.0,10/31,23.77%,EGFR;STRN3;GGT7;LCOR;CRHBP;SFRP1;SOCS2;WNT8B;ANXA1;CTNNB1
prerank,mitochondrial membrane organization (GO:0007006),0.22112528580862653,0.7093624802052177,0.8928571428571429,0.972608077539188,1.0,14/32,28.28%,MICOS13;DNAJC11;TIMM50;MTX1;TMEM11;MAIP1;PMAIP1;BCL2L1;OPA1;CHCHD6;MFN2;SAMM50;MICOS10;SLC25A5
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2159395819147688,0.7088154395213088,0.9011925042589438,0.9727149638531054,1.0,19/40,32.64%,CDK9;PRKCD;UBE2V2;PARG;ABL1;ARMT1;FXR2;MAPT;RFWD3;KMT5A;WRNIP1;WDR76;RADX;IER3;SIRT7;FXR1;HMGA2;USP51;RPA2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.2971467370589997,0.7073619245609203,0.8316633266533067,0.9737687740898374,1.0,4/10,24.80%,PRKCB;ARNT;ITGB3;HIF1A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.21520176705509217,-0.7071730951690225,0.9080188679245284,0.981037452811274,1.0,10/32,23.83%,CCT2;MAPKAPK5;AURKB;TNKS2;PRKCQ;XRCC5;MAPK1;TCP1;CTNNB1;MAPK15
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.21123220191302183,-0.7066785967179268,0.9221967963386728,0.9808282883129668,1.0,13/31,29.07%,SYT1;SYT10;CBARP;ADRA2A;SYT3;TRPV6;CACNA1G;DOC2B;REST;SYT5;DOC2A;SYT8;CLTRN
prerank,vasculature development (GO:0001944),0.26179783738097345,0.7064362075674385,0.8661844484629295,0.9742815231639899,1.0,5/16,22.78%,NOTCH4;PDGFRB;ACVR2B;ERRFI1;PIK3CA
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2653324317505097,-0.706387775089057,0.8329571106094809,0.980438284559291,1.0,4/14,21.89%,AK3;AK4;NME2;DCTPP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.211323867977127,0.7062603118125119,0.9055944055944056,0.9739805883008268,1.0,8/39,18.25%,ACSL4;TM7SF3;SLC30A8;GPER1;DRD2;LRRC8A;RASL10B;SELENOT
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.21450559108691075,-0.7062251072960386,0.9198113207547169,0.9799169425300207,1.0,4/29,8.98%,ACSL3;ELOVL7;HACD1;ELOVL5
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.20145727452997778,-0.7059634867025552,0.942643391521197,0.9794709689674909,1.0,12/44,20.39%,PRKAG2;LBR;PER2;CYP39A1;PSAT1;EBP;HMGCR;HSD3B7;OSBPL9;DHCR7;MSMO1;ALOX15
prerank,telomere maintenance via telomerase (GO:0007004),0.23078791542396676,0.7058485572691212,0.8771626297577855,0.9739517178435516,1.0,10/28,27.90%,PPP6R3;TNKS1BP1;TERF1;NHP2;RFC1;ACD;SHQ1;TELO2;RTEL1;RPA1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.30309089472806505,0.7051738424393874,0.8351851851851851,0.974163208091554,1.0,2/10,14.34%,WHRN;SOD1
prerank,DNA modification (GO:0006304),0.24741839347012412,0.7051667420884679,0.8823529411764706,0.9736952285662106,1.0,6/22,19.17%,MPG;TERF1;EXOSC5;NEIL2;NTHL1;ACD
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.27699354496258055,0.7051632836137256,0.8664122137404581,0.9732216543015086,1.0,2/14,9.20%,LOXL3;LIMS1
prerank,plasma membrane tubulation (GO:0097320),0.2760166720797036,0.7040051882019306,0.8560747663551402,0.9739338211881655,1.0,1/13,1.37%,BIN2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.2986991878698806,-0.7032449958585052,0.8348214285714286,0.9815366657498109,1.0,3/10,14.97%,PTPN12;PTPN2;SNCA
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2798591199549834,0.7029553616085386,0.8592057761732852,0.9745359425771103,1.0,3/13,12.55%,TBL3;RCL1;NOP14
prerank,negative regulation of immune system process (GO:0002683),0.2677530246426096,0.7018059254276509,0.8524305555555556,0.9752140326384168,1.0,5/16,24.37%,LYN;GPER1;SPINK5;FADD;SOX9
prerank,"base-excision repair, AP site formation (GO:0006285)",0.26271399015693286,0.701192207615805,0.8786231884057971,0.9753387048990947,1.0,5/17,19.17%,MPG;TERF1;NEIL2;NTHL1;ACD
prerank,pyroptosis (GO:0070269),0.2647504775782613,0.7011603337822354,0.8538324420677362,0.974893662103601,1.0,2/15,6.85%,CASP1;DHX9
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.24708497450411504,0.7011475170925011,0.9,0.974435977561179,1.0,4/20,15.48%,BRCA1;GPER1;CEACAM1;WDTC1
prerank,regulation of cellular component biogenesis (GO:0044087),0.2105530395508639,0.7011114328046367,0.9241622574955908,0.974000857609719,1.0,9/39,17.76%,SNCAIP;GFAP;TJP1;ANKRA2;PINK1;PTPN11;SPTY2D1;AGT;ROCK2
prerank,ERAD pathway (GO:0036503),0.18494909921193103,0.7008199497353761,0.9716088328075709,0.9738158737960897,1.0,24/83,27.68%,BAG6;SEL1L;DNAJB9;ERLEC1;USP19;OS9;RNF103;UFD1;AUP1;MAN1B1;EDEM1;UBE4A;ANKZF1;STUB1;SYVN1;RNF121;NPLOC4;DNAJB14;UBE2G2;ECPAS;RHBDD2;FBXO2;FBXO17;SGTA
prerank,nuclear body organization (GO:0030575),-0.2766180167278241,-0.7004066687117617,0.8410041841004184,0.9836102149659629,1.0,5/12,20.11%,HIPK2;WRAP53;AFF2;SRPK2;USPL1
prerank,GPI anchor metabolic process (GO:0006505),0.23114873484313014,0.700183490174177,0.8799283154121864,0.9739770815669531,1.0,4/26,11.96%,PIGV;PGAP2;DPM3;PIGO
prerank,nucleosome organization (GO:0034728),0.19823804631210612,0.6999494550047727,0.9666666666666667,0.9737215147566539,1.0,16/55,24.37%,SART3;RNF8;SRCAP;SMARCD3;SMARCA5;SETD2;SPTY2D1;HMGB2;ARID1A;CHAF1B;PRDM9;KAT6B;SMARCA4;LIN54;NAA60;SOX9
prerank,fibrinolysis (GO:0042730),-0.2690378166976206,-0.699729819527185,0.8648648648648649,0.9835403683257448,1.0,5/13,29.59%,PLAT;SERPINB2;PLAU;PLAUR;HRG
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2440732834589571,-0.699609531071059,0.8796296296296297,0.9829811302804667,1.0,7/18,24.85%,CDC73;SFRP1;B4GALT7;GSTP1;EMD;PARP10;NLRC3
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.25568478565090635,-0.6994298524199692,0.8726899383983573,0.9817779481124493,1.0,4/15,18.91%,AP3M1;AP3S2;DTNBP1;BLOC1S3
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.25568478565090635,-0.6994298524199692,0.8726899383983573,0.9817779481124493,1.0,4/15,18.91%,AP3M1;AP3S2;DTNBP1;BLOC1S3
prerank,spliceosomal complex assembly (GO:0000245),0.20640687122261964,0.6992157426828215,0.9339774557165862,0.9739784370491816,1.0,8/46,16.45%,NCBP1;SF3B1;CELF2;SRSF5;SMN1;LUC7L3;SF3A1;LUC7L
prerank,aspartate family amino acid metabolic process (GO:0009066),0.25417900826789475,0.6985250206275961,0.8925318761384335,0.9741914822475989,1.0,5/18,16.06%,NAALAD2;NIT2;GADL1;MTHFD1;ASPG
prerank,positive regulation of intracellular transport (GO:0032388),-0.2020549159435998,-0.6983893033755985,0.9478908188585607,0.9820923164634577,1.0,12/38,28.16%,EHD1;ACTN2;SPAG5;PRR5L;OAZ1;ZFAND1;EHD2;BCAS3;PCNT;ATP2A1;CAPN10;DYNC1H1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.2605406531056727,-0.698222779068824,0.8586956521739131,0.9815771035226375,1.0,7/15,27.93%,CPEB3;PABPC1;TNRC6A;POLR2G;BTG2;ZFP36;AGO2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.23416457605121643,0.6970158885928581,0.9105839416058394,0.9751666703812625,1.0,4/26,9.87%,GPS2;FLOT2;GPR108;APPL1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.27783552029721126,-0.6967444418552123,0.8492239467849224,0.9822927610081373,1.0,3/12,11.93%,TAF7;GTF2B;BDP1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.269521536146046,0.696732496808265,0.8747591522157996,0.9749631233952782,1.0,2/13,7.31%,NFE2L2;MET
prerank,mRNA methylation (GO:0080009),0.2659776083757227,0.6962438908321477,0.870242214532872,0.974956060117558,1.0,5/15,23.27%,TRMT6;METTL14;TRMT61A;PCIF1;METTL8
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.2924439968601441,0.6952862541379087,0.8310940499040307,0.9754134548391331,1.0,1/11,1.62%,QDPR
prerank,female gamete generation (GO:0007292),0.22389932570500315,0.6952249708109902,0.9158878504672897,0.974993979426125,1.0,9/29,28.48%,KMT2D;NANOS2;FSHR;DIAPH2;PRDM9;NANOS1;PARN;HORMAD1;MDK
prerank,cellular response to hormone stimulus (GO:0032870),0.19087354274550056,0.6948343678122635,0.9676375404530745,0.9748764113550524,1.0,8/69,9.97%,BRD8;MEF2C;SRC;CTSS;ZFP36L1;GPER1;LHCGR;INPP5K
prerank,regulation of gastrulation (GO:0010470),-0.2610612042084887,-0.6938538055016388,0.8805309734513275,0.9843188504354992,1.0,6/14,33.28%,TENM4;SCX;DAG1;RACK1;FOXA2;PHLDB2
prerank,positive regulation of bone resorption (GO:0045780),0.2913497157671485,0.6937455294926845,0.8734402852049911,0.9754341303536379,1.0,1/11,2.69%,PRKCA
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.2873185048659652,-0.693060778862751,0.8325991189427313,0.9843950314558018,1.0,1/10,1.21%,CCR2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.20323220454621668,-0.6929636955168327,0.9381188118811881,0.9837956329902248,1.0,9/42,16.84%,ROMO1;TIMM23;TIMM17B;DNAJC15;PEX12;SEC62;TIMM17A;HSPA5;CHCHD4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.22995172539577358,0.6922373660413087,0.9118705035971223,0.97633497549124,1.0,13/26,34.43%,MLXIPL;BRCA1;CEACAM1;WDTC1;NR1H2;ADIPOR1;MID1IP1;ERLIN2;ACADVL;PRKAB2;NR1H3;EIF6;ACADL
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2172760857168344,-0.691839896134176,0.8943820224719101,0.9841452718015787,1.0,6/29,13.30%,NT5C3B;EXOSC1;HBS1L;LSM1;LSM3;EXOSC7
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.22936496037969337,0.6911456917559925,0.9140893470790378,0.9768899495746011,1.0,2/25,4.37%,SLC7A5;PLCG2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.21413462707347675,-0.6908273776119593,0.9352678571428571,0.9843592517688738,1.0,5/27,12.30%,UBE2E2;UBE2W;PRKN;UBE2C;ANAPC10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.26474709034696253,0.6905451500099897,0.8834782608695653,0.9769718029022894,1.0,4/15,16.08%,WHRN;HPN;COL11A1;TMEM120A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.19165060655540173,0.6902146885572572,0.9691558441558441,0.9768101672770383,1.0,17/59,24.37%,CSF1R;MOV10;JUN;MED10;MED4;MED25;MITF;TNRC6C;TNRC6B;CDK8;MED7;TWIST1;MED12;MED20;TP53;AGO1;SOX9
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.29423557956903934,0.689726091886182,0.8587786259541985,0.9767653485345524,1.0,6/10,35.19%,PDK2;ZNF692;SIRT7;OGT;USP7;SELENOS
prerank,monocyte chemotaxis (GO:0002548),0.2230121486805458,0.6893552515469891,0.9222423146473779,0.9766199149191881,1.0,3/32,9.05%,CCL3;PDGFB;IL6R
prerank,regulation of protein dephosphorylation (GO:0035304),-0.20579506073552392,-0.6891782263039694,0.9434447300771208,0.9851604989490208,1.0,9/37,20.52%,HTT;PPIA;CALM1;CDH5;TIPRL;PPP1R7;CNEP1R1;PPP6R2;TSC1
prerank,histone deubiquitination (GO:0016578),0.24474273026452842,0.6887968515799026,0.8816029143897997,0.9766404782530882,1.0,6/18,28.07%,EPOP;USP36;ATXN7;TAF10;ATXN7L3;ENY2
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2772623666169153,-0.688658527264178,0.8686440677966102,0.9849598756863737,1.0,4/11,20.22%,ASF1A;H3-3A;NASP;HAT1
prerank,response to interferon-alpha (GO:0035455),-0.24419622888627834,-0.6881837423455008,0.9022727272727272,0.9846997256321948,1.0,6/16,25.79%,IFITM3;IFITM2;IFITM1;BST2;KLHL20;ADAR
prerank,apoptotic DNA fragmentation (GO:0006309),0.2641733477655098,0.6865350016012387,0.9052224371373307,0.9782411231961773,1.0,6/16,35.68%,DNASE2;HMGB2;EXOG;DFFB;KPNA1;KPNB1
prerank,meiosis I (GO:0007127),0.23912374357100147,0.6863494412141677,0.8948306595365418,0.9779479021549469,1.0,3/23,12.18%,FOXJ2;ZSCAN21;HSF2BP
prerank,regulation of exosomal secretion (GO:1903541),0.24946414537675354,0.6863178780497121,0.8913793103448275,0.9775017815699756,1.0,6/19,22.44%,SMPD3;VPS4A;TSG101;CHMP2A;HGS;PDCD6IP
prerank,hexose biosynthetic process (GO:0019319),-0.19591276883744435,-0.6854169676262105,0.9454094292803971,0.9864778633512763,1.0,7/42,15.00%,PFKFB1;SLC37A4;PER2;GPI;RBP4;ALDOC;SLC25A12
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.24069541038049558,0.6844957232019396,0.9094076655052264,0.9786349003968644,1.0,7/21,28.89%,HK2;RPE;SHPK;HK3;TKT;TALDO1;PGM2
prerank,response to amino acid (GO:0043200),0.21662085851660257,0.6837718995645536,0.9508196721311475,0.978839276920842,1.0,6/31,14.91%,LAMTOR2;RPTOR;MTOR;LAMTOR5;TMBIM6;RRAGA
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.26907813206491615,0.6836199796761658,0.8827708703374778,0.9785026296847513,1.0,2/14,9.67%,VEGFB;PIK3CD
prerank,positive regulation of cellular protein localization (GO:1903829),0.18708581598613977,0.6832689897698806,0.9701492537313433,0.9783157194835556,1.0,19/69,23.86%,TMEM35A;NUMA1;LAMTOR5;GNL3L;STX4;CROCC;ENTR1;AKT1;SLC5A3;DTX3L;NUP62;SYT11;MARK4;EIF2AK3;MAPT;CENPQ;PARK7;TGFB1;TYROBP
prerank,regulation of extracellular matrix organization (GO:1903053),0.25999966377584066,0.6829508653815679,0.8851224105461394,0.9781284931145405,1.0,5/15,20.52%,LRP1;DDR2;RUNX1;AGT;FGFR4
prerank,regulation of microtubule-based movement (GO:0060632),0.2868257254215232,0.6826368538428249,0.8779174147217235,0.9779295451043405,1.0,2/11,6.18%,DRC1;DYNLT2B
prerank,negative regulation of mitochondrion organization (GO:0010823),0.21411835796752798,0.6825834105527891,0.935042735042735,0.9775107103545013,1.0,13/33,29.75%,CLU;FLCN;PINK1;AKT1;MAPT;ACAA2;BCL2L1;OPA1;FZD9;SLC35F6;SLC25A5;TMEM14A;OMA1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.22681103530366625,-0.6825213199645611,0.9080717488789237,0.9883391431376062,1.0,3/21,11.43%,RPS7;BTRC;UBE2C
prerank,peptidyl-lysine methylation (GO:0018022),-0.21884259813329354,-0.6823689902068463,0.9164835164835164,0.9878006766292747,1.0,11/26,27.37%,SUV39H1;EEF1AKMT1;EEF1AKMT2;SMYD2;METTL21A;TRMT112;SUV39H2;EHMT1;METTL21C;EEF1AKMT3;ETFBKMT
prerank,regulation of viral life cycle (GO:1903900),0.23745159449586717,0.6821886340110064,0.8927335640138409,0.9773612985337977,1.0,6/21,19.55%,TRIM5;AXL;TRIM62;NECTIN2;VPS4A;TSG101
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2601360075960202,0.6817397872449399,0.8857142857142857,0.9772872999615666,1.0,7/16,21.36%,PYGB;PHKB;AGL;PHKG2;PHKA2;MGAM;GAA
prerank,protein kinase A signaling (GO:0010737),0.27861039694376133,0.6817293174652819,0.8731343283582089,0.9768278007873618,1.0,1/12,2.70%,PRKACA
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.24725356749023636,-0.6814064778435329,0.9004329004329005,0.9879580848616586,1.0,4/16,14.23%,PARP14;PTPN2;PPP2R1A;INPP5F
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.23644198764640884,0.6805190769808646,0.9056261343012704,0.9773606556361408,1.0,7/20,23.69%,INCA1;CDK5RAP1;LATS2;IPO7;TFAP4;CDKN1B;IPO5
prerank,regulation of cellular respiration (GO:0043457),-0.24607425712048048,-0.6798992334685358,0.910828025477707,0.9885563032330447,1.0,3/17,13.84%,TRAP1;PRDM16;CBFA2T3
prerank,glycoprotein catabolic process (GO:0006516),-0.24201486501265038,-0.6796477358743294,0.884090909090909,0.9880750494901991,1.0,8/17,37.47%,MMP12;MANBA;OGA;ADAMTS12;ADAMTS9;FBXO27;FBXO44;CTSL
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.25383394865283104,0.6790734665037123,0.8843283582089553,0.9781318340240768,1.0,9/17,33.43%,MBTPS1;MBTPS2;SOD1;SCAP;FGF1;ERLIN2;ABCG1;LPCAT3;SEC14L2
prerank,negative regulation of lipid storage (GO:0010888),-0.23689814668742248,-0.6790264939943144,0.9134396355353075,0.9879561850213919,1.0,4/19,11.37%,PPARG;PTPN2;NFKBIA;OSBPL8
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.23312634415455286,-0.6789499785459548,0.8980477223427332,0.9873398754322986,1.0,6/19,23.60%,PAPSS2;SULT2B1;SLC26A2;SLC35B3;BPNT1;BPNT2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.2900362102363869,0.6785719494321986,0.8771593090211133,0.9780704582258726,1.0,3/10,20.62%,NUMA1;NCOA3;PRKCH
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.23761518008220517,-0.6778772825710676,0.8903225806451613,0.9875564933642917,1.0,3/18,10.80%,SLC45A3;TENM4;OPALIN
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.27883549698942023,0.6778708992926505,0.8566176470588235,0.978198840395801,1.0,4/12,14.92%,MIA3;FUT7;WNK1;AKT1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2263593673637213,-0.6770634118965464,0.9147465437788018,0.9875721957910815,1.0,12/21,39.18%,YWHAE;GSK3B;TIPRL;BOD1;PPP1R16B;PPP1R15A;ARPP19;YWHAB;FKBP1A;PPP1R8;PPP1R11;MFHAS1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.27272362502533337,-0.6767811825873324,0.8766233766233766,0.9864324580383204,1.0,2/11,8.68%,AGO4;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.27272362502533337,-0.6767811825873324,0.8766233766233766,0.9864324580383204,1.0,2/11,8.68%,AGO4;TNRC6A
prerank,regulation of catabolic process (GO:0009894),0.2474894485281784,0.6763777140963154,0.9162210338680927,0.9789690023874934,1.0,6/18,21.25%,CHEK2;HPGD;ZDHHC7;CENATAC;HGS;FURIN
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21687424191411186,0.6756572531235938,0.9333333333333333,0.9790746221762664,1.0,9/30,23.36%,POLR2H;GTF2H2;ERCC2;POLR1C;POLR2E;UBTF;TBP;POLR1E;POLR1G
prerank,regulation of autophagosome assembly (GO:2000785),-0.2043698309141153,-0.6750905193290065,0.9434389140271493,0.987080465671759,1.0,9/33,23.45%,LRRK2;RAB1B;SCFD1;SMCR8;UBQLN2;RAB5A;MTMR3;NPRL3;SEC22B
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2692987859585312,0.6748863020080815,0.8795180722891566,0.979226510921946,1.0,4/13,22.69%,BMF;PMAIP1;VDAC2;BCL2L11
prerank,cellular respiration (GO:0045333),-0.18973156446414288,-0.6747871122809813,0.9712230215827338,0.9866337962220832,1.0,11/41,21.01%,SDHC;NDUFS1;SDHA;SDHAF4;ETFRF1;MTFR2;NDUFS7;CYCS;MTFR1;UQCRH;COQ10B
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.22215293818868193,0.674542701454118,0.9396709323583181,0.9790247283909667,1.0,7/25,23.60%,GPER1;BMF;PINK1;PYCARD;PMAIP1;BCL2L11;TP53
prerank,sarcomere organization (GO:0045214),0.22194243339204678,0.6742399781699289,0.9411764705882353,0.9787960333836973,1.0,1/27,1.12%,CAPN3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2703562826743262,0.6741188774630698,0.8888888888888888,0.9784271684985398,1.0,6/13,31.28%,YAE1;MMS19;LTO1;ISCA1;CIAO2B;BOLA2
prerank,maturation of SSU-rRNA (GO:0030490),0.20996492710416825,0.6738464939568302,0.9221453287197232,0.9781758367997412,1.0,6/34,18.39%,UTP6;WDR46;NOP14;RPS8;MRPS11;WDR3
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.23354077425247835,-0.6733119204197816,0.9098901098901099,0.9871788395610843,1.0,10/18,33.74%,BAK1;BCL2;SPG7;SLC25A31;PPIF;ALKBH7;BNIP3;HEBP2;CAMK2A;SLC25A4
prerank,miRNA metabolic process (GO:0010586),0.23600834260512538,0.6727048511915893,0.9124087591240876,0.9786663712017897,1.0,6/20,25.73%,DIS3L2;DDX17;BCDIN3D;SND1;XPO5;PARN
prerank,organic acid transport (GO:0015849),0.1737479020773593,0.6724229670967155,0.9831649831649831,0.9784254948638142,1.0,16/94,20.28%,SLCO2B1;SLC7A8;SLC36A1;PPARD;SLC25A45;SLC22A6;SLC27A4;CEACAM1;SLC25A11;SLC38A1;SLC25A14;SLC23A2;SLC23A1;SLC19A1;LRRC8D;SLC25A10
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.19808188602665708,0.6723186574792568,0.9592169657422512,0.9780353863978885,1.0,4/45,12.68%,TGFBR1;LEFTY1;INHA;ENG
prerank,microtubule anchoring at centrosome (GO:0034454),-0.28168288649355055,-0.6713944822395564,0.875,0.9880175681847558,1.0,2/10,15.31%,CEP19;CCDC120
prerank,amyloid-beta metabolic process (GO:0050435),-0.2437684730569674,-0.6710959315640762,0.9140461215932913,0.9875790556803018,1.0,5/16,23.37%,MME;MGAT3;ACE;NCSTN;ABCA7
prerank,alcohol catabolic process (GO:0046164),-0.2792486769625479,-0.6710643216542505,0.8620689655172413,0.9869239027765716,1.0,3/10,16.38%,APOE;SCARF1;SRD5A3
prerank,cellular response to sterol (GO:0036315),0.2672999672301267,0.6705300400724671,0.8848167539267016,0.9790029431097018,1.0,5/13,28.94%,GRAMD1A;SMO;PTCH1;GPLD1;INSIG2
prerank,response to interferon-beta (GO:0035456),-0.2228093308871148,-0.6698170218231307,0.9297423887587822,0.9872704976820563,1.0,6/22,16.04%,IFITM3;IRGM;UBE2K;IFITM2;IKBKE;IFITM1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2473506401418984,-0.6692619930603024,0.8867102396514162,0.987047715892349,1.0,7/14,33.73%,COPS8;CARD10;CARD14;TNFSF15;IRAK1;TRAF2;MAP3K7
prerank,mRNA catabolic process (GO:0006402),0.19393186203602705,0.6691603360822629,0.96,0.9796031552876322,1.0,8/44,16.72%,DDX5;DXO;DIS3L2;ZFP36L2;NANOS2;LSM5;EXOSC10;RIDA
prerank,mitochondrion transport along microtubule (GO:0047497),-0.2555938373769379,-0.6679990255897887,0.911340206185567,0.9873236712138549,1.0,2/13,10.02%,SYBU;RHOT2
prerank,regulation of microtubule-based process (GO:0032886),-0.19566328497048402,-0.6677897062575817,0.9542168674698795,0.986803348537101,1.0,3/36,5.28%,BICD1;TPPP;GSK3B
prerank,regulation of inclusion body assembly (GO:0090083),0.2756016539824271,0.667386725469182,0.8917910447761194,0.980536640562621,1.0,1/11,2.52%,SNCAIP
prerank,stress granule assembly (GO:0034063),0.23910678222664528,0.6663137174131994,0.9176029962546817,0.9808715462452684,1.0,3/20,10.44%,ATXN2L;EIF2S1;G3BP1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.2715415455159244,0.6649595957906166,0.8857142857142857,0.9814185114737358,1.0,4/12,22.69%,PIK3R1;PTPN1;TMEM33;BCL2L11
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26453848594839335,-0.6645940818232188,0.9001996007984032,0.9878819456967837,1.0,3/11,20.89%,CCT2;TCP1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26453848594839335,-0.6645940818232188,0.9001996007984032,0.9878819456967837,1.0,3/11,20.89%,CCT2;TCP1;MEPCE
prerank,cytoplasmic sequestering of protein (GO:0051220),0.26963175123307626,0.6644509921310126,0.8760907504363001,0.9813305755713569,1.0,3/13,10.02%,DBN1;MDFI;NFKBIE
prerank,DNA packaging (GO:0006323),-0.23822285799141488,-0.6643834071632315,0.8912529550827423,0.987377328903773,1.0,5/16,27.61%,KAT6A;BANF1;HAT1;NOC2L;H1-0
prerank,apical protein localization (GO:0045176),-0.2866550927742866,-0.6640876788788308,0.904862579281184,0.9869158269762202,1.0,3/10,13.37%,ACTB;MAL;JAM3
prerank,protein palmitoylation (GO:0018345),0.21399847840726474,0.664057424241917,0.9409660107334525,0.98116873107475,1.0,6/30,13.72%,PORCN;ZDHHC5;CLIP3;ZDHHC13;ZDHHC7;ZDHHC4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.19042632516295205,0.6634821052339269,0.964527027027027,0.9811226289338204,1.0,13/50,22.95%,RPS6KA1;CSNK2A1;SRC;RFFL;DPEP1;LAMTOR5;PAX2;AKT1;XIAP;THBS1;RNF34;DDX3X;PARK7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.27209190261393207,-0.6623064690927192,0.8921775898520085,0.9875508157097607,1.0,2/11,7.51%,SP100;HIPK2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.2750891679835319,-0.6613965013764627,0.9122448979591836,0.9875598114164609,1.0,2/10,7.51%,SP100;HIPK2
prerank,regulation of aerobic respiration (GO:1903715),0.24836495231167754,0.660040559723812,0.8899082568807339,0.983180163298268,1.0,4/15,23.04%,COX7A2L;PINK1;UQCC2;ABCD1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.21138253740057894,-0.6598148666935055,0.9363207547169812,0.9880039393578213,1.0,5/25,16.02%,SOX11;PER2;NSD1;HEY2;NIBAN2
prerank,histone H4 deacetylation (GO:0070933),0.2839233358362389,0.6597430284923318,0.881578947368421,0.98292029707994,1.0,1/10,2.62%,SIRT2
prerank,mRNA modification (GO:0016556),0.2276759614960006,0.6578969807209482,0.9209138840070299,0.9837782355287703,1.0,6/22,23.27%,TRMT6;RPUSD2;METTL14;TRMT61A;PCIF1;METTL8
prerank,establishment of epithelial cell polarity (GO:0090162),0.24047050677731377,0.6572171839878488,0.9306759098786829,0.9838018665680097,1.0,2/19,9.40%,OPHN1;CYTH3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.20377234815324446,-0.6570171729031237,0.945823927765237,0.9893334374519042,1.0,9/31,20.88%,NT5C3B;EXOSC1;HBS1L;LSM1;LSM3;EXOSC7;PATL1;POLR2G;EDC4
prerank,negative regulation of T cell proliferation (GO:0042130),0.21474773210041526,0.6565227651668308,0.9476635514018692,0.9838435541618084,1.0,4/28,8.26%,LGALS9;TNFRSF21;CD86;PDCD1LG2
prerank,regulation of steroid metabolic process (GO:0019218),0.22691409566717996,0.6562607101774194,0.9103690685413005,0.9835579815562536,1.0,5/23,18.52%,ASAH1;PANK2;TTC39B;FMO5;STUB1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.26732939836848707,-0.6562120619544868,0.9232456140350878,0.9892234602715191,1.0,4/11,22.56%,ATG7;ATP6V1A;FOXO1;ATP6V0D1
prerank,NAD biosynthetic process (GO:0009435),0.23118954905162672,0.6559301710918617,0.9194991055456172,0.9833185663338191,1.0,20/20,76.91%,NAXD;NAXE;NADSYN1;PARP16;NMNAT1;NAPRT;PTGS2;QPRT;SLC22A13;SLC5A8;NNMT;KYNU;NAMPT;PTGIS;HAAO;NMNAT3;NUDT12;PARP9;NMNAT2;PARP10
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.26748894705563675,0.6555056523203455,0.9032882011605415,0.9831369531682599,1.0,5/11,26.11%,TERF1;CCT3;CCT8;CCT7;CCT5
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.23852612787204913,0.6552188343300588,0.9181494661921709,0.9828657758990914,1.0,3/18,14.99%,MAP3K3;GATA2;CIB1
prerank,histone lysine methylation (GO:0034968),0.20338228600649672,0.6537001716080373,0.9467140319715808,0.9834688798890687,1.0,16/33,31.24%,KMT2D;CXXC1;EHMT2;EZH2;PRDM9;SETD3;DPY30;SMYD1;KMT2B;SETDB1;WDR5;KMT2A;PAXIP1;DYDC2;SETD6;DOT1L
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.25730187083167644,0.6532037938529726,0.9127272727272727,0.9833464086348607,1.0,4/14,18.17%,SHISA2;SPRY2;GATA3;THBS1
prerank,purine ribonucleotide transport (GO:0015868),0.24518104686147407,0.6529582344978434,0.9110320284697508,0.983050679629969,1.0,5/16,20.03%,SLC25A42;LRRC8A;SLC17A9;SLC19A1;LRRC8D
prerank,carnitine shuttle (GO:0006853),-0.2647603432652239,-0.6526453763056317,0.8884462151394422,0.9909891412816771,1.0,2/11,14.52%,PRKAG2;CPT1B
prerank,pteridine-containing compound metabolic process (GO:0042558),0.2625033444172484,0.6524882020753666,0.8983050847457628,0.9829168390416309,1.0,1/13,1.62%,QDPR
prerank,negative regulation of transposition (GO:0010529),-0.2371405635010128,-0.6521586632674554,0.9213973799126638,0.9906293761980226,1.0,8/16,29.56%,TUT4;SPOCD1;TDRD9;MYBL1;PIWIL2;SMYD5;AICDA;PIWIL4
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2370126979584867,0.651003908234157,0.9270462633451957,0.9834457982612561,1.0,10/18,32.62%,TMBIM6;NUDT16;SHQ1;ZC3H12A;TGFB1;PTBP3;RPS26;RPS13;KAT2B;NRDE2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.22957041232615652,0.6505176026802386,0.9371633752244165,0.9833162743653274,1.0,10/21,30.52%,CNOT1;TNKS1BP1;CNOT3;PAN3;CNOT2;PARN;PNLDC1;SAMD4B;CNOT11;CNOT8
prerank,chromatin disassembly (GO:0031498),-0.24580694721803134,-0.65033774149249,0.9102844638949672,0.9904718438346852,1.0,2/14,8.10%,SMARCE1;NFE2
prerank,nucleosome disassembly (GO:0006337),-0.24580694721803134,-0.65033774149249,0.9102844638949672,0.9904718438346852,1.0,2/14,8.10%,SMARCE1;NFE2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2593546244591963,0.6487153177737107,0.925589836660617,0.9840929357729299,1.0,4/13,26.95%,TMEM35A;STX4;TYROBP;SNX33
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.26361396515539814,0.6480637006238761,0.8842504743833017,0.9840487395902642,1.0,7/12,39.64%,BRCA1;PCGF3;RBM15;RLIM;SMCHD1;HNRNPU;METTL3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.21859446164436833,0.6478125414562085,0.9446494464944649,0.9837540014166815,1.0,7/24,24.80%,PRKCB;PTPN1;ARNT;PDCD6;HGS;ITGB3;HIF1A
prerank,linoleic acid metabolic process (GO:0043651),-0.23134212504861662,-0.6466226484662695,0.9460043196544277,0.9921677242810252,1.0,5/17,21.84%,ALOX5;ELOVL5;GSTP1;ALOX15;ACSL1
prerank,response to steroid hormone (GO:0048545),0.20838588344050782,0.6462764881092523,0.9679595278246206,0.984278893531601,1.0,13/31,34.03%,PAQR7;UBE3A;THBS1;TFPI;WBP2;CATSPER2;TGFB1;AR;URI1;NR1H3;UBE2L3;ATP1A2;CATSPER3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.26843283729912937,-0.6459531548088544,0.9139784946236559,0.9919377140901577,1.0,4/11,18.01%,LILRB1;AHR;KLRD1;FOXP3
prerank,actin filament network formation (GO:0051639),-0.25739740693965063,-0.6451966188008341,0.9227373068432672,0.9917675804303752,1.0,6/11,33.84%,CARMIL1;PLS1;FHOD3;CARMIL2;ACTN1;PLS3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.18459741713565264,0.644304914809583,0.9877408056042032,0.9851167111823482,1.0,17/52,26.14%,CNOT1;POLR2D;TNKS1BP1;DCPS;DCP1B;EXOSC5;CNOT3;LSM5;PAN3;DIS3;EXOSC8;LSM7;RC3H2;CNOT2;PARN;PNLDC1;SAMD4B
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2381355460889059,-0.6434780296272202,0.9237472766884531,0.9922162285828503,1.0,4/14,18.33%,LILRB1;LILRA5;TLR8;IRAK3
prerank,membrane lipid catabolic process (GO:0046466),-0.26669841885479173,-0.6434486621436608,0.9021739130434783,0.9915624907264409,1.0,4/10,19.18%,SGPL1;ENPP2;NAGA;FUCA1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.23734076752453628,0.6424173164670673,0.935251798561151,0.9858814839959936,1.0,6/18,26.10%,ZFP36L1;ZFP36L2;PCK2;BCL2L11;SSTR2;ISL1
prerank,DNA geometric change (GO:0032392),-0.2073978751404688,-0.6399710354373584,0.9643652561247216,0.9930264203818223,1.0,3/24,6.24%,MCM9;ZRANB3;ASCC3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.23849005509507637,0.639951952417194,0.9297912713472486,0.9869038896731578,1.0,9/18,29.54%,APPL1;CLN3;ZDHHC7;LDLRAP1;VPS4A;STX8;AR;ZDHHC2;STX7
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.2484292235144493,0.6394667170066792,0.9211009174311927,0.986745126963821,1.0,2/13,21.33%,NAXD;NAXE
prerank,regulation of oxidoreductase activity (GO:0051341),-0.2457102857773082,-0.6389893774170232,0.9243119266055045,0.9929393092880064,1.0,3/13,16.06%,ATP7A;ECSIT;HP
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2316426676927198,-0.6389767179201014,0.9344608879492601,0.9922767248572515,1.0,4/15,21.03%,HMGCS1;MVD;PPCS;ACLY
prerank,establishment of melanosome localization (GO:0032401),0.223916740470611,0.6388912735200557,0.9358288770053476,0.9866262226212199,1.0,4/19,16.70%,MLPH;SHROOM2;BBS2;RAB27A
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2057265702018271,-0.6384679619104222,0.9675925925925926,0.9919290715705426,1.0,6/29,13.67%,PTPN2;UBE2K;TTLL12;RNASEL;SAMHD1;OAS3
prerank,eosinophil migration (GO:0072677),-0.24518331975177332,-0.6378195270549092,0.9282608695652174,0.9909556769258128,1.0,6/14,35.13%,CCL5;CX3CL1;CCL7;CCL8;CCL4;SCG2
prerank,eosinophil chemotaxis (GO:0048245),-0.24518331975177332,-0.6378195270549092,0.9282608695652174,0.9909556769258128,1.0,6/14,35.13%,CCL5;CX3CL1;CCL7;CCL8;CCL4;SCG2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.22323289253437206,0.6377430207455235,0.9335664335664335,0.9868840057178747,1.0,5/21,22.63%,JUN;MED4;MITF;TWIST1;MED12
prerank,protein acetylation (GO:0006473),-0.19905592635689537,-0.637234334832785,0.9666666666666667,0.9906520834372411,1.0,8/30,21.77%,GTF2B;SIRT1;CLOCK;KAT6A;ESCO2;FOXO1;HAT1;ING4
prerank,positive regulation of transporter activity (GO:0032411),0.2505232572925245,0.635698825619873,0.9153439153439153,0.9876505078038518,1.0,6/13,31.77%,KCTD7;STK39;WNK3;KMT2A;PDZK1;NR1H3
prerank,mitochondrial fusion (GO:0008053),-0.2212196895878123,-0.6355445965163811,0.9531914893617022,0.9909830116142648,1.0,3/18,9.61%,MIGA1;FIS1;MFF
prerank,embryonic axis specification (GO:0000578),0.24156135785045493,0.6337909945110326,0.9408396946564885,0.9882721847883499,1.0,7/15,37.24%,TASOR;PTCH1;FZD5;SMAD6;RIPPLY2;HOXD8;COBL
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.21568087493766255,-0.6331133799928764,0.9376498800959233,0.9916573343536842,1.0,2/20,7.43%,GSS;GGCT
prerank,protein oxidation (GO:0018158),0.2579217153132621,0.6311866739657078,0.9163424124513618,0.9893166926780683,1.0,1/11,4.97%,LOXL3
prerank,cellular response to interleukin-7 (GO:0098761),-0.2231727102679437,-0.6309262127770924,0.9505376344086022,0.9915591609202385,1.0,1/17,2.37%,IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2231727102679437,-0.6309262127770924,0.9505376344086022,0.9915591609202385,1.0,1/17,2.37%,IRS1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.17486363387197132,-0.6302227516965204,0.9855769230769231,0.9912741378836003,1.0,9/49,15.74%,PRKN;XRN2;RNASE3;RNASEH2C;EXOSC7;MANBA;OGA;DENND3;RNASEH2B
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.21108165647553603,-0.6301103173400181,0.9293598233995585,0.9900211340849474,1.0,6/22,23.30%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.21108165647553603,-0.6301103173400181,0.9293598233995585,0.9900211340849474,1.0,6/22,23.30%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.25935666467415414,0.6298801274517627,0.9297297297297298,0.9896031677382711,1.0,3/12,17.19%,RAB1A;CDC14B;GORASP1
prerank,aminoglycan metabolic process (GO:0006022),-0.25642833149292127,-0.6297418091081516,0.9222689075630253,0.9895687171130323,1.0,4/10,36.21%,B3GAT2;B4GALT7;CLN6;XYLT1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.2314452578082888,-0.6290699212231035,0.9264069264069265,0.9892787445280039,1.0,7/15,42.87%,RAI2;NR5A2;CELF4;RICTOR;CAMSAP3;UBR3;USP22
prerank,relaxation of muscle (GO:0090075),-0.23802444941113904,-0.6271101958453438,0.9428571428571428,0.989756912243482,1.0,2/13,11.25%,GSN;ATP1A1
prerank,protein-containing complex disassembly (GO:0032984),-0.16902642787783362,-0.6266438452627137,0.9896103896103896,0.9893700973120414,1.0,6/54,7.80%,LRP6;SNX14;STX17;GSK3B;UVRAG;AXIN1
prerank,response to estrogen (GO:0043627),0.19802787721676018,0.6265899554195271,0.9724612736660929,0.9909184265860979,1.0,10/31,30.99%,KMT2D;BRCA1;CITED4;GATA3;NCOA4;WBP2;AR;SRA1;EP300;CD24
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2700901095898999,0.6264943265581295,0.9285714285714286,0.9905001498483614,1.0,2/10,16.32%,RPUSD2;NHP2
prerank,T cell homeostasis (GO:0043029),0.26848074451500165,0.6261389395004944,0.9380692167577414,0.9902274804811518,1.0,4/10,24.34%,NCKAP1L;AKT1;PMAIP1;FADD
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.23334108228597777,-0.6253019507734399,0.9379157427937915,0.9894287699708662,1.0,8/15,32.42%,SULT2B1;NME2;BMP4;FOXC1;TRIM16;KDF1;MED1;VDR
prerank,inner ear morphogenesis (GO:0042472),0.21716172212317486,0.6250941041612662,0.9519572953736655,0.9903278212138055,1.0,7/22,24.55%,CHD7;PAX2;ZIC1;HPN;POU3F4;SOX9;FGFR2
prerank,mitotic cytokinetic process (GO:1902410),0.2236805091709998,0.624834670496501,0.956442831215971,0.9900068062292293,1.0,5/20,22.44%,KLHDC8B;CHMP1A;VPS4A;CHMP2A;PDCD6IP
prerank,regulation of sensory perception of pain (GO:0051930),0.2572108347456541,0.623543205822159,0.9116541353383458,0.9902271164488686,1.0,3/11,23.07%,CCL3;VIP;TMEM100
prerank,megakaryocyte differentiation (GO:0030219),0.257444858952035,0.6233304445631328,0.935969868173258,0.9898727405611611,1.0,2/11,14.80%,UBA5;TAL1
prerank,adenine nucleotide transport (GO:0051503),0.2304318419729633,0.6211856766294558,0.9533213644524237,0.990576631777251,1.0,5/17,20.03%,SLC25A42;LRRC8A;SLC17A9;SLC19A1;LRRC8D
prerank,protein localization to centrosome (GO:0071539),0.23060172360301806,0.6199437030487589,0.9376146788990826,0.9907501824970355,1.0,5/17,25.15%,NUDCD3;DCTN2;CSNK1D;HOOK3;CCDC14
prerank,inositol phosphate catabolic process (GO:0071545),0.2527311048020414,0.6191773329907158,0.9194991055456172,0.9906715962097095,1.0,4/12,19.57%,INPP5K;INPP1;IMPA1;IMPA2
prerank,rRNA 3'-end processing (GO:0031125),0.25803467433963956,0.6188545477987302,0.9325842696629213,0.9903633353477991,1.0,3/10,19.16%,EXOSC10;ERI3;EXOSC8
prerank,regulation of trophoblast cell migration (GO:1901163),0.23928908358669299,0.6188375304832126,0.9382940108892922,0.9899112358997428,1.0,5/14,29.04%,C1QBP;GJA1;ACVR1B;YTHDF3;CALR
prerank,organophosphate biosynthetic process (GO:0090407),0.19233339133596866,0.6184168427641704,0.9708904109589042,0.989663641161995,1.0,12/37,25.43%,GK5;MOCS2;MBOAT1;FADS1;MOCS1;LPCAT1;IP6K1;PNPO;GNPAT;TKT;MOCS3;IPPK
prerank,estrogen metabolic process (GO:0008210),-0.22936252255075196,-0.6180170239738441,0.945054945054945,0.9925248211780165,1.0,8/15,36.11%,HSD17B2;HSD17B11;HSD17B14;UGT1A7;UGT1A1;CYP19A1;HSD17B8;SULT1A1
prerank,cellular response to virus (GO:0098586),0.19744280245274604,0.6171918429910231,0.9767441860465116,0.9897935354539039,1.0,9/30,24.80%,LGALS9;MAPK14;POU2F2;IRF3;ARF1;DDX3X;ZC3H12A;CXCL10;HIF1A
prerank,homologous chromosome segregation (GO:0045143),-0.2054826660699254,-0.6169783100533895,0.9670588235294117,0.9923600852790706,1.0,8/20,37.17%,PTTG1;MEI4;IHO1;MEIKIN;SYCP1;TERB1;CENPC;SGO1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.17085299204041976,0.6167696714038797,0.9935794542536116,0.989520799346912,1.0,13/68,18.08%,CD320;SLC19A3;SLC52A3;VNN1;PANK2;SLC52A2;MMAB;SLC52A1;MTHFD1;MCCC2;SLC23A2;SLC23A1;SLC19A1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.1828337776534668,-0.6149922604453032,0.9837962962962963,0.9926727858907574,1.0,10/35,23.83%,CCT2;MAPKAPK5;AURKB;TNKS2;PRKCQ;XRCC5;MAPK1;TCP1;CTNNB1;MAPK15
prerank,intraciliary retrograde transport (GO:0035721),-0.24378068544230513,-0.6139273166646066,0.924643584521385,0.9925018032639689,1.0,2/12,8.24%,WDR35;DYNC2I2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.25226461443929016,0.6133093482110084,0.9209558823529411,0.9907674548286233,1.0,1/12,2.49%,SERINC3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.22090691073621,0.6112800772887401,0.9419014084507042,0.9912963929842046,1.0,5/18,23.67%,DDX5;MAP2K1;ZC3H12A;TP53;TGFB1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.23134469919714656,0.6104252094919057,0.9429590017825312,0.9912379663994692,1.0,4/15,22.63%,CLU;AKT1;BCL2L1;OPA1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.2433256381854956,-0.6099103165342453,0.9330357142857143,0.99372135159477,1.0,3/11,21.65%,ZRANB3;SMARCAL1;TIPIN
prerank,morphogenesis of an epithelium (GO:0002009),-0.1931386943878209,-0.6080574814844855,0.980349344978166,0.9938958157081471,1.0,8/25,26.26%,LRP6;ACTB;AHI1;LAMA5;DAG1;ACTG1;ARHGAP12;KDF1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.24705415105886913,0.6069538707145363,0.9288194444444444,0.992326457407859,1.0,2/11,12.53%,IL12B;NFKBID
prerank,negative regulation of cell division (GO:0051782),-0.24728478957943245,-0.6068450759806344,0.9396551724137931,0.9937771053485102,1.0,2/11,11.12%,AURKB;E2F7
prerank,positive regulation of hormone secretion (GO:0046887),-0.2128073251032328,-0.6043661944278965,0.9629629629629629,0.9941938836704148,1.0,3/17,11.64%,SOX11;SPP1;TFR2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.256038971115354,0.6038846699990178,0.9261261261261261,0.9932038165514414,1.0,2/10,17.28%,RYK;FZD1
prerank,vitamin D metabolic process (GO:0042359),0.24226254002134467,0.6030707817328932,0.9341864716636198,0.9930771296233234,1.0,13/13,75.79%,LGMN;CYP2R1;GC;PIAS4;CYP1A1;CYP24A1;CYP11A1;CYP27B1;VDR;FGF23;LRP2;UGT1A4;CUBN
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.19397399784505548,0.6027552645922419,0.9766187050359713,0.992775064282354,1.0,3/30,9.74%,ABCD2;HACD3;SLC27A4
prerank,ncRNA metabolic process (GO:0034660),-0.17619554121375725,-0.6014179908697815,0.9929411764705882,0.9947459175601506,1.0,11/37,29.56%,RAN;TUT4;DTD2;DROSHA;MEPCE;TDRD12;TDRD9;PIWIL2;AGO2;MOV10L1;PIWIL4
prerank,negative regulation of catalytic activity (GO:0043086),0.2016253495613939,0.6005799644694299,0.9752650176678446,0.9932456769040299,1.0,12/24,31.93%,CLN3;NOS1;PLN;TP53;CAND1;ATP5IF1;HDAC6;TMBIM1;OXA1L;IFIT1;NOTCH1;MT3
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2325983502186027,-0.598959764347027,0.9502164502164502,0.9950911093078084,1.0,4/12,23.77%,BUB1;CTCF;FEN1;CTNNB1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.20324079889461125,-0.5986048574931563,0.9773755656108597,0.9945821525824352,1.0,20/20,79.71%,AGO4;DROSHA;TERT;AGO2;ZC3H7B;TARBP2;PRKRA;MRPL44;PUM2;AGO3;ZC3H7A;DICER1;HENMT1;TRIM71;SPOUT1;PUM1;AGO1;SNIP1;TSN;TSNAX
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.20344359846706586,0.5982897997515819,0.9710144927536232,0.9937125089360042,1.0,7/22,23.69%,INCA1;CDK5RAP1;LATS2;IPO7;TFAP4;CDKN1B;IPO5
prerank,positive regulation of mRNA processing (GO:0050685),0.21030613507391288,0.597986401578344,0.9548872180451128,0.9933637715479083,1.0,5/21,22.56%,NCBP1;TRA2B;TRA2A;RBMX;DAZAP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.21646808173918852,0.5972982190996783,0.9512195121951219,0.99317000395458,1.0,7/18,29.51%,PABPN1;DDX19B;PCID2;IWS1;ZC3H11A;ENY2;POLDIP3
prerank,vascular process in circulatory system (GO:0003018),0.24062447307466533,0.5964735799040811,0.9549718574108818,0.992593215284418,1.0,3/13,17.76%,ADCY6;GCLC;ROCK2
prerank,regulation of tube diameter (GO:0035296),0.24062447307466533,0.5964735799040811,0.9549718574108818,0.992593215284418,1.0,3/13,17.76%,ADCY6;GCLC;ROCK2
prerank,early endosome to Golgi transport (GO:0034498),-0.2410453522467377,-0.5963211683560906,0.9526748971193416,0.9948459273065932,1.0,4/11,20.71%,RAB6A;LMAN1;SNX8;SNX2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.20461888493746158,0.5961115387677649,0.9550359712230215,0.9922799590769723,1.0,5/22,17.92%,MGAT5;IL10RB;IL10RA;GHR;IL7R
prerank,cardiac atrium morphogenesis (GO:0003209),0.22457490861249607,0.5960750771696721,0.9600760456273765,0.9918374057129765,1.0,5/16,26.10%,ENG;PROX1;NOG;BMP2;ISL1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.23447334558612598,-0.5956909818276171,0.9610983981693364,0.9944276808212321,1.0,4/12,22.59%,PTPN22;PAX5;BLK;CD19
prerank,protein-DNA complex disassembly (GO:0032986),-0.2177611590081116,-0.594872532973162,0.9607843137254902,0.9940839905695672,1.0,2/16,8.10%,SMARCE1;NFE2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.23624866600239391,0.594850088019974,0.9504761904761905,0.9918657488640098,1.0,5/12,26.11%,GNL3L;CCT3;CCT8;CCT7;CCT5
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.19156967230260832,0.5915860617538998,0.9774305555555556,0.9926651566221254,1.0,10/29,27.90%,PPP6R3;TNKS1BP1;TERF1;NHP2;RFC1;ACD;SHQ1;TELO2;RTEL1;RPA1
prerank,positive regulation by host of viral transcription (GO:0043923),0.22729391675534516,0.5905532142820212,0.9652509652509652,0.9925927056178129,1.0,4/15,22.36%,JUN;HPN;TFAP4;SMARCA4
prerank,electron transport chain (GO:0022900),-0.2188941362988598,-0.589783016111236,0.9656652360515021,0.9953943350000414,1.0,3/15,11.50%,SDHA;ETFRF1;CYB561
prerank,cellular response to interferon-beta (GO:0035458),0.22765485395243448,0.5890912154035031,0.9710144927536232,0.9927072097499133,1.0,6/14,26.38%,CDC34;NDUFA13;AIM2;HTRA2;ACOD1;UBE2G2
prerank,phosphate ion homeostasis (GO:0055062),0.25545717089212616,0.5885283551992976,0.9447619047619048,0.9924575105857989,1.0,2/10,20.98%,FGFR4;SFRP4
prerank,cellular response to amino acid stimulus (GO:0071230),0.18470841324443887,0.5869090465210022,0.9838129496402878,0.9925824237579923,1.0,9/33,23.69%,LAMTOR2;RPTOR;MTOR;LAMTOR5;RRAGA;CASTOR1;CPEB1;SESN1;IPO5
prerank,positive regulation of telomere maintenance (GO:0032206),-0.17797072847145923,-0.5859948447820988,0.9933774834437086,0.9961060099172957,1.0,12/31,28.36%,MAPKAPK5;AURKB;TNKS2;PRKCQ;MRE11;MAPK1;NABP2;PPP1R10;MAPK15;PML;ERCC1;GNL3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.2154586731085391,0.5853746137993555,0.9605026929982047,0.9927024729504725,1.0,1/16,1.84%,IGFBP3
prerank,pentose-phosphate shunt (GO:0006098),0.24403051985425595,0.5843685628964781,0.9541284403669725,0.9925993182962636,1.0,5/11,28.89%,RPE;SHPK;TKT;TALDO1;PGM2
prerank,embryonic heart tube development (GO:0035050),-0.22224306502011168,-0.583979037429731,0.9550321199143469,0.9961469694184274,1.0,1/14,2.52%,RYR2
prerank,acyl-CoA metabolic process (GO:0006637),-0.1734918472032827,-0.5835180553840822,0.9909502262443439,0.995642815125624,1.0,10/35,29.66%,ACOT13;ACOT11;HMGCS1;MCEE;GLYAT;ACOT12;ACSM3;ACSL6;ACSM5;BAAT
prerank,lysine catabolic process (GO:0006554),0.2351317734894694,0.5829313205941438,0.9500924214417745,0.9921993338999089,1.0,5/12,36.12%,CRYM;SLC25A21;PHYKPL;ALDH7A1;DLD
prerank,lysine metabolic process (GO:0006553),0.2351317734894694,0.5829313205941438,0.9500924214417745,0.9921993338999089,1.0,5/12,36.12%,CRYM;SLC25A21;PHYKPL;ALDH7A1;DLD
prerank,tetrapyrrole metabolic process (GO:0033013),-0.19887912426386864,-0.5787632366474574,0.9606986899563319,0.9966057312159942,1.0,9/18,38.48%,ABCD4;TCN2;ABCC1;CUBN;ABCB6;MMADHC;LMBRD1;MTRR;AMN
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.19823320810866296,0.577011150641319,0.9750889679715302,0.9937873519868688,1.0,5/25,19.78%,SORT1;LEPROT;LAPTM4B;CHMP1A;CHMP2A
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.19845034148861013,-0.5766750140667398,0.981651376146789,0.9966128904365571,1.0,4/19,19.77%,PRDX1;CYBA;MAOB;CAT
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.1804361061794317,0.575957771539701,0.9855334538878843,0.9936862572151415,1.0,11/35,27.00%,VHL;LEPROT;IL10RB;IL10RA;GHR;PIGU;HGS;ADIPOR1;PTPRC;SOCS3;CRLF3
prerank,cellular response to interleukin-4 (GO:0071353),-0.2428645290024267,-0.575702073416644,0.9607843137254902,0.9962416419092965,1.0,5/10,31.44%,TCF7;LEF1;DCSTAMP;XBP1;RUFY4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.22200842482045277,0.5742311194860766,0.953757225433526,0.9937808421710836,1.0,3/14,16.93%,EDN3;EDN2;RASL10B
prerank,melanosome localization (GO:0032400),0.19784983125869796,0.5706980248721509,0.9818181818181818,0.9944268026219256,1.0,4/21,16.70%,MLPH;SHROOM2;BBS2;RAB27A
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.23100969130569243,-0.5680208408776602,0.962882096069869,0.9979157857944267,1.0,3/10,21.08%,CCAR2;ETAA1;CRY1
prerank,serine family amino acid metabolic process (GO:0009069),0.2098348425578,0.5660767073033234,0.9669724770642202,0.9953669367087956,1.0,3/16,15.76%,SARS1;GCLC;MTHFD1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.22111132523051108,-0.5652740376438334,0.9711340206185567,0.9980698379556495,1.0,2/12,14.72%,RORB;NKD1
prerank,regulation of JUN kinase activity (GO:0043506),0.17503717284180376,0.5637413353628719,0.9927536231884058,0.9955949304941235,1.0,16/33,32.16%,MAP3K11;MAP3K10;MAPK8IP1;ARHGEF5;DVL2;PDCD4;DUSP19;FZD10;TLR9;PPEF2;DNAJA1;TRAF6;TLR6;TAOK3;DVL3;MAP3K4
prerank,DNA replication initiation (GO:0006270),0.17401321917862198,0.5627032742602912,0.9913941480206541,0.9954436042059737,1.0,12/37,29.75%,MCM2;CDC34;ORC3;MCM3;TOPBP1;RPA3;CDC7;ORC2;GMNN;MCM6;RPA1;MCM7
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.22574344679404854,0.5624858204930644,0.9482439926062847,0.9950434143895744,1.0,5/12,25.29%,LAMA3;ZDHHC7;VANGL2;CELSR1;SCRIB
prerank,negative regulation of nervous system development (GO:0051961),-0.20051082175694135,-0.5622913870244883,0.9685393258426966,0.9982720734210292,1.0,4/17,23.42%,B2M;WNT7A;ROBO2;REST
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.21633055456115824,-0.5622706609197695,0.9723404255319149,0.9976212658666814,1.0,6/12,41.07%,UPP2;CDA;CAD;UMPS;DHODH;TK2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.20870316380343068,0.561876778373091,0.9796264855687606,0.9947677993362344,1.0,6/17,26.62%,SRC;GPER1;ACOD1;TFPI;AR;URI1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.17888402677589826,-0.5603048344102366,0.9837209302325581,0.9974802572326591,1.0,6/27,17.81%,PPIA;CALM1;CDH5;CHP2;PPP1R7;CNEP1R1
prerank,positive regulation of rRNA processing (GO:2000234),0.23844410674963895,0.5602882361737325,0.9563567362428842,0.9947520682773754,1.0,1/10,4.35%,BUD23
prerank,erythrocyte development (GO:0048821),0.238508596434439,0.5594328308458424,0.9574468085106383,0.994528269698955,1.0,3/10,30.27%,NCKAP1L;DMTN;ALAS2
prerank,positive regulation of phospholipase activity (GO:0010518),-0.19028041767049847,-0.5579613652860281,0.9775280898876404,0.9974573362751187,1.0,4/22,13.88%,NTRK3;FGFR3;KIT;CCL5
prerank,nucleoside salvage (GO:0043174),0.23617816231738567,0.5560049423564009,0.9622641509433962,0.995014000203392,1.0,1/10,8.40%,UPP1
prerank,negative regulation of ATPase activity (GO:0032780),0.20861472073770299,0.5553504630994531,0.9772727272727273,0.9947327746111114,1.0,8/16,30.11%,PXK;PLN;TP53;ATP5IF1;TLR9;PAM16;OXA1L;IFIT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.20719844046409178,0.5534145830197961,0.9858906525573192,0.9947670348879069,1.0,6/16,35.65%,LEPROT;VPS36;VTA1;CHMP7;CHMP5;CHMP6
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.19442351168048227,-0.552943185527131,0.9882629107981221,0.9980793564551134,1.0,18/18,80.59%,POLR2K;LYAR;DHX33;FLNA;MAF1;UTP15;WDR43;POLR2L;RASL11A;ERBB2;BNC1;ATF4;WDR75;SIRT7;HEATR1;PHF8;EIF2AK3;UBTF
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.22220827317808045,-0.5483968007137787,0.9622222222222222,0.9984675710440625,1.0,11/11,77.80%,ITPKC;IPMK;IP6K2;PPIP5K2;IP6K3;ITPKB;ITPKA;FGF2;PPIP5K1;IPPK;IP6K1
prerank,gas transport (GO:0015669),-0.22857176458702874,-0.5467025535167926,0.9713656387665198,0.9981974391320947,1.0,4/10,31.57%,CYGB;AQP1;RHAG;NGB
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.1801673790152922,-0.5418266841735444,0.9809523809523809,0.9986100910039133,1.0,9/22,29.62%,DUSP10;CD46;IL2RA;FOXP3;SOX12;IL2;CTLA4;IRF1;TNFRSF18
prerank,pseudouridine synthesis (GO:0001522),0.2109775258007675,0.5413095540396369,0.9854545454545455,0.9971570983174213,1.0,2/13,16.32%,RPUSD2;NHP2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.20661287937088968,-0.5404702836708966,0.9835294117647059,0.9982470779110312,1.0,4/13,25.77%,CADM4;NIBAN2;TNMD;CNMD
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.21036578418671728,-0.5388210046970126,0.9888392857142857,0.9979538787140901,1.0,5/13,37.59%,SAR1B;GCC2;SEC16B;BRSK2;SORL1
prerank,peptidyl-amino acid modification (GO:0018193),-0.2226045983379626,-0.5375193269294383,0.9807280513918629,0.9975505618393241,1.0,1/10,8.85%,ATP7A
prerank,negative regulation of translational initiation (GO:0045947),-0.2027717912100795,-0.5267733842115782,0.9809976247030879,0.9989245892185485,1.0,6/13,35.10%,EIF3E;EIF2AK4;EIF4EBP1;AGO2;PAIP2B;FMR1
prerank,cardiocyte differentiation (GO:0035051),-0.22126959801805618,-0.5266993279899984,0.9832285115303984,0.9982954667063993,1.0,4/10,31.88%,SIK1;CBY1;NRG1;MYOCD
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.18080763675186837,-0.5264240253512815,0.9930875576036866,0.9976983148921368,1.0,19/19,81.95%,CCSAP;HSPA1B;CHMP1B;PLK1;DRG1;CHMP2B;VPS4B;CHMP4C;CHMP4B;HSPA1A;TPR;HNRNPU;EML3;CHMP3;CHMP5;CEP97;PDCD6IP;CHMP2A;CHMP1A
prerank,protein O-linked glycosylation via serine (GO:0018242),0.22562070815493518,0.5234957135860063,0.9776536312849162,1.0,1.0,3/10,20.61%,GALNT1;GALNT3;GALNT2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.18835938971557734,-0.5216980535708748,0.9889380530973452,0.9978653300242586,1.0,15/15,81.19%,SPAG5;STIL;CEP83;BBS4;NEDD1;CEP131;C2CD3;PCM1;SNX10;PIBF1;CEP192;CCDC14;HOOK3;CSNK1D;DCTN2
prerank,nuclear migration (GO:0007097),-0.2006113381606539,-0.5210387467762732,0.9766454352441614,0.9973047007769169,1.0,5/13,28.72%,SYNE2;CEP120;SYNE3;DYNC1H1;DOCK7
prerank,chromatin assembly or disassembly (GO:0006333),0.21486235153207095,0.5187417026237344,0.9811676082862524,1.0,1.0,4/11,23.60%,HDAC8;HIRIP3;CHAF1B;TP53
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.19666153513106183,0.5180426928235097,0.9866666666666667,1.0,1.0,4/16,19.18%,CGAS;SHLD2;FBH1;UBQLN4
prerank,methylguanosine-cap decapping (GO:0110156),0.21602381413136443,0.5101346221896509,0.9794776119402985,1.0,1.0,2/10,12.48%,DCPS;DCP1B
prerank,ketone body metabolic process (GO:1902224),0.2180561465455385,0.5096253209911406,0.9789473684210527,1.0,1.0,1/10,6.45%,OXCT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.15653223645483552,-0.5039761876805152,0.9977426636568849,0.9984930979160023,1.0,10/29,32.81%,ACOT13;ACOT11;GLYAT;ACLY;ACOT12;ACSM3;ACSL6;ACSM5;BAAT;MLYCD
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.15653223645483552,-0.5039761876805152,0.9977426636568849,0.9984930979160023,1.0,10/29,32.81%,ACOT13;ACOT11;GLYAT;ACLY;ACOT12;ACSM3;ACSL6;ACSM5;BAAT;MLYCD
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.20314898636850742,0.5018937569677833,0.9903100775193798,1.0,1.0,2/13,16.35%,SAR1A;EDEM1
prerank,polyol biosynthetic process (GO:0046173),0.18661027164595356,0.5010257967962218,0.9857904085257548,1.0,1.0,5/16,30.13%,ACER3;CYP2R1;IP6K1;IPPK;PPIP5K1
prerank,positive regulation of lipid localization (GO:1905954),0.20876368990273647,0.5008259505019628,0.9920948616600791,1.0,1.0,4/11,31.20%,LRP1;ZC3H12A;NFKB1;LPL
prerank,midbody abscission (GO:0061952),-0.18078492935635793,-0.4997984718382576,0.9955456570155902,0.9983759643707101,1.0,17/17,81.95%,KIF20A;CHMP1B;CEP55;CHMP2B;VPS4B;CHMP4C;CHMP4B;CHMP4A;MITD1;CHMP3;CHMP6;CHMP5;CHMP7;PDCD6IP;CHMP2A;VPS4A;CHMP1A
prerank,regulation of spindle assembly (GO:0090169),-0.16035883590543196,-0.49750878486515165,1.0,0.9979871354766068,1.0,8/25,28.32%,CCSAP;SPAG5;GPSM2;HSPA1B;CHMP1B;SENP6;DYNC1H1;PLK1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.21233304254837276,0.4972219839617827,0.9836660617059891,1.0,1.0,6/10,34.93%,ADAM17;AREG;BTC;HBEGF;TGFA;NCF1
prerank,sympathetic nervous system development (GO:0048485),-0.1830340087465792,-0.49676518494795874,0.9914893617021276,0.9974338217652277,1.0,1/15,4.37%,SOX11
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.2003591207865154,-0.49514578220377936,0.9811320754716981,0.9969748207471166,1.0,3/12,17.71%,HSPA5;GPAA1;RER1
prerank,pigment granule transport (GO:0051904),-0.17416892100483564,-0.4898066828391196,1.0,0.9962362637823174,1.0,4/18,18.91%,MYO5A;MREG;RAB27B;BLOC1S3
prerank,melanosome transport (GO:0032402),-0.17416892100483564,-0.4898066828391196,1.0,0.9962362637823174,1.0,4/18,18.91%,MYO5A;MREG;RAB27B;BLOC1S3
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.19792833053385017,0.4889584817130979,0.9857397504456328,1.0,1.0,4/12,26.13%,BCDIN3D;ZC3H12A;TGFB1;STAT3
prerank,regulation of multicellular organism growth (GO:0040014),0.18650731110924298,0.48465944945007644,0.9963833634719711,1.0,1.0,5/15,24.14%,BBS2;SOD1;GHR;PTCH1;STAT5B
prerank,magnesium ion transport (GO:0015693),0.1923532184802941,0.4781924883793284,0.9873188405797102,1.0,1.0,3/12,24.73%,CNNM4;NIPAL1;NIPAL3
prerank,DNA replication checkpoint signaling (GO:0000076),0.179596899619478,0.478188669851628,0.9927797833935018,1.0,1.0,3/16,22.07%,RAD17;RAD9A;TOPBP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.19400095499933973,0.4715858473428719,0.9925512104283054,1.0,1.0,1/12,6.84%,ACO2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.191857718364844,0.4710044184387199,0.9887640449438202,1.0,1.0,5/12,31.85%,SLC29A4;OAZ2;HNMT;SRM;ODC1
prerank,cobalamin metabolic process (GO:0009235),0.176541753976662,0.4646827209825467,0.9945652173913043,1.0,1.0,2/17,12.28%,CD320;MMAB
prerank,cellular response to interleukin-2 (GO:0071352),0.18929301577757407,0.45658373001362595,0.9892665474060823,0.9996518005632617,1.0,1/11,5.64%,PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.18929301577757407,0.45658373001362595,0.9892665474060823,0.9996518005632617,1.0,1/11,5.64%,PTK2B
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.15672110552763835,0.45453306320767534,1.0,0.9993174532339139,1.0,22/22,84.35%,MED4;PSMC2;MED12;TP53;PAXIP1;MED13;PSMC3;PSMC6;HNF1A;MED24;MED30;SUB1;PSMC4;MED17;ESR1;DHX36;PSMC5;MED1;MED16;MED14;HNF1B;SRF
prerank,detection of visible light (GO:0009584),0.16657286523734086,0.4457694427602528,0.9981684981684982,0.9993035734568847,1.0,3/16,30.80%,REEP6;CACNA2D4;PDE6B
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.17849779699148116,0.4457332319298901,0.9981481481481481,0.9988516616993051,1.0,3/13,18.32%,DUT;NEIL2;NTHL1
prerank,RNA interference (GO:0016246),0.1569213493309924,0.42460689503253823,1.0,0.9991681385888571,1.0,4/17,23.84%,DHX9;TSNAX;TSN;AGO1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.135435348742367,-0.38815832862079735,1.0,0.9998335820323037,1.0,1/19,5.21%,ASPA
